Authors,Title,Year,Source title,Volume,Issue,Art. No.,Page start,Page end,Page count,Cited by,DOI,Link,Affiliations,Authors with affiliations,Abstract,Author Keywords,Index Keywords,Molecular Sequence Numbers,Chemicals/CAS,Tradenames,Manufacturers,Funding Details,References,Correspondence Address,Editors,Sponsors,Publisher,Conference name,Conference date,Conference location,Conference code,ISSN,ISBN,CODEN,PubMed ID,Language of Original Document,Abbreviated Source Title,Document Type,Source,EID
"Prior, M., Chiruta, C., Currais, A., Goldberg, J., Ramsey, J., Dargusch, R., Maher, P.A., Schubert, D.","Back to the future with phenotypic screening",2014,"ACS Chemical Neuroscience","5","7",,"503","513",,4,10.1021/cn500051h,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84904415617&partnerID=40&md5=6bc59ccfd25ca71146ab58941bf8535c","Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037-1002, United States","Prior, M., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037-1002, United States; Chiruta, C., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037-1002, United States; Currais, A., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037-1002, United States; Goldberg, J., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037-1002, United States; Ramsey, J., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037-1002, United States; Dargusch, R., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037-1002, United States; Maher, P.A., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037-1002, United States; Schubert, D., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037-1002, United States","There are no disease-modifying drugs for any old age associated neurodegenerative disease or stroke. This is at least in part due to the failure of drug developers to recognize that the vast majority of neurodegenerative diseases arise from a confluence of multiple toxic insults that accumulate during normal aging and interact with genetic and environmental risk factors. Thus, it is unlikely that the current single target approach based upon rare dominant mutations or even a few preselected targets is going to yield useful drugs for these conditions. Therefore, the identification of drug candidates for neurodegeneration should be based upon their efficacy in phenotypic screening assays that reflect the biology of the aging brain, not a single, preselected target. It is argued here that this approach to drug discovery is the most likely to produce safe and effective drugs for neurodegenerative diseases. © 2014 American Chemical Society.","aging; Alzheimer's; cell culture; drug discovery; medicinal chemistry; neurodegeneration; Phenotypic screening","brain derived neurotrophic factor; curcumin; cyclic GMP; donepezil; fisetin; glucose; j 147; natural product; neurotrophic factor; polyphenol derivative; unclassified drug; neuroprotective agent; aging; article; degenerative disease; drug development; drug screening; excitotoxicity; high throughput screening; molecularly targeted therapy; nerve degeneration; nonhuman; phenotype; priority journal; animal; brain; chemistry; devices; drug effects; drug screening; human; Neurodegenerative Diseases; pathophysiology; phenotype; physiology; procedures; Aging; Animals; Brain; Drug Evaluation, Preclinical; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Phenotype",,"brain derived neurotrophic factor, 218441-99-7; curcumin, 458-37-7; cyclic GMP, 7665-99-8; donepezil, 120011-70-3, 120014-06-4, 142057-77-0; fisetin, 528-48-3; glucose, 50-99-7, 84778-64-3; Neuroprotective Agents","j 147",,"AG035055, NIH, National Institutes of Health","Pangalos, M.N., Schechter, L.E., Hurko, O., Drug development for CNS disorders: Strategies for balancing risk and reducing attrition (2007) Nature Reviews Drug Discovery, 6 (7), pp. 521-532. , DOI 10.1038/nrd2094, PII NRD2094; Zhang, H.Y., Chen, L.L., Li, X.J., Zhang, J., Evolutionary inspirations for drug discovery (2010) Trends Pharmacol. Sci., 31, pp. 443-448; Swinney, D.C., Anthony, J., How were new medicines discovered? (2011) Nat. Rev. Drug Discovery, 10, pp. 507-519; Munos, B., Lessons from 60 years of pharmaceutical innovation (2009) Nat. Rev. Drug Discovery, 8, pp. 959-968; Paul, S.M., Mytelka, D.S., Dunwiddie, C.T., Persinger, C.C., Munos, B.H., Lindborg, S.R., Schacht, A.L., How to improve R&D productivity: The pharmaceutical industry's grand challenge (2010) Nat. Rev. Drug Discovery, 9, pp. 203-214; Newman, D.J., Cragg, G.M., Snader, K.M., Natural products as sources of new drugs over the period 1981-2002 (2003) Journal of Natural Products, 66 (7), pp. 1022-1037. , DOI 10.1021/np030096l; Newman, D.J., Cragg, G.M., Natural products as sources of new drugs over the 30 years from 1981 to 2010 (2012) J. Nat. Prod., 75, pp. 311-335; Rishton, G.M., Natural products as a robust source of new drugs and drug leads: Past successes and present day issues (2008) Am. J. Cardiol., 101, pp. 43D-49D; Overington, J.P., Al-Lazikani, B., Hopkins, A.L., How many drug targets are there? (2006) Nature Reviews Drug Discovery, 5 (12), pp. 993-996. , DOI 10.1038/nrd2199, PII NRD2199; Kennedy, J.P., Williams, L., Bridges, T.M., Daniels, R.N., Weaver, D., Lindsley, C.W., Application of combinatorial chemistry science on modern drug discovery (2008) J. Comb. Chem., 10, pp. 345-354; Demehri, S., Turkoz, A., Kopan, R., Epidermal Notch1 loss promotes skin tumorigenesis by impacting the stromal microenvironment (2009) Cancer Cell, 16, pp. 55-66; Elliott, R.L., Four lessons from global health drug discovery: Medicine for an ailing industry? (2012) ACS Med. Chem. Lett., 3, pp. 688-690; Roden, D.M., Antiarrhythmic Drugs: Past, Present, and Future (2003) Journal of Cardiovascular Electrophysiology, 14 (12), pp. 1389-1396. , DOI 10.1046/j.1540-8167.2003.03441.x; Imming, P., Sinning, C., Meyer, A., Drugs, their targets and the nature and number of drug targets (2006) Nature Reviews Drug Discovery, 5 (10), pp. 821-834. , DOI 10.1038/nrd2132, PII NRD2132; Roth, B.L., Sheffer, D.J., Kroeze, W.K., Magic shotguns versus magic bullets: Selectively non-selective drugs for mood disorders and schizophrenia (2004) Nature Reviews Drug Discovery, 3 (4), pp. 353-359; Ganesan, A., The impact of natural products upon modern drug discovery (2008) Curr. Opin. Chem. Biol., 12, pp. 306-317; Nurnberger, T., Brunner, F., Kemmerling, B., Piater, L., Innate immunity in plants and animals: Striking similarities and obvious differences (2004) Immunological Reviews, 198, pp. 249-266. , DOI 10.1111/j.0105-2896.2004.0119.x; Pfizer Material Safety Data Sheet Version 4.0 for Donepezil Hydrochloride Film Coated Tablets, , www.pfizer.com/files/products/material_safety_data/PZ01067.pdf, Pfizer; Prior, M., Dargusch, R., Ehren, J.L., Chiruta, C., Schubert, D., The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease mice (2013) Alzheimer's Res. Ther., 5, p. 25; Harmer, N.J., Insights into the role of heparan sulphate in fibroblast growth factor signalling (2006) Biochemical Society Transactions, 34 (3), pp. 442-445. , DOI 10.1042/BST0340442; Chen, Q., Prior, M., Dargusch, R., Roberts, A., Riek, R., Eichmann, C., Chiruta, C., Schubert, D., A novel neurotrophic drug for cognitive enhancement and Alzheimer's disease (2011) PLoS One, 6, p. 27865; Chiruta, C., Schubert, D., Dargusch, R., Maher, P., Chemical modification of the multitarget neuroprotective compound fisetin (2012) J. Med. Chem., 55, pp. 378-389; Halliwell, B., Free radicals and antioxidants - Quo vadis? (2011) Trends Pharmacol. Sci., 32, pp. 125-130; Scalbert, A., Johnson, I.T., Saltmarsh, M., Polyphenols: Antioxidants and beyond (2005) Am. J. Clin. Nutr., 81, pp. 215S-217S; Correia-Da-Silva, M., Sousa, E., Pinto, M.M., Emerging sulfated flavonoids and other polyphenols as drugs: Nature as an inspiration (2014) Med. Res. Rev., 34, pp. 223-279; Garcia-Alloza, M., Borrelli, L.A., Rozkalne, A., Hyman, B.T., Bacskai, B.J., Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model (2007) Journal of Neurochemistry, 102 (4), pp. 1095-1104. , DOI 10.1111/j.1471-4159.2007.04613.x; Toledo, J.B., Arnold, S.E., Raible, K., Brettschneider, J., Xie, S.X., Grossman, M., Monsell, S.E., Trojanowski, J.Q., Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre (2013) Brain, 136, pp. 2697-2706; Yang, D.P., Ji, H.F., Tang, G.Y., Ren, W., Zhang, H.Y., How many drugs are catecholics (2007) Molecules, 12, pp. 878-884; Ashe, K.H., Synaptic structure and function in transgenic APP mice (2000) Annals of the New York Academy of Sciences, 924, pp. 39-41; Liu, Y., Dargusch, R., Maher, P., Schubert, D., A broadly neuroprotective derivative of curcumin (2008) Journal of Neurochemistry, 105 (4), pp. 1336-1345. , DOI 10.1111/j.1471-4159.2008.05236.x; Ishige, K., Schubert, D., Sagara, Y., Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms (2001) Free Radical Biology and Medicine, 30 (4), pp. 433-446. , DOI 10.1016/S0891-5849(00)00498-6, PII S0891584900004986; Maher, P., Salgado, K.F., Zivin, J.A., Lapchak, P.A., A novel approach to screening for new neuroprotective compounds for the treatment of stroke (2007) Brain Research, 1173 (1), pp. 117-125. , DOI 10.1016/j.brainres.2007.07.061, PII S0006899307018094; Dargusch, R., Schubert, D., Specificity of resistance to oxidative stress (2002) Journal of Neurochemistry, 81 (6), pp. 1394-1400. , DOI 10.1046/j.1471-4159.2002.00950.x; Valera, E., Dargusch, R., Maher, P.A., Schubert, D.R., Modulation of 5-lipoxygenase in proteotoxicity and Alzheimer's disease (2013) J. Neurosci., 33, pp. 10512-10525; Murphy, T.H., Miyamoto, M., Sastre, A., Schnaar, R.L., Coyle, J.T., Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress (1989) Neuron, 2, pp. 1547-1558; Tan, S., Schubert, D., Maher, P., Oxytosis: A novel form of programmed cell death (2001) Curr. Top. Med. Chem., 1, pp. 497-506; Davis, J.B., Maher, P., Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line (1994) Brain Research, 652 (1), pp. 169-173. , DOI 10.1016/0006-8993(94)90334-4; Lewerenz, J., Baxter, P., Kassubek, R., Albrecht, P., Liefferinge, J.V., Westhoff, M.A., Halatsch, M.E., Maher, P., Phosphoinositide 3-Kinases Upregulate System xc - via Eukaryotic Initiation Factor 2α and Activating Transcription Factor 4 - A Pathway Active in Glioblastomas and Epilepsy (2014) Antioxid. Redox Signaling, 20, pp. 2907-2922; Choi, D.W., Glutamate neurotoxicity and diseases of the nervous system (1988) Neuron, 1, pp. 623-634; Currais, A., Maher, P., Functional consequences of age-dependent changes in glutathione status in the brain (2013) Antioxid. Redox Signaling, 19, pp. 813-822; Maher, P., Modulation of multiple pathways involved in the maintenance of neuronal function during aging by fisetin (2009) Genes Nutr., 4, pp. 297-307; Ray, W.J., Yao, M., Nowotny, P., Mumm, J., Zhang, W., Wu, J.Y., Kopan, R., Goate, A.M., Evidence for a physical interaction between presenilin and Notch (1999) Proceedings of the National Academy of Sciences of the United States of America, 96 (6), pp. 3263-3268. , DOI 10.1073/pnas.96.6.3263; Allen, S.J., Watson, J.J., Shoemark, D.K., Barua, N.U., Patel, N.K., GDNF, NGF and BDNF as therapeutic options for neurodegeneration (2013) Pharmacol. Ther., 138, pp. 155-175; Olanow, C.W., Parkinson disease: Gene therapy for Parkinson disease - A hope, or a dream? (2014) Nat. Rev. Neurol., 10, pp. 186-187; Tuszynski, M.H., Thal, L., Pay, M., Salmon, D.P., Sang U, H., Bakay, R., Patel, P., Conner, J., A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease (2005) Nature Medicine, 11 (5), pp. 551-555. , DOI 10.1038/nm1239; Nelson, N., (2008) Monkeys in the Middle: How One Drug Company Kept A Parkinson's Disease Breakthrough out of Reach, p. 272. , p, BookSurge Publishing, North Charleston, SC; Abe, K., Takayanagi, M., Saito, H., Effects of recombinant human basic fibroblast growth factor and its modified protein CS23 on survival of primary cultured neurons from various regions of fetal rat brain (1990) Japanese Journal of Pharmacology, 53 (2), pp. 221-227; Chen, J., Zacharek, A., Zhang, C., Jiang, H., Li, Y., Roberts, C., Lu, M., Chopp, M., Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice (2005) Journal of Neuroscience, 25 (9), pp. 2366-2375. , DOI 10.1523/JNEUROSCI.5071-04.2005; Olin, D., MacMurray, J., Comings, D.E., Risk of late-onset Alzheimer's Disease associated with BDNF C270T polymorphism (2005) Neuroscience Letters, 381 (3), pp. 275-278. , DOI 10.1016/j.neulet.2005.02.017, PII S0304394005001941; Tapia-Arancibia, L., Aliaga, E., Silhol, M., Arancibia, S., New insights into brain BDNF function in normal aging and Alzheimer disease (2008) Brain Res. Rev., 59, pp. 201-220; Pezet, S., Malcangio, M., Brain-derived neurotrophic factor as a drug target for CNS disorders (2004) Expert Opinion on Therapeutic Targets, 8 (5), pp. 391-399. , DOI 10.1517/14728222.8.5.391; Massa, S.M., Yang, T., Xie, Y., Shi, J., Bilgen, M., Joyce, J.N., Nehama, D., Longo, F.M., Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents (2010) J. Clin. Invest., 120, pp. 1774-1785; Wong, J., Higgins, M., Halliday, G., Garner, B., Amyloid beta selectively modulates neuronal TrkB alternative transcript expression with implications for Alzheimer's disease (2012) Neuroscience, 210, pp. 363-374; Rossler, O.G., Giehl, K.M., Thiel, G., Neuroprotection of immortalized hippocampal neurones by brain-derived neurotrophic factor and Raf-1 protein kinase: Role of extracellular signal-regulated protein kinase and phosphatidylinositol 3-kinase (2004) Journal of Neurochemistry, 88 (5), pp. 1240-1252. , DOI 10.1046/j.1471-4159.2003.02255.x; Warren, R.E., Frier, B.M., Hypoglycaemia and cognitive function (2005) Diabetes, Obesity and Metabolism, 7 (5), pp. 493-503. , DOI 10.1111/j.1463-1326.2004.00421.x; Winkler, B.S., Sauer, M.W., Starnes, C.A., Modulation of the Pasteur effect in retinal cells: Implications for understanding compensatory metabolic mechanisms (2003) Experimental Eye Research, 76 (6), pp. 715-723. , DOI 10.1016/S0014-4835(03)00052-6; Rego, A.C., Areias, F.M., Santos, M.S., De Oliveira, C.I.R., Distinct glycolysis inhibitors determine retinal cell sensitivity to glutamate-mediated injury (1999) Neurochemical Research, 24 (3), pp. 351-358. , DOI 10.1023/A:1020977331372; Reiner, P.B., Laycock, A.G., Doll, C.J., A pharmacological model of ischemia in the hippocampal slice (1990) Neuroscience Letters, 119 (2), pp. 175-178. , DOI 10.1016/0304-3940(90)90827-V; Reshef, A., Sperling, O., Zoref-Shani, E., Activation and inhibition of protein kinase C protect rat neuronal cultures against ischemia-reperfusion insult (1997) Neuroscience Letters, 238 (1-2), pp. 37-40. , DOI 10.1016/S0304-3940(97)00841-0, PII S0304394097008410; Sigalov, E., Fridkin, M., Brenneman, D.E., Gozes, I., VIP-related protection against iodoacetate toxicity in pheochromocytoma (PC12) cells: A model for ischemic/hypoxic injury (2000) Journal of Molecular Neuroscience, 15 (3), pp. 147-154. , DOI 10.1385/JMN:15:3:147; Sperling, O., Bromberg, Y., Oelsner, H., Zoref-Shani, E., Reactive oxygen species play an important role in iodoacetate-induced neurotoxicity in primary rat neuronal cultures and in differentiated PC12 cells (2003) Neuroscience Letters, 351 (3), pp. 137-140. , DOI 10.1016/S0304-3940(03)00858-9; Laferla, F.M., Green, K.N., Oddo, S., Intracellular amyloid-beta in Alzheimer's disease (2007) Nat. Rev. Neurosci., 8, pp. 499-509; Chui, D.-H., Tanahashi, H., Ozawa, K., Ikeda, S., Checler, F., Ueda, O., Suzuki, H., Tabira, T., Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation (1999) Nature Medicine, 5 (5), pp. 560-564. , DOI 10.1038/8438; Billings, L.M., Oddo, S., Green, K.N., McGaugh, J.L., LaFerla, F.M., Intraneuronal Aβ causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice (2005) Neuron, 45 (5), pp. 675-688. , DOI 10.1016/j.neuron.2005.01.040; Oakley, H., Cole, S.L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Vassar, R., Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: Potential factors in amyloid plaque formation (2006) Journal of Neuroscience, 26 (40), pp. 10129-10140. , http://www.jneurosci.org/cgi/reprint/26/40/10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Tampellini, D., Capetillo-Zarate, E., Dumont, M., Huang, Z., Yu, F., Lin, M.T., Gouras, G.K., Effects of synaptic modulation on beta-amyloid, synaptophysin, and memory performance in Alzheimer's disease transgenic mice (2010) J. Neurosci., 30, pp. 14299-14304; Wirths, O., Multhaup, G., Czech, C., Blanchard, V., Moussaoui, S., Tremp, G., Pradier, L., Bayer, T.A., Intraneuronal Aβ accumulation precedes plaque formation in β-amyloid precursor protein and presenilin-1 double-transgenic mice (2001) Neuroscience Letters, 306 (1-2), pp. 116-120. , DOI 10.1016/S0304-3940(01)01876-6, PII S0304394001018766; Oddo, S., Caccamo, A., Tran, L., Lambert, M.P., Glabe, C.G., Klein, W.L., Laferla, F.M., Temporal profile of amyloid-beta (Aβ) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology (2006) J. Biol. Chem., 281, pp. 1599-1604; Himeno, E., Ohyagi, Y., Ma, L., Nakamura, N., Miyoshi, K., Sakae, N., Motomura, K., Kira, J., Apomorphine treatment in Alzheimer mice promoting amyloid-beta degradation (2011) Ann. Neurol., 69, pp. 248-256; Sopher, B.L., Fukuchi, K.-I., Smith, A.C., Leppiga, K.A., Furlong, C.E., Martin, G.M., Cytotoxicity mediated by conditional expression of a carboxyl-terminal derivative of the β-amyloid precursor protein (1994) Molecular Brain Research, 26 (1-2), pp. 207-217. , DOI 10.1016/0169-328X(94)90092-2; Maezawa, I., Hong, H.-S., Wu, H.-C., Battina, S.K., Rana, S., Iwamoto, T., Radke, G.A., Jin, L.-W., A novel tricyclic pyrone compound ameliorates cell death associated with intracellular amyloid-β oligomeric complexes (2006) Journal of Neurochemistry, 98 (1), pp. 57-67. , DOI 10.1111/j.1471-4159.2006.03862.x; Hong, H.-S., Maezawa, I., Yao, N., Xu, B., Diaz-Avalos, R., Rana, S., Hua, D.H., Jin, L.-W., Combining the rapid MTT formazan exocytosis assay and the MC65 protection assay led to the discovery of carbazole analogs as small molecule inhibitors of Aβ oligomer-induced cytotoxicity (2007) Brain Research, 1130 (1), pp. 223-234. , DOI 10.1016/j.brainres.2006.10.093, PII S0006899306032124; Yankner, B.A., Duffy, L.K., Kirschner, D.A., Neurotrophic and neurotoxic effects of amyloid beta protein: Reversal by tachykinin neuropeptides (1990) Science, 250, pp. 279-282; Klein, W.L., Synaptotoxic amyloid-beta oligomers: A molecular basis for the cause, diagnosis, and treatment of Alzheimer's disease? (2013) J. Alzheimer's Dis., 33 (SUPPL. 1), pp. 49-65; Behl, C., Davis, J., Cole, G.M., Schubert, D., Vitamin e protects nerve cells from amyloid beta protein toxicity (1992) Biochem. Biophys. Res. Commun., 186, pp. 944-950; Behl, C., Davis, J.B., Lesley, R., Schubert, D., Hydrogen peroxide mediates amyloid β protein toxicity (1994) Cell, 77 (6), pp. 817-827. , DOI 10.1016/0092-8674(94)90131-7; Liu, Y., Peterson, D.A., Kimura, H., Schubert, D., Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) reduction (1997) Journal of Neurochemistry, 69 (2), pp. 581-593; Liu, Y., Schubert, D., Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2- yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis (1997) Journal of Neurochemistry, 69 (6), pp. 2285-2293; Cole, G.M., Teter, B., Frautschy, S.A., Neuroprotective effects of curcumin (2007) Adv. Exp. Med. Biol., 595, pp. 197-212; Chiruta, C., Zhao, Y., Tang, F., Wang, T., Schubert, D., Metabolism of a potent neuroprotective hydrazone (2013) Bioorg. Med. Chem., 21, pp. 2733-2741; Pajouhesh, H., Lenz, G.R., Medicinal chemical properties of successful central nervous system drugs (2005) NeuroRx, 2 (4), pp. 541-553. , DOI 10.1602/neurorx.2.4.541; Maher, P., Akaishi, T., Schubert, D., Abe, K., A pyrazole derivative of curcumin enhances memory (2010) Neurobiol. Aging, 31, pp. 706-709; Lapchak, P.A., Schubert, D.R., Maher, P.A., Delayed treatment with a novel neurotrophic compound reduces behavioral deficits in rabbit ischemic stroke (2011) J. Neurochem., 116, pp. 122-131; Wu, A., Ying, Z., Schubert, D., Gomez-Pinilla, F., Brain and spinal cord interaction: A dietary curcumin derivative counteracts locomotor and cognitive deficits after brain trauma (2011) Neurorehabil. Neural Repair, 25, pp. 332-342; Sharma, S., Ying, Z., Gomez-Pinilla, F., A pyrazole curcumin derivative restores membrane homeostasis disrupted after brain trauma (2010) Exp. Neurol., 226, pp. 191-199; Sharma, S., Wu, A., Ying, L., Schubert, D., Gomez-Pinilla, F., Dietary curcumin derivative promotes membrane repair after brain trauma (2009) Neuroscience 2009 (Society for Neuroscience), , Abstact No. 2009-S-10843-SfN; Narumoto, O., Matsuo, Y., Sakaguchi, M., Shoji, S., Yamashita, N., Schubert, D., Abe, K., Yamashita, N., Suppressive effects of a pyrazole derivative of curcumin on airway inflammation and remodeling (2012) Exp. Mol. Pathol., 93, pp. 18-25; Maher, P., Akaishi, T., Abe, K., Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory (2006) Proceedings of the National Academy of Sciences of the United States of America, 103 (44), pp. 16568-16573. , DOI 10.1073/pnas.0607822103; Gelderblom, M., Leypoldt, F., Lewerenz, J., Birkenmayer, G., Orozco, D., Ludewig, P., Thundyil, J., Magnus, T., The flavonoid fisetin attenuates post-ischemic immune cell infiltration, activation and infarct size after transient cerebral middle artery occlusion in mice (2012) J. Cereb. Blood Flow Metab., 32, pp. 835-843; Maher, P., Dargusch, R., Bodai, R., Gerard, P., Purcell, J., Marsh, J.L., ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease (2011) Hum. Mol. Genet., 20, pp. 261-270; Maher, P., Dargusch, R., Ehren, J.L., Okada, S., Sharma, K., Schubert, D., Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetes (2011) PLoS One, 6, p. 21226; Currais, A., Prior, M., Dargusch, R., Armando, A., Ehren, J., Schubert, D., Quehenberger, O., Maher, P., Modulation of p25 and Inflammatory Pathways by Fisetin Maintains Cognitive Function in Alzheimer's Disease Transgenic Mice (2014) Aging Cell, pp. 379-390; Currais, A., Chiruta, C., Goujon-Svrzic, M., Costa, G., Santos, T., Batista, M.T., Paiva, J., Maher, P., Screening and identification of neuroprotective compounds relevant to Alzheimer's disease from medicinal plants of S. Tomé e Principe (2014) J. Ethnopharmacol., , in press","Prior, M.; Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037-1002, United States; email: mprior@salk.edu",,,"American Chemical Society",,,,,19487193,,ACNCD,24902068,"English","ACS Chem. Neurosci.",Article,Scopus,2-s2.0-84904415617
"Currais, A., Prior, M., Dargusch, R., Armando, A., Ehren, J., Schubert, D., Quehenberger, O., Maher, P.","Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer's disease transgenic mice",2014,"Aging Cell","13","2",,"379","390",,15,10.1111/acel.12185,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84895780810&partnerID=40&md5=c40565716eda07a0b9f8c01351f40e72","Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, La Jolla, CA, 92037, United States; Depatment of Medicine, University of California, 9500 Gilman Drive #0601, La Jolla, San Diego, CA, 92093-0601, United States","Currais, A., Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, La Jolla, CA, 92037, United States; Prior, M., Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, La Jolla, CA, 92037, United States; Dargusch, R., Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, La Jolla, CA, 92037, United States; Armando, A., Depatment of Medicine, University of California, 9500 Gilman Drive #0601, La Jolla, San Diego, CA, 92093-0601, United States; Ehren, J., Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, La Jolla, CA, 92037, United States; Schubert, D., Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, La Jolla, CA, 92037, United States; Quehenberger, O., Depatment of Medicine, University of California, 9500 Gilman Drive #0601, La Jolla, San Diego, CA, 92093-0601, United States; Maher, P., Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, La Jolla, CA, 92037, United States","Summary: Alzheimer's disease (AD) is the most common type of dementia. It is the only one of the top ten causes of death in the USA for which prevention strategies have not been developed. Although AD has traditionally been associated with the deposition of amyloid β plaques and tau tangles, it is becoming increasingly clear that it involves disruptions in multiple cellular systems. Therefore, it is unlikely that hitting a single target will result in significant benefits to patients with AD. An alternative approach is to identify molecules that have multiple biological activities that are relevant to the disease. Fisetin is a small, orally active molecule which can act on many of the target pathways implicated in AD. We show here that oral administration of fisetin to APPswe/PS1dE9 double transgenic AD mice from 3 to 12 months of age prevents the development of learning and memory deficits. This correlates with an increase in ERK phosphorylation along with a decrease in protein carbonylation, a marker of oxidative stress. Importantly, fisetin also reduces the levels of the cyclin-dependent kinase 5 (Cdk5) activator p35 cleavage product, p25, in both control and AD brains. Elevated levels of p25 relative to p35 cause dysregulation of Cdk5 activity leading to neuroinflammation and neurodegeneration. These fisetin-dependent changes correlate with additional anti-inflammatory effects, including alterations in global eicosanoid synthesis, and the maintenance of markers of synaptic function in the AD mice. Together, these results suggest that fisetin may provide a new approach to the treatment of AD. © 2013 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.","Astrogliosis; Eicosanoid; ERK; Lipoxygenase; Oxidative stress; prostaglandin","biological marker; cyclin dependent kinase 5; fisetin; icosanoid; mitogen activated protein kinase; protein p25; protein p35; Alzheimer disease; amnesia; animal behavior; animal cell; animal experiment; animal model; animal tissue; antiinflammatory activity; article; brain dysfunction; cognition; controlled study; enzyme activity; enzyme phosphorylation; infant; inflammatory pathway; male; Morris water maze test; mouse; nerve degeneration; nervous system inflammation; neuromodulation; nonhuman; oxidative stress; priority journal; protein carbonylation; protein cleavage; signal transduction; spatial learning; spatial memory; transgenic mouse; wild type; Mus; Mus musculus; astrogliosis; eicosanoid; ERK; lipoxygenase; oxidative stress; prostaglandin; Alzheimer Disease; Animals; Arachidonic Acid; Astrocytes; Biological Markers; Cognition; Docosahexaenoic Acids; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Hippocampus; Humans; Inflammation; Memory; Mice; Mice, Transgenic; Models, Biological; Nerve Tissue Proteins; Oxidative Stress; Protein Carbonylation; Signal Transduction; Toll-Like Receptors",,"fisetin, 528-48-3; mitogen activated protein kinase, 142243-02-5",,,,"Beking, K., Vieira, A., Flavonoid intake and disability-adjuested life years due to Alzheimer's and related dementias: a population-based study involving twenty-three developed countries (2010) Public Health Nutr., 13, pp. 1403-1409; Benoit, M.E., Hernandez, M.X., Dinh, M.L., Benavente, F., Vasquez, O., Tenner, A.J., C1q-induced LRP1B and GPR6 proteins expressed early in Alzheimer's disease mouse models, are essential for the C1q-mediated protection against amyloid-β neurotoxicity (2013) J. Biol. Chem., 288, pp. 654-665; Buczynski, M.W., Dumlao, D.S., Dennis, E.A., An integrated omics analysis of eicosanoid biology (2009) J. Lipid Res., 50, pp. 1015-1038; Butchart, J., Holmes, C., Systemic and central immunity in Alzheimer's disease: therapeutic implications (2012) CNS Neurosci. Ther., 18, pp. 64-76; Chen, Q., Prior, M., Dargusch, R., Roberts, A., Riek, R., Eichmann, C., Chiruta, C., Schubert, D., A novel neurotrophic drug for cognitive enhancement and Alzheimer's disease (2011) PLoS One, 6, pp. e27865; Choi, Y.H., Lee, S.N., Aoyagi, H., Yamasaki, Y., Yoo, J.Y., Park, B., Shin, D.M., Yoon, J.H., The extracellular signal-regulated kinase mitogen-activated protein kinase/ribosomal S6 protein kinase 1 cascade phosphorylates cAMP response element-binding protein to induce MUC5B gene expression via D-prostanoid receptor signaling (2011) J. Biol. Chem., 286, pp. 34199-34214; Cortes-Canteli, M., Paul, J., Norris, E.H., Bronstein, R., Ahn, H.J., Zamolodchikov, D., Bhuvanendran, S., Strickland, S., Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease (2010) Neuron, 66, pp. 695-709; Cruz, J.C., Tsai, L.-H., Cdk5 deregulation in the pathogenesis of Alzheimer's disease (2004) Trends Mol. Med., 10, pp. 452-458; Desbarats, J., Birge, R.B., Mimouni-Rongy, M., Weinstein, D.E., Palerme, J.-S., Newell, M.K., Fas engagement induces neurite growth through ERK activation and p35 upregulation (2003) Nat. Cell Biol., 5, pp. 118-125; Frautschy, S.A., Cole, G.M., Why pleiotropic interventions are needed for Alzheimer's disease (2010) Mol. Neurobiol., 41, pp. 392-409; Gelderblom, M., Leypoldt, F., Lewerenz, J., Birkenmayer, G., Orozco, D., Ludewig, P., Thundyil, J., Magnus, T., The flavonoid fisetin attenuates postischemic immune cell infiltration, activation and infarct size after transient cerebral middle artery occlusion in mice (2012) J. Cereb. Blood Flow Metab., 32, pp. 835-843; Giovannini, M.G., Cerbai, F., Bellucci, A., Melani, C., Grossi, C., Bartolozzi, C., Nosi, D., Casamenti, F., Differential activation of mitogen-activated protein kinase signalling pathways in the hippocampus of CRND8 transgenic mouse, a model of Alzheimer's disease (2008) Neuroscience, 153, pp. 618-633; Giunta, B., Rezai-Zadeh, K., Tan, J., Impact of the CD40-CD40L dyad in Alzheimer's disease (2010) CNS Neurol. Disord. Drug Targets, 9, pp. 149-155; Golde, T.E., Schneider, L.S., Koo, E.H., Anti-Abeta therapeutics in Alzheimer's disease: the need for a paradigm shift (2011) Neuron, 69, pp. 203-213; Gulinello, M., Gertner, M., Mendoza, G., Schoenfeld, B.P., Oddo, S., LaFerla, F.M., Choi, C.H., Faber, D.S., Validation of a 2-day water maze protocol in mice (2009) Behav. Brain Res., 196, pp. 220-227; Hardwick, J.P., Eckman, K., Lee, Y.K., Abdelmegeed, M.A., Esterle, A., Chilian, W.M., Chiang, J.Y., Song, B.J., Eicosanoids in metabolic syndrome (2013) Adv. Pharmacol., 66, pp. 157-266; Herrup, K., Reimagining Alzheimer's disease - an age-based hypothesis (2010) J. Neurosci., 30, pp. 16755-16762; Ishige, K., Schubert, D., Sagara, Y., Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms (2001) Free Radic. Biol. Med., 30, pp. 433-446; Jankowsky, J.L., Slunt, H.H., Ratovitski, T., Jenkins, N.A., Copeland, N.G., Borshelt, D.R., Co-Expression of multiple transgenes in mouse CNS: comparison of strategies (2001) Biomol. Eng., 17, pp. 157-165; Jankowsky, J.L., Melnikova, T., Fadale, D.J., Xu, G.M., Slunt, H.H., Gonzales, V., Younkin, L.H., Savonenko, A.V., Environmental enrichment mitigates cognitive defects in a mouse model of Alzheimer's disease (2005) J. Neurosci., 25, pp. 5217-5224; Kesse-Guyot, E., Fezeu, L., Andreeva, V.A., Touvier, M., Scalbert, A., Herchberg, S., Galan, P., Total and specific polyphenol intakes in midlife are associated with cognitive function measured 13 years later (2011) J. Nutr., 142, pp. 76-83; Kim, H., Park, B.-S., Lee, K.-G., Choi, C.Y., Jang, S.S., Kim, Y.-H., Lee, S.-E., Effects of naturally occurring compounds on fibril formation and oxidative stress of β-amyloid (2005) J. Agric. Food Chem., 53, pp. 8537-8541; Landreth, G.E., Reed-Geaghan, E.G., Toll-like receptors in Alzheimer's disease (2009) Curr. Top. Microbiol. Immunol., 336, pp. 137-153; Lopes, J.P., Oliveira, C.R., Agostinho, P., Neurodegeneration in an Aβ-induced model of Alzheimer's disease: the role of Cdk5 (2010) Aging Cell, 9, pp. 64-77; Maher, P., Modulation of multiple pathways involved in the maintenance of neuronal function during aging by fisetin (2009) Genes Nutr., 4, pp. 297-307; Maher, P., Akaishi, T., Abe, K., Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory (2006) Proc. Natl Acad. Sci. USA, 103, pp. 16568-16573; Maher, P., Dargusch, R., Bodai, L., Gerard, P., Purcell, J.M., Marsh, J.L., ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease (2011) Hum. Mol. Gen., 20, pp. 261-270; Maron, D.M., Ames, B.N., Revised method for the Salmonella mutagenicity test (1983) Mutat. Res., 113, pp. 173-215; Mohri, I., Kadoyama, K., Kanekiyo, T., Sato, Y., Kagitani-Shimono, K., Saito, Y., Suzuki, K., Taniike, M., Hematopoietic prostaglandin D synthase and DP1 receptor are selectively upregulated in microglia and astrocytes within senile plaques from human patients and in a mouse model of Alzheimer disease (2007) J. Neuropathol. Exp. Neurol., 66, pp. 469-480; Muyllaert, D., Terwel, D., Kremer, A., Sennvik, K., Borghgraef, P., Devijver, H., Dewachter, I., Van Leuven, F., Neurodegeneration and neuroinflammation in cdk5/p25-inducible mice (2008) Am. J. Pathol., 172, pp. 470-485; Pugh, P.L., Richardson, J.C., Bate, S.T., Upton, N., Sunter, D., Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease (2007) Behav. Brain Res., 178, pp. 18-28; Quehenberger, O., Dennis, E.A., The human plasma lipidome (2011) N. Engl. J. Med., 365, pp. 1812-1823; Quehenberger, O., Yamashita, T., Armando, A.M., Dennis, E.A., Palinski, W., Effect of gestational hypercholesterolemia and maternal immunization on offspring plasma eicosanoids (2011) Am. J. Obstet. Gynecol., 205, pp. e15-e25; Rackoff, J., Yang, Q., DePetrillo, P.B., Inhibition of rat PC12 cell calpain activity by glutathione, oxidized glutathione and nitric oxide (2001) Neurosci. Lett., 311, pp. 129-132; Rao, J.S., Rapoport, S.I., Kim, H.-W., Altered neuroinflammatory, arachidonic acid cascade and synaptic markers in postmortem Alzheimer's disease brain (2011) Transl. Psychiatry, 1, pp. e31; Reynaud, D., Thickitt, C.P., Pace-Asciak, C.R., Facile preparation and structural determination of monohydroxy derivatives of docosahexaenoic acid (HDoHE) by alpha-tocopherol-directed autoxidation (1993) Anal. Biochem., 214, pp. 165-170; Sadleir, K.R., Vassar, R., Cdk5 protein inhibition and Aβ42 increase BACE1 protein level in primary neurons by a post-transcriptional mechanism (2012) J. Biol. Chem., 287, pp. 7224-7235; Sagara, Y., Vahnnasy, J., Maher, P., Induction of PC12 cell differentiation by flavonoids is dependent upon extracellular signal-regulated kinase activation (2004) J. Neurochem., 90, pp. 1144-1155; Scher, J.U., Pillinger, M.H., The anti-inflammatory effects of prostaglandins (2009) J. Investig. Med., 57, pp. 703-708; Schubert, D., Maher, P., An alternative approach to drug discovery for Alzheimer's disease dementia (2012) Future Med. Chem., 4, pp. 1681-1688; Sonnen, J.A., Breitner, J.C., Lovell, M.A., Markesbery, W.R., Quinn, J.F., Montine, T.J., Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models (2008) Free Radic. Biol. Med., 45, pp. 219-230; Steele, M.L., Robinson, S.R., Reactive astrocytes give neurons less support: implications for Alzheimer's disease (2012) Neurobiol. Aging, 33, p. 423. , e421-413; Sundaram, J.R., Chan, E.S., Poore, C.P., Pareek, T.K., Cheong, W.F., Shui, G., Tang, N., Kesavapany, S., Cdk5/p25-induced cytosolic PLA2-mediated lysophosphatidylcholine production regulates neuroinflammation and triggers neurodegeneration (2012) J. Neurosci., 32, pp. 1020-1034; Sweatt, J.D., Mitogen-activated protein kinases in synaptic plasticity and memory (2004) Curr. Opin. Neurobiol., 14, pp. 311-317; Vorhees, C.V., Williams, M.T., Morris water maze: procedures for assessing spatial and related forms of learning and memory (2006) Nat. Protoc., 1, pp. 848-858; Walf, A.A., Frye, C.A., The use of the elevated plus maze as an assay of anxiety-related behavior in rodents (2007) Nat. Protoc., 2, pp. 311-328; Wirths, O., Breyhan, H., Marcello, A., Cotel, M.-C., Bruck, W., Bayer, T.A., Inflammatory changes are tightly associated with neurodegeneration in the brain and spinal cord of the APP/PS1KI mouse model of Alzheimer's disease (2010) Neurobiol. Aging, 31, pp. 747-757; Yoon, H.J., Jeon, S.B., Kim, I.H., Park, E.J., Regulation of TLR2 expression by prostaglandins in brain glia (2008) J. Immunol., 180, pp. 8400-8409","Maher, P.; Salk Institute for Biological Studies, 10010 N. Torrey Pine Road, La Jolla, CA 92037, United States; email: pmaher@salk.edu",,,"Blackwell Publishing Ltd",,,,,14749718,,ACGEC,24341874,"English","Aging Cell",Article,Scopus,2-s2.0-84895780810
"Valera, E., Dargusch, R., Maher, P.A., Schubert, D.","Modulation of 5-lipoxygenase in proteotoxicity and Alzheimer's disease",2013,"Journal of Neuroscience","33","25",,"10512","10525",,8,10.1523/JNEUROSCI.5183-12.2013,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84879128268&partnerID=40&md5=b63c229eef1bbb2e1f6a1c0c262d2444","The Salk Institute for Biological Studies, La Jolla, CA 92037-1002, United States","Valera, E., The Salk Institute for Biological Studies, La Jolla, CA 92037-1002, United States; Dargusch, R., The Salk Institute for Biological Studies, La Jolla, CA 92037-1002, United States; Maher, P.A., The Salk Institute for Biological Studies, La Jolla, CA 92037-1002, United States; Schubert, D., The Salk Institute for Biological Studies, La Jolla, CA 92037-1002, United States","The accumulation of intracellular βamyloid (Aβ) may be one of the factors leading to neuronal cell death in Alzheimer's disease (AD). Using a pyrazole called CNB-001, which was selected for its ability to reduce intracellular Aβ, we show that the activation of the eIF2α/ ATF4 arm of the unfolded protein response is sufficient to degrade aggregated intracellular Aβ. CNB-001 is a potent inhibitor of 5-lipoxygenase (5-LOX), decreases 5-LOX expression, and increases proteasome activity. 5-LOX inhibition induces eIF2α and PERK (protein kinase R-like extracellular signal-regulated kinase) phosphorylation, and HSP90 and ATF4 levels. When fed to AD transgenic mice, CNB-001 also increases eIF2α phosphorylation and HSP90 and ATF4 levels, and limits the accumulation of soluble Aβ and ubiquitinated aggregated proteins. Finally, CNB-001 maintains the expression of synapse-associated proteins and improves memory. Therefore, 5-LOX metabolism is a key element in the promotion of endoplasmic reticulum dysfunction, and its inhibition under conditions of stress is sufficient to reduce proteotoxicity both in vivo and in vitro. © 2013 the authors.",,"4, 4' [(1 phenyl 1h pyrazole 3, 5 diyl) diethene 2, 1 diyl] bis (2 methoxyphenol); 4,4' [(1 phenyl 1h pyrazole 3,5 diyl)diethene 2,1 diyl]bis(2 methoxyphenol); activating transcription factor 4; arachidonate 5 lipoxygenase; heat shock protein 90; messenger RNA; mitogen activated protein kinase; proteasome; unclassified drug; Alzheimer disease; animal behavior; animal cell; article; autophagy; cell death; confocal microscopy; controlled study; embryo; endoplasmic reticulum stress; immunoblotting; immunofluorescence; male; mouse; neuroprotection; nonhuman; phosphorylation; polyacrylamide gel electrophoresis; priority journal; reverse transcription polymerase chain reaction; transgenic mouse; unfolded protein response; Western blotting; Activating Transcription Factor 4; Alzheimer Disease; Amyloid beta-Peptides; Animals; Apomorphine; Arachidonate 5-Lipoxygenase; Behavior, Animal; Blotting, Western; Curcumin; Dopamine Agonists; Electrophoresis, Polyacrylamide Gel; Eukaryotic Initiation Factor-2; Humans; Lipoxygenase Inhibitors; Maze Learning; Mice; Mice, Transgenic; Peptide Fragments; Phosphorylation; Proteasome Endopeptidase Complex; Protein Folding; Pyrazoles; RNA, Messenger; Ubiquitin",,"4,4' [(1 phenyl 1h pyrazole 3,5 diyl)diethene 2,1 diyl]bis(2 methoxyphenol), 828911-76-8; arachidonate 5 lipoxygenase, 80619-02-9; mitogen activated protein kinase, 142243-02-5; proteasome, 140879-24-9; Activating Transcription Factor 4, 145891-90-3; Amyloid beta-Peptides; Apomorphine, 58-00-4; Arachidonate 5-Lipoxygenase, 1.13.11.34; Atf4 protein, mouse; CNB 001; Curcumin, 458-37-7; Dopamine Agonists; Eukaryotic Initiation Factor-2; Lipoxygenase Inhibitors; Peptide Fragments; Proteasome Endopeptidase Complex, 3.4.25.1; Pyrazoles; RNA, Messenger; Ubiquitin; amyloid beta-protein (1-42)","cnb 001",,"R01AG035055, NIH, National Institutes of Health; Alzheimer's Association","Billings, L.M., Oddo, S., Green, K.N., McGaugh, J.L., Laferla, F.M., Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice (2005) Neuron, 45, pp. 675-688. , CrossRef Medline; Chakrabortee, S., Liu, Y., Zhang, L., Matthews, H.R., Zhang, H., Pan, N., Cheng, C.R., Tunnacliffe, A., Macromolecular and small molecule modulation of intracellular Abeta42 aggregation and associated toxicity (2012) Biochem J, 442, pp. 507-515. , CrossRef Medline; Chen, G., Fan, Z., Wang, X., Ma, C., Bower, K.A., Shi, X., Ke, Z.J., Luo, J., Brain-derived neurotrophic factor suppresses tunicamycin-induced upregulation of CHOP in neurons (2007) J Neurosci Res, 85, pp. 1674-1684. , CrossRef Medline; Chen, Q., Prior, M., Dargusch, R., Roberts, A., Riek, R., Eichmann, C., Chiruta, C., Schubert, D., A novel neurotrophic drug for cognitive enhancement and Alzheimer's disease (2011) PLoS One, 6, pp. e27865. , CrossRef Medline; Chui, D.H., Tanahashi, H., Ozawa, K., Ikeda, S., Checler, F., Ueda, O., Suzuki, H., Tabira, T., Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation (1999) Nat Med, 5, pp. 560-564. , CrossRef Medline; Evans, C.G., Wisén, S., Gestwicki, J.E., Heat shock proteins 70 and 90 inhibit early stages of amyloid beta-(1-42) aggregation in vitro (2006) J Biol Chem, 281, pp. 33182-33191. , CrossRef Medline; Firuzi, O., Zhuo, J., Chinnici, C.M., Wisniewski, T., Praticò D (2008) 5-Lipoxygenase gene disruption reduces amyloid-beta pathology in a mouse model of Alzheimer's disease FASEB J, 22, pp. 1169-1178. , CrossRef Medline; Goldsbury, C., Whiteman, I.T., Jeong, E.V., Lim, Y.A., Oxidative stress increases levels of endogenous amyloid-beta peptides secreted from primary chick brain neurons (2008) Aging Cell, 7, pp. 771-775. , CrossRef Medline; Hayashi, A., Kasahara, T., Iwamoto, K., Ishiwata, M., Kametani, M., Kakiuchi, C., Furuichi, T., Kato, T., The role of brain-derived neurotrophic factor (BDNF)-induced XBP1 splicing during brain development (2007) J Biol Chem, 282, pp. 34525-34534. , CrossRef Medline; Himeno, E., Ohyagi, Y., Ma, L., Nakamura, N., Miyoshi, K., Sakae, N., Motomura, K., Kira, J., Apomorphine treatment in Alzheimer mice promoting amyloidbeta degradation (2011) Ann Neurol, 69, pp. 248-256. , CrossRef Medline; Hong, H.S., Maezawa, I., Yao, N., Xu, B., Diaz-Avalos, R., Rana, S., Hua, D.H., Jin, L.W., Combining the rapid MTT formazan exocytosis assay and the MC65 protection assay led to the discovery of carbazole analogs as small molecule inhibitors of Abeta oligomer-induced cytotoxicity (2007) Brain Res, 1130, pp. 223-234. , CrossRef Medline; Ishige, K., Chen, Q., Sagara, Y., Schubert, D., The activation of dopamine D4 receptors inhibits oxidative stress-induced nerve cell death (2001) J Neurosci, 21, pp. 6069-6076. , Medline; Jankowsky, J.L., Melnikova, T., Fadale, D.J., Xu, G.M., Slunt, H.H., Gonzales, V., Younkin, L.H., Savonenko, A.V., Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease (2005) J Neurosci, 25, pp. 5217-5224. , CrossRef Medline; Jankowsky, J.L., Younkin, L.H., Gonzales, V., Fadale, D.J., Slunt, H.H., Lester, H.A., Younkin, S.G., Borchelt, D.R., Rodent A beta modulates the solubility and distribution of amyloid deposits in transgenic mice (2007) J Biol Chem, 282, pp. 22707-22720. , CrossRef Medline; Kaneko, M., Koike, H., Saito, R., Kitamura, Y., Okuma, Y., Nomura, Y., Loss of HRD1-mediated protein degradation causes amyloid precursor protein accumulation and amyloidgeneration (2010) J Neurosci, 30, pp. 3924-3932. , CrossRef Medline; Kögel, D., Concannon, C.G., Muller, T., König, H., Bonner, C., Poeschel, S., Chang, S., Prehn, J.H., The APP intracellular domain (AICD) potentiates ER stress-induced apoptosis (2012) Neurobiol Aging, 33, pp. 2200-2209. , CrossRef Medline; Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J., Tanida, I., Ueno, T., Tanaka, K., Loss of autophagy in the central nervous system causes neurodegeneration in mice (2006) Nature, 441, pp. 880-884. , CrossRef Medline; Krafft, G.A., Klein, W.L., ADDLs and the signaling web that leads to Alzheimer's disease (2010) Neuropharmacology, 59, pp. 230-242. , CrossRef Medline; Kunte, M.M., Choudhury, S., Manheim, J.F., Shinde, V.M., Miura, M., Chiodo, V.A., Hauswirth, W.W., Gorbatyuk, M.S., ER stress is involved in T17M rhodopsin-induced retinal degeneration (2012) Invest Ophthalmol Vis Sci, 53, pp. 3792-3800. , CrossRef Medline; Laferla, F.M., Green, K.N., Oddo, S., Intracellular amyloid-beta in Alzheimer's disease (2007) Nat Rev Neurosci, 8, pp. 499-509. , CrossRef Medline; Lee, D.Y., Lee, K.S., Lee, H.J., Kimdo, H., Noh, Y.H., Yu, K., Jung, H.Y., Kim, S.S., Activation of PERK signaling attenuates Abeta-mediated ER stress (2010) PLoS One, 5, pp. e10489. , CrossRef Medline; Lee, J.H., Won, S.M., Suh, J., Son, S.J., Moon, G.J., Park, U.J., Gwag, B.J., Induction of the unfolded protein response and cell death pathway in Alzheimer's disease, but not in aged Tg2576 mice (2010) Exp Mol Med, 42, pp. 386-394. , CrossRef Medline; Lewerenz, J., Maher, P., Basal levels of eIF2alpha phosphorylation determine cellular antioxidant status by regulating ATF4 and xCT expression (2009) J Biol Chem, 284, pp. 1106-1115. , CrossRef Medline; Liu, Y., Dargusch, R., Maher, P., Schubert, D., A broadly neuroprotective derivative of curcumin (2008) J Neurochem, 105, pp. 1336-1345. , CrossRef Medline; Luo, M., Jones, S.M., Flamand, N., Aronoff, D.M., Peters-Golden, M., Brock, T.G., Phosphorylation by protein kinase a inhibits nuclear import of 5-lipoxygenase (2005) J Biol Chem, 280, pp. 40609-40616. , CrossRef Medline; Maezawa, I., Jin, L.W., Woltjer, R.L., Maeda, N., Martin, G.M., Montine, T.J., Montine, K.S., Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment-associated cytotoxicity (2004) J Neurochem, 91, pp. 1312-1321. , CrossRef Medline; Maezawa, I., Hong, H.S., Wu, H.C., Battina, S.K., Rana, S., Iwamoto, T., Radke, G.A., Jin, L.W., A novel tricyclic pyrone compound ameliorates cell death associated with intracellular amyloid-beta oligomeric complexes (2006) J Neurochem, 98, pp. 57-67. , CrossRef Medline; Maher, P., Akaishi, T., Schubert, D., Abe, K., A pyrazole derivative of curcumin enhances memory (2010) Neurobiol Aging, 31, pp. 706-709. , CrossRef Medline; Michalski, B., Fahnestock, M., Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease (2003) Brain Res Mol Brain Res, 111, pp. 148-154. , CrossRef Medline; Nixon, R.A., Autophagy, amyloidogenesis and Alzheimer disease (2007) J Cell Sci, 120, pp. 4081-4091. , CrossRef Medline; Oakley, H., Cole, S.L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Vassar, R., Intraneuronalamyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: Potential factors in amyloid plaque formation (2006) J Neurosci, 26, pp. 10129-10140. , CrossRef Medline; Oddo, S., Caccamo, A., Tran, L., Lambert, M.P., Glabe, C.G., Klein, W.L., Laferla, F.M., Temporal profile of amyloid-(A) oligomerization in an in vivo model of Alzheimer disease. A link between A and tau pathology (2006) J Biol Chem, 281, pp. 1599-1604. , CrossRef Medline; Oliveira, T.G., Chan, R.B., Tian, H., Laredo, M., Shui, G., Staniszewski, A., Zhang, H., Di Paolo, G., Phospholipase D2 ablation ameliorates Alzheimer's disease-linked synaptic dysfunction and cognitive deficits (2010) J Neurosci, 30, pp. 16419-16428. , CrossRef Medline; Qu, T., Uz, T., Manev, H., Inflammatory 5-LOX mRNA and protein are increased in brain of aging rats (2000) Neurobiol Aging, 21, pp. 647-652. , CrossRef Medline; Sanchez-Mejia, R.O., Newman, J.W., Toh, S., Yu, G.Q., Zhou, Y., Halabisky, B., Cissé, M., Mucke, L., Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease (2008) Nat Neurosci, 11, pp. 1311-1318. , CrossRef Medline; Sato, M., Suzuki, K., Nakanishi, S., NMDA receptor stimulation and brain-derived neurotrophic factor upregulate homer 1a mRNA via the mitogen-activated protein kinase cascade in cultured cerebellar granule cells (2001) J Neurosci, 21, pp. 3797-3805. , Medline; Schubert, D., The substrate attached material synthesized by clonal cell lines of nerve, glia, and muscle (1977) Brain Res, 132, pp. 337-346. , CrossRef Medline; Schubert, D., Maher, P., An alternative approach to drug discovery for Alzheimer's disease dementia (2012) Future Med Chem, 4, pp. 1681-1688. , CrossRef Medline; Simonsen, A., Cumming, R.C., Brech, A., Isakson, P., Schubert, D.R., Finley, K.D., Promoting basal levels of autophagy in the nervous system enhances longevity and oxidant resistance in adult Drosophila (2008) Autophagy, 4, pp. 176-184. , Medline; Song, X., Luo, Y., The regulatory mechanism of Hsp90alpha secretion from endothelial cells and its role in angiogenesis during wound healing (2010) Biochem Biophys Res Commun, 398, pp. 111-117. , CrossRef Medline; Sopher, B.L., Fukuchi, K., Smith, A.C., Leppig, K.A., Furlong, C.E., Martin, G.M., Cytotoxicity mediated by conditional expression of a carboxylterminal derivative of the beta-amyloid precursor protein (1994) Brain Res Mol Brain Res, 26, pp. 207-217. , CrossRef Medline; Steele, J.W., Gandy, S., Apomorphine and Alzheimer Abeta: Roles for regulated alpha cleavage, autophagy, and antioxidation? (2011) Ann Neurol, 69, pp. 221-225. , CrossRef Medline; Tampellini, D., Capetillo-Zarate, E., Dumont, M., Huang, Z., Yu, F., Lin, M.T., Gouras, G.K., Effects of synaptic modulation onamyloid, synaptophysin, and memory performance in Alzheimer's disease transgenic mice (2010) J Neurosci, 30, pp. 14299-14304. , CrossRef Medline; Tampellini, D., Rahman, N., Lin, M.T., Capetillo-Zarate, E., Gouras, G.K., Impairedamyloid secretion in Alzheimer's disease pathogenesis (2011) J Neurosci, 31, pp. 15384-15390. , CrossRef Medline; Tan, S., Somia, N., Maher, P., Schubert, D., Regulation of antioxidant metabolism by translation initiation factor-2 alpha (2001) J Cell Biol, 152, pp. 997-1006. , CrossRef Medline; Tan, S., Schubert, D., Maher, P., Oxytosis: A novel form of programmed cell death (2001) Curr Top Med Chem, 1, pp. 497-506. , CrossRef Medline; Trinh, M.A., Kaphzan, H., Wek, R.C., Pierre, P., Cavener, D.R., Klann, E., Brain-specific disruption of the eIF2alpha kinase PERK decreases ATF4 expression and impairs behavioral flexibility (2012) Cell Reports, 1, pp. 676-688. , CrossRef Medline; Wilhelmus, M.M., de Waal, R.M., Verbeek, M.M., Heat shock proteins and amateur chaperones in amyloid-Beta accumulation and clearance in Alzheimer's disease (2007) Mol Neurobiol, 35, pp. 203-216. , CrossRef Medline; Wirths, O., Multhaup, G., Czech, C., Blanchard, V., Moussaoui, S., Tremp, G., Pradier, L., Bayer, T.A., Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice (2001) Neurosci Lett, 306, pp. 116-120. , CrossRef Medline; Wu, A., Ying, Z., Schubert, D., Gomez-Pinilla, F., Brain and spinal cord interaction: A dietary curcumin derivative counteracts locomotor and cognitive deficits after brain trauma (2011) Neurorehabil Neural Repair, 25, pp. 332-342. , CrossRef Medline; Wu, Z.-C., Yu, J.-T., Li, Y., Tan, L., Clusterin in Alzheimer's Disease (2012) Advances In Clinical Chemistry, 56, pp. 155-173. , (Makowski GS, ed.), Salt Lake City, UT: Academic; Zhang, W., Hao, J., Liu, R., Zhang, Z., Lei, G., Su, C., Miao, J., Li, Z., Soluble Abeta levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease (2011) Behav Brain Res, 222, pp. 342-350. , CrossRef Medline; Zhu, K., Dunner Jr., K., McConkey, D.J., Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells (2010) Oncogene, 29, pp. 451-462. , CrossRef Medline","Schubert, D.10010 North Torrey Pines Road, La Jolla, CA 92037-1002, United States; email: schubert@salk.edu",,,,,,,,02706474,,JNRSD,23785163,"English","J. Neurosci.",Article,Scopus,2-s2.0-84879128268
"Prior, M., Dargusch, R., Ehren, J.L., Chiruta, C., Schubert, D.","The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease mice",2013,"Alzheimer's Research and Therapy","5","3", 25,"","",,12,10.1186/alzrt179,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84878398422&partnerID=40&md5=f562c16cbb8ca8e10984ee412220546f","Salk Institute for Biological Studies, Cellular Neurobiology Laboratory, 10010 North Torrey Pines Road, San Diego, CA 92037, United States","Prior, M., Salk Institute for Biological Studies, Cellular Neurobiology Laboratory, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; Dargusch, R., Salk Institute for Biological Studies, Cellular Neurobiology Laboratory, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; Ehren, J.L., Salk Institute for Biological Studies, Cellular Neurobiology Laboratory, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; Chiruta, C., Salk Institute for Biological Studies, Cellular Neurobiology Laboratory, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; Schubert, D., Salk Institute for Biological Studies, Cellular Neurobiology Laboratory, 10010 North Torrey Pines Road, San Diego, CA 92037, United States","Introduction. Despite years of research, there are no disease-modifying drugs for Alzheimer's disease (AD), a fatal, age-related neurodegenerative disorder. Screening for potential therapeutics in rodent models of AD has generally relied on testing compounds before pathology is present, thereby modeling disease prevention rather than disease modification. Furthermore, this approach to screening does not reflect the clinical presentation of AD patients which could explain the failure to translate compounds identified as beneficial in animal models to disease modifying compounds in clinical trials. Clearly a better approach to pre-clinical drug screening for AD is required. Methods. To more accurately reflect the clinical setting, we used an alternative screening strategy involving the treatment of AD mice at a stage in the disease when pathology is already advanced. Aged (20-month-old) transgenic AD mice (APP/swePS1ΔE9) were fed an exceptionally potent, orally active, memory enhancing and neurotrophic molecule called J147. Cognitive behavioral assays, histology, ELISA and Western blotting were used to assay the effect of J147 on memory, amyloid metabolism and neuroprotective pathways. J147 was also investigated in a scopolamine-induced model of memory impairment in C57Bl/6J mice and compared to donepezil. Details on the pharmacology and safety of J147 are also included. Results: Data presented here demonstrate that J147 has the ability to rescue cognitive deficits when administered at a late stage in the disease. The ability of J147 to improve memory in aged AD mice is correlated with its induction of the neurotrophic factors NGF (nerve growth factor) and BDNF (brain derived neurotrophic factor) as well as several BDNF-responsive proteins which are important for learning and memory. The comparison between J147 and donepezil in the scopolamine model showed that while both compounds were comparable at rescuing short term memory, J147 was superior at rescuing spatial memory and a combination of the two worked best for contextual and cued memory. Conclusion: J147 is an exciting new compound that is extremely potent, safe in animal studies and orally active. J147 is a potential AD therapeutic due to its ability to provide immediate cognition benefits, and it also has the potential to halt and perhaps reverse disease progression in symptomatic animals as demonstrated in these studies. © 2013 Prior et al.; licensee BioMed Central Ltd.",,"amyloid beta protein; brain derived neurotrophic factor; donepezil; j 147; n (2,4 dimethylphenyl( 2,2,2 trifluoro n' (3 methoxybenzylidene)acetohydrazide; nerve growth factor; neuroprotective agent; nootropic agent; scopolamine; unclassified drug; Alzheimer disease; animal behavior; animal cell; animal experiment; animal model; animal tissue; article; cognition; cognitive defect; controlled study; disease course; drug effect; drug efficacy; drug potency; drug safety; enzyme linked immunosorbent assay; female; histopathology; male; memory; memory disorder; mouse; neuropathology; nonhuman; priority journal; protein metabolism; short term memory; spatial memory; Western blotting",,"amyloid beta protein, 109770-29-8; brain derived neurotrophic factor, 218441-99-7; donepezil, 120011-70-3, 120014-06-4, 142057-77-0; nerve growth factor, 9061-61-4; scopolamine, 138-12-5, 51-34-3, 55-16-3","j 147, Salk","Salk",,"Goedert, M., Spillantini, M.G., A century of Alzheimer's disease (2006) Science, 314 (5800), pp. 777-781. , DOI 10.1126/science.1132814; McKhann, G., Drachman, D., Folstein, M., Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease (1984) Neurology, 34 (7), pp. 939-944; McKeith, I., Cummings, J., Behavioural changes and psychological symptoms in dementia disorders (2005) Lancet Neurology, 4 (11), pp. 735-742. , DOI 10.1016/S1474-4422(05)70219-2, PII S1474442205702192; Haas, C., Strategies, development, and pitfalls of therapeutic options for Alzheimer's disease (2012) J Alzheimers Dis, 28, pp. 241-281. , 21987594; Rafii, M.S., Aisen, P.S., Recent developments in Alzheimer's disease therapeutics (2009) BMC Med, 7, p. 7. , 10.1186/1741-7015-7-7 19228370; Liu, Y., Dargusch, R., Maher, P., Schubert, D., A broadly neuroprotective derivative of curcumin (2008) Journal of Neurochemistry, 105 (4), pp. 1336-1345. , DOI 10.1111/j.1471-4159.2008.05236.x; Chen, Q., Prior, M., Dargusch, R., Roberts, A., Riek, R., Eichmann, C., Chiruta, C., Schubert, D., A novel neurotrophic drug for cognitive enhancement and Alzheimer's disease (2011) PloS One, 6, p. 527865. , 10.1371/journal.pone.0027865 22194796; Lim, G.P., Chu, T., Yang, F., Beech, W., Frautschy, S.A., Cole, G.M., The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse (2001) Journal of Neuroscience, 21 (21), pp. 8370-8377; Yang, F., Lim, G.P., Begum, A.N., Ubeda, O.J., Simmons, M.R., Ambegaokar, S.S., Chen, P., Cole, G.M., Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo (2005) Journal of Biological Chemistry, 280 (7), pp. 5892-5901. , DOI 10.1074/jbc.M404751200; Savonenko, A., Xu, G.M., Melnikova, T., Morton, J.L., Gonzales, V., Wong, M.P.F., Price, D.L., Borchelt, D.R., Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: Relationships to β-amyloid deposition and neurotransmitter abnormalities (2005) Neurobiology of Disease, 18 (3), pp. 602-617. , DOI 10.1016/j.nbd.2004.10.022; Jankowsky, J.L., Slunt, H.H., Gonzales, V., Savonenko, A.V., Wen, J.C., Jenkins, N.A., Copeland, N.G., Borchelt, D.R., Persistent amyloidosis following suppression of Aβ production in a transgenic model of Alzheimer disease (2005) PLoS Medicine, 2 (12), pp. 1318-1333. , http://medicine.plosjournals.org/archive/1549-1676/2/12/pdf/10. 1371_journal.pmed.0020355-L.pdf, DOI 10.1371/journal.pmed.0020355, e355; Gulinello, M., Gertner, M., Mendoza, G., Schoenfeld, B.P., Oddo, S., Laferla, F., Choi, C.H., Faber, D.S., Validation of a 2-day water maze protocol in mice (2009) Behav Brain Res, 196, pp. 220-227. , 10.1016/j.bbr.2008.09.002 18831990; Belzung, C., Griebel, G., Measuring normal and pathological anxiety-like behaviour in mice: A review (2001) Behavioural Brain Research, 125 (1-2), pp. 141-149. , DOI 10.1016/S0166-4328(01)00291-1, PII S0166432801002911; Lister, R.G., The use of a plus-maze to measure anxiety in the mouse (1987) Psychopharmacology, 92 (2), pp. 180-185; Thompson, R.F., Krupa, D.J., Organization of memory traces in the mammalian brain (1994) Annual Review of Neuroscience, 17, pp. 519-549; Kim, J.J., Jung, M.W., Neural circuits and mechanisms involved in Pavlovian fear conditioning: A critical review (2006) Neuroscience and Biobehavioral Reviews, 30 (2), pp. 188-202. , DOI 10.1016/j.neubiorev.2005.06.005, PII S0149763405001065; Bangasser, D.A., Waxler, D.E., Santollo, J., Shors, T.J., Trace conditioning and the hippocampus: The importance of contiguity (2006) Journal of Neuroscience, 26 (34), pp. 8702-8706. , http://www.jneurosci.org/cgi/reprint/26/34/8702.pdf, DOI 10.1523/JNEUROSCI.1742-06.2006; Maren, S., Fanselow, M.S., The amygdala and fear conditioning: Has the nut been cracked? (1996) Neuron, 16 (2), pp. 237-240. , DOI 10.1016/S0896-6273(00)80041-0; Rogan, M.T., LeDoux, J.E., Emotion: Systems, cells, synaptic plasticity (1996) Cell, 85 (4), pp. 469-475. , DOI 10.1016/S0092-8674(00)81247-7; Sarnyai, Z., Sibille, E.L., Pavlides, C., Fenster, R.J., McEwen, B.S., Toth, M., Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin1A receptors (2000) Proceedings of the National Academy of Sciences of the United States of America, 97 (26), pp. 14731-14736. , DOI 10.1073/pnas.97.26.14731; Young, J.W., Powell, S.B., Risbrough, V., Marston, H.M., Geyer, M.A., Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia (2009) Pharmacol Ther, 122, pp. 150-202. , 10.1016/j.pharmthera.2009.02.004 19269307; Tan, S., Sagara, Y., Liu, Y., Maher, P., Schubert, D., The regulation of reactive oxygen species production during programmed cell death (1998) Journal of Cell Biology, 141 (6), pp. 1423-1432. , DOI 10.1083/jcb.141.6.1423; Davis, J.B., Maher, P., Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line (1994) Brain Research, 652 (1), pp. 169-173. , DOI 10.1016/0006-8993(94)90334-4; Gautier, L., Cope, L., Bolstad, B.M., Irizarry, R.A., Affy - Analysis of Affymetrix GeneChip data at the probe level (2004) Bioinformatics, 20 (3), pp. 307-315. , DOI 10.1093/bioinformatics/btg405; Edgar, R., Domrachev, M., Lash, A.E., Gene Expression Omnibus: NCBI gene expression and hybridization array data repository (2002) Nucleic Acids Research, 30 (1), pp. 207-210; NCBI Gene Expression Omnibus (GEO), , http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE45534; Golde, T.E., Schneider, L.S., Koo, E.H., Anti-abeta therapeutics in Alzheimer's disease: The need for a paradigm shift (2011) Neuron, 69, pp. 203-213. , 10.1016/j.neuron.2011.01.002 21262461; Abramowski, D., Wiederhold, K.H., Furrer, U., Jaton, A.L., Neuenschwander, A., Runser, M.J., Danner, S., Staufenbiel, M., Dynamics of Abeta turnover and deposition in different beta-amyloid precursor protein transgenic mouse models following gamma-secretase inhibition (2008) J Pharmacol Exp Ther, 327, pp. 411-424. , 10.1124/jpet.108.140327 18687920; Das, P., Murphy, M.P., Younkin, L.H., Younkin, S.G., Golde, T.E., Reduced effectiveness of Aβ1-42 immunization in APP transgenic mice with significant amyloid deposition (2001) Neurobiology of Aging, 22 (5), pp. 721-727. , DOI 10.1016/S0197-4580(01)00245-7, PII S0197458001002457; Zahs, K.R., Ashe, K.H., 'Too much good news' - Are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease? (2010) Trends Neurosci, 33, pp. 381-389. , 10.1016/j.tins.2010.05.004 20542579; Van Groen, T., Kiliaan, A.J., Kadish, I., Deposition of mouse amyloid β in human APP/PS1 double and single AD model transgenic mice (2006) Neurobiology of Disease, 23 (3), pp. 653-662. , DOI 10.1016/j.nbd.2006.05.010, PII S0969996106001240; Minkeviciene, R., Ihalainen, J., Malm, T., Matilainen, O., Keksa-Goldsteine, V., Goldsteins, G., Iivonen, H., Tanila, H., Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild-type mice (2008) Journal of Neurochemistry, 105 (3), pp. 584-594. , DOI 10.1111/j.1471-4159.2007.05147.x; Vorhees, C.V., Williams, M.T., Morris water maze: Procedures for assessing spatial and related forms of learning and memory (2006) Nat Protoc, 1, pp. 848-858. , 10.1038/nprot.2006.116 17406317; Seignourel, P.J., Kunik, M.E., Snow, L., Wilson, N., Stanley, M., Anxiety in dementia: A critical review (2008) Clin Psychol Rev, 28, pp. 1071-1082. , 10.1016/j.cpr.2008.02.008 18555569; Chin, J., Palop, J.J., Puolivali, J., Massaro, C., Bien-Ly, N., Gerstein, H., Scearce-Levie, K., Mucke, L., Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer's disease (2005) Journal of Neuroscience, 25 (42), pp. 9694-9703. , DOI 10.1523/JNEUROSCI.2980-05.2005; Cheng, I.H., Scearce-Levie, K., Legleiter, J., Palop, J.J., Gerstein, H., Bien-Ly, N., Puolivali, J., Mucke, L., Accelerating amyloid-β fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models (2007) Journal of Biological Chemistry, 282 (33), pp. 23818-23828. , http://www.jbc.org/cgi/reprint/282/33/23818, DOI 10.1074/jbc.M701078200; Roberson, E.D., Scearce-Levie, K., Palop, J.J., Yan, F., Cheng, I.H., Wu, T., Gerstein, H., Mucke, L., Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model (2007) Science, 316 (5825), pp. 750-754. , DOI 10.1126/science.1141736; Meilandt, W.J., Cisse, M., Ho, K., Wu, T., Esposito, L.A., Scearce-Levie, K., Cheng, I.H., Mucke, L., Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice (2009) J Neurosci, 29, pp. 1977-1986. , 10.1523/JNEUROSCI.2984-08.2009 19228952; Puolivali, J., Wang, J., Heikkinen, T., Heikkila, M., Tapiola, T., Van Groen, T., Tanila, H., Hippocampal Aβ42 levels correlate with spatial memory deficit in APP and PS1 double transgenic mice (2002) Neurobiology of Disease, 9 (3), pp. 339-347. , DOI 10.1006/nbdi.2002.0481; Lalonde, R., Kim, H.D., Maxwell, J.A., Fukuchi, K., Exploratory activity and spatial learning in 12-month-old APP 695SWE/co + PS1/ΔE9 mice with amyloid plaques (2005) Neuroscience Letters, 390 (2), pp. 87-92. , DOI 10.1016/j.neulet.2005.08.028, PII S0304394005009237; Lalonde, R., Kim, H.D., Fukuchi, K., Exploratory activity, anxiety, and motor coordination in bigenic APPswe + PS1/ΔE9 mice (2004) Neuroscience Letters, 369 (2), pp. 156-161. , DOI 10.1016/j.neulet.2004.07.069, PII S0304394004009528; Chung, J.A., Cummings, J.L., Neurobehavioral and neuropsychiatric symptoms in Alzheimer's disease: Characteristics and treatment (2000) Neurologic Clinics, 18 (4), pp. 829-846. , DOI 10.1016/S0733-8619(05)70228-0; Martinez, R.C.R., Garcia, A.M.B., Lamprea, M.R., Morato, S., Thermal stress decreases general motor activity of rats in the elevated plus-maze but does not alter aversion to the open arms (2007) Behavioural Brain Research, 182 (1), pp. 135-139. , DOI 10.1016/j.bbr.2007.04.015, PII S0166432807002124; Cramer, P.E., Cirrito, J.R., Wesson, D.W., Lee, C.Y., Karlo, J.C., Zinn, A.E., Casali, B.T., Landreth, G.E., ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models (2012) Science, 335, pp. 1503-1506. , 10.1126/science.1217697 22323736; Bishop, N.A., Lu, T., Yankner, B.A., Neural mechanisms of ageing and cognitive decline (2010) Nature, 464, pp. 529-535. , 10.1038/nature08983 20336135; Zhang, W., Hao, J., Liu, R., Zhang, Z., Lei, G., Su, C., Miao, J., Li, Z., Soluble Abeta levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease (2011) Behav Brain Res, 222, pp. 342-350. , 10.1016/j.bbr.2011.03.072 21513747; Hussain, I., Powell, D., Howlett, D.R., Tew, D.G., Meek, T.D., Chapman, C., Gloger, I.S., Christie, G., Identification of a novel aspartic protease (Asp 2) as β-secretase (1999) Molecular and Cellular Neurosciences, 14 (6), pp. 419-427. , DOI 10.1006/mcne.1999.0811; Lin, X., Koelsch, G., Wu, S., Downs, D., Dashti, A., Tang, J., Human aspartic protease memapsin 2 cleaves the β-secretase site of β- amyloid precursor protein (2000) Proceedings of the National Academy of Sciences of the United States of America, 97 (4), pp. 1456-1460. , DOI 10.1073/pnas.97.4.1456; Sinha, S., Anderson, J.P., Barbour, R., Basi, G.S., Caccavello, R., Davis, D., Doan, M., John, V., Purification and cloning of amyloid precursor protein beta-secretase from human brain (1999) Nature, 402, pp. 537-540. , 10.1038/990114 10591214; Vassar, R., Bennett, B.D., Babu-Khan, S., Kahn, S., Mendiaz, E.A., Denis, P., Teplow, D.B., Citron, M., β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE (1999) Science, 286 (5440), pp. 735-741. , DOI 10.1126/science.286.5440.735; Yan, R., Bienkowski, M.J., Shuck, M.E., Miao, H., Tory, M.C., Pauley, A.M., Brashier, J.R., Gurney, M.E., Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity (1999) Nature, 402, pp. 533-537. , 10.1038/990107 10591213; Schubert, D., The possible role of adhesion in synaptic modification (1991) Trends Neurosci, 14, pp. 127-130. , 10.1016/0166-2236(91)90078-9 1710846; Tyan, S.H., Shih, A.Y., Walsh, J.J., Maruyama, H., Sarsoza, F., Ku, L., Eggert, S., Dickstein, D.L., Amyloid precursor protein (APP) regulates synaptic structure and function (2012) Mol Cell Neurosci, 51, pp. 43-52. , 10.1016/j.mcn.2012.07.009 22884903; Wu, A., Ying, Z., Schubert, D., Gomez-Pinilla, F., Brain and spinal cord interaction: A dietary curcumin derivative counteracts locomotor and cognitive deficits after brain trauma (2011) Neurorehabil Neural Repair, 25, pp. 332-342. , 10.1177/1545968310397706 21343524; Chao, M.V., Neurotrophins and their receptors: A convergence point for many signalling pathways (2003) Nature Reviews Neuroscience, 4 (4), pp. 299-309. , DOI 10.1038/nrn1078; Chao, M.Y., Rajagopal, R., Lee, F.S., Neurotrophin signalling in health and disease (2006) Clinical Science, 110 (2), pp. 167-173. , DOI 10.1042/CS20050163; Dragunow, M., Beilharz, E., Mason, B., Lawlor, P., Abraham, W., Gluckman, P., Brain-derived neurotrophic factor expression after long-term potentiation (1993) Neuroscience Letters, 160 (2), pp. 232-236. , DOI 10.1016/0304-3940(93)90420-P; Ying, S.-W., Futter, M., Rosenblum, K., Webber, M.J., Hunt, S.P., Bliss, T.V.P., Bramham, C.R., Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: Requirement for ERK activation coupled to CREB and upregulation of Arc synthesis (2002) Journal of Neuroscience, 22 (5), pp. 1532-1540; Korte, M., Carroll, P., Wolf, E., Brem, G., Thoenen, H., Bonhoeffer, T., Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor (1995) Proc Natl Acad Sci USA, 92, pp. 8856-8860. , 10.1073/pnas.92.19.8856 7568031; Figurov, A., Pozzo-Miller, L.D., Olafsson, P., Wang, T., Lu, B., Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus (1996) Nature, 381 (6584), pp. 706-709. , DOI 10.1038/381706a0; Kelly, A., Conroy, S., Lynch, M.A., Evidence that nerve growth factor plays a role in long-term potentiation in the rat dentate gyrus (1998) Neuropharmacology, 37 (4-5), pp. 561-570. , DOI 10.1016/S0028-3908(98)00048-3, PII S0028390898000483; Nakajo, Y., Miyamoto, S., Nakano, Y., Xue, J.H., Hori, T., Yanamoto, H., Genetic increase in brain-derived neurotrophic factor levels enhances learning and memory (2008) Brain Res, 1241, pp. 103-109. , 18801341; Marini, A.M., Rabin, S.J., Lipsky, R.H., Mocchetti, I., Activity-dependent release of brain-derived neurotrophic factor underlies the neuroprotective effect of N-methyl-D-aspartate (1998) Journal of Biological Chemistry, 273 (45), pp. 29394-29399. , DOI 10.1074/jbc.273.45.29394; Lee, J., Duan, W., Mattson, M.P., Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice (2002) J Neurochem, 82, pp. 1367-1375. , 10.1046/j.1471-4159.2002.01085.x 12354284; Seidaha, N.G., Benjannet, S., Pareek, S., Chretien, M., Murphy, R.A., Cellular processing of the neurotrophin precursors of NT3 and BDNF by the mammalian proprotein convertases (1996) FEBS Letters, 379 (3), pp. 247-250. , DOI 10.1016/0014-5793(95)01520-5; Fahnestock, M., Michalski, B., Xu, B., Coughlin, M.D., The precursor pro-nerve growth factor is the predominant form of nerve growth factor in brain and is increased in Alzheimer's disease (2001) Molecular and Cellular Neuroscience, 18 (2), pp. 210-220. , DOI 10.1006/mcne.2001.1016; Al-Shawi, R., Hafner, A., Chun, S., Raza, S., Crutcher, K., Thrasivoulou, C., Simons, P., Cowen, T., ProNGF, sortilin, and age-related neurodegeneration (2007) Annals of the New York Academy of Sciences, 1119 (1), pp. 208-215. , DOI 10.1196/annals.1404.024, Molecular Mechanisms of Aging; Peng, S., Wuu, J., Mufson, E.J., Fahnestock, M., Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease (2004) Journal of Neuropathology and Experimental Neurology, 63 (6), pp. 641-649; Lee, R., Kermani, P., Teng, K.K., Hempstead, B.L., Regulation of cell survival by secreted proneurotrophins (2001) Science, 294 (5548), pp. 1945-1948. , DOI 10.1126/science.1065057; Chen, Z.-Y., Patel, P.D., Sant, G., Meng, C.-X., Teng, K.K., Hempstead, B.L., Lee, F.S., Variant Brain-Derived Neurotrophic Factor (BDNF) (Met66) Alters the Intracellular Trafficking and Activity-Dependent Secretion of Wild-Type BDNF in Neurosecretory Cells and Cortical Neurons (2004) Journal of Neuroscience, 24 (18), pp. 4401-4411. , DOI 10.1523/JNEUROSCI.0348-04.2004; Pang, P.T., Teng, H.K., Zaitsev, E., Woo, N.T., Sakata, K., Zhen, S., Teng, K.K., Lu, B., Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity (2004) Science, 306 (5695), pp. 487-491. , DOI 10.1126/science.1100135; Sato, M., Suzuki, K., Nakanishi, S., NMDA receptor stimulation and brain-derived neurotrophic factor upregulate homer 1a mRNA via the mitogen-activated protein kinase cascade in cultured cerebellar granule cells (2001) Journal of Neuroscience, 21 (11), pp. 3797-3805; Shiraishi-Yamaguchi, Y., Furuichi, T., The Homer family proteins (2007) Genome Biology, 8 (2), p. 206. , DOI 10.1186/gb-2007-8-2-206; Foa, L., Gasperini, R., Developmental roles for Homer: More than just a pretty scaffold (2009) J Neurochem, 108, pp. 1-10. , 19222714; Xiao, B., Cheng Tu, J., Worley, P.F., Homer: A link between neural activity and glutamate receptor function (2000) Current Opinion in Neurobiology, 10 (3), pp. 370-374. , DOI 10.1016/S0959-4388(00)00087-8; O'Donovan, K.J., Tourtellotte, W.G., Milbrandt, J., Baraban, J.M., The EGR family of transcription-regulatory factors: Progress at the interface of molecular and systems neuroscience (1999) Trends in Neurosciences, 22 (4), pp. 167-173. , DOI 10.1016/S0166-2236(98)01343-5; O'Donovan, K.J., Levkovitz, Y., Ahn, D., Baraban, J.M., Functional comparison of Egr3 transcription factor isoforms: Identification of an activation domain in the N-terminal segment absent from Egr3beta, a major isoform expressed in brain (2000) J Neurochem, 75, pp. 1352-1357. , 10987814; Li, L., Yun, S.H., Keblesh, J., Trommer, B.L., Xiong, H., Radulovic, J., Tourtellotte, W.G., Egr3, a synaptic activity regulated transcription factor that is essential for learning and memory (2007) Molecular and Cellular Neuroscience, 35 (1), pp. 76-88. , DOI 10.1016/j.mcn.2007.02.004, PII S1044743107000292; Lee, Y.S., Silva, A.J., The molecular and cellular biology of enhanced cognition (2009) Nat Rev Neurosci, 10, pp. 126-140. , 19153576; West, A.E., Chen, W.G., Dalva, M.B., Dolmetsch, R.E., Kornhauser, J.M., Shaywitz, A.J., Takasu, M.A., Greenberg, M.E., Calcium regulation of neuronal gene expression (2001) Proceedings of the National Academy of Sciences of the United States of America, 98 (20), pp. 11024-11031. , DOI 10.1073/pnas.191352298; Wen, A.Y., Sakamoto, K.M., Miller, L.S., The role of the transcription factor CREB in immune function (2010) J Immunol, 185, pp. 6413-6419. , 10.4049/jimmunol.1001829 21084670; Gallagher, M., Koh, M.T., Episodic memory on the path to Alzheimer's disease (2011) Curr Opin Neurobiol, 21, pp. 929-934. , 10.1016/j.conb.2011.10.021 22079495; Geula, C., Mesulam, M.-M., Cortical cholinergic fibers in aging and Alzheimer's disease: A morphometric study (1989) Neuroscience, 33 (3), pp. 469-481. , DOI 10.1016/0306-4522(89)90399-0; Geula, C., Mesulam, M.-M., Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease (1996) Cerebral Cortex, 6 (2), pp. 165-177. , DOI 10.1093/cercor/6.2.165; Conner, J.M., Franks, K.M., Titterness, A.K., Russell, K., Merrill, D.A., Christie, B.R., Sejnowski, T.J., Tuszynski, M.H., NGF is essential for hippocampal plasticity and learning (2009) J Neurosci, 29, pp. 10883-10889. , 10.1523/JNEUROSCI.2594-09.2009 19726646; Geula, C., Nagykery, N., Nicholas, A., Wu, C.-K., Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer disease (2008) Journal of Neuropathology and Experimental Neurology, 67 (4), pp. 309-318. , DOI 10.1097/NEN.0b013e31816a1df3, PII 0000507220080400000005; Schliebs, R., Arendt, T., The cholinergic system in aging and neuronal degeneration (2011) Behav Brain Res, 221, pp. 555-563. , 10.1016/j.bbr.2010.11.058 21145918; Tricco, A.C., Vandervaart, S., Soobiah, C., Lillie, E., Perrier, L., Chen, M.H., Hemmelgarn, B., Straus, S.E., Efficacy of cognitive enhancers for Alzheimer's disease: Protocol for a systematic review and network meta-analysis (2012) Syst Rev, 1, p. 31. , 10.1186/2046-4053-1-31 22742585; Lanctot, K.L., Herrmann, N., Yau, K.K., Khan, L.R., Liu, B.A., LouLou, M.M., Einarson, T.R., Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: A meta-analysis (2003) Canadian Medical Association Journal, 169 (6), pp. 557-564; Klinkenberg, I., Blokland, A., The validity of scopolamine as a pharmacological model for cognitive impairment: A review of animal behavioral studies (2010) Neurosci Biobehav Rev, 34, pp. 1307-1350. , 10.1016/j.neubiorev.2010.04.001 20398692; Lenz, R.A., Baker, J.D., Locke, C., Rueter, L.E., Mohler, E.G., Wesnes, K., Abi-Saab, W., Saltarelli, M.D., The scopolamine model as a pharmacodynamic marker in early drug development (2012) Psychopharmacology, 220, pp. 97-107. , 10.1007/s00213-011-2456-4 21901320; Buccafusco, J.J., Terry Jr., A.V., Webster, S.J., Martin, D., Hohnadel, E.J., Bouchard, K.A., Warner, S.E., The scopolamine-reversal paradigm in rats and monkeys: The importance of computer-assisted operant-conditioning memory tasks for screening drug candidates (2008) Psychopharmacology, 199 (3), pp. 481-494. , DOI 10.1007/s00213-007-0887-8; Snyder, P.J., Bednar, M.M., Cromer, J.R., Maruff, P., Reversal of scopolamine-induced deficits with a single dose of donepezil, an acetylcholinesterase inhibitor (2005) Alzheimer's and Dementia, 1 (2), pp. 126-135. , DOI 10.1016/j.jalz.2005.09.004, PII S1552526005004619; Kwon, S.H., Kim, H.C., Lee, S.Y., Jang, C.G., Loganin improves learning and memory impairments induced by scopolamine in mice (2009) Eur J Pharmacol, 619, pp. 44-49. , 10.1016/j.ejphar.2009.06.062 19666019; Yang, J.H., Han, S.J., Ryu, J.H., Jang, I.S., Kim, D.H., Ginsenoside Rh2 ameliorates scopolamine-induced learning deficit in mice (2009) Biol Pharm Bull, 32, pp. 1710-1715. , 10.1248/bpb.32.1710 19801832; Joh, E.H., Yang, J.W., Kim, D.H., Gypenoside LXXIV ameliorates scopolamine-induced learning deficit in mice (2010) Planta Med, 76, pp. 793-795. , 10.1055/s-0029-1240795 20104445; Rudy, J.W., Scopolamine administered before and after training impairs both contextual and auditory-cue fear conditioning (1996) Neurobiology of Learning and Memory, 65 (1), pp. 73-81. , DOI 10.1006/nlme.1996.0008; Wollen, K.A., Alzheimer's disease: The pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners (2010) Altern Med Rev, 15, pp. 223-244. , 21155625; Sehgal, N., Gupta, A., Valli, R.K., Joshi, S.D., Mills, J.T., Hamel, E., Khanna, P., Ravindranath, V., Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver (2012) Proc Natl Acad Sci USA, 109, pp. 3510-3515. , 10.1073/pnas.1112209109 22308347; Morris, R.G.M., Garrud, P., Rawlins, J.N.P., O'Keefe, J., Place navigation impaired in rats with hippocampal lesions (1982) Nature, 297 (5868), pp. 681-683. , DOI 10.1038/297681a0; Kim, J.J., Fanselow, M.S., Modality-specific retrograde amnesia of fear (1992) Science, 256, pp. 675-677. , 10.1126/science.1585183 1585183; Cleary, J.P., Walsh, D.M., Hofmeister, J.J., Shankar, G.M., Kuskowski, M.A., Selkoe, D.J., Ashe, K.H., Natural oligomers of the amyloid-β protein specifically disrupt cognitive function (2005) Nature Neuroscience, 8 (1), pp. 79-84. , DOI 10.1038/nn1372; Lesne, S., Koh, M.T., Kotilinek, L., Kayed, R., Glabe, C.G., Yang, A., Gallagher, M., Ashe, K.H., A specific amyloid-beta protein assembly in the brain impairs memory (2006) Nature, 440, pp. 352-357. , 10.1038/nature04533 16541076; Blurton-Jones, M., Kitazawa, M., Martinez-Coria, H., Castello, N.A., Muller, F.J., Loring, J.F., Yamasaki, T.R., Laferla, F.M., Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease (2009) Proc Natl Acad Sci USA, 106, pp. 13594-13599. , 10.1073/pnas.0901402106 19633196; Schindowski, K., Belarbi, K., Buée, L., Neurotrophic factors in Alzheimer's disease: Role of axonal transport (2008) Genes Brain Behav, 7 (SUPPL. 1), pp. 43-56. , 18184369; Hock, C., Heese, K., Hulette, C., Rosenberg, C., Otten, U., Region-specific neurotrophin imbalances in Alzheimer disease: Decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas (2000) Archives of Neurology, 57 (6), pp. 846-851; Scott, S.A., Mufson, E.J., Weingartner, J.A., Skau, K.A., Crutcher, K.A., Nerve growth factor in Alzheimer's disease: Increased levels throughout the brain coupled with declines in nucleus basalis (1995) J Neurosci, 15, pp. 6213-6221. , 7666203; Mufson, E.J., Lavine, N., Jaffar, S., Kordower, J.H., Quirion, R., Saragovi, H.U., Reduction in p140-trkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease (1997) Experimental Neurology, 146 (1), pp. 91-103. , DOI 10.1006/exnr.1997.6504; Counts, S.E., Nadeem, M., Wuu, J., Ginsberg, S.D., Saragovi, H.U., Mufson, E.J., Reduction of cortical TrkA but not p75NTR protein in early-stage Alzheimer's disease (2004) Annals of Neurology, 56 (4), pp. 520-531. , DOI 10.1002/ana.20233; Li, Y., Holtzman, D.M., Kromer, L.F., Kaplan, D.R., Chua-Couzens, J., Clary, D.O., Knusel, B., Mobley, W.C., Regulation of TrkA and ChAT expression in developing rat basal forebrain: Evidence that both exogenous and endogenous NGF regulate differentiation of cholinergic neurons (1995) J Neurosci, 15, pp. 2888-2905. , 7536822; Mobley, W.C., Rutkowski, J.L., Tennekoon, G.I., Gemski, J., Buchanan, K., Johnston, M.V., Nerve growth factor increases choline acetyltransferase activity in developing basal forebrain neurons (1986) Brain Res, 387, pp. 53-62. , 3742234; Tapia-Arancibia, L., Aliaga, E., Silhol, M., Arancibia, S., New insights into brain BDNF function in normal aging and Alzheimer disease (2008) Brain Res Rev, 59, pp. 201-220. , 10.1016/j.brainresrev.2008.07.007 18708092; Barnes, P., Thomas, K.L., Proteolysis of proBDNF is a key regulator in the formation of memory (2008) PloS One, 3, p. 53248. , 10.1371/journal.pone.0003248 18813339; Bimonte, H.A., Nelson, M.E., Granholm, A.-C.E., Age-related deficits as working memory load increases: Relationships with growth factors (2003) Neurobiology of Aging, 24 (1), pp. 37-48. , DOI 10.1016/S0197-4580(02)00015-5, PII S0197458002000155; Hunter, C.L., Quintero, E.M., Gilstrap, L., Bhat, N.R., Granholm, A.-C., Minocycline protects basal forebrain cholinergic neurons from mu p75-saporin immunotoxic lesioning (2004) European Journal of Neuroscience, 19 (12), pp. 3305-3316. , DOI 10.1111/j.0953-816X.2004.03439.x; Kordower, J.H., Fiandaca, M.S., Response of the monkey cholinergic septohippocampal system to fornix transection: A histochemical and cytochemical analysis (1990) Journal of Comparative Neurology, 298 (4), pp. 443-457. , DOI 10.1002/cne.902980406; Haller, M.F., Saltzman, W.M., Nerve growth factor delivery systems (1998) Journal of Controlled Release, 53 (1-3), pp. 1-6. , DOI 10.1016/S0168-3659(97)00232-0, PII S0168365997002320; Anand, P., Neurotrophins and peripheral neuropathy (1996) Philosophical Transactions of the Royal Society B: Biological Sciences, 351 (1338), pp. 449-454; Lindsay, R.M., Therapeutic potential of the neurotrophins and neurotrophin-CNTF combinations in peripheral neuropathies and motor neuron diseases (1996) Ciba Found Symp, 196, pp. 39-48. , discussion 48-53 8866127; Jonhagen, M.E., Nordberg, A., Amberla, K., Backman, L., Ebendal, T., Meyerson, B., Olson, L., Wahlund, L.-O., Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease (1998) Dementia and Geriatric Cognitive Disorders, 9 (5), pp. 246-257. , DOI 10.1159/000017069; Winkler, J., Ramirez, G.A., Kuhn, H.G., Peterson, D.A., Day-Lollini, P.A., Stewart, G.R., Tuszynski, M.H., Thal, L.J., Reversible schwann cell hyperplasia and sprouting of sensory and sympathetic neurites after intraventricular administration of nerve growth factor (1997) Annals of Neurology, 41 (1), pp. 82-93. , DOI 10.1002/ana.410410114; Weissmiller, A.M., Wu, C., Current advances in using neurotrophic factors to treat neurodegenerative disorders (2012) Transl Neurodegener, 1, p. 14. , 10.1186/2047-9158-1-14 23210531; Tuszynski, M.H., Thal, L., Pay, M., Salmon, D.P., Sang U, H., Bakay, R., Patel, P., Conner, J., A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease (2005) Nature Medicine, 11 (5), pp. 551-555. , DOI 10.1038/nm1239; Bymaster, F.P., Heath, I., Hendrix, J.C., Shannon, H.E., Comparative behavioral and neurochemical activities of cholinergic antagonists in rats (1993) Journal of Pharmacology and Experimental Therapeutics, 267 (1), pp. 16-24; Wesnes, K.A., Simpson, P.M., White, L., Pinker, S., Jertz, G., Murphy, M., Siegfried, K., Cholinesterase inhibition in the scopolamine model of dementia (1991) Ann N y Acad Sci, 640, pp. 268-271. , 1776749; Draft Guidance for Industry on Alzheimer's Disease: Developing Drugs for the Treatment of Early Stage Disease; Availability, , http://www.gpo.gov/fdsys/pkg/FR-2013-02-08/html/2013-02863.htm","Schubert, D.; Salk Institute for Biological Studies, Cellular Neurobiology Laboratory, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; email: schubert@salk.edu",,,,,,,,17589193,,,,"English","Alzheimers Res. Ther.",Article,Scopus,2-s2.0-84878398422
"Chiruta, C., Zhao, Y., Tang, F., Wang, T., Schubert, D.","Metabolism of a potent neuroprotective hydrazide",2013,"Bioorganic and Medicinal Chemistry","21","10",,"2733","2741",,4,10.1016/j.bmc.2013.03.020,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84876678963&partnerID=40&md5=ee27a86c38cc1d10a9a07500a04e57af","Salk Institute for Biological Studies, San Diego, CA 92037-1002, United States; Pharmaron-Beijing, Beijing 100176, China","Chiruta, C., Salk Institute for Biological Studies, San Diego, CA 92037-1002, United States; Zhao, Y., Pharmaron-Beijing, Beijing 100176, China; Tang, F., Pharmaron-Beijing, Beijing 100176, China; Wang, T., Pharmaron-Beijing, Beijing 100176, China; Schubert, D., Salk Institute for Biological Studies, San Diego, CA 92037-1002, United States","Abstract Using a drug discovery scheme for Alzheimer's disease (AD) that is based upon multiple pathologies of old age, we identified a potent compound with efficacy in rodent memory and AD animal models. Since this compound, J147, is a phenyl hydrazide, there was concern that it can be metabolized to aromatic amines/hydrazines that are potentially carcinogenic. To explore this possibility, we examined the metabolites of J147 in human and mouse microsomes and mouse plasma. It is shown that J147 is not metabolized to aromatic amines or hydrazines, that the scaffold is exceptionally stable, and that the oxidative metabolites are also neuroprotective. It is concluded that the major metabolites of J147 may contribute to its biological activity in animals. © 2013 Elsevier Ltd.All rights reserved.","Alzheimer's; Hydrazines; Metabolites; Microsomes; Neuroprotective","2,2,2 trifluoro n (4 (hydroxymethyl) 2 methylphenyl) n' (3 methoxybenzylidene)acetohydrazide; aromatic amine; drug metabolite; hydrazide derivative; hydrazine; n (2,4 dimethylphenyl) 2,2,2 trifluoro n' (3 hydroxybenzyli dene)acetohydrazide; n (2,4 dimethylphenyl) 2,2,2 trifluoro n' (3 methoxybenzyli dene)acetohydrazide; n' (3,4 dihydroxybenzylidene) n (2,4 dimethylphenyl) 2,2,2 trifluoroacetohydrazide; neuroprotective agent; unclassified drug; aerobic metabolism; animal cell; animal experiment; animal model; animal tissue; article; biological activity; carcinogenicity; controlled study; drug determination; drug metabolism; drug stability; embryo; human; human cell; microsome; mouse; neuroprotection; nonhuman; plasma; rat; Alzheimer Disease; Animals; Drug Discovery; Humans; Hydrazines; Male; Mice; Mice, Inbred BALB C; Animalia; Rodentia",,"hydrazine, 10217-52-4, 13775-80-9, 18500-32-8, 302-01-2, 7803-57-8; Hydrazines",,,,"Chen, Q., Prior, M., Dargusch, R., Roberts, A., Riek, R., Eichmann, C., Chiruta, C., Schubert, D., (2011) PLoS One, 6, p. 27865; Kucukguzel, S.G., Kucukguzel, I., Ulgen, M., (2000) Farmaco, 55, p. 624; Neumann, H.G., (2007) Crit. Rev. Toxicol., 37, p. 211; Benigni, R., Passerini, L., (2002) Mutat Res., 511, p. 191; Malca-Mor, L., Stark, A.A., (1982) Appl. Environ. Microbiol., 44, p. 801; Rollas, S., Kucukguzel, S.G., (1910) Molecules, 2007, p. 12; Behl, C., Davis, J.B., Lesley, R., Schubert, D., (1994) Cell, 77, p. 817; Maezawa, I., Hong, H.S., Wu, H.C., Battina, S.K., Rana, S., Iwamoto, T., Radke, G.A., Jin, L.W., (2006) J. Neurochem., 98, p. 57; Liu, Y., Dargusch, R., Maher, P., Schubert, D., (2008) J. Neurochem., 105, p. 1336; Ulgen, M., Ozer, U., Kucukguzel, I., Gorrod, J.W., (1997) Drug Metab. Drug Interact., 14, p. 83; Ulgen, M., Durgun, B.B., Rollas, S., Gorrod, J.W., (1997) Drug Metab. Drug Interact., 13, p. 285; Tapia-Arancibia, L., Aliaga, E., Silhol, M., Arancibia, S., (2008) Brain Res. Rev., 59, p. 201; Abe, K., Takayanagi, M., Saito, H., (1990) Jpn. J. Pharmacol., 53, p. 221; McPhie, D.L., Lee, R.K., Eckman, C.B., Olstein, D.H., Durham, S.P., Yager, D., Younkin, S.G., Neve, R.L., (1997) J. Biol. Chem., 272, p. 24743; Laferla, F.M., Green, K.N., Oddo, S., (2007) Nat. Rev. Neurosci., 8, p. 499; Sopher, B.L., Fukuchi, K., Smith, A.C., Leppig, K.A., Furlong, C.E., Martin, G.M., (1994) Brain Res. Mol. Brain Res., 26, p. 207; Davis, J.B., Maher, P., (1994) Brain Res., 652, p. 169; Tan, S., Schubert, D., Maher, P., (2001) Curr. Top. Med. Chem., 1, p. 497","Schubert, D.; Salk Institute for Biological Studies, San Diego, CA 92037-1002, United States; email: schubert@salk.edu",,,,,,,,09680896,,BMECE,23582448,"English","Bioorg. Med. Chem.",Article,Scopus,2-s2.0-84876678963
"Currais, A., Prior, M., Lo, D., Jolivalt, C., Schubert, D., Maher, P.","Diabetes exacerbates amyloid and neurovascular pathology in aging-accelerated mice",2012,"Aging Cell","11","6",,"1017","1026",,16,10.1111/acel.12002,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84869179307&partnerID=40&md5=c7565b3d9ad92ba83e65d15c3c6a3b62","The Salk Institute for Biological Studies, Laboratory of Cellular Neurobiology, 10010N. Torrey Pines Rd, La Jolla, CA 92037, United States; The Salk Institute for Biological Studies, Laboratory of Neuronal Structure and Function, 10010N. Torrey Pines Rd, La Jolla, CA 92037, United States; University of California San Diego, Department of Pathology, 9500 Gilman Dr., La Jolla, CA 92093, United States","Currais, A., The Salk Institute for Biological Studies, Laboratory of Cellular Neurobiology, 10010N. Torrey Pines Rd, La Jolla, CA 92037, United States; Prior, M., The Salk Institute for Biological Studies, Laboratory of Cellular Neurobiology, 10010N. Torrey Pines Rd, La Jolla, CA 92037, United States; Lo, D., The Salk Institute for Biological Studies, Laboratory of Neuronal Structure and Function, 10010N. Torrey Pines Rd, La Jolla, CA 92037, United States; Jolivalt, C., University of California San Diego, Department of Pathology, 9500 Gilman Dr., La Jolla, CA 92093, United States; Schubert, D., The Salk Institute for Biological Studies, Laboratory of Cellular Neurobiology, 10010N. Torrey Pines Rd, La Jolla, CA 92037, United States; Maher, P., The Salk Institute for Biological Studies, Laboratory of Cellular Neurobiology, 10010N. Torrey Pines Rd, La Jolla, CA 92037, United States","Mounting evidence supports a link between diabetes, cognitive dysfunction, and aging. However, the physiological mechanisms by which diabetes impacts brain function and cognition are not fully understood. To determine how diabetes contributes to cognitive dysfunction and age-associated pathology, we used streptozotocin to induce type 1 diabetes (T1D) in senescence-accelerated prone 8 (SAMP8) and senescence-resistant 1 (SAMR1) mice. Contextual fear conditioning demonstrated that T1D resulted in the development of cognitive deficits in SAMR1 mice similar to those seen in age-matched, nondiabetic SAMP8 mice. No further cognitive deficits were observed when the SAMP8 mice were made diabetic. T1D dramatically increased Aβ and glial fibrillary acidic protein immunoreactivity in the hippocampus of SAMP8 mice and to a lesser extent in age-matched SAMR1 mice. Further analysis revealed aggregated Aβ within astrocyte processes surrounding vessels. Western blot analyses from T1D SAMP8 mice showed elevated amyloid precursor protein processing and protein glycation along with increased inflammation. T1D elevated tau phosphorylation in the SAMR1 mice but did not further increase it in the SAMP8 mice where it was already significantly higher. These data suggest that aberrant glucose metabolism potentiates the aging phenotype in old mice and contributes to early stage central nervous system pathology in younger animals. © 2012 The Authors. Aging Cell © 2012 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland.","Advanced glycation end-products; Aging; Alzheimer's disease; Amyloid angiopathy; Diabetes; Neurovascular inflammation","amyloid beta protein; amyloid precursor protein; glial fibrillary acidic protein; tau protein; aging; Alzheimer disease; animal cell; animal experiment; animal model; animal tissue; article; astrocyte; astrocytosis; behavior; cognitive defect; controlled study; disease association; disease exacerbation; fear; glucose metabolism; hippocampus; immunoreactivity; male; mouse; neuropathology; non insulin dependent diabetes mellitus; nonhuman; phenotype; priority journal; protein aggregation; protein glycosylation; protein phosphorylation; protein processing; senescence accelerated mouse; Western blotting; Age Factors; Aging; Amyloid beta-Peptides; Animals; Astrocytes; Blood Vessels; Cognition Disorders; Diabetes Mellitus, Experimental; Gene Expression; Glial Fibrillary Acidic Protein; Glycosylation; Glycosylation End Products, Advanced; Hippocampus; Humans; Male; Mice; Mice, Transgenic; Phosphorylation; Streptozocin; tau Proteins; Animalia; Mus",,"amyloid beta protein, 109770-29-8; Amyloid beta-Peptides; Glial Fibrillary Acidic Protein; Glycosylation End Products, Advanced; Streptozocin, 18883-66-4; tau Proteins",,,,"Abbott, N.J., Ronnback, L., Hansson, E., Astrocyte-endothelial interactions at the blood-brain barrier (2006) Nat. Rev., 7, pp. 41-53; Akter, K., Lanza, E.A., Martin, S.A., Myronyuk, N., Rua, M., Raffa, R.B., Diabetes mellitus and Alzheimer's disease: shared pathology and treatment? (2011) Br. J. Clin. Pharmacol., 71, pp. 365-376; Berg, L., McKeel Jr, D.W., Miller, J.P., Storandt, M., Rubin, E.H., Morris, J.C., Baty, J., Saunders, A.M., Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype (1998) Arch. Neurol., 55, pp. 326-335; Biessels, G.J., Deary, I.J., Ryan, C.M., Cognition and diabetes: a lifespan perspective (2008) Lancet Neurol., 7, pp. 184-190; Bishop, N.A., Lu, T., Yankner, B.A., Neural mechanisms of ageing and cognitive decline (2010) Nature, 464, pp. 529-535; Buettner, G.R., Superoxide dismutase in redox biology: the roles of superoxide and hydrogen peroxide (2011) Anticancer Agents Med. Chem., 11, pp. 341-346; Burdo, J.R., Chen, Q., Calcutt, N.A., Schubert, D., The pathological interaction between diabetes and presymptomatic Alzheimer's disease (2009) Neurobiol. Aging, 30, pp. 1910-1917; Canudas, A.M., Gutierrez-Cuesta, J., Rodriguez, M.I., Acuna-Castroviejo, D., Sureda, F.X., Camins, A., Pallas, M., Hyperphosphorylation of microtubule-associated protein tau in senescence-accelerated mouse (SAM) (2005) Mech. Ageing Dev., 126, pp. 1300-1304; Deane, R., Zlokovic, B.V., Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease (2007) Curr. Alzheimer Res., 4, pp. 191-197; Del Valle, J., Duran-Vilaregut, J., Manich, G., Casadesus, G., Smith, M.A., Camins, A., Pallas, M., Vilaplana, J., Early amyloid accumulation in the hippocampus of SAMP8 mice (2010) J. Alzheimers Dis., 19, pp. 1303-1315; Del Valle, J., Duran-Vilaregut, J., Manich, G., Pallas, M., Camins, A., Vilaplana, J., Pelegri, C., Cerebral amyloid angiopathy, blood-brain barrier disruption and amyloid accumulation in SAMP8 mice (2011) Neurodegener. Dis., 8, pp. 421-429; Duvernoy, H.M., (2005) The Human Hippocampus: Functional Anatomy, Vascularization and Serial Sections with MRI, , 3rd edn. New York: Springer; Dyer, D.G., Dunn, J.A., Thorpe, S.R., Bailie, K.E., Lyons, T.J., McCance, D.R., Baynes, J.W., Accumulation of Maillard reaction products in skin collagen in diabetes and aging (1993) J. Clin. Invest., 91, pp. 2463-2469; Gerich, J.E., Insulin-dependent diabetes mellitus: pathophysiology (1986) Mayo Clin. Proc., 61, pp. 787-791; Giannakopoulos, P., Kovari, E., Gold, G., von Gunten, A., Hof, P.R., Bouras, C., Pathological substrates of cognitive decline in Alzheimer's disease (2009) Front Neurol. Neurosci., 24, pp. 20-29; Grammas, P., Neurovascular dysfunction, inflammation and endothelial activation: implications for the pathogenesis of Alzheimer's disease (2011) J. Neuroinflammation, 8, p. 26; Greenberg, M.E., Xu, B., Lu, B., Hempstead, B.L., New insights in the biology of BDNF synthesis and release: implications in CNS function (2009) J. Neurosci., 29, pp. 12764-12767; Hoozemans, J.J., Rozemuller, J.M., van Haastert, E.S., Veerhuis, R., Eikelenboom, P., Cyclooxygenase-1 and -2 in the different stages of Alzheimer's disease pathology (2008) Curr. Pharm. Des., 14, pp. 1419-1427; Huber, J.D., VanGilder, R.L., Houser, K.A., Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats (2006) Am. J. Physiol. Heart Circ. Physiol., 291, pp. H2660-H2668; Ikura, Y., Kudo, T., Tanaka, T., Tanii, H., Grundke-Iqbal, I., Iqbal, K., Takeda, M., Levels of tau phosphorylation at different sites in Alzheimer disease brain (1998) NeuroReport, 9, pp. 2375-2379; Jolivalt, C.G., Lee, C.A., Beiswenger, K.K., Smith, J.L., Orlov, M., Torrance, M.A., Masliah, E., Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin (2008) J. Neurosci. Res., 86, pp. 3265-3274; Jolivalt, C.G., Hurford, R., Lee, C.A., Dumaop, W., Rockenstein, E., Masliah, E., Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice (2010) Exp. Neurol., 223, pp. 422-431; Kim, B., Backus, C., Oh, S., Hayes, J.M., Feldman, E.L., Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes (2009) Endocrinology, 150, pp. 5294-5301; Kuhla, B., Boeck, K., Schmidt, A., Ogunlade, V., Arendt, T., Munch, G., Luth, H.J., Age- and stage-dependent glyoxalase I expression and its activity in normal and Alzheimer's disease brains (2007) Neurobiol. Aging, 28, pp. 29-41; Kumar, V.B., Farr, S.A., Flood, J.F., Kamlesh, V., Franko, M., Banks, W.A., Morley, J.E., Site-directed antisense oligonucleotide decreases the expression of amyloid precursor protein and reverses deficits in learning and memory in aged SAMP8 mice (2000) Peptides, 21, pp. 1769-1775; Li, C., Zhao, R., Gao, K., Wei, Z., Yin, M.Y., Lau, L.T., Chui, D., Hoi Yu, A.C., Astrocytes: implications for neuroinflammatory pathogenesis of Alzheimer's disease (2011) Curr. Alzheimer Res., 8, pp. 67-80; Maher, P.A., Schubert, D.R., Metabolic links between diabetes and Alzheimer's disease (2009) Expert Rev. Neurother., 9, pp. 617-630; Mazzone, T., Chait, A., Plutzky, J., Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies (2008) Lancet, 371, pp. 1800-1809; Mulder, S.D., Veerhuis, R., Blankenstein, M.A., Nielsen, H.M., The effect of amyloid associated proteins on the expression of genes involved in amyloid-beta clearance by adult human astrocytes (2011) Exp. Neurol., 233, pp. 373-379; Pallas, M., Camins, A., Smith, M.A., Perry, G., Lee, H.G., Casadesus, G., From aging to Alzheimer's disease: unveiling ""the switch"" with the senescence-accelerated mouse model (SAMP8) (2008) J. Alzheimers Dis., 15, pp. 615-624; Roriz-Filho, J.S., Sa-Roriz, T.M., Rosset, I., Camozzato, A.L., Santos, A.C., Chaves, M.L., Moriguti, J.C., Roriz-Cruz, M., (Pre)diabetes, brain aging, and cognition (2009) Biochim. Biophys. Acta, 1792, pp. 432-443; Schleicher, E.D., Wagner, E., Nerlich, A.G., Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging (1997) J. Clin. Invest., 99, pp. 457-468; Shoji, M., Okada, M., Ohta, A., Higuchi, K., Hosokawa, M., Honda, Y., A morphological and morphometrical study of the retina in aging SAM mice (1998) Ophthalmic Res., 30, pp. 172-179; Singh, R., Barden, A., Mori, T., Beilin, L., Advanced glycation end-products: a review (2001) Diabetologia, 44, pp. 129-146; Srikanth, V., Maczurek, A., Phan, T., Steele, M., Westcott, B., Juskiw, D., Munch, G., Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease (2011) Neurobiol. Aging, 32, pp. 763-777; Swerdlow, R.H., Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging? (2007) Neurobiol. Aging, 28, pp. 1465-1480; Takeda, T., Senescence-accelerated mouse (SAM) with special references to neurodegeneration models, SAMP8 and SAMP10 mice (2009) Neurochem. Res., 34, pp. 639-659; Takeda, S., Sato, N., Uchio-Yamada, K., Sawada, K., Kunieda, T., Takeuchi, D., Kurinami, H., Morishita, R., Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes (2010) Proc. Natl Acad. Sci. U.S.A., 107, pp. 7036-7041; Thinakaran, G., Koo, E.H., Amyloid precursor protein trafficking, processing, and function (2008) J. Biol. Chem., 283, pp. 29615-29619; Thornalley, P.J., Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification - a role in pathogenesis and antiproliferative chemotherapy (1996) Gen. Pharmacol., 27, pp. 565-573; Utter, S., Tamboli, I.Y., Walter, J., Upadhaya, A.R., Birkenmeier, G., Pietrzik, C.U., Ghebremedhin, E., Thal, D.R., Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes (2008) J. Neuropathol. Exp. Neurol., 67, pp. 842-856; Wrighten, S.A., Piroli, G.G., Grillo, C.A., Reagan, L.P., A look inside the diabetic brain: contributors to diabetes-induced brain aging (2009) Biochim. Biophys. Acta, 1792, pp. 444-453; Xue, M., Rabbani, N., Thornalley, P.J., Glyoxalase in ageing (2011) Semin. Cell Dev. Biol., 22, pp. 293-301","Maher, P.; Laboratory of Cellular Neurobiology, The Salk Institute for Biological Studies, 10010N. Torrey Pines Rd, La Jolla, CA 92037, United States; email: pmaher@salk.edu",,,,,,,,14749718,,ACGEC,22938075,"English","Aging Cell",Article,Scopus,2-s2.0-84869179307
"Schubert, D., Maher, P.","An alternative approach to drug discovery for Alzheimers disease dementia",2012,"Future Medicinal Chemistry","4","13",,"1681","1688",,13,10.4155/fmc.12.109,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84865721851&partnerID=40&md5=099cd89a5ed56459821ec9e64c5febb2","Salk Institute for Biological Studies, Cellular Neurobiology Laboratory, 10010 North Torrey Pines Road, San Diago, CA 92037-1002, United States","Schubert, D., Salk Institute for Biological Studies, Cellular Neurobiology Laboratory, 10010 North Torrey Pines Road, San Diago, CA 92037-1002, United States; Maher, P., Salk Institute for Biological Studies, Cellular Neurobiology Laboratory, 10010 North Torrey Pines Road, San Diago, CA 92037-1002, United States","There are no drugs that halt the progression of any age-associated neurodegenerative disease. This may be due to the failure of drug developers to recognize that while there are mutations that predispose individuals to disease as they get older, the vast majority of neurodegenerative diseases arise from a confluence of multiple toxic insults. Thus, it is unlikely that the current single-target approach is going to yield useful drugs for these conditions. The identification of multi-target lead compounds is needed and their selection should be based upon a requirement for their efficacy in phenotypic screening assays that reflect the biology of the aging brain. This approach to neurodegenerative disease drug discovery is likely to produce safe and effective drugs. © 2012 Future Science Ltd.",,"natural product; polyphenol derivative; aging; Alzheimer disease; degenerative disease; drug efficacy; drug research; drug targeting; gene mutation; genetic predisposition; human; nonhuman; phenotype; priority journal; review; Alzheimer Disease; Animals; Biological Agents; Brain; Dementia; Drug Discovery; Humans",,"Biological Agents",,,,"McKhann, G.M., Knopman, D.S., Chertkow, H., The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease (2011) Alzheimers Dement, 7 (3), pp. 263-269; Polidori, M.C., Pientka, L., Bridging the pathophysiology of Alzheimer's disease with vascular pathology: The feed-back, the feed-forward, and oxidative stress (2012) J. Alzheimers Dis., 28 (1), pp. 1-9; Schneider, J.A., Arvanitakis, Z., Bang, W., Bennett, D.A., Mixed brain pathologies account for most dementia cases in community-dwelling older persons (2007) Neurology, 69 (24), pp. 2197-2204; Chen, M., Maleski, J.J., Sawmiller, D.R., Scientific truth or false hope? Understanding Alzheimer's disease from an aging perspective (2011) J. Alzheimers Dis., 24 (1), pp. 3-10; Harman, D., Alzheimer's disease pathogenesis: Role of aging (2006) Ann. NY Acad. Sci., 1067, pp. 454-460; Brayne, C., Matthews, F.E., Xuereb, J.H., Pathological correlates of lateonset dementia in a multicentre, community-based population in England and Wales (2001) Lancet, 357, pp. 169-175. , Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS; Rishton, G.M., Natural products as a robust source of new drugs and drug leads: Past successes and present day issues (2008) Am. J. Cardiol., 101 (10 A), pp. 43D-49D; Swinney, D.C., Anthony, J., How were new medicines discovered? (2011) Nat. Rev. Drug Discov., 10 (7), pp. 507-519; Munos, B., Lessons from 60 years of pharmaceutical innovation (2009) Nat. Rev. Drug Discov., 8 (12), pp. 959-968; Paul, S.M., Mytelka, D.S., Dunwiddie, C.T., How to improve R&D productivity: The pharmaceutical industry's grand challenge (2010) Nat. Rev. Drug Discov., 9 (3), pp. 203-214; Pangalos, M.N., Schechter, L.E., Hurko, O., Drug development for CNS disorders: Strategies for balancing risk and reducing attrition (2007) Nat. Rev. Drug Discov., 6 (7), pp. 521-532; Overington, J.P., Al-Lazikani, B., Hopkins, A.L., How many drug targets are there? (2006) Nat. Rev. Drug Discov., 5 (12), pp. 993-996; Hyman, S.E., Fenton, W.S., Medicine What are the right targets for psychopharmacology? (2003) Science, 299 (5605), pp. 350-351; Golde, T.E., Schneider, L.S., Koo, E.H., Anti-abeta therapeutics in Alzheimer's disease: The need for a paradigm shift (2011) Neuron, 69 (2), pp. 203-213; Bouras, C., Hof, P.R., Giannakopoulos, P., Michel, J.P., Morrison, J.H., Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: A quantitative evaluation of a one-year autopsy population from a geriatric hospital (1994) Cereb. Cortex, 4 (2), pp. 138-150; Price, J.L., Morris, J.C., Tangles and plaques in nondemented aging and 'preclinical' alzheimer's disease (1999) Ann. Neurol., 45 (3), pp. 358-368; Ashe, K.H., Zahs, K.R., Probing the biology of Alzheimer's disease in mice (2010) Neuron, 66 (5), pp. 631-645; Tomobe, K., Nomura, Y., Neurochemistry, neuropathology, and heredity in SAMP8: A mouse model of senescence (2009) Neurochem. Res., 34 (4), pp. 660-669; De Jager, P.L., Shulman, J.M., Chibnik, L.B., A genome-wide scan for common variants affecting the rate of age-related cognitive decline (2011) Neurobiol. Aging, 33 (5), pp. e1-e15; Logue, M.W., Schu, M., Vardarajan, B.N., A comprehensive genetic association study of Alzheimer disease in African Americans (2011) Arch. Neurol., 68 (12), pp. 1569-1579; Radak, Z., Hart, N., Sarga, L., Exercise plays a preventive role against Alzheimer's disease (2010) J. Alzheimers Dis., 20 (3), pp. 777-783; Gu, Y., Nieves, J.W., Stern, Y., Luchsinger, J.A., Scarmeas, N., Food combination and Alzheimer disease risk: A protective diet (2010) Arch. Neurol., 67 (6), pp. 699-706; Mangialasche, F., Kivipelto, M., Mecocci, P., High plasma levels of vitamin e forms and reduced Alzheimer's disease risk in advanced age (2010) J. Alzheimers Dis., 20 (4), pp. 1029-1037; Pezet, S., Malcangio, M., Brain-derived neurotrophic factor as a drug target for CNS disorders (2004) Expert Opin. Ther. Targets, 8 (5), pp. 391-399; Lewerenz, J., Maher, P., Control of redox state and redox signaling by neural antioxidant systems (2011) Antioxid. Redox Signal., 14, pp. 1449-1465; Stranahan, A.M., Mattson, M.P., Metabolic reserve as a determinant of cognitive aging (2011) J. Alzheimers Dis., , doi:10.3233/JAD-2011-110899, Epub; Simonsen, A., Cumming, R.C., Brech, A., Promoting basal levels of autophagy in the nervous system enhances longevity and oxidant resistance in adult Drosophila (2008) Autophagy, 4 (2), pp. 176-184; Le Luo, G.R.W.D., Collective roles of molecular chaperones in protein degradation pathways associated with neurodegenerative diseases (2010) Curr. Pharm. Biotechnol., 11 (2), pp. 180-187; Hopkins, A.L., Drug discovery: Predicting promiscuity (2009) Nature, 462 (7270), pp. 167-168; Extance, A., Alzheimer's failure raises questions about disease-modifying strategies (2010) Nat. Rev. Drug Discov., 9 (10), pp. 749-751; Demehri, S., Turkoz, A., Kopan, R., Epidermal Notch1 loss promotes skin tumorigenesis by impacting the stromal microenvironment (2009) Cancer Cell, 16 (1), pp. 55-66; Ginsberg, M.D., Neuroprotection for ischemic stroke: Past, present and future (2008) Neuropharmacology, 55 (3), pp. 363-389; Liu, Y., Dargusch, R., Maher, P., Schubert, D., A broadly neuroprotective derivative of curcumin (2008) J. Neurochem., 105, pp. 1336-1345; Chen, Q., Prior, M., Dargusch, R., A novel neurotrophic drug for cognitive enhancement and Alzheimer's disease (2011) PLoS ONE, 6 (12), pp. e26755; Abe, K., Takayanagi, M., Saito, H., Effects of recombinant human basic FGF and its modified protein CS23 on survival of primary cultured neurons from various regions of fetal rat brain (1990) Jpn J. Pharmacol., 53, pp. 221-227; Rossler, O.G., Giehl, K.M., Thiel, G., Neuroprotection of immortalized hippocampal neurones by brain-derived neurotrophic factor and Raf-1 protein kinase: Role of extracellular signal-regulated protein kinase and phosphatidylinositol 3-kinase (2004) J. Neurochem., 88 (5), pp. 1240-1252; Chen, J., Zacharek, A., Zhang, C., Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice (2005) J. Neurosci., 25 (9), pp. 2366-2375; Olin, D., MacMurray, J., Comings, D.E., Risk of late-onset Alzheimer's disease associated with BDNF C270T polymorphism (2005) Neurosci. Lett., 381 (3), pp. 275-278; Tapia-Arancibia, L., Aliaga, E., Silhol, M., Arancibia, S., New insights into brain BDNF function in normal aging and Alzheimer disease (2008) Brain Res. Rev., 59 (1), pp. 201-220; Tan, S., Schubert, D., Maher, P., Oxytosis: A novel form of programmed cell death (2001) Curr. Topics Med. Chem., 1, pp. 497-506; Dixon, S.J., Lemberg, K.M., Lamprecht, M.R., Ferroptosis: An iron-dependent form of nonapoptotic cell death (2012) Cell, 149 (5), pp. 1060-1072; Winkler, B.S., Sauer, M.W., Starnes, C.A., Modulation of the Pasteur effect in retinal cells: Implications for understanding compensatory metabolic mechanisms (2003) Exp. Eye Res., 76 (6), pp. 715-723; Maher, P., Salgado, K.F., Zivin, J.A., Lapchak, P.A., A novel approach to screening for new neuroprotective compounds for the treatment of stroke (2007) Brain Res., 1173, pp. 117-125; Yankner, B.A., Duffy, L.K., Kirschner, D.A., Neurotrophic and neurotoxic effects of amyloid beta protein: Reversal by tachykinin neuropeptides (1990) Science, 250 (4978), pp. 279-282; Sopher, B.L., Fukuchi, K., Kavanagh, T.J., Furlong, C.E., Martin, G.M., Neurodegenerative mechanisms in Alzheimer disease. A role for oxidative damage in amyloid beta protein precursor-mediated cell death (1996) Mol. Chem. Neuropathol., 29 (2-3), pp. 153-168; Schubert, D., Piasecki, D., Oxidative glutamate toxicity can be a component of the excitotoxicity cascade (2001) J. Neurosci., 21, pp. 7455-7462; Maher, P., Akaishi, T., Schubert, D., Abe, K., A pyrazole derivative of curcumin enhances memory (2010) Neurobiol. Aging, 31 (4), pp. 706-709; Lapchak, P.A., Schubert, D.R., Maher, P.A., Delayed treatment with a novel neurotrophic compound reduces behavioral deficits in rabbit ichemic stroke (2011) J. Neurochem., 116, pp. 122-131; Wu, A., Ying, Z., Schubert, D., Gomez-Pinilla, F., Brain and spinal cord interaction: A dietary curcumin derivative counteracts locomotor and cognitive deficits after brain trauma (2011) Neurorehabil. Neural Repair, 25 (4), pp. 332-342; Sharma, S., Ying, Z., Gomez-Pinilla, F., A pyrazole curcumin derivative restores membrane homeostasis disrupted after brain trauma (2010) Exp. Neurol., 226 (1), pp. 191-199; Sharma, S., Zhuang, Y., Ying, Z., Wu, A., Gomez-Pinilla, F., Dietary curcumin supplementation counteracts reduction in levels of molecules involved in energy homeostasis after brain trauma (2009) Neuroscience, 161 (4), pp. 1037-1044; Maher, P., Akaishi, T., Abe, K., Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory (2006) Proc. Natl Acad. Sci. USA, 103 (44), pp. 16568-16573; Gelderblom, M., Leypoldt, F., Lewerenz, J., The flavonoid fisetin attenuates post-ischemic immune cell infiltration, activation and infarct size after transient cerebral middle artery occlusion in mice (2012) J. Cereb. Blood Flow Metab., 32, pp. 835-843; Maher, P., Dargusch, R., Bodai, R., ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease (2011) Human Mol. Genet., 20 (2), pp. 261-270; Maher, P., Dargusch, R., Ehren, J.L., Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetes (2011) PLoS ONE, 6 (6), pp. e21226; Chiruta, C., Schubert, D., Dargusch, R., Maher, P.A., Chemical modification of the multi-target neuroprotective compound fisetin (2012) J. Med. Chem., 55 (1), pp. 378-389; Ganesan, A., The impact of natural products upon modern drug discovery (2008) Curr. Opin. Chem. Biol., 12 (3), pp. 306-317; Harmer, N.J., Insights into the role of heparan sulphate in fibroblast growth factor signalling (2006) Biochem. Soc. Trans., 34 (3), pp. 442-445; Halliwell, B., Free radicals and antioxidants - Quo vadis? (2011) Trends Pharmacol Sci., 32 (3), pp. 125-130; Frautschy, S.A., Cole, G.M., Why pleiotropic interventions are needed for Alzheimer's disease (2010) Mol. Neurobiol., 41 (2-3), pp. 392-409; Herrup, K., Reimagining Alzheimer's disease - An age-based hypothesis (2010) J. Neurosci., 30 (50), pp. 16755-16762; Zhan, P., Liu, X., Designed multiple ligands: An emerging anti-HIV drug discovery paradigm (2009) Curr. Pharm. Des., 15 (16), pp. 1893-1917; Law, M.R., Wald, N.J., Morris, J.K., Jordan, R.E., Value of low dose combination treatment with blood pressure lowering drugs: Analysis of 354 randomised trials (2003) BMJ, 326 (7404), p. 1427; Yang, F., Lim, G.P., Begum, A.N., Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo (2005) J. Biol. Chem., 280, pp. 5892-5901; www.clinicaltrials.gov, ClinicalTrials.gov","Schubert, D.; Salk Institute for Biological Studies, Cellular Neurobiology Laboratory, 10010 North Torrey Pines Road, San Diago, CA 92037-1002, United States; email: schubert@salk.edu",,,,,,,,17568919,,,22924506,"English","Future. Med. Chem.",Review,Scopus,2-s2.0-84865721851
"Narumoto, O., Matsuo, Y., Sakaguchi, M., Shoji, S., Yamashita, N., Schubert, D., Abe, K., Horiguchi, K., Nagase, T., Yamashita, N.","Suppressive effects of a pyrazole derivative of curcumin on airway inflammation and remodeling",2012,"Experimental and Molecular Pathology","93","1",,"18","25",,8,10.1016/j.yexmp.2012.04.011,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84860787059&partnerID=40&md5=25ffac7a9e30c38445cbe7e224baf97a","Department of Pharmacotherapy, Research Institute of Pharmaceutical Sciences, Musashino University, Tokyo, Japan; Department of Pulmonary Medicine, Faculty of Medicine University of Tokyo, Tokyo, Japan; Department of Veterinary Microbiology, School of Veterinary Medicine, Azabu University, Kanagawa, Japan; Division of Clinical Research, National Hospital Organization Tokyo National Hospital, Tokyo, Japan; Department of Advanced Medical Science, Institute of Medical Science University of Tokyo, Tokyo, Japan; The Salk Institute, Laboratories for Cellular Neurobiology, La Jolla, CA, United States; Department of Pharmacology, Research Institute of Pharmaceutical Sciences, Musashino University, Tokyo, Japan; Department of Anatomy, Faculty of Medical Science, University of Fukui, Fukui, Japan","Narumoto, O., Department of Pharmacotherapy, Research Institute of Pharmaceutical Sciences, Musashino University, Tokyo, Japan, Department of Pulmonary Medicine, Faculty of Medicine University of Tokyo, Tokyo, Japan; Matsuo, Y., Department of Pharmacotherapy, Research Institute of Pharmaceutical Sciences, Musashino University, Tokyo, Japan; Sakaguchi, M., Department of Veterinary Microbiology, School of Veterinary Medicine, Azabu University, Kanagawa, Japan; Shoji, S., Division of Clinical Research, National Hospital Organization Tokyo National Hospital, Tokyo, Japan; Yamashita, N., Department of Advanced Medical Science, Institute of Medical Science University of Tokyo, Tokyo, Japan; Schubert, D., The Salk Institute, Laboratories for Cellular Neurobiology, La Jolla, CA, United States; Abe, K., Department of Pharmacology, Research Institute of Pharmaceutical Sciences, Musashino University, Tokyo, Japan; Horiguchi, K., Department of Anatomy, Faculty of Medical Science, University of Fukui, Fukui, Japan; Nagase, T., Department of Pulmonary Medicine, Faculty of Medicine University of Tokyo, Tokyo, Japan; Yamashita, N., Department of Pharmacotherapy, Research Institute of Pharmaceutical Sciences, Musashino University, Tokyo, Japan","To advance the control of airway epithelial cell function and asthma, we investigated the effects of a new curcumin derivative, CNB001, which possesses improved pharmacological properties. Normal human bronchial epithelial (NHBE) cells were stimulated with synthetic double-stranded RNA, Poly(I:C). CNB001 significantly suppressed IL-6, TNF-α, and GM-CSF production by NHBE cells, and did so more effectively than did curcumin or dexamethasone (DEX). CNB001 significantly inhibited the decrease of E-cadherin mRNA expression and increase of vimentin mRNA expression observed in NHBE cells induced by a combination of TGF-β1 and TNF-α, which are markers of airway remodeling. In NHBE cells stimulated by TGF-β1, CNB001 significantly downregulated the level of active serine peptidase inhibitor clade E member (SERPINE) 1, which is also reported to be related to airway remodeling. Whereas DEX alone significantly increased the active SERPINE1 level, the combination of DEX and CNB001 significantly suppressed active SERPINE1. In addition, CNB001 significantly suppressed neutrophil infiltration, IL-6, TNF-α, IL-13 and active SERPINE1 production in bronchoalveolar lavage fluid of the murine asthma model, which was not observed in the case of DEX. In conclusion, the curcumin derivative, CNB001, is a promising candidate to treat asthma associated with neutrophilic airway inflammation and remodeling. © 2012 Elsevier Inc.","Airway remodeling; Asthma; Curcumin derivative; EMT","cnb 001; curcumin; dexamethasone; granulocyte macrophage colony stimulating factor; interleukin 13; interleukin 6; messenger RNA; plasminogen activator inhibitor 1; polyinosinic polycytidylic acid; pyrazole derivative; transforming growth factor beta1; tumor necrosis factor alpha; unclassified drug; uvomorulin; vimentin; airway remodeling; animal experiment; animal model; animal tissue; antiinflammatory activity; article; asthma; bronchus mucosa; cell protection; controlled study; down regulation; drug effect; epithelium cell; female; human; human cell; human cell culture; immunoassay; in vitro study; in vivo study; lung lavage; mouse; neutrophil chemotaxis; nonhuman; real time polymerase chain reaction; respiratory tract inflammation; Airway Remodeling; Animals; Asthma; Bronchi; Cadherins; Curcumin; Cytokines; Dexamethasone; Female; Glucocorticoids; Humans; Mice; Mice, Inbred BALB C; Plasminogen Activator Inhibitor 1; Pyrazoles; RNA, Double-Stranded; Murinae",,"curcumin, 458-37-7; dexamethasone, 50-02-2; interleukin 13, 148157-34-0; plasminogen activator inhibitor 1, 140208-23-7; polyinosinic polycytidylic acid, 24939-03-5, 26301-44-0; uvomorulin, 112956-45-3; CNB 001; Cadherins; Curcumin, 458-37-7; Cytokines; Dexamethasone, 50-02-2; Glucocorticoids; Plasminogen Activator Inhibitor 1; Pyrazoles; RNA, Double-Stranded; SERPINE1 protein, human","cnb 001","Sigma Aldrich, United States",,"Aggarwal, B.B., Harikumar, K.B., Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases (2009) The International Journal of Biochemistry & Cell Biology, 41, pp. 40-59; Anand, P., Kunnumakkara, A.B., Newman, R.A., Aggarwal, B.B., Bioavailability of curcumin: problems and promises (2007) Molecular Pharmaceutics, 4, pp. 807-818; Ather, J.L., Ckless, K., Martin, R., Foley, K.L., Suratt, B.T., Boyson, J.E., Fitzgerald, K.A., Poynter, M.E., Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice (2011) Journal of Immunology, 187, pp. 64-73; Bachar, O., Adner, M., Uddman, R., Cardell, L.O., Toll-like receptor stimulation induces airway hyper-responsiveness to bradykinin, an effect mediated by JNK and NF-kappa B signaling pathways (2004) European Journal of Immunology, 34, pp. 1196-1207; Bruewer, M., Luegering, A., Kucharzik, T., Parkos, C.A., Madara, J.L., Hopkins, A.M., Nusrat, A., Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms (2003) Journal of Immunology, 171, pp. 6164-6172; Brusselle, G., Kips, J., Joos, G., Bluethmann, H., Pauwels, R., Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice (1995) American Journal of Respiratory Cell and Molecular Biology, 12, pp. 254-259; Camacho-Barquero, L., Villegas, I., Sanchez-Calvo, J.M., Talero, E., Sanchez-Fidalgo, S., Motilva, V., Alarcon de la Lastra, C., Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis (2007) International Immunopharmacology, 7, pp. 333-342; Chi, X.Y., Jiang, S.J., Wang, J., Wang, J.P., Effect of glucocorticoid in mice of asthma induced by ovalbumin sensitisation and RSV infection (2011) Asian Pacific Journal of Allergy and Immunology, 29, pp. 176-180; Dennler, S., Itoh, S., Vivien, D., ten Dijke, P., Huet, S., Gauthier, J.M., Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene (1998) EMBO Journal, 17, pp. 3091-3100; Doerner, A.M., Zuraw, B.L., TGF-beta1 induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells is enhanced by IL-1beta but not abrogated by corticosteroids (2009) Respiratory Research, 10, p. 100; Doherty, T.A., Croft, M., Therapeutic potential of targeting TNF/TNFR family members in asthma (2011) Immunotherapy, 3, pp. 919-921; Fahy, J.V., Kim, K.W., Liu, J., Boushey, H.A., Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation (1995) The Journal of Allergy and Clinical Immunology, 95, pp. 843-852; Fang, J., Lu, J., Holmgren, A., Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity (2005) Journal of Biological Chemistry, 280, pp. 25284-25290; Fattouh, R., Pouladi, M.A., Alvarez, D., Johnson, J.R., Walker, T.D., Goncharova, S., Inman, M.D., Jordana, M., House dust mite facilitates ovalbumin-specific allergic sensitization and airway inflammation (2005) American Journal of Respiratory and Critical Care Medicine, 172, pp. 314-321; Gaedeke, J., Noble, N.A., Border, W.A., Curcumin blocks multiple sites of the TGF-beta signaling cascade in renal cells (2004) Kidney International, 66, pp. 112-120; Gizycki, M.J., Adelroth, E., Rogers, A.V., O'Byrne, P.M., Jeffery, P.K., Myofibroblast involvement in the allergen-induced late response in mild atopic asthma (1997) American Journal of Respiratory Cell and Molecular Biology, 16, pp. 664-673; Gough, L., Campbell, E., Bayley, D., Van Heeke, G., Shakib, F., Proteolytic activity of the house dust mite allergen Der p 1 enhances allergenicity in a mouse inhalation model (2003) Clinical and Experimental Allergy, 33, pp. 1159-1163; Groskreutz, D.J., Monick, M.M., Powers, L.S., Yarovinsky, T.O., Look, D.C., Hunninghake, G.W., Respiratory syncytial virus induces TLR3 protein and protein kinase R, leading to increased double-stranded RNA responsiveness in airway epithelial cells (2006) Journal of Immunology, 176, pp. 1733-1740; Ha, H., Oh, E.Y., Lee, H.B., The role of plasminogen activator inhibitor 1 in renal and cardiovascular diseases (2009) Nature Reviews Nephrology, 5, pp. 203-211; Hackett, T.L., Warner, S.M., Stefanowicz, D., Shaheen, F., Pechkovsky, D.V., Murray, L.A., Argentieri, R., Knight, D.A., Induction of epithelial-mesenchymal transition in primary airway epithelial cells from patients with asthma by transforming growth factor-beta1 (2009) American Journal of Respiratory and Critical Care Medicine, 180, pp. 122-133; Holgate, S.T., A look at the pathogenesis of asthma: the need for a change in direction (2010) Discovery Medicine, 9, pp. 439-447; Holgate, S.T., Davies, D.E., Lackie, P.M., Wilson, S.J., Puddicombe, S.M., Lordan, J.L., Epithelial-mesenchymal interactions in the pathogenesis of asthma (2000) The Journal of Allergy and Clinical Immunology, 105, pp. 193-204; Huang, W., Xu, C., Kahng, K.W., Noble, N.A., Border, W.A., Huang, Y., Aldosterone and TGF-beta1 synergistically increase PAI-1 and decrease matrix degradation in rat renal mesangial and fibroblast cells (2008) American Journal of Physiology. Renal Physiology, 294, pp. F1287-F1295; Jang, B.C., Lim, K.J., Suh, M.H., Park, J.G., Suh, S.I., Dexamethasone suppresses interleukin-1beta-induced human beta-defensin 2 mRNA expression: involvement of p38 MAPK, JNK, MKP-1, and NF-kappaB transcriptional factor in A549 cells (2007) FEMS Immunology and Medical Microbiology, 51, pp. 171-184; Kim, T.B., Kim, S.Y., Moon, K.A., Park, C.S., Jang, M.K., Yun, E.S., Cho, Y.S., Lee, K.Y., Five-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates poly (I:C)-induced airway inflammation in a murine model of asthma (2007) Clinical and Experimental Allergy, 37, pp. 1709-1719; Kimura, H., Li, X., Torii, K., Okada, T., Kamiyama, K., Mikami, D., Takahashi, N., Yoshida, H., Dexamethasone enhances basal and TNF-alpha-stimulated production of PAI-1 via the glucocorticoid receptor regardless of 11beta-hydroxysteroid dehydrogenase 2 status in human proximal renal tubular cells (2009) Nephrology, Dialysis, Transplantation, 24, pp. 1759-1765; Kowal, K., Zukowski, S., Moniuszko, M., Bodzenta-Lukaszyk, A., Plasminogen activator inhibitor-1 (PAI-1) and urokinase plasminogen activator (uPA) in sputum of allergic asthma patients (2008) Folia Histochemica et Cytobiologica, 46, pp. 193-198; Kucharewicz, I., Kowal, K., Buczko, W., Bodzenta-Lukaszyk, A., The plasmin system in airway remodeling (2003) Thrombosis Research, 112, pp. 1-7; Kuramoto, E., Nishiuma, T., Kobayashi, K., Yamamoto, M., Kono, Y., Funada, Y., Kotani, Y., Nishimura, Y., Inhalation of urokinase-type plasminogen activator reduces airway remodeling in a murine asthma model (2009) American Journal of Physiology. Lung Cellular and Molecular Physiology, 296, pp. L337-L346; Lee, G., Walser, T.C., Dubinett, S.M., Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer (2009) Current Opinion in Pulmonary Medicine, 15, pp. 303-307; Liu, Y., Dargusch, R., Maher, P., Schubert, D., A broadly neuroprotective derivative of curcumin (2008) Journal of Neurochemistry, 105, pp. 1336-1345; Maher, P., Akaishi, T., Schubert, D., Abe, K., A pyrazole derivative of curcumin enhances memory (2010) Neurobiology of Aging, 31, pp. 706-709; Matsuo, Y., Ishihara, T., Ishizaki, J., Miyamoto, K., Higaki, M., Yamashita, N., Effect of betamethasone phosphate loaded polymeric nanoparticles on a murine asthma model (2009) Cellular Immunology, 260, pp. 33-38; Miyamoto, S., Hattori, N., Senoo, T., Onari, Y., Iwamoto, H., Kanehara, M., Ishikawa, N., Kohno, N., Intra-airway administration of small interfering RNA targeting plasminogen activator inhibitor-1 attenuates allergic asthma in mice (2011) American Journal of Physiology. Lung Cellular and Molecular Physiology, 301, pp. L908-L916; Morjaria, J.B., Babu, K.S., Vijayanand, P., Chauhan, A.J., Davies, D.E., Holgate, S.T., Sputum IL-6 concentrations in severe asthma and its relationship with FEV1 (2011) Thorax, 66, p. 537; Oh, S.W., Cha, J.Y., Jung, J.E., Chang, B.C., Kwon, H.J., Lee, B.R., Kim, D.Y., Curcumin attenuates allergic airway inflammation and hyper-responsiveness in mice through NF-kappaB inhibition (2011) Journal of Ethnopharmacology, 136, pp. 414-421; Phipps, S., Lam, C.E., Kaiko, G.E., Foo, S.Y., Collison, A., Mattes, J., Barry, J., Foster, P.S., Toll/IL-1 signaling is critical for house dust mite-specific helper T cell type 2 and type 17 [corrected] responses (2009) American Journal of Respiratory and Critical Care Medicine, 179, pp. 883-893; Ray, S., Chattopadhyay, N., Mitra, A., Siddiqi, M., Chatterjee, A., Curcumin exhibits antimetastatic properties by modulating integrin receptors, collagenase activity, and expression of Nm23 and E-cadherin (2003) Journal of Environmental Pathology, Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer, 22, pp. 49-58; Saha, S., Doe, C., Mistry, V., Siddiqui, S., Parker, D., Sleeman, M., Cohen, E.S., Brightling, C.E., Granulocyte-macrophage colony-stimulating factor expression in induced sputum and bronchial mucosa in asthma and COPD (2009) Thorax, 64, pp. 671-676; Santel, T., Pflug, G., Hemdan, N.Y., Schafer, A., Hollenbach, M., Buchold, M., Hintersdorf, A., Birkenmeier, G., Curcumin inhibits glyoxalase 1: a possible link to its anti-inflammatory and anti-tumor activity (2008) PloS One, 3, pp. e3508; Shetty, S., Padijnayayveetil, J., Tucker, T., Stankowska, D., Idell, S., The fibrinolytic system and the regulation of lung epithelial cell proteolysis, signaling, and cellular viability (2008) American Journal of Physiology. Lung Cellular and Molecular Physiology, 295, pp. L967-L975; Sisson, T.H., Nguyen, M.H., Yu, B., Novak, M.L., Simon, R.H., Koh, T.J., Urokinase-type plasminogen activator increases hepatocyte growth factor activity required for skeletal muscle regeneration (2009) Blood, 114, pp. 5052-5061; Skold, C.M., Remodeling in asthma and COPD-differences and similarities (2010) The Clinical Respiratory Journal, 4 (SUPPL. 1), pp. 20-27; Song, W.B., Wang, Y.Y., Meng, F.S., Zhang, Q.H., Zeng, J.Y., Xiao, L.P., Yu, X.P., Zhang, Z.S., Curcumin protects intestinal mucosal barrier function of rat enteritis via activation of MKP-1 and attenuation of p38 and NF-kappaB activation (2010) PloS One, 5, pp. e12969; Sugimoto, K., Hanai, H., Tozawa, K., Aoshi, T., Uchijima, M., Nagata, T., Koide, Y., Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice (2002) Gastroenterology, 123, pp. 1912-1922; Takahashi, E., Nagano, O., Ishimoto, T., Yae, T., Suzuki, Y., Shinoda, T., Nakamura, S., Saya, H., Tumor necrosis factor-alpha regulates transforming growth factor-beta-dependent epithelial-mesenchymal transition by promoting hyaluronan-CD44-moesin interaction (2010) Journal of Biological Chemistry, 285, pp. 4060-4073; Takayama, S., Tamaoka, M., Takayama, K., Okayasu, K., Tsuchiya, K., Miyazaki, Y., Sumi, Y., Inase, N., Synthetic double-stranded RNA enhances airway inflammation and remodelling in a rat model of asthma (2011) Immunology, 134, pp. 140-150; Takizawa, H., Ohtoshi, T., Yamashita, N., Oka, T., Ito, K., Interleukin 6-receptor expression on human bronchial epithelial cells: regulation by IL-1 and IL-6 (1996) The American Journal of Physiology, 270, pp. L346-L352; Trompette, A., Divanovic, S., Visintin, A., Blanchard, C., Hegde, R.S., Madan, R., Thorne, P.S., Karp, C.L., Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein (2009) Nature, 457, pp. 585-588; Venugopal, S.K., Chen, J., Zhang, Y., Clemens, D., Follenzi, A., Zern, M.A., Role of MAPK phosphatase-1 in sustained activation of JNK during ethanol-induced apoptosis in hepatocyte-like VL-17A cells (2007) Journal of Biological Chemistry, 282, pp. 31900-31908; Vieira, R.P., Muller, T., Grimm, M., von Gernler, V., Vetter, B., Durk, T., Cicko, S., Idzko, M., Purinergic receptor type 6 contributes to airway inflammation and remodeling in experimental allergic airway inflammation (2011) American Journal of Respiratory and Critical Care Medicine, 184, pp. 215-223; Wark, P.A., Johnston, S.L., Moric, I., Simpson, J.L., Hensley, M.J., Gibson, P.G., Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma (2002) European Respiratory Journal, 19, pp. 68-75; Weber, W.M., Hunsaker, L.A., Abcouwer, S.F., Deck, L.M., Vander Jagt, D.L., Anti-oxidant activities of curcumin and related enones (2005) Bioorganic & Medicinal Chemistry, 13, pp. 3811-3820; Westergren-Thorsson, G., Larsen, K., Nihlberg, K., Andersson-Sjoland, A., Hallgren, O., Marko-Varga, G., Bjermer, L., Pathological airway remodelling in inflammation (2010) The Clinical Respiratory Journal, 4 (SUPPL. 1), pp. 1-8; Wickert, L., Chatain, N., Kruschinsky, K., Gressner, A.M., Glucocorticoids activate TGF-beta induced PAI-1 and CTGF expression in rat hepatocytes (2007) Comparative Hepatology, 6, p. 5; Willis, B.C., duBois, R.M., Borok, Z., Epithelial origin of myofibroblasts during fibrosis in the lung (2006) Proceedings of the American Thoracic Society, 3, pp. 377-382; Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T.Y., Karp, C.L., Donaldson, D.D., Interleukin-13: central mediator of allergic asthma (1998) Science, 282, pp. 2258-2261; Wong, E.T., Tergaonkar, V., Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential (2009) Clinical Science (London, England), 116, pp. 451-465; Wong, T.S., Chan, W.S., Li, C.H., Liu, R.W., Tang, W.W., Tsao, S.W., Tsang, R.K., Chan, J.Y., Curcumin alters the migratory phenotype of nasopharyngeal carcinoma cells through up-regulation of E-cadherin (2010) Anticancer Research, 30, pp. 2851-2856; Yadav, U.C., Ramana, K.V., Srivastava, S.K., Aldose reductase inhibition suppresses airway inflammation (2011) Chemico-Biological Interactions, 191, pp. 339-345; Yamamoto, Y., Ishizu, A., Ikeda, H., Otsuka, N., Yoshiki, T., Dexamethasone increased plasminogen activator inhibitor-1 expression on human umbilical vein endothelial cells: an additive effect to tumor necrosis factor-alpha (2004) Pathobiology, 71, pp. 295-301; Yamashita, N., Tashimo, H., Matsuo, Y., Ishida, H., Yoshiura, K., Sato, K., Kakiuchi, T., Ohta, K., Role of CCL21 and CCL19 in allergic inflammation in the ovalbumin-specific murine asthmatic model (2006) The Journal of Allergy and Clinical Immunology, 117, pp. 1040-1046; Zavadil, J., Bottinger, E.P., TGF-beta and epithelial-to-mesenchymal transitions (2005) Oncogene, 24, pp. 5764-5774","Yamashita, N.; Department of Pharmacotherapy, Research Institute of Pharmaceutical Sciences, Musashino University, 1-1-20 Shinmachi Nishitokyo-shi, Tokyo 202-8585, Japan; email: naoyama@musashino-u.ac.jp",,,,,,,,00144800,,EXMPA,22542791,"English","Exp. Mol. Pathol.",Article,Scopus,2-s2.0-84860787059
"Herrera, F., Maher, P., Schubert, D.","C-Jun N-terminal kinase controls a negative loop in the regulation of glial fibrillary acidic protein expression by retinoic acid",2012,"Neuroscience","208",,,"143","149",,1,10.1016/j.neuroscience.2012.02.011,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84858618710&partnerID=40&md5=0ca751801c469b56530739ab8dac6aba","Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037, United States","Herrera, F., Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037, United States; Maher, P., Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037, United States; Schubert, D., Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037, United States","Glial fibrillary acidic protein (GFAP) is a protein widely used as a molecular marker for astroglial differentiation and mature astrocytes. We and others have shown previously that retinoic acid and specific cytokines induce the expression of GFAP in neural precursor cells by activating the phosphatidylinositol-4,5-bisphosphate-3-kinase (PI3K) phosphorylation pathway. Here, we extend our previous work and show that retinoic acid also activates specifically the c-Jun N-terminal kinase (JNK) phosphorylation pathway, which in turn inhibits GFAP expression. Our results suggest the existence of a negative self-regulatory loop in the phosphorylation pathways that regulates GFAP expression. This loop is constitutively repressed by the PI3K pathway. Our results could be relevant for disorders involving sustained GFAP overexpression in precursor cells, such as glioblastoma and Alexander disease. © 2012 IBRO.","C-Jun N-terminal kinase; GFAP; Neural precursor cells; Retinoic acid","glial fibrillary acidic protein; phosphatidylinositol 4,5 bisphosphate 3 kinase; retinoic acid; stress activated protein kinase; animal cell; article; controlled study; enzyme activation; enzyme activity; enzyme phosphorylation; negative feedback; nonhuman; priority journal; protein expression; rat; Animals; Astrocytes; Blotting, Western; Cytokines; Electrophoresis, Gel, Two-Dimensional; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Hippocampus; Immunohistochemistry; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Nerve Tissue Proteins; Neural Stem Cells; Phosphatidylinositol 3-Kinases; Phosphorylation; Rats; Tretinoin",,"phosphatidylinositol 4,5 bisphosphate 3 kinase, 103843-30-7; retinoic acid, 302-79-4; stress activated protein kinase, 155215-87-5; Cytokines; Enzyme Inhibitors; Glial Fibrillary Acidic Protein; JNK Mitogen-Activated Protein Kinases, 2.7.11.24; Mitogen-Activated Protein Kinases, 2.7.11.24; Nerve Tissue Proteins; Phosphatidylinositol 3-Kinases, 2.7.1.-; Tretinoin, 302-79-4",,,,"Balasingam, V., Tejada-Berges, T., Wright, E., Bouckova, R., Yong, V.W., Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines (1994) J Neurosci, 14, pp. 846-856; Barnabe-Heider, F., Wasylnka, J.A., Fernandes, K.J., Porsche, C., Sendtner, M., Kaplan, D.R., Miller, F.D., Evidence that embryonic neurons regulate the onset of cortical gliogenesis via cardiotrophin-1 (2005) Neuron, 48, pp. 253-265; Bayer, S.A., Altman, J., Russo, R.J., Zhang, X., Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat (1993) Neurotoxicology, 14, pp. 83-144; Bonni, A., Sun, Y., Nadal-Vicens, M., Bhatt, A., Frank, D.A., Rozovsky, I., Stahl, N., Greenberg, M.E., Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway (1997) Science, 278, pp. 477-483; Fu, C.A., Shen, M., Huang, B.C., Lasaga, J., Payan, D.G., Luo, Y., TNIK, a novel member of the germinal center kinase family that activates the c-Jun N-terminal kinase pathway and regulates the cytoskeleton (1999) J Biol Chem, 274, pp. 30729-30737; Herrera, F., Chen, Q., Fischer, W.H., Maher, P., Schubert, D.R., Synaptojanin-1 plays a key role in astrogliogenesis: possible relevance for Down's syndrome (2009) Cell Death Differ, 16, pp. 910-920; Herrera, F., Chen, Q., Schubert, D., Synergistic effect of retinoic acid and cytokines on the regulation of glial fibrillary acidic protein expression (2010) J Biol Chem, 285, pp. 38915-38922; Kamakura, S., Oishi, K., Yoshimatsu, T., Nakafuku, M., Masuyama, N., Gotoh, Y., Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling (2004) Nat Cell Biol, 6, pp. 547-554; Kasai, M., Satoh, K., Akiyama, T., Wnt signaling regulates the sequential onset of neurogenesis and gliogenesis via induction of BMPs (2005) Genes Cells, 10, pp. 777-783; Machida, N., Umikawa, M., Takei, K., Sakima, N., Myagmar, B.E., Taira, K., Uezato, H., Kariya, K., Mitogen-activated protein kinase kinase kinase kinase 4 as a putative effector of Rap2 to activate the c-Jun N-terminal kinase (2004) J Biol Chem, 279, pp. 15711-15714; Menet, V., Gimenez, Y.R., Sandillon, F., Privat, A., GFAP null astrocytes are a favorable substrate for neuronal survival and neurite growth (2000) Glia, 31, pp. 267-272; Middeldorp, J., Hol, E.M., GFAP in health and disease (2011) Prog Neurobiol, 93, pp. 421-443; Mito, T., Becker, L.E., Developmental changes of S-100 protein and glial fibrillary acidic protein in the brain in Down syndrome (1993) Exp Neurol, 120, pp. 170-176; Nakashima, K., Yanagisawa, M., Arakawa, H., Kimura, N., Hisatsune, T., Kawabata, M., Miyazono, K., Taga, T., Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300 (1999) Science, 284, pp. 479-482; Nawashiro, H., Brenner, M., Fukui, S., Shima, K., Hallenbeck, J.M., High susceptibility to cerebral ischemia in GFAP-null mice (2000) J Cereb Blood Flow Metab, 20, pp. 1040-1044; Okada, S., Nakamura, M., Katoh, H., Miyao, T., Shimazaki, T., Ishii, K., Yamane, J., Okano, H., Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury (2006) Nat Med, 12, pp. 829-834; Pekny, M., Nilsson, M., Astrocyte activation and reactive gliosis (2005) Glia, 50, pp. 427-434; Prestegarden, L., Svendsen, A., Wang, J., Sleire, L., Skaftnesmo, K.O., Bjerkvig, R., Yan, T., Enger, P.O., Glioma cell populations grouped by different cell type markers drive brain tumor growth (2010) Cancer Res, 70, pp. 4274-4279; Rajan, P., McKay, R.D., Multiple routes to astrocytic differentiation in the CNS (1998) J Neurosci, 18, pp. 3620-3629; Rajan, P., Panchision, D.M., Newell, L.F., McKay, R.D., BMPs signal alternately through a SMAD or FRAP-STAT pathway to regulate fate choice in CNS stem cells (2003) J Cell Biol, 161, pp. 911-921; Ramjaun, A.R., Angers, A., Legendre-Guillemin, V., Tong, X.K., McPherson, P.S., Endophilin regulates JNK activation through its interaction with the germinal center kinase-like kinase (2001) J Biol Chem, 276, pp. 28913-28919; Ray, J., Gage, F.H., Differential properties of adult rat and mouse brain-derived neural stem/progenitor cells (2006) Mol Cell Neurosci, 31, pp. 560-573; Sawaishi, Y., Review of Alexander disease: beyond the classical concept of leukodystrophy (2009) Brain Dev, 31, pp. 493-498; Schubert, D., Herrera, F., Cumming, R., Read, J., Low, W., Maher, P., Fischer, W.H., Neural cells secrete a unique repertoire of proteins (2009) J Neurochem, 109, pp. 427-435; Schubert, D., Klar, A., Park, M., Dargusch, R., Fischer, W.H., F-spondin promotes nerve precursor differentiation (2006) J Neurochem, 96, pp. 444-453; Skoff, R.P., Price, D.L., Stocks, A., Electron microscopic autoradiographic studies of gliogenesis in rat optic nerve. II. Time of origin (1976) J Comp Neurol, 169, pp. 313-334; Sriram, K., Benkovic, S.A., Hebert, M.A., Miller, D.B., O'Callaghan, J.P., Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo? (2004) J Biol Chem, 279, pp. 19936-19947; Takeda, K., Shimozono, R., Noguchi, T., Umeda, T., Morimoto, Y., Naguro, I., Tobiume, K., Ichijo, H., Apoptosis signal-regulating kinase (ASK) 2 functions as a mitogen-activated protein kinase kinase kinase in a heteromeric complex with ASK1 (2007) J Biol Chem, 282, pp. 7522-7531; Triolo, D., Dina, G., Lorenzetti, I., Malaguti, M., Morana, P., Del, C.U., Comi, G., Previtali, S.C., Loss of glial fibrillary acidic protein (GFAP) impairs Schwann cell proliferation and delays nerve regeneration after damage (2006) J Cell Sci, 119, pp. 3981-3993; Yokogami, K., Wakisaka, S., Avruch, J., Reeves, S.A., Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR (2000) Curr Biol, 10, pp. 47-50","Schubert, D.; Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037, United States; email: schubert@salk.edu",,,,,,,,03064522,,NRSCD,22387108,"English","Neuroscience",Article,Scopus,2-s2.0-84858618710
"Chiruta, C., Schubert, D., Dargusch, R., Maher, P.","Chemical modification of the multitarget neuroprotective compound fisetin",2012,"Journal of Medicinal Chemistry","55","1",,"378","389",,19,10.1021/jm2012563,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84855854014&partnerID=40&md5=a9900efb80f1bd219af1a1e6c8a0e508","Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States","Chiruta, C., Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States; Schubert, D., Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States; Dargusch, R., Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States; Maher, P., Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States","Many factors are implicated in age-related central nervous system (CNS) disorders, making it unlikely that modulating only a single factor will provide effective treatment. Perhaps a better approach is to identify small molecules that have multiple biological activities relevant to the maintenance of brain function. Recently, we identified an orally active, neuroprotective, and cognition-enhancing molecule, the flavonoid fisetin, that is effective in several animal models of CNS disorders. Fisetin has direct antioxidant activity and can also increase the intracellular levels of glutathione (GSH), the major endogenous antioxidant. In addition, fisetin has both neurotrophic and anti-inflammatory activity. However, its relatively high EC 50 in cell based assays, low lipophilicity, high topological polar surface area (tPSA), and poor bioavailability suggest that there is room for medicinal chemical improvement. Here we describe a multitiered approach to screening that has allowed us to identify fisetin derivatives with significantly enhanced activity in an in vitro neuroprotection model while at the same time maintaining other key activities. © 2011 American Chemical Society.",,"3 (3,4 dihydroxyphenyl) 1 (2 hydroxy 4,5 dimethylphenyl)prop 2 en 1 one; 3 hydroxy 2 [3 hydroxy 4 (pyrrolidin 1 yl)phenyl] 4h benzo[h]chromen 4 one; 4 [4 (cyclopentyloxy)quinolin 2 yl)benzene 1,2 diol; fisetin; flavonol derivative; glutathione; neuroprotective agent; unclassified drug; animal cell; antiinflammatory activity; article; chemical modification; concentration (parameters); controlled study; drug activity; drug potency; drug screening; drug structure; mouse; neuroprotection; nonhuman; rat; structure activity relation; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cell Line; Cell Survival; Chalcones; Flavonoids; Glutathione; Humans; Mice; Microglia; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Quinolines; Rats; Structure-Activity Relationship",,"fisetin, 528-48-3; glutathione, 70-18-8; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Chalcones; Flavonoids; Glutathione, 70-18-8; NF-E2-Related Factor 2; Neuroprotective Agents; Quinolines; fisetin, 528-48-3",,,,"Véronique, L., Roger, V.L., Go, A.S., Lloyd-Jones, D.M., Adams, R.J., Berry, J.D., Brown, T.M., Wylie-Rosett, J., Heart disease and stroke statistics-2011 update: A report from the American Heart Association (2011) Circulation, 123, pp. 18-e209; Donnan, G.A., Fisher, M., MacLeod, M., Davis, S.M., Stroke (2008) Lancet, 371, pp. 1612-1623; Lipton, P., Ischemic death in brain neurons (1999) Physiol. Rev., 79, pp. 1431-1568; Pandya, R.S., Mao, L., Zhou, H., Zhou, S., Zeng, J., Popp, A.J., Wang, X., Central nervous system agents for ischemic stroke: Neuroprotection mechanisms (2011) Cent. Nerv. Syst. Agents Med. Chem., , [Online early access]. DOI: 10.2174/187152411796011321, Apr 27; Green, A.R., Shuaib, A., Therapeutic strategies for the treatment of stroke (2006) Drug Discovery Today, 11, pp. 681-693; Maher, P., Modulation of multiple pathways involved in the maintenance of neuronal function during aging by fisetin (2009) Genes Nutr., p. 10; Maher, P., Salgado, K.F., Zivin, J.A., Lapchak, P.A., A novel approach for new neuroprotective compounds for the treatment of dtroke (2007) Brain Res., 1173, pp. 117-125; Sogawa, S., Nihro, Y., Ueda, H., Izumi, A., Miki, T., Matsumoto, H., Satoh, T., 3,4-Dihydroxychalcones as potent 5-lipoxygenase and cyclooxygenase inhibitors (1993) J. Med. Chem., 36, pp. 3904-3909; Chu, H.W., Wu, H.T., Lee, J.Y., Regioselective hydroxylation of 2-hydroxychalcones by dimethyldioxirane towards polymethoxylated flavonoids (2004) Tetrahedron, 60, pp. 2647-2655; Cabrera, M., Simoens, M., Falchi, G., Lavaggi, M.L., Piro, O.E., Castellano, E.E., Vidal, A., Gonzáleza, M., Synthetic chalcones, flavanones, and flavones as antitumoral agents: Biological evaluation and structure-activity relationships (2007) Bioorg. Med. Chem., 15, pp. 3356-3367; Horie, T., Tsukayama, M., Kourai, H., Yokoyama, C., Furukawa, M., Yoshimoto, T., Yamamoto, S., Ohataf, K., Syntheses of 5,6,7- and 5,7,8-trioxygenated 3′,4′- dihydroxyflavones having alkoxy groups and their inhibitory activities against arachidonate 5-lipoxygenase (1986) J. Med. Chem., 29, pp. 2256-2262; Qin, C.X., Chen, X., Hughes, R.A., Williams, S.J., Woodman, O.L., Understanding the cardioprotective effects of flavonols: Discovery of relaxant flavonols without antioxidant activity (2008) J. Med. Chem., 51, pp. 1874-1884; Wang, Y., Peng, C., Liu, L., Zhao, J., Su, L., Zhu, Q., Sulfuric acid promoted condensation cyclization of 2-(2-(trimethylsilyl) ethynyl) anilines with arylaldehydes in alcoholic solvents: An efficient one-pot synthesis of 4-alkoxy-2-arylquinolines (2009) Tetrahedron Lett., 50, pp. 2261-2265; Pangalos, M.N., Schechter, L.E., Hurko, O., Drug development for CNS disorders: Strategies for balancing risk and reducing attrition (2007) Nat. Rev. Drug Discovery, 6, pp. 521-532; Winkler, B.S., Sauer, M.W., Starnes, C.A., Modulation of the Pasteur effect in retinal cells: Implications for understanding compensatory metabolic mechanisms (2003) Exp. Eye Res., 76, pp. 715-723; Reshef, A., Sperling, O., Zoref-Shani, E., Activation and inhibition of protein kinase C protect rat neuronal cultures against ischemia-reperfusion insult (1997) Neurosci. Lett., 238, pp. 37-40; Sperling, O., Bromberg, Y., Oelsner, H., Zoref-Shani, E., Reactive oxygen species play an important role in iodoacetate-induced neurotoxicity in primary rat neuronal cultures and in differentiated PC12 cells (2003) Neursci. Lett., 351, pp. 137-140; Rego, A.C., Areias, F.M., Santos, M.S., Oliveira, C.R., Distinct glycolysis inhibitors determine retinal cell sensitivity to glutamate-mediated injury (1999) Neurochem. Res., 24, pp. 351-358; Sigalov, E., Fridkin, M., Brenneman, D.E., Gozes, I., VIP-related protection against iodoacetate toxicity in pheochromocytoma (PC12) cells: A model for ischemic/hypoxic injury (2000) J. Mol. Neurosci., 15, pp. 147-154; Reiner, P.B., Laycock, A.G., Doll, C.J., A pharmacological model of ischemia in the hippocampal slice (1990) Neurosci. Lett., 119, pp. 175-178; Biraboneye, A.C., Madonna, S., Laras, Y., Maher, P., Kraus, J.L., Potential neuroprotective drugs in cerebral ischemia: New saturated and polyunsaturated lipids coupled to hydrophilic moieties: Synthesis and biological activity (2009) J. Med. Chem., 52, pp. 4358-4369; Biraboneye, A.C., Madonna, S., Maher, P., Kraus, J.L., Neuroprotective effects of N -alkyl-1,2,4-oxadiazolidine-3,5-diones and their corresponding synthetic intermediates N -alkylhydroxylamines and N -1-alkyl-3-carbonyl-1-hydroxyureas against in vitro cerebral ischemia (2010) Chem. Med. Chem., 5, pp. 79-85; Lipton, P., Ischemic death in brain neurons (1999) Physiol. Rev., 79, pp. 1431-1568; Reiner, P.B., Laycock, A.G., Doll, C.J., A pharmacological model of ischemia in the hippocampal slice (1990) Neurosci. Lett., 119, pp. 175-178; Taylor, B.M., Fleming, W.E., Benjamin, C.W., Wu, Y., Mathews, R., Sun, F.F., The mechanism of cytoprotective action of lazaroids: I. Inhibition of reactive oxygen species formation and lethal cell injury during periods of energy depletion (1996) J. Pharmacol. Exp. Ther., 276, pp. 1224-1231; Winkler, B.S., Sauer, M.W., Starnes, C.A., Modulation of the Pasteur effect in retinal cells: Implications for understanding compensatory metabolic mechanisms (2003) Exp. Eye Res., 76, pp. 715-723; Sperling, O., Bromberg, Y., Oelsner, H., Zoref-Shani, E., Reactive oxygen species play an important role in iodoacetate-induced neurotoxicity in primary rat neuronal cultures and in differentiated PC12 cells (2003) Neursci. Lett., 351, pp. 137-140; Sperling, O., Bromberg, Y., Oelsner, H., Zoref-Shani, E., Reactive oxygen species play an important role in iodoacetate-induced neurotoxicity in primary rat neuronal cultures and in differentiated PC12 cells (2003) Neursci. Lett., 351, pp. 137-140; Gelderblom, M., Leypoldt, F., Steinbach, K., Behrens, D., Choe, C.U., Siler, D.A., Arumugam, T.V., Magnus, T., Temporal and spatial dynamics of cerebral immune cell accumulation in stroke (2009) Stroke, 40, pp. 1849-1857; Pandya, R.S., Mao, L., Zhou, H., Zhou, S., Zeng, J., Popp, A.J., Wang, X., Central nervous system agents for ischemic stroke: Neuroprotection mechanisms (2011) Cent. Nerv. Syst. Agents Med. Chem., , [Online early access]. DOI: 10.2174/187152411796011321, Apr 27; Lewerenz, J., Dargusch, R., Maher, P., Lactacidosis modulates glutathione metabolism and oxidative glutamate toxicity (2010) J. Neurochem., 113, pp. 502-504; Tan, S., Schubert, D., Maher, P., Oxytosis: A novel form of programmed cell death (2001) Curr. Top. Med. Chem., 1, pp. 497-506; Maher, P., A comparison of the neurotrophic activities of the flavonoid fisetin and some of its derivatives (2006) Free Radical Res., 40, pp. 1105-1111; Zheng, L.T., Ock, J., Kwon, B.M., Suk, K., Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity (2008) Int. Immunopharmacol., 8, pp. 484-494; Sagara, Y., Vanhnasy, J., Maher, P., Induction of PC12 cell differentiation by flavonoids is dependent upon extracellular signal-regulated kinase activation (2004) J. Neurochem., 90, pp. 1144-1155; Hitchcock, S.A., Pennington, L.D., Structure-brain exposure relationships (2006) J. Med. Chem., 49, pp. 7559-7583; Lewerenz, J., Maher, P., Control of redox state and redox signaling by neural antioxidant systems (2011) Antioxid. Redox Signaling, 14, pp. 1449-1465; Shia, C.S., Tsai, S.Y., Kuo, S.C., Hou, Y.C., Chao, P.D., Metabolism and pharmacokinetics of 3,3′,4′,7- tetrahydroxyflavone (fisetin), 5-hydroxyflavone, and 7-hydroxyflavone and antihemolysis effects of fisetin and its serum metabolites (2009) J. Agric. Food Chem., 57, pp. 83-89; Maher, P., Dargusch, R., Bodai, L., Gerard, P.E., Purcell, J.M., Marsh, J.L., ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntingtons disease (2011) Hum. Mol. Genet., 20, pp. 261-270; Maher, P., Dargusch, R., Ehren, J.L., Okada, S., Sharma, K., Schubert, D., Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetes (2011) PLoS One, 6, p. 21226; Maher, P., A comparison of the neurotrophic activities of the flavonoid fisetin and some of its derivatives (2006) Free Radical Res., 40, pp. 1105-1111; Schreiber, E., Matthias, P., Muller, M.M., Schaffner, W., Rapid detection of octamer binding proteins with ""mini- extracts"", prepared from a small number of cells (1989) Nucleic Acids Res., 17, p. 6419; Pajouhesh, H., Lenz, G.R., Medicinal chemical properties of successful central nervous system drugs (2005) NeuroRx, 2, pp. 541-553; Lloyed, E.J., Andrews, P.R., A common structural model for central nervous system drugs and their receptors (1986) J. Med. Chem., 29, pp. 453-462","Maher, P.; Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States; email: pmaher@salk.edu",,,,,,,,00222623,,JMCMA,22192055,"English","J. Med. Chem.",Article,Scopus,2-s2.0-84855854014
"Chen, Q., Prior, M., Dargusch, R., Roberts, A., Riek, R., Eichmann, C., Chiruta, C., Akaishi, T., Abe, K., Maher, P., Schubert, D.","A novel neurotrophic drug for cognitive enhancement and Alzheimer's disease",2011,"PLoS ONE","6","12", e27865,"","",,29,10.1371/journal.pone.0027865,"http://www.scopus.com/inward/record.url?eid=2-s2.0-83355173051&partnerID=40&md5=545e53d2c1dd12283b7d0e907173ceae","Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, United States; Structural Biology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, United States; Laboratory of Pharmacology, Research Institute of Pharmaceutical Sciences, Musashino University, Nishitokyo-shi, Tokyo, Japan; Molecular Neurosciences, The Scripps Research Institute, La Jolla, CA, United States; Laboratorium f. Physikalische Chemie, ETH Zurich, Zurich, Switzerland","Chen, Q., Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, United States; Prior, M., Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, United States; Dargusch, R., Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, United States; Roberts, A., Molecular Neurosciences, The Scripps Research Institute, La Jolla, CA, United States; Riek, R., Structural Biology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, United States, Laboratorium f. Physikalische Chemie, ETH Zurich, Zurich, Switzerland; Eichmann, C., Laboratorium f. Physikalische Chemie, ETH Zurich, Zurich, Switzerland; Chiruta, C., Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, United States; Akaishi, T., Laboratory of Pharmacology, Research Institute of Pharmaceutical Sciences, Musashino University, Nishitokyo-shi, Tokyo, Japan; Abe, K., Laboratory of Pharmacology, Research Institute of Pharmaceutical Sciences, Musashino University, Nishitokyo-shi, Tokyo, Japan; Maher, P., Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, United States; Schubert, D., Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, United States","Currently, the major drug discovery paradigm for neurodegenerative diseases is based upon high affinity ligands for single disease-specific targets. For Alzheimer's disease (AD), the focus is the amyloid beta peptide (Aß) that mediates familial Alzheimer's disease pathology. However, given that age is the greatest risk factor for AD, we explored an alternative drug discovery scheme that is based upon efficacy in multiple cell culture models of age-associated pathologies rather than exclusively amyloid metabolism. Using this approach, we identified an exceptionally potent, orally active, neurotrophic molecule that facilitates memory in normal rodents, and prevents the loss of synaptic proteins and cognitive decline in a transgenic AD mouse model. © 2011 Chen et al.",,"amyloid beta protein; arachidonate 5 lipoxygenase; brain derived neurotrophic factor; cnb 001; cnb 023; galantamine; glutathione; heat shock protein; heme oxygenase 1; inducible nitric oxide synthase; j 147; neuroprotective agent; pyrazole derivative; unclassified drug; amyloid beta protein; brain derived neurotrophic factor; cnb 001; curcumin; drug derivative; heat shock protein; nerve growth factor; neuroprotective agent; oxidizing agent; pyrazole derivative; Alzheimer disease; amyloid plaque; animal cell; animal experiment; animal model; animal tissue; article; cognitive defect; controlled study; drug mechanism; drug potency; drug structure; drug synthesis; embryo; glutathione metabolism; inflammation; long term potentiation; male; maze test; memory disorder; mouse; neuroprotection; nonhuman; oxidative stress; protein depletion; protein expression; protein phosphorylation; rat; structure activity relation; animal; animal behavior; chemistry; cognition; disease model; drug effect; hippocampus; human; immunohistochemistry; memory; metabolism; pathology; pathophysiology; phosphorylation; solubility; synapse; upregulation; Alzheimer Disease; Amyloid beta-Peptides; Animals; Behavior, Animal; Brain-Derived Neurotrophic Factor; Cognition; Curcumin; Disease Models, Animal; Heat-Shock Proteins; Hippocampus; Humans; Immunohistochemistry; Inflammation; Long-Term Potentiation; Memory; Mice; Nerve Growth Factors; Neuroprotective Agents; Oxidants; Oxidative Stress; Phosphorylation; Pyrazoles; Rats; Solubility; Structure-Activity Relationship; Synapses; Up-Regulation",,"amyloid beta protein, 109770-29-8; arachidonate 5 lipoxygenase, 80619-02-9; brain derived neurotrophic factor, 218441-99-7; galantamine, 1953-04-4, 357-70-0; glutathione, 70-18-8; inducible nitric oxide synthase, 501433-35-8; curcumin, 458-37-7; nerve growth factor, 9061-61-4; Amyloid beta-Peptides; Brain-Derived Neurotrophic Factor; CNB 001; Curcumin, 458-37-7; Heat-Shock Proteins; Nerve Growth Factors; Neuroprotective Agents; Oxidants; Pyrazoles","cnb 001; cnb 023; j 147",,,"Pangalos, M.N., Schechter, L.E., Hurko, O., Drug development for CNS disorders: strategies for balancing risk and reducing attrition (2007) Nat Rev Drug Discov, 6, pp. 521-532; Herrup, K., Reimagining Alzheimer's disease-an age-based hypothesis (2010) J Neurosci, 30, pp. 16755-16762; Frautschy, S.A., Cole, G.M., Why pleiotropic interventions are needed for Alzheimer's disease (2010) Mol Neurobiol, 41, pp. 392-409; Ganesan, A., The impact of natural products upon modern drug discovery (2008) Curr Opin Chem Biol, 12, pp. 306-317; Cole, G.M., Teter, B., Frautschy, S.A., Neuroprotective effects of curcumin (2007) Adv Exp Med Biol, 595, pp. 197-212; Lim, G.P., Chu, T., Yang, F., Beech, W., Frautschy, S.A., The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse (2001) J Neurosci, 21, pp. 8370-8377; Schubert, D.R., Liu, Y., (2002) Method for preventing and/or decreasing amyloid production with polycyclic compounds, , US Patent No. 6,472,436B1 US Patent No 6,472,436B1; Liu, Y., Dargusch, R., Maher, P., Schubert, D., A broadly neuroprotective derivative of curcumin (2008) J Neurochem 105, pp. 1336-1345; Haigis, M.C., Yankner, B.A., The aging stress response (2010) Mol Cell, 40, pp. 333-344; Shia, C.S., Tsai, S.Y., Kuo, S.C., Hou, Y.C., Chao, P.D., Metabolism and pharmacokinetics of 3,3′,4′,7-tetrahydroxyflavone (fisetin), 5-hydroxyflavone, and 7-hydroxyflavone and antihemolysis effects of fisetin and its serum metabolites (2009) J Agric Food Chem, 57, pp. 83-89; Abe, K., Takayanagi, M., Saito, H., Effects of recombinant human basic FGF and its modified protein CS23 on survival of primary cultured neurons from various regions of fetal rat brain (1990) Japan J Pharmacol, 53, pp. 221-227; Tan, S., Schubert, D., Maher, P., Oxytosis: A novel form of programmed cell death (2001) Curr Topics Med Chem, 1, pp. 497-506; Yankner, B.A., Duffy, L.K., Kirschner, D.A., Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides (1990) Science, 250, pp. 279-282; Pajouhesh, H., Lenz, G.R., Medicinal chemical properties of successful central nervous system drugs (2005) NeuroRx, 2, pp. 541-553; Rossler, O.G., Giehl, K.M., Thiel, G., Neuroprotection of immortalized hippocampal neurones by brain-derived neurotrophic factor and Raf-1 protein kinase: role of extracellular signal-regulated protein kinase and phosphatidylinositol 3-kinase (2004) J Neurochem, 88, pp. 1240-1252; Maher, P., Modulation of multiple pathways involved in the maintenance of neuronal function by fisetin (2010) Micronutrients and Brain Health, pp. 189-206. , In: Parker L, Sies H, Eggersdorfer M, Cardenas E, editors, Boca Raton, FL, CRC Press; Winkler, B.S., Sauer, M.W., Starnes, C.A., Modulation of the Pasteur effect in retinal cells: implications for understanding compensatory metabolic mechanisms (2003) Exp Eye Res, 76, pp. 715-723; Maher, P., Salgado, K.F., Zivin, J.A., Lapchak, P.A., A novel approach to screening for new neuroprotective compounds for the treatment of stroke (2007) Brain Res, 1173, pp. 117-125; Chen, J., Zacharek, A., Zhang, C., Jiang, H., Li, Y., Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice (2005) J Neurosci, 25, pp. 2366-2375; Olin, D., MacMurray, J., Comings, D.E., Risk of late-onset Alzheimer's disease associated with BDNF C270T polymorphism (2005) Neurosci Lett, 381, pp. 275-278; Tapia-Arancibia, L., Aliaga, E., Silhol, M., Arancibia, S., New insights into brain BDNF function in normal aging and Alzheimer disease (2008) Brain Res Rev, 59, pp. 201-220; Pezet, S., Malcangio, M., Brain-derived neurotrophic factor as a drug target for CNS disorders (2004) Expert Opin Ther Targets, 8, pp. 391-399; Aisen, P.S., Andrieu, S., Sampaio, C., Carrillo, M., Khachaturian, Z.S., Report of the task force on designing clinical trials in early (predementia) AD (2011) Neurology, 76, pp. 280-286; Ennaceur, A., Delacour, J., A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data (1988) Behav Brain Res, 31, pp. 47-59; Zhang, H.T., Huang, Y., Suvarna, N.U., Deng, C., Crissman, A.M., Effects of the novel PDE4 inhibitors MEM1018 and MEM1091 on memory in the radial-arm maze and inhibitory avoidance tests in rats (2005) Psychopharmacology (Berl), 179, pp. 613-619; Woodruff-Pak, D.S., Vogel III, R.W., Wenk, G.L., Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning (2001) Proc Natl Acad Sci U S A, 98, pp. 2089-2094; Sarnyai, Z., Sibille, E.L., Pavlides, C., Fenster, R.J., McEwen, B.S., Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin(1A) receptors (2000) Proc Natl Acad Sci U S A, 97, pp. 14731-14736; Young, J.W., Powell, S.B., Risbrough, V., Marston, H.M., Geyer, M.A., Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia (2009) Pharmacol Ther, 122, pp. 150-202; Bach, M.E., Hawkins, R.D., Osman, M., Kandel, E.R., Mayford, M., Impairment of spatial but not contextual memory in CaMKII mutant mice with a selective loss of hippocampal LTP in the range of the theta frequency (1995) Cell, 81, pp. 905-915; Jankowsky, J.L., Melnikova, T., Fadale, D.J., Xu, G.M., Slunt, H.H., Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease (2005) J Neurosci, 25, pp. 5217-5224; Savonenko, A., Xu, G.M., Melnikova, T., Morton, J.L., Gonzales, V., Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities (2005) Neurobiol Dis, 18, pp. 602-617; van Groen, T., Kiliaan, A.J., Kadish, I., Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice (2006) Neurobiol Dis, 23, pp. 653-662; Lalonde, R., Kim, H.D., Maxwell, J.A., Fukuchi, K., Exploratory activity and spatial learning in 12-month-old APP(695)SWE/co+PS1/DeltaE9 mice with amyloid plaques (2005) Neurosci Lett, 390, pp. 87-92; Vorhees, C.V., Williams, M.T., Morris water maze: procedures for assessing spatial and related forms of learning and memory (2006) Nat Protoc, 1, pp. 848-858; Wang, F., Chen, H., Sun, X., Age-related spatial cognitive impairment is correlated with a decrease in ChAT in the cerebral cortex, hippocampus and forebrain of SAMP8 mice (2009) Neurosci Lett, 454, pp. 212-217; Harrison, F.E., Hosseini, A.H., McDonald, M.P., May, J.M., Vitamin C reduces spatial learning deficits in middle-aged and very old APP/PSEN1 transgenic and wild-type mice (2009) Pharmacol Biochem Behav, 93, pp. 443-450; Krafft, G.A., Klein, W.L., ADDLs and the signaling web that leads to Alzheimer's disease (2010) Neuropharmacology, 59, pp. 230-242; Bishop, N.A., Lu, T., Yankner, B.A., Neural mechanisms of ageing and cognitive decline (2010) Nature, 464, pp. 529-535; Cameron, B., Landreth, G.E., Inflammation, microglia, and Alzheimer's disease (2010) Neurobiol Dis, 37, pp. 503-509; Dore, S., Decreased activity of the antioxidant heme oxygenase enzyme: implications in ischemia and in Alzheimer's disease (2002) Free Radic Biol Med, 32, pp. 1276-1282; Schipper, H.M., Song, W., Zukor, H., Hascalovici, J.R., Zeligman, D., Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement (2009) J Neurochem, 110, pp. 469-485; Radmark, O., Werz, O., Steinhilber, D., Samuelsson, B., 5-Lipoxygenase: regulation of expression and enzyme activity (2007) Trends Biochem Sci, 32, pp. 332-341; Phillis, J.W., Horrocks, L.A., Farooqui, A.A., Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders (2006) Brain Res Rev, 52, pp. 201-243; Di Domenico, F., Sultana, R., Tiu, G.F., Scheff, N.N., Perluigi, M., Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in the progression of Alzheimer disease (2010) Brain Res, 1333, pp. 72-81; Reddy, P.H., Mani, G., Park, B.S., Jacques, J., Murdoch, G., Differential loss of synaptic proteins in Alzheimer's disease: implications for synaptic dysfunction (2005) J Alzheimers Dis, 7, pp. 103-117. , discussion 173-180; Zhao, L., Ma, Q.L., Calon, F., Harris-White, M.E., Yang, F., Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease (2006) Nat Neurosci, 9, pp. 234-242; Dawson, G.R., Seabrook, G.R., Zheng, H., Smith, D.W., Graham, S., Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein (1999) Neuroscience, 90, pp. 1-13; Cunha, C., Brambilla, R., Thomas, K.L., A simple role for BDNF in learning and memory? (2010) Front Mol Neurosci, 3, p. 1; Sato, M., Suzuki, K., Nakanishi, S., NMDA receptor stimulation and brain-derived neurotrophic factor upregulate homer 1a mRNA via the mitogen-activated protein kinase cascade in cultured cerebellar granule cells (2001) J Neurosci, 21, pp. 3797-3805; Yoshimura, Y., Shinkawa, T., Taoka, M., Kobayashi, K., Isobe, T., Identification of protein substrates of Ca(2+)/calmodulin-dependent protein kinase II in the postsynaptic density by protein sequencing and mass spectrometry (2002) Biochem Biophys Res Commun, 290, pp. 948-954; Guerreiro, R.J., Gustafson, D.R., Hardy, J., The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE (2010) Neurobiol Aging, , 2010 Jun 2029 Epub ahead of print; Figurov, A., Pozzo-Miller, L.D., Olafsson, P., Wang, T., Lu, B., Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus (1996) Nature, 381, pp. 706-709; Allen, G.L., Kirasic, K.C., Rashotte, M.A., Haun, D.B., Aging and path integration skill: kinesthetic and vestibular contributions to wayfinding (2004) Percept Psychophys, 66, pp. 170-179; Bach, M.E., Barad, M., Son, H., Zhuo, M., Lu, Y.F., Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway (1999) Proc Natl Acad Sci U S A, 96, pp. 5280-5285; Barnes, C.A., Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat (1979) J Comp Physiol Psychol, 93, pp. 74-104; Aggleton, J.P., Hunt, P.R., Rawlins, J.N., The effects of hippocampal lesions upon spatial and non-spatial tests of working memory (1986) Behav Brain Res, 19, pp. 133-146; Morris, R.G., Garrud, P., Rawlins, J.N., O'Keefe, J., Place navigation impaired in rats with hippocampal lesions (1982) Nature, 297, pp. 681-683; Broadbent, N.J., Gaskin, S., Squire, L.R., Clark, R.E., Object recognition memory and the rodent hippocampus (2010) Learn Mem, 17, pp. 5-11; Lanni, C., Lenzken, S.C., Pascale, A., Del Vecchio, I., Racchi, M., Cognition enhancers between treating and doping the mind (2008) Pharmacol Res, 57, pp. 196-213; Minichiello, L., TrkB signalling pathways in LTP and learning (2009) Nat Rev Neurosci, 10, pp. 850-860; Dugich-Djordjevic, M.M., Peterson, C., Isono, F., Ohsawa, F., Widmer, H.R., Immunohistochemical visualization of brain-derived neurotrophic factor in the rat brain (1995) Eur J Neurosci, 7, pp. 1831-1839; Berchtold, N.C., Castello, N., Cotman, C.W., Exercise and time-dependent benefits to learning and memory (2010) Neuroscience, 167, pp. 588-597; Griesbach, G.S., Hovda, D.A., Gomez-Pinilla, F., Exercise-induced improvement in cognitive performance after traumatic brain injury in rats is dependent on BDNF activation (2009) Brain Res, 1288, pp. 105-115; Radak, Z., Hart, N., Sarga, L., Koltai, E., Atalay, M., Exercise plays a preventive role against Alzheimer's disease (2010) J Alzheimers Dis, 20, pp. 777-783; Monteggia, L.M., Barrot, M., Powell, C.M., Berton, O., Galanis, V., Essential role of brain-derived neurotrophic factor in adult hippocampal function (2004) Proc Natl Acad Sci U S A, 101, pp. 10827-10832; Gorski, J.A., Balogh, S.A., Wehner, J.M., Jones, K.R., Learning deficits in forebrain-restricted brain-derived neurotrophic factor mutant mice (2003) Neuroscience, 121, pp. 341-354; Engert, F., Bonhoeffer, T., Dendritic spine changes associated with hippocampal long-term synaptic plasticity (1999) Nature, 399, pp. 66-70; Calhoun, M.E., Jucker, M., Martin, L.J., Thinakaran, G., Price, D.L., Comparative evaluation of synaptophysin-based methods for quantification of synapses (1996) J Neurocytol, 25, pp. 821-828; Dun, X.P., Chilton, J.K., Control of cell shape and plasticity during development and disease by the actin-binding protein Drebrin (2010) Histol Histopathol, 25, pp. 533-540; Yamagata, Y., New aspects of neurotransmitter release and exocytosis: dynamic and differential regulation of synapsin I phosphorylation by acute neuronal excitation in vivo (2003) J Pharmacol Sci, 93, pp. 22-29; Bonda, D.J., Wang, X., Perry, G., Nunomura, A., Tabaton, M., Oxidative stress in Alzheimer disease: A possibility for prevention (2010) Neuropharmacology, 59, pp. 290-294; Dumont, M., Wille, E., Stack, C., Calingasan, N.Y., Beal, M.F., Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease (2009) FASEB J, 23, pp. 2459-2466; Orozco-Ibarra, M., Chirino, Y.I., Pedraza-Chaverri, J., Role of hemeoxygenase-1 in the neurodegenerative disorders (2006) Rev Neurol, 43, pp. 556-562; Yao, Y., Clark, C.M., Trojanowski, J.Q., Lee, V.M., Pratico, D., Elevation of 12/15 lipoxygenase products in AD and mild cognitive impairment (2005) Ann Neurol, 58, pp. 623-626; Ikonomovic, M.D., Abrahamson, E.E., Uz, T., Manev, H., Dekosky, S.T., Increased 5-lipoxygenase immunoreactivity in the hippocampus of patients with Alzheimer's disease (2008) J Histochem Cytochem, 56, pp. 1065-1073; Wollen, K.A., Alzheimer's disease: the pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners (2010) Altern Med Rev, 15, pp. 223-244; Zahs, K.R., Ashe, K.H., Too much good news' - are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease? (2010) Trends Neurosci, 33, pp. 381-389; Coma, M., Sereno, L., Da Rocha-Souto, B., Scotton, T.C., Espana, J., Triflusal reduces dense-core plaque load, associated axonal alterations and inflammatory changes, and rescues cognition in a transgenic mouse model of Alzheimer's disease (2010) Neurobiol Dis, 38, pp. 482-491; Golde, T.E., Schneider, L.S., Koo, E.H., Anti-abeta therapeutics in Alzheimer's disease: the need for a paradigm shift (2011) Neuron, 69, pp. 203-213; Behl, C., Davis, J.B., Lesley, R., Schubert, D., Hydrogen peroxide mediates amyloid beta protein toxicity (1994) Cell, 77, pp. 817-827; Abe, K., Kimura, H., The possible role of hydrogen sulfide as an endogenous neuromodulator (1996) J Neurosci, 16, pp. 1066-1071; Bourtchouladze, R., Lidge, R., Catapano, R., Stanley, J., Gossweiler, S., A mouse model of Rubinstein-Taybi syndrome: Defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4 (2003) Proc Natl Acad Sci USA, 100, pp. 10518-10522; Jankowsky, J.L., Younkin, L.H., Gonzales, V., Fadale, D.J., Slunt, H.H., Rodent A beta modulates the solubility and distribution of amyloid deposits in transgenic mice (2007) J Biol Chem, 282, pp. 22707-22720; Lapchak, P.A., Schubert, D.R., Maher, P.A., Delayed treatment with a novel neurotrophic compound reduces behavioral deficits in rabbit ichemic stroke (2011) J Neurochem, 116, pp. 122-131","Schubert, D.; Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, United States; email: Schubert@salk.edu",,,,,,,,19326203,,,22194796,"English","PLoS ONE",Article,Scopus,2-s2.0-83355173051
"Maher, P., Dargusch, R., Ehren, J.L., Okada, S., Sharma, K., Schubert, D.","Fisetin lowers methylglyoxal dependent protein glycation and limits the complications of diabetes",2011,"PLoS ONE","6","6", e21226,"","",,46,10.1371/journal.pone.0021226,"http://www.scopus.com/inward/record.url?eid=2-s2.0-79959596092&partnerID=40&md5=a83a5004a1fbc852f06be992d3a1840a","Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, United States; Department of Medicine, Center for Renal Translational Medicine, University of California San Diego, La Jolla, CA, United States","Maher, P., Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, United States; Dargusch, R., Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, United States; Ehren, J.L., Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, United States; Okada, S., Department of Medicine, Center for Renal Translational Medicine, University of California San Diego, La Jolla, CA, United States; Sharma, K., Department of Medicine, Center for Renal Translational Medicine, University of California San Diego, La Jolla, CA, United States; Schubert, D., Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, United States","The elevated glycation of macromolecules by the reactive dicarbonyl and α-oxoaldehyde methylglyoxal (MG) has been associated with diabetes and its complications. We have identified a rare flavone, fisetin, which increases the level and activity of glyoxalase 1, the enzyme required for the removal of MG, as well as the synthesis of its essential co-factor, glutathione. It is shown that fisetin reduces two major complications of diabetes in Akita mice, a model of type 1 diabetes. Although fisetin had no effect on the elevation of blood sugar, it reduced kidney hypertrophy and albuminuria and maintained normal levels of locomotion in the open field test. This correlated with a reduction in proteins glycated by MG in the blood, kidney and brain of fisetin-treated animals along with an increase in glyoxalase 1 enzyme activity and an elevation in the expression of the rate-limiting enzyme for the synthesis of glutathione, a co-factor for glyoxalase 1. The expression of the receptor for advanced glycation end products (RAGE), serum amyloid A and serum C-reactive protein, markers of protein oxidation, glycation and inflammation, were also increased in diabetic Akita mice and reduced by fisetin. It is concluded that fisetin lowers the elevation of MG-protein glycation that is associated with diabetes and ameliorates multiple complications of the disease. Therefore, fisetin or a synthetic derivative may have potential therapeutic use for the treatment of diabetic complications. © 2011 Maher et al.",,"advanced glycation end product receptor; amyloid A protein; C reactive protein; fisetin; flavone; glutathione; lactoylglutathione lyase; lipid hydroperoxide; methylglyoxal; osteopontin; advanced glycosylation end product receptor; advanced glycosylation end-product receptor; fisetin; flavonoid; immunoglobulin receptor; methylglyoxal; serum amyloid A; Akita mouse; albuminuria; animal experiment; animal tissue; article; blood; brain; controlled study; diabetes mellitus; enzyme activity; glucose blood level; glutathione metabolism; inflammation; insulin dependent diabetes mellitus; kidney; kidney hypertrophy; locomotion; male; mouse; mouse strain; nonhuman; open field test; oxidation; protein expression; protein glycosylation; animal; anxiety; C57BL mouse; cell line; drug effect; glycosylation; metabolism; Animalia; Mus; Animals; Anxiety; Cell Line; Diabetes Complications; Diabetes Mellitus; Flavonoids; Glycosylation; Mice; Mice, Inbred C57BL; Pyruvaldehyde; Receptors, Immunologic; Serum Amyloid A Protein",,"C reactive protein, 9007-41-4; advanced glycation end product receptor, 198785-73-8, 247590-69-8; amyloid A protein, 59165-71-8; fisetin, 528-48-3; flavone, 525-82-6; glutathione, 70-18-8; lactoylglutathione lyase, 9033-12-9; methylglyoxal, 78-98-8; osteopontin, 106441-73-0; Flavonoids; Pyruvaldehyde, 78-98-8; Receptors, Immunologic; Serum Amyloid A Protein; advanced glycosylation end-product receptor; fisetin, 528-48-3",,,,"Zhu, Y., Usui, H.K., Sharma, K., Regulation of transforming growth factor beta in diabetic nephropathy: implications for treatment (2007) Semin Nephrol, 27, pp. 153-160; Stirban, A., Rosen, P., Tschoepe, D., Complications of type 1 diabetes: new molecular findings (2008) Mt Sinai J Med, 75, pp. 328-351; Brownlee, M., Biochemistry and molecular cell biology of diabetic complications (2001) Nature, 414, pp. 813-820; Calcutt, N.A., Cooper, M.E., Kern, T.S., Schmidt, A.M., Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials (2009) Nat Rev Drug Discov, 8, pp. 417-429; Maher, P., Modulation of multiple pathways involved in the maintenance of neuronal function by fisetin (2010) Micronutrients and Brain Health, pp. 189-206. , In: Parker L, Sies H, Eggersdorfer M, Cardenas E, editors, Boca Raton, FL, CRC Press; Zheng, L.T., Ock, J., Kwon, B.M., Suk, K., Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity (2008) Int Immunopharmacol, 8, pp. 484-494; Geraets, L., Haegens, A., Brauers, K., Haydock, J.A., Vernooy, J.H., Inhibition of LPS-induced pulmonary inflammation by specific flavonoids (2009) Biochem Biophys Res Commun, 382, pp. 598-603; Bierhaus, A., Nawroth, P.P., Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications (2009) Diabetologia, 52, pp. 2251-2263; Gao, L., Mann, G.E., Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling (2009) Cardiovasc Res, 82, pp. 9-20; Thornalley, P.J., Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification-a role in pathogenesis and antiproliferative chemotherapy (1996) Gen Pharmacol, 27, pp. 565-573; Brownlee, M., Negative consequences of glycation (2000) Metabolism, 49, pp. 9-13; Goh, S.Y., Cooper, M.E., Clinical review: The role of advanced glycation end products in progression and complications of diabetes (2008) J Clin Endocrinol Metab, 93, pp. 1143-1152; Jacobson, A.M., Ryan, C.M., Cleary, P.A., Waberski, B.H., Weinger, K., Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohort (2011) Diabetologia, 54, pp. 245-255; Gurley, S.B., Clare, S.E., Snow, K.P., Hu, A., Meyer, T.W., Impact of genetic background on nephropathy in diabetic mice (2006) Am J Physiol Renal Physiol, 290, pp. 214-222; Asakawa, A., Toyoshima, M., Inoue, K., Koizumi, A., Ins2Akita mice exhibit hyperphagia and anxiety behavior via the melanocortin system (2007) Int J Mol Med, 19, pp. 649-652; Reagan, L.P., Grillo, C.A., Piroli, G.G., The As and Ds of stress: metabolic, morphological and behavioral consequences (2008) Eur J Pharmacol, 585, pp. 64-75; Maher, P., Akaishi, T., Abe, K., Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory (2006) Proc Natl Acad Sci U S A, 103, pp. 16568-16573. , PMCID: PMC1637622; Barber, A.J., Antonetti, D.A., Kern, T.S., Reiter, C.E., Soans, R.S., The Ins2Akita mouse as a model of early retinal complications in diabetes (2005) Invest Ophthalmol Vis Sci, 46, pp. 2210-2218; Biessels, G.J., Deary, I.J., Ryan, C.M., Cognition and diabetes: a lifespan perspective (2008) Lancet Neurol, 7, pp. 184-190; Jolivalt, C.G., Lee, C.A., Beiswenger, K.K., Smith, J.L., Orlov, M., Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin (2008) J Neurosci Res, 86, pp. 3265-3274; Burdo, J.R., Chen, Q., Calcutt, N.A., Schubert, D., The pathological interaction between diabetes and presymptomatic Alzheimer's disease (2009) Neurobiol Aging, 30, pp. 1910-1917. , [Not funded by NIH]; Choeiri, C., Hewitt, K., Durkin, J., Simard, C.J., Renaud, J.M., Longitudinal evaluation of memory performance and peripheral neuropathy in the Ins2C96Y Akita mice (2005) Behav Brain Res, 157, pp. 31-38; Seiler, A., Schneider, M., Forster, H., Roth, S., Wirth, E.K., Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent- and AIF-mediated cell death (2008) Cell Metab, 8, pp. 237-248; Susztak, K., Bottinger, E., Novetsky, A., Liang, D., Zhu, Y., Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease (2004) Diabetes, 53, pp. 784-794; Nicholas, S.B., Liu, J., Kim, J., Ren, Y., Collins, A.R., Critical role for osteopontin in diabetic nephropathy (2010) Kidney Int, 77, pp. 588-600; Miyata, T., de Strihou, C.Y., Diabetic nephropathy: a disorder of oxygen metabolism? (2010) Nat Rev Nephrol, 6, pp. 83-95; Gamcsik, M.P., Dubay, G.R., Cox, B.R., Increased rate of glutathione synthesis from cystine in drug-resistant MCF-7 cells (2002) Biochem Pharmacol, 63, pp. 843-851; Yan, S.F., Yan, S.D., Ramasamy, R., Schmidt, A.M., Tempering the wrath of RAGE: an emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation (2009) Ann Med, 41, pp. 408-422; Wersching, H., Duning, T., Lohmann, H., Mohammadi, S., Stehling, C., Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function (2010) Neurology, 74, pp. 1022-1029; Ochrietor, J.D., Harrison, K.A., Zahedi, K., Mortensen, R.F., Role of STAT3 and C/EBP in cytokine-dependent expression of the mouse serum amyloid P-component (SAP) and C-reactive protein (CRP) genes (2000) Cytokine, 12, pp. 888-899; Zhang, K., Shen, X., Wu, J., Sakaki, K., Saunders, T., Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response (2006) Cell, 124, pp. 587-599; Yao, D., Brownlee, M., Hyperglycemia-induced reactive oxygen species increase expression of the receptor for advanced glycation end products (RAGE) and RAGE ligands (2010) Diabetes, 59, pp. 249-255; Meerwaldt, R., Links, T., Zeebregts, C., Tio, R., Hillebrands, J.L., The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes (2008) Cardiovasc Diabetol, 7, p. 29; Tan, S., Schubert, D., Maher, P., Oxytosis: A novel form of programmed cell death (2001) Curr Topics Med Chem, 1, pp. 497-506; Queisser, M.A., Yao, D., Geisler, S., Hammes, H.P., Lochnit, G., Hyperglycemia impairs proteasome function by methylglyoxal (2010) Diabetes, 59, pp. 670-678; Brouwers, O., Niessen, P.M., Ferreira, I., Miyata, T., Scheffer, P.G., Overexpression of glyoxalase-1 reduces hyperglycemia-induced levels of advanced glycation end products and oxidative stress in diabetic rats (2011) J Biol Chem, 286, pp. 1374-1380; Takasawa, R., Takahashi, S., Saeki, K., Sunaga, S., Yoshimori, A., Structure-activity relationship of human GLO I inhibitory natural flavonoids and their growth inhibitory effects (2008) Bioorg Med Chem, 16, pp. 3969-3975; Santel, T., Pflug, G., Hemdan, N.Y., Schafer, A., Hollenbach, M., Curcumin inhibits glyoxalase 1: a possible link to its anti-inflammatory and anti-tumor activity (2008) PLoS One, 3, pp. e3508; Wu, L., Davies, G.F., Roesler, W.J., Juurlink, B.H., Regulation of the glyoxalase pathway in human brain microvascular endothelium: effects of troglitazone and tertiary butylhydroperoxide (2002) Endothelium, 9, pp. 273-278; Sagara, Y., Vanhnasy, J., Maher, P., Induction of PC12 cell differentiation by flavonoids is dependent upon extracellular signal-regulated kinase activation (2004) J Neurochem, 90, pp. 1144-1155; Maher, P., Salgado, K.F., Zivin, J.A., Lapchak, P.A., A novel approach to screening for new neuroprotective compounds for the treatment of stroke (2007) Brain Res, 1173, pp. 117-125. , PMCID: PMC2111291; Cumming, R.C., Schubert, D., Amyloid-beta induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease (2005) FASEB J, 19, pp. 2060-2062; King, G.L., The role of inflammatory cytokines in diabetes and its complications (2008) J Periodontol, 79, pp. 1527-1534; Closhen, D., Bender, B., Luhmann, H.J., Kuhlmann, C.R., CRP-induced levels of oxidative stress are higher in brain than aortic endothelial cells (2010) Cytokine, 50, pp. 117-120; Scatena, M., Liaw, L., Giachelli, C.M., Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease (2007) Arterioscler Thromb Vasc Biol, 27, pp. 2302-2309; Maziere, C., Gomila, C., Maziere, J.C., Oxidized low-density lipoprotein increases osteopontin expression by generation of oxidative stress (2010) Free Radic Biol Med, 48, pp. 1382-1387; Goshen, I., Yirmiya, R., Interleukin-1 (IL-1): a central regulator of stress responses (2009) Front Neuroendocrinol, 30, pp. 30-45; Manach, C., Williamson, G., Morand, C., Scalbert, A., Remesy, C., Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies (2005) Am J Clin Nutr, 81, pp. 230S-242S; Prasain, J.K., Barnes, S., Metabolism and bioavailability of flavonoids in chemoprevention: current analytical strategies and future prospectus (2007) Mol Pharm, 4, pp. 846-864; Shia, C.S., Tsai, S.Y., Kuo, S.C., Hou, Y.C., Chao, P.D., Metabolism and pharmacokinetics of 3,3′,4′,7-tetrahydroxyflavone (fisetin), 5-hydroxyflavone, and 7-hydroxyflavone and antihemolysis effects of fisetin and its serum metabolites (2009) J Agric Food Chem, 57, pp. 83-89; Arai, Y., Watanabe, S., Kimira, M., Shimoi, K., Mochizuki, R., Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration (2000) J Nutr, 130, pp. 2243-2250; Yoshioka, M., Kayo, T., Ikeda, T., Koizumi, A., A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice (1997) Diabetes, 46, pp. 887-894; RamachandraRao, S.P., Zhu, Y., Ravasi, T., McGowan, T.A., Toh, I., Pirfenidone is renoprotective in diabetic kidney disease (2009) J Am Soc Nephrol, 20, pp. 1765-1775; MacKay, K., Striker, L.J., Elliot, S., Pinkert, C.A., Brinster, R.L., Glomerular epithelial, mesangial, and endothelial cell lines from transgenic mice (1988) Kidney Int, 33, pp. 677-684; Davis, J.B., Maher, P., Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line (1994) Brain Res, 652, pp. 169-173","Maher, P.; Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, United States; email: pmaher@salk.edu",,,,,,,,19326203,,,21738623,"English","PLoS ONE",Article,Scopus,2-s2.0-79959596092
"Bartlett, B.J., Isakson, P., Lewerenz, J., Sanchez, H., Kotzebue, R.W., Cumming, R., Harris, G.L., Nezis, I.P., Schubert, D., Simonsen, A., Finley, K.D.","p62, Ref(2)P and ubiquitinated proteins are conserved markers of neuronal aging, aggregate formation and progressive autophagic defects",2011,"Autophagy","7","6",,"572","583",,43,10.4161/auto.7.6.14943,"http://www.scopus.com/inward/record.url?eid=2-s2.0-79957916551&partnerID=40&md5=bc8af4c61a655f1ef9c3d45913911b24","BioScience Center, San Diego State University, San Diego, United States; Department of Biology, San Diego State University, San Diego, United States; Expression Drug Designs, LLC, San Diego, United States; Department of Biochemistry, Oslo University Hospital, University of Oslo, Oslo, Norway; Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States","Bartlett, B.J., BioScience Center, San Diego State University, San Diego, United States, Department of Biology, San Diego State University, San Diego, United States, Expression Drug Designs, LLC, San Diego, United States; Isakson, P., Department of Biochemistry, Oslo University Hospital, University of Oslo, Oslo, Norway; Lewerenz, J., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; Sanchez, H., Department of Biology, San Diego State University, San Diego, United States, Expression Drug Designs, LLC, San Diego, United States; Kotzebue, R.W., BioScience Center, San Diego State University, San Diego, United States, Department of Biology, San Diego State University, San Diego, United States; Cumming, R., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; Harris, G.L., Department of Biology, San Diego State University, San Diego, United States, Expression Drug Designs, LLC, San Diego, United States; Nezis, I.P., Department of Biochemistry, Oslo University Hospital, University of Oslo, Oslo, Norway; Schubert, D., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; Simonsen, A., Department of Biochemistry, Oslo University Hospital, University of Oslo, Oslo, Norway; Finley, K.D., BioScience Center, San Diego State University, San Diego, United States, Expression Drug Designs, LLC, San Diego, United States","Suppression of macroautophagy, due to mutations or through processes linked to aging, results in the accumulation of cytoplasmic substrates that are normally eliminated by the pathway. This is a significant problem in long-lived cells like neurons, where pathway defects can result in the accumulation of aggregates containing ubiquitinated proteins. The p62/Ref(2)P family of proteins is involved in the autophagic clearance of cytoplasmic protein bodies or sequestosomes. These unique structures are closely associated with protein inclusions containing ubiquitin as well as key components of the autophagy pathway. In this study we show that detergent fractionation followed by western blot analysis of insoluble ubiquitinated proteins (IUP), mammalian p62 and its Drosophila homologue, Ref(2)P can be used to quantitatively assess the activity level of aggregate clearance (aggrephagy) in complex tissues. Using this technique we show that genetic or age-dependent changes that modify the long-term enhancement or suppression of aggrephagy can be identified. Moreover, using the Drosophila model system this method can be used to establish autophagy-dependent protein clearance profiles that are occurring under a wide range of physiological conditions including developmental, fasting and altered metabolic pathways. This technique can also be used to examine proteopathies that are associated with human disorders such as frontotemporal dementia, Huntington and Alzheimer disease. Our findings indicate that measuring IUP profiles together with an assessment of p62/Ref(2)P proteins can be used as a screening or diagnostic tool to characterize genetic and age-dependent factors that alter the long-term function of autophagy and the clearance of protein aggregates occurring within complex tissues and cells. © 2011 Landes Bioscience.","Aggregates; Aging; Alzheimer disease; Insoluble ubiquitinated proteins; Macroautophagy; Neural degeneration; p62; Ref(2)P","autophagy protein 5; Drosophila protein; protein p62; ubiquitinated protein; Alzheimer disease; article; autophagy; cell activity; cell aggregation; cell fractionation; dementia; diagnostic value; disease association; disease marker; female; genetic predisposition; human; Huntington chorea; male; nerve degeneration; physiological process; screening test; Western blotting; Adaptor Proteins, Signal Transducing; Alzheimer Disease; Animals; Animals, Genetically Modified; Autophagy; Cytoplasm; Detergents; Drosophila melanogaster; Drosophila Proteins; Gene Expression Regulation, Developmental; Humans; Microscopy, Electron, Transmission; Models, Biological; Models, Genetic; Mutation; Neurons; Nuclear Proteins; Time Factors; Mammalia",,"Adaptor Proteins, Signal Transducing; Detergents; Drosophila Proteins; Nuclear Proteins; SQSTM1 protein, human; refractory to sigma P protein, Drosophila",,,,"Cuervo, A.M., Bergamini, E., Brunk, U.T., Droge, W., Ffrench, M., Terman, A., Autophagy and aging: The importance of maintaining ""clean"" cells (2005) Autophagy, 1, pp. 131-140; Zerovnik, E., Protein Conformational Pathology in Alzheimer's and other Neurodegenerative Diseases; New Targets for Therapy (2009) Curr Alzheimer Res; Nagaoka, U., Kim, K., Nihar, R.J., Doi, H., Maruyama, M., Mitsui, K., Oyama, F., Nukina, N., Increased expression of p62 in expanded polyglutamine-expressing cells and its association with polyglutamine inclusions (2004) Journal of Neurochemistry, 91 (1), pp. 57-68. , DOI 10.1111/j.1471-4159.2004.02692.x; Ding, W.X., Yin, X.M., Sorting, recognition and activation of the misfolded protein degradation pathways through macroautophagy and the proteasome (2008) Autophagy, 4, pp. 141-150; Moscat, J., Diaz-Meco, M.T., p62 at the crossroads of autophagy, apoptosis and cancer (2009) Cell, 137, pp. 1001-1004; Melendez, A., Neufeld, T.P., The cell biology of autophagy in metazoans: A developing story (2008) Development, 135, pp. 2347-2360; Klionsky, D.J., Cuervo, A.M., Dunn Jr., W.A., Levine, B., Van Der Klei, I., Seglen, P.O., How shall I eat thee? (2007) Autophagy, 3, pp. 413-416; Simonsen, A., Cumming, R.C., Brech, A., Isakson, P., Schubert, D.R., Finley, K.D., Promoting basal levels of autophagy in the nervous system enhances longevity and oxidant resistance in adult Drosophila (2008) Autophagy, 4 (2), pp. 176-184; Finley, K.D., Edeen, P.T., Cumming, R.C., Mardahl-Dumesnil, M.D., Taylor, B.J., Rodriguez, M.H., Hwang, C.E., McKeown, M., Blue cheese mutations define a novel, conserved gene involved in progressive neural degeneration (2003) Journal of Neuroscience, 23 (4), pp. 1254-1264; Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice (2006) Nature, 441, pp. 885-889; Juhasz, G., Neufeld, T.P., Drosophila Atg7: Required for stress resistance, longevity and neuronal homeostasis, but not for metamorphosis (2008) Autophagy, 4 (3), pp. 357-358; Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J., Tanida, I., Loss of autophagy in the central nervous system causes neurodegeneration in mice (2006) Nature, 441, pp. 880-884; Komatsu, M., Waguri, S., Koike, M., Sou, Y.-s., Ueno, T., Hara, T., Mizushima, N., Tanaka, K., Homeostatic Levels of p62 Control Cytoplasmic Inclusion Body Formation in Autophagy-Deficient Mice (2007) Cell, 131 (6), pp. 1149-1163. , DOI 10.1016/j.cell.2007.10.035, PII S0092867407013542; Lindmo, K., Brech, A., Finley, K.D., Gaumer, S., Contamine, D., Rusten, T.E., Stenmark, H., The PI 3-kinase regulator Vps15 is required for autophagic clearance of protein aggregates (2008) Autophagy, 4 (4), pp. 500-506; Pankiv, S., Clausen, T.H., Lamark, T., Brech, A., Bruun, J.-A., Outzen, H., Overvatn, A., Johansen, T., p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy[S] (2007) Journal of Biological Chemistry, 282 (33), pp. 24131-24145. , http://www.jbc.org/cgi/reprint/282/33/24131, DOI 10.1074/jbc.M702824200; Zatloukal, K., Stumptner, C., Fuchsbichler, A., Heid, H., Schnoelzer, M., Kenner, L., Kleinert, R., Denk, H., p62 is a common component of cytoplasmic inclusions in protein aggregation diseases (2002) American Journal of Pathology, 160 (1), pp. 255-263; Clausen, T.H., Lamark, T., Isakson, P., Finley, K., Larsen, K.B., Brech, A., p62/SQSTM1 and ALFY interact to facilitate the formation of p62 bodies/ALIS and their degradation by autophagy (2010) Autophagy, 6; Riley, B.E., Kaiser, S.E., Shaler, T.A., Ng, A.C., Hara, T., Hipp, M.S., Ubiquitin accumulation in autophagy-deficient mice is dependent on the Nrf2-mediated stress response pathway: A potential role for protein aggregation in autophagic substrate selection (2010) J Cell Biol, 191, pp. 537-552; Nezis, I.P., Simonsen, A., Sagona, A.P., Finley, K., Gaumer, S., Contamine, D., Ref(2)P, the Drosophila melanogaster homologue of mammalian p62, is required for the formation of protein aggregates in adult brain (2008) J Cell Biol, 180, pp. 1065-1071; Hoozemans, J.J., Van Haastert, E.S., Nijholt, D.A., Rozemuller, A.J., Eikelenboom, P., Scheper, W., The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus (2009) Am J Pathol, 174, pp. 1241-1251; Waguri, S., Komatsu, M., Biochemical and morphological detection of inclusion bodies in autophagy-deficient mice (2009) Methods Enzymol, 453, pp. 181-196; Filimonenko, M., Stuffers, S., Raiborg, C., Yamamoto, A., Malerod, L., Fisher, E.M.C., Isaacs, A., Simonsen, A., Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease (2007) Journal of Cell Biology, 179 (3), pp. 485-500. , http://www.jcb.org/cgi/reprint/179/3/485, DOI 10.1083/jcb.200702115; Rusten, T.E., Simonsen, A., ESCRT functions in autophagy and associated disease (2008) Cell Cycle, 7 (9), pp. 1166-1172. , http://www.landesbioscience.com/journals/cc/article/RustenCC7-9.pdf; Kuusisto, E., Salminen, A., Alafuzoff, I., Early accumulation of p62 in neurofibrillary tangles in alzheimer's disease: Possible role in tangle formation (2002) Neuropathology and Applied Neurobiology, 28 (3), pp. 228-237. , DOI 10.1046/j.1365-2990.2002.00394.x; Boland, B., Kumar, A., Lee, S., Platt, F.M., Wegiel, J., Yu, W.H., Autophagy induction and autophagosome clearance in neurons: Relationship to autophagic pathology in Alzheimer's disease (2008) J Neurosci, 28, pp. 6926-6937; Nixon, R.A., Autophagy, amyloidogenesis and Alzheimer disease (2007) J Cell Sci, 120, pp. 4081-4091; Filimonenko, M., Isakson, P., Finley, K.D., Anderson, M., Jeong, H., Melia, T.J., The selective macroautophagic degradation of aggregated proteins requires the PI3Pbinding protein Alfy (2010) Mol Cell, 38, pp. 265-279; Seelaar, H., Klijnsma, K.Y., De Koning, I., Van Der Lugt, A., Chiu, W.Z., Azmani, A., Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration (2009) J Neurol; Simonsen, A., Cumming, R.C., Lindmo, K., Galaviz, V., Cheng, S., Rusten, T.E., Finley, K.D., Genetic modifiers of the drosophila blue cheese gene link defects in lysosomal transport with decreased life span and altered ubiquitinated-protein profiles (2007) Genetics, 176 (2), pp. 1283-1297. , http://www.genetics.org/cgi/reprint/176/2/1283, DOI 10.1534/genetics.106.065011; Simonsen, A., Birkeland, H.C.G., Gillooly, D.J., Mizushima, N., Kuma, A., Yoshimori, T., Slagsvold, T., Stenmark, H., Alfy, a novel FYVE-domain-containing protein associated with protein granules and autophagic membranes (2004) Journal of Cell Science, 117 (18), pp. 4239-4251. , DOI 10.1242/jcs.01287; Kopito, R.R., Aggresomes, inclusion bodies and protein aggregation (2000) Trends Cell Biol, 10, pp. 524-530; Garcia-Mata, R., Gao, Y.-S., Sztul, E., Hassles with taking out the garbage: Aggravating aggresomes (2002) Traffic, 3 (6), pp. 388-396. , DOI 10.1034/j.1600-0854.2002.30602.x; Johnston, J.A., Illing, M.E., Kopito, R.R., Cytoplasmic dynein/dynactin mediates the assembly of aggresomes (2002) Cell Motility and the Cytoskeleton, 53 (1), pp. 26-38. , DOI 10.1002/cm.10057; Lindmo, K., Simonsen, A., Brech, A., Finley, K., Rusten, T.E., Stenmark, H., A dual function for Deep orange in programmed autophagy in the Drosophila melanogaster fat body (2006) Exp Cell Res, 312, pp. 2018-2027; Scott, R.C., Schuldiner, O., Neufeld, T.P., Role and regulation of starvation-induced autophagy in the Drosophila fat body (2004) Developmental Cell, 7 (2), pp. 167-178. , DOI 10.1016/j.devcel.2004.07.009, PII S153458070400245X; Young, J.E., Martinez, R.A., La Spada, A.R., Nutrient deprivation induces neuronal autophagy and implicates reduced insulin signaling in neuroprotective autophagy activation (2009) J Biol Chem, 284, pp. 2363-2373; Mizushima, N., Yamamoto, A., Matsui, M., Yoshimori, T., Ohsumi, Y., In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker (2004) Mol Biol Cell, 15, pp. 1101-1111; Bjorkoy, G., Lamark, T., Pankiv, S., Overvatn, A., Brech, A., Johansen, T., Monitoring autophagic degradation of p62/SQSTM1 (2009) Methods Enzymol, 452, pp. 181-197; Lamark, T., Kirkin, V., Dikic, I., Johansen, T., NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets (2009) Cell Cycle, 8, pp. 1986-1990; Hwangbo, D.S., Garsham, B., Tu, M.-P., Palmer, M., Tatar, M., Drosophila dFOXO controls lifespan and regulates insulin signalling in brain and fat body (2004) Nature, 429 (6991), pp. 562-566. , DOI 10.1038/nature02549; Tu, M.P., Epstein, D., Tatar, M., The demography of slow aging in male and female Drosophila mutant for the insulin-receptor substrate homologue chico (2002) Aging Cell, 1, pp. 75-80; Clancy, D.J., Gems, D., Harshman, L.G., Oldham, S., Stocker, H., Hafen, E., Leevers, S.J., Partridge, L., Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein (2001) Science, 292 (5514), pp. 104-106. , DOI 10.1126/science.1057991; Hansen, M., Chandra, A., Mitic, L.L., Onken, B., Driscoll, M., Kenyon, C., A role for autophagy in the extension of lifespan by dietary restriction in C. elegans (2008) PLoS Genet, 4, p. 24; Arsham, A.M., Neufeld, T.P., Thinking globally and acting locally with TOR (2006) Curr Opin Cell Biol, 18, pp. 589-597; Diaz-Troya, S., Perez-Perez, M.E., Florencio, F.J., Crespo, J.L., The role of TOR in autophagy regulation from yeast to plants and mammals (2008) Autophagy, 4, pp. 851-865; Ravikumar, B., Vacher, C., Berger, Z., Davies, J.E., Luo, S., Oroz, L.G., Scaravilli, F., Rubinsztein, D.C., Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease (2004) Nature Genetics, 36 (6), pp. 585-595. , DOI 10.1038/ng1362; Cole, G.M., Timiras, P.S., Ubiquitin-protein conjugates in Alzheimer's lesions (1987) Neuroscience Letters, 79 (1-2), pp. 207-212; Kadokura, A., Yamazaki, T., Lemere, C.A., Takatama, M., Okamoto, K., Regional distribution of TDP-43 inclusions in Alzheimer disease (AD) brains: Their relation to AD common pathology (2009) Neuropathology, 29, pp. 566-573; Cumming, R.C., Schubert, D., Amyloid-beta induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease (2005) FASEB Journal, 19 (14), pp. 2060-2062. , DOI 10.1096/fj.05-4195fje; Metsaars, W.P., Hauw, J.-J., Van Welsem, M.E., Duyckaerts, C., A grading system of Alzheimer disease lesions in neocortical areas (2003) Neurobiology of Aging, 24 (4), pp. 563-572. , DOI 10.1016/S0197-4580(02)00134-3, PII S0197458002001343; Long, J., Garner, T.P., Pandya, M.J., Craven, C.J., Chen, P., Shaw, B., Dimerisation of the UBA domain of p62 inhibits ubiquitin binding and regulates NFkappaB signalling (2010) J Mol Biol, 396, pp. 178-194; Ling, D., Song, H.J., Garza, D., Neufeld, T.P., Salvaterra, P.M., Abeta42-induced neurodegeneration via an agedependent autophagic-lysosomal injury in Drosophila (2009) PLoS ONE, 4, p. 4201; Yang, D.S., Lee, J.H., Nixon, R.A., Monitoring autophagy in Alzheimer's disease and related neurodegenerative diseases (2009) Methods Enzymol, 453, pp. 111-144; Lee, J.A., Gao, F.B., Inhibition of autophagy induction delays neuronal cell loss caused by dysfunctional ESCRT-III in frontotemporal dementia (2009) J Neurosci, 29, pp. 8506-8511; Simonsen, A., Tooze, S.A., Coordination of membrane events during autophagy by multiple class III PI3- Kinase complexes (2009) J Cell Biol, 186, pp. 773-782; Rollinson, S., Rizzu, P., Sikkink, S., Baker, M., Halliwell, N., Snowden, J., Ubiquitin associated protein1 is a risk factor for frontotemporal lobar degeneration (2009) Neurobiol Aging, 30, pp. 656-665; Rusten, T.E., Filimonenko, M., Rodahl, L.M., Stenmark, H., Simonsen, A., ESCRTing autophagic clearance of aggregating proteins (2007) Autophagy, 4; Rusten, T.E., Vaccari, T., Lindmo, K., Rodahl, L.M.W., Nezis, I.P., Sem-Jacobsen, C., Wendler, F., Stenmark, H., ESCRTs and Fab1 Regulate Distinct Steps of Autophagy (2007) Current Biology, 17 (20), pp. 1817-1825. , DOI 10.1016/j.cub.2007.09.032, PII S0960982207019914; Zheng, Y.T., Shahnazari, S., Brech, A., Lamark, T., Johansen, T., Brumell, J.H., The adaptor protein p62/SQSTM1 targets invading bacteria to the autophagy pathway (2009) J Immunol, 183, pp. 5909-5916; Yoshikawa, Y., Ogawa, M., Hain, T., Yoshida, M., Fukumatsu, M., Kim, M., Listeria monocytogenes ActA-mediated escape from autophagic recognition (2009) Nat Cell Biol, 11, pp. 1233-1240; Dupont, N., Lacas-Gervais, S., Bertout, J., Paz, I., Freche, B., Van Nhieu, G.T., Shigella phagocytic vacuolar membrane remnants participate in the cellular response to pathogen invasion and are regulated by autophagy (2009) Cell Host Microbe, 6, pp. 137-149; Lamark, T., Perander, M., Outzen, H., Kristiansen, K., Overvatn, A., Michaelsen, E., BjOrkoy, G., Johansen, T., Interaction Codes within the Family of Mammalian Phox and Bem1p Domain-containing Proteins (2003) Journal of Biological Chemistry, 278 (36), pp. 34568-34581. , DOI 10.1074/jbc.M303221200; Komatsu, M., Kurokawa, H., Waguri, S., Taguchi, K., Kobayashi, A., Ichimura, Y., The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1 (2010) Nat Cell Biol, 12, pp. 213-223; Cumming, R.C., Simonsen, A., Finley, K.D., Quantitative analysis of autophagic activity in Drosophila neural tissues by measuring the turnover rates of pathway substrates (2008) Methods Enzymol, 451, pp. 639-651; Neufeld, T.P., Baehrecke, E.H., Eating on the fly: Function and regulation of autophagy during cell growth, survival and death in Drosophila (2008) Autophagy, 4, pp. 557-562; Juhasz, G., Csikos, G., Sinka, R., Erdelyi, M., Sass, M., The Drosophila homolog of Aut1 is essential for autophagy and development (2003) FEBS Letters, 543 (1-3), pp. 154-158. , DOI 10.1016/S0014-5793(03)00431-9; Rusten, T.E., Lindmo, K., Juhasz, G., Sass, M., Seglen, P.O., Brech, A., Stenmark, H., Programmed autophagy in the Drosophila fat body is induced by ecdysone through regulation of the PI3K Pathway (2004) Developmental Cell, 7 (2), pp. 179-192. , DOI 10.1016/j.devcel.2004.07.005, PII S1534580704002400; Papaconstantinou, J., DeFord, J.H., Gerstner, A., Hsieh, C.-C., Boylston, W.H., Guigneaux, M.M., Flurkey, K., Harrison, D.E., Hepatic gene and protein expression of primary components of the IGF-I axis in long lived Snell dwarf mice (2005) Mechanisms of Ageing and Development, 126 (6-7), pp. 692-704. , DOI 10.1016/j.mad.2005.01.002, PII S0047637405000229; Tu, M.-P., Yin, C.-M., Tatar, M., Mutations in insulin signaling pathway alter juvenile hormone synthesis in Drosophila melanogaster (2005) General and Comparative Endocrinology, 142 (3), pp. 347-356. , DOI 10.1016/j.ygcen.2005.02.009, PII S0016648005000389; Bergamini, E., Cavallini, G., Donati, A., Gori, Z., The anti-ageing effects of caloric restriction may involve stimulation of macroautophagy and lysosomal degradation, and can be intensified pharmacologically (2003) Biomedicine and Pharmacotherapy, 57 (5-6), pp. 203-208. , DOI 10.1016/S0753-3322(03)00048-9; Lee, J.-A., Beigneux, A., Ahmad, S.T., Young, S.G., Gao, F.-B., ESCRT-III Dysfunction Causes Autophagosome Accumulation and Neurodegeneration (2007) Current Biology, 17 (18), pp. 1561-1567. , DOI 10.1016/j.cub.2007.07.029, PII S0960982207017071; Nixon, R.A., Wegiel, J., Kumar, A., Yu, W.H., Peterhoff, C., Cataldo, A., Cuervo, A.M., Extensive involvement of autophagy in Alzheimer disease: An immuno-electron microscopy study (2005) Journal of Neuropathology and Experimental Neurology, 64 (2), pp. 113-122; Yamamoto, A., Cremona, M.L., Rothman, J.E., Autophagymediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway (2006) J Cell Biol, 172, pp. 719-731; Tan, S., Wood, M., Maher, P., Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells (1998) Journal of Neurochemistry, 71 (1), pp. 95-105","Finley, K. D.; BioScience Center, San Diego State University, San Diego, United States; email: kfinley@sciences.sdsu.edu",,,,,,,,15548627,,,21325881,"English","Autophagy",Article,Scopus,2-s2.0-79957916551
"Lapchak, P.A., Schubert, D.R., Maher, P.A.","De-Risking of Stilbazulenyl Nitrone (STAZN), a Lipophilic Nitrone to Treat Stroke Using a Unique Panel of In Vitro Assays",2011,"Translational Stroke Research","2","2",,"209","217",,4,10.1007/s12975-011-0071-7,"http://www.scopus.com/inward/record.url?eid=2-s2.0-79955707791&partnerID=40&md5=2241d48dd9b743677f4c6236ff400ce3","Department of Neurology, Cedars-Sinai Medical Center, Davis Research Building, D-2091, 110 N. George Burns Road, Los Angeles, CA 90048, United States; Cellular Neurobiology Laboratories, The Salk Institute, 10010 North Torrey Pines Road, La Jolla, San Diego, CA 92037-1099, United States","Lapchak, P.A., Department of Neurology, Cedars-Sinai Medical Center, Davis Research Building, D-2091, 110 N. George Burns Road, Los Angeles, CA 90048, United States; Schubert, D.R., Cellular Neurobiology Laboratories, The Salk Institute, 10010 North Torrey Pines Road, La Jolla, San Diego, CA 92037-1099, United States; Maher, P.A., Cellular Neurobiology Laboratories, The Salk Institute, 10010 North Torrey Pines Road, La Jolla, San Diego, CA 92037-1099, United States","In the present study, we used a comprehensive panel of in vitro assays to evaluate the efficacy and safety of stilbazulenyl nitrone (STAZN) as a lead compound to treat acute ischemic stroke. First, we measured neuroprotection in vitro using two different HT22 hippocampal nerve cell assays. Secondly, to de-risk drug development, we used CeeTox analysis with the H4IIE rat hepatoma cell line to determine the acute toxicity profile of STAZN. Third, STAZN was tested in microsomes from four species for measures of metabolic stability. Last, we determined the Ames test genotoxicity profile of STAZN using Salmonella typhimurium TA989 and TA100. In vitro, STAZN was neuroprotective against toxicity induced by iodoacetic acid, and oxytosis-induced glutathione depletion was initiated by glutamate, with an EC 50 value of 1-5 μM. Secondly, using CeeTox analysis, the estimated C Tox value (i. e., sustained concentration expected to produce toxicity in a rat 14-day repeat dose study) for STAZN was calculated to be 260 μM. Third, the half-life of STAZN in humans, dogs, and rats was 60-78 min. Last, the genotoxicity profile showed that STAZN did not induce bacterial colony growth under any conditions tested, indicating the lack of mutagenicity with this compound. STAZN appears to be a multi-target neuroprotective compound that has an excellent safety profile in both the CeeTox and Ames mutagenicity assays. STAZN may have significant potential as a novel neuroprotective agent to treat stroke and should be pursued in clinically relevant embolic stroke models. © 2011 Springer Science+Business Media, LLC.","Antioxidant; CeeTox; Efficacy; Genotoxicity; Nitrone; Safety","glutathione; iodoacetic acid; nitrone derivative; stilbazulenyl nitrone; unclassified drug; Ames test; animal experiment; animal model; article; bacterial growth; bacterium colony; controlled study; drug efficacy; drug half life; drug safety; genotoxicity; hepatoma cell; human; in vitro study; microsome; mouse; mutagenicity; neuroprotection; nonhuman; priority journal; rat; Salmonella typhimurium; stroke",,"glutathione, 70-18-8; iodoacetic acid, 64-69-7",,,,"Ingall, T., Stroke-incidence, mortality, morbidity and risk (2004) J Insur Med, 36 (2), pp. 143-152; Lloyd-Jones, D., Adams, R., Carnethon, M., de Simone, G., Ferguson, T.B., Flegal, K., Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee to Stroke Statistics Subcommittee (2009) Circulation, 119 (3), pp. 480-486; Moskowitz, M.A., Lo, E.H., Iadecola, C., The science of stroke: mechanisms in search of treatments (2010) Neuron, 67 (2), pp. 181-198; Bath, P.M., Gray, L.J., Bath, A.J., Buchan, A., Miyata, T., Green, A.R., Effects of NXY-059 in experimental stroke: an individual animal meta-analysis (2009) Br J Pharmacol, 157 (7), pp. 1157-1171; Dirnagl, U., Iadecola, C., Moskowitz, M.A., Pathobiology of ischaemic stroke: an integrated view (1999) Trends Neurosci, 22 (9), pp. 391-397; Lapchak, P.A., A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy? (2010) Expert Opin Pharmacother, 11 (10), pp. 1753-1763; Savitz, S.I., A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: a need for more rigorous testing of neuroprotective agents in animal models of stroke (2007) Exp Neurol, 205 (1), pp. 20-25; Lees, K.R., Zivin, J.A., Ashwood, T., Davalos, A., Davis, S.M., Diener, H.C., NXY-059 for acute ischemic stroke (2006) N Engl J Med, 354 (6), pp. 588-600; Otomo, E., Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters (2003) Cerebrovasc Dis, 15 (3), pp. 222-229; Watanabe, T., Tahara, M., Todo, S., The novel antioxidant edaravone: from bench to bedside (2008) Cardiovasc Ther, 26 (2), pp. 101-114; Tirilazad mesylate in acute ischemic stroke: a systematic review (2000) Stroke, 31 (9), pp. 2257-2265. , Tirilazad International Steering Committee; Lapchak, P.A., Translational stroke research using a rabbit embolic stroke model: a correlative analysis hypothesis for novel therapy development (2010) Transl Stroke Res, 1 (2), pp. 96-107. , Perspective Review; Shuaib, A., Lees, K.R., Lyden, P., Grotta, J., Davalos, A., Davis, S.M., NXY-059 for the treatment of acute ischemic stroke (2007) N Engl J Med, 357 (6), pp. 562-571; Feuerstein, G.Z., Zaleska, M.M., Krams, M., Wang, X., Day, M., Rutkowski, J.L., Missing steps in the STAIR case: a Translational Medicine perspective on the development of NXY-059 for treatment of acute ischemic stroke (2008) J Cereb Blood Flow Metab., 28, pp. 217-219; Lapchak, P.A., Araujo, D.M., Song, D., Wei, J., Zivin, J.A., Neuroprotective effects of the spin trap agent disodium-[(tert- butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: combination studies with the thrombolytic tissue plasminogen activator (2002) Stroke, 33 (5), pp. 1411-1415; Otomo, E., Tohgi, H., Kogure, K., Hirai, S., Terashi, A., Gotoh, F., Clinical efficacy of a free radical scavenger, MCI-186, on acute cerebral infarction: early phase II clinical trial (1998) Ther Res, 19, pp. 1311-1332; Ginsberg, M.D., Becker, D.A., Busto, R., Belayev, A., Zhang, Y., Khoutorova, L., Stilbazulenyl nitrone, a novel antioxidant, is highly neuroprotective in focal ischemia (2003) Ann Neurol, 54 (3), pp. 330-342; Becker, D.A., Ley, J.J., Echegoyen, L., Alvarado, R., Stilbazulenyl nitrone (STAZN): a nitronyl-substituted hydrocarbon with the potency of classical phenolic chain-breaking antioxidants (2002) J Am Chem Soc, 124 (17), pp. 4678-4684; Ley, J.J., Vigdorchik, A., Belayev, L., Zhao, W., Busto, R., Khoutorova, L., Stilbazulenyl nitrone, a second-generation azulenyl nitrone antioxidant, confers enduring neuroprotection in experimental focal cerebral ischemia in the rat: neurobehavior, histopathology, and pharmacokinetics (2005) J Pharmacol Exp Ther, 313 (3), pp. 1090-1100; Kuroda, S., Tsuchidate, R., Smith, M.L., Maples, K.R., Siesjo, B.K., Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat (1999) J Cereb Blood Flow Metab, 19 (7), pp. 778-787; Lapchak, P.A., Zhang, J.H., Resolving the negative data publication dilemna in translational stroke research (2011) Transl Stroke Research, 2 (1), pp. 1-6; Recommendations for standards regarding preclinical neuroprotective and restorative drug development (1999) Stroke, 30 (12), pp. 2752-2758. , STAIR; Becker, D.A., Ley, J., (2008) Inventors. Azulenyl Nitrone Spin Trapping Agents, Methods of Making and Using Same, , US patent number 0888290; Davis, J.B., Maher, P., Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line (1994) Brain Res, 652, pp. 169-173; Maher, P., Davis, J., The role of monoamine metabolism in oxidative glutamate toxicity (1996) J Neurosci, 16, pp. 6394-6401; Lapchak, P.A., Schubert, D.R., Maher, P.A., Delayed treatment with a novel neurotrophic compound reduces behavioral deficits in rabbit ischemic stroke (2011) J Neurochem, 116 (1), pp. 122-131; Maher, P., Salgado, K.F., Zivin, J.A., Lapchak, P.A., A novel approach to screening for new neuroprotective compounds for the treatment of stroke (2007) Brain Res, 1173, pp. 117-125; Tan, S., Schubert, D., Maher, P., Oxytosis: a novel form of programmed cell death (2001) Curr Top Med Chem, 1 (6), pp. 497-506; Liu, Y., Dargusch, R., Maher, P., Schubert, D., A broadly neuroprotective derivative of curcumin (2008) J Neurochem, 105 (4), pp. 1336-1345; Lapchak, P.A., KcKim, J.M., CeeTox™ analysis of CNB-001 a novel curcumin-based neurotrophic/neuroprotective lead compound to treat stroke: comparison with NXY-059 and radicut (2011) Transl Stroke Research, 2 (1), pp. 51-59; McKim Jr., J.M., Building a tiered approach to in vitro predictive toxicity screening: a focus on assays with in vivo relevance (2010) Comb Chem High Throughput Screen, 13 (2), pp. 188-206; McKim Jr., J.M., (2009) Inventor. Ceetox, Inc., Assignee. Toxicity Screening Methods, , US patent number 7615361; Ames, B., Lee, F., Durston, W., An improved bacterial test system for the detection and classification of mutagens and carcinogens (1973) Proc Natl Acad Sci USA, 70, pp. 782-786; Ames, B.N., Carcinogens are mutagens: their detection and classification (1973) Environ Health Perspect, 6, pp. 115-118; Ames, B.N., Durston, W.E., Yamasaki, E., Lee, F.D., Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection (1973) Proc Natl Acad Sci USA, 70 (8), pp. 2281-2285; Mortelmans, K., Zeiger, E., The Ames Salmonella/microsome mutagenicity assay (2000) Mutat Res, 455 (1-2), pp. 29-60; Zeiger, E., Historical perspective on the development of the genetic toxicity test battery in the United States (2010) Environ Mol Mutagen, 51 (8-9), pp. 781-791; Jemnitz, K., Veres, Z., Torok, G., Toth, E., Vereczkey, L., Comparative study in the Ames test of benzo[a]pyrene and 2-aminoanthracene metabolic activation using rat hepatic S9 and hepatocytes following in vivo or in vitro induction (2004) Mutagenesis, 19 (3), pp. 245-250; Ayrton, A.D., Neville, S., Ioannides, C., Cytosolic activation of 2-aminoanthracene: implications in its use as diagnostic mutagen in the Ames test (1992) Mutat Res, 265 (1), pp. 1-8; Hannan, M.A., Recio, L., Deluca, P.P., Enoch, H., Co-mutagenic effects of 2-aminoanthracene and cigarette smoke condensate on smoker's urine in the Ames Salmonella assay system (1981) Cancer Lett, 13 (3), pp. 203-212; Kawalek, J.C., Andrews, A.W., Effect of aromatic hydrocarbons on the metabolism of 2-aminoanthracene to mutagenic products in the Ames assay (1981) Carcinogenesis, 2 (12), pp. 1367-1369; Aly, H.A., Domenech, O., Aroclor 1254 induced cytotoxicity and mitochondrial dysfunction in isolated rat hepatocytes (2009) Toxicology, 262 (3), pp. 175-183; Aly, H.A., Domenech, O., Abdel-Naim, A.B., Aroclor 1254 impairs spermatogenesis and induces oxidative stress in rat testicular mitochondria (2009) Food Chem Toxicol, 47 (8), pp. 1733-1738; Lapchak, P.A., Maher, P., Schubert, D., Zivin, J.A., Baicalein, an antioxidant 12/15-lipoxygenase inhibitor improves clinical rating scores following multiple infarct embolic strokes (2007) Neuroscience, 150 (3), pp. 585-591; Maher, P., A comparison of the neurotrophic activities of the flavonoid fisetin and some of its derivatives (2006) Free Radic Res, 40 (10), pp. 1105-1111; Maher, P., Akaishi, T., Schubert, D., Abe, K., A pyrazole derivative of curcumin enhances memory (2010) Neurobiol Aging, 31 (4), pp. 706-709; D'Amelio, M., Cavallucci, V., Cecconi, F., Neuronal caspase-3 signaling: Not only cell death (2010) Cell Death Differ, 17 (7), pp. 1104-1114; Legos, J.J., Tuma, R.F., Barone, F.C., Pharmacological interventions for stroke: failures and future (2002) Expert Opin Investig Drugs, 11 (5), pp. 603-614; Green, A.R., Why do neuroprotective drugs that are so promising in animals fail in the clinic? An industry perspective (2002) Clin Exp Pharmacol Physiol, 29 (11), pp. 1030-1034; Liebeskind, D.S., Kasner, S.E., Neuroprotection for ischaemic stroke: an unattainable goal? (2001) CNS Drugs, 15 (3), pp. 165-174; O'Collins, V.E., Macleod, M.R., Donnan, G.A., Horky, L.L., van der Worp, B.H., Howells, D.W., 1,026 experimental treatments in acute stroke (2006) Ann Neurol, 59 (3), pp. 467-477; Yan, J., Wang, L., Fu, P.P., Yu, H., Photomutagenicity of 16 polycyclic aromatic hydrocarbons from the US EPA priority pollutant list (2004) Mutat Res, 557 (1), pp. 99-108; Wang, L., Yan, J., Fu, P.P., Parekh, K.A., Yu, H., Photomutagenicity of cosmetic ingredient chemicals azulene and guaiazulene (2003) Mutat Res, 530 (1-2), pp. 19-26; Ginsberg, M.D., Life after cerovive: a personal perspective on ischemic neuroprotection in the post-NXY-059 era (2007) Stroke, 38 (6), pp. 1967-1972","Lapchak, P. A.; Department of Neurology, Cedars-Sinai Medical Center, Davis Research Building, D-2091, 110 N. George Burns Road, Los Angeles, CA 90048, United States; email: Paul.Lapchak@cshs.org",,,,,,,,18684483,,,,"English","Transl. Stroke Res.",Article,Scopus,2-s2.0-79955707791
"Newington, J.T., Pitts, A., Chien, A., Arseneault, R., Schubert, D., Cumming, R.C.","Amyloid beta resistance in nerve cell lines is mediated by the warburg effect",2011,"PLoS ONE","6","4", e19191,"","",,27,10.1371/journal.pone.0019191,"http://www.scopus.com/inward/record.url?eid=2-s2.0-79955629694&partnerID=40&md5=b79bedef967e54aab17eb51250406847","Department of Biology, The University of Western Ontario, London, ON, Canada; Cellular Neurobiology Laboratory, Salk Institute, La Jolla, CA, United States","Newington, J.T., Department of Biology, The University of Western Ontario, London, ON, Canada; Pitts, A., Department of Biology, The University of Western Ontario, London, ON, Canada; Chien, A., Department of Biology, The University of Western Ontario, London, ON, Canada; Arseneault, R., Department of Biology, The University of Western Ontario, London, ON, Canada; Schubert, D., Cellular Neurobiology Laboratory, Salk Institute, La Jolla, CA, United States; Cumming, R.C., Department of Biology, The University of Western Ontario, London, ON, Canada","Amyloid beta (Aβ) peptide accumulation in the brains of patients with Alzheimer's disease (AD) is closely associated with increased nerve cell death. However, many cells survive and it is important to understand the mechanisms involved in this survival response. Recent studies have shown that an anti-apoptotic mechanism in cancer cells is mediated by aerobic glycolysis, also known as the Warburg effect. One of the major regulators of aerobic glycolysis is pyruvate dehydrogenase kinase (PDK), an enzyme which represses mitochondrial respiration and forces the cell to rely heavily on glycolysis, even in the presence of oxygen. Recent neuroimaging studies have shown that the spatial distribution of aerobic glycolysis in the brains of AD patients strongly correlates with Aβ deposition. Interestingly, clonal nerve cell lines selected for resistance to Aβ exhibit increased glycolysis as a result of activation of the transcription factor hypoxia inducible factor 1. Here we show that Aβ resistant nerve cell lines upregulate Warburg effect enzymes in a manner reminiscent of cancer cells. In particular, Aβ resistant nerve cell lines showed elevated PDK1 expression in addition to an increase in lactate dehydrogenase A (LDHA) activity and lactate production when compared to control cells. In addition, mitochondrial derived reactive oxygen species (ROS) were markedly diminished in resistant but not sensitive cells. Chemically or genetically inhibiting LDHA or PDK1 re-sensitized resistant cells to Aβ toxicity. These findings suggest that the Warburg effect may contribute to apoptotic-resistance mechanisms in the surviving neurons of the AD brain. Loss of the adaptive advantage afforded by aerobic glycolysis may exacerbate the pathophysiological processes associated with AD. © 2011 Newington et al.",,"amyloid beta protein; lactate dehydrogenase; pyruvate dehydrogenase kinase; reactive oxygen metabolite; amyloid beta protein; lactate dehydrogenase; lactic acid; protein serine threonine kinase; pyruvate dehydrogenase (acetyl transferring) kinase; pyruvate dehydrogenase (acetyl-transferring) kinase; reactive oxygen metabolite; Alzheimer disease; animal cell; apoptosis; article; cancer cell; cell line; cell survival; controlled study; enzyme activity; glycolysis; nerve cell; nonhuman; protein expression; rat; upregulation; Warburg effect; animal; biological model; biosynthesis; cell strain; drug antagonism; drug effect; metabolism; mitochondrion; nerve cell; Amyloid beta-Peptides; Animals; Glycolysis; L-Lactate Dehydrogenase; Lactic Acid; Mitochondria; Models, Biological; Neurons; PC12 Cells; Protein-Serine-Threonine Kinases; Rats; Reactive Oxygen Species",,"amyloid beta protein, 109770-29-8; lactate dehydrogenase, 9001-60-9; pyruvate dehydrogenase kinase, 9074-01-5; lactic acid, 113-21-3, 50-21-5; Amyloid beta-Peptides; L-Lactate Dehydrogenase, 1.1.1.27; Lactic Acid, 50-21-5; Protein-Serine-Threonine Kinases, 2.7.11.1; Reactive Oxygen Species; pyruvate dehydrogenase (acetyl-transferring) kinase, 2.7.11.2",,,,"Selkoe, D.J., Alzheimer disease: mechanistic understanding predicts novel therapies (2004) Ann Intern Med, 140, pp. 627-638; Masters, C.L., Simms, G., Weinman, N.A., Multhaup, G., McDonald, B.L., Amyloid plaque core protein in Alzheimer disease and Down syndrome (1985) Proc Natl Acad Sci U S A, 82, pp. 4245-4249; Hardy, J., Amyloid, the presenilins and Alzheimer's disease (1997) Trends Neurosci, 20, pp. 154-159; Selkoe, D.J., The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease (1998) Trends Cell Biol, 8, pp. 447-453; Behl, C., Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease (1997) Cell Tissue Res, 290, pp. 471-480; Behl, C., Davis, J., Cole, G.M., Schubert, D., Vitamin E protects nerve cells from amyloid beta protein toxicity (1992) Biochem Biophys Res Commun, 186, pp. 944-950; Behl, C., Davis, J.B., Lesley, R., Schubert, D., Hydrogen peroxide mediates amyloid beta protein toxicity (1994) Cell, 77, pp. 817-827; Butterfield, D.A., Reed, T., Newman, S.F., Sultana, R., Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment (2007) Free Radic Biol Med, 43, pp. 658-677; Markesbery, W.R., Oxidative stress hypothesis in Alzheimer's disease (1997) Free Radic Biol Med, 23, pp. 134-147; Bouras, C., Hof, P.R., Giannakopoulos, P., Michel, J.P., Morrison, J.H., Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital (1994) Cereb Cortex, 4, pp. 138-150; Price, J.L., Morris, J.C., Tangles and plaques in nondemented aging and ""preclinical"" Alzheimer's disease (1999) Ann Neurol, 45, pp. 358-368; Sagara, Y., Dargusch, R., Klier, F.G., Schubert, D., Behl, C., Increased antioxidant enzyme activity in amyloid beta protein-resistant cells (1996) J Neurosci, 16, pp. 497-505; Dargusch, R., Schubert, D., Specificity of resistance to oxidative stress (2002) J Neurochem, 81, pp. 1394-1400; Soucek, T., Cumming, R., Dargusch, R., Maher, P., Schubert, D., The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide (2003) Neuron, 39, pp. 43-56; Cumming, R.C., Dargusch, R., Fischer, W.H., Schubert, D., Increase in expression levels and resistance to sulfhydryl oxidation of peroxiredoxin isoforms in amyloid beta-resistant nerve cells (2007) J Biol Chem, 282, pp. 30523-30534; Semenza, G.L., Jiang, B.H., Leung, S.W., Passantino, R., Concordet, J.P., Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1 (1996) J Biol Chem, 271, pp. 32529-32537; Semenza, G.L., Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1 (1999) Annu Rev Cell Dev Biol, 15, pp. 551-578; Kim, J.W., Tchernyshyov, I., Semenza, G.L., Dang, C.V., HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia (2006) Cell Metab, 3, pp. 177-185; Papandreou, I., Cairns, R.A., Fontana, L., Lim, A.L., Denko, N.C., HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption (2006) Cell Metab, 3, pp. 187-197; Semenza, G.L., HIF-1 mediates the Warburg effect in clear cell renal carcinoma (2007) J Bioenerg Biomembr, 39, pp. 231-234; Semenza, G.L., HIF-1: upstream and downstream of cancer metabolism (2010) Curr Opin Genet Dev, 20, pp. 51-56; Bonnet, S., Archer, S.L., Allalunis-Turner, J., Haromy, A., Beaulieu, C., A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth (2007) Cancer Cell, 11, pp. 37-51; Michelakis, E.D., Webster, L., Mackey, J.R., Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer (2008) Br J Cancer, 99, pp. 989-994; Gatenby, R.A., Gillies, R.J., Why do cancers have high aerobic glycolysis? (2004) Nat Rev Cancer, 4, pp. 891-899; Warburg, O., On respiratory impairment in cancer cells (1956) Science, 124, pp. 269-270; Koukourakis, M.I., Giatromanolaki, A., Sivridis, E., Gatter, K.C., Harris, A.L., Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma (2005) Neoplasia, 7, pp. 1-6; Michelakis, E.D., Sutendra, G., Dromparis, P., Webster, L., Haromy, A., Metabolic modulation of glioblastoma with dichloroacetate (2010) Sci Transl Med, 2, pp. 31ra34; Vlassenko, A.G., Vaishnavi, S.N., Couture, L., Sacco, D., Shannon, B.J., Spatial correlation between brain aerobic glycolysis and amyloid-beta (Abeta) deposition (2010) Proc Natl Acad Sci U S A, 107, pp. 17763-17767; Bigl, M., Bruckner, M.K., Arendt, T., Bigl, V., Eschrich, K., Activities of key glycolytic enzymes in the brains of patients with Alzheimer's disease (1999) J Neural Transm, 106, pp. 499-511; Gibson, G.E., Sheu, K.F., Blass, J.P., Abnormalities of mitochondrial enzymes in Alzheimer disease (1998) J Neural Transm, 105, pp. 855-870; Liang, W.S., Reiman, E.M., Valla, J., Dunckley, T., Beach, T.G., Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons (2008) Proc Natl Acad Sci U S A, 105, pp. 4441-4446; Brooks, W.M., Lynch, P.J., Ingle, C.C., Hatton, A., Emson, P.C., Gene expression profiles of metabolic enzyme transcripts in Alzheimer's disease (2007) Brain Res, 1127, pp. 127-135; Casley, C.S., Canevari, L., Land, J.M., Clark, J.B., Sharpe, M.A., Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities (2002) J Neurochem, 80, pp. 91-100; Caspersen, C., Wang, N., Yao, J., Sosunov, A., Chen, X., Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease (2005) Faseb J, 19, pp. 2040-2041; Zamzami, N., Kroemer, G., The mitochondrion in apoptosis: how Pandora's box opens (2001) Nat Rev Mol Cell Biol, 2, pp. 67-71; Greene, L.A., Tischler, A.S., Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor (1976) Proc Natl Acad Sci U S A, 73, pp. 2424-2428; Schubert, D., Heinemann, S., Carlisle, W., Tarikas, H., Kimes, B., Clonal cell lines from the rat central nervous system (1974) Nature, 249, pp. 224-227; Lamster, I.B., Hartley, L.J., Oshrain, R.L., Gordon, J.M., Evaluation and modification of spectrophotometric procedures for analysis of lactate dehydrogenase, beta-glucuronidase and arylsulphatase in human gingival crevicular fluid collected with filter-paper strips (1985) Arch Oral Biol, 30, pp. 235-242; Itoh, Y., Esaki, T., Shimoji, K., Cook, M., Law, M.J., Dichloroacetate effects on glucose and lactate oxidation by neurons and astroglia in vitro and on glucose utilization by brain in vivo (2003) Proc Natl Acad Sci U S A, 100, pp. 4879-4884; Hansen, M.B., Nielsen, S.E., Berg, K., Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill (1989) J Immunol Methods, 119, pp. 203-210; Goldman, R.D., Kaplan, N.O., Hall, T.C., Lactic Dehydrogenase in Human Neoplastic Tissues (1964) Cancer Res, 24, pp. 389-399; Le, A., Cooper, C.R., Gouw, A.M., Dinavahi, R., Maitra, A., Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression (2010) Proc Natl Acad Sci U S A, 107, pp. 2037-2042; Fantin, V.R., St-Pierre, J., Leder, P., Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance (2006) Cancer Cell, 9, pp. 425-434; Cumming, R.C., Andon, N.L., Haynes, P.A., Park, M., Fischer, W.H., Protein disulfide bond formation in the cytoplasm during oxidative stress (2004) J Biol Chem, 279, pp. 21749-21758; Yasykova, M.Y., Petukhov, S.P., Muronetz, V.I., Phosphorylation of lactate dehydrogenase by protein kinases (2000) Biochemistry (Mosc), 65, pp. 1192-1196; Cooper, J.A., Esch, F.S., Taylor, S.S., Hunter, T., Phosphorylation sites in enolase and lactate dehydrogenase utilized by tyrosine protein kinases in vivo and in vitro (1984) J Biol Chem, 259, pp. 7835-7841; Fritz, P.J., Rabbit muscle lactate dehydrogenase 5; a regulatory enzyme (1965) Science, 150, pp. 364-366; Zhou, M., Zhao, Y., Ding, Y., Liu, H., Liu, Z., Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol (2010) Mol Cancer, 9, p. 33; Schubert, D., Glucose metabolism and Alzheimer's disease (2005) Ageing Res Rev, 4, pp. 240-257; Cardoso, S.M., Santos, S., Swerdlow, R.H., Oliveira, C.R., Functional mitochondria are required for amyloid beta-mediated neurotoxicity (2001) Faseb J, 15, pp. 1439-1441; Dumont, M., Wille, E., Stack, C., Calingasan, N.Y., Beal, M.F., Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease (2009) Faseb J, 23, pp. 2459-2466; McFate, T., Mohyeldin, A., Lu, H., Thakar, J., Henriques, J., Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells (2008) J Biol Chem, 283, pp. 22700-22708; Raichle, M.E., Posner, J.B., Plum, F., Cerebral blood flow during and after hyperventilation (1970) Arch Neurol, 23, pp. 394-403; Boyle, P.J., Scott, J.C., Krentz, A.J., Nagy, R.J., Comstock, E., Diminished brain glucose metabolism is a significant determinant for falling rates of systemic glucose utilization during sleep in normal humans (1994) J Clin Invest, 93, pp. 529-535; Powers, W.J., Videen, T.O., Markham, J., McGee-Minnich, L., Antenor-Dorsey, J.V., Selective defect of in vivo glycolysis in early Huntington's disease striatum (2007) Proc Natl Acad Sci U S A, 104, pp. 2945-2949; Vaishnavi, S.N., Vlassenko, A.G., Rundle, M.M., Snyder, A.Z., Mintun, M.A., Regional aerobic glycolysis in the human brain (2010) Proc Natl Acad Sci U S A, 107, pp. 17757-17762; Lewerenz, J., Dargusch, R., Maher, P., Lactacidosis modulates glutathione metabolism and oxidative glutamate toxicity (2010) J Neurochem, 113, pp. 502-514; Zhang, X., Zhou, K., Wang, R., Cui, J., Lipton, S.A., Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation (2007) J Biol Chem, 282, pp. 10873-10880; Wang, R., Zhang, Y.W., Zhang, X., Liu, R., Hong, S., Transcriptional regulation of APH-1A and increased gamma-secretase cleavage of APP and Notch by HIF-1 and hypoxia (2006) Faseb J, 20, pp. 1275-1277","Cumming, R. C.; Department of Biology, The University of Western Ontario, London, ON, Canada; email: rcummin5@uwo.ca",,,,,,,,19326203,,,21541279,"English","PLoS ONE",Article,Scopus,2-s2.0-79955629694
"Wu, A., Ying, Z., Schubert, D., Gomez-Pinilla, F.","Brain and spinal cord interaction: A dietary curcumin derivative counteracts locomotor and cognitive deficits after brain trauma",2011,"Neurorehabilitation and Neural Repair","25","4",,"332","342",,33,10.1177/1545968310397706,"http://www.scopus.com/inward/record.url?eid=2-s2.0-79954580263&partnerID=40&md5=e1a4f81da4cbb669114ee5a040f46188","University of California at Los Angeles, Los Angeles, CA, United States; Salk Institute, San Diego, CA, United States; Department of Physiological Science, University of California at Los Angeles, 621 Charles E. Young Drive, Los Angeles, CA 90095, United States","Wu, A., University of California at Los Angeles, Los Angeles, CA, United States; Ying, Z., University of California at Los Angeles, Los Angeles, CA, United States; Schubert, D., Salk Institute, San Diego, CA, United States; Gomez-Pinilla, F., University of California at Los Angeles, Los Angeles, CA, United States, Department of Physiological Science, University of California at Los Angeles, 621 Charles E. Young Drive, Los Angeles, CA 90095, United States","Background. In addition to cognitive dysfunction, locomotor deficits are prevalent in traumatic brain injured (TBI) patients; however, it is unclear how a concussive injury can affect spinal cord centers. Moreover, there are no current efficient treatments that can counteract the broad pathology associated with TBI. Objective. The authors have investigated potential molecular basis for the disruptive effects of TBI on spinal cord and hippocampus and the neuroprotection of a curcumin derivative to reduce the effects of experimental TBI. Methods. The authors performed fluid percussion injury (FPI) and then rats were exposed to dietary supplementation of the curcumin derivative (CNB-001; 500 ppm). The curry spice curcumin has protective capacity in animal models of neurodegenerative diseases, and the curcumin derivative has enhanced brain absorption and biological activity. Results. The results show that FPI in rats, in addition to reducing learning ability, reduced locomotor performance. Behavioral deficits were accompanied by reductions in molecular systems important for synaptic plasticity underlying behavioral plasticity in the brain and spinal cord. The post-TBI dietary supplementation of the curcumin derivative normalized levels of BDNF, and its downstream effectors on synaptic plasticity (CREB, synapsin I) and neuronal signaling (CaMKII), as well as levels of oxidative stress-related molecules (SOD, Sir2). Conclusions. These studies define a mechanism by which TBI can compromise centers related to cognitive processing and locomotion. The findings also show the influence of the curcumin derivative on synaptic plasticity events in the brain and spinal cord and emphasize the therapeutic potential of this noninvasive dietary intervention for TBI. © The Author(s) 2011.","BDNF; Curcumin derivative; Hippocampus; Learning; Traumatic brain injury","brain derived neurotrophic factor; cnb 001; curcumin; cyclic AMP responsive element binding protein; silent information regulator protein 2; superoxide dismutase; synapsin I; unclassified drug; animal experiment; animal model; article; behavior disorder; biological activity; brain; cognition; cognitive defect; controlled study; degenerative disease; diet supplementation; drug absorption; hippocampus; learning; locomotion; male; motor performance; nerve cell plasticity; neuroprotection; nonhuman; oxidative stress; rat; spinal cord; traumatic brain injury; Animals; Brain Injuries; Cognition Disorders; Curcumin; Disease Models, Animal; Gait Disorders, Neurologic; Male; Neuroprotective Agents; Paresis; Pyrazoles; Rats; Rats, Sprague-Dawley",,"brain derived neurotrophic factor, 218441-99-7; curcumin, 458-37-7; cyclic AMP responsive element binding protein, 130428-87-4, 130939-96-7; superoxide dismutase, 37294-21-6, 9016-01-7, 9054-89-1; CNB 001; Curcumin, 458-37-7; Neuroprotective Agents; Pyrazoles","cnb 001",,,"Langlois, J.A., Rutland-Brown, W., Thomas, K.E., The incidence of traumatic brain injury among children in the United States: Differences by race (2005) Journal of Head Trauma Rehabilitation, 20 (3), pp. 229-238; Ashman, T.A., Gordon, W.A., Cantor, J.B., Hibbard, M.R., Neurobehavioral consequences of traumatic brain injury (2006) Mount Sinai Journal of Medicine, 73 (7), pp. 999-1005. , http://www.mssm.edu/msjournal/73/73_7_pages_999_1005.pdf; Levin, H.S., Prediction of recovery from traumatic brain injury (1995) J Neurotrauma, 12, pp. 913-922; Kim, Y.H., Yoo, W.K., Ko, M.H., Park, C.H., Kim, S.T.Y., Na, D.L., Plasticity of the attentional network after brain injury and cognitive rehabilitation (2009) Neurorehabil Neural Repair, 23, pp. 468-477; Piot-Grosjean, O., Wahl, F., Gobbo, O., Stutzmann, J.-M., Assessment of sensorimotor and cognitive deficits induced by a moderate traumatic injury in the right parietal cortex of the rat (2001) Neurobiology of Disease, 8 (6), pp. 1082-1093. , DOI 10.1006/nbdi.2001.0450; Fox, G.B., Fan, L., Levasseur, R.A., Faden, A.I., Sustained sensory/motor and cognitive deficits with neuronal apoptosis following controlled cortical impact brain injury in the mouse (1998) Journal of Neurotrauma, 15 (8), pp. 599-614; Smith, D.H., Soares, H.D., Pierce, J.S., A model of parasagittal controlled cortical impact in the mouse: Cognitive and histopathologic effects J Neurotrauma, pp. 169-178; Wu, A., Molteni, R., Ying, Z., Gomez-Pinilla, F., A saturated-fat diet aggravates the outcome of traumatic brain injury on hippocampal plasticity and cognitive function by reducing brain-derived neurotrophic factor (2003) Neuroscience, 119 (2), pp. 365-375. , DOI 10.1016/S0306-4522(03)00154-4; Johnk, K., Kuhtz-Buschbeck, J.P., Stolze, H., Serocki, G., Kalwa, S., Ritz, A., Benz, B., Illert, M., Assessment of sensorimotor functions after traumatic brain injury (TBI) in childhood - Methodological aspects (1999) Restorative Neurology and Neuroscience, 14 (2-3), pp. 143-152; Williams, G., Morris, M.E., Schache, A., McCrory, P.R., People preferentially increase hip joint power generation to walk faster following traumatic brain injury (2010) Neurorehabil Neural Repair, 24, pp. 550-558; Niechwiej-Szwedo, E., Inness, E.L., Howe, J.A., Jaglal, S., McIlroy, W.E., Verrier, M.C., Changes in gait variability during different challenges to mobility in patients with traumatic brain injury (2007) Gait and Posture, 25 (1), pp. 70-77. , DOI 10.1016/j.gaitpost.2006.01.002, PII S0966636206000063; Venturi, L., Miranda, M., Selmi, V., Systemic sepsis exacerbates mild post-traumatic brain injury in the rat (2009) J Neurotrauma, 26, pp. 1547-1556; Exo, J.L., Shellington, D.K., Bayir, H., Resuscitation of traumatic brain injury and hemorrhagic shock with polynitroxylated albumin, hextend, hypertonic saline, and lactated Ringer's: Effects on acute hemodynamics, survival, and neuronal death in mice (2009) J Neurotrauma, 26, pp. 2403-2408; Clough, R.W., Neese, S.L., Sherill, L.K., Tan, A.A., Duke, A., Roosevelt, R.W., Browning, R.A., Smith, D.C., Cortical edema in moderate fluid percussion brain injury is attenuated by vagus nerve stimulation (2007) Neuroscience, 147 (2), pp. 286-293. , DOI 10.1016/j.neuroscience.2007.04.043, PII S0306452207005465; Wu, A., Ying, Z., Gomez-Pinilla, F., Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats (2004) Journal of Neurotrauma, 21 (10), pp. 1457-1467. , DOI 10.1089/neu.2004.21.1457; Griesbach, G.S., Hovda, D.A., Gomez-Pinilla, F., Exercise-induced improvement in cognitive performance after traumatic brain injury in rats is dependent on BDNF activation (2009) Brain Res., 1288, pp. 105-115; Ying, Z., Roy, R.R., Edgerton, V.R., Gomez-Pinilla, F., Exercise restores levels of neurotrophins and synaptic plasticity following spinal cord injury (2005) Experimental Neurology, 193 (2), pp. 411-419. , DOI 10.1016/j.expneurol.2005.01.015; Ying, Z., Roy, R.R., Zhong, H., Zdunowski, S., Edgerton, V.R., Gomez-Pinilla, F., BDNF-exercise interactions in the recovery of symmetrical stepping after a cervical hemisection in rats (2008) Neuroscience, 155, pp. 1070-1078; Kang, H., Schuman, E.M., A requirement for local protein synthesis in neurotrophin-induced hippocampal synaptic plasticity (1996) Science, 273 (5280), pp. 1402-1406; Levine, E.S., Crozier, R.A., Black, I.B., Plummer, M.R., Brain-derived neurotrophic factor modulates hippocampal synaptic transmission by increasing N-methyl-D-aspartic acid receptor activity (1998) Proceedings of the National Academy of Sciences of the United States of America, 95 (17), pp. 10235-10239. , DOI 10.1073/pnas.95.17.10235; Sherwood, N.T., Lo, D.C., Long-term enhancement of central synaptic transmission by chronic brain- derived neurotrophic factor treatment (1999) Journal of Neuroscience, 19 (16), pp. 7025-7036; Tyler, W.J., Pozzo-Miller, L.D., BDNF enhances quantal neurotransmitter release and increases the number of docked vesicles at the active zones of hippocampal excitatory synapses (2001) Journal of Neuroscience, 21 (12), pp. 4249-4258; Jovanovic, J.N., Benfenati, F., Siow, Y.L., Sihra, T.S., Sanghera, J.S., Pelech, S.L., Greengard, P., Czernik, A.J., Neurotrophins stimulate phosphorylation of synapsin I by MAP kinase and regulate synapsin I-actin interactions (1996) Proceedings of the National Academy of Sciences of the United States of America, 93 (8), pp. 3679-3683. , DOI 10.1073/pnas.93.8.3679; Brock, T.O., O'Callaghan, J.P., Quantitative changes in the synaptic vesicle proteins synapsin I and p38 and the astrocyte-specific protein glial fibrillary acidic protein are associated with chemical-induced injury to the rat central nervous system (1987) Journal of Neuroscience, 7 (4), pp. 931-942; Wang, T., Xie, K., Lu, B., Neurotrophins promote maturation of developing neuromuscular synapses (1995) J Neurosci, 15, pp. 4796-4805; Finkbeiner, S., CREB couples neurotrophin signals to survival messages (2000) Neuron, 25 (1), pp. 11-14; Vaynman, S., Ying, Z., Gomez-Pinilla, F., The select action of hippocampal calcium calmodulin protein kinase II in mediating exercise-enhanced cognitive function (2007) Neuroscience, 144 (3), pp. 825-833. , DOI 10.1016/j.neuroscience.2006.10.005, PII S0306452206013728; Aggarwal, B.B., Sundaram, C., Malani, N., Ichikawa, H., Curcumin: The Indian solid gold (2007) Adv Exp Med Biol, 595, pp. 1-75; Wu, A., Ying, Z., Gomez-Pinilla, F., Dietary curcumin counteracts the outcome of traumatic brain injury on oxidative stress, synaptic plasticity, and cognition (2006) Experimental Neurology, 197 (2), pp. 309-317. , DOI 10.1016/j.expneurol.2005.09.004, PII S0014488605003274; Liu, Y., Dargusch, R., Maher, P., Schubert, D., A broadly neuroprotective derivative of curcumin (2008) Journal of Neurochemistry, 105 (4), pp. 1336-1345. , DOI 10.1111/j.1471-4159.2008.05236.x; Wu, A., Ying, Z., Gomez-Pinilla, F., Oxidative stress modulates Sir2α in rat hippocampus and cerebral cortex (2006) European Journal of Neuroscience, 23 (10), pp. 2573-2580. , DOI 10.1111/j.1460-9568.2006.04807.x; Wu, A., Ying, Z., Gomez-Pinilla, F., Omega-3 fatty acids supplementation restores mechanisms that maintain brain homeostasis in traumatic brain injury (2007) Journal of Neurotrauma, 24 (10), pp. 1587-1595. , DOI 10.1089/neu.2007.0313; Wu, A., Ying, Z., Gomez-Pinilla, F., Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition (2008) Neuroscience, 155, pp. 751-759; Loane, D.J., Pocivavsek, A., Moussa, C.E., Amyloid precursor protein secretases as therapeutic targets for traumatic brain injury (2009) Nat Med, 15, pp. 377-379; Gomez-Pinilla, F., Ying, Z., Opazo, P., Roy, R.R., Edgerton, V.R., Differential regulation by exercise of BDNF and NT-3 in rat spinal cord and skeletal muscle (2001) European Journal of Neuroscience, 13 (6), pp. 1078-1084. , DOI 10.1046/j.0953-816X.2001.01484.x; Molteni, R., Barnard, R.J., Ying, Z., Roberts, C.K., Gomez-Pinilla, F., A high-fat, refined sugar diet reduces hippocampal brain-derived neurotrophic factor, neuronal plasticity, and learning (2002) Neuroscience, 112 (4), pp. 803-814. , DOI 10.1016/S0306-4522(02)00123-9, PII S0306452202001239; Ying, S.-W., Futter, M., Rosenblum, K., Webber, M.J., Hunt, S.P., Bliss, T.V.P., Bramham, C.R., Brain-derived neurotrophic factor induces long-term potentiation in intact adult hippocampus: Requirement for ERK activation coupled to CREB and upregulation of Arc synthesis (2002) Journal of Neuroscience, 22 (5), pp. 1532-1540; Walker, W.C., Pickett, T.C., Motor impairment after severe traumatic brain injury: A longitudinal multicenter study (2007) J Rehabil Res Dev, 44, pp. 975-982; Vaynman, S., Gomez-Pinilla, F., License to run: Exercise impacts functional plasticity in the intact and injured central nervous system by using neurotrophins (2005) Neurorehabilitation and Neural Repair, 19 (4), pp. 283-295. , DOI 10.1177/1545968305280753; Bregman, B.S., McAtee, M., Dai, H.N., Kuhn, P.L., Neurotrophic factors increase axonal growth after spinal cord injury and transplantation in the adult rat (1997) Experimental Neurology, 148 (2), pp. 475-494. , DOI 10.1006/exnr.1997.6705; Jakeman, L.B., Wei, P., Guan, Z., Stokes, B.T., Brain-derived neurotrophic factor stimulates hindlimb stepping and sprouting of cholinergic fibers after spinal cord injury (1998) Experimental Neurology, 154 (1), pp. 170-184. , DOI 10.1006/exnr.1998.6924; Gomez-Pinilla, F., Huie, J.R., Ying, Z., Ferguson, A.R., Crown, E.D., Baumbauer, K.M., Edgerton, V.R., Grau, J.W., BDNF and learning: Evidence that instrumental training promotes learning within the spinal cord by up-regulating BDNF expression (2007) Neuroscience, 148 (4), pp. 893-906. , DOI 10.1016/j.neuroscience.2007.05.051, PII S0306452207006392; Colicos, M.A., Dash, P.K., Apoptotic morphology of dentate gyrus granule cells following experimental cortical impact injury in rats: Possible role in spatial memory deficits (1996) Brain Research, 739 (1-2), pp. 120-131. , DOI 10.1016/S0006-8993(96)00824-4, PII S0006899396008244; Arciniegas, D., Adler, L., Topkoff, J., Cawthra, E., Filley, C.M., Reite, M., Attention and memory dysfunction after traumatic brain injury: Cholinergic mechanisms, sensory gating, and a hypothesis for further investigation (1999) Brain Injury, 13 (1), pp. 1-13. , DOI 10.1080/026990599121827; Levin, H.S., Goldstein, F.C., High Jr., W.M., Eisenberg, H.M., Disproportionately severe memory deficit in relation to normal intellectual functioning after closed head injury (1988) J Neurol Neurosurg Psychiatry, 51, pp. 1294-1301; Dash, P.K., Mach, S.A., Moore, A.N., The role of extracellular signal-regulated kinase in cognitive and motor deficits following experimental traumatic brain injury (2002) Neuroscience, 114 (3), pp. 755-767. , DOI 10.1016/S0306-4522(02)00277-4, PII S0306452202002774; Bolton, M.M., Lo, D.C., Sherwood, N.T., Long-term regulation of excitatory and inhibitory synaptic transmission in hippocampal cultures by brain-derived neurotrophic factor (2000) Progress in Brain Research, 128, pp. 203-218. , DOI 10.1016/S0079-6123(00)28018-7; Hariri, A.R., Goldberg, T.E., Mattay, V.S., Kolachana, B.S., Callicott, J.H., Egan, M.F., Weinberger, D.R., Brain-derived neurotrophic factor val 66met polymorphism affects human memory-related hippocampal activity and predicts memory performance (2003) Journal of Neuroscience, 23 (17), pp. 6690-6694; Mu, J.S., Li, W.P., Yao, Z.B., Zhou, X.F., Deprivation of endogenous brain-derived neurotrophic factor results in impairment of spatial learning and memory in adult rats (1999) Brain Res., 835, pp. 259-265; Daitoku, H., Hatta, M., Matsuzaki, H., Aratani, S., Ohshima, T., Miyagishi, M., Nakajima, T., Fukamizu, A., Silent information regulator 2 potentiates Foxo 1-mediated transcription through its deacetylase activity (2004) Proceedings of the National Academy of Sciences of the United States of America, 101 (27), pp. 10042-10047. , DOI 10.1073/pnas.0400593101","Gomez-Pinilla, F.; Department of Physiological Science, University of California at Los Angeles, 621 Charles E. Young Drive, Los Angeles, CA 90095, United States; email: fgomezpi@ucla.edu",,,,,,,,15459683,,JNRHF,21343524,"English","Neurorehabil. Neural Repair",Article,Scopus,2-s2.0-79954580263
"Lapchak, P.A., Schubert, D.R., Maher, P.A.","Delayed treatment with a novel neurotrophic compound reduces behavioral deficits in rabbit ischemic stroke",2011,"Journal of Neurochemistry","116","1",,"122","131",,21,10.1111/j.1471-4159.2010.07090.x,"http://www.scopus.com/inward/record.url?eid=2-s2.0-78650136403&partnerID=40&md5=eb86e1aa3ef16557772f91fa0ac96826","Cedars-Sinai Medical Center, Department of Neurology, Burns and Allen Research Institute, Los Angeles, CA, United States; Salk Institute, Cellular Neurobiology Laboratories, 10010 North Torrey Pines Road, San Diego, CA 92037-1099, United States","Lapchak, P.A., Cedars-Sinai Medical Center, Department of Neurology, Burns and Allen Research Institute, Los Angeles, CA, United States; Schubert, D.R., Salk Institute, Cellular Neurobiology Laboratories, 10010 North Torrey Pines Road, San Diego, CA 92037-1099, United States; Maher, P.A., Salk Institute, Cellular Neurobiology Laboratories, 10010 North Torrey Pines Road, San Diego, CA 92037-1099, United States","Acute ischemic stroke is a major risk for morbidity and mortality in our aging population. Currently only one drug, the thrombolytic tissue plasminogen activator, is approved by the US Food and Drug Administration to treat stroke. Therefore, there is a need to develop new drugs that promote neuronal survival following stroke. We have synthesized a novel neuroprotective molecule called CNB-001 (a pyrazole derivative of curcumin) that has neurotrophic activity, enhances memory, and blocks cell death in multiple toxicity assays related to ischemic stroke. In this study, we tested the efficacy of CNB-001 in a rigorous rabbit ischemic stroke model and determined the molecular basis of its in vivo activity. CNB-001 has substantial beneficial properties in an in vitro ischemia assay and improves the behavioral outcome of rabbit ischemic stroke even when administered 1 h after the insult, a therapeutic window in this model comparable to tissue plasminogen activator. In addition, we elucidated the protein kinase pathways involved in neuroprotection. CNB-001 maintains the calcium-calmodulin- dependent kinase signaling pathways associated with neurotrophic growth factors that are critical for the maintenance of neuronal function. On the basis of its in vivo efficacy and novel mode of action, we conclude that CNB-001 has a great potential for the treatment of ischemic stroke as well as other CNS pathologies. © 2010 International Society for Neurochemistry.","drugs; ischemia; models; neuroprotection; protein kinases; trophic factor","4,4' isopropylidenediphenol; adenosine triphosphate; brain derived neurotrophic factor; calcium calmodulin dependent protein kinase; cnb 001; curcumin; glutathione; mitogen activated protein kinase; neuroprotective agent; oxygen regulated protein 150; phosphatidylinositol 3 kinase; protein kinase; protein kinase B; protein tyrosine kinase A; Ras protein; tissue plasminogen activator; unclassified drug; animal behavior; animal cell; animal experiment; animal model; article; artificial embolism; behavior disorder; brain ischemia; cell death; cell viability; controlled study; dose response; drug efficacy; drug mechanism; drug structure; drug synthesis; enzyme phosphorylation; excitotoxicity; experimental rabbit; in vitro study; male; motor performance; neuroprotection; neurotropism; nonhuman; priority journal; protein expression; signal transduction; Animals; Brain Ischemia; Cells, Cultured; Curcumin; Disease Models, Animal; Male; Mice; Mice, Inbred BALB C; Motor Activity; Neuroprotective Agents; Pyrazoles; Rabbits; Stroke; Time Factors; Treatment Outcome; Oryctolagus cuniculus",,"4,4' isopropylidenediphenol, 80-05-7; adenosine triphosphate, 15237-44-2, 56-65-5, 987-65-5; brain derived neurotrophic factor, 218441-99-7; calcium calmodulin dependent protein kinase, 97350-82-8; curcumin, 458-37-7; glutathione, 70-18-8; mitogen activated protein kinase, 142243-02-5; phosphatidylinositol 3 kinase, 115926-52-8; protein kinase, 9026-43-1; protein kinase B, 148640-14-6; tissue plasminogen activator, 105913-11-9; CNB 001; Curcumin, 458-37-7; Neuroprotective Agents; Pyrazoles","cnb 001, AQ, China","AQ, China; Sigma Aldrich, United States",,"Cole, G.M., Teter, B., Frautschy, S.A., Neuroprotective effects of curcumin (2007) Adv. Exp. Med. Biol., 595, pp. 197-212; Davis, J.B., Maher, P., Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line (1994) Brain Res., 652, pp. 169-173; Dirnagl, U., Iadecola, C., Moskowitz, M.A., Pathobiology of ischaemic stroke: An integrated view (1999) Trends Neurosci., 22, pp. 391-397; Dohare, P., Garg, P., Jain, V., Nath, C., Ray, M., Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat (2008) Behav. Brain Res., 193, pp. 289-297; Ferguson, K.N., Kidwell, C.S., Starkman, S., Saver, J.L., Hyperacute treatment initiation in neuroprotective agent stroke trials (2004) J. Stroke Cerebrovasc. Dis., 13, pp. 109-112; Frautschy, S.A., Hu, W., Kim, P., Miller, S.A., Chu, T., Harris-White, M.E., Cole, G.M., Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology (2001) Neurobiol. Aging, 22, pp. 993-1005; Hacke, W., Kaste, M., Bluhmki, E., Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke (2008) N. Engl. J. Med., 359, pp. 1317-1329; Ingall, T., Stroke-incidence, mortality, morbidity and risk (2004) J. Insur. Med., 36, pp. 143-152; Lahair, M.M., Howe, C.J., Rodriguez-Mora, O., McCubrey, J.A., Franklin, R.A., Molecular pathways leading to oxidative stress-induced phosphorylation of Akt (2006) Antioxid. Redox Signal., 8, pp. 1749-1756; Lapchak, P.A., Efficacy and safety profile of the carotenoid trans sodium crocetinate administered to rabbits following multiple infarct ischemic strokes: A combination therapy study with tissue plasminogen activator (2010) Brain Res., 1309, pp. 136-145; Lapchak, P.A., Translational stroke research using a rabbit embolic stroke model: A correlative analysis hypothesis for novel therapy development (2010) Trans. Stroke Res., 1, pp. 96-107; Lapchak, P.A., Araujo, D.M., Advances in ischemic stroke treatment: Neuroprotective and combination therapies (2007) Expert Opin. Emerg. Drugs, 12, pp. 97-112; Lapchak, P.A., De Taboada, L., Transcranial near infrared laser treatment (NILT) increases cortical adenosine-5′-triphosphate (ATP) content following embolic strokes in rabbits (2010) Brain Res., 1306, pp. 100-105; Lapchak, P.A., Wei, J., Zivin, J.A., Transcranial infrared laser therapy improves clinical eating scores after embolic strokes in rabbits (2004) Stroke, 35 (8), pp. 1985-1988. , DOI 10.1161/01.STR.0000131808.69640.b7; Lapchak, P.A., Maher, P., Schubert, D., Zivin, J.A., Baicalein, an antioxidant 12/15 lipoxygenase inhibitor improves clinical rating scores following multiple infarct embolic strokes (2007) Neuroscience, 150, pp. 585-591; Li, N., Wang, C., Wu, Y., Liu, X., Cao, X., Ca(2+)/calmodulin-dependent protein kinase II promotes cell cycle progression by directly activating MEK1 and subsequently modulating p27 phosphorylation (2009) J. Biol. Chem., 284, pp. 3021-3027; Liu, Y., Dargusch, R., Maher, P., Schubert, D., A broadly neuroprotective derivative of curcumin (2008) J. Neurochem., 105, pp. 1336-1345. , [Accepted for publication prior to April 1337, 2008]; Liu, C., Wu, J., Xu, K., Cai, F., Gu, J., Ma, L., Chen, J., Neuroprotection by baicalein in ischemic brain injury involves PTEN/AKT pathway (2010) J. Neurochem., 112, pp. 1500-1512; Lyden, P., Lu, M., Jackson, C., Marler, J., Kothari, R., Brott, T., Zivin, J., Underlying structure of the National Institutes of Health Stroke Scale: Results of a factor analysis. NINDS tPA Stroke Trial Investigators (1999) Stroke, 30, pp. 2347-2354; Maher, P., Davis, J., The role of monoamine metabolism in oxidative glutamate toxicity (1996) J. Neurosci., 16, pp. 6394-6401; Maher, P., Salgado, K.F., Zivin, J.A., Lapchak, P.A., A novel approach to screening for new neuroprotective compounds for the treatment of stroke (2007) Brain Res., 1173, pp. 117-125. , PMCID: PMC2111291; Maher, P., Akaishi, T., Schubert, D., Abe, K., A pyrazole derivative of curcumin enhances memory (2008) Neurobiol. Aging, 31, pp. 706-709. , Not funded by NIH; Mattson, M.P., Glutamate and neurotrophic factors in neuronal plasticity and disease (2008) Ann. N y Acad. Sci., 1144, pp. 97-112; Mehta, S.L., Manhas, N., Raghubir, R., Molecular targets in cerebral ischemia for developing novel therapeutics (2007) Brain Res. Rev., 54, pp. 34-66; Nakatani, Y., Kaneto, H., Kawamori, D., Yoshiuchi, K., Hatazaki, M., Matsuoka, T.-A., Ozawa, K., Matsuhisa, M., Involvement of endoplasmic reticulum stress in insulin resistance and diabetes (2005) Journal of Biological Chemistry, 280 (1), pp. 847-851. , DOI 10.1074/jbc.M411860200; Rossler, O.G., Giehl, K.M., Thiel, G., Neuroprotection of immortalized hippocampal neurones by brain-derived neurotrophic factor and Raf-1 protein kinase: Role of extracellular signal-regulated protein kinase and phosphatidylinositol 3-kinase (2004) J. Neurochem., 88, pp. 1240-1252; Sanson, M., Auge, N., Vindis, C., Oxidized low-density lipoproteins trigger endoplasmic reticulum stress in vascular cells: Prevention by oxygen-regulated protein 150 expression (2009) Circ. Res., 104, pp. 328-336; Saver, J.L., Gornbein, J., Treatment effects for which shift or binary analyses are advantageous in acute stroke trials (2009) Neurology, 72, pp. 1310-1315; Schratt, G.M., Nigh, E.A., Chen, W.G., Hu, L., Greenberg, M.E., BDNF regulates the translation of a select group of mRNAs by a mammalian target of rapamycin-phosphatidylinositol 3-kinase-dependent pathway during neuronal development (2004) J. Neurosci., 24, pp. 7366-7377; Schubert, D., Piasecki, D., Oxidative glutamate toxicity can be a component of the excitotoxicity cascade (2001) J. Neurosci., 21, pp. 7455-7462; Sigalov, E., Fridkin, M., Brenneman, D.E., Gozes, I., VIP-Related protection against lodoacetate toxicity in pheochromocytoma (PC12) cells: A model for ischemic/hypoxic injury (2000) J. Mol. Neurosci., 15, pp. 147-154; Tamatani, M., Matsuyama, T., Yamaguchi, A., ORP150 protects against hypoxia/ischemia-induced neuronal death (2001) Nat. Med., 7, pp. 317-323; Tan, S., Schubert, D., Maher, P., Oxytosis: A novel form of programmed cell death (2001) Curr. Top. Med. Chem., 1, pp. 497-506; Taylor, B.M., Fleming, W.E., Benjamin, C.W., Wu, Y., Mathews, W.R., Sun, F.F., The mechanism of cytoprotective action of lazaroids I: Inhibition of reactive oxygen species formation and lethal cell injury during periods of energy depletion (1996) J. Pharmacol. Exp. Ther., 276, pp. 1224-1231; Thiyagarajan, M., Sharma, S.S., Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats (2004) Life Sci., 74, pp. 969-985; Vanlangenakker, N., Vanden Berghe, T., Krysko, D.V., Festjens, N., Vandenabeele, P., Molecular mechanisms and pathophysiology of necrotic cell death (2008) Curr. Mol. Med., 8, pp. 207-220; Waud, D.R., On biological assays involving quantal responses (1972) J. Pharmacol. Exp. Ther., 183, pp. 577-607; Wu, A., Ying, Z., Gomez-Pinilla, F., Dietary curcumin counteracts the outcome of traumatic brain injury on oxidative stress, synaptic plasticity, and cognition (2006) Exp. Neurol., 197, pp. 309-317; Zhao, H., Sapolsky, R.M., Steinberg, G.K., Phosphoinositide-3-kinase/akt survival signal pathways are implicated in neuronal survival after stroke (2006) Mol. Neurobiol., 34, pp. 249-270; Zivin, J.A., Waud, D.R., Quantal bioassay and stroke (1992) Stroke, 23, pp. 767-773; Zivin, J.A., Fisher, M., Degirolami, U., Hemenway, C.C., Stashak, J.A., Tissue plasminogen activator reduces neurological damage after cerebral embolism (1985) Science, 230, pp. 1289-1292","Schubert, D. R.; Salk Institute, Cellular Neurobiology Laboratories, 10010 North Torrey Pines Road, San Diego, CA 92037-1099, United States; email: schubert@salk.edu",,,,,,,,00223042,,JONRA,21054387,"English","J. Neurochem.",Article,Scopus,2-s2.0-78650136403
"Herrera, F., Chen, Q., Schubert, D.","Synergistic effect of retinoic acid and cytokines on the regulation of glial fibrillary acidic protein expression",2010,"Journal of Biological Chemistry","285","50",,"38915","38922",,7,10.1074/jbc.M110.170274,"http://www.scopus.com/inward/record.url?eid=2-s2.0-78649811314&partnerID=40&md5=ea19492841f2f206b1090b464e008224","Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, 10010 North Torrey Pines Rd, San Diego, CA 92037-1099, United States","Herrera, F., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, 10010 North Torrey Pines Rd, San Diego, CA 92037-1099, United States; Chen, Q., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, 10010 North Torrey Pines Rd, San Diego, CA 92037-1099, United States; Schubert, D., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, 10010 North Torrey Pines Rd, San Diego, CA 92037-1099, United States","Glial fibrillary acidic protein (GFAP) is the main astroglial marker during astrogliogenesis, but it is also expressed in other cell types, including neural stem cells and old neurons. Activation of the JAK/STAT pathway by the IL-6 family of cytokines is the canonical pathway regulating GFAP expression, whereas retinoic acid is thought to be the only inducer of GFAP to operate independently of this pathway. Here, we show that retinoic acid receptor α not only links retinoic acid signaling to the canonical cytokine-stimulated pathway leading to GFAP expression but that it also plays a key role in the synergistic actions of retinoic acid and cytokines on this pathway. Cytokines both potentiate retinoic acid receptor α expression and enhance its binding to DNA and to the Stat3-p300/CBP-Smad transcriptional complex, the cornerstone of the canonical pathway. PI3K is upstream to all the key events leading to the expression of GFAP. Our results give new insights about the role of retinoic acid signaling in GFAP expression. © 2010 by The American Society for Biochemistry and Molecular Biology, Inc.",,"Cell types; Cytokines; Glial fibrillary acidic proteins; JAK/STAT; Neural stem cell; Retinoic acid receptors; Retinoic acids; Synergistic action; Synergistic effect; Transcriptional complexes; Signaling; Stem cells; cytokine; glial fibrillary acidic protein; histone acetyltransferase PCAF; phosphatidylinositol 3 kinase; retinoic acid; retinoic acid receptor alpha; Smad protein; STAT3 protein; article; complex formation; controlled study; DNA binding; gene expression regulation; gene function; gene identification; human; human cell; priority journal; protein protein interaction; signal transduction; Animals; Astrocytes; Brain; Cell Differentiation; Cytokines; Disulfides; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Hippocampus; Interleukin-6; Nerve Growth Factors; Rats; Receptors, Retinoic Acid; Transcription, Genetic; Tretinoin",,"Smad protein, 62395-38-4; phosphatidylinositol 3 kinase, 115926-52-8; retinoic acid, 302-79-4; Cytokines; Disulfides; Glial Fibrillary Acidic Protein; Interleukin-6; Nerve Growth Factors; Receptors, Retinoic Acid; Tretinoin, 302-79-4; retinoic acid receptor alpha",,,,"Hol, E.M., Roelofs, R.F., Moraal, E., Sonnemans, M.A., Sluijs, J.A., Proper, E.A., De Graan, P.N., Van Leeuwen, F.W., (2003) Mol. Psychiatry, 8, pp. 786-796; Chojnacki, A.K., Mak, G.K., Weiss, S., (2009) Nat. Rev. Neurosci., 10, pp. 153-163; Theus, M.H., Ricard, J., Bethea, J.R., Liebl, D.J., (2010) Stem Cells, 28, pp. 1231-1242; Silbereis, J., Heintz, T., Taylor, M.M., Ganat, Y., Ment, L.R., Bordey, A., Vaccarino, F., (2010) Mol. Cell. Neurosci., 44, pp. 362-373; Liang, X.Y., Wang, H.Z., Wang, N.L., (2010) Chin. Med. J., 123, pp. 949-953; Prestegarden, L., Svendsen, A., Wang, J., Sleire, L., Skaftnesmo, K.O., Bjerkvig, R., Yan, T., Enger, P.Ø., (2010) Cancer Res., 70, pp. 4274-4279; Barnabé-Heider, F., Wasylnka, J.A., Fernandes, K.J., Porsche, C., Sendtner, M., Kaplan, D.R., Miller, F.D., (2005) Neuron, 48, pp. 253-265; Bonni, A., Sun, Y., Nadal-Vicens, M., Bhatt, A., Frank, D.A., Rozovsky, I., Stahl, N., Greenberg, M.E., (1997) Science, 278, pp. 477-483; Rajan, P., McKay, R.D., (1998) J. Neurosci., 18, pp. 3620-3629; Kamakura, S., Oishi, K., Yoshimatsu, T., Nakafuku, M., Masuyama, N., Gotoh, Y., (2004) Nat. Cell Biol., 6, pp. 547-554; Kasai, M., Satoh, K., Akiyama, T., (2005) Genes Cells, 10, pp. 777-783; Nakashima, K., Yanagisawa, M., Arakawa, H., Taga, T., (1999) FEBS Lett., 457, pp. 43-46; Yanagisawa, M., Nakashima, K., Takizawa, T., Ochiai, W., Arakawa, H., Taga, T., (2001) FEBS Lett., 489, pp. 139-143; Herrera, F., Chen, Q., Fischer, W.H., Maher, P., Schubert, D.R., (2009) Cell Death Differ., 16, pp. 910-920; Ray, J., Gage, F.H., (2006) Mol. Cell. Neurosci., 31, pp. 560-573; Faigle, R., Liu, L., Cundiff, P., Funa, K., Xia, Z., (2008) J. Neurochem., 106, pp. 1681-1698; Goncalves, M.B., Boyle, J., Webber, D.J., Hall, S., Minger, S.L., Corcoran, J.P., (2005) Dev. Biol., 278, pp. 60-70; Jang, Y.K., Park, J.J., Lee, M.C., Yoon, B.H., Yang, Y.S., Yang, S.E., Kim, S.U., (2004) J. Neurosci. Res., 75, pp. 573-584; Asano, H., Aonuma, M., Sanosaka, T., Kohyama, J., Namihira, M., Nakashima, K., (2009) Stem Cells, 27, pp. 2744-2752; Metallo, C.M., Ji, L., De Pablo, J.J., Palecek, S.P., (2008) Stem Cells, 26, pp. 372-380; Martín-Ibáñez, R., Urbán, N., Sergent-Tanguy, S., Pineda, J.R., Garrido-Clua, N., Alberch, J., Canals, J.M., (2007) J. Neurosci. Res., 85, pp. 2686-2701; Hoffman, L.M., Garcha, K., Karamboulas, K., Cowan, M.F., Drysdale, L.M., Horton, W.A., Underhill, T.M., (2006) J. Cell Biol., 174, pp. 101-113; Schubert, D., Klar, A., Park, M., Dargusch, R., Fischer, W.H., (2006) J. Neurochem., 96, pp. 444-453; Krohn, K., Rozovsky, I., Wals, P., Teter, B., Anderson, C.P., Finch, C.E., (1999) J. Neurochem., 72, pp. 1353-1361; Nakashima, K., Yanagisawa, M., Arakawa, H., Kimura, N., Hisatsune, T., Kawabata, M., Miyazono, K., Taga, T., (1999) Science, 284, pp. 479-482; Kawasaki, H., Eckner, R., Yao, T.P., Taira, K., Chiu, R., Livingston, D.M., Yokoyama, K.K., (1998) Nature, 393, pp. 284-289; Mulholland, D.J., Dedhar, S., Coetzee, G.A., Nelson, C.C., (2005) Endocr. Rev., 26, pp. 898-915; Keidel, S., LeMotte, P., Apfel, C., (1994) Mol. Cell. Biol., 14, pp. 287-298; Fan, G., Martinowich, K., Chin, M.H., He, F., Fouse, S.D., Hutnick, L., Hattori, D., Sun, Y.E., (2005) Development, 132, pp. 3345-3356; Hermanson, O., Jepsen, K., Rosenfeld, M.G., (2002) Nature, 419, pp. 934-939; Yokogami, K., Wakisaka, S., Avruch, J., Reeves, S.A., (2000) Curr. Biol., 10, pp. 47-50; Pekny, M., Nilsson, M., (2005) Glia, 50, pp. 427-434; Mito, T., Becker, L.E., (1993) Exp. Neurol., 120, pp. 170-176; Holtzman, D.M., Santucci, D., Kilbridge, J., Chua-Couzens, J., Fontana, D.J., Daniels, S.E., Johnson, R.M., Mobley, W.C., (1996) Proc. Natl. Acad. Sci. U.S.A., 93, pp. 13333-13338; Croisier, E., Graeber, M.B., (2006) Acta Neuropathol., 112, pp. 517-530; Okada, S., Nakamura, M., Mikami, Y., Shimazaki, T., Mihara, M., Ohsugi, Y., Iwamoto, Y., Okano, H., (2004) J. Neurosci. Res., 76, pp. 265-276; Yung, W.K., Kyritsis, A.P., Gleason, M.J., Levin, V.A., (1996) Clin. Cancer Res., 2, pp. 1931-1935; Das, A., Banik, N.L., Ray, S.K., (2009) Neurochem. Res., 34, pp. 87-101; Das, A., Banik, N.L., Ray, S.K., (2008) J. Neurooncol., 87, pp. 9-22; Bouterfa, H., Picht, T., Kess, D., Herbold, C., Noll, E., Black, P.M., Roosen, K., Tonn, J.C., (2000) Neurosurgery, 46, pp. 419-430; Park, D.M., Li, J., Okamoto, H., Akeju, O., Kim, S.H., Lubensky, I., Vortmeyer, A., Zhuang, Z., (2007) Cell Cycle, 6, pp. 467-470","Schubert, D.; Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, 10010 North Torrey Pines Rd, San Diego, CA 92037-1099, United States; email: schubert@salk.edu",,,,,,,,00219258,,JBCHA,20876578,"English","J. Biol. Chem.",Article,Scopus,2-s2.0-78649811314
"Wang, L., Schubert, D., Sawaya, M.R., Eisenberg, D., Riek, R.","Multidimensional structure-activity relationship of a protein in its aggregated states",2010,"Angewandte Chemie - International Edition","49","23",,"3904","3908",,21,10.1002/anie.201000068,"http://www.scopus.com/inward/record.url?eid=2-s2.0-77952985307&partnerID=40&md5=0090a254f0af2535ab22bc46000a4e5f","Laboratorium für Physikalische Chemie, ETH Zürich, 8093 Zürich, Switzerland; Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037, United States; Howard Hughes Medical Institute, University of California, Los Angeles, CA 90095, United States; UCLA-DOE Institute for Genomics and Proteomics, University of California, Los Angeles, United States; Structural Biology Laboratory, Salk Institute for Biological Studies, United States","Wang, L., Laboratorium für Physikalische Chemie, ETH Zürich, 8093 Zürich, Switzerland; Schubert, D., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037, United States; Sawaya, M.R., Howard Hughes Medical Institute, University of California, Los Angeles, CA 90095, United States, UCLA-DOE Institute for Genomics and Proteomics, University of California, Los Angeles, United States; Eisenberg, D., Howard Hughes Medical Institute, University of California, Los Angeles, CA 90095, United States, UCLA-DOE Institute for Genomics and Proteomics, University of California, Los Angeles, United States; Riek, R., Laboratorium für Physikalische Chemie, ETH Zürich, 8093 Zürich, Switzerland, Structural Biology Laboratory, Salk Institute for Biological Studies, United States","(Figure Presented) The same, but very different: Diverse chemical, physical, and biological conditions induced the aggregation of a single protein into five structurally distinct protein aggregates (see electron micrographs, scale bars: 500 nm), all of which contained the cross-ß-sheet motif. The aggregates differed in their affinity for adenosine-5'-triphosphate, thioflavin T, DNA, and membrane mimics, and in their interference with cell viability. © 2010 Wiley-VCH Verlag GmbH & Co. KGaA, weinheim.","Aggregation amyloid; Biological activity ir spectroscopy; Fibrils; Protein structures","Biological activities; Cell viability; Electron micrograph; IR spectroscopy; Multi-dimensional structure; Protein aggregates; Protein structures; Thioflavin T; Triphosphate; Bioactivity; Glycoproteins; Proteins; adenosine triphosphate; DNA; protein; thiazole derivative; thioflavine; article; cell survival; chemistry; protein secondary structure; structure activity relation; ultrastructure; Adenosine Triphosphate; Cell Survival; DNA; Protein Structure, Secondary; Proteins; Structure-Activity Relationship; Thiazoles",,"DNA, 9007-49-2; adenosine triphosphate, 15237-44-2, 56-65-5, 987-65-5; protein, 67254-75-5; thioflavine, 2390-54-7; Adenosine Triphosphate, 56-65-5; DNA, 9007-49-2; Proteins; Thiazoles; thioflavin T, 2390-54-7",,,,"Selkoe, D.J., (2003) Nature, 426, p. 900; Dobson, C.M., (2003) Nature, 426, p. 884; Kelly, J.W., (2005) N. Engl. J. Med., 352, p. 722; Tanaka, M., Collins, S.R., Toyama, B.H., Weissman, J.S., (2006) Nature, 442, p. 585; Kopito, R.R., (2000) Trends Cell Biol, 10, p. 524; Wang, L., Maji, S.K., Sawaya, M.R., Eisenberg, D., Riek, R., (2008) PLoS Biol., 6, pp. e195; True, H.L., Lindquist, S.L., (2000) Nature, 407, p. 477; Fowler, M., Koulov, A.V., Alory-Jost, C., Marks, M.S., Balch, W.E., Kelly, J.W., (2006) PLoS Biol, 4, pp. e6; Maji, S.K., Perrin, M.H., Sawaya, M.R., Jessberger, S., Vadodaria, K., Rissman, R.A., Singru, P.S., Riek, R., (2009) Science, 325, p. 328; Ventura, S., Villaverde, A., (2006) Trends Biotechnol., 24, p. 179; Isaacson, T., Damasceno, C.M.B., Saravanan, R.S., He, Y., Cátala, C., Saladié, M., Rose, J.K.C., (2006) Nat. Protoc., 7, p. 769; Astbury, W.T., Dickinson, S., (1935) Biochem. J., 29, p. 2351; Sunde, M., Serpell, L.C., Bartlam, M., Fraser, P.E., Pepys, M.B., Blake, C.C., (1997) J. Mol. Biol., 273, p. 729; Nelson, R., Sawaya, M.R., Balbirnie, M., Madsen, A.O., Riekel, C., Grothe, R., Eisenberg, D., (2005) Nature, 435, p. 773; Ritter, C., Maddelein, M.L., Siemer, A.B., Luhrs, T., Ernst, M., Meier, B.H., Saupe, S.J., Riek, R., (2005) Nature, 435, p. 844; Luhrs, T., Ritter, C., Adrian, M., Riek-Loher, D., Bohrmann, B., Dobeli, H., Schubert, D., Riek, R., (2005) Proc. Natl. Acad. Sci. USA, 102, p. 17342; Sawaya, M.R., Sambashivan, S., Nelson, R., Ivanova, M.I., Sievers, S.A., Apostol, M.I., Thompson, M.J., Eisenberg, D., (2007) Nature, 447, p. 453; Wasmer, C., Lange, A., Van Melckebeke, H., Siemer, A.B., Riek, R., Meier, B.H., (2008) Science, 319, p. 1523; Ignatova, Z., Gierasch, L.M., (2005) Biochemistry, 44, p. 7266; Wang, L., (2009) Prion, 3, p. 139; Carrió, M., González-Montalbán, N., Vera, A., Villaverde, A., Ventura, S., (2005) J. Mol. Biol., 347, p. 1025; Okuno, A., Kato, M., Taniguchi, Y., (2006) Biochim. Biophys. Acta Proteins Proteomics, 1764, p. 1407; Chang, E.S., Liao, T.Y., Lim, T.S., Fann, W., Chen, R.P., (2009) J. Mol. Biol., 385, p. 1257; Kendrick, B.S., Cleland, J.L., Lam, X., Nguyen, T., Randolph, T.W., Manning, M.C., Carpenter, J.F., (1998) J. Pharm. Sci., 87, p. 1069; Chiti, F., Bucciantini, M., Capanni, C., Taddei, N., Dobson, C.M., Stefani, M., (2001) Protein Sci., 10, p. 2541; Calloni, G., Lendel, C., Campioni, S., Giannini, S., Gliozzi, A., Relini, A., Vendruscolo, M., Chiti, F., (2008) J. Am. Chem. Soc., 130, p. 13040; Rosano, C., Zuccotti, S., Bucciantini, M., Stefani, M., Ramponi, G., Bolognesi, M., (2002) J. Mol Biol., 321, p. 785; Hoshino, M., Katou, H., Hagihara, Y., Hasegawa, K., Naiki, H., Goto, Y., (2002) Nat. Struct. Biol., 9, p. 332; Petkova, A.T., Leapman, R.D., Guo, Z., Yau, W.M., Mattson, M.P., Tycko, R., (2005) Science, 307, p. 262; Heise, H., Hoyer, W., Becker, S., Andronesi, O.C., Riedel, D., Baldus, M., (2005) Proc. Natl. Acad. Sci. USA, 102, p. 15871; Van Der Wel, P.C., Lewandowski, J.R., Griffin, R.G., (2007) J. Am. Chem. Soc, 129, p. 5117; Liu, Y., Schubert, D., (1997) J. Neurochem., 69, p. 2285; Toyama, B.H., Kelly, M.J., Gross, J.D., Weissman, J.S., (2007) Nature, 449, p. 233; Maury, C.P., (2009) Origins Life Evol. Biosphere, 39, p. 141; Cecchi, C., Pensalfini, A., Liguri, G., Baglioni, S., Fiorillo, C., Guadagna, S., Zampagni, M., Stefani, M., (2008) Neurochem. Res., 33, p. 2516","Wang, L.; Laboratorium für Physikalische Chemie, ETH Zürich, 8093 Zürich, Switzerland",,,,,,,,14337851,,ACIEA,20397175,"English","Angew. Chem. Int. Ed.",Article,Scopus,2-s2.0-77952985307
"Maher, P., Akaishi, T., Schubert, D., Abe, K.","A pyrazole derivative of curcumin enhances memory",2010,"Neurobiology of Aging","31","4",,"706","709",,26,10.1016/j.neurobiolaging.2008.05.020,"http://www.scopus.com/inward/record.url?eid=2-s2.0-77049097404&partnerID=40&md5=cc44b88873b3fad2af52cf96a10240c5","The Salk Institute, Laboratories for Cellular Neurobiology, 10010 North Torrey Pines Road, La Jolla, CA 92037-1099, United States; Laboratory of Pharmacology, Research Institute of Pharmaceutical Sciences, Musashino University, Nishitokyo-shi, Tokyo 202-8585, Japan","Maher, P., The Salk Institute, Laboratories for Cellular Neurobiology, 10010 North Torrey Pines Road, La Jolla, CA 92037-1099, United States; Akaishi, T., Laboratory of Pharmacology, Research Institute of Pharmaceutical Sciences, Musashino University, Nishitokyo-shi, Tokyo 202-8585, Japan; Schubert, D., The Salk Institute, Laboratories for Cellular Neurobiology, 10010 North Torrey Pines Road, La Jolla, CA 92037-1099, United States; Abe, K., Laboratory of Pharmacology, Research Institute of Pharmaceutical Sciences, Musashino University, Nishitokyo-shi, Tokyo 202-8585, Japan","Reduced cognitive function is associated with Alzheimer's and Parkinson's diseases as well as brain trauma and ischemia. However, there are few compounds that enhance memory and are also orally active. We recently synthesized a pyrazole derivative of curcumin called CNB-001 that enhances the activity of Ca2+/calmodulin dependent protein kinase II (CaMKII). Since CaMKII plays a central role in long-term potentiation (LTP) and memory, it was asked if CNB-001 can facilitate the induction of LTP in rat hippocampal slices and enhance memory in a rat object recognition test. It is shown that CNB-001 enhances both LTP and memory. © 2008 Elsevier Inc.","Alzheimer's disease; Curcumin; Long-term potentiation; Memory; Parkinson's disease; Pyrazole","calcium calmodulin dependent protein kinase II; calcium ion; cnb 001; curcumin; forskolin; galantamine; rolipram; unclassified drug; animal tissue; article; cognition; controlled study; enzyme activity; long term potentiation; male; memory; neuroprotection; neurotropism; nonhuman; priority journal; protein protein interaction; rat; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cognition Disorders; Curcumin; Hippocampus; Long-Term Potentiation; Male; Memory; Memory Disorders; Nerve Degeneration; Neurodegenerative Diseases; Neuroprotective Agents; Neuropsychological Tests; Nootropic Agents; Organ Culture Techniques; Pyrazoles; Rats; Rats, Wistar; Recognition (Psychology); Treatment Outcome",,"calcium calmodulin dependent protein kinase II, 141467-21-2; calcium ion, 14127-61-8; curcumin, 458-37-7; forskolin, 66575-29-9; galantamine, 1953-04-4, 357-70-0; rolipram, 61413-54-5; CNB 001; Calcium-Calmodulin-Dependent Protein Kinase Type 2, 2.7.11.17; Curcumin, 458-37-7; Neuroprotective Agents; Nootropic Agents; Pyrazoles","cnb 001","Calbiochem; Sigma",,"Blokland, A., Schreiber, R., Prickaerts, J., Improving memory: a role for phosphodiesterases (2006) Curr. Pharm. Des., 12 (20), pp. 2511-2523; Bramham, C.R., Messaoudi, E., BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis (2005) Prog. Neurobiol., 76 (2), pp. 99-125; Cole, G.M., Teter, B., Frautschy, S.A., Neuroprotective effects of curcumin (2007) Adv. Exp. Med. Biol., 595, pp. 197-212; Ennaceur, A., Delacour, J., A new one-trial test for neurobiological studies of memory in rats. 1. Behavioral data (1988) Behav. Brain Res., 31 (1), pp. 47-59; Liu, Y., Dargusch, R., Maher, P., Schubert, D., A broadly neuroprotective derivative of curcumin (2008) J. Neurochem., 105, pp. 1336-1345; Liu, Y., Schubert, D., Steroid hormones block amyloid fibril-induced 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) formazan exocytosis: relationship to neurotoxicity (1998) J. Neurochem., 71, pp. 2322-2329; Maher, P., Akaishi, T., Abe, K., Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory (2006) Proc. Natl. Acad. Sci. U.S.A., 103 (44), pp. 16568-16573; Musial, A., Bajda, M., Malawska, B., Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment (2007) Curr. Med. Chem., 14 (25), pp. 2654-2679; Yamauchi, T., Neuronal Ca2+/calmodulin-dependent protein kinase II-discovery, progress in a quarter of a century, and perspective: implication for learning and memory (2005) Biol. Pharm. Bull., 28 (8), pp. 1342-1354","Schubert, D.; The Salk Institute, Laboratories for Cellular Neurobiology, 10010 North Torrey Pines Road, La Jolla, CA 92037-1099, United States; email: Schubert@salk.edu",,,,,,,,01974580,,NEAGD,18639368,"English","Neurobiol. Aging",Article,Scopus,2-s2.0-77049097404
"Burdo, J.R., Chen, Q., Calcutt, N.A., Schubert, D.","The pathological interaction between diabetes and presymptomatic Alzheimer's disease",2009,"Neurobiology of Aging","30","12",,"1910","1917",,26,10.1016/j.neurobiolaging.2008.02.010,"http://www.scopus.com/inward/record.url?eid=2-s2.0-70349871576&partnerID=40&md5=f85847da588535568e151704c3b62c35","Cellular Neurobiology Laboratory, The Salk Institute For Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037-1099, United States; Department of Pathology, University of California at San Diego, La Jolla, CA 92093-0612, United States","Burdo, J.R., Cellular Neurobiology Laboratory, The Salk Institute For Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037-1099, United States; Chen, Q., Cellular Neurobiology Laboratory, The Salk Institute For Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037-1099, United States; Calcutt, N.A., Department of Pathology, University of California at San Diego, La Jolla, CA 92093-0612, United States; Schubert, D., Cellular Neurobiology Laboratory, The Salk Institute For Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037-1099, United States","Since diabetes is a risk factor for Alzheimer's disease (AD), we asked if there is a functional interaction between high glucose and elevated beta amyloid peptide (Aβ) in cultured brain microvascular endothelial cells and presymptomatic AD transgenic mice. When cultured brain microvascular endothelial cells are exposed to both high glucose and low levels of Aβ, there is a synergistic interaction to cause an increased accumulation of advanced glycation products (AGE) and reactive oxygen species (ROS). When presymptomatic mice expressing mutant human amyloid precursor protein and presenilin are made diabetic, they have a decrease in cognitive function relative to control mice. Associated with the cognitive deficit are increases in brain microvascular AGE and iNOS expression, and the loss of the synaptic spine protein drebrin. No amyloid plaques or tangles are observed within the brains of any group. These data show that diabetes causes a synergistic potentiation of some indices of AD in transgenic animals that are presymptomatic for the classical features of the disease. © 2008 Elsevier Inc. All rights reserved.","Alzheimer's disease; Amyloid; Diabetes; Memory; Neurodegeneration","advanced glycation end product; amyloid beta protein; amyloid precursor protein; drebrin; glucose; inducible nitric oxide synthase; presenilin; reactive oxygen metabolite; Alzheimer disease; animal experiment; animal model; animal tissue; article; brain microcirculation; cognitive defect; controlled study; diabetes mellitus; endothelium cell; human; human cell; hyperglycemia; learning disorder; mouse; nonhuman; oxidative stress; priority journal; protein expression; transgenic mouse; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Cells, Cultured; Cognition Disorders; Diabetes Mellitus, Experimental; Glycosylation End Products, Advanced; Humans; Hyperglycemia; Male; Memory Disorders; Mice; Mice, Transgenic; Microvessels; Mutation; Neuropeptides; Nitric Oxide Synthase Type II; Presenilins; Reactive Oxygen Species; Receptors, Cell Surface",,"amyloid beta protein, 109770-29-8; glucose, 50-99-7, 84778-64-3; inducible nitric oxide synthase, 501433-35-8; Amyloid beta-Protein Precursor; Glycosylation End Products, Advanced; Neuropeptides; Nitric Oxide Synthase Type II, 1.14.13.39; Nos2 protein, mouse, 1.14.13.39; Presenilins; Reactive Oxygen Species; Receptors, Cell Surface; drebrins; protease nexins",,,,"Arvanitakis, Z., Wilson, R.S., Bienias, J.L., Evans, D.A., Bennett, D.A., Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function (2004) Arch. Neurol., 61, pp. 661-666; Behl, C., Davis, J.B., Lesley, R., Schubert, D., Hydrogen peroxide mediates amyloid beta protein toxicity (1994) Cell, 77, pp. 817-827; Biessels, G.J., Bravenboer, B., Gispen, W.H., Glucose, insulin and the brain-modulation of cognition and synaptic plasticity in health and disease: a preface (2004) Eur. J. Pharmacol., 490, pp. 1-4; Biessels, G.J., Staekenborg, S., Brunner, E., Brayne, C., Scheltens, P., Risk of dementia in diabetes mellitus: a systematic review (2006) Lancet Neurol., 5, pp. 64-74; Brands, A.M., Biessels, G.J., Kappelle, L.J., de Haan, E.H., de Valk, H.W., Algra, A., Kessels, R.P., Cognitive functioning and brain MRI in patients with type 1 and type 2 diabetes mellitus: a comparative study (2007) Dement. Geriatr. Cogn. Disorders, 23, pp. 343-350; Burdo, J.R., Simpson, I.A., Menzies, S., Beard, J., Connor, J.R., Regulation of the profile of iron-management proteins in brain microvasculature (2004) J. Cereb. Blood Flow Metab., 24, pp. 67-74; Chibber, R., Molinatti, P.A., Rosatto, N., Lambourne, B., Kohner, E.M., Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: relevance to diabetic retinopathy (1997) Diabetologia, 40, pp. 156-164; Choeiri, C., Hewitt, K., Durkin, J., Simard, C.J., Renaud, J.M., Messier, C., Longitudinal evaluation of memory performance and peripheral neuropathy in the Ins2C96Y Akita mice. (2005) Behav. Brain Res., 157, pp. 31-38; Das, P., Parsons, A.D., Scarborough, J., Hoffman, J., Wilson, J., Thompson, R.N., Overton, J.M., Fadool, D.A., Electrophysiological and behavioral phenotype of insulin receptor defective mice (2005) Physiol. Behav., 86, pp. 287-296; Gentile, M.T., Vecchione, C., Maffei, A., Aretini, A., Marino, G., Poulet, R., Capobianco, L., Lembo, G., Mechanisms of soluble beta-amyloid impairment of endothelial function (2004) J. Biol. Chem., 279, pp. 48135-48142; Glenner, G.G., Wong, C.W., Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein (1984) Biochem. Biophys. Res. Commun., 120, pp. 885-890; Goldin, A., Beckman, J.A., Schmidt, A.M., Creager, M.A., Advanced glycation end products: sparking the development of diabetic vascular injury (2006) Circulation, 114, pp. 597-605; Gruetter, R., Novotny, E.J., Boulware, S.D., Rothman, D.L., Shulman, R.G., 1H NMR studies of glucose transport in the human brain (1996) J. Cereb. Blood Flow Metab., 16, pp. 427-438; Hebert, L.E., Scherr, P.A., Bienias, J.L., Bennett, D.A., Evans, D.A., Alzheimer disease in the US population: prevalence estimates using the 2000 census (2003) Arch. Neurol., 60, pp. 1119-1122; Heneka, M.T., Sastre, M., Dumitrescu-Ozimek, L., Dewachter, I., Walter, J., Klockgether, T., Van Leuven, F., Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice (2005) J. Neuroinflammat., 2, p. 22; Ho, L., Qin, W., Pompl, P.N., Xiang, Z., Wang, J., Zhao, Z., Peng, Y., Pasinetti, G.M., Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease (2004) FASEB J., 18, pp. 902-904; Huang, H.J., Liang, K.C., Chen, C.P., Chen, C.M., Hsieh-Li, H.M., Intrahippocampal administration of A beta(1-40) impairs spatial learning and memory in hyperglycemic mice (2007) Neurobiol. Learn. Mem., 87, pp. 483-494; Jankowsky, J.L., Younkin, L.H., Gonzales, V., Fadale, D.J., Slunt, H.H., Lester, H.A., Younkin, S.G., Borchelt, D.R., Rodent A beta modulates the solubility and distribution of amyloid deposits in transgenic mice (2007) J. Biol. Chem., 282, pp. 22707-22720; Li, Z.G., Zhang, W., Sima, A.A., Alzheimer-like changes in rat models of spontaneous diabetes (2007) Diabetes, 56, pp. 1817-1824; Lovell, M.A., Markesbery, W.R., Oxidative damage in mild cognitive impairment and early Alzheimer's disease (2007) J. Neurosci. Res., 85, pp. 3036-3040; Minkeviciene, R., Banerjee, P., Tanila, H., Memantine improves spatial learning in a transgenic mouse model of Alzheimer's disease (2004) J. Pharmacol. Exp. Ther., 311, pp. 677-682; Mohmmad Abdul, H., Wenk, G.L., Gramling, M., Hauss-Wegrzyniak, B., Butterfield, D.A., APP and PS-1 mutations induce brain oxidative stress independent of dietary cholesterol: implications for Alzheimer's disease (2004) Neurosci. Lett., 368, pp. 148-150; Morris, R., Developments of a water-maze procedure for studying spatial learning in the rat (1984) J. Neurosci. Methods, 11, pp. 47-60; Muriach, M., Bosch-Morell, F., Alexander, G., Blomhoff, R., Barcia, J., Arnal, E., Almansa, I., Miranda, M., Lutein effect on retina and hippocampus of diabetic mice (2006) Free Radic. Biol. Med., 41, pp. 979-984; Muruganandam, A., Herx, L.M., Monette, R., Durkin, J.P., Stanimirovic, D.B., Development of immortalized human cerebromicrovascular endothelial cell line as an in vitro model of the human blood-brain barrier (1997) FASEB J., 11, pp. 1187-1197; Rodriguez-Manas, L., Angulo, J., Vallejo, S., Peiro, C., Sanchez-Ferrer, A., Cercas, E., Lopez-Doriga, P., Sanchez-Ferrer, C.F., Early and intermediate Amadori glycosylation adducts, oxidative stress, and endothelial dysfunction in the streptozotocin-induced diabetic rats vasculature (2003) Diabetologia, 46, pp. 556-566; Rolo, A.P., Palmeira, C.M., Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress (2006) Toxicol. Appl. Pharmacol., 212, pp. 167-178; Saxena, G., Singh, S.P., Pal, R., Singh, S., Pratap, R., Nath, C., Gugulipid, an extract of Commiphora whighitii with lipid-lowering properties, has protective effects against streptozotocin-induced memory deficits in mice (2007) Pharmacol. Biochem. Behav., 86, pp. 797-805; Takahashi, H., Mizui, T., Shirao, T., Down-regulation of drebrin A expression suppresses synaptic targeting of NMDA receptors in developing hippocampal neurones (2006) J Neurochem., 97 (SUPPL. 1), pp. 110-115; Vlassara, H., Palace, M.R., Glycoxidation: the menace of diabetes and aging (2003) Mt. Sinai J. Med., 70, pp. 232-241; Xie, W., Du, L., High-cholesterol diets impair short-term retention of memory in alloxan-induced diabetic mice, but not acquisition of memory nor retention of memory in prediabetic mice (2005) Life Sci., 77, pp. 481-495; Xu, J., Chen, S., Ku, G., Ahmed, S.H., Xu, J., Chen, H., Hsu, C.Y., Amyloid beta peptide-induced cerebral endothelial cell death involves mitochondrial dysfunction and caspase activation (2001) J. Cereb. Blood Flow Metab., 21, pp. 702-710; Zhao, L., Ma, Q.L., Calon, F., Harris-White, M.E., Yang, F., Lim, G.P., Morihara, T., Cole, G.M., Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease (2006) Nat. Neurosci., 9, pp. 234-242; Zhou, Q., Homma, K.J., Poo, M.M., Shrinkage of dendritic spines associated with long-term depression of hippocampal synapses (2004) Neuron, 44, pp. 749-757","Schubert, D.; Cellular Neurobiology Laboratory, The Salk Institute For Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037-1099, United States; email: schubert@salk.edu",,,,,,,,01974580,,NEAGD,18372080,"English","Neurobiol. Aging",Article,Scopus,2-s2.0-70349871576
"Liu, Y., Schubert, D.R.","The specificity of neuroprotection by antioxidants",2009,"Journal of Biomedical Science","16","1", 98,"","",,37,10.1186/1423-0127-16-98,"http://www.scopus.com/inward/record.url?eid=2-s2.0-73449145990&partnerID=40&md5=95d2c08070fa9d933d1ca4a5b6257157","Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, Sao Diego, CA 92037-1099, United States","Liu, Y., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, Sao Diego, CA 92037-1099, United States; Schubert, D.R., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, Sao Diego, CA 92037-1099, United States","Background. Reactive oxygen species (ROS) play an important role in aging and age-related diseases such as Parkinson's disease and Alzheimer's disease. Much of the ROS production under conditions of toxic stress is from mitochondria, and multiple antioxidants prevent ROS accumulation. The aim of this study is to examine the specificity of the interaction between the antioxidants and ROS production in stressed cells. Methods. Using fluorescent dyes for ROS detection and mitochondrial inhibitors of known specificities, we studied ROS production under three conditions where ROS are produced by mitochondria: oxidative glutamate toxicity, state IV respiration induced by oligomycin, and tumor necrosis factor-induced cell death. Results. We demonstrated that there are at least four mitochondrial ROS-generating sites in cells, including the flavin mononucleotide (FMN) group of complex I and the three ubiquinone-binding sites in complexes I, II and III. ROS production from these sites is modulated in an insult-specific manner and the sites are differentially accessible to common antioxidants. Conclusion. The inhibition of ROS accumulation by different antioxidants is specific to the site of ROS generation as well as the antioxidant. This information should be useful for devising new interventions to delay aging or treat ROS-related diseases. © 2009 Liu and Schubert; licensee BioMed Central Ltd.",,"antioxidant; flavine mononucleotide; fluorescent dye; glutamic acid; oligomycin; quinone derivative; reactive oxygen metabolite; reduced nicotinamide adenine dinucleotide dehydrogenase (ubiquinone); tumor necrosis factor alpha; ubiquinone; fluorescent dye; neuroprotective agent; oxygen; animal cell; article; binding site; cell culture; cell death; cell viability; controlled study; mitochondrion; mouse; neuroprotection; nonhuman; oxidative stress; priority journal; Alzheimer disease; animal; cell membrane potential; cell survival; chemistry; fluorescence microscopy; metabolism; methodology; Parkinson disease; phosphorylation; Alzheimer Disease; Animals; Antioxidants; Cell Survival; Fluorescent Dyes; Glutamic Acid; Membrane Potentials; Mice; Microscopy, Fluorescence; Mitochondria; Neuroprotective Agents; Oxygen; Parkinson Disease; Phosphorylation; Reactive Oxygen Species",,"flavine mononucleotide, 130-40-5, 146-17-8; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; oligomycin, 1404-19-9; reduced nicotinamide adenine dinucleotide dehydrogenase (ubiquinone), 9028-04-0; ubiquinone, 1339-63-5; oxygen, 7782-44-7; Antioxidants; Fluorescent Dyes; Glutamic Acid, 56-86-0; Neuroprotective Agents; Oxygen, 7782-44-7; Reactive Oxygen Species",,,,"Schriner, S.E., Linford, N.J., Martin, G.M., Treuting, P., Ogburn, C.E., Emond, M., Coskun, P.E., Rabinovitch, P.S., Extension of murine life span by overexpression of catalase targeted to mitochondria (2005) Science, 308, pp. 1909-1911; Wallace, D.C., A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine (2005) Annu Rev Genet, 39, pp. 359-407; Wilson, D.F., Erecinska, M., Dutton, P.L., Thermodynamic relationships in mitochondrial oxidative phosphorylation (1974) Annu Rev Biophys Bioeng, 3, pp. 203-230; Turrens, J.F., Alexandre, A., Lehninger, A.L., Ubisemiquinone is the electron donor for superoxide formation by complex iii of heart mitochondria (1985) Arch Biochem Biophys, 237, pp. 408-414; Genova, M.L., Ventura, B., Giuliano, G., Bovina, C., Formiggini, G., Parenti Castelli, G., Lenaz, G., The site of production of superoxide radical in mitochondrial complex i is not a bound ubisemiquinone but presumably iron-sulfur cluster n2 (2001) FEBS Lett, 505, pp. 364-368; Lambert, A.J., Brand, M.D., Inhibitors of the quinone-binding site allow rapid superoxide production from mitochondrial nadh:Ubiquinone oxidoreductase (complex i) (2004) J Biol Chem, 279, pp. 39414-39420; Cino, M., Del Maestro, R.F., Generation of hydrogen peroxide by brain mitochondria: The effect of reoxygenation following postdecapitative ischemia (1989) Arch Biochem Biophys, 269, pp. 623-638; Liu, Y., Fiskum, G., Schubert, D., Generation of reactive oxygen species by the mitochondrial electron transport chain (2002) J Neurochem, 80, pp. 780-787; Kudin, A.P., Bimpong-Buta, N.Y., Vielhaber, S., Elger, C.E., Characterization of superoxide-producing sites in isolated brain mitochondria (2004) J Biol Chem, 279, pp. 4127-4135; Morimoto, B.H., Koshland Jr., D.E., Induction and expression of long- and short-term neurosecretory potentiation in a neural cell line (1990) Neuron, 5, pp. 875-880; Reers, M., Smiley, S.T., Mottola-Hartshorn, C., Chen, A., Lin, M., Chen, L.B., Mitochondrial membrane potential monitored by jc-1 dye (1995) Methods Enzymol, 260, pp. 406-417; Lebel, C.P., Ischiropoulos, H., Bondy, S.C., Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress (1992) Chem Res Toxicol, 5, pp. 227-231; Robinson, K.M., Janes, M.S., Beckman, J.S., The selective detection of mitochondrial superoxide by live cell imaging (2008) Nat Protoc, 3, pp. 941-947; Patel, M., Day, B.J., Metalloporphyrin class of therapeutic catalytic antioxidants (1999) Trends Pharmacol Sci, 20, pp. 359-364; Ohnishi, T., Iron-sulfur clusters/semiquinones in complex i (1998) Biochim Biophys Acta, 1364, pp. 186-206; Geromel, V., Kadhom, N., Cebalos-Picot, I., Ouari, O., Polidori, A., Munnich, A., Rotig, A., Rustin, P., Superoxide-induced massive apoptosis in cultured skin fibroblasts harboring the neurogenic ataxia retinitis pigmentosa (narp) mutation in the atpase-6 gene of the mitochondrial DNA (2001) Hum Mol Genet, 10, pp. 1221-1228; Sian, J., Dexter, D.T., Lees, A.J., Daniel, S., Agid, Y., Javoy-Agid, F., Jenner, P., Marsden, C.D., Alterations in glutathione levels in parkinson's disease and other neurodegenerative disorders affecting basal ganglia (1994) Ann Neurol, 36, pp. 348-355; Murphy, T.H., Baraban, J.M., Glutamate toxicity in immature cortical neurons precedes development of glutamate receptor currents (1990) Brain Res, 57, pp. 146-150; Tan, S., Sagara, Y., Liu, Y., Maher, P., Schubert, D., The regulation of reactive oxygen species production during programmed cell death (1998) J Cell Biol, 141, pp. 1423-1432; Li, Y., Trush, M.A., Diphenyleneiodonium, an nad(p)h oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production (1998) Biochem Biophys Res Commun, 253, pp. 295-299; Holland, P.C., Clark, M.G., Bloxham, D.P., Lardy, H.A., Mechanism of action of the hypoglycemic agent diphenyleneiodonium (1973) J Biol Chem, 248, pp. 6050-6056; McCoy, M.K., Martinez, T.N., Ruhn, K.A., Szymkowski, D.E., Smith, C.G., Botterman, B.R., Tansey, K.E., Tansey, M.G., Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of parkinson's disease (2006) J Neurosci, 26, pp. 9365-9375; Schulze-Osthoff, K., Bakker, A.C., Vanhaesebroeck, B., Beyaert, R., Jacob, W.A., Fiers, W., Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation (1992) J Biol Chem, 267, pp. 5317-5323; St-Pierre, J., Buckingham, J.A., Roebuck, S.J., Brand, M.D., Topology of superoxide production from different sites in the mitochondrial electron transport chain (2002) J Biol Chem, 277, pp. 44784-44790; Wong, G.H., Elwell, J.H., Oberley, L.W., Goeddel, D.V., Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor (1989) Cell, 58, pp. 923-931; Taylor, E.R., Hurrell, F., Shannon, R.J., Lin, T.K., Hirst, J., Murphy, M.P., Reversible glutathionylation of complex i increases mitochondrial superoxide formation (2003) J Biol Chem, 278, pp. 19603-19610; Lee, A.C., Fenster, B.E., Ito, H., Takeda, K., Bae, N.S., Hirai, T., Yu, Z.X., Finkel, T., Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species (1999) J Biol Chem, 274, pp. 7936-7940; Martinez, B., Perez-Castillo, A., Santos, A., The mitochondrial respiratory complex i is a target for 15-deoxy-delta12,14-prostaglandin j2 action (2005) J Lipid Res, 46, pp. 736-743; Reynolds, I.J., Hastings, T.G., Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following nmda receptor activation (1995) Journal of Neuroscience, 15, pp. 3318-3327; Shen, D., Dalton, T.P., Nebert, D.W., Shertzer, H.G., Glutathione redox state regulates mitochondrial reactive oxygen production (2005) J Biol Chem, 280, pp. 25305-25312; Gunter, T.E., Pfeiffer, D.R., Mechanisms by which mitochondria transport calcium (1990) Am J Physiol, 258, pp. 3755-786; Zhang, J.G., Fariss, M.W., Thenoyltrifluoroacetone, a potent inhibitor of carboxylesterase activity (2002) Biochem Pharmacol, 63, pp. 751-754; Pitkanen, S., Robinson, B.H., Mitochondrial complex i deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase (1996) J Clin Invest, 98, pp. 345-351; Rustin, P., Rotig, A., Inborn errors of complex ii - Unusual human mitochondrial diseases (2002) Biochim Biophys Acta, 1553, pp. 117-122; Ishii, N., Fujii, M., Hartman, P.S., Tsuda, M., Yasuda, K., Senoo-Matsuda, N., Yanase, S., Suzuki, K., A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes (1998) Nature, 394, pp. 694-697; Nishikawa, T., Edelstein, D., Du, X.L., Yamagishi, S., Matsumura, T., Kaneda, Y., Yorek, M.A., Brownlee, M., Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage (2000) Nature, 404, pp. 787-790; Sun, F., Huo, X., Zhai, Y., Wang, A., Xu, J., Su, D., Bartlam, M., Rao, Z., Crystal structure of mitochondrial respiratory membrane protein complex ii (2005) Cell, 121, pp. 1043-1057","Schubert, D. R.; Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, Sao Diego, CA 92037-1099, United States; email: schubert@salk.edu",,,,,,,,10217770,,JBCIE,19891782,"English","J. Biomed. Sci.",Article,Scopus,2-s2.0-73449145990
"Lewerenz, J., Albrecht, P., Tien, M.-L.T., Henke, N., Karumbayaram, S., Kornblum, H.I., Wiedau-Pazos, M., Schubert, D., Maher, P., Methner, A.","Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxone in vitro",2009,"Journal of Neurochemistry","111","2",,"332","343",,75,10.1111/j.1471-4159.2009.06347.x,"http://www.scopus.com/inward/record.url?eid=2-s2.0-70349314704&partnerID=40&md5=a518b08af6315d6753bfc8562c8527a5","Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Neurology, Heinrich-Heine Universität Düsseldorf, Moorenstr. 5, 40225 Düsseldorf, Germany; Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States; Department of Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States; Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States","Lewerenz, J., Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Albrecht, P., Department of Neurology, Heinrich-Heine Universität Düsseldorf, Moorenstr. 5, 40225 Düsseldorf, Germany; Tien, M.-L.T., Department of Neurology, Heinrich-Heine Universität Düsseldorf, Moorenstr. 5, 40225 Düsseldorf, Germany; Henke, N., Department of Neurology, Heinrich-Heine Universität Düsseldorf, Moorenstr. 5, 40225 Düsseldorf, Germany; Karumbayaram, S., Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States; Kornblum, H.I., Department of Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States; Wiedau-Pazos, M., Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA, United States; Schubert, D., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; Maher, P., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; Methner, A., Department of Neurology, Heinrich-Heine Universität Düsseldorf, Moorenstr. 5, 40225 Düsseldorf, Germany","In amyotrophic lateral sclerosis, down-regulation of the astrocyte-specific glutamate excitatory amino acid transporter 2 is hypothesized to increase extracellular glutamate, thereby leading to excitotoxic motor neuron death. The antibiotic ceftriaxone was recently reported to induce excitatory amino acid transporter 2 and to prolong the survival of mutant superoxide dismutase 1 transgenic mice. Here we show that ceftriaxone also protects fibroblasts and the hippocampal cell line HT22, which are not sensitive to excitotoxicity, against oxidative glutamate toxicity, where extracellular glutamate blocks cystine import via the glutamate/cystine-antiporter system xc -. Lack of intracellular cystine leads to glutathione depletion and cell death because of oxidative stress. Ceftriaxone increased system xc - and glutathione levels independently of its effect on excitatory amino acid transporters by induction of the transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2), a known inducer of system x c -, and the specific xc - subunit xCT. No significant effect was apparent in fibroblasts deficient in Nrf2 or xCT. Similar ceftriaxone-stimulated changes in Nrf2, system xc -, and glutathione were observed in rat cortical and spinal astrocytes. In addition, ceftriaxone induced xCT mRNA expression in stem cell-derived human motor neurons. We conclude that ceftriaxone-mediated neuroprotection might relate more strongly to activation of the antioxidant defense system including Nrf2 and system xc - than to excitatory amino acid transporter induction. © 2009 International Society for Neurochemistry.","Amyotrophic lateral sclerosis; Ceftriaxone; Excitatory amino acid transporter; Glutathione; Nrf2; XCT","antiporter; ceftriaxone; cystine; excitatory amino acid transporter; glutamate cystine antiporter; glutamic acid; glutathione; transcription factor Nrf2; unclassified drug; amyotrophic lateral sclerosis; animal cell; antioxidant activity; article; astrocyte; cell death; controlled study; down regulation; excitotoxicity; fibroblast; human; human cell; human tissue; motoneuron; mouse; nerve cell; neuroprotection; nonhuman; oxidative stress; priority journal; protein expression; rat; Amino Acid Transport System y+; Animals; Anti-Bacterial Agents; Astrocytes; Ceftriaxone; Cell Line; Fibroblasts; Glutamic Acid; Glutathione; Hippocampus; Humans; Mice; Mice, Knockout; Motor Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Rats; Spinal Cord; Stem Cells; Superoxide Dismutase; Mus musculus; Rattus",,"ceftriaxone, 73384-59-5, 74578-69-1; cystine, 24645-67-8, 56-89-3, 6020-39-9; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; glutathione, 70-18-8; Amino Acid Transport System y+; Anti-Bacterial Agents; Ceftriaxone, 73384-59-5; Glutamic Acid, 56-86-0; Glutathione, 70-18-8; NF-E2-Related Factor 2; NFE2L2 protein, human; Neuroprotective Agents; Nfe2l2 protein, mouse; Nfe2l2 protein, rat; SLC7A11 protein, human; Slc7a11 protein, mouse; Superoxide Dismutase, 1.15.1.1; superoxide dismutase 1, 1.15.1.-; xCT protein, rat",,,,"Bahia, P.K., Rattray, M., Williams, R.J., Dietary flavonoid (-)epicatechin stimulates phosphatidylinositol 3-kinase-dependent anti-oxidant response element activity and up-regulates glutathione in cortical astrocytes (2008) J. Neurochem., 106, pp. 2194-2204; Bannai, S., Exchange of cystine and glutamate across plasma membrane of human fibroblasts (1986) J. Biol. Chem., 261, pp. 2256-2263; Bogdanov, M.B., Andreassen, O.A., Dedeoglu, A., Ferrante, R.J., Beal, M.F., Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease (2001) J. Neurochem., 79, pp. 1246-1249; Bruijn, L.I., Miller, T.M., Cleveland, D.W., Unraveling the mechanisms involved in motor neuron degeneration in ALS (2004) Annu. Rev. Neurosci., 27, pp. 723-749; Burdo, J., Dargusch, R., Schubert, D., Distribution of the cystine/glutamate antiporter system xc- in the brain, kidney, and duodenum (2006) J. Histochem. Cytochem., 54, pp. 549-557; Chi, L., Ke, Y., Luo, C., Gozal, D., Liu, R., Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo (2007) Neuroscience, 144, pp. 991-1003; Choi, D.W., Excitotoxic cell death (1992) J. Neurobiol., 23, pp. 1261-1276; Chu, K., Lee, S.T., Sinn, D.I., Pharmacological induction of ischemic tolerance by glutamate transporter-1 (EAAT2) upregulation (2007) Stroke, 38, pp. 177-182; Clement, A.M., Nguyen, M.D., Roberts, E.A., Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice (2003) Science, 302, pp. 113-117; Davis, J.B., Maher, P., Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line (1994) Brain Res., 652, pp. 169-173; Dringen, R., Glutathione metabolism and oxidative stress in neurodegeneration (2000) Eur. J. Biochem., 267, p. 4903; Dringen, R., Hirrlinger, J., Glutathione pathways in the brain (2003) Biol. Chem., 384, pp. 505-516; Fogal, B., Li, J., Lobner, D., McCullough, L.D., Hewett, S.J., System x(c)- activity and astrocytes are necessary for interleukin-1 beta-mediated hypoxic neuronal injury (2007) J. Neurosci., 27, pp. 10094-10105; Fox, J.H., Barber, D.S., Singh, B., Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation (2004) J. Neurochem., 91, pp. 413-422; Gurney, M.E., Pu, H., Chiu, A.Y., Dal Canto, M.C., Polchow, C.Y., Alexander, D.D., Caliendo, J., Siddique, T., Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation (1994) Science, 264 (5166), pp. 1772-1775; Hanneken, A., Lin, F.F., Johnson, J., Maher, P., Flavonoids protect human retinal pigment epithelial cells from oxidative-stress-induced death (2006) Invest. Ophthalmol. Vis. Sci., 47, pp. 3164-3177; Hosoya, K., Saeki, S., Terasaki, T., Activation of carrier-mediated transport of L-cystine at the blood-brain and blood-retinal barriers in vivo (2001) Microvasc. Res., 62, pp. 136-142; Ishii, T., Itoh, K., Takahashi, S., Sato, H., Yanagawa, T., Katoh, Y., Bannai, S., Yamamoto, M., Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages (2000) J. Biol. Chem., 275, pp. 16023-16029; Karumbayaram, S., Kelly, T.K., Paucar, A.A., Roe, A.J., Umbach, J.A., Charles, A., Goldman, S.A., Wiedau-Pazos, M., Human embryonic stem cell-derived motor neurons expressing SOD1 mutants exhibit typical signs of motor neuron degeneration linked to ALS (2009) Dis. Model Mech., 2, pp. 189-195; Kensler, T.W., Wakabayashi, N., Biswal, S., Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway (2007) Annu. Rev. Pharmacol. Toxicol., 47, pp. 89-116; Kirby, J., Halligan, E., Baptista, M.J., Mutant SOD1 alters the motor neuronal transcriptome: Implications for familial ALS (2005) Brain, 128, pp. 1686-1706; Krobert, K., Lopez-Colberg, I., Cunningham, L.A., Astrocytes promote or impair the survival and function of embryonic ventral mesencephalon co-grafts: Effects of astrocyte age and expression of recombinant brain-derived neurotrophic factor (1997) Exp. Neurol., 145, pp. 511-523; Lewerenz, J., Maher, P., Basal levels of eIF2alpha phosphorylation determine cellular antioxidant status by regulating ATF4 and xCT expression (2009) J. Biol. Chem., 284, pp. 1106-1115; Lewerenz, J., Letz, J., Methner, A., Activation of stimulatory heterotrimeric G proteins increases glutathione and protects neuronal cells against oxidative stress (2003) J. Neurochem., 87, pp. 522-531; Lewerenz, J., Klein, M., Methner, A., Cooperative action of glutamate transporters and cystine/glutamate antiporter system Xc - protects from oxidative glutamate toxicity (2006) J. Neurochem., 98, pp. 916-925; Lipski, J., Wan, C.K., Bai, J.Z., Pi, R., Li, D., Donnelly, D., Neuroprotective potential of ceftriaxone in in vitro models of stroke (2007) Neuroscience, 146, pp. 617-629; Maher, P., A comparison of the neurotrophic activities of the flavonoid fisetin and some of its derivatives (2006) Free Radic. Res., 40, pp. 1105-1111; Maher, P., Davis, J.B., The role of monoamine metabolism in oxidative glutamate toxicity (1996) J. Neurosci., 16, pp. 6394-6401; Maher, P., Hanneken, A., The molecular basis of oxidative stress-induced cell death in an immortalized retinal ganglion cell line (2005) Invest. Ophthalmol. Vis. Sci., 46, pp. 749-757; Melzer, N., Meuth, S.G., Torres-Salazar, D., A beta-lactam antibiotic dampens excitotoxic inflammatory CNS damage in a mouse model of multiple sclerosis (2008) PLoS ONE, 3, p. 3149; Miller, B.R., Dorner, J.L., Shou, M., Sari, Y., Barton, S.J., Sengelaub, D.R., Kennedy, R.T., Rebec, G.V., Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse (2008) Neuroscience, 153, pp. 329-337; Miyamoto, M., Murphy, T.H., Schnaar, R.L., Coyle, J.T., Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line (1989) J. Pharmacol. Exp. Ther., 250, pp. 1132-1140; Murphy, T.H., Miyamoto, M., Sastre, A., Schnaar, R.L., Coyle, J.T., Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress (1989) Neuron, 2, pp. 1547-1558; Murphy, T.H., Schnaar, R.L., Coyle, J.T., Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake (1990) FASEB J., 4, pp. 1624-1633; Nau, R., Prange, H.W., Muth, P., Mahr, G., Menck, S., Kolenda, H., Sorgel, F., Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges (1993) Antimicrob. Agents Chemother., 37, pp. 1518-1524; Nguyen, T., Sherratt, P.J., Pickett, C.B., Regulatory mechanisms controlling gene expression mediated by the antioxidant response element (2003) Annu. Rev. Pharmacol. Toxicol., 43, pp. 233-260; Ouyang, Y.B., Voloboueva, L.A., Xu, L.J., Giffard, R.G., Selective dysfunction of hippocampal CA1 astrocytes contributes to delayed neuronal damage after transient forebrain ischemia (2007) J. Neurosci., 27, pp. 4253-4260; Oyama, Y., Hayashi, A., Ueha, T., Maekawa, K., Characterization of 2′,7′-dichlorofluorescin fluorescence in dissociated mammalian brain neurons: Estimation on intracellular content of hydrogen peroxide (1994) Brain Res., 635, pp. 113-117; Poon, H.F., Hensley, K., Thongboonkerd, V., Merchant, M.L., Lynn, B.C., Pierce, W.M., Klein, J.B., Butterfield, D.A., Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice - A model of familial amyotrophic lateral sclerosis (2005) Free Radical Biology and Medicine, 39 (4), pp. 453-462. , DOI 10.1016/j.freeradbiomed.2005.03.030, PII S0891584905001875; Ratan, R.R., Murphy, T.H., Baraban, J.M., Oxidative stress induces apoptosis in embryonic cortical neurons (1994) J. Neurochem., 62, pp. 376-379; Re, R., Pellegrini, N., Proteggente, A., Pannala, A., Yang, M., Rice-Evans, C., Antioxidant activity applying an improved ABTS radical cation decolorization assay (1999) Free Radic. Biol. Med., 26, pp. 1231-1237; Rimaniol, A.C., Mialocq, P., Clayette, P., Dormont, D., Gras, G., Role of glutamate transporters in the regulation of glutathione levels in human macrophages (2001) Am. J. Physiol. Cell Physiol., 281, pp. 1964-C1970; Rothstein, J.D., Van Kammen, M., Levey, A.I., Martin, L.J., Kuncl, R.W., Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis (1995) Ann. Neurol., 38, pp. 73-84; Rothstein, J.D., Patel, S., Regan, M.R., Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression (2005) Nature, 433, pp. 73-77; Rumbaugh, J.A., Li, G., Rothstein, J., Nath, A., Ceftriaxone protects against the neurotoxicity of human immunodeficiency virus proteins (2007) J. Neurovirol., 13, pp. 168-172; Sasaki, H., Sato, H., Kuriyama-Matsumura, K., Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression (2002) J. Biol. Chem., 277, pp. 44765-44771; Sato, H., Tamba, M., Ishii, T., Bannai, S., Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins (1999) J. Biol. Chem., 274, pp. 11455-11458; Sato, H., Shiiya, A., Kimata, M., Redox imbalance in cystine/glutamate transporter-deficient mice (2005) J. Biol. Chem., 280, pp. 37423-37429; Schluter, K., Figiel, M., Rozyczka, J., Engele, J., CNS region-specific regulation of glial glutamate transporter expression (2002) Eur. J. Neurosci., 16, pp. 836-842; Schulz, J.B., Lindenau, J., Seyfried, J., Dichgans, J., Glutathione, oxidative stress and neurodegeneration (2000) Eur. J. Biochem., 267, pp. 4904-4911; Sheldon, A.L., Robinson, M.B., The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention (2007) Neurochem. Int., 51, pp. 333-355; Shih, A.Y., Johnson, D.A., Wong, G., Kraft, A.D., Jiang, L., Erb, H., Johnson, J.A., Murphy, T.H., Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress (2003) J. Neurosci., 23, pp. 3394-3406; Shih, A.Y., Erb, H., Sun, X., Toda, S., Kalivas, P.W., Murphy, T.H., Cystine/glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation (2006) J. Neurosci., 26, pp. 10514-10523; Sun, X., Shih, A.Y., Johannssen, H.C., Erb, H., Li, P., Murphy, T.H., Two-photon imaging of glutathione levels in intact brain indicates enhanced redox buffering in developing neurons and cells at the cerebrospinal fluid and blood-brain interface (2006) J. Biol. Chem., 281, pp. 17420-17431; Swanson, R.A., Liu, J., Miller, J.W., Rothstein, J.D., Farrell, K., Stein, B.A., Longuemare, M.C., Neuronal regulation of glutamate transporter subtype expression in astrocytes (1997) J. Neurosci., 17, pp. 932-940; Tan, S., Schubert, D., Maher, P., Oxytosis: A novel form of programmed cell death (2001) Curr. Top. Med. Chem., 1, pp. 497-506; Tomizawa, S., Imai, H., Tsukada, S., The detection and quantification of highly reactive oxygen species using the novel HPF fluorescence probe in a rat model of focal cerebral ischemia (2005) Neurosci. Res., 53, pp. 304-313; Urushitani, M., Ezzi, S.A., Julien, J.P., Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis (2007) Proc. Natl Acad. Sci. USA, 104, pp. 2495-2500; Wang, W., Jaiswal, A.K., Nuclear factor Nrf2 and antioxidant response element regulate NRH:quinone oxidoreductase 2 (NQO2) gene expression and antioxidant induction (2006) Free Radic. Biol. Med., 40, pp. 1119-1130; Zargari, M., Allameh, A., Sanati, M.H., Tiraihi, T., Lavasani, S., Emadyan, O., Relationship between the clinical scoring and demyelination in central nervous system with total antioxidant capacity of plasma during experimental autoimmune encephalomyelitis development in mice (2007) Neurosci. Lett., 412, pp. 24-28","Methner, A.; Department of Neurology, Heinrich-Heine Universität Düsseldorf, Moorenstr. 5, 40225 Düsseldorf, Germany; email: axel.methner@gmail.com",,,,,,,,00223042,,JONRA,19694903,"English","J. Neurochem.",Article,Scopus,2-s2.0-70349314704
"Schubert, D.","Commercialized GM crops and yield",2009,"Nature Biotechnology","27","9",,"802","803",,2,10.1038/nbt0909-802,"http://www.scopus.com/inward/record.url?eid=2-s2.0-70249093968&partnerID=40&md5=0ee91697110aa61d095de522afae8bf7","Salk Institute, San Diego, CA, United States","Schubert, D., Salk Institute, San Diego, CA, United States",[No abstract available],,"chemical industry; cotton; crop improvement; crop pest; crop protection; developed country; developing country; drug industry; food industry; genetic engineering; genetic trait; harvest; letter; maize; plant biotechnology; plant breeding; priority journal; rapeseed; soybean; world health organization; Agriculture; Bias (Epidemiology); Plants, Genetically Modified; Private Sector",,,,,,"Sheridan, C., (2009) Nat. Biotechnol., (27), pp. 588-589. , http://www.ucsusa.org/assets/documents/food-and-agricul-ture/ failure-to-yield.pdf, Accessed July 2009; Gurian-sherman D. Failure to Yield: Evaluating the Performance of Genetically Engineered Crops, , (Union of Concerned scientists, Washington, dC, 2009); Heinemann, J.A., (2009) Hope Not Hype: The Future of Agriculture Guided by the International Assessment of Agricultural Knowledge, Science and Technology for Development, , Third World Network, penang, Malaysia; Begley, S., Feeding the 900 million: Let them eat micronutrients (2008) Newsweek, 152, pp. 53-54. , http://newsweek.com/id/160075; Fernandez-Cornejo, J., (2004) The Seed Industry in U.S. Agriculture. Agriculture Information Bulletin Number 786, pp. 30-40. , http://www.ers.usda.gov/publica-tions/aib786/aib786h.pdf, (publishing resource economics division, economic research service, UsdA, Washington, dC; (2005) Monsanto Vs. U.S. Farmers, , http://www.centerforfoodsafety.org/Monsantovsusfarmersreport.cfm, Kimbrell A. Mendelson J. (eds.) Center for Food safety, Washington, dC; Stone, G.D., (2007) Curr. Anthropol., 48, pp. 67-103. , http://news.bbc.co.uk/2/hi/business/4153635.stm, Anonymous. Monsanto fined $1.5m for bribery. BBC News, January 7, 2005","Schubert, D.; Salk Institute, San Diego, CA, United States; email: schubert@salk.edu",,,,,,,,10870156,,NABIF,19741629,"English","Nat. Biotechnol.",Letter,Scopus,2-s2.0-70249093968
"Maji, S.K., Perrin, M.H., Sawaya, M.R., Jessberger, S., Vadodaria, K., Rissman, R.A., Singru, P.S., Nilsson, K.P.R., Simon, R., Schubert, D., Eisenberg, D., Rivier, J., Sawchenko, P., Vale, W., Riek, R.","Functional amyloids as natural storage of peptide hormones in pituitary secretory granules",2009,"Science","325","5938",,"328","332",,318,10.1126/science.1173155,"http://www.scopus.com/inward/record.url?eid=2-s2.0-67650809307&partnerID=40&md5=7736cdacaf85d5d739d4db13dad28b80","Laboratory of Physical Chemistry, Eidgendssische Technische Hochschule (ETH) Zurich, Wolfgang-Paulistrasse 10, CH-8093 Zurich, Switzerland; Clayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, San Diego, CA 92037, United States; Howard Hughes Medical Institute, UCLA-DOE Institute for Genomics and Proteomics, University of California, San Diego, CA 90095, United States; Institute of Cell Biology, Department of Biology, ETH Zurich, 8093 Zurich, Switzerland; Department of Neuroscience, University of California, San Diego, San Diego, CA 92093, United States; Division of Endocrinology, Diabetes and Metabolism, Tufts Medical Center, Boston, MA 02111, United States; Department of Chemistry, IFM, Linkdping University, SE-581 83 Linkdping, Sweden; Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037, United States; Structural Biology, Salk Institute for Biological Studies, San Diego, CA 92037, United States; School of Bioscience and Bioengineering, IIT Bombay, Powai, Mumbai 400076, India","Maji, S.K., Laboratory of Physical Chemistry, Eidgendssische Technische Hochschule (ETH) Zurich, Wolfgang-Paulistrasse 10, CH-8093 Zurich, Switzerland; Perrin, M.H., Clayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, San Diego, CA 92037, United States, School of Bioscience and Bioengineering, IIT Bombay, Powai, Mumbai 400076, India; Sawaya, M.R., Howard Hughes Medical Institute, UCLA-DOE Institute for Genomics and Proteomics, University of California, San Diego, CA 90095, United States; Jessberger, S., Institute of Cell Biology, Department of Biology, ETH Zurich, 8093 Zurich, Switzerland; Vadodaria, K., Institute of Cell Biology, Department of Biology, ETH Zurich, 8093 Zurich, Switzerland; Rissman, R.A., Department of Neuroscience, University of California, San Diego, San Diego, CA 92093, United States; Singru, P.S., Division of Endocrinology, Diabetes and Metabolism, Tufts Medical Center, Boston, MA 02111, United States; Nilsson, K.P.R., Department of Chemistry, IFM, Linkdping University, SE-581 83 Linkdping, Sweden; Simon, R., Department of Chemistry, IFM, Linkdping University, SE-581 83 Linkdping, Sweden; Schubert, D., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037, United States; Eisenberg, D., Howard Hughes Medical Institute, UCLA-DOE Institute for Genomics and Proteomics, University of California, San Diego, CA 90095, United States; Rivier, J., Clayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, San Diego, CA 92037, United States; Sawchenko, P., Clayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, San Diego, CA 92037, United States; Vale, W., Clayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, San Diego, CA 92037, United States; Riek, R., Laboratory of Physical Chemistry, Eidgendssische Technische Hochschule (ETH) Zurich, Wolfgang-Paulistrasse 10, CH-8093 Zurich, Switzerland, Structural Biology, Salk Institute for Biological Studies, San Diego, CA 92037, United States","Amyloids are highly organized cross-p-sheet-rich protein or peptide aggregates that are associated with pathological conditions including Alzheimer's disease and type II diabetes. However, amyloids may also have a normal biological function, as demonstrated by fungal prions, which are involved in prion replication, and the amyloid protein Pmel17, which is involved in mammalian skin pigmentation. We found that peptide and protein hormones in secretory granules of the endocrine system are stored in an amyloid-like cross-p-sheet-rich conformation. Thus, functional amyloids in the pituitary and other organs can contribute to normal cell and tissue physiology.",,"amyloid; peptide hormone; disease incidence; endocrine system; fungal disease; hormone; mammal; pathogenicity; peptide; pigment; secretion; Alzheimer disease; article; beta sheet; human; hypophysis; non insulin dependent diabetes mellitus; nonhuman; prion; priority journal; protein analysis; protein conformation; secretory granule; virus replication; Adrenocorticotropic Hormone; Amyloid; Animals; beta-Endorphin; Cell Survival; Corticotropin-Releasing Hormone; Heparin, Low-Molecular-Weight; Humans; Hydrogen-Ion Concentration; Mice; Neurons; Peptide Hormones; Pituitary Gland; Pituitary Gland, Anterior; Pituitary Gland, Posterior; Pituitary Hormones; Protein Conformation; Rats; Secretory Vesicles; Sheep; Urocortins; fungal prion; Mammalia",,"amyloid, 11061-24-8; Adrenocorticotropic Hormone, 9002-60-2; Amyloid; Corticotropin-Releasing Hormone, 9015-71-8; Heparin, Low-Molecular-Weight; Peptide Hormones; Pituitary Hormones; Urocortins; beta-Endorphin, 60617-12-1",,,,"Kelly, R.B., (1985) Science, 230, p. 25; Kelly, R.B., (1987) Nature, 326, p. 14; Aryan, P., Castle, D., (1998) Biochem. J, 332, p. 593; Dannies, P.S., (2001) MoL Cell. Endocrinol, 177, p. 87; Aryan, P., Zhang, B.Y., Feng, L., Liu, M., Kuliawat, R., (2002) Curr. Opin. Cell Biol, 14, p. 448; Tooze, S.A., (1998) Biochim. Biophys. Acta, 1404, p. 231; Miller, F., de Harven, E., Palade, G.E., (1966) J. Cell Biol, 31, p. 349; Keeler, C., Hodsdon, M.E., Dannies, P.S., (2004) J. Mol. Neurosci, 22, p. 43; Fowler, D.M., Koulov, A.V., Balch, W.E., Kelly, J.W., (2007) Trends Biochem. Sci, 32, p. 217; Barnhart, M.M., Chapman, M.R., (2006) Annu. Rev. Microbiol, 60, p. 131; Iconomidou, V.A., Vriend, G., Hamodrakas, S.J., (2000) FEBS Lett, 479, p. 141; Maddelein, M.L., Dos Reis, S., Duvezin-Caubet, S., Coulary-Salin, B., Saupe, S.J., (2002) Proc. Natl. Acad. Sci. U.S.A, 99, p. 7402; Fowler, D.M., (2006) PLoS Biol, 4, pp. e6; Kolset, S.O., Prydz, K., Pejler, G., (2004) Biochem. J, 379, p. 217; Reggio, H.A., Palade, G.E., (1978) J. Cell Biol, 77, p. 288; Zanini, A., (1980) J. Cell Biol, 86, p. 260; Rosa, P., Zanini, A., (1983) Eur. J. Cell Biol, 31, p. 94; Carlson, S.S., Kelly, R.B., (1983) J. Biol. Chem, 258, p. 11082; Kisilevsky, R., (2000) J. Struct. Biol, 130, p. 99; Cohlberg, J.A., Li, J., Uversky, V.N., Fink, A.L., (2002) Biochemistry, 41, p. 1502; Maji, S.K., (2008) PLoS Biol, 6, pp. e17; Suk, J.Y., Zhang, F., Balch, W.E., Linhardt, R.J., Kelly, J.W., (2006) Biochemistry, 45, p. 2234; See supporting material on Science OnlineGiannattasio, G., Zanini, A., Meldolesi, J., (1975) J. Cell Biol, 64, p. 246; Liu, Y., Schubert, D., (1998) J. Neurochem, 71, p. 2322; Onoue, S., (2004) Pharm. Res, 21, p. 1274; Gumbiner, B., Kelly, R.B., (1981) Proc. Natl. Acad. Sci. U.S.A, 78, p. 318; Yonemoto, I.T., Kroon, G.J., Dyson, H.J., Balch, W.E., Kelly, J.W., (2008) Biochemistry, 47, p. 9900; Giasson, B.I., (2003) Science, 300, p. 636; Gellermann, G.P., (2005) Proc. Natl. Acad. Sci. U.S.A, 102, p. 6297; Hardy, J.A., Higgins, G.A., (1992) Science, 256, p. 184; Farquhar, M.G., (1971) Subcellular Structure and Function in Endocrine Organs, pp. 79-122. , H. Heller, K. Lederis, Eds, Cambridge Univ. Press, Cambridge; Hook, V., Schechter, I., Demuth, H.U., Hook, G., (2008) Biol. Chem, 389, p. 993; Moore, H.P., Gumbiner, B., Kelly, R.B., (1983) Nature, 302, p. 434; Korth, C., May, B.C., Cohen, F.E., Prusiner, S.B., (2001) Proc. Natl. Acad. Sci. U.S.A, 98, p. 9836; Yang, F., (2005) J. Biol. Chem, 280, p. 5892; Miller, M., Chen, S., Woodliff, J., Kansra, S., (2008) Endocrinology, 149, p. 4158; Chiti, F., Dobson, C.M., (2006) Annu.Rev.Biochem, 75, p. 333; We thank S. Maji for the cartoon drawing in fig. S14; S. Pisani and C. Peto for technical assistance; C. R. Grace and C. Tzitzilonis for valuable suggestions; P. S. Dannies and M. E. Hodsdon for valuable suggestions and the plasmid of human prolactin; and C. Glabe for the OC antibody. Supported by the Swiss National Foundation, Clayton Medical Research Foundation Inc., and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant PO1 DK026741-29. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIDDK or NIH. W.V. is a cofounder, consultant, equity holder, and member of the Board of Directors and Scientific Advisory Board of Neurocrine Biosciences Inc. and Acceleron Pharma Inc. J.R. is founder and owner of Sentia Medical Sciences Inc. and is coinventor in several patents covering CRF receptor ligands","Riek, R.; Laboratory of Physical Chemistry, Eidgendssische Technische Hochschule (ETH) Zurich, Wolfgang-Paulistrasse 10, CH-8093 Zurich, Switzerland; email: roland.riek@phys.chem.ethz.ch",,,,,,,,00368075,,SCIEA,19541956,"English","Science",Article,Scopus,2-s2.0-67650809307
"Maher, P.A., Schubert, D.R.","Metabolic links between diabetes and Alzheimer's disease",2009,"Expert Review of Neurotherapeutics","9","5",,"617","630",,46,10.1586/ern.09.18,"http://www.scopus.com/inward/record.url?eid=2-s2.0-66249126971&partnerID=40&md5=3b3baa1326be9dde6f96267e625d883d","Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037-1099, United States","Maher, P.A., Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037-1099, United States; Schubert, D.R., Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037-1099, United States","There is a cluster of risk factors for Type 2 diabetes and vascular disease that include high blood glucose, obesity, high blood pressure, increased blood triacylglycerols and insulin resistance. All of these factors, both individually and collectively, increase the risk of Alzheimer's disease (AD) and vascular dementia. Alterations in insulin signaling, glucose and fatty acid metabolism, as well as the accumulation of oxidatively modified and glycated proteins, are associated with both diabetes and the dementias. Data from animal and cell culture models have shown that there is a synergistic interaction between most of these stresses in both AD and diabetes, and with the elevated β-amyloid peptide levels that are also linked to AD. Some of these parameters can be modified by diet and others may require novel drugs. However, because of the multiplicity of physiological pathways involved, conventional drug therAβies directed against a single target are not going to be effective in treating AD or the complications of diabetes. It is therefore likely that the only successful therAβy will involve the use of drugs with multiple targets in concert with changes in diet and lifestyle. © 2009 Expert Reviews Ltd.","Alzheimer's disease; Diabetes; Drugs; Epidemiology; Fatty acid; Glycation; Lifestyle; Molecular pathway","amyloid beta protein; glucose; insulin; Alzheimer disease; animal cell culture; diabetes mellitus; diet; disease association; disease course; epidemiological data; fatty acid metabolism; glucose blood level; human; insulin resistance; lifestyle; metabolism; nonhuman; protein glycosylation; review; risk factor; Alzheimer Disease; Amyloid beta-Protein; Animals; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Risk Factors",,"amyloid beta protein, 109770-29-8; glucose, 50-99-7, 84778-64-3; insulin, 9004-10-8; Amyloid beta-Protein; Hypoglycemic Agents",,,,"Arvanitakis, Z., Wilson, R.S., Bienias, J.L., Evans, D.A., Bennett, D.A., Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function (2004) Arch. Neurol, 61 (5), pp. 661-666; Biessels, G.J., Staekenborg, S., Brunner, E., Brayne, C., Scheltens, P., Risk of dementia in diabetes mellitus: A systemic review (2006) Lancet Neurol, 5, pp. 64-74; Excellent review and summary of the relationship between Alzheimer's disease (AD) and diabetesCali, A.M., CAβrio, S., Prediabetes and Type 2 diabetes in youth: An emerging epidemic disease? (2008) Curr. Opin. Endocrinol. Diabetes Obes, 15 (2), pp. 123-127; Craft, S., Insulin resistance and Alzheimer's disease pathogenesis: Potential mechanisms and implications for treatment (2007) Curr. Alzheimer Res, 4 (2), pp. 147-152; Ott, A., Stolk, R.P., van Harskamp, F., Pols, H.A., Hofman, A., Breteler, M.M., Diabetes mellitus and the risk of dementia: The Rotterdam Study (1999) Neurology, 53, pp. 1937-1942; Katzman, R., Aronson, M., Fuld, P., Development of dementing illnesses in an 80-year-old volunteer cohort (1989) Ann. Neurol, 25, pp. 317-324; Hassing, L.B., Johansson, B., Nilsson, S.E., Diabetes mellitus is a risk factor for vascular dementia, but not Alzheimer's disease: A population-based study of the oldest old (2002) Int. Psychogeriatr, 14, pp. 239-248; Bruce, D.G., Davis, W.A., Casey, G.P., Predictors of cognitive impairment and dementia in older people with diabetes (2008) Diabetologia, 51, pp. 241-248; Akomolafe, A., Beiser, A., Meigs, J.B., Diabetes mellitus and risk of developing Alzheimer disease (2006) Arch. Neurol, 63, pp. 1551-1555; Xu, W., Qiu, C., Winblad, B., Fratriglioni, L., The effect of borderline diabetes on the risk of dementia and Alzheimer's disease (2007) Diabetes, 56, pp. 211-216; Peila, R., Rodriguez, B.L., Launer, L.J., Type 2 diabetes, AβOE gene, and the risk for dementia and related pathologies (2002) Diabetes, 51, pp. 1256-1262; Luchsinger, J.A., Tang, M.-X., Shea, S., Mayeux, R., Hyperinsulinemia and risk of Alzheimer disease (2004) Neurology, 63, pp. 1187-1192; Young, S.E., Mainous, A.G., Carnemolla, M., Hyperinsulinemia and cognitive decline in a middle-aged cohort (2006) Diabetes Care, 29, pp. 2688-2693; Yaffe, K., Blackwell, T., Kanaya, A.M., Davidowitz, N., Barrett-Connor, E., Krueger, K., Diabetes, impaired fasting glucose, and development of cognitive impairment in older women (2004) Neurology, 63, pp. 658-663; Luchsinger, J.A., Tang, M.-X., Stern, Y., Shea, S., Mayeux, R., Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort (2001) Am. J. Epidemiol, 154, pp. 635-641; Xu, W., Qiu, C.X., Wahlin, A., Winblad, B., Fratriglioni, L., Diabetes mellitus and risk of dementia in the Kungsholmen project (2004) Neurology, 63, pp. 1181-1186; Ronnemaa, E., Zethelius, B., Sundelof, J., Impaired insulin secretion increases the risk of Alzheimer disease (2008) Neurology, 71, pp. 1065-1071; Youngren, J.F., Regulation of insulin receptor function (2007) Cell. Mol. Life Sci, 64, pp. 873-891; Stumvoll, M., Goldstein, B.J., van Haeften, T.W., Type 2 diabetes: Principles of pathogenesis and therAβy (2005) Lancet, 365, pp. 1333-1346; Cole, A.R., Astell, A., Green, C., Sutherland, C., Molecular connections between dementia and diabetes (2007) Neurosci. Biobehav. Rev, 31, pp. 1046-1063; Excellent discussion of insulin metabolism and how alterations in insulin metabolism can impact on cognitive functionNeumann, K.F., Rojo, L., Navarrete, L.P., Farias, G., Reyes, P., Maccioni, R.B., Insulin resistance and Alzheimer's disease: Molecular links & clinical implications (2008) Curr. Alzheimer Res, 5, pp. 438-447; Sweatt, J.D., Mitogen-activated protein kinases in synAβtic plasticity and memory (2004) Curr. Opin. Neurobiol, 14, pp. 311-317; Tully, T., Bourtchouladze, R., Scott, R., Tallman, J., Targeting the CREB pathway for memory enhancers (2003) Nat. Rev. Drug Discov, 2, pp. 267-277; Carlezon, W.A., Duman, R.S., Nestler, E.J., The many faces of CREB (2005) Trends Neurosci, 28, pp. 436-445; Horwood, J.M., Dufour, F., Laroche, S., Davis, S., Signalling mechanisms mediated by the phosphoinositide 3-kinase/Akt cascade in synAβtic plasticity and memory in the rat (2006) Eur.J. Neurosci, 23, pp. 3375-3384; Phiel, C.J., Wilson, C.A., Lee, V.M.-Y., Klein, P.S., GSK-3a regulates production of Alzheimer's disease amyloid-βeptides (2003) Nature, 423, pp. 435-439; Alafuzoff, I., Aho, L., Helisalmi, S., Mannermaa, A., Soininen, H., β-amyloid deposition in brains of subjects with diabetes (2009) Neuropathol. Aβpl. Neurobiol, 35 (1), pp. 60-68; Arvanitakis, Z., Schneider, J.A., Wilson, R.S., Diabetes is related to cerebral infarction but not to AD pathology in older persons (2006) Neurology, 67 (11), pp. 1960-1965; Harrington, L.S., Findlay, G.M., Lamb, R.F., Restraining PI3K: MTOR signalling goes back to the membrane (2005) Trends Biochem. Sci, 30, pp. 35-42; Higuchi, M., Onishi, K., Kikuchi, C., Gotoh, Y., Scaffolding function of PAK in the PDKl-Akt pathway (2008) Nat. Cell Biol, 10, pp. 1356-1364; Zhao, L., Ma, Q.-L., Calon, F., Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease (2006) Nat. Neurosci, 9, pp. 234-242; Schubert, M., Gautam, D., Surjo, D., Role for neuronal insulin resistance in neurodegenerative diseases (2004) Proc. Natl Acad. Sci. USA, 101, pp. 3100-3105; Mielke, J.G., Taghibiglou, C., Liu, L., A biochemical and functional characterization of diet-induced brain insulin resistance (2005) J. Neurochem, 93, pp. 1568-1578; Stranahan, A.M., Norman, E.D., Lee, K., Diet-induced insulin resistance impairs hippocampal synAβtic plasticity and cognition in middle-aged rats (2008) Hippocampus, 18, pp. 1085-1088; Some of the best experiments showing a relationship between bad diet and brain structure and functionHo, L., Qin, W., Pompl, P.N., Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease (2004) FASEBJ, 18, pp. 902-904; Farris, W., Mansourian, S., Chang, Y., Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo (2003) Proc. Natl Acad. Sci. USA, 100, pp. 4162-4167; Burdo, J.R., Chen, Q., Calcutt, N.A., Schubert, D., The pathological interaction between diabetes and presymptomatic Alzheimer's disease (2008) Neurobiol. Aging, , Epub ahead of print, DOI:10.1016/j.neurobiolaging.2008.02.010; A clear demonstration of the effect of diabetes on animals predisposed to AD. A warning of the potential result of the increasing amount of diabetes and prediabetes in our youthJenkins, A.J., Best, J.D., Klein, R.L., Lyons, T.J., Lipoproteins, glycoxidation and diabetic angiopathy (2004) Diabetes Metab. Res. Rev, 20 (5), pp. 349-368; Eckel, R.H., Grundy, S.M., Zimmet, P.Z., The metabolic syndrome (2005) Lancet, 365 (9468), pp. 1415-1428; Hillered, L., Chan, P.H., Role of arachidonic acid and other free fatty acids in mitochondrial dysfunction in brain ischemia (1988) J. Neurosci. Res, 20 (4), pp. 451-456; Hamel, F.G., Upward, J.L., Bennett, R.G., In vitro inhibition of insulin-degrading enzyme by long-chain fatty acids and their coenzyme A thioesters (2003) Endocrinology, 144 (6), pp. 2404-2408; Dahlen, S.E., Bjork, J., Hedqvist, P., Leukotrienes promote plasma leakage and leukocyte adhesion in postcAβillary venules: In vivo effects with relevance to the acute inflammatory response (1981) Proc. Natl Acad. Sci. USA, 78 (6), pp. 3887-3891; Wilson, D.M., Binder, L.I., Free fatty acids stimulate the polymerization of tau and amyloid P peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease (1997) Am. J. Pathol, 150 (6), pp. 2181-2195; Gamblin, T.C., King, M.E., Kuret, J., Berry, R.W., Binder, L.I., Oxidative regulation of fatty acid-induced tau polymerization (2000) Biochemistry, 39 (46), pp. 14203-14210; Craft, S., Insulin resistance syndrome and Alzheimer's disease: Age- and obesity-related effects on memory, amyloid, and inflammation (2005) Neurobiol. Aging, 26 (SUPPL. 1), pp. 65-69; RAβoport, S.I., Brain arachidonic and docosahexaenoic acid cascades are selectively altered by drugs, diet and disease (2008) Prostaglandins Leukot. Essent. Fatty Acids, 79 (3-5), pp. 153-156; Firuzi, O., Zhuo, J., Chinnici, C.M., Wisniewski, T., Pratico, D., 5-lipoxygenase gene disruption reduces amyloid-β pathology in a mouse model of Alzheimer's disease (2008) FASEBJ, 22 (4), pp. 1169-1178; Sanchez-Mejia, R.O., Newman, J.W., Toh, S., Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease (2008) Nat. Neurosci, 11 (11), pp. 1311-1318; Lim, G.P., Calon, F., Morihara, T., A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model (2005) J. Neurosci, 25 (12), pp. 3032-3040; This publication is the most direct demonstration of the influence of dietary fatty acid intake on AD pathology, defining a potential AD therAβyRoland, I., De Leval, X., Evrard, B., Pirotte, B., Dogne, J.M., Delattre, L., Modulation of the arachidonic cascade with omega3 fatty acids or analogues: Potential therAβeutic benefits (2004) Mini Rev. Med. Chem, 4 (6), pp. 659-668; Great review on how fatty acid consumption and metabolism can have profound influences on many aspects of brain physiologyWilliams, J.H., Errington, M.L., Lynch, M.A., Bliss, T.V., Arachidonic acid induces a long-term activity-dependent enhancement of synAβtic transmission in the hippocampus (1989) Nature, 341 (6244), pp. 739-742; Massicotte, G., Modification of glutamate receptors by phospholipase A2: Its role in adAβtive neural plasticity (2000) Cell. Mol. Life Sci, 57 (11), pp. 1542-1550; Scorrano, L., Penzo, D., Petronilli, V., Pagano, F., Bernardi, P., Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor-a aopototic signaling (2001) J. Biol. Chem, 276 (15), pp. 12035-12040; Penzo, D., Petronilli, V., Angelin, A., Arachidonic acid released by phospholipase A(2) activation triggers Ca2*-dependent Aβoptosis through the mitochondrial pathway (2004) J. Biol. Chem, 279 (24), pp. 25219-25225; Tanaka, E., Niiyama, S., Sato, S., Yamada, A., Higashi, H., Arachidonic acid metabolites contribute to the irreversible depolarization induced by in vitro ischemia (2003) J. Neurophysiol, 90 (5), pp. 3213-3223; Cherny, V.V., Henderson, L.M., Xu, W., Thomas, L.L., DeCoursey, T.E., Activation of NADPH oxidase-related proton and electron currents in human eosinophils by arachidonic acid (2001) J. Physiol, 535 (PART 3), pp. 783-794; Zhu, D., Lai, Y., Shelat, P.B., Hu, C., Sun, G.Y., Lee, J.C., Phospholipases A2 mediate amyloid-β peptide-induced mitochondrial dysfunction (2006) Neurosci, 26 (43), pp. 11111-11119; Bianca, V.D., Dusi, S., Bianchini, E., Dal Pra, I., Rossi, F., β-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease (1999) J. Biol. Chem, 274 (22), pp. 15493-15499; Schubert, D., Soucek, T., Blouw, B., HIF-1 protects astrocytes from activation by amyloid P peptide (2009) Eur. J. Neurosci, 29, pp. 1323-1334; Takeuchi, M., Yamagishi, S., Possible involvement of advanced glycation end-products (AGEs) in the pathogenesis of Alzheimer's disease (2008) Curr. Pharmaceut. Des, 14 (10), pp. 973-978; Sun, G.Y., Horrocks, L.A., Farooqui, A.A., The roles of NADPH oxidase and phospholipases A2 in oxidative and inflammatory responses in neurodegenerative diseases (2007) J. Neurochem, 103 (1), pp. 1-16; Sun, G.Y., Xu, J., Jensen, M.D., Simonyi, A., Phospholipase A2 in the central nervous system: Implications for neurodegenerative diseases (2004) J. LipidRes, 45 (2), pp. 205-213; Uz, T., Pesold, C., Longone, P., Manev, H., Aging-associated up-regulation of neuronal 5-lipoxygenase expression: Putative role in neuronal vulnerability (1998) FASEBJ, 12 (6), pp. 439-449; Wyss-Coray, T., Inflammation in Alzheimer disease: Driving force, bystander or beneficial response? (2006) Nat. Med, 12 (9), pp. 1005-1015; Tan, S., Sagara, Y., Liu, Y., Maher, P., Schubert, D., The regulation of reactive oxygen species production during programmed cell death (1998) J. Cell Biol, 141 (6), pp. 1423-1432; Mitchell, D.C., Gawrisch, K., Litman, B.J., Salem Jr, N., Why is docosahexaenoic acid essential for nervous system function? (1998) Biochem. Soc. Trans, 26 (3), pp. 365-370; Soderberg, M., Edlund, C., Kristensson, K., Dallner, G., Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease (1991) Lipids, 26 (6), pp. 421-425; Prasad, M.R., Lovell, M.A., Yatin, M., Dhillon, H., Markesbery, W.R., Regional membrane phospholipid alterations in Alzheimer's disease (1998) Neurochem. Res, 23 (1), pp. 81-88; Kalmijn, S., Launer, L.J., Ott, A., Witteman, J.C., Hofman, A., Breteler, M.M., Dietary fat intake and the risk of incident dementia in the Rotterdam Study (1997) Ann. Neurol, 42 (5), pp. 776-782; Hooijmans, C.R., Rutters, F., Dederen, P.J., Changes in cerebral blood volume and amyloid pathology in aged Alzheimer AβP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched typical Western diet (TWD) (2007) Neurobiol. Dis, 28 (1), pp. 16-29; Wakil, S.J., Abu-Elheiga, L.A., Fatty acid metabolism: Target for metabolic syndrome (2008) J. Lipid Res, , Epub ahead of print DOI:10.1194/jlr. R800079-JLR200; Parks, E.J., Skokan, L.E., Timlin, M.T., Dingfelder, C.S., Dietary sugars stimulate fatty acid synthesis in adults (2008) J. Nutr, 138 (6), pp. 1039-1046; Cumming, R.C., Dargusch, R., Fischer, W.H., Schubert, D., Increase in expression levels and resistance to sulfhydryl oxidation of peroxiredoxin isoforms in amyloid P-resistant nerve cells (2007) J. Biol. Chem, 282 (42), pp. 30523-30534; Thornalley, P.J., Pharmacology of methylglyoxal: Formation, modification of proteins and nucleic acids, and enzymatic detoxification - a role in pathogenesis and antiproliferative chemotherAβy (1996) Gen. Pharmacol, 27 (4), pp. 565-573; Brownlee, M., Biochemistry and molecular cell biology of diabetic complications (2001) Nature, 414 (6865), pp. 813-820; An excellent review of the role of glycation in diabetic complicationsKuhla, B., Luth, H.J., Haferburg, D., Boeck, K., Arendt, T., Munch, G., Methylglyoxal, glyoxal, and their detoxification in Alzheimer's disease (2005) Ann. NYAcad. Sci, 1043, pp. 211-216; Chen, F., Wollmer, M.A., Hoerndli, F., Role for glyoxalase I in Alzheimer's disease (2004) Proc. Natl Acad. Sci. USA, 101 (20), pp. 7687-7692; Fukunaga, M., Miyata, S., Higo, S., Hamada, Y., Ueyama, S., Kasuga, M., Methylglyoxal induces Aβoptosis through oxidative stress-mediated activation of p38 mitogen-activated protein kinase in rat Schwann cells (2005) Ann. NY Acad. Sci, 1043, pp. 151-157; Hipkiss, A.R., On the mechanisms of ageing suppression by dietary restriction-is persistent glycolysis the problem? (2006) Mec. AgeingDev, 127 (1), pp. 8-15; Morcos, M., Du, X., Pfisterer, F., Glyoxalase-1 prevents mitochondrial protein modification and enhances lifespan in Caenorhabditis elegans (2008) Aging Cell, 7 (2), pp. 260-269; Schubert, D., Glucose metabolism and Alzheimer's disease (2005) Ageing Res. Rev, 4, pp. 240-257; Soucek, T., Cumming, R., Dargusch, R., Maher, P., Schubert, D., The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid P peptide (2003) Neuron, 39 (1), pp. 43-56; Ishige, K., Schubert, D., Sagara, Y., Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms (2001) Free Radic. Biol. Med, 30, pp. 433-446; Thornalley, P.J., Glycation in diabetic neuropathy: Characteristics, consequences, causes, and therAβeutic options (2002) Int. Rev. Neurobiol, 50, pp. 37-57; Important review by the leading chemist studying glycationThurston, J.H., McDougal Jr, D.B., Hauhart, R.E., Schulz, D.W., Effects of acute, subacute, and chronic diabetes on carbohydrate and energy metabolism in rat sciatic nerve. Relation to mechanisms of peripheral neuropathy (1995) Diabetes, 44 (2), pp. 190-195; Williamson, J.R., Chang, K., Frangos, M., Hyperglycemic pseudohypoxia and diabetic complications (1993) Diabetes, 42 (6), pp. 801-813; Munch, G., Kuhla, B., Luth, H.J., Arendt, T., Robinson, S.R., Anti-AGEing defences against Alzheimer's disease (2003) Biochem. Soc. Trans, 31 (PT6), pp. 1397-1399; Smith, M.A., Taneda, S., Richey, P.L., Advanced Maillard reaction end products are associated with Alzheimer disease pathology (1994) Proc. Natl Acad. Sci. USA, 91 (12), pp. 5710-5714; Yan SD, Yan SF, Chen X et al. Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid β-peptide. Nat. Med. 1(7), 693-699 (1995)Choei, H., Sasaki, N., Takeuchi, M., Glyceraldehyde-derived advanced glycation end products in Alzheimer's disease (2004) Acta Neuropathol, 108 (3), pp. 189-193; Li, Z.G., Zhang, W., Sima, A.A., Alzheimer-like changes in rat models of spontaneous diabetes (2007) Diabetes, 56 (7), pp. 1817-1824; Vitek, M.P., Bhattacharya, K., Glendening, J.M., Advanced glycation end products contribute to amyloidosis in Alzheimer disease (1994) Proc. Natl Acad. Sci. USA, 91 (11), pp. 4766-4770; Ledesma, M.D., Bonay, P., Colaco, C., Avila, J., Analysis of microtubule- associated protein tau glycation in paired helical filaments (1994) J. Biol. Chem, 269 (34), pp. 21614-21619; Yan, S.D., Chen, X., Schmidt, A.M., Glycated tau protein in Alzheimer disease: A mechanism for induction of oxidant stress (1994) Proc. Natl Acad. Sci. USA, 91 (16), pp. 7787-7791; Takeuchi, M., Bucala, R., Suzuki, T., Neurotoxicity of advanced glycation end-products for cultured cortical neurons (2000) J. Neuropathol. Exp. Neurol, 59 (12), pp. 1094-1105; Dyck, P.J., Hansen, S., Karnes, J., CAβillary number and percentage closed in human diabetic sural nerve (1985) Proc. Natl Acad. Sci. USA, 82 (8), pp. 2513-2517; Huber, J.D., Diabetes, cognitive function, and the blood-brain barrier (2008) Curr. Pharmaceut. Des, 14 (16), pp. 1594-1600; Ristow, M., Neurodegenerative disorders associated with diabetes mellitus (2004) J. Mol. Med, 82 (8), pp. 510-529; Zlokovic, B.V., The blood-brain barrier in health and chronic neurodegenerative disorders (2008) Neuron, 57 (2), pp. 178-201; Excellent review on the BBBBiessels, G.J., De Leeuw, F.E., Lindeboom, J., Barkhof, F., Scheltens, P., Increased cortical atrophy in patients with Alzheimer's disease and Type 2 diabetes mellitus (2006) J. Neurol. Neurosurg. Psychiatry, 77 (3), pp. 304-307; Sato, T., Shimogaito, N., Wu, X., Kikuchi, S., Yamagishi, S., Takeuchi, M., Toxic advanced glycation end products (TAGE) theory in Alzheimer's disease (2006) Am. J. Alzheimers Dis. OtherDemen, 21 (3), pp. 197-208; Good review by the leading proponent for the role of advanced glycation end products in ADHuber, J.D., VanGilder, R.L., Houser, K.A., Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats (2006) Am. J. Physiol, 291 (6), pp. H2660-H2668; Banks, W.A., Jaspan, J.B., Kastin, A.J., Effect of diabetes mellitus on the permeability of the blood-brain barrier to insulin (1997) Peptides, 18 (10), pp. 1577-1584; Seaquist, E.R., Tkac, I., Damberg, G., Thomas, W., Gruetter, R., Brain glucose concentrations in poorly controlled diabetes mellitus as measured by high-field magnetic resonance spectroscopy (2005) Metabolism, 54 (8), pp. 1008-1013; Clodfelder-Miller, B., De Sarno, P., Zmijewska, A.A., Song, L., Jope, R.S., Physiological and pathological changes in glucose regulate brain Akt and glycogen synthasekinase-3 (2005) J. Biol. Chem, 280 (48), pp. 39723-39731; Girouard, H., Iadecola, C., Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease (2006) J. Aβpl. Physiol, 100 (1), pp. 328-335; Koehler, R.C., Gebremedhin, D., Harder, D.R., Role of astrocytes in cerebrovascular regulation (2006) J. Aβpl. Physiol, 100 (1), pp. 307-317; Rosengarten, B., Huwendiek, O., KAβs, M., Neurovascular coupling and cerebral autoregulation can be described in terms of a control system (2001) Ultrasound Med. Biol, 27 (2), pp. 189-193; Orozco, L.J., Buchleitner, A.M., Gimenez-Perez, G., Roque, I.F.M., Richter, B., Mauricio, D., Exercise or exercise and diet for preventing Type 2 diabetes mellitus (2008) Cochrane Database Syst. Rev, , 3, CD003054; Taubes, G., (2008) Good Calories, Bad Calories, , AA Knopf, NY, USA; Must read book by anyone interested in the role of diet in disease and healthCritser, G., (2004) Fat Land: How Americans Became the Fattest People in the World, , Houghton Mifflin Co, MA, USA; This book details how US politicians and the agricultural industry initiated the diabetes epidemicNielsen, S.J., Siega-Riz, A.M., Popkin, B.M., Trends in energy intake in U.S. between 1977 and 1996: Similar shifts seen across age groups (2002) Obes. Res, 10 (5), pp. 370-378; Bray, G.A., Nielsen, S.J., Popkin, B.M., Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity (2004) Am. J. Clin. Nutr, 79 (4), pp. 537-543; Wolf, A., Bray, G.A., Popkin, B.M., A short history of beverages and how our body treats them (2007) Obes. Rev, 9, pp. 151-164; Johnson, R.J., Segal, M.S., Sautin, Y., Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease (2007) Am. J. Clin. Nutr, 86 (4), pp. 899-906; Oates, P.J., Polyol pathway and diabetic peripheral neuropathy (2002) Int. Rev. Neurobiol, 50, pp. 325-392; Cassese, A., Esposito, I., Fiory, F., In skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs (2008) J. Biol. Chem, 283 (52), pp. 36088-36099; Stirban, A., Negrean, M., GottingC, Dietary advanced glycation endproducts and oxidative stress: In vivo effects on endothelial function and adipokines (2008) Ann. NY Acad. Sci, 1126, pp. 276-279; Tan, D., Wang, Y., Lo, C.Y., Sang, S., Ho, C.T., Methylglyoxal: Its presence in beverages and potential scavengers (2008) Ann. NY Acad. Sci, 1126, pp. 72-75; Koschinsky, T., He, C.J., Mitsuhashi, T., Orally absorbed reactive glycation products (glycotoxins): An environmental risk factor in diabetic nephropathy (1997) Proc. Natl Acad. Sci. USA, 94 (12), pp. 6474-6479; He, C., Sabol, J., Mitsuhashi, T., Vlassara, H., Dietary glycotoxins: Inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration (1999) Diabetes, 48 (6), pp. 1308-1315; Vlassara, H., Advanced glycation in health and disease: Role of the modern environment (2005) Ann. NY Acad. Sci, 1043, pp. 452-460; Hightower, J.M., (2008) Diagnosis: Mercury: Money, Politics, and Poison, , Island Press, London, UK; Orgogozo, J.M., Dartigues, J.F., Lafont, S., Wine consumption and dementia in the elderly: A prospective community study in the Bordeaux area (1997) Rev. Neurol. (Paris), 153 (3), pp. 185-192; Collins, M.A., Neafsey, E.J., Mukamal, K.J., Alcohol in moderation, cardioprotection, and neuroprotection: Epidemiological considerations and mechanistic studies (2008) Alcohol Clin. Exp. Res, 33 (2), pp. 206-219; Wang, Z., Barker, T.H., Fuller, G.M., Alcohol at moderate levels decreases fibrinogen expression in vivo and in vitro (1999) Alcohol Clin. Exp. Res, 23 (12), pp. 1927-1932; Wang, J., Ho, L., Qin, W., Caloric restriction attenuates β-amyloid neuropathology in a mouse model of Alzheimer's disease (2005) FASEBJ, 19 (6), pp. 659-661; Lim, G.P., Chu, T., Yang, F., Beech, W., Frautschy, S.A., Cole, G.M., The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse (2001) J. Neurosci, 21, pp. 8370-8377; Garcia-Alloza, M., Borrelli, L.A., Rozkalne, A., Hyman, B.T., Bacskai, B.J., Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model (2007) J. Neurochem, 102 (4), pp. 1095-1104; Maher, P., Akaishi, T., Abe, K., Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory (2006) Proc. Natl Acad. Sci. USA, 103 (44), pp. 16568-16573; Hu, G., Lakka, T.A., Kilpelainen, T.O., Tuomilehto, J., Epidemiological studies of exercise in diabetes prevention (2007) Aβpl. Physiol. Nutr. Metab, 32 (3), pp. 583-595; Balogun, E., Hoque, M., Gong, P., Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element (2003) Biochem. J, 371 (PART 3), pp. 887-895; Liu, Y., Dargusch, R., Maher, P., Schubert, D., A broadly neuroprotective derivative of curcumin (2008) J. Neurochem, 105, pp. 1336-1345; Maher, P., Akaishi, T., Schubert, D., Abe, K., A pyrazole derivative of curcumin enhances memory (2008) Neurobiol. Aging, , Epub ahead of print; Peyroux, J., Sternberg, M., Advanced glycation endproducts (AGEs): Pharmacological inhibition in diabetes (2006) Pathol. Biol. (Paris), 54 (7), pp. 405-419; Wu, C.H., Yen, G.C., Inhibitory effect of naturally occurring flavonoids on the formation of advanced glycation endproducts (2005) J. Agric. Food. Chem, 53 (8), pp. 3167-3173; Akaishi, T., Morimoto, T., Shibao, M., Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid β protein (2008) Neurosci. Lett, 444 (3), pp. 280-285; Van Acker, S.A., van den Berg, D.J., Tromp, M.N., Structural aspects of antioxidant activity of flavonoids (1996) Free Radic. Biol. Med, 20 (3), pp. 331-342; Sagara, Y., Vanhnasy, J., Maher, P., Induction of PC12 cell differentiation by flavonoids is dependent upon extracellular signal-regulated kinase activation (2004) J. Neurochem, 90 (5), pp. 1144-1155","Schubert, D. R.; Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037-1099, United States; email: schubert@salk.edu",,,,,,,,14737175,,ERNXA,19402773,"English","Expert Rev. Neurother.",Review,Scopus,2-s2.0-66249126971
"Schubert, D., Soucek, T., Blouw, B.","The induction of HIF-1 reduces astrocyte activation by amyloid beta peptide",2009,"European Journal of Neuroscience","29","7",,"1323","1334",,32,10.1111/j.1460-9568.2009.06712.x,"http://www.scopus.com/inward/record.url?eid=2-s2.0-64049105735&partnerID=40&md5=a6ff1816b351c6fadd0f9ed1f5b0b021","Cellular Neurobiology Laboratory, Salk Institute, 10010 N. Torrey Pines Rd, San Diego, CA 92037, United States; BiochemicalSerological Control, Baxter Vaccine AG, Uferstrasse 15, A-2304 OrthDonau, Austria; Burnham Institute for Medical Research, 10901 North Torrey Pines Road, San Diego, CA 92037, United States","Schubert, D., Cellular Neurobiology Laboratory, Salk Institute, 10010 N. Torrey Pines Rd, San Diego, CA 92037, United States; Soucek, T., Cellular Neurobiology Laboratory, Salk Institute, 10010 N. Torrey Pines Rd, San Diego, CA 92037, United States, BiochemicalSerological Control, Baxter Vaccine AG, Uferstrasse 15, A-2304 OrthDonau, Austria; Blouw, B., Burnham Institute for Medical Research, 10901 North Torrey Pines Road, San Diego, CA 92037, United States","Reduced glucose metabolism and astrocyte activation in selective areas of the brain are pathological features of Alzheimer's disease (AD). The underlying mechanisms of low energy metabolism and a molecular basis for preventing astrocyte activation are not, however, known. Here we show that amyloid beta peptide (A)-dependent astrocyte activation leads to a long-term decrease in hypoxia-inducible factor (HIF)-1 expression and a reduction in the rate of glycolysis. Glial activation and the glycolytic changes are reversed by the maintenance of HIF-1 levels with conditions that prevent the proteolysis of HIF-1. A increases the long-term production of reactive oxygen species (ROS) through the activation of nicotinamide adenine dinucleotide phosphate oxidase and reduces the amount of HIF-1 via the activation of the proteasome. ROS are not required for glial activation, but are required for the reduction in glycolysis. These data suggest a significant role for HIF-1-mediated transcription in maintaining the metabolic integrity of the AD brain and identify the probable cause of the observed lower energy metabolism in afflicted areas. They may also explain the therapeutic success of metal chelators in animal models of AD. © 2009 Federation of European Neuroscience Societies and Blackwell Publishing Ltd.","Alzheimer's disease; Amyloid beta peptide; Astrocytes; Glycolysis; Hypoxia-inducible factor; Rodents","amyloid beta protein; hypoxia inducible factor 1; metal; proteasome; reactive oxygen metabolite; reduced nicotinamide adenine dinucleotide phosphate; animal cell; animal tissue; article; astrocyte; chelation; energy metabolism; female; glia cell; glycolysis; mouse; nonhuman; priority journal; protein degradation; rat; Alzheimer Disease; Amyloid beta-Protein; Animals; Astrocytes; Cells, Cultured; Deferoxamine; Glucose; Glycolysis; Hypoxia-Inducible Factor 1, alpha Subunit; Iron Chelating Agents; Mice; Mice, Inbred C57BL; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species",,"amyloid beta protein, 109770-29-8; proteasome, 140879-24-9; reduced nicotinamide adenine dinucleotide phosphate, 53-57-6; Amyloid beta-Protein; Deferoxamine, 70-51-9; Glucose, 50-99-7; Hif1a protein, mouse; Hif1a protein, rat; Hypoxia-Inducible Factor 1, alpha Subunit; Iron Chelating Agents; Proteasome Endopeptidase Complex, 3.4.25.1; Reactive Oxygen Species",,,,"Abramov, A.Y., Canevari, L., Duchen, M.R., Calcium signals induced by amyloid beta peptide and their consequences in neurons and astrocytes in culture (2004) Biochim. Biophys. Acta., 1742, pp. 81-87; Akama, K.T., Van Eldik, L.J., Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1beta- and tumor necrosis factor-alpha (TNFalpha)-dependent, and involves a TNFalpha receptor-associated factor- and NFkappaB-inducing kinase-dependent signaling mechanism (2000) J. Biol. Chem., 275, pp. 7918-7924; Akama, K.T., Albanese, C., Pestell, R.G., Van Eldik, L.J., Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism (1998) Proc. Natl Acad. Sci. USA, 95, pp. 5795-5800; Ashcroft, S.J.H., Weerasinghe, L.C.C., Bassett, J.M., Randle, P.J., The pentose cycle and insulin release in mouse pancreatic islets (1972) Biochem J., 126, pp. 525-532; Avasolla, K., Khan, M., Singh, A.K., Singh, I., Inflammatory mediator and beta-amyloid (25-35)-induced ceramide generation and iNOS expression are inhibited by vitamin e (2004) Free Radic. Biol. Med., 37, pp. 325-338; Bajenaru, M.L., Zhu, Y., Hedrick, N.M., Donahoe, J., Parada, L.F., Gutmann, D.H., Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation (2002) Mol. Cell. Biol., 22, pp. 5100-5113; Behl, C., Schubert, D., Heat shock partially protects rat pheochromocytoma PC12 cells from amyloid beta peptide toxicity (1993) Neurosci. Lett., 154, pp. 1-4; Behl, C., Davis, J.B., Lesley, R., Schubert, D., Hydrogen peroxide mediates amyloid beta protein toxicity (1994) Cell, 77, pp. 817-827; Bianchi, L., Tacchini, L., Cairo, G., HIF-1-mediated activation of transferrin receptor gene transcription by iron chelation (1999) Nucleic Acids Res., 27, pp. 4223-4227; Block, K., Gorin, Y., Hoover, P., Williams, P., Chelmicki, T., Clark, R.A., Yoneda, T., Abboud, H.E., NAD(P)H oxidases regulate HIF-2alpha protein expression (2007) J. Biol. Chem., 282, pp. 8019-8026; Callapina, M., Zhou, J., Schmid, T., Kohl, R., Brune, B., NO restores HIF-1alpha hydroxylation during hypoxia: Role of reactive oxygen species (2005) Free Radic. Biol. Med., 39, pp. 925-936; Cappai, R., Barnham, K.J., Delineating the mechanism of Alzheimer's disease A beta peptide neurotoxicity (2008) Neurochem. Res., 33, pp. 526-532; Cherny, R.A., Atwood, C.S., Xilinas, M.E., Gray, D.N., Jones, W.D., McLean, C.A., Barnham, K.J., Bush, A.I., Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice (2001) Neuron, 30, pp. 641-642; Chin, B.Y., Jiang, G., Wegiel, B., Wang, H.J., MacDonald, T., Zhang, X.C., Gallo, D., Otterbein, L.E., Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioning (2007) Proc. Natl Acad. Sci. USA, 104, pp. 5109-5114; Cumming, R.C., Schubert, D., Amyloid-beta induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease (2005) FASEB J., 19, pp. 2060-2062; Dienel, G.A., Cruz, N.F., Astrocyte activation in working brain: Energy supplied by minor substrates (2006) Neurochem. Int., 48, pp. 586-595; Favit, A., Grimaldi, M., Alkon, D.L., Prevention of beta-amyloid neurotoxicity by blockade of the ubiquitin-proteasome proteolytic pathway (2000) J. Neurochem., 75, pp. 1258-1263; Gao, H.M., Liu, B., Zhang, W., Hong, J.S., Critical role of microglial NADPH oxidase-derived free radicals in the in vitro MPTP model of Parkinson's disease (2003) FASEB J., 17, pp. 1954-1956; Gitter, B.D., Cox, L.M., Rydel, R.E., May, P.C., Amyloid beta peptide potentiates cytokine secretion by interleukin-1 beta-activated human astrocytoma cells (1995) Proc. Natl Acad. Sci. USA, 92, pp. 10738-10741; Gregori, L., Fuchs, C., Figueiredo-Pereira, M.E., Van Nostrand, W.E., Goldgaber, D., Amyloid beta-protein inhibits ubiquitin-dependent protein degradation in vitro (1995) J. Biol. Chem., 270, pp. 19702-19708; Griguer, C.E., Oliva, C.R., Kelley, E.E., Giles, G.I., Lancaster, Jr.J.R., Gillespie, G.Y., Xanthine oxidase-dependent regulation of hypoxia-inducible factor in cancer cells (2006) Cancer Res., 66, pp. 2257-2263; Hewitson, K.S., Lienard, B.M., McDonough, M.A., Clifton, I.J., Butler, D., Soares, A.S., Oldham, N.J., Schofield, C.J., Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates (2007) J. Biol. Chem., 282, pp. 3293-3301; Hu, J., Castets, F., Guevara, J.L., Van Eldik, L.J., S100 beta stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes (1996) J. Biol. Chem., 271, pp. 2543-2547; Hu, J., Akama, K., Krafft, G., Chromy, B., Eldik, L., Amyloid-beta peptide activates cultured astrocytes: Morphological alterations, cytokine induction and nitric oxide release (1998) Brain Res., 785, pp. 195-206; Hyslop, P.A., Hinshaw, D.B., Halsey, Jr.W.A., Schraufstatter, I.U., Sauerhebet, R.D., Spragg, R.G., Jackson, J.H., Cochrane, C.G., Mechanisms of oxidant-mediated cell injury (1988) J. Biol. Chem., 263, pp. 1665-1675; Kallio, P.J., Wilson, W.J., O'Brien, S., Makino, Y., Poellinger, L., Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway (1999) J. Biol. Chem., 274, pp. 6519-6525; Kaluz, S., Kaluzova, M., Stanbridge, E.J., Proteasomal inhibition attenuates transcriptional activity of hypoxia-inducible factor 1 (HIF-1) via specific effect on the HIF-1alpha C-terminal activation domain (2006) Mol. Cell. Biol., 26, pp. 5895-5907; Koh, M.Y., Spivak-Kroizman, T.R., Powis, G., HIF-1 regulation: Not so easy come, easy go (2008) Trends Biochem. Sci., 33, pp. 526-534; De Leon, M.J., Mosconi, L., Blennow, K., Desanti, S., Zinkowski, R., Mehta, P.D., Pratico, D., Rusinek, H., Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease (2007) Ann. NY Acad. Sci., 1097, pp. 114-145; Lesley, J.F., Schulte, R.J., Selection of cell lines resistant to anti-transferrin receptor antibody: Evidence for a mutation in transferrin receptor (1984) Mol. Cell. Biol., 4, pp. 1675-1681; Lian, X.Y., Stringer, J.L., Energy failure in astrocytes increases the vulnerability of neurons to spreading depression (2004) Eur. J. Neurosci., 19, pp. 2446-2454; Liu, Y., Piasecki, D., A cell-based method for the detection of nanomolar concentrations of bioactive amyloid (2001) Anal. Biochem., 289, pp. 130-136; Lopez Salon, M., Pasquini, L., Besio Moreno, M., Pasquini, J.M., Soto, E., Relationship between beta-amyloid degradation and the 26S proteasome in neural cells (2003) Exp. Neurol., 180, pp. 131-143; Maragakis, N.J., Rothstein, J.D., Mechanisms of Disease: Astrocytes in neurodegenerative disease (2006) Nat. Clin. Pract. Neurol., 2, pp. 679-689; Maxwell, P.H., Wiesener, M.S., Chang, G.W., Clifford, S.C., Vaux, E.C., Cockman, M.E., Wykoff, C.C., Ratcliffe, P.J., The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis (1999) Nature, 399, pp. 203-204; Parpura-Gill, A., Beitz, D., Uemura, E., The inhibitory effects of beta-amyloid on glutamate and glucose uptakes by cultured astrocytes (1997) Brain Res., 754, pp. 65-71; Pekny, M., Nilsson, M., Astrocyte activation and reactive gliosis (2005) Glia, 50, pp. 427-434; Perneczky, R., Hartmann, J., Grimmer, T., Drzezga, A., Kurz, A., Cerebral metabolic correlates of the clinical dementia rating scale in mild cognitive impairment (2007) J. Geriatr. Psychiatry Neurol., 20, pp. 84-88; Prat, E., Baron, P., Meda, L., Scarpini, E., Galimberti, D., Ardolino, G., Catania, A., Scarlato, G., The human astrocytoma cell line U373MG produces monocyte chemotactic protein (MCP)-1 upon stimulation with beta-amyloid protein (2000) Neurosci. Lett., 283, pp. 177-180; Raivich, G., Bohatschek, M., Kloss, C.U., Werner, A., Jones, L.L., Kreutzberg, G.W., Neuroglial activation repertoire in the injured brain: Graded response, molecular mechanisms and cues to physiological function (1999) Brain Res. Rev., 30, pp. 77-105; Rayner, B.S., Duong, T.T., Myers, S.J., Witting, P.K., Protective effect of a synthetic anti-oxidant on neuronal cell apoptosis resulting from experimental hypoxia re-oxygenation injury (2006) J. Neurochem., 97, pp. 211-221; Ryan, H.E., Poloni, M., McNulty, W., Elson, D., Gassmann, M., Arbeit, J.M., Johnson, R.S., Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth (2000) Cancer Res., 60, pp. 4010-4015; Salnikow, K., Su, W., Blagosklonny, M.V., Costa, M., Carcinogenic metals induce hypoxia-inducible factor-stimulated transcription by reactive oxygen species-independent mechanism (2000) Cancer Res., 60, pp. 3375-3378; Schubert, D., Glucose metabolism and Alzheimer's disease (2005) Ageing Res. Rev., 4, pp. 240-257; Schubert, D., Chevion, M., The role of iron in beta amyloid toxicity (1995) Biochem. Biophys. Res. Commun., 216, pp. 702-707; Schubert, D., Behl, C., Lesley, R., Brack, A., Dargusch, R., Sagara, Y., Kimura, H., Amyloid peptides are toxic via a common oxidative mechanism (1995) Proc. Natl Acad. Sci. USA, 92, pp. 1989-1993; Semenza, G.L., Regulation of mammalian O 2 homeostasis by hypoxia-inducible factor 1 (1999) Ann. Rev. Cell. Dev. Biol., 15, pp. 551-578; Shalova, I.N., Cechalova, K., Rehakova, Z., Dimitrova, P., Ognibene, E., Caprioli, A., Schmalhausen, E.V., Saso, L., Decrease of dehydrogenase activity of cerebral glyceraldehyde-3-phosphate dehydrogenase in different animal models of Alzheimer's disease (2007) Biochim. Biophys. Acta., 1770, pp. 826-832; Shatrov, V.A., Sumbayev, V.V., Zhou, J., Brune, B., Oxidized low-density lipoprotein (oxLDL) triggers hypoxia-inducible factor-1alpha (HIF-1alpha) accumulation via redox-dependent mechanisms (2003) Blood, 101, pp. 4847-4849; Soucek, T., Cumming, R., Dargusch, R., Maher, P., Schubert, D., The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide (2003) Neuron, 39, pp. 43-56; Steinbach, J.H., Schubert, D., Multiple modes of dibutyryl cyclic AMP-induced process formation by clonal nerve and glial cells (1975) Exp. Cell Res., 91, pp. 449-453; Tan, S., Sagara, Y., Liu, Y., Maher, P., Schubert, D., The regulation of reactive oxygen species production during programmed cell death (1998) J. Cell. Biol., 141, pp. 1423-1432; Wang, G.L., Jiang, B.H., Rue, E.A., Semenza, G.L., Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O 2 tension (1995) Proc. Natl Acad. Sci. USA, 92, pp. 5510-5514; Wang, J.Y., Wen, L.L., Huang, Y.N., Chen, Y.T., Ku, M.C., Dual effects of antioxidants in neurodegeneration: Direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation (2006) Curr. Pharm. Des., 12, pp. 3521-3533; Worthington, C., (1947) Worthington Enzyme Manual., , Worthington Biochemical Corp. Frehold, NJ; Wyss-Coray, T., Loike, J.D., Brionne, T.C., Lu, E., Anankov, R., Yan, F., Silverstein, S.C., Husemann, J., Adult mouse astrocytes degrade amyloid-beta in vitro and in situ (2003) Nat. Med., 9, pp. 453-457; Yuan, Y., Hilliard, G., Ferguson, T., Millhorn, D.E., Cobalt inhibits the interaction between hypoxia-inducible factor-alpha and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-alpha (2003) J. Biol. Chem., 278, pp. 15911-15916; Zhang, Z., Yu, J., Stanton, R.C., A method for determination of pyridine nucleotides using a single extract (2000) Anal. Biochem., 285, pp. 163-167","Schubert, D.; Cellular Neurobiology Laboratory, Salk Institute, 10010 N. Torrey Pines Rd, San Diego, CA 92037, United States; email: schubert@salk.edu",,,,,,,,0953816X,,EJONE,19519624,"English","Eur. J. Neurosci.",Article,Scopus,2-s2.0-64049105735
"Schubert, D., Herrera, F., Cumming, R., Read, J., Low, W., Maher, P., Fischer, W.H.","Neural cells secrete a unique repertoire of proteins",2009,"Journal of Neurochemistry","109","2",,"427","435",,9,10.1111/j.1471-4159.2009.05968.x,"http://www.scopus.com/inward/record.url?eid=2-s2.0-62649150690&partnerID=40&md5=9b31a95c3e85db39e83b174b42285ae6","Salk Institute for Biological Studies, Peptide Biology Laboratory, 10010 North Torrey Pines Road, San Diego, CA 92037-1099, United States; Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; Clayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, San Diego, CA, United States","Schubert, D., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; Herrera, F., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; Cumming, R., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; Read, J., Clayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, San Diego, CA, United States; Low, W., Clayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, San Diego, CA, United States; Maher, P., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; Fischer, W.H., Salk Institute for Biological Studies, Peptide Biology Laboratory, 10010 North Torrey Pines Road, San Diego, CA 92037-1099, United States, Clayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, San Diego, CA, United States","Proteins that are released from cells consist of those in the extracellular matrix, as well as extracellular signaling and adhesion molecules. The majority of these extracellular proteins are, however, unknown. To determine their identity, we have used a proteomics approach to define proteins released from neurons, astrocytes and neural precursor cells. Using two-dimensional gels and liquid chromatography/mass spectrometry technology, it is shown that while astrocytes release a relatively small number of proteins, neurons and neuronal precursor cells release a larger number of proteins with more functional diversity. Although there is overlap between the different cell types, the exact composition of the extracellular protein pool is unique for each cell population. The various subsets of extracellular neural proteins include those involved in cellular Redox regulation and chaperones. In addition, many proteolytic enzymes are found outside of the cell. These data show that the extracellular space within the nervous system has a more diverse protein composition than previously thought. © 2009 International Society for Neurochemistry.","Astrocytes; Neuronal cells; Neurons; Proteomics; Secreted proteins","cell protein; chaperone; proteinase; animal cell; animal tissue; article; astrocyte; cell population; cell secretion; cell type; embryo; extracellular space; liquid chromatography; mass spectrometry; nerve cell; nervous system; neural stem cell; nonhuman; oxidation reduction reaction; priority journal; protein determination; protein secretion; rat; structural proteomics; two dimensional gel electrophoresis; Animals; Cell Line; Cells, Cultured; Nerve Tissue Proteins; Neurons; Proteomics; Rats; Rats, Sprague-Dawley; Stem Cells",,"proteinase, 9001-92-7; Nerve Tissue Proteins",,,,"Andoh, T., Chock, P.B., Chiueh, C.C., The roles of thioredoxin in protection against oxidative stress-induced apoptosis in SH-SY5Y cells (2002) J. Biol. Chem., 277, pp. 9655-9660; Arribas, J., Coodly, L., Vollmer, P., Kishimoto, T.K., Rose-John, S., Massague, J., Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors (1996) J. Biol. Chem., 271, pp. 11376-11382; Asea, A., Stress proteins and initiation of immune response: Chaperokine activity of hsp72 (2005) Exerc. Immunol. Rev., 11, pp. 34-45; Brewer, G.J., Isolation and culture of adult rat hippocampal neurons (1997) J. Neurosci. Methods, 71, pp. 143-155; Garrels, J.I., Two dimensional gel electrophoresis and computer analysis of proteins synthesized by clonal cell lines (1979) J. Biol. Chem., 254, pp. 7961-7977; Hanneken, A., Maher, P.A., Baird, A., High affinity immunoreactive FGF receptors in the extracellular matrix of vascular endothelial cells - Implications for the modulation of FGF-2 (1995) J. Cell Biol., 128, pp. 1221-1228; Hori, K., Katayama, M., Sato, N., Ishii, K., Waga, S., Yodoi, J., Neuroprotection by glial cells through adult T cell leukemia-derived factor/human thioredoxin (ADF/TRX) (1994) Brain Res., 652, pp. 304-310; Inomata, Y., Nakamura, H., Tanito, M., Teratani, A., Kawaji, T., Kondo, N., Yodoi, J., Tanihara, H., Thioredoxin inhibits NMDA-induced neurotoxicity in the rat retina (2006) J. Neurochem., 98, pp. 372-385; Jakob, C., Egerer, K., Liebisch, P., Circulating proteasome levels are an independent prognostic factor for survival in multiple myeloma (2007) Blood, 109, pp. 2100-2105; Kim, S., Ock, J., Kim, A.K., Lee, H.W., Cho, J.Y., Kim, D.R., Park, J.Y., Suk, K., Neurotoxicity of microglial cathepsin D revealed by secretome analysis (2007) J. Neurochem. Oct., 22 (103), pp. 2640-2650; Lafon-Cazal, M., Adjali, O., Galeotti, N., Poncet, J., Jouin, P., Homburger, V., Bockaert, J., Marin, P., Proteomic analysis of astrocytic secretion in the mouse (2003) J. Biol. Chem., 278, pp. 24438-24448; Lavabre-Bertrand, T., Henry, L., Guiraud, I., Carillo, S., Bureau, J.P., The proteasome and malignant hemopathies (2000) Morphologie, 84, pp. 39-43; Liu, Y., Piasecki, D., A cell-based method for the detection of nanomolar concentrations of bioactive amyloid (2001) Anal. Biochem., 289, pp. 130-136; Massague, J., Pandiella, A., Membrane-anchored growth factors (1993) Annu. Rev. Biochem., 62, pp. 515-541; Mizejewski, G.J., The phylogeny of alpha-fetoprotein in vertebrates: Survey of biochemical and physiological data (1995) Crit. Rev. Eukaryot. Gene Expr., 5, pp. 281-316; Mor-Vaknin, N., Punturieri, A., Sitwala, K., Markovitz, D.M., Vimentin is secreted by activated macrophages (2003) Nat. Cell Biol., 5, pp. 59-63; Nakamura, H., Extracellular functions of thioredoxin (2008) Novartis Found. Symp., 291, pp. 184-192. , discussion 192-195, 221-224; Pappin, D.J., Hojrup, P., Bleasby, A.J., Rapid identification of proteins by peptide-mass fingerprinting (1993) Curr. Biol., 3, pp. 327-332; Perkins, D.N., Pappin, D.J., Creasy, D.M., Cottrell, J.S., Probability-based protein identification by searching sequence databases using mass spectrometry data (1999) Electrophoresis, 20, pp. 3551-3567; Plaisant, F., Clippe, A., Vander Stricht, D., Knoops, B., Gressens, P., Recombinant peroxiredoxin 5 protects against excitotoxic brain lesions in newborn mice (2003) Free Radic. Biol. Med., 34, pp. 862-872; Ray, J., Peterson, D.A., Schinstine, M., Gage, F.H., Proliferation, differentiation, and long-term culture of primary hippocampal neurons (1993) Proc. Natl Acad. Sci. USA, 90, pp. 3602-3606; Reizes, O., Goldberger, O., Smith, A.C., Xu, Z., Bernfield, M., Bickel, P.E., Insulin promotes shedding of syndecan ectodomains from 3T3-L1 adipocytes: A proposed mechanism for stabilization of extracellular lipoprotein lipase (2006) Biochemistry, 45, pp. 5703-5711; Rose-John, S., Heinrich, P.C., Soluble receptors for cytokines and growth factors: Generation and biological function (1994) Biochem. J., 300, pp. 281-290; Schubert, D., Protein secretion by clonal glial and neuronal cell lines (1973) Brain Res., 56, pp. 387-391; Schubert, D., Induced differentiation of clonal rat nerve and glia cells (1974) Neurobiology, 4, pp. 376-387; Schubert, D., Heinemann, S., Carlisle, W., Tarikas, H., Kimes, B., Steinbach, J.H., Culp, W., Brandt, B.L., Clonal cell lines from the rat central nervous system (1974) Nature, 249, pp. 224-227; Schubert, D., Brass, B., Dumas, J.P., Protein complexity of central nervous system cell lines (1986) J. Neurosci., 6, pp. 2829-2836; Schubert, D., Schroeder, R., Lacorbiere, M., Saitoh, T., Cole, G., Amyloid beta protein precursor is possibly a heparan sulfate proteoglycan core protein (1988) Science, 241, pp. 223-226; Shevchenko, A., Wilm, M., Vorm, O., Mann, M., Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels (1996) Anal. Chem., 68, pp. 850-858; Stallcup, W.B., Cohn, M., Correlation of surface antigens and cell type in cloned cell lines from the rat central nervous system (1976) Exp. Cell Res., 98, pp. 285-297; Stallcup, W.B., Cohn, M., Electrical properties of a clonal cell line as determined by measurement of ion fluxes (1976) Exp. Cell Res., 98, pp. 277-284; Stoebner, P.E., Lavabre-Bertrand, T., Henry, L., Guiraud, I., Carillo, S., Dandurand, M., Joujoux, J.M., Meunier, L., High plasma proteasome levels are detected in patients with metastatic malignant melanoma (2005) Br. J. Dermatol., 152, pp. 948-953; Sun, P.D., Davies, D.R., The cystine-knot growth-factor superfamily (1995) Annu. Rev. Biophys. Biomol. Struct., 24, pp. 269-291; Taupin, P., Ray, J., Fischer, W.H., Suhr, S.T., Hakansson, K., Grubb, A., Gage, F.H., FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor (2000) Neuron, 28, pp. 385-397; Tomimoto, H., Akiguchi, I., Wakita, H., Kimura, J., Hori, K., Yodoi, J., Astroglial expression of ATL-derived factor, a human thioredoxin homologue, in the gerbil brain after transient global ischemia (1993) Brain Res., 625, pp. 1-8; Truding, R., Shelanski, M.L., Morell, P., Glycoproteins released into the culture medium of differentiating murine neuroblastoma cells (1975) J. Biol. Chem., 250, pp. 9348-9354; Tytell, M., Release of heat shock proteins (Hsps) and the effects of extracellular Hsps on neural cells and tissues (2005) Int. J. Hyperthermia, 21, pp. 445-455; Yaffe, D., Retention of differentiation potentialities during prolonged cultivation of myogenic cells (1968) Proc. Natl Acad. Sci. USA, 61, pp. 477-483","Fischer, W. H.; Salk Institute for Biological Studies, Peptide Biology Laboratory, 10010 North Torrey Pines Road, San Diego, CA 92037-1099, United States; email: fischer@salk.edu",,,,,,,,00223042,,JONRA,19200335,"English","J. Neurochem.",Article,Scopus,2-s2.0-62649150690
"Herrera, F., Chen, Q., Fischer, W.H., Maher, P., Schubert, D.R.","Synaptojanin-1 plays a key role in astrogliogenesis: Possible relevance for Down's syndrome",2009,"Cell Death and Differentiation","16","6",,"910","920",,16,10.1038/cdd.2009.24,"http://www.scopus.com/inward/record.url?eid=2-s2.0-67349177778&partnerID=40&md5=74d5e1b824b1a63fa4e369457150963b","Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, United States; Peptide Biology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, United States","Herrera, F., Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, United States; Chen, Q., Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, United States; Fischer, W.H., Peptide Biology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, United States; Maher, P., Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, United States; Schubert, D.R., Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, United States","There is increasing interest in gliogenesis as the relevance of glia to both brain development and pathology becomes better understood. However, little is known about this process. The use of multidimensional protein identification technology (MudPIT) to identify changes in phosphoprotein levels in rat neural precursor cells treated with cytokines or retinoic acid showed that phosphorylation of the catalytic subunit of phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K p110α) and dephosphorylation of the inositol phosphatase synaptojanin-1 were common to the gliogenic stimuli. Although PI3K was found to be involved in both neuro- and astrogliogenesis, synaptojanin-1 was specifically involved in astrogliogenesis of neural precursor cells. The role of synaptojanin-1 in astrogliogenesis was further confirmed by analysis of neuron- and glia-specific markers in synaptojanin-1 knockout mouse brain. Additional experiments showed that the Sac1-like phosphatase domain of synaptojanin-1 is responsible for the observed astrogliogenic effect. Our results strongly indicate that phosphatidylinositol metabolism plays a key role in astrogliogenesis. The relevance of our findings for Down's syndrome pathology is discussed.",,"cytokine; phosphatidylinositol 4,5 bisphosphate phosphodiesterase; phosphoprotein; retinoic acid; synaptojanin; synaptojanin 1; unclassified drug; animal cell; animal experiment; animal tissue; article; controlled study; Down syndrome; enzyme activity; enzyme specificity; human; human cell; mouse; nerve cell differentiation; nervous system development; nonhuman; priority journal; protein analysis; protein determination; protein function; protein metabolism; protein phosphorylation; protein targeting; rat; stimulus response; 1-Phosphatidylinositol 3-Kinase; Animals; Astrocytes; Brain; Cell Differentiation; Cell Line; Cytokines; Down Syndrome; Mice; Mice, Knockout; Nerve Tissue Proteins; Phosphatidylinositols; Phosphoric Monoester Hydrolases; Phosphorylation; Rats; Stem Cells; Tretinoin; Rattus",,"phosphatidylinositol 4,5 bisphosphate phosphodiesterase, 37213-51-7, 63551-76-8; retinoic acid, 302-79-4; synaptojanin, 119699-77-3; 1-Phosphatidylinositol 3-Kinase, 2.7.1.137; Cytokines; Nerve Tissue Proteins; Phosphatidylinositols; Phosphoric Monoester Hydrolases, 3.1.3.-; Tretinoin, 302-79-4; synaptojanin, 3.1.3.-",,,,"Croisier, E., Graeber, M.B., Glial degeneration and reactive gliosis in alpha-synucleinopathies: The emerging concept of primary gliodegeneration (2006) Acta Neuropathol (Berl), 112, pp. 517-530; Qian, X., Shen, Q., Goderie, S.K., He, W., Capela, A., Davis, A.A., Timing of CNS cell generation: A programmed sequence of neuron and glial cell production from isolated murine cortical stem cells (2000) Neuron, 28, pp. 69-80; Barnabe-Heider, F., Wasylnka, J.A., Fernandes, K.J., Porsche, C., Sendtner, M., Kaplan, D.R., Evidence that embryonic neurons regulate the onset of cortical gliogenesis via cardiotrophin-1 (2005) Neuron, 48, pp. 253-265; Bonni, A., Sun, Y., Nadal-Vicens, M., Bhatt, A., Frank, D.A., Rozovsky, I., Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway (1997) Science, 278, pp. 477-483; Nakashima, K., Yanagisawa, M., Arakawa, H., Kimura, N., Hisatsune, T., Kawabata, M., Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300 (1999) Science, 284, pp. 479-482; Hermanson, O., Jepsen, K., Rosenfeld, M.G., N-CoR controls differentiation of neural stem cells into astrocytes (2002) Nature, 419, pp. 934-939; Rajan, P., McKay, R.D., Multiple routes to astrocytic differentiation in the CNS (1998) J Neurosci, 18, pp. 3620-3629; Rajan, P., Panchision, D.M., Newell, L.F., McKay, R.D., BMPs signal alternately through a SMAD or FRAP-STAT pathway to regulate fate choice in CNS stem cells (2003) J Cell Biol, 161, pp. 911-921; Goncalves, M.B., Boyle, J., Webber, D.J., Hall, S., Minger, S.L., Corcoran, J.P., Timing of the retinoid-signalling pathway determines the expression of neuronal markers in neural progenitor cells (2005) Dev Biol, 278, pp. 60-70; Wohl, C.A., Weiss, S., Retinoic acid enhances neuronal proliferation and astroglial differentiation in cultures of CNS stem cell-derived precursors (1998) J Neurobiol, 37, pp. 281-290; Chambers, C.B., Peng, Y., Nguyen, H., Gaiano, N., Fishell, G., Nye, J.S., Spatiotemporal selectivity of response to Notch1 signals in mammalian forebrain precursors (2001) Development, 128, pp. 689-702; Taylor, M.K., Yeager, K., Morrison, S.J., Physiological Notch signaling promotes gliogenesis in the developing peripheral and central nervous systems (2007) Development, 134, pp. 2435-2447; Bastien, J., Plassat, J.L., Payrastre, B., Rochette-Egly, C., The phosphoinositide 3-kinase/Akt pathway is essential for the retinoic acid-induced differentiation of F9 cells (2006) Oncogene, 25, pp. 2040-2047; Lopez-Carballo, G., Moreno, L., Masia, S., Perez, P., Barettino, D., Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway by retinoic acid is required for neural differentiation of SH-SY5Y human neuroblastoma cells (2002) J Biol Chem, 277, pp. 25297-25304; Cremona, O., Di, P.G., Wenk, M.R., Luthi, A., Kim, W.T., Takei, K., Essential role of phosphoinositide metabolism in synaptic vesicle recycling (1999) Cell, 99, pp. 179-188; Ray, J., Gage, F.H., Differential properties of adult rat and mouse brain-derived neural stem/progenitor cells (2006) Mol Cell Neurosci, 31, pp. 560-573; Schubert, D., Klar, A., Park, M., Dargusch, R., Fischer, W.H., F-spondin promotes nerve precursor differentiation (2006) J Neurochem, 96, pp. 444-453; MacCoss, M.J., McDonald, W.H., Saraf, A., Sadygov, R., Clark, J.M., Tasto, J.J., Shotgun identification of protein modifications from protein complexes and lens tissue (2002) Proc Natl Acad Sci USA, 99, pp. 7900-7905; Licklider, L.J., Thoreen, C.C., Peng, J., Gygi, S.P., Automation of nanoscale microcapillary liquid chromatography-tandem mass spectrometry with a vented column (2002) Anal Chem, 74, pp. 3076-3083; Florens, L., Washburn, M.P., Raine, J.D., Anthony, R.M., Grainger, M., Haynes, J.D., A proteomic view of the Plasmodium falciparum life cycle (2002) Nature, 419, pp. 520-526; Irie, F., Okuno, M., Pasquale, E.B., Yamaguchi, Y., EphrinB-EphB signalling regulates clathrin-mediated endocytosis through tyrosine phosphorylation of synaptojanin 1 (2005) Nat Cell Biol, 7, pp. 501-509; Arai, Y., Ijuin, T., Takenawa, T., Becker, L.E., Takashima, S., Excessive expression of synaptojanin in brains with Down syndrome (2002) Brain Dev, 24, pp. 67-72; Mito, T., Becker, L.E., Developmental changes of S-100 protein and glial fibrillary acidic protein in the brain in Down syndrome (1993) Exp Neurol, 120, pp. 170-176; Antonarakis, S.E., Lyle, R., Dermitzakis, E.T., Reymond, A., Deutsch, S., Chromosome 21 and down syndrome: From genomics to pathophysiology (2004) Nat Rev Genet, 5, pp. 725-738; Guo, S., Stolz, L.E., Lemrow, S.M., York, J.D., SAC1-like domains of yeast SAC1, INP52, and INP53 and of human synaptojanin encode polyphosphoinositide phosphatases (1999) J Biol Chem, 274, pp. 12990-12995; Mani, M., Lee, S.Y., Lucast, L., Cremona, O., Di PG, D.C., The dual phosphatase activity of synaptojanin1 is required for both efficient synaptic vesicle endocytosis and reavailability at nerve terminals (2007) Neuron, 56, pp. 1004-1018; Woscholski, R., Finan, P.M., Radley, E., Totty, N.F., Sterling, A.E., Hsuan, J.J., Synaptojanin is the major constitutively active phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase in rodent brain (1997) J Biol Chem, 272, pp. 9625-9628; Voronov, S.V., Frere, S.G., Giovedi, S., Pollina, E.A., Borel, C., Zhang, H., Synaptojanin 1-linked phosphoinositide dyshomeostasis and cognitive deficits in mouse models of Down's syndrome (2008) Proc Natl Acad Sci USA, 105, pp. 9415-9420; Li, L., Liu, F., Ross, A.H., PTEN regulation of neural development and CNS stem cells (2003) J Cell Biochem, 88, pp. 24-28; Carricaburu, V., Lamia, K.A., Lo, E., Favereaux, L., Payrastre, B., Cantley, L.C., The phosphatidylinositol (PI)-5-phosphate 4-kinase type II enzyme controls insulin signaling by regulating PI-3,4,5-trisphosphate degradation (2003) Proc Natl Acad Sci USA, 100, pp. 9867-9872; Vives, V., Alonso, G., Solal, A.C., Joubert, D., Legraverend, C., Visualization of S100B-positive neurons and glia in the central nervous system of EGFP transgenic mice (2003) J Comp Neurol, 457, pp. 404-419; Steiner, J., Bernstein, H.G., Bielau, H., Berndt, A., Brisch, R., Mawrin, C., Evidence for a wide extra-astrocytic distribution of S100B in human brain (2007) BMC Neurosci, 8, p. 2; Mendis, D.B., Brown, I.R., Expression of the gene encoding the extracellular matrix glycoprotein SPARC in the developing and adult mouse brain (1994) Brain Res Mol Brain Res, 24, pp. 11-19; Plachez, C., Martin, A., Guiramand, J., Recasens, M., Astrocytes repress the neuronal expression of GLAST and GLT glutamate transporters in cultured hippocampal neurons from embryonic rats (2004) Neurochem Int, 45, pp. 1113-1123; Plachez, C., Danbolt, N.C., Recasens, M., Transient expression of the glial glutamate transporters GLAST and GLT in hippocampal neurons in primary culture (2000) J Neurosci Res, 59, pp. 587-593; Rampon, C., Weiss, N., Deboux, C., Chaverot, N., Miller, F., Buchet, D., Molecular mechanism of systemic delivery of neural precursor cells to the brain: Assembly of brain endothelial apical cups and control of transmigration by CD44 (2008) Stem Cells, 26, pp. 1673-1682; Seri, B., Garcia-Verdugo, J.M., McEwen, B.S., varez-Buylla, A., Astrocytes give rise to new neurons in the adult mammalian hippocampus (2001) J Neurosci, 21, pp. 7153-7160; Holtzman, D.M., Santucci, D., Kilbridge, J., Chua-Couzens, J., Fontana, D.J., Daniels, S.E., Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome (1996) Proc Natl Acad Sci USA, 93, pp. 13333-13338; Kornyei, Z., Gocza, E., Ruhl, R., Orsolits, B., Voros, E., Szabo, B., Astroglia-derived retinoic acid is a key factor in glia-induced neurogenesis (2007) FASEB J, 21, pp. 2496-2509; Quinlan, R.A., Brenner, M., Goldman, J.E., Messing, A., GFAP and its role in Alexander disease (2007) Exp Cell Res, 313, pp. 2077-2087","Schubert, D.R.; Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA, United States",,,,,,,,13509047,,CDDIE,19282871,"English","Cell Death Differ.",Article,Scopus,2-s2.0-67349177778
"Chen, Q., Peto, C.A., Shelton, G.D., Mizisin, A., Sawchenko, P.E., Schubert, D.","Loss of modifier of cell adhesion reveals a pathway leading to axonal degeneration",2009,"Journal of Neuroscience","29","1",,"118","130",,31,10.1523/JNEUROSCI.3985-08.2009,"http://www.scopus.com/inward/record.url?eid=2-s2.0-58149389013&partnerID=40&md5=b6030b0a8f51323c55d8b74810c4ca19","Cellular Neurobiology Laboratory; Neuronal Structure and Function Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037, United States; Department of Pathology, University of California, San Diego, San Diego, CA 92093, United States; Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States","Chen, Q., Cellular Neurobiology Laboratory; Peto, C.A., Neuronal Structure and Function Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037, United States; Shelton, G.D., Department of Pathology, University of California, San Diego, San Diego, CA 92093, United States; Mizisin, A., Department of Pathology, University of California, San Diego, San Diego, CA 92093, United States; Sawchenko, P.E., Neuronal Structure and Function Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037, United States; Schubert, D., Cellular Neurobiology Laboratory, Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States","Axonal dysfunction is the major phenotypic change in many neurodegenerative diseases, but the processes underlying this impairment are not clear. Modifier of cell adhesion (MOCA) is a presenilin binding protein that functions as a guanine nucleotide exchange factor for Rac1. The loss of MOCA in mice leads to axonal degeneration and causes sensorimotor impairments by decreasing cofilin phosphorylation and altering its upstream signaling partners LIM kinase and p21-activated kinase, an enzyme directly downstream of Rac1. The dystrophic axons found in MOCA-deficient mice are associated with abnormal aggregates of neurofilament protein, the disorganization of the axonal cytoskeleton, and the accumulation of autophagic vacuoles and polyubiquitinated proteins. Furthermore, MOCA deficiency causes an alteration in the actin cytoskeleton and the formation of cofilin-containing rod-like structures. The dystrophic axons show functional abnormalities, including impaired axonal transport. These findings demonstrate that MOCA is required for maintaining the functional integrity of axons and define a model for the steps leading to axonal degeneration. Copyright © 2009 Society for Neuroscience.","Axonal degeneration; DOCK180; Guanine nucleotide exchange factor; MOCA; Neurodegeneration; Sensorimotor defects","actin; binding protein; cofilin; LIM kinase; neurofilament protein; p21 activated kinase; presenilin; protein modifier of cell adhesion; Rac1 protein; unclassified drug; animal experiment; animal tissue; article; cell adhesion; cell vacuole; controlled study; dorsal root; mouse; nerve fiber degeneration; nonhuman; priority journal; protein phosphorylation; sciatic nerve; spinal cord; ubiquitination; ventral root; Actin Depolymerizing Factors; Analysis of Variance; Animals; Axonal Transport; Axons; Carrier Proteins; Cells, Cultured; Cerebral Cortex; Cytoskeleton; Gait Disorders, Neurologic; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Electron, Transmission; Motor Activity; Nerve Degeneration; Nerve Tissue Proteins; Neurofilament Proteins; Neurons; Sciatic Neuropathy; Signal Transduction; Spinal Cord; Stilbamidines; Ubiquitin C",,"2-hydroxy-4,4'-diamidinostilbene, methanesulfonate salt; Actin Depolymerizing Factors; Carrier Proteins; Dock3 protein, mouse; Nerve Tissue Proteins; Neurofilament Proteins; Stilbamidines; Ubiquitin C; neurofilament protein NF 68",,,,"Arber, S., Barbayannis, F.A., Hanser, H., Schneider, C., Stanyon, C.A., Bernard, O., Caroni, P., Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase (1998) Nature, 393, pp. 805-809; Bray, J.J., Fernyhough, P., Bamburg, J.R., Bray, D., Actin depolymerizing factor is a component of slow axonal transport (1992) J Neurochem, 58, pp. 2081-2087; Brown, D.A., Sawchenko, P.E., Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis (2007) J Comp Neurol, 502, pp. 236-260; Cai, D., Leem, J.Y., Greenfield, J.P., Wang, P., Kim, B.S., Wang, R., Lopes, K.O., Xu, H., Presenilin-1 regulates intracellular trafficking and cell surface delivery of β-amyloid precursor protein (2003) J Biol Chem, 278, pp. 3446-3454; Chen, Q., Yoshida, H., Schubert, D., Maher, P., Mallory, M., Masliah, E., Presenilin binding protein is associated with neurofibrillary alterations in Alzheimer's disease and stimulates tau phosphorylation (2001) Am J Pathol, 159, pp. 1597-1602; Chen, Q., Kimura, H., Schubert, D., A novel mechanism for the regulation of amyloid precursor protein metabolism (2002) J Cell Biol, 158, pp. 79-89; Chen, Q., Chen, T.J., Letourneau, P.C., LdaF, C., Schubert, D., Modifier of cell adhesion regulates N-cadherin-mediated cell-cell adhesion and neurite outgrowth (2005) J Neurosci, 25, pp. 281-290; Chevalier-Larsen, E., Holzbaur, E.L., Axonal transport and neurodegenerative disease (2006) Biochim Biophys Acta, 1762, pp. 1094-1108; Coleman, M., Axon degeneration mechanisms: Commonality amid diversity (2005) Nat Rev Neurosci, 6, pp. 889-898; Côté, J.F., Vuori, K., Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity (2002) J Cell Sci, 115, pp. 4901-4913; de Silva, M.G., Elliott, K., Dahl, H.H., Fitzpatrick, E., Wilcox, S., Delatycki, M., Williamson, R., Forrest, S., Disruption of a novel member of a sodium/hydrogen exchanger family and DOCK3 is associated with an attention deficit hyperactivity disorder-like phenotype (2003) J Med Genet, 40, pp. 733-740; Duncan, J.E., Goldstein, L.S., The genetics of axonal transport and axonal transport disorders (2006) PLoS Genet, 2, pp. e124; Edwards, D.C., Sanders, L.C., Bokoch, G.M., Gill, G.N., Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics (1999) Nat Cell Biol, 1, pp. 253-259; Ehlers, M.D., Deconstructing the axon: Wallerian degeneration and the ubiquitin-proteasome system (2004) Trends Neurosci, 27, pp. 3-6; Gandy, S., Zhang, Y.W., Ikin, A., Schmidt, S.D., Bogush, A., Levy, E., Sheffield, R., Ehrlich, M.E., Alzheimer's presenilin 1 modulates sorting of APP and its carboxyl-terminal fragments in cerebral neurons in vivo (2007) J Neurochem, 102, pp. 619-626; Glaumann, H., Ericsson, J.L., Marzella, L., Mechanisms of intralysosomal degradation with special reference to autophagocytosis and heterophagocytosis of cell organelles (1981) Int Rev Cytol, 73, pp. 149-182; Gohla, A., Bokoch, G.M., 14-3-3 regulates actin dynamics by stabilizing phosphorylated cofilin (2002) Curr Biol, 12, pp. 1704-1710; Grimsley, C.M., Kinchen, J.M., Tosello-Trampont, A.C., Brugnera, E., Haney, L.B., Lu, M., Chen, Q., Ravichandran, K.S., Dock180 and ELMO1 proteins cooperate to promote evolutionarily conserved Rac-dependent cell migration (2004) J Biol Chem, 279, pp. 6087-6097; Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mizushima, N., Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice (2006) Nature, 441, pp. 885-889; Herrera, F., Martin, V., Carrera, P., García-Santos, G., Rodriguez-Blanco, J., Rodriguez, C., Antolin, I., Tryptamine induces cell death with ultrastructural features of autophagy in neurons and glia: Possible relevance for neurodegenerative disorders. Anat Rec A Discov Mol Cell (2006) Evol Biol, 288 A, pp. 1026-1030; Hirokawa, N., Glicksman, M.A., Willard, M.B., Organization of mammalian neurofilament polypeptides within the neuronal cytoskeleton (1984) J Cell Biol, 98, pp. 1523-1536; Hoffman, P.N., Lasek, R.J., The slow component of axonal transport: Identification of major structural polypeptides of the axon and their generality among mammalian neurons (1975) J Cell Biol, 66, pp. 351-366; Hollenbeck, P.J., Products of endocytosis and autophagy are retrieved from axons by regulated retrograde organelle transport (1993) J Cell Biol, 121, pp. 306-315; Ito, D., Imai, Y., Ohsawa, K., Nakajima, K., Fukuuchi, Y., Kohsaka, S., Microglia-specific localisation of a novel calcium binding protein, Iba1 (1998) Mol Brain Res, 57, pp. 1-9; Jung, C., Chylinski, T.M., Pimenta, A., Ortiz, D., Shea, T.B., Neurofilament transport is dependent on actin and myosin (2004) J Neurosci, 24, pp. 9486-9496; Kamal, A., Stokin, G.B., Yang, Z., Xia, C.H., Goldstein, L.S., Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I (2000) Neuron, 28, pp. 449-459; Kashiwa, A., Yoshida, H., Lee, S., Paladino, T., Liu, Y., Chen, Q., Dargusch, R., Kimura, H., Isolation and characterization of novel presenilin binding protein (2000) J Neurochem, 75, pp. 109-116; Kim, S.H., Lah, J.J., Thinakaran, G., Levey, A., Sisodia, S.S., Subcellular localization of presenilins: Association with a unique membrane pool in cultured cells (2000) Neurobiol Dis, 7, pp. 99-117; Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J., Tanida, I., Ueno, T., Tanaka, K., Loss of autophagy in the central nervous system causes neurodegeneration in mice (2006) Nature, 441, pp. 880-884; Koo, E.H., Sisodia, S.S., Archer, D.R., Martin, L.J., Weidemann, A., Beyreuther, K., Fischer, P., Price, D.L., Precursor of amyloid protein in Alzheimer disease undergoes fast anterograde axonal transport (1990) Proc Natl Acad Sci U S A, 87, pp. 1561-1565; Lah, J.J., Levey, A.I., Endogenous presenilin-1 targets to endocytic rather than biosynthetic compartments (2000) Mol Cell Neurosci, 16, pp. 111-126; LaMonte, B.H., Wallace, K.E., Holloway, B.A., Shelly, S.S., Ascaño, J., Tokito, M., Van Winkle, T., Holzbaur, E.L.F., Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration (2002) Neuron, 34, pp. 715-727; Lazarov, O., Morfini, G.A., Lee, E.B., Farah, M.H., Szodorai, A., DeBoer, S.R., Koliatsos, V.E., Sisodia, S.S., Axonal transport, amyloid precursor protein, kinesin-1, and the processing apparatus: Revisited (2005) J Neurosci, 25, pp. 2386-2395; Lazarov, O., Morfini, G.A., Pigino, G., Gadadhar, A., Chen, X., Robinson, J., Ho, H., Sisodia, S.S., Impairments in fast axonal transport and motor neuron deficits in transgenic mice expressing familial Alzheimer's disease-linked mutant presenilin 1 (2007) J Neurosci, 27, pp. 7011-7020; Lee, M.K., Cleveland, D.W., Neuronal intermediate filaments (1996) Annu Rev Neurosci, 19, pp. 187-217; Leem, J.Y., Vijayan, S., Han, P., Cai, D., Machura, M., Lopes, K.O., Veselits, M., Thinakaran, G., Presenilin 1 is required for maturation and cell surface accumulation of nicastrin (2002) J Biol Chem, 277, pp. 19236-19240; Maloney, M.T., Bamburg, J.R., Cofilin-mediated neurodegeneration in Alzheimer's disease and other amyloidopathies (2007) Mol Neurobiol, 35, pp. 21-44; Masliah, E., Crews, L., Hansen, L., Synaptic remodeling during aging and in Alzheimer's disease (2006) J Alzheimers Dis, 9 (SUPPL. 3), pp. 91-99; Meberg, P.J., Bamburg, J.R., Increase in neurite outgrowth mediated by overexpression of actin depolymerizing factor (2000) J Neurosci, 20, pp. 2459-2469; Medana, I.M., Esiri, M.M., Axonal damage: A key predictor of outcome in human CNS diseases (2003) Brain, 126, pp. 515-530; Medori, R., Jenich, H., Autilio-Gambetti, L., Gambetti, P., Experimental diabetic neuropathy: Similar changes of slow axonal transport and axonal size in different animal models (1988) J Neurosci, 8, pp. 1814-1821; Meller, N., Merlot, S., Guda, C., CZH proteins: A new family of Rho-GEFs (2005) J Cell Sci, 118, pp. 4937-4946; Minamide, L.S., Striegl, A.M., Boyle, J.A., Meberg, P.J., Bamburg, J.R., Neurodegenerative stimuli induce persistent ADF/cofilin-actin rods that disrupt distal neurite function (2000) Nat Cell Biol, 2, pp. 628-636; Mizisin, A.P., Bache, M., DiStefano, P.S., Acheson, A., Lindsay, R.M., Calcutt, N.A., BDNF attenuates functional and structural disorders in nerves of galactose-fed rats (1997) J Neuropathol Exp Neurol, 56, pp. 1290-1301; Namekata, K., Enokido, Y., Iwasawa, K., Kimura, H., MOCA induces membrane spreading by activating Rac1 (2004) J Biol Chem, 279, pp. 14331-14337; Naruse, S., Thinakaran, G., Luo, J.J., Kusiak, J.W., Tomita, T., Iwatsubo, T., Qian, X., Sisodia, S.S., Effects of PS1 deficiency on membrane protein trafficking in neurons (1998) Neuron, 21, pp. 1213-1221; Nixon, R.A., Autophagy in neurodegenerative disease: Friend, foe or turncoat? (2006) Trends Neurosci, 29, pp. 528-535; Ono, S., Regulation of actin filament dynamics by actin depolymerizing factor/cofilin and actin-interacting protein 1: New blades for twisted filaments (2003) Biochemistry, 42, pp. 13363-13370; Pasinelli, P., Brown, R.H., Molecular biology of amyotrophic lateral sclerosis: Insights from genetics (2006) Nat Rev Neurosci, 7, pp. 710-723; Petzold, A., Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss (2005) J Neurol Sci, 233, pp. 183-198; Pigino, G., Morfini, G., Pelsman, A., Mattson, M.P., Brady, S.T., Busciglio, J., Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport (2003) J Neurosci, 23, pp. 4499-4508; Ridley, A.J., Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking (2006) Trends Cell Biol, 16, pp. 522-529; Rubinsztein, D.C., The roles of intracellular protein-degradation pathways in neurodegeneration (2006) Nature, 443, pp. 780-786; Sarmiere, P.D., Bamburg, J.R., Regulation of the neuronal actin cytoskeleton by ADF/cofilin (2004) J Neurobiol, 58, pp. 103-117; Schmued, L.C., Stowers, C.C., Scallet, A.C., Xu, L., Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons (2005) Brain Res, 1035, pp. 24-31; Shintani, T., Klionsky, D.J., Autophagy in health and disease: A double-edged sword (2004) Science, 306, pp. 990-995; Simonsen, A., Cumming, R.C., Finley, K.D., Linking lysosomal trafficking defects with changes in aging and stress response in Drosophila (2007) Autophagy, 3, pp. 499-501; Stokin, G.B., Lillo, C., Falzone, T.L., Brusch, R.G., Rockenstein, E., Mount, S.L., Raman, R., Goldstein, L.S., Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease (2005) Science, 307, pp. 1282-1288; Wirths, O., Weis, J., Kayed, R., Saido, T.C., Bayer, T.A., Age-dependent axonal degeneration in an Alzheimer mouse model (2007) Neurobiol Aging, 28, pp. 1689-1699; Yang, Y.C., Bauer, C., Strasser, G., Wollman, R., Julien, J.P., Fuchs, E., Integrators of the cytoskeleton that stabilize microtubules (1999) Cell, 98, pp. 229-238; Yu, W.H., Cuervo, A.M., Kumar, A., Peterhoff, C.M., Schmidt, S.D., Lee, J.H., Mohan, P.S., Nixon, R.A., Macroautophagy-a novel Beta-amyloid peptide-generating pathway activated in Alzheimer's disease (2005) J Cell Biol, 171, pp. 87-98","Schubert, D.; Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; email: schubert@salk.edu",,,,,,,,02706474,,JNRSD,19129390,"English","J. Neurosci.",Article,Scopus,2-s2.0-58149389013
"Schubert, D.R.","The problem with nutritionally enhanced plants",2008,"Journal of Medicinal Food","11","4",,"601","605",,9,10.1089/jmf.2008.0094,"http://www.scopus.com/inward/record.url?eid=2-s2.0-57349182776&partnerID=40&md5=3150eec2a96d20d97579b4bee6c7fb3d","Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037-1099, United States","Schubert, D.R., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States, Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037-1099, United States","Among the next generation of genetically modified (GM) plants are those that are engineered to produce elevated levels of nutritional molecules such as vitamins, omega-3 fatty acids, and amino acids. Based upon the U.S. current regulatory scheme, the plants and their products may enter our food supply without any required safety testing. The potential risks of this type of GM plant are discussed in the context of human health, and it is argued that there should be very careful safety testing of plants designed to produce biologically active molecules before they are commercially grown and consumed. This will require a mandatory, scientifically rigorous review process. © 2008 Mary Ann Liebert, Inc.","Bioactive compounds; Cancer; Diet; Natural food; Nutrigenomics; Nutrition","alpha tocopherol; amino acid; beta carotene; glucose; lycopene; omega 3 fatty acid; retinoid; tryptophan; vitamin; amino acid metabolism; bioengineering; biological activity; carbohydrate metabolism; corn; depression; diet supplementation; DNA modification; eosinophilia myalgia syndrome; fermentation; food safety; glucose metabolism; health care policy; insomnia; maize; nervous system development; nutritional science; plant; priority journal; review; rheumatoid arthritis; rice; United States; vision; wine; yeast; Antioxidants; beta Carotene; Consumer Product Safety; Crops, Agricultural; Dietary Supplements; Food Supply; Food, Genetically Modified; Humans; Organisms, Genetically Modified; Oryza sativa; Plants, Genetically Modified; Transfection; Tryptophan; United States; United States Food and Drug Administration; Yeasts",,"alpha tocopherol, 1406-18-4, 1406-70-8, 52225-20-4, 58-95-7, 59-02-9; amino acid, 65072-01-7; beta carotene, 7235-40-7; glucose, 50-99-7, 84778-64-3; lycopene, 502-65-8; tryptophan, 6912-86-3, 73-22-3; Antioxidants; beta Carotene, 7235-40-7; Tryptophan, 73-22-3",,,,"Ye, X., Al-Babili, S., Kloti, A., Engineering the provitamin A (beta-carotene) biosynthetic pathway into (carotenoid-free) rice endosperm (2000) Science, 287, pp. 303-305; Cahoon, E.B., Hall, S.E., Ripp, K.G., Metabolic redesign of vitamin E biosynthesis in plants for tocotrienol production and increased antioxidant content (2003) Nat Biotechnol, 21, pp. 1082-1087; Van Eenennaam, A.L., Lincoln, K., Durrett, T.P., Engineering vitamin E content: From Arabidopsis mutant to soy oil (2003) Plant Cell, 15, pp. 3007-3019; Kinney, A.J., Metabolic engineering in plants for human health and nutrition (2006) Curr Opin Biotechnol, 17, pp. 130-138; Schubert, D., A different perspective on GM food (2002) Nat Biotechnol, 20, p. 969; Prescott, V.E., Campbell, P.M., Moore, A., Transgenic expression of bean alpha-amylase inhibitor in peas results in altered structure and immunogenicity (2005) J Agric Food Chem, 53, pp. 9023-9030; van Ree, R., Cabanes-Macheteau, M., Akkerdaas, J., Beta(1,2)-xylose and alpha(1,3)-fucose residues have a strong contribution in IgE binding to plant glycoallergens (2000) J Biol Chem, 275, pp. 11451-11458; POLICY, F., Statement of policy: Foods derived from new plant varieties; notice (1992) Federal Register, 57 (104), pp. 22983-23005; List of completed consultations on bioengineered foods, , http://www.cfsan.fda.gov/~lrd/consulpr.html, accessed November 2007; Schwab, W., Metabolome diversity: Too few genes, too many metabolites? (2003) Phytochemistry, 62, pp. 837-849; Krawinkel, M.B., What we know and don't know about Golden Rice (2007) Nat Biotechnol, 25, p. 623. , author reply 624; Enserink, M., Tough lessons from golden rice (2008) Science, 320, pp. 468-471; Adams, J., Holson, R.R., The neurobehavioral teratology of vitamin A analogs (1998) Handbook of Developmental Neurotoxicology, pp. 631-642. , Slikker W, Chang LW, eds, Academic Press, San Diego, CA; Marcus, R., Coulston, A.M., Fat-soluble vitamins (2001) The Pharmacological Basis of Therapeutics, pp. 1773-1791. , 10th ed, Hardman JG, Limbird LE, Gilman AG, eds, McGraw Hill, New York; Teelmann, K., Retinoids: Toxicology and teratogenicity to date (1989) Pharmacol Ther, 40, pp. 29-43; Wyatt, E.L., Sutter, S.H., Drake, L.A., Dermatological pharmacology (2001) The Pharmacological Basis of Therapeutics, pp. 1795-1818. , 10th edition Hardman JG, Limbird LE, Gilman AG, eds, McGraw Hill, New York; Wilson, A., Latham, J., Steinbrecher, R., (2004) Genome Scrambling - Myth or Reality? Transformation - Induced Mutations in Transgenic Crop Plants, p. 35. , EcoNexus, Brighton, UK; Zubieta, C., Ross, J.R., Koscheski, P., Structural basis for substrate recognition in the0 salicylic acid carboxyl methyltransferase family (2003) Plant Cell, 15, pp. 1704-1716; Johnson, E.T., Ryu, S., Yi, H., Alteration of a single amino acid changes the substrate specificity of dihydroflavonol 4-reductase (2001) Plant J, 25, pp. 325-333; Poerschmanna, J., Gathmannb, A., Augustinc, J., Langera, U., Goreckid, T., Molecular composition of leaves and stems of genetically modified Bt and near-isogenic non-Bt maize - characterization of lignin patterns (2005) J Environ Qual, 34, pp. 1508-1518; Diamond, J.M., (1997) Guns, Germs, and Steel: The Fates of Human Societies, , W.W. Norton, New York; Mayeno, A.N., Gleich, G.J., Eosinophilia-myalgia syndrome and tryptophan production: A cautionary tale (1994) Trends Biotechnol, 12, pp. 346-352; Hill, R.H., Caudill, S.P., Philen, R.M., Contaminants in L-tryptophan associated with eosinophilia myalgia syndrome (1993) Arch Environ Contam Toxicol, 25, pp. 134-142; Munn, D.H., Zhou, M., Attwood, J.T., Prevention of allogeneic fetal rejection by tryptophan catabolism (1998) Science, 281, pp. 1191-1193; Platten, M., Ho, P.P., Youssef, S., Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite (2005) Science, 310, pp. 850-855; Romani, L., Fallarino, F., De Luca, A., Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease (2008) Nature, 451, pp. 211-215; Huang, S., Frizzi, A., Florida, C.A., Kruger, D.E., Luethy, M.H., High lysine and high tryptophan transgenic maize resulting from the reduction of both 19- and 22-kD alpha-zeins (2006) Plant Mol Biol, 61, pp. 525-535; Inose, T., Murata, K., Enhanced accumulation of toxic compound in yeast cells having high glycolytic activity: A case study on the safety of genetically engineered yeast (1995) Int J Food Sci Technol, 30, pp. 141-146; Kurien, B.T., Hensley, K., Bachmann, M., Scofield, R.H., Oxidatively modified autoantigens in autoimmune diseases (2006) Free Radic Biol Med, 41, pp. 549-556; BioSpringer: ML01: The first, , http://www.lesaffreyeastcorp.com/wineyeast/ML01%20KH%206-13-05.pdfOE828.11/04, available malolactic wine yeast, accessed November 11, 2004; DellaPenna, D., Pogson, B.J., Vitamin synthesis in plants: Tocopherols and carotenoids (2006) Annu Rev Plant Biol, 57, pp. 711-738; Verpoorte, R., Plant secondary metabolism (2000) Metabolic Engineering of Plant Secondary Metabolism, pp. 1-29. , Verpoorte R, Alfermann AW, eds, Kluwer Academic Publishers, Dordrecht, The Netherlands; Roessner, U., Luedemann, A., Brust, D., Metabolic profiling allows comprehensive phenotyping of genetically or environmentally modified plant systems (2001) Plant Cell, 13, pp. 11-29; Romer, S., Lubeck, J., Kauder, F., Genetic engineering of a zeaxanthin-rich potato by antisense inactivation and co-suppression of carotenoid epoxidation (2002) Metab Eng, 4, pp. 263-272; (2004) The Safety of Genetically Engineered Foods: Approaches to Assessing Unintended Health Effects, , http://books.nap.edu/catalog/10977.html, National Research Council, National Academy of Science:, National Academies Press, Washington, DC, accessed July 28, 2004; Sommer, A., New imperatives for an old vitamin (A) (1989) J Nutr, 119, pp. 96-100; Khush, G., Productivity improvements in rice (2003) Nutr Rev, 61 (SUPPL.), pp. S114-S116; McCaffery, P.J., Adams, J., Maden, M., Rosa-Molinar, E., Too much of a good thing: Retinoic acid as an endogenous regulator of neural differentiation and exogenous teratogen (2003) Eur J Neurosci, 18, pp. 457-472; Allen, J.G., Bloxham, D.P., The pharmacology and pharmacokinetics of the retinoids (1989) Pharmacol Ther, 40, pp. 1-27; Donahue, S.P., Recurrence of idiopathic intracranial hypertension after weight loss: The carrot craver (2000) Am J Ophthalmol, 130, pp. 850-851; Auldridge, M.E., McCarty, D.R., Klee, H.J., Plant carotenoid cleavage oxygenases and their apocarotenoid products (2006) Curr Opin Plant Biol, 9, pp. 315-321; Moise, A.R., von Lintig, J., Palczewski, K., Related enzymes solve evolutionarily recurrent problems in the metabolism of carotenoids (2005) Trends Plant Sci, 10, pp. 178-186; Dawson, M.I., Zhang, X.K., Discovery and design of retinoic acid receptor and retinoid X receptor class- and subtype-selective synthetic analogs of all-trans-retinoic acid and 9-cis-retinoic acid (2002) Curr Med Chem, 9, pp. 623-637; Grotewold, E., Plant metabolic diversity: A regulatory perspective (2005) Trends Plant Sci, 10, pp. 57-62; Cole, G.M., Teter, B., Frautschy, S.A., Neuroprotective effects of curcumin (2007) Adv Exp Med Biol, 595, pp. 197-212; Roland, I., De Leval, X., Evrard, B., Modulation of the arachidonic cascade with omega3 fatty acids or analogues: Potential therapeutic benefits (2004) Mini Rev Med Chem, 4, pp. 659-668; Cuddihy, S.L., Ali, S.S., Musiek, E.S., Prolonged alpha-tocopherol deficiency decreases oxidative stress and unmasks alpha-tocopherol-dependent regulation of mitochondrial function in brain (2008) J Biol Chem, 283, pp. 6915-6924; Lonn, E., Bosch, J., Yusuf, S., Effects of long-term vitamin E supplementation on cardiovascular events and cancer: A randomized controlled trial (2005) JAMA, 293, pp. 1338-1347; The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med 1994;330:1029-1035McHughen, A., Smyth, S., US regulatory system for genetically modified [genetically modified organism (GMO), rDNA or transgenic] crop cultivars (2008) Plant Biotechnol J, 6, pp. 2-12; Bradford, K.J., Van Deynze, A., Gutterson, N., Parrott, W., Strauss, S.H., Regulating transgenic crops sensibly: Lessons from plant breeding, biotechnology and genomics (2005) Nat Biotechnol, 23, pp. 439-444; Miller, H.I., Conko, C., Kershen, D.L., Why spurning food biotech has become a liability (2006) Nat Biotechnol, 24, pp. 1075-1077; Schubert, D., Two views of the emperor's new clones (2007) Nat Biotechnol, 25, pp. 282-283; (2007) Multigenerational Reproductive Toxicology Study of Ethinyl Estradiol (CAS No. 57-63-6) in Sprague-Dawley Rats (Feed Studies), , National Toxicology Program:, National Toxicology Program, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, NC; Pusztai, A., Bardocz, S., GMO in animal nutrition: Potential benefits and risks (2006) Biology of Nutrition in Growing Animals, pp. 513-540. , Mosenthin R, Zentek J, Zebrowska T, eds, Elsevier, Amsterdam, The Netherlands; Freese, W., Schubert, D., Safety testing of genetically engineered food (2004) Biotechnol Genet Eng Rev, 21, pp. 299-325; Domingo, J.L., Toxicity studies of genetically modified plants: A review of the published literature (2007) Crit Rev Food Sci Nutr, 47, pp. 721-733; Mandel GN: Gaps, inexperience, inconsistencies, and overlaps: crisis in the regulation of genetically modified plants and animals. In: William & Mary Law Review, 45. William & Mary Marshall-Wythe School of Law, Williamsburg, VA, 2004, pp. 2167-2259","Schubert, D. R.; Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037-1099, United States; email: schubert@salk.edu",,,,,,,,1096620X,,JMFOF,18721071,"English","J. Med. Food",Review,Scopus,2-s2.0-57349182776
"Schubert, D.","Pharmed food: Consume with caution",2008,"Ecologist","38","9",,"34","",,,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-56549128389&partnerID=40&md5=ae1c2b02866b3ea94687f1a1d7634d26","Salk Institute for Biological Studies, La Jolla, CA, United States","Schubert, D., Salk Institute for Biological Studies, La Jolla, CA, United States",[No abstract available],,"food consumption; genetically modified organism; health risk",,,,,,,"Schubert, D.; Salk Institute for Biological Studies, La Jolla, CA, United States",,,,,,,,02613131,,,,"English","Ecologist",Article,Scopus,2-s2.0-56549128389
"Schubert, D.","Errors in text",2008,"Journal of the Royal Society of Medicine","101","9",,"435","",,,10.1258/jrsm.2008.08k016,"http://www.scopus.com/inward/record.url?eid=2-s2.0-51849169160&partnerID=40&md5=7b6d56bdcb6a77169b0ff79ddc0bf4da","Salk Institute for Biological Studies","Schubert, D., Salk Institute for Biological Studies",[No abstract available],,"DNA modification; drug industry; drug safety; food and drug administration; food industry; health promotion; labeling index; letter; plant; safety; Food Industry; Food, Genetically Modified; Humans",,,,,,"Key, S., Ma, J.K.-C., Drake, P.M.W., Genetically modified plants and human health (2008) J R Soc Med, 101, pp. 290-298; Domingo, J.L., Toxicity studies of genetically modified plants: A review of the published literature (2007) Crit Rev Food Sci Nutr, 47, pp. 721-733; Freese, W., Schubert, D., Safety testing and regulation of genetically engineered foods (2004) Biotechnol Genet Eng, 21, pp. 299-324; Schubert, D., Two views of the emperor's new clones (2007) Nat Biotechnol, 25, pp. 282-283; http://www.ucsusa.org/food_and_environment/genetic_engineering","Schubert, D.; Salk Institute for Biological StudiesUnited States; email: schubert@salk.edu",,,,,,,,01410768,,JRSMD,18779242,"English","J. R. Soc. Med.",Letter,Scopus,2-s2.0-51849169160
"Liu, Y., Dargusch, R., Maher, P., Schubert, D.","A broadly neuroprotective derivative of curcumin",2008,"Journal of Neurochemistry","105","4",,"1336","1345",,46,10.1111/j.1471-4159.2008.05236.x,"http://www.scopus.com/inward/record.url?eid=2-s2.0-42549169394&partnerID=40&md5=9298e2c2bd4426290f733e61cbd24cb9","Salk Institute, Laboratories for Cellular Neurobiology, San Diego, CA, United States; Salk Institute, Laboratories for Cellular Neurobiology, 10010 North Torrey Pines Road, San Diego, CA 92037-1099, United States","Liu, Y., Salk Institute, Laboratories for Cellular Neurobiology, San Diego, CA, United States; Dargusch, R., Salk Institute, Laboratories for Cellular Neurobiology, San Diego, CA, United States; Maher, P., Salk Institute, Laboratories for Cellular Neurobiology, San Diego, CA, United States; Schubert, D., Salk Institute, Laboratories for Cellular Neurobiology, San Diego, CA, United States, Salk Institute, Laboratories for Cellular Neurobiology, 10010 North Torrey Pines Road, San Diego, CA 92037-1099, United States","The plant polyphenolic curcumin alters the response of nerve cells to some forms of toxic stress. The steroid-like compound, cyclohexyl bisphenol A, has broad neuroprotective properties that are very distinct from those of curcumin. To incorporate both families of biological activities into a single molecule, a pyrazole derivative of curcumin, called CNB-001, was synthesized. CNB-001 acquires a new activity and is far superior in neuroprotection assays to either parental molecule, but retains some of the properties of both. It is neuroprotective in cell culture assays for trophic factor withdrawal, oxidative stress, excitotoxicity, and glucose starvation, as well as toxicity from both intracellular and extracellular amyloid. While the creation of CNB-001 was based upon an uncommon approach to drug design, it has the potential of a lead drug candidate for treating multiple conditions involving nerve cell death. © 2008 The Authors.","Amyloid; Curcumin; Drug; Glutamate; Neuroprotection; Oxytosis; Toxicity","cnb 001; curcumin; neuroprotective agent; animal cell; animal experiment; article; cell survival; cell viability; controlled study; drug bioavailability; drug design; drug inhibition; drug synthesis; mouse; nerve cell necrosis; neuroprotection; nonhuman; oxidative stress; priority journal; rat; Animals; Cell Survival; Cells, Cultured; Curcumin; Dose-Response Relationship, Drug; Mice; Neuroprotective Agents; Oxidative Stress; Pyrazoles; Rats",,"curcumin, 458-37-7; CNB 001; Curcumin, 458-37-7; Neuroprotective Agents; Pyrazoles",,,,"Abe, K., Takayanagi, M., Saito, H., Effects of recombinant human basic FGF and its modified protein CS23 on survival of primary cultured neurons from various regions of fetal rat brain (1990) Jpn. J. Pharmacol., 53, pp. 221-227; Aggarwal, B.B., Kumar, A., Bharti, A.C., Anticancer potential of curcumin: Preclinical and clinical studies (2003) Anticancer Res., 23, pp. 363-398; Aoki, H., Takada, Y., Kondo, S., Sawaya, R., Aggarwal, B.B., Kondo, Y., Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: Role of Akt and extracellular signal-regulated kinase signaling pathways (2007) Mol. Pharmacol., 72, pp. 29-39; Barten, D.M., Meredith Jr., J.E., Zaczek, R., Houston, J.G., Albright, C.F., Gamma-secretase inhibitors for Alzheimer's disease: Balancing efficacy and toxicity (2006) Drugs Res. Dev., 7, pp. 87-97; Behl, C., Davis, J.B., Lesley, R., Schubert, D., Hydrogen peroxide mediates amyloid beta protein toxicity (1994) Cell, 77, pp. 817-827; Berger, C., Schabitz, W.R., Wolf, M., Mueller, H., Sommer, C., Schwab, S., Hypothermia and brain-derived neurotrophic factor reduce glutamate synergistically in acute stroke (2004) Exp. Neurol., 185, pp. 305-312; Chen, J., Zacharek, A., Zhang, C., Jiang, H., Li, Y., Roberts, C., Lu, M., Chopp, M., Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice (2005) J. Neurosci., 25, pp. 2366-2375; Cole, G.M., Teter, B., Frautschy, S.A., Neuroprotective effects of curcumin (2007) Adv. Exp. Med. Biol., 595, pp. 197-212; Corson, T.W., Crews, C.M., Molecular understanding and modern application of traditional medicines: Triumphs and trials (2007) Cell, 130, pp. 769-774; Davis, J.B., Maher, P., Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line (1994) Brain Res., 652, pp. 169-173; Frautschy, S.A., Hu, W., Kim, P., Miller, S.A., Chu, T., Harris-White, M.E., Cole, G.M., Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology (2001) Neurobiol. Aging, 22, pp. 993-1005; Goodman, Y., Steiner, M.R., Steiner, S.M., Mattson, M.P., Nordihydroguaiaretic acid protects hippocampal neurons against amyloid [beta]-peptide toxicity, and attenuates free radical and calcium accumulation (1994) Brain Res., 654, pp. 171-176; Harvey, A.L., Medicines from nature: Are natural products still relevant to drug discovery? (1999) Trends Pharmacol. Sci., 20, pp. 196-198; Kang, J.H., Kondo, F., Katayama, Y., Human exposure to bisphenol a (2006) Toxicology, 226, pp. 79-89; Keller, C., Bruelisauer, A., Lemaire, M., Enz, A., Brain pharmacokinetics of a nonpeptidic corticotropin-releasing factor receptor antagonist (2002) Drug Metab. Dispos., 30, pp. 173-176; Kim, H., Park, B.S., Lee, K.G., Choi, C.Y., Jang, S.S., Kim, Y.H., Lee, S.E., Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid (2005) J. Agric. Food Chem., 53, pp. 8537-8541; Koehn, F.E., Carter, G.T., The evolving role of natural products in drug discovery (2005) Nat. Rev. Drug Discov., 4, pp. 206-220; Kurozumi, K., Nakamura, K., Tamiya, T., Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model (2005) Mol Ther., 11, pp. 96-104; Laferla, F.M., Green, K.N., Oddo, S., Intracellular amyloid-beta in Alzheimer's disease (2007) Nat. Rev. Neurosci., 8, pp. 499-509; Lansbury, P.T., Lashuel, H.A., A century-old debate on protein aggregation and neurodegeneration enters the clinic (2006) Nature, 443, pp. 774-779; Van Leyen, K., Kim, H.Y., Lee, S.R., Jin, G., Arai, K., Lo, E.H., Baicalein and 12/15-Lipoxygenase in the Ischemic Brain (2006) Stroke, 37, pp. 3014-3018. , 2006 Oct 19; [E-Pub ahead of print]; Lim, G.P., Chu, T., Yang, F., Beech, W., Frautschy, S.A., Cole, G.M., The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse (2001) J. Neurosci., 21, pp. 8370-8377; Liu, Y., Schubert, D., Steroid hormones block amyloid fibril-induced 3-(4,5-dimethylthiazol-2- yl)-2,5-diphenyltetrazolium bromide (MTT) formazan exocytosis: Relationship to neurotoxicity (1998) J. Neurochem., 71, pp. 2322-2329; Liu, Y., Peterson, D.A., Schubert, D., Amyloid beta peptide alters intracellular vesicle trafficking and cholesterol homeostasis (1998) Proc. Natl Acad. Sci. USA, 95, pp. 13266-13271; Maezawa, I., Hong, H.S., Wu, H.C., A novel tricyclic pyrone compound ameliorates cell death associated with intracellular amyloid-beta oligomeric complexes (2006) J. Neurochem., 98, pp. 57-67; Maher, P., Redox control of neural functions: Background, mechanisms and significance (2006) Antioxid. Redox Signal., 8, pp. 1941-1970; Mattson, M.P., Cheng, A., Neurohormetic phytochemicals: Low-dose toxins that induce adaptive neuronal stress responses (2006) Trends Neurosci., 29, pp. 632-639; McPhie, D.L., Lee, R.K., Eckman, C.B., Olstein, D.H., Durham, S.P., Yager, D., Younkin, S.G., Neve, R.L., Neuronal expression of beta-amyloid precursor protein Alzheimer mutations causes intracellular accumulation of a C-terminal fragment containing both the amyloid beta and cytoplasmic domains (1997) J. Biol. Chem., 272, pp. 24743-24746; Molina-Holgado, F., Hider, R.C., Gaeta, A., Williams, R., Francis, P., Metals ions and neurodegeneration (2007) Biometals, 20, pp. 639-654; Olney, J.W., Inciting excitotoxic cytocide among central neurons (1986) Advances in Experimental Medicine and Biology, pp. 632-645. , in. Schwarcz, R. Ben-Ari, Y., eds. pp. Plenum Press, New York; Pangalos, M.N., Schechter, L.E., Hurko, O., Drug development for CNS disorders: Strategies for balancing risk and reducing attrition (2007) Nat. Rev. Drug Discov., 6, pp. 521-532; Paterson, I., Anderson, E.A., The renaissance of natural products as drug candidates (2005) Science, 310, pp. 451-453; Pezet, S., Malcangio, M., Brain-derived neurotrophic factor as a drug target for CNS disorders (2004) Exp. Opin. Ther. Targets, 8, pp. 391-399; Reinke, A.A., Gestwicki, J.E., Structure-activity relationships of amyloid beta-aggregation inhibitors based on curcumin: Influence of linker length and flexibility (2007) Chem Biol Drug Des., 70, pp. 206-215; Rice-Evans, C., Miller, N.J., Total antioxidant status in plasma and body fluids (1994) Methods Enzymol., 234, pp. 279-293; Rice-Evans, C.A., Miller, N.J., Paganga, G., Structure-antioxidant activity relationships of flavonoids and phenolic acids (1996) Free Radic. Biol. Med., 20, pp. 933-956; Rossler, O.G., Giehl, K.M., Thiel, G., Neuroprotection of immortalized hippocampal neurones by brain-derived neurotrophic factor and Raf-1 protein kinase: Role of extracellular signal-regulated protein kinase and phosphatidylinositol 3-kinase (2004) J. Neurochem., 88, pp. 1240-1252; Rothman, S.M., The neurotoxicity of excitatory amino acids is produced by passive chloride influx (1985) J. Neurosci., 5, pp. 1483-1489; Rothman, S.M., Olney, J.W., Glutamate and the pathophysiology of hypoxic - Ischemic brain damage (1986) Ann. Neurol., 19, pp. 105-111; Scatena, R., Martorana, G.E., Bottoni, P., Botta, G., Pastore, P., Giardina, B., An update on pharmacological approaches to neurodegenerative diseases (2007) Exp. Opin. Invest. Drugs, 16, pp. 59-72; Schubert, D.R., Liu, Y., (2002) Method for Preventing And/or Decreasing Amyloid Production with Polycyclic Compounds, , US Patent No. 6,472,436B1; Schubert, D., Piasecki, D., Oxidative glutamate toxicity can be a component of the excitotoxicity cascade (2001) J. Neurosci., 21, pp. 7455-7462; Sharma, R.A., Steward, W.P., Gescher, A.J., Pharmacokinetics and pharmacodynamics of curcumin (2007) Adv. Exp. Med. Biol., 595, pp. 453-470; Sopher, B.L., Fukuchi, K., Smith, A.C., Leppig, K.A., Furlong, C.E., Martin, G.M., Cytotoxicity mediated by conditional expression of a carboxyl-terminal derivative of the beta-amyloid precursor protein (1994) Brain Res. Mol. Brain Res., 26, pp. 207-217; Tan, S., Schubert, D., Maher, P., Oxytosis: A novel form of programmed cell death (2001) Curr. Topics Med. Chem., 1, pp. 497-506; Warren, R.E., Frier, B.M., Hypoglycaemia and cognitive function (2005) Diabetes Obes Metab., 7, pp. 493-503; Woltjer, R.L., Nghiem, W., Maezawa, I., Milatovic, D., Vaisar, T., Montine, K.S., Montine, T.J., Role of glutathione in intracellular amyloid-alpha precursor protein/carboxy-terminal fragment aggregation and associated cytotoxicity (2005) J. Neurochem., 93, pp. 1047-1056; Yang, F., Lim, G.P., Begum, A.N., Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo (2005) J. Biol. Chem., 280, pp. 5892-5901; Yankner, B.A., Duffy, L.K., Kirschner, D.A., Neurotrophic and neurotoxic effects of amyloid beta protein: Reversal by tachykinin neuropeptides (1990) Science, 250, pp. 279-282","Schubert, D.; Salk Institute, Laboratories for Cellular Neurobiology, 10010 North Torrey Pines Road, San Diego, CA 92037-1099, United States; email: Schubert@salk.edu",,,,,,,,00223042,,JONRA,18208543,"English","J. Neurochem.",Article,Scopus,2-s2.0-42549169394
"Simonsen, A., Cumming, R.C., Brech, A., Isakson, P., Schubert, D.R., Finley, K.D.","Promoting basal levels of autophagy in the nervous system enhances longevity and oxidant resistance in adult Drosophila",2008,"Autophagy","4","2",,"176","184",,222,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-38949099761&partnerID=40&md5=3857e306e776695a96c5ef20caf2f1f6","Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; University of Oslo, Department of Biochemistry, Norwegian Radium Hospital, Montebello 0310 Oslo, Norway; Department of Biology, University of Western Ontario, London, ON N6A 5B7, Canada; Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037, United States","Simonsen, A., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States, University of Oslo, Department of Biochemistry, Norwegian Radium Hospital, Montebello 0310 Oslo, Norway; Cumming, R.C., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States, Department of Biology, University of Western Ontario, London, ON N6A 5B7, Canada; Brech, A., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States, University of Oslo, Department of Biochemistry, Norwegian Radium Hospital, Montebello 0310 Oslo, Norway; Isakson, P., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States, University of Oslo, Department of Biochemistry, Norwegian Radium Hospital, Montebello 0310 Oslo, Norway; Schubert, D.R., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; Finley, K.D., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States, Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037, United States","Autophagy is involved with the turnover of intracellular components and the management of stress responses. Genetic studies in mice have shown that suppression of neuronal autophagy can lead to the accumulation of protein aggregates and neurodegeneration. However, no study has shown that increasing autophagic gene expression can be beneficial to an aging nervous system. Here we demonstrate that expression of several autophagy genes is reduced in Drosophila neural tissues as a normal part of aging. The age-dependent suppression of autophagy occurs concomitantly with the accumulation of insoluble ubiquitinated proteins (IUP), a marker of neuronal aging and degeneration. Mutations in the Atg8a gene (autophagy-related 8a) result in reduced lifespan, IUP accumulation and increased sensitivity to oxidative stress. In contrast, enhanced Atg8a expression in older fly brains extends the average adult lifespan by 56% and promotes resistance to oxidative stress and the accumulation of ubiquitinated and oxidized proteins. These data indicate that genetic or age-dependent suppression of autophagy is closely associated with the buildup of cellular damage in neurons and a reduced lifespan, while maintaining the expression of a rate-limiting autophagy gene prevents the age-dependent accumulation of damage in neurons and promotes longevity. ©2008 Landes Bioscience.","Aging; Atg8a; Drosophila; Insoluble ubiquitinated proteins; Macroautophagy; Oxidative stress; Protein aggregates; Quantitative RT-PCR","oxidizing agent; reactive oxygen metabolite; aging; article; Atg8a gene; autophagy; cell damage; controlled study; Drosophila; gene; gene expression; gene mutation; lifespan; longevity; nerve degeneration; nervous system; nonhuman; oxidative stress; protein aggregation; ubiquitination; Aging; Amino Acid Sequence; Animals; Animals, Genetically Modified; Autophagy; Drosophila; Drosophila Proteins; Female; Gene Expression Regulation; Immunity, Natural; Longevity; Male; Membrane Proteins; Models, Biological; Molecular Sequence Data; Nerve Tissue Proteins; Nervous System Physiology; Oxidants; Oxidative Stress; Reactive Oxygen Species; Sequence Homology, Amino Acid; Ubiquitin; Mus",,"Appl protein, Drosophila; Atg8a protein, Drosophila; Drosophila Proteins; Membrane Proteins; Nerve Tissue Proteins; Oxidants; Reactive Oxygen Species; Ubiquitin",,,,"Reggiori, F., Klionsky, D.J., Autophagosomes: Biogenesis from scratch? (2005) Curr Opin Cell Biol, 17, pp. 415-422; Klionsky, D.J., Cregg, J.M., Dunn Jr, W.A., Emr, S.D., Sakai, Y., Sandoval, I.V., Sibirny, A., Ohsumi, Y., A unified nomenclature for yeast autophagy-related genes (2003) Dev Cell, 5, pp. 539-545; Cuervo, A.M., Bergamini, E., Brunk, U.T., Droge, W., Ffrench, M., Terman, A., Autophagy and aging: The importance of maintaining ""clean"" cells (2005) Autophagy, 1, pp. 131-140; Huang, J., Klionsky, D.J., Autophagy and human disease (2007) Cell Cycle, 6, pp. 1837-1849. , Georgetown, Tex; Levine, B., Cell biology: Autophagy and cancer (2007) Nature, 446, pp. 745-747; Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mizushima, N., Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice (2006) Nature, 441, pp. 885-889; Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J., Tanida, I., Ueno, T., Tanaka, K., Loss of autophagy in the central nervous system causes neurodegeneration in mice (2006) Nature, 441, pp. 880-884; Donati, A., The involvement of macroautophagy in aging and anti-aging interventions (2006) Mol Aspects Med, 27, pp. 455-470; Hwangbo, D.S., Gershman, B., Tu, M.P., Palmer, M., Tatar, M., Drosophila dFOXO controls lifespan and regulates insulin signalling in brain and fat body (2004) Nature, 429, pp. 562-566; Finley, K.D., Edeen, P.T., Cumming, R.C., Mardahl-Dumesnil, M.D., Taylor, B.J., Rodriguez, M.H., Hwang, C.E., McKeown, M., Blue cheese mutations define a novel, conserved gene involved in progressive neural degeneration (2003) J Neurosci, 23, pp. 1254-1264; Tatar, M., Khazaeli, A.A., Curtsinger, J.W., Chaperoning extended life (1997) Nature, 390, p. 30; Whitworth, A.J., Theodore, D.A., Greene, J.C., Benes, H., Wes, P.D., Pallanck, L.J., Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease (2005) Proc Natl Acad Sci USA, 102, pp. 8024-8029; Rorth, P., A modular misexpression screen in Drosophila detecting tissue-specific phenotypes (1996) Proc Natl Acad Sci USA, 93, pp. 12418-12422; Simonsen, A., Cumming, R.C., Lindmo, K., Galaviz, V., Cheng, S., Rusten, T.E., Finley, K.D., Genetic modifiers of the Drosophila blue cheese gene link defects in lysosomal transport with decreased life span and altered ubiquitinated-protein profiles (2007) Genetics, 176, pp. 1283-1297; Bustin, S.A., Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays (2000) J Mol Endocrinol, 25, pp. 169-193; Bjorkoy, G., Lamark, T., Brech, A., Outzen, H., Perander, M., Overvatn, A., Stenmark, H., Johansen, T., p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death (2005) J Cell Biol, 171, pp. 603-614; Giasson, B.I., Duda, J.E., Murray, I.V., Chen, Q., Souza, J.M., Hurtig, H.I., Ischiropoulos, H., Lee, V.M., Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions (2000) Science, 290, pp. 985-989; Yorimitsu, T., Klionsky, D.J., Autophagy: Molecular machinery for self-eating (2005) Cell Death and Differentiation, 12, pp. 1542-1552; Girardor, F., Lasbleiz, C., Monnier, V., Tricoire, H., Specific age-related signatures in Drosophila body parts transcriptome (2006) BMC Genomics, 7, p. 69; Sou, Y.S., Tanida, I., Komatsu, M., Ueno, T., Kominami, E., Phosphatidylserine in addition to phosphatidylethanolamine is an in vitro target of the mammalian Atg8 modifiers, LC3, GABARAP, and GATE-16 (2006) J Biol Chem, 281, pp. 3017-3024; Tanida, I., Komatsu, M., Ueno, T., Kominami, E., GATE-16 and GABARAP are authentic modifiers mediated by Apg7 and Apg3 (2003) Biochem Biophys Res Commun, 300, pp. 637-644; Johnston, J.A., Ward, C.L., Kopito, R.R., Aggresomes: A cellular response to misfolded proteins (1998) J Cell Biol, 143, pp. 1883-1898; Finkel, T., Holbrook, N.J., Oxidants, oxidative stress and the biology of ageing (2000) Nature, 408, pp. 239-247; Brunk, U.T., Terman, A., The mitochondrial-lysosomal axis theory of aging: Accumulation of damaged mitochondria as a result of imperfect autophagocytosis (2002) Eur J Biochem, 269, pp. 1996-2002; Parkes, T.L., Elia, A.J., Dickinson, D., Hilliker, A.J., Phillips, J.P., Boulianne, G.L., Extension of Drosophila lifespan by overexpression of human SOD1 in motorneurons (1998) Nat Genet, 19, pp. 171-174; Das, N., Levine, R.L., Orr, W.C., Sohal, R.S., Selectivity of protein oxidative damage during aging in Drosophila melanogaster (2001) Biochem J, 360, pp. 209-216; Nixon, R.A., Wegiel, J., Kumar, A., Yu, W.H., Peterhoff, C., Cataldo, A., Cuervo, A.M., Extensive involvement of autophagy in Alzheimer disease: An immuno-electron microscopy study (2005) J Neuropathol Exp Neurol, 64, pp. 113-122; Cohen, E., Bieschke, J., Perciavalle, R.M., Kelly, J.W., Dillin, A., Opposing activities protect against age-onset proteotoxicity (2006) Science, 313, pp. 1604-1610; Kapahi, P., Zid, B.M., Harper, T., Koslover, D., Sapin, V., Benzer, S., Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway (2004) Curr Biol, 14, pp. 885-890; Hekimi, S., Guarente, L., Genetics and the specificity of the aging process (2003) Science, 299, pp. 1351-1354; Melendez, A., Talloczy, Z., Seaman, M., Eskelinen, E.L., Hall, D.H., Levine, B., Autophagy genes are essential for dauer development and life-span extension in C. elegans (2003) Science, 301, pp. 1387-1391; Scott, B.A., Avidan, M.S., Crowder, C.M., Regulation of hypoxic death in C. elegans by the insulin/IGF receptor homolog DAF-2 (2002) Science, 296, pp. 2388-2391; Scott, R.C., Schuldiner, O., Neufeld, T.P., Role and regulation of starvation-induced autophagy in the Drosophila fat body (2004) Dev Cell, 7, pp. 167-178; Tanida, I., Sou, Y.S., Ezaki, J., Minematsu-Ikeguchi, N., Ueno, T., Kominami, E., HsAtg4B/HsApg4B/autophagin-1 cleaves the carboxyl termini of three human Atg8 homologues and delipidates microtubule-associated protein light chain 3- and GABAA receptor-associated protein-phospholipid conjugates (2004) J Biol Chem, 279, pp. 36268-36276; Kumanomidou, T., Mizushima, T., Komatsu, M., Suzuki, A., Tanida, I., Sou, Y.S., Ueno, T., Yamane, T., The crystal structure of human Atg4b, a processing and de-conjugating enzyme for autophagosome-forming modifiers (2006) J Mol Biol, 355, pp. 612-618","Finley, K.D.; Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037, United States; email: finley@salk.edu",,,,,,,,15548627,,,18059160,"English","Autophagy",Article,Scopus,2-s2.0-38949099761
"Maji, S.K., Schubert, D., Rivier, C., Lee, S., Rivier, J.E., Riek, R.","Amyloid as a depot for the formulation of long-acting drugs",2008,"PLoS Biology","6","2",,"0240","0252",,82,10.1371/journal.pbio.0060017,"http://www.scopus.com/inward/record.url?eid=2-s2.0-40149111861&partnerID=40&md5=397576e3b455aa52b18902f99578ce3a","Structural Biology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; Clayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, San Diego, CA, United States; Laboratory for Physical Chemistry, Zurich, Switzerland","Maji, S.K., Structural Biology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; Schubert, D., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; Rivier, C., Clayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, San Diego, CA, United States; Lee, S., Clayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, San Diego, CA, United States; Rivier, J.E., Clayton Foundation Laboratories for Peptide Biology, Salk Institute for Biological Studies, San Diego, CA, United States; Riek, R., Structural Biology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States, Laboratory for Physical Chemistry, Zurich, Switzerland","Amyloids are highly organized protein aggregates that are associated with both neurodegenerative diseases such as Alzheimer disease and benign functions like skin pigmentation. Amyloids self-polymerize in a nucleation-dependent manner by recruiting their soluble protein/peptide counterpart and are stable against harsh physical, chemical, and biochemical conditions. These extraordinary properties make amyloids attractive for applications in nanotechnology. Here, we suggest the use of amyloids in the formulation of long-acting drugs. It is our rationale that amyloids have the properties required of a long-acting drug because they are stable depots that guarantee a controlled release of the active peptide drug from the amyloid termini. This concept is tested with a family of short- and long-acting analogs of gonadotropin-releasing hormone (GnRH), and it is shown that amyloids thereof can act as a source for the sustained release of biologically active peptides. © 2008 Maji et al.",,"amyloid protein; gonadorelin derivative; peptide; amyloid; drug carrier; animal cell; animal experiment; animal tissue; article; controlled study; drug formulation; embryo; male; nonhuman; rat; bioavailability; delayed release formulation; human; Amyloid; Biological Availability; Delayed-Action Preparations; Drug Carriers; Humans",,"amyloid, 11061-24-8; Amyloid; Delayed-Action Preparations; Drug Carriers",,,,"Chiti, F., Dobson, C.M., Protein misfolding, functional amyloid, and human disease (2006) Annu Rev Biochem, 75, pp. 333-366; Barnhart, M.M., Chapman, M.R., Curli biogenesis and function (2006) Annu Rev Microbiol, 60, pp. 131-147; Iconomidou, V.A., Vriend, G., Hamodrakas, S.J., Amyloids protect the silkmoth oocyte and embryo (2000) FEBS Lett, 479, pp. 141-145; Osherovich, L.Z., Weissman, J.S., The utility of prions (2002) Dev Cell, 2, pp. 143-151; True, H.L., Lindquist, S.L., A yeast prion provides a mechanism for genetic variation and phenotypic diversity (2000) Nature, 407, pp. 477-483; Maddelein, M.L., Dos Reis, S., Duvezin-Caubet, S., Coulary-Salin, B., Saupe, S.J., Amyloid aggregates of the HET-s prion protein are infectious (2002) Proc Natl Acad Sci U S A, 99, pp. 7402-7407; Fowler, D.M., Koulov, A.V., Alory-Jost, C., Marks, M.S., Balch, W.E., Functional amyloid formation within mammalian tissue (2006) PLoS Biol, 4, pp. e6. , doi:10.1371/journal.pbio.0040006; Hardy, J., Selkoe, D.J., The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics (2002) Science, 297, pp. 353-356; Guijarro, J.I., Sunde, M., Jones, J.A., Campbell, I.D., Dobson, C.M., Amyloid fibril formation by an SH3 domain (1998) Proc Natl Acad Sci U S A, 95, pp. 4224-4228; Chiti, F., Webster, P., Taddei, N., Clark, A., Stefani, M., Designing conditions for in vitro formation of amyloid protofilaments and fibrils (1999) Proc Natl Acad Sci U S A, 96, pp. 3590-3594; Dobson, C.M., The structural basis of protein folding and its links with human disease (2001) Philos Trans R Soc Lond B Biol Sci, 356, pp. 133-145; Sunde, M., Blake, C., The structure of amyloid fibrils by electron microscopy and X-ray diffraction (1997) Adv Protein Chem, 50, pp. 123-159; Sunde, M., Serpell, L.C., Bartlam, M., Fraser, P.E., Pepys, M.B., Common core structure of amyloid fibrils by synchrotron X-ray diffraction (1997) J Mol Biol, 273, pp. 729-739; Klunk, W.E., Jacob, R.F., Mason, R.P., Quantifying amyloid by Congo red spectral shift assay (1999) Methods Enzymol, 309, pp. 285-305; LeVine, H., Quantification of β-sheet amyloid fibril structures with thioflavin T (1999) Methods Enzymol, 309, pp. 274-284; Harper, J.D., Lansbury Jr, P.T., Models of amyloid seeding in Alzheimer's disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins (1997) Annu Rev Biochem, 66, pp. 385-407; Reches, M., Gazit, E., Casting metal nanowires within discrete self-assembled peptide nanotubes (2003) Science, 300, pp. 625-627; Scheibel, T., Parthasarathy, R., Sawicki, G., Lin, X.M., Jaeger, H., Conducting nanowires built by controlled self-assembly of amyloid fibers and selective metal deposition (2003) Proc Natl Acad Sci U S A, 100, pp. 4527-4532; MacPhee, C.E.W., Woolfson, D.N., Engineered and designed peptide-based fibrous biomaterials (2004) Curr Opin Solid State Mat Sci, 8, pp. 141-149; Scheibel, T., Protein fibers as performance proteins: New technologies and applications (2005) Curr Opin Biotechnol, 16, pp. 427-433; Holmes, T.C., de Lacalle, S., Su, X., Liu, G., Rich, A., Extensive neurite outgrowth and active synapse formation on self-assembling peptide scaffolds (2000) Proc Natl Acad Sci U S A, 97, pp. 6728-6733; Smith, J.F., Knowles, T.P., Dobson, C.M., Macphee, C.E., Welland, M.E., Characterization of the nanoscale properties of individual amyloid fibrils (2006) Proc Natl Acad Sci U S A, 103, pp. 15806-15811; Langer, R., New methods of drug delivery (1990) Science, 249, pp. 1527-1533; Fowler, S.B., Poon, S., Muff, R., Chiti, F., Dobson, C.M., Rational design of aggregation-resistant bioactive peptides: Reengineering human calcitonin (2005) Proc Natl Acad Sci U S A, 102, pp. 10105-10110; Matsuo, H., Baba, Y., Nair, R.M., Arimura, A., Schally, A.V., Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence (1971) Biochem Biophys Res Commun, 43, pp. 1334-1339; Herbst, K.L., Gonadotropin-releasing hormone antagonists (2003) Curr Opin Pharmacol, 3, pp. 660-666; Karten, M.J., Rivier, J.E., Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: Rationale and perspective (1986) Endocr Rev, 7, pp. 44-66; Lunenfeld B, Editor (1999) GnRH analogues. the state of the art at the millennium. Pearl River (New York): The Parthenon Publishing Group. 136 pJiang, G., Stalewski, J., Galyean, R., Dykert, J., Schteingart, C., GnRH antagonists: A new generation of long acting analogues incorporating pureido-phenylalanines at positions 5 and 6 (2001) J Med Chem, 44, pp. 453-467; Broqua, P., Riviere, P.J., Conn, P.M., Rivier, J.E., Aubert, M.L., Pharmacological profile of a new, potent, and long-acting gonadotropin-releasing hormone antagonist: Degarelix (2002) J Pharmacol Exp Ther, 301, pp. 95-102; Powell, M.F., Fleitman, J., Sanders, L.M., Si, V.C., Peptide liquid crystals: Inverse correlation of kinetic-formation and thermodynamic stability in aqueous solution (1994) Pharm Res, 11, pp. 1352-1354; Cannon, J.B., Krill, S.L., Porter, W.R., Physicochemical properties of A-75998, an antagonist of luteinizing hormone releasing hormone (1995) J Pharm Sci, 84, pp. 953-958; Tan, M.M., Corley, C.A., Stevenson, C.L., Effect of gelation on the chemical stability and conformation of leuprolide (1998) Pharm Res, 15, pp. 1442-1448; Jiang, G., Gavini, E., Dani, B.A., Murty, S.B., Schrier, B., Identification and determination of GnRH antagonist gelling at injection site (2002) Int J Pharm, 233, pp. 19-27; Klunk, W.E., Pettegrew, J.W., Abraham, D.J., Quantitative evaluation of congo red binding to amyloid-like proteins with a β-pleated sheet conformation (1989) J Histochem Cytochem, 37, pp. 1273-1281; Plourde, F., Motulsky, A., Couffin-Hoarau, A.C., Hoarau, D., Ong, H., First report on the efficacy of l-alanine-based in situ-forming implants for the long-term parenteral delivery of drugs (2005) J Control Release, 108, pp. 433-441; Tennent, G.A., Lovat, L.B., Pepys, M.B., Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis (1995) Proc Natl Acad Sci U S A, 92, pp. 4299-4303; Suk, J.Y., Zhang, F., Balch, W.E., Linhardt, R.J., Kelly, J.W., Heparin accelerates gelsolin amyloidogenesis (2006) Biochemistry, 45, pp. 2234-2242; Westermark, G.T., Johnson, K.H., Westermark, P., Staining methods for identification of amyloid in tissue (1999) Methods Enzymol, 309, pp. 3-25; Dische, F.E., Wernstedt, C., Westermark, G.T., Westermark, P., Pepys, M.B., Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient (1988) Diabetologia, 31, pp. 158-161; Betts, P.R., Jefferson, I.G., Swift, P.G., Diabetes care in childhood and adolescence (2002) Diabet Med, 19, pp. 61-65; Samant, M.P., White, R., Hong, D.J., Croston, G., Conn, P.M., Structure-activity relationship studies of gonadotropin-releasing hormone antagonists containing S-aryl/alkyl norcysteines and their oxidized derivatives (2007) J Med Chem, 50, pp. 2067-2077; Samant, M.P., Hong, D.J., Croston, G., Rivier, C., Rivier, J., Novel analogues of degarelix incorporating hydroxy-, methoxy-, and pegylated-urea moieties at positions 3, 5, 6 and the N-terminus. Part III (2006) J Med Chem, 49, pp. 3536-3543; Behl, C., Davis, J.B., Lesley, R., Schubert, D., Hydrogen peroxide mediates amyloid β-protein toxicity (1994) Cell, 77, pp. 817-827; Wright, C.F., Teichmann, S.A., Clarke, J., Dobson, C.M., The importance of sequence diversity in the aggregation and evolution of proteins (2005) Nature, 438, pp. 878-881; Han, H.Y., Weinreb, P.H., Lansbury, P.T., The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by β-amyloid: Is NAC a common trigger or target in neurodegenerative disease? (1995) Chem Biol, 2, pp. 163-169; Kessler, J.C., Rochet, J.C., Lansbury, P.T., The N-terminal repeat domain of α-synuclein inhibits β-sheet and amyloid fibril formation (2003) Biochemistry, 42, pp. 672-678; Langer, R., Drug delivery and targeting (1998) Nature, 392, pp. 5-10; Putney, S.D., Burke, P.A., Improving protein therapeutics with sustained-release formulations (1998) Nat Biotechnol, 16, pp. 153-157; Jen, A., Madorin, K., Vosbeck, K., Arvinte, T., Merkle, H.P., Transforming growth factor β-3 crystals as reservoirs for slow release of active TGF-β3 (2002) J Control Release, 78, pp. 25-34; Brader, M.L., Sukumar, M., Pekar, A.H., McClellan, D.S., Chance, R.E., Hybrid insulin cocrystals for controlled release delivery (2002) Nat Biotechnol, 20, pp. 800-804; Langer, R., Drug delivery (2001) Drugs on target. Science, 293, pp. 58-59; Orive, G., Hernandez, R.M., Rodriguez Gascon, A., Dominguez-Gil, A., Pedraz, J.L., Drug delivery in biotechnology: Present and future (2003) Curr Opin Biotechnol, 14, pp. 659-664; Richards Grayson, A.C., Choi, I.S., Tyler, B.M., Wang, P.P., Brem, H., Multi-pulse drug delivery from a resorbable polymeric microchip device (2003) Nat Mater, 2, pp. 767-772; Guptabansal, R., Frederickson, R.C.A., Brunden, K.R., Proteoglycan-mediated inhibition of Aβ proteolysis: A potential cause of senile plaque accumulation (1995) J Biol Chem, 270, pp. 18666-18671; Cotman, S.L., Halfter, W., Cole, G.J., Agrin binds to β-amyloid (Aβ), accelerates ab fibril formation, and is localized to Aβ deposits in Alzheimer's disease brain (2000) Mol Cell Neurosci, 15, pp. 183-198; Van Poppel, H., De La Rosette, J., Persson, B., Jensen, J.K., Olesen, T.K., A one-year, multicentre, randomised study of degarelix, a gonadatrophin-releasing bord-7-0910 hormone (GnRH) receptor blocker (2006) prostate cancer patients. 21st Annual Meeting of the European Association of Urology (EAU), 5-8 April 2006, Paris, France. Eur Urol, (SUPPL. 5), p. 251; O'Nuallain, B., Shivaprasad, S., Kheterpal, I., Wetzel, R., Thermodynamics of Aβ(1-40) amyloid fibril elongation (2005) Biochemistry, 44, pp. 12709-12718; Rivier, C., Grigoriadis, D., Rivier, J., Role of corticotropin releasing factor receptors type 1 and 2 in modulating the rat adrenocorticotropin response to stressors (2003) Endocrinology, 144, pp. 2396-2403; Rivier, C., Decreased plasma gonadotropin and testosterone levels in arthritic rats: Are corticosteroids involved? (1995) Endocrine, 3, pp. 383-390","Riek, R.; Structural Biology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; email: riek@salk.edu",,,,,,,,15449173,,PBLIB,18254658,"English","PloS Biol.",Article,Scopus,2-s2.0-40149111861
"Burdo, J., Schubert, D., Maher, P.","Glutathione production is regulated via distinct pathways in stressed and non-stressed cortical neurons",2008,"Brain Research","1189","1",,"12","22",,23,10.1016/j.brainres.2007.10.077,"http://www.scopus.com/inward/record.url?eid=2-s2.0-44449133306&partnerID=40&md5=49477e5bf845df9f8a254163a1724aea","The Salk Institute For Biological Studies, Cellular Neurobiology Laboratory, 10010 N. Torrey Pines Rd, La Jolla, CA 92037, United States","Burdo, J., The Salk Institute For Biological Studies, Cellular Neurobiology Laboratory, 10010 N. Torrey Pines Rd, La Jolla, CA 92037, United States; Schubert, D., The Salk Institute For Biological Studies, Cellular Neurobiology Laboratory, 10010 N. Torrey Pines Rd, La Jolla, CA 92037, United States; Maher, P., The Salk Institute For Biological Studies, Cellular Neurobiology Laboratory, 10010 N. Torrey Pines Rd, La Jolla, CA 92037, United States","Peroxynitrite-mediated damage has been linked to numerous neurological and neurodegenerative diseases, including stroke, Alzheimer's and Parkinson's Diseases, amyotrophic lateral sclerosis and multiple sclerosis. Studies on the toxic effects of peroxynitrite in neurons have focused primarily on adverse effects resulting from the nitration of cellular proteins as the principal mode of toxicity while the consequences of the modulation of kinase pathways by peroxynitrite have received relatively less attention. Our results show that treatment of primary rat neurons with the peroxynitrite donor, SIN-1, leads to decreases in glutathione (GSH) levels and cell viability via a novel extracellular-signal-related kinase (ERK)/c-Myc phosphorylation pathway and a reduction in the nuclear expression of NF-E2-related factor-2 (Nrf2) that down-regulate the expression of glutamate cysteine ligase, the rate limiting enzyme for GSH synthesis. The flavonoid fisetin protects against the SIN-1-mediated alterations in ERK/c-Myc phosphorylation, nuclear Nrf2 levels, glutamate cysteine ligase levels, GSH concentration and cell viability. We also show that inhibition of mitogen-activated protein kinase kinase or Raf kinase can increase GSH levels in unstressed primary rat neurons through the same ERK/c-Myc phosphorylation pathway. Together, these results demonstrate that distinct signaling pathways modulate GSH metabolism in unstressed and stressed cortical neurons. © 2007 Elsevier B.V. All rights reserved.","c-Myc; ERK; Fisetin; Nrf2; Peroxynitrite; Raf1","fisetin; glutamate cysteine ligase; glutathione; linsidomine; mitogen activated protein kinase; Myc protein; peroxynitrite; transcription factor Nrf2; 3 morpholino sydnonimine; 3-morpholino-sydnonimine; drug derivative; flavonoid; molsidomine; neuroprotective agent; Nfe2l2 protein, rat; nitric oxide donor; nitro derivative; peroxynitrous acid; animal cell; article; cell viability; cytokine production; down regulation; enzyme inhibition; enzyme regulation; enzyme synthesis; nerve cell; nonhuman; priority journal; protein expression; protein phosphorylation; rat; animal; brain cortex; cell culture; cell survival; dose response; drug antagonism; drug effect; metabolism; oxidative stress; pathophysiology; phosphorylation; physiology; signal transduction; Sprague Dawley rat; Rattus; Animals; Cell Survival; Cells, Cultured; Cerebral Cortex; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Glutathione; MAP Kinase Signaling System; Molsidomine; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Nitric Oxide Donors; Nitro Compounds; Oxidative Stress; Peroxynitrous Acid; Phosphorylation; Proto-Oncogene Proteins c-myc; Rats; Rats, Sprague-Dawley; Signal Transduction",,"fisetin, 528-48-3; glutamate cysteine ligase, 9023-64-7; glutathione, 70-18-8; linsidomine, 16142-27-1, 33876-97-0; mitogen activated protein kinase, 142243-02-5; molsidomine, 25717-80-0; peroxynitrous acid, 14691-52-2; 3-morpholino-sydnonimine, 33876-97-0; Extracellular Signal-Regulated MAP Kinases, EC 2.7.1.37; fisetin, 528-48-3; Flavonoids; Glutathione, 70-18-8; Molsidomine, 25717-80-0; Neuroprotective Agents; NF-E2-Related Factor 2; Nfe2l2 protein, rat; Nitric Oxide Donors; Nitro Compounds; Peroxynitrous Acid, 14691-52-2; Proto-Oncogene Proteins c-myc",,,,"Alessi, D.R., Cohen, P., Dudley, D.T., Saltiel, A.R., PD98059 is a specific inhibitor of the mitogen-activated protein kinase kinase in vitro and in vivo (1995) J. Biol. Chem., 270, pp. 27489-27494; Andreadi, C.K., Howells, L.M., Atherfold, P.A., Manson, M.M., Involvement of Nrf2, p38, B-Raf, and nuclear factor-kappaB, but not phosphatidylinositol 3-kinase, in induction of hemeoxygenase-1 by dietary polyphenols (2006) Mol. Pharmacol., 69, pp. 1033-1040; Arnold, H.K., Sears, R.C., Protein phosphatase 2A regulatory subunit B56alpha associates with c-myc and negatively regulates c-myc accumulation (2006) Mol. Cell. Biol., 26, pp. 2832-2844; Bapat, S., Verkleij, A., Post, J.A., Peroxynitrite activates mitogen-activated protein kinase (MAPK) via a MEK-independent pathway: role for protein kinase C (2001) FEBS Lett., 499, pp. 21-26; Beckman, J.S., Beckman, T.W., Chen, J., Marshall, P.A., Freeman, B.A., Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide (1990) Proc. Natl. Acad. Sci. U. S. A., 87, pp. 1620-1624; Beckman, J.S., Ischiropoulos, H., Zhu, L., van der Woerd, M., Smith, C., Chen, J., Harrison, J., Tsai, M., Kinetics of superoxide dismutase- and iron-catalyzed nitration of phenolics by peroxynitrite (1992) Arch. Biochem. Biophys., 298, pp. 438-445; Benassi, B., Fanciulli, M., Fiorentino, F., Porrello, A., Chiorino, G., Loda, M., Zupi, G., Biroccio, A., c-Myc phosphorylation is required for cellular response to oxidative stress (2006) Mol. Cell, 21, pp. 509-519; Bolanos, J.P., Heales, S.J.R., Land, J.M., Clark, J.B., Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture (1995) J. Neurochem., 64, pp. 1965-1972; Brito, P.M., Mariano, A., Almeida, L.M., Dinis, T.C.P., Resveratrol affords protection against peroxynitrite-mediated endothelial cell death: a role for intracellular glutathione (2006) Chem. Biol. Interact., 164, pp. 157-166; Chen, C., Kong, A.-N.T., Dietary chemopreventive compounds and ARE/EpRE signaling (2004) Free Radic. Biol. Med., 36, pp. 1505-1516; Chen, T.J., Jeng, J.Y., Lin, C.W., Wu, C.Y., Chen, Y.C., Quercetin inhibition of ROS-dependent and -independent apoptosis in rat glioma C6 cells (2006) Toxicology, 223, pp. 113-126; Chen, Y.C., Chow, J.M., Lin, C.W., Wu, C.Y., Shen, S.C., Baicalein inhibition of oxidative stress-induced apoptosis via modulation of ERKs activation and induction of HO-1 gene expression in rat glioma cells C6 (2006) Toxicol. Appl. Pharmacol., 216, pp. 263-273; Choi, Y.J., Jeong, Y.J., Lee, Y.J., Kwon, H.M., Kang, Y.H., (-) Epigallocatechin gallate and quercetin enhance survival signaling in response to oxidant-induced human endothelial apoptosis (2005) J. Nutr., 135, pp. 707-713; Chong, H., Vikis, H.G., Guan, K.L., Mechanisms of regulating the Raf kinase family (2003) Cell. Signal., 15, pp. 463-469; Dajas, F., Rivera, F., Blasina, F., Arredondo, F., Echeverry, C., Lafon, L., Morquio, A., Heizen, H., Cell culture protection and in vivo neuroprotective capacity of flavonoids (2003) Neurotox. Res., 5, pp. 425-432; de Bernardo, S., Canals, S., Casarejos, M.J., Solano, R.M., Menendez, J., Mena, M.A., Role of extracellular signal-regulated protein kinase in neuronal cell death induced by glutathione depletion in neuron/glia mesencephalic cultures (2004) J. Neurochem., 91, pp. 667-682; Dickinson, D.A., Levonen, A.-L., Moellering, D.R., Arnold, E.K., Zhang, H., Darley-Usmar, V.M., Forman, H.J., Human glutamate cysteine ligase gene regulation through the electrophile response element (2004) Free Radic. Biol. Med., 37, pp. 1152-1159; Dringen, R., Oxidative and antioxidative potential of brain microglial cells (2005) Antioxid. Redox Signal., 7, pp. 1223-1233; El-Remessy, A.B., Ali Behzadian, M., Abou-Mohamed, G., Franklin, T., Caldwell, R.W., Caldwell, R.B., Experimental diabetes causes a breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor (2003) Am. J. Pathol., 162, pp. 1995-2004; Eliasson, M.J.L., Huang, Z., Ferrante, R.J., Sasamata, M., Molliver, M.E., Snyder, S.H., Moskowitz, M.A., Neuronal nitric oxide synthase activation and peroxynitrite formation in ischemic stroke linked to neuronal damage (1999) J. Neurosci., 19, pp. 5910-5918; Favata, M.F., Horiuchi, K.Y., Manos, E.J., Daulerio, A.J., Stradley, D.A., Feeser, W.S., Van Dyk, D.E., Trzaskos, J.M., Identification of a novel inhibitor of mitogen-activated protein kinase kinase (1998) J. Biol. Chem., 273, pp. 18623-18632; Hanneken, A., Lin, F.-F., Johnson, J., Maher, P., Flavonoids protect human pigmented retinal epithelial cells from oxidative stress-induced death (2006) Invest. Ophthalmol. Vis. Sci., 47, pp. 3164-3177; Hansen, M.B., Nielsen, S.E., Berg, K., Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill (1989) J. Immunol. Methods, 119, pp. 203-210; Heim, K.E., Tagliaferro, A.R., Bobilya, D.J., Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships (2002) J. Nutr. Biochem, 13, pp. 572-584; Ho, H.Y., Wei, T.T., Cheng, M.L., Chiu, D.T., Green tea polyphenol epigallocatechin-3-gallate protects cells against peroxynitrite-induced cytotoxicity: modulatory effect of cellular G6PD status (2006) J. Agric. Food Chem., 54, pp. 1638-1645; Hoeldtke, R.D., Bryner, K.D., McNeill, D.R., Hobbs, G.R., Baylis, C., Peroxynitrite versus nitric oxide in early diabetes (2003) Am. J. Hypertens, 16, pp. 761-766; Hou, D.-X., Fukuda, M., Johnson, J.A., Miyamori, K., Ushikai, M., Fujii, M., Fisetin induces transcription of NADPH:quinone oxidoreductase gene through an antioxidant responsive element-involved activation (2001) Int. J. Oncol., 18, pp. 1175-1179; Iravani, M.M., Haddon, C.O., Rose, S., Jenner, P., 3-Nitrotyrosine-dependent dopaminergic neurotoxicity following direct nigral administration of a peroxynitrite but not a nitric oxide donor (2006) Brain Res., 1067, pp. 256-262; Ischiropoulos, H., Zhu, L., Chen, J., Tsai, M., Martin, J.C., Smith, C.D., Beckman, J.S., Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase (1992) Arch. Biochem. Biophys., 298, pp. 431-437; Ishige, K., Schubert, D., Sagara, Y., Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms (2001) Free Radic. Biol. Med., 30, pp. 433-446; Ishii, N., Patel, K.P., Lane, P.H., Taylor, T., Bian, K., Murad, F., Pollock, J.S., Carmines, P.K., Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus (2001) J. Am. Soc. Nephrol., 12, pp. 1630-1639; Kensler, T.W., Wakabayashi, N., Biswal, S., Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway (2007) Annu. Rev. Pharmacol. Toxicol., 47, pp. 89-116; Klejman, A., Wegrzynowicz, M., Szatmari, E.M., Mioduszewska, B., Hetman, M., Albrecht, J., Mechanisms of ammonia-induced cell death in rat cortical neurons: roles of NMDA receptors and glutathione (2005) Neurochem. Int., 47, pp. 51-57; Klotz, L.-O., Oxidant-induced signaling: effects of peroxynitrite and singlet oxygen (2002) Biol. Chem., 383, pp. 443-456; Klotz, L.-O., Sies, H., Defenses against peroxynitrite: selenocompounds and flavonoids (2003) Toxicol. Lett., 140-141, pp. 125-132; Kuperstein, F., Yavin, E., ERK activation and nuclear translocation in amyloid-beta peptide- and iron-stressed neuronal cell cultures (2002) Eur. J. Neurosci., 16, pp. 44-54; Lau, F.C., Shukitt-Hale, J., Joseph, J., The beneficial effects of fruits polyphenols on brain aging (2005) Neurobiol. Aging, 26, pp. 128-132; Levinthal, D.J., DeFranco, D.B., Transient phosphatidylinositol 3-kinase inhibition protects immature primary cortical neurons from oxidative toxicity via suppression of extracellular signal-regulated kinase activation (2004) J. Biol. Chem., 279, pp. 11206-11213; Levrand, S., Pesse, B., Feihl, F., Waeber, B., Pacher, P., Rolli, J., Schaller, M.-D., Liaudet, L., Peroxynitrite is a potent inhibitor of NF-kB activation triggered by inflammatory stimuli in cardiac and endothelial cell lines (2005) J. Biol. Chem., 280, pp. 34878-34887; Li, Y., Maher, P., Schubert, D., A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion (1997) Neuron, 19, pp. 453-463; Lim, S.Y., Jang, J.H., Na, H.K., Lu, S.C., Rahman, I., Surh, Y.J., 15-Deoxy-delta 12,14-prostaglandin J(2) protects against nitrosative PC12 cell death through up-regulation of intracellular glutathione synthesis (2004) J. Biol. Chem., 279, pp. 46263-46270; Lin, H.C., Cheng, T.H., Chen, Y.C., Juan, S.H., Mechanism of heme oxygenase-1 gene induction by quercetin in rat aortic smooth muscle cells (2004) Pharmacology, 71, pp. 107-112; Maher, P., A comparison of the neurotrophic activities of the flavonoid fisetin and some of its derivatives (2006) Free Radic. Res., 40, pp. 1105-1111; Maher, P., Hanneken, A., Flavonoids protect retinal ganglion cells from oxidative stress-induced death (2005) Invest. Ophthalmol. Vis. Sci., 46, pp. 4796-4803; Maher, P., Akaishi, T., Abe, K., The flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory (2006) Proc. Natl. Acad. Sci. U. S. A., 103, pp. 16568-16573; Maher, P., Salgado, K.F., Zivin, J.A., Lapchak, P.A., A novel approach to screening for new neuroprotective compounds for the treatment of stroke (2007) Brain Res., 1173, pp. 117-125; Manabe, Y., Wang, J.M., Murakami, T., Warita, H., Hayashi, T., Shoji, M., Abe, K., Expressions of nitrotyrosine and TUNEL immunoreactivities in cultured rat spinal cord neurons after exposure to glutamate, nitric oxide, or peroxynitrite (2001) J. Neurosci. Res., 65, pp. 371-377; Middleton, E., Kandaswami, C., Theoharides, T.C., The effects of flavonoids on mammalian cells: implications for inflammation, heart disease and cancer (2000) Pharmacol. Rev., 52, pp. 673-751; Misko, T.P., Highkin, M.K., Veenhuizen, A.W., Manning, P.T., Stern, M.K., Currie, M.G., Salvemini, D., Characterization of the cytoprotective action of peroxynitrite decomposition catalysts (1998) J. Biol. Chem., 273, pp. 15646-15653; Myhrstad, M.C.W., Carlsen, H., Nordstrom, O., Blomhoff, R., Moskaug, J.O., Flavonoids increase the intracellular glutathione level by transactivation of the γ-glutamylcysteine synthetase catalytical subunit promoter (2002) Free Radic. Biol. Med., 32, pp. 386-393; Nakamura, K., Bindokas, V.P., Kowlessur, D., Elas, M., Milstein, S., Marks, J.D., Halpern, H.J., Kang, U.J., Tetrahydrobiopterin scavenges superoxide in dopaminergic neurons (2001) J. Biol. Chem., 276, pp. 34402-34407; Naoi, M., Maruyama, W., Shamoto-Nagai, M., Yi, H., Akao, Y., Tanaka, M., Oxidative stress in mitochondria (2005) Mol. Neurobiol., 31, pp. 81-93; Nguyen, T., Sherratt, P.J., Pickett, C.B., Regulatory mechanisms controlling gene expression mediated by the antioxidant response element (2003) Annu. Rev. Pharmacol. Toxicol., 43, pp. 233-260; Nowak, P., Olas, B., Bald, E., Glowacki, R., Wachowicz, B., Peroxynitrite-induced changes of thiol groups in human blood platelets (2003) Platelets, 14, pp. 375-379; Oh-hashi, K., Maruyama, W., Yi, H., Takahashi, T., Naoi, M., Isobe, K.-I., Mitogen-activated protein kinase pathway mediates peroxynitrite-induced apoptosis in human dopaminergic neuroblastoma SH-SY5Y cells (1999) Biochem. Biophys. Res. Commun., 263, pp. 504-509; Pannala, A., Rice-Evans, C.A., Halliwell, B., Singh, S., Inhibition of peroxynitrite-mediated tyrosine nitration by catechin polyphenols (1997) Biochem. Biophys. Res. Commun., 232, pp. 164-168; Radi, R., Beckman, J.S., Bush, K.M., Freeman, B.A., Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide (1991) J. Biol. Chem., 266, pp. 4244-42450; Rahman, I., Biswas, S.K., Kirkham, P.A., Regulation of inflammation and redox signaling by dietary polyphenols (2006) Biochem. Pharmacol., 72, pp. 1439-1452; Ramassamy, C., Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets (2006) Eur. J. Pharmacol., 545, pp. 51-64; Sagara, Y., Vahnnasy, J., Maher, P., Induction of PC12 cell differentiation by flavonoids is dependent upon extracellular signal-regulated kinase activation (2004) J. Neurochem., 90, pp. 1144-1155; Schieke, S.M., Briviba, K., Klotz, L.-O., Sies, H., Activation pattern of mitogen-activated protein kinases elicited by peroxynitrite: attentuation by selenite supplementation (1999) FEBS Lett., 448, pp. 301-303; Schreiber, E., Matthias, P., Muller, M.M., Schaffner, W., Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells (1989) Nucleic Acids Res., 17, p. 6419; Singh, I.N., Sullivan, P.G., Deng, Y., Mbye, L.H., Hall, E.D., Time course of post-traumatic mitochondrial oxidative damage and dysfunction in a mouse model of focal traumatic brain injury: implications for neuroprotective therapy (2006) J. Cereb. Blood Flow Metab., 26, pp. 1407-1418; Sun, X., Erb, H., Murphy, T.H., Coordinate regulation of glutathione metabolism in actrocytes by Nrf2 (2005) Biochem. Biophys. Res. Commun., 326, pp. 371-377; Thuraisingham, R.C., Nott, C.A., Dodd, S.M., Yaqoob, M.M., Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy (2000) Kidney Int., 57, pp. 1968-1972; Torreilles, F., Salman-Tabcheh, S., Guerin, M., Torreilles, J., Neurodegenerative disorders: the role of peroxynitrite (1999) Brain Res. Brain Res. Rev., 30, pp. 153-163; Valerio, L.G., Kepa, J.K., Pickwell, G.V., Quattrochi, L.C., Induction of human NAD(P)H:quinone oxidoreductase (NQO1) gene expression by the flavonol quercetin (2001) Toxicol. Lett., 119, pp. 49-57; van Acker, F.A., Schouten, O., Haenen, G.R., van der Vijgh, W.J., Bast, A., Flavonoids can replace alpha-tocopherol as an antioxidant (2000) FEBS Lett., 473, pp. 145-148; White, A.R., Cappai, R., Neurotoxicity from glutathione depletion is dependent on extracellular trace copper (2003) J. Neurosci. Res., 71, pp. 889-897; Wild, A.C., Mulcahy, R.T., Regulation of γ-glutamylcysteine synthetase subunit gene expression: insights into transcriptional control of antioxidant defenses (2000) Free Radic. Res., 32, pp. 281-301; Wu, Z., Wu, L., Tashiro, S., Onodera, S., Ikejima, T., Phosphorylated extracellular signal-regulated kinase up-regulated p53 expression in shikonon-induced HeLa cell apoptosis (2005) Chin. Med. J. (Engl.), 118, pp. 671-677; Wu, C.C., Hsu, M.C., Hsieh, C.W., Lin, J.B., Lai, P.H., Wung, B.S., Upregulation of heme oxygenase-1 by epigallocatechin-3-gallter via the phosphatidylinositol 3-kinase/Akt and ERK pathways (2006) Life Sci., 78, pp. 2889-2897; Zhang, D.D., Mechanistic studies of the Nrf2-Keap1 signaling pathway (2006) Drug Metab. Rev., 38, pp. 769-789; Zhang, Y., Rosenberg, P.A., Caspase-1 and poly (ADP-ribose) polymerase inhibitors may protect against peroxynitrite-induced neurotoxicity independent of their enzyme inhibitor activity (2004) Eur. J. Neurosci., 20, pp. 1727-1736; Zhang, P., Wang, Y.-Z., Kagan, E., Bonner, J.C., Peroxynitrite targets the epidermal growth factor receptor, Raf-1, and MEK independently to activate MAPK (2000) J. Biol. Chem., 275, pp. 22479-22486; Zhang, Y., Wang, H., Li, J., Jimenez, D.A., Levitan, E.S., Aizenman, E., Rosenberg, P.A., Peroxynitrite-induced neuronal apoptosis is mediated by intracellular zinc release and 12-lipoxygenase activation (2004) J. Neurosci., 24, pp. 10616-10627; Zouki, C., Jozsef, L., Ouellet, S., Paquette, Y., Filep, J.G., Peroxynitrite mediates cytokine-induced IL-8 gene expression and production by human leukocytes (2001) J. Leukoc. Biol., 69, pp. 815-824","Maher, P.; The Salk Institute For Biological Studies, Cellular Neurobiology Laboratory, 10010 N. Torrey Pines Rd, La Jolla, CA 92037, United States; email: pmaher@salk.edu",,,,,,,,00068993,,BRREA,18048013,"English","Brain Res.",Article,Scopus,2-s2.0-44449133306
"Lapchak, P.A., Maher, P., Schubert, D., Zivin, J.A.","Baicalein, an antioxidant 12/15-lipoxygenase inhibitor improves clinical rating scores following multiple infarct embolic strokes",2007,"Neuroscience","150","3",,"585","591",,63,10.1016/j.neuroscience.2007.09.033,"http://www.scopus.com/inward/record.url?eid=2-s2.0-36749068009&partnerID=40&md5=20ce2010ca458473fe2bf0a325ad9ad9","University of California, San Diego, Department of Neuroscience, 9500 Gilman Drive, La Jolla, CA 92093-0624, United States; Veterans Administration San Diego Healthcare System, 3350 La Jolla Village Drive, Room 6197, San Diego, CA 92161, United States; Veterans Medical Research Foundation, 3350 La Jolla Village Drive, San Diego, CA 92161, United States; The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037, United States","Lapchak, P.A., University of California, San Diego, Department of Neuroscience, 9500 Gilman Drive, La Jolla, CA 92093-0624, United States, Veterans Administration San Diego Healthcare System, 3350 La Jolla Village Drive, Room 6197, San Diego, CA 92161, United States, Veterans Medical Research Foundation, 3350 La Jolla Village Drive, San Diego, CA 92161, United States; Maher, P., The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037, United States; Schubert, D., The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037, United States; Zivin, J.A., University of California, San Diego, Department of Neuroscience, 9500 Gilman Drive, La Jolla, CA 92093-0624, United States, Veterans Administration San Diego Healthcare System, 3350 La Jolla Village Drive, Room 6197, San Diego, CA 92161, United States, Veterans Medical Research Foundation, 3350 La Jolla Village Drive, San Diego, CA 92161, United States","The present study assessed whether baicalein (5,6,7-trihydroxyflavone), a polyphenolic antioxidant 12/15-lipoxygenase inhibitor would attenuate oxidative cell death in vitro using a mouse hippocampal HT22 cell assay. Moreover, we determined if baicalein would be useful to attenuate behavioral deficits associated with multiple infarct ischemic events in vivo using a rabbit small clot embolic stroke model (RSCEM). Using HT22 cell in vitro, baicalein was shown to significantly promote cell survival with an estimated dose for 50% cell survival of 2 μM following incubation in the presence of iodoacetic acid (20 μM), an irreversible inhibitor of the glycolytic pathway that results in the free radical production, lipid peroxidation and cell death. Since baicalein was neuroprotective and attenuated iodoacetic acid (IAA) toxicity in vitro, we studied its effects in vivo in an embolic stroke model using behavioral measures as the endpoint. Quantal analysis for each treatment in the embolism model identifies the quantity of microclots (mg) that produce neurologic dysfunction in 50% of a group of animals (P 50), with intervention considered neuroprotective if it increases the P 50 compared with controls. Baicalein (100 mg/kg, s.c.) injected 5 and 60 min post-embolization significantly (P&lt;0.05) improved behavioral function. The calculated P 50 values were 2.85±0.64 mg (n=21) and 2.15±0.12 mg (n=14), respectively compared with 1.37±0.20 mg (n=23) for the control group. In conclusion, we have shown that baicalein effectively attenuated cell death in vitro using HT22 cells and also significantly reduced behavioral deficits in rabbits when given up to 1 h following an embolic stroke. The results suggest that baicalein, or derivatives of baicalein with multiple pharmacological activities may be useful to develop as novel treatments for acute ischemic stroke. © 2007 IBRO.","12/15-LOX inhibitor; anti-inflammatory; antioxidant; free radical; matrix metalloproteinase inhibitor; neuroprotection","baicalein; animal cell; animal experiment; article; cell death; cell survival; cerebrovascular accident; controlled study; drug effect; drug mechanism; in vitro study; motor performance; mouse; neuroprotection; nonhuman; oxidative stress; priority journal; rabbit; scoring system; Animals; Antioxidants; Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; Cell Survival; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Flavanones; Intracranial Embolism; Male; Motor Activity; Neuroprotective Agents; Oxidative Stress; Rabbits; Severity of Illness Index; Stroke",,"baicalein, 491-67-8; 12-15-lipoxygenase; Antioxidants; Arachidonate 12-Lipoxygenase, EC 1.13.11.31; Arachidonate 15-Lipoxygenase, EC 1.13.11.33; baicalein, 491-67-8; Flavanones; Neuroprotective Agents",,,,"Aronowski, J., Strong, R., Shirzadi, A., Grotta, J.C., Ethanol plus caffeine (caffeinol) for treatment of ischemic stroke: preclinical experience (2003) Stroke, 34, pp. 1246-1251; Bousova, I., Martin, J., Jahodar, L., Dusek, J., Palicka, V., Drsata, J., Evaluation of in vitro effects of natural substances of plant origin using a model of protein glycoxidation (2005) J Pharm Biomed Anal, 37, pp. 957-962; Broderick, J.P., Lu, M., Kothari, R., Levine, S.R., Lyden, P.D., Haley, E.C., Brott, T.G., Frankel, M., Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trial (2000) Stroke, 31, pp. 2335-2341; Buttke, T.M., McCubrey, J.A., Owen, T.C., Use of an aqueous soluble tetrazolium/formazan assay to measure viability and proliferation of lymphokine-dependent cell lines (1993) J Immunol Methods, 157, pp. 233-240; Christou, I., Alexandrov, A.V., Burgin, W.S., Wojner, A.W., Felberg, R.A., Malkoff, M., Grotta, J.C., Timing of recanalization after tissue plasminogen activator therapy determined by transcranial Doppler correlates with clinical recovery from ischemic stroke (2000) Stroke, 31, pp. 1812-1816; Grotta, J.C., Burgin, W.S., El-Mitwalli, A., Long, M., Campbell, M., Morgenstern, L.B., Malkoff, M., Alexandrov, A.V., Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000 (2001) Arch Neurol, 58, pp. 2009-2013; Hanneken, A., Lin, F.F., Johnson, J., Maher, P., Flavonoids protect human retinal pigment epithelial cells from oxidative-stress-induced death (2006) Invest Ophthalmol Vis Sci, 47, pp. 3164-3177; Huang, W.H., Lee, A.R., Chien, P.Y., Chou, T.C., Synthesis of baicalein derivatives as potential anti-aggregatory and anti-inflammatory agents (2005) J Pharm Pharmacol, 57, pp. 219-225; Huang, Y., Tsang, S.Y., Yao, X., Chen, Z.Y., Biological properties of baicalein in cardiovascular system (2005) Curr Drug Targets Cardiovasc Haematol Disord, 5, pp. 177-184; Lapchak, P.A., 3alpha-OL-5-beta-pregnan-20-one hemisuccinate, a steroidal low-affinity NMDA receptor antagonist improves clinical rating scores in a rabbit multiple infarct ischemia model: synergism with tissue plasminogen activator (2006) Exp Neurol, 197, pp. 531-537; Lapchak, P.A., Memantine, an uncompetitive low affinity NMDA open-channel antagonist improves clinical rating scores in a multiple infarct embolic stroke model in rabbits (2006) Brain Res, 1088, pp. 141-147; Lapchak, P.A., The phenylpropanoid micronutrient chlorogenic acid improves clinical rating scores in rabbits following multiple infarct ischemic strokes: Synergism with tissue plasminogen activator (2007) Exp Neurol, 205, pp. 407-413; Lapchak, P.A., Araujo, D.M., Advances in ischemic stroke treatment: neuroprotective and combination therapies (2007) Expert Opin Emerg Drugs, 12, pp. 97-112; Lapchak, P.A., Araujo, D.M., Song, D., Wei, J., Purdy, R., Zivin, J.A., Effects of the spin trap agent disodium-[tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) on intracerebral hemorrhage in a rabbit large clot embolic stroke model: combination studies with tissue plasminogen activator (2002) Stroke, 33, pp. 1665-1670; Lapchak, P.A., Araujo, D.M., Song, D., Wei, J., Zivin, J.A., Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: combination studies with the thrombolytic tissue plasminogen activator (2002) Stroke, 33, pp. 1411-1415; Lapchak, P.A., Araujo, D.M., Zivin, J.A., Comparison of tenecteplase with alteplase on clinical rating scores following small clot embolic strokes in rabbits (2004) Exp Neurol, 185, pp. 154-159; Lapchak, P.A., Song, D., Wei, J., Zivin, J.A., Coadministration of NXY-059 and tenecteplase six hours following embolic strokes in rabbits improves clinical rating scores (2004) Exp Neurol, 188, pp. 279-285; Lapchak, P.A., Wei, J., Zivin, J.A., Transcranial infrared laser therapy improves clinical rating scores after embolic strokes in rabbits (2004) Stroke, 35, pp. 1985-1988; Lapchak, P.A., Chapman, D.F., Zivin, J.A., Pharmacological effects of the spin trap agents N-t-butyl-phenylnitrone (PBN) and 2,2,6,6-tetramethylpiperidine-N-oxyl (TEMPO) in a rabbit thromboembolic stroke model: combination studies with the thrombolytic tissue plasminogen activator (2001) Stroke, 32, pp. 147-153; Lapchak, P.A., Zivin, J.A., Ebselen, a seleno-organic antioxidant, is neuroprotective after emoblic strokes in rabbits: Synergism with low dose tissue plasminogen activator (2003) Stroke, 34, pp. 2013-2018; Li, Y., Maher, P., Schubert, D., A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion (1997) Neuron, 19, pp. 453-463; Li, Y., Maher, P., Schubert, D., Phosphatidylcholine-specific phospholipase C regulates glutamate-induced nerve cell death (1998) Proc Natl Acad Sci U S A, 95, pp. 7748-7753; Ma, Z., Otsuyama, K., Liu, S., Abroun, S., Ishikawa, H., Tsuyama, N., Obata, M., Kawano, M.M., Baicalein, a component of Scutellaria radix from Huang-Lian-Jie-Du-Tang (HLJDT), leads to suppression of proliferation and induction of apoptosis in human myeloma cells (2005) Blood, 105, pp. 3312-3318; Rego, A.C., Areias, F.M., Santos, M.S., Oliveira, C.R., Distinct glycolysis inhibitors determine retinal cell sensitivity to glutamate-mediated injury (1999) Neurochem Res, 24, pp. 351-358; Roy, M.K., Nakahara, K., Na, T.V., Trakoontivakorn, G., Takenaka, M., Isobe, S., Tsushida, T., Baicalein, a flavonoid extracted from a methanolic extract of Oroxylum indicum inhibits proliferation of a cancer cell line in vitro via induction of apoptosis (2007) Pharmazie, 62, pp. 149-153; Sigalov, E., Fridkin, M., Brenneman, D.E., Gozes, I., VIP-Related protection against lodoacetate toxicity in pheochromocytoma (PC12) cells: a model for ischemic/hypoxic injury (2000) J Mol Neurosci, 15, pp. 147-154; Sperling, O., Bromberg, Y., Oelsner, H., Zoref-Shani, E., Reactive oxygen species play an important role in iodoacetate-induced neurotoxicity in primary rat neuronal cultures and in differentiated PC12 cells (2003) Neurosci Lett, 351, pp. 137-140; Tan, S., Sagara, Y., Liu, Y., Maher, P., Schubert, D., The regulation of reactive oxygen species production during programmed cell death (1998) J Cell Biol, 141, pp. 1423-1432; Tanahashi, N., Fukuuchi, Y., Treatment of acute ischemic stroke: recent progress (2002) Intern Med, 41, pp. 337-344; van Leyen, K., Kim, H.Y., Lee, S.R., Jin, G., Arai, K., Lo, E.H., Baicalein and 12/15-lipoxygenase in the ischemic brain (2006) Stroke, 37, pp. 3014-3018; Waud, D.R., On biological assays involving quantal responses (1972) J Pharmacol Exp Theory, 183, pp. 577-607; Zhang, L., Zhang, Z.G., Liu, X., Hozeska, A., Stagliano, N., Riordan, W., Lu, M., Chopp, M., Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator (2006) Thromb Haemost, 95, pp. 166-173; Zhang, L., Zhang, Z.G., Zhang, R.L., Lu, M., Adams, J., Elliott, P.J., Chopp, M., Postischemic (6-hour) treatment with recombinant human tissue plasminogen activator and proteasome inhibitor PS-519 reduces infarction in a rat model of embolic focal cerebral ischemia (2001) Stroke, 32, pp. 2926-2931; Zhang, L., Zhang, Z.G., Zhang, R.L., Lu, M., Krams, M., Chopp, M., Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke (2003) Stroke, 34, pp. 1790-1795; Zhang, R.L., Zhang, Z.G., Chopp, M., Increased therapeutic efficacy with rt-PA and anti-CD18 antibody treatment of stroke in the rat (1999) Neurology, 52, pp. 273-279; Zhao, X., Liu, S.J., Zhang, J., Strong, R., Aronowski, J., Grotta, J.C., Combining insulin-like growth factor derivatives plus caffeinol produces robust neuroprotection after stroke in rats (2005) Stroke, 36, pp. 129-134; Zivin, J.A., Grotta, J.C., Animal stroke models. They are relevant to human disease (1990) Stroke, 21, pp. 981-983; Zivin, J.A., Lyden, P.D., DeGirolami, U., Kochhar, A., Mazzarella, V., Hemenway, C.C., Johnston, P., Tissue plasminogen activator. Reduction of neurologic damage after experimental embolic stroke (1988) Arch Neurol, 45, pp. 387-391; Zivin, J.A., Waud, D.R., Quantal bioassay and stroke (1992) Stroke, 23, pp. 767-773","Lapchak, P.A.; University of California, San Diego, Department of Neuroscience, 9500 Gilman Drive, La Jolla, CA 92093-0624, United States; email: plapchak@ucsd.edu",,,,,,,,03064522,,NRSCD,17942241,"English","Neuroscience",Article,Scopus,2-s2.0-36749068009
"Cumming, R.C., Dargusch, R., Fischer, W.H., Schubert, D.","Increase in expression levels and resistance to sulfhydryl oxidation of peroxiredoxin isoforms in amyloid β-resistant nerve cells",2007,"Journal of Biological Chemistry","282","42",,"30523","30534",,38,10.1074/jbc.M700869200,"http://www.scopus.com/inward/record.url?eid=2-s2.0-35648943697&partnerID=40&md5=73a880bba961736e18d01a6b53a53c1a","Salk Institute for Biological Studies, Cellular Neurobiology Laboratory, San Diego, CA 92037, United States; Salk Institute for Biological Studies, Peptide Biology Laboratory, San Diego, CA 92037, United States; Salk Institute for Biological Studies, Cellular Neurobiology Laboratory, 10010 N. Torrey Pines Rd., San Diego, CA 92037, United States","Cumming, R.C., Salk Institute for Biological Studies, Cellular Neurobiology Laboratory, San Diego, CA 92037, United States; Dargusch, R., Salk Institute for Biological Studies, Cellular Neurobiology Laboratory, San Diego, CA 92037, United States; Fischer, W.H., Salk Institute for Biological Studies, Peptide Biology Laboratory, San Diego, CA 92037, United States; Schubert, D., Salk Institute for Biological Studies, Cellular Neurobiology Laboratory, San Diego, CA 92037, United States, Salk Institute for Biological Studies, Cellular Neurobiology Laboratory, 10010 N. Torrey Pines Rd., San Diego, CA 92037, United States","Peroxiredoxins (Prxs) are a ubiquitously expressed family of thiol peroxidases that reduce hydrogen peroxide, peroxynitrite, and hydroperoxides using a highly conserved cysteine. There is substantial evidence that oxidative stress elicited by amyloid β (Aβ) accumulation is a causative factor in the pathogenesis of Alzheimer disease (AD). Here we show that Aβ-resistant PC12 cell lines exhibit increased expression of multiple Prx isoforms with reduced cysteine oxidation. Aβ-resistant PC12 cells also display higher levels of thioredoxin and thioredoxin reductase, two enzymes critical for maintaining Prx activity. PC12 cells and rat primary hippocampal neurons transfected with wild type Prx1 exhibit increased Aβ resistance, whereas mutant Prx1, lacking a catalytic cysteine, confers no protection. Using an antibody that specifically recognizes sulfinylated and sulfonylated Prxs, it is demonstrated that primary rat cortical nerve cells exposed to Aβ display a time-dependent increase in cysteine oxidation of the catalytic site of Prxs that can be blocked by the addition of the thiol-antioxidant N-acetylcysteine. In support of previous findings, expression of Prx1 is higher in post-mortem human AD cortex tissues than in age-matched controls. In addition, two-dimensional gel electrophoresis and mass spectrometry analysis revealed that Prx2 exists in a more oxidized state in AD brains than in control brains. These findings suggest that increased Prx expression and resistance to sulfhydryl oxidation in Aβ-resistant nerve cells is a compensatory response to the oxidative stress initiated by chronic pro-oxidant Aβ exposure. © 2007 by The American Society for Biochemistry and Molecular Biology, Inc.",,"Amino acids; Catalyst activity; Diseases; Hydrogen peroxide; Oxidation; Oxidative stress; Tissue; Acetylcysteine; Alzheimer disease (AD); Hydroperoxides; Peroxynitrite; Neurons; acetylcysteine; amyloid beta protein; antioxidant; cysteine; isoprotein; peroxiredoxin; protein antibody; thiol derivative; thioredoxin; thioredoxin reductase; aged; Alzheimer disease; animal cell; article; autopsy; brain cell; brain cortex; brain region; catalysis; cell strain; control group; controlled study; female; genetic transfection; hippocampus; human; male; mass spectrometry; nerve cell; neuroprotection; nonhuman; oxidative stress; priority journal; protein function; rat; time; two dimensional gel electrophoresis; wild type; Acetylcysteine; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Protein; Animals; Catalytic Domain; Cerebellar Cortex; Female; Free Radical Scavengers; Gene Expression; Hippocampus; Humans; Isoenzymes; Male; Middle Aged; Neurons; Oxidation-Reduction; Oxidative Stress; PC12 Cells; Peroxiredoxins; Rats; Sulfhydryl Compounds; Rattus",,"acetylcysteine, 616-91-1; amyloid beta protein, 109770-29-8; cysteine, 4371-52-2, 52-89-1, 52-90-4; thiol derivative, 13940-21-1; thioredoxin reductase, 9074-14-0; thioredoxin, 52500-60-4; Acetylcysteine, 616-91-1; Amyloid beta-Protein; Free Radical Scavengers; Isoenzymes; Peroxiredoxins, EC 1.11.1.15; PRDX1 protein, human, EC 1.11.1.15; Prdx1 protein, rat, EC 1.11.1.14; PRDX2 protein, human, EC 1.11.1.15; Sulfhydryl Compounds",,,,"Butterfield, D.A., Griffin, S., Munch, G., Pasinetti, G.M., (2002) J. Alzheimers Dis, 4, pp. 193-201; Behl, C., Davis, J.B., Lesley, R., Schubert, D., (1994) Cell, 77, pp. 817-827; Aksenov, M.Y., Aksenova, M.V., Markesbery, W.R., Butterfield, D.A., (1998) J. Mol. Neurosci, 10, pp. 181-192; Butterfield, D.A., Lauderback, C.M., (2002) Free Radic. Biol. Med, 32, pp. 1050-1060; Sagara, Y., Dargusch, R., Klier, F.G., Schubert, D., Behl, C., (1996) J. Neurosci, 16, pp. 497-505; Yankner, B.A., Duffy, L.K., Kirschner, D.A., (1990) Science, 250, pp. 279-282; Soucek, T., Cumming, R., Dargusch, R., Maher, P., Schubert, D., (2003) Neuron, 39, pp. 43-56; Arner, E.S., Holmgren, A., (2000) Eur. J. Biochem, 267, pp. 6102-6109; Wood, Z.A., Schroder, E., Robin Harris, J., Poole, L.B., (2003) Trends Biochem. Sci, 28, pp. 32-40; Rhee, S.G., Kang, S.W., Jeong, W., Chang, T.S., Yang, K.S., Woo, H.A., (2005) Curr. Opin. Cell Biol, 17, pp. 183-189; Woo, H.A., Chae, H.Z., Hwang, S.C., Yang, K.S., Kang, S.W., Kim, K., Rhee, S.G., (2003) Science, 300, pp. 653-656; Woo, H.A., Jeong, W., Chang, T.S., Park, K.J., Park, S.J., Yang, J.S., Rhee, S.G., (2005) J. Biol. Chem, 280, pp. 3125-3128; Monteiro, G., Horta, B.B., Pimenta, D.C., Augusto, O., Netto, L.E., (2007) Proc. Natl. Acad. Sci. U. S. A, 104, pp. 4886-4891; Ralat, L.A., Manevich, Y., Fisher, A.B., Colman, R.F., (2006) Biochemistry, 45, pp. 360-372; Seo, M.S., Kang, S.W., Kim, K., Baines, I.C., Lee, T.H., Rhee, S.G., (2000) J. Biol. Chem, 275, pp. 20346-20354; Jin, M.H., Lee, Y.H., Kim, J.M., Sun, H.N., Moon, E.Y., Shong, M.H., Kim, S.U., Lee, D.S., (2005) Neurosci. Lett, 381, pp. 252-257; Krapfenbauer, K., Engidawork, E., Cairns, N., Fountoulakis, M., Lubec, G., (2003) Brain Res, 967, pp. 152-160; Basso, M., Giraudo, S., Corpillo, D., Bergamasco, B., Lopiano, L., Fasano, M., (2004) Proteomics, 4, pp. 3943-3952; Krapfenbauer, K., Yoo, B.C., Fountoulakis, M., Mitrova, E., Lubec, G., (2002) Electrophoresis, 23, pp. 2541-2547; Kato, S., Kato, M., Abe, Y., Matsumura, T., Nishino, T., Aoki, M., Itoyama, Y., Ohama, E., (2005) Acta Neuropathol. (Berl), 110, pp. 101-112; Li, Y., Maher, P., Schubert, D., (1997) Neuron, 19, pp. 453-463; Ohki, E.C., Tilkins, M.L., Ciccarone, V.C., Price, P.J., (2001) J. Neurosci. Methods, 112, pp. 95-99; Garrels, J.I., (1979) J. Biol. Chem, 254, pp. 7961-7977; Shevchenko, A., Wilm, M., Vorm, O., Mann, M., (1996) Anal. Chem, 68, pp. 850-858; Dargusch, R., Schubert, D., (2002) J. Neurochem, 81, pp. 1394-1400; Ichimiya, S., Davis, J.G., O'Rourke, D.M., Katsumata, M., Greene, M.I., (1997) DNA Cell Biol, 16, pp. 311-321; Zitzler, J., Link, D., Schafer, R., Liebetrau, W., Kazinski, M., Bonin-Debs, A., Behl, C., Brinkmann, U., (2004) Mol. Cell. Proteomics, 3, pp. 834-840; Yang, K.S., Kang, S.W., Woo, H.A., Hwang, S.C., Chae, H.Z., Kim, K., Rhee, S.G., (2002) J. Biol. Chem, 277, pp. 38029-38036; Woo, H.A., Kang, S.W., Kim, H.K., Yang, K.S., Chae, H.Z., Rhee, S.G., (2003) J. Biol. Chem, 278, pp. 47361-47364; Schonberger, S.J., Edgar, P.F., Kydd, R., Faull, R.L., Cooper, G.J., (2001) Proteomics, 1, pp. 1519-1528; Lovell, M.A., Xie, C., Gabbita, S.P., Markesbery, W.R., (2000) Free Radic. Biol. Med, 28, pp. 418-427; Chang, T.S., Jeong, W., Choi, S.Y., Yu, S.Q., Kang, S.W., Rhee, S.G., (2002) J. Biol. Chem, 277, pp. 25370-25376; Mukhopadhyay, S.S., Leung, K.S., Hicks, M.J., Hastings, P.J., Youssoufian, H., Plon, S.E., (2006) J. Cell Biol, 175, pp. 225-235; Wagner, E., Luche, S., Penna, L., Chevallet, M., Van Dorsselaer, A., Leize-Wagner, E., Rabilloud, T., (2002) Biochem. J, 366, pp. 777-785; Chevallet, M., Wagner, E., Luche, S., van Dorsselaer, A., Leize-Wagner, E., Rabilloud, T., (2003) J. Biol. Chem, 278, pp. 37146-37153; Hattori, F., Murayama, N., Noshita, T., Oikawa, S., (2003) J. Neurochem, 86, pp. 860-868; Sarafian, T.A., Verity, M.A., Vinters, H.V., Shih, C.C., Shi, L., Ji, X.D., Dong, L., Shau, H., (1999) J. Neurosci. Res, 56, pp. 206-212; D'Andrea, M.R., Cole, G.M., Ard, M.D., (2004) Neurobiol. Aging, 25, pp. 675-683; Johnstone, M., Gearing, A.J., Miller, K.M., (1999) J. Neuroimmunol, 93, pp. 182-193; Zabel, C., Sagi, D., Kaindl, A.M., Steireif, N., Klare, Y., Mao, L., Peters, H., Klose, J., (2006) J. Proteome Res, 5, pp. 1948-1958; Sizova, D., Charbaut, E., Delalande, F., Poirier, F., High, A.A., Parker, F., Van Dorsselaer, A., Diu-Hercend, A., (2007) Neurobiol. Aging, 28, pp. 357-370; Wilson, K.E., Marouga, R., Prime, J.E., Pashby, D.P., Orange, P.R., Crosier, S., Keith, A.B., Morris, C.M., (2005) Proteomics, 5, pp. 3851-3858; Akterin, S., Cowburn, R.F., Miranda-Vizuete, A., Jimenez, A., Bogdanovic, N., Winblad, B., Cedazo-Minguez, A., (2006) Cell Death Differ, 13, pp. 1454-1465; Chen, Z.H., Saito, Y., Yoshida, Y., Sekine, A., Noguchi, N., Niki, E., (2005) J. Biol. Chem, 280, pp. 41921-41927; Williams, J.F., (1980) Trends Biochem. Sci, 5, pp. 315-320; Schubert, D., (2005) Ageing Res. Rev, 4, pp. 240-257","Schubert, D.; Salk Institute for Biological Studies, Cellular Neurobiology Laboratory, 10010 N. Torrey Pines Rd., San Diego, CA 92037, United States; email: schubert@salk.edu",,,,,,,,00219258,,JBCHA,17761673,"English","J. Biol. Chem.",Article,Scopus,2-s2.0-35648943697
"Schubert, D.","Two views of the emperor's new clones [2]",2007,"Nature Biotechnology","25","3",,"282","283",,2,10.1038/nbt0307-282,"http://www.scopus.com/inward/record.url?eid=2-s2.0-33947144218&partnerID=40&md5=378909efa8dff70ef98a1da613fcba9e","Salk Institute, 10010 N. Torrey Pines Road, San Deigo, CA 92037, United States","Schubert, D., Salk Institute, 10010 N. Torrey Pines Road, San Deigo, CA 92037, United States",[No abstract available],,"animal product; cloning; food and drug administration; food biotechnology; food safety; letter; priority journal; Animals; Animals, Genetically Modified; Cloning, Organism; Commerce; Food Industry; Food Labeling; Food, Genetically Modified; Nuclear Transfer Techniques; Product Labeling; Safety; United States; United States Food and Drug Administration",,,,,,"Animal Cloning. A Draft Risk Assessment (2006) FDA Report Center for Veterinary Medicine, , http://www.fda.gov/cvm/Documents/Cloning_Risk_Assessment.pdf, Department of Health and Human Services, Rockville, MD; Pryce, J.E., Coffey, M.P., Brotherstone, S., (2000) J. Dairy Sci, 83, pp. 2664-2671; Tian, X.C., (2005) Proc. Natl. Acad. Sci. USA, 102, pp. 6261-6266; Shibata, M., (2006) J. Reprod. Dev, 52, pp. 583-590; Walker, S.C., (2007) Theriogenology, 67, pp. 178-184; Blelloch, R., (2006) Stem Cells, 24, pp. 2007-2013; Betts, D.H., (2005) Mol. Reprod. Dev, 72, pp. 461-470; Ortegon, H. et al. J. Theriogenology 67, 116-126 (2007)Green, M.S., (2002) Isr. Med. Assoc. J, 4, pp. 3-6; Rajput, A.H., (1992) Can. J. Neurol. Sci, 19, pp. 103-107; Wills, C., Green, D.R., (1995) Immunol. Rev, 143, pp. 263-292; Hwang, S.-C., Ko, W.-H., (2004) Plant Dis, 88, pp. 580-588; (2002) Animal Biotechnology: Science-Based Concerns, , http://www.nap.edu/books/0309084393/html, National Research Council, National Academies Press, Washington, DC; Vermij, P., (2006) Nat. Biotechnol, 24, pp. 1301-1302; Marvier, M., Van Acker, R., (2005) Front. Ecol. Environ, 3, pp. 93-100; Vogel, G., (2006) Science, 313, p. 1714; Pew Initiative on Food and Biotechnology/The Mellman Group. Public Sentiment About Genetically Engineered Foods, 2006 Survey (The Pew Charitable Trusts, Washington, DC, November 2006). 〈http://www.pewtrusts. com/pdf/pew_agbiotech_public1106.pdf〉(2005) Communique, 1-12. , ETC Group; Freese, W., Schubert, D., (2004) Biotechnology and Genetic Engineering Reviews, 21, pp. 299-325. , ed. Harding, S.E, Intercept Ltd, Andover","Schubert, D.; Salk Institute, 10010 N. Torrey Pines Road, San Deigo, CA 92037, United States; email: schubert@salk.edu",,,,,,,,10870156,,NABIF,17344873,"English","Nat. Biotechnol.",Letter,Scopus,2-s2.0-33947144218
"Schubert, D., Williams, D.","'Cisgenic' as a product designation [5]",2006,"Nature Biotechnology","24","11",,"1327","1329",,6,10.1038/nbt1106-1327,"http://www.scopus.com/inward/record.url?eid=2-s2.0-33750855286&partnerID=40&md5=db2fa33fdaa2abf19e5356cb1ae3a3a4","Cellular Neurobiology Laboratory, Salk Institute, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States; UCSD Department of Pharmacology, 9500 Gilman Drive 0912, San Diego, CA 92093-0912, United States","Schubert, D., Cellular Neurobiology Laboratory, Salk Institute, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States; Williams, D., UCSD Department of Pharmacology, 9500 Gilman Drive 0912, San Diego, CA 92093-0912, United States",[No abstract available],,"DNA fragment; plant DNA; biotechnology; Cauliflower mosaic virus; DNA modification; food packaging; gene technology; genetic linkage; genetic manipulation; genetic regulation; genetic similarity; genetic susceptibility; genetically modified crop; immune response; immunogenetics; letter; molecular epidemiology; nonhuman; plant breeding; plant genetics; priority journal; protein glycosylation; protein modification; transgenic plant; Breeding; Food Industry; Food, Genetically Modified; Plants, Genetically Modified; Product Labeling; Public Policy; Terminology",,,,,,"Schouten, H.J., Krens, F.A., Jacobsen, E., (2006) EMBO Rep., 7, pp. 750-753; Schaart, J.G., Towards consumer-friendly cisgenic strawberries which are less susceptible to Botrytis cinerea (2004) Plant Research International, 128. , Wageningen University, Wageningen, The Netherlands; Rommens, C.M., (2004) Plant Physiol., 135, pp. 421-431; Wilson, A., Latham, J., Steinbrecher, R., (2004) Genome Scrambling-myth or Reality. Transformation-induced Mutations in Plants, , EcoNexus, Brighton, UK; Prescott, V.E., (2005) J. Agric. Food Chem, 53, pp. 9023-9030; De Folter, S., Angenent, G.C., (2006) Trends Plant Sci., 11, pp. 224-231; Tetko, I.V., (2006) PLoS Comput. Biol., 2, pp. e21; Lessard, P.A., Kulaveerasingam, H., York, G.M., Strong, A., Sinskey, A.J., (2002) Metab. Eng., 4, pp. 67-79; Brodersen, P., Voinnet, O., (2006) Trends Genet., 22, pp. 268-280; Bradford, K.J., Van Deynze, A., Gutterson, N., Parrott, W., Strauss, S.H., (2005) Nat. Biotechnol., 23, pp. 439-444; Schubert, D., (2005) Nat. Biotechnol., 23, pp. 785-787; Lai, J., Li, Y., Messing, J., Dooner, H.K., (2005) Proc. Natl. Acad. Sci. USA, 102, pp. 9068-9073; Cecchini, E., Mulligan, B.J., Covey, S.N., Milner, J.J., (1998) Mutat. Res., 401, pp. 199-206; Vizir, I.Y., Thorlby, G., Mullian, B.J., (1996) Gene Isolation, Principles and Practice, pp. 215-245. , (eds. G.D. Foster & D. Twell) (Wiley, London); Cook, G.W.D., (2005) Genetically Modified Language. The Discourse of Arguments for GE Crops and Food, , Routledge, London; Bradford, K.J., Gutterson, N., Parrott, W., Van Deynze, A., Strauss, S.H., (2005) Nat. Biotechnol., 23, pp. 787-789; Fernandez-Cornejo, J., Caswell, M., (2006) Adoption of Bioengineered Crops, , United States Department of Agriculture, Economic Research Service, Washington; Kumar, S., Allen, G.C., Thompson, W.F., (2006) Trends Plant Sci., 11, pp. 159-161; Varshney, R.K., Graner, A., Sorrells, M.E., (2005) Trends Plant Sci., 10, pp. 621-630","Schubert, D.; Cellular Neurobiology Laboratory, Salk Institute, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States; email: schubert@salk.edu",,,,,,,,10870156,,NABIF,17093469,"English","Nat. Biotechnol.",Letter,Scopus,2-s2.0-33750855286
"Liu, Y., Ritter, C., Riek, R., Schubert, D.","The formation of bioactive amyloid species by prion proteins in vitro and in cells",2006,"Neuroscience Letters","406","3",,"200","204",,2,10.1016/j.neulet.2006.07.047,"http://www.scopus.com/inward/record.url?eid=2-s2.0-33748146884&partnerID=40&md5=3b972f4ef716c8ecc8ba54c40d2a37cf","Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, La Jolla, CA 92037-1099, United States; Structural Biology Laboratory, The Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, La Jolla, CA 92037-1099, United States","Liu, Y., Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, La Jolla, CA 92037-1099, United States; Ritter, C., Structural Biology Laboratory, The Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, La Jolla, CA 92037-1099, United States; Riek, R., Structural Biology Laboratory, The Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, La Jolla, CA 92037-1099, United States; Schubert, D., Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, La Jolla, CA 92037-1099, United States","Amyloid proteins are a group of proteins that can polymerize into cross β-sheeted amyloid species. We have found that enhancing cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) formazan exocytosis is a common property of bioactive amyloid species formed from all of the amyloid proteins tested to date. In this report, we show that the infectious amyloid species of the prion protein HET-s of the filamentous fungus Podospora anserina, like other amyloidogenic proteins, also enhances MTT formazan exocytosis. More strikingly, cellular MTT formazan exocytosis revealed the formation of bioactive amyloid species in prion-infected mouse N2a neuroblastoma cells. These findings suggest that cellular MTT formazan exocytosis can be useful for studying the roles of bioactive amyloid species in prion infectivity and prion-induced neurodegeneration. © 2006 Elsevier Ireland Ltd. All rights reserved.","Amyloid; HET-s; MTT; Prion protein","3 (4,5 dimethyl 2 thiazolyl) 2,5 diphenyltetrazolium bromide; amyloid; prion protein; animal cell; article; controlled study; exocytosis; fungus; in vitro selection; infection; mouse; nerve degeneration; neuroblastoma cell; nonhuman; Podospora anserina; polymerization; priority journal; species identification; Amyloid beta-Protein; Animals; Blotting, Western; Cell Line, Tumor; Drug Interactions; Formazans; Fungal Proteins; Mice; Neuroblastoma; Peptide Fragments; Podospora; Prions; Protein Conformation; Rats; Tetrazolium Salts; Time Factors",,"3 (4,5 dimethyl 2 thiazolyl) 2,5 diphenyltetrazolium bromide, 298-93-1; amyloid, 11061-24-8; Amyloid beta-Protein; Formazans; Fungal Proteins; HET-S protein, Podospora anserina; MTT formazan, 23305-68-2; Peptide Fragments; Prions; Tetrazolium Salts",,,,"Caughey, B., Race, R.E., Potent inhibition of scrapie-associated PrP accumulation by Congo red (1992) J. Neurochem., 59, pp. 768-771; Caughey, B.W., Dong, A., Bhat, K.S., Ernst, D., Hayes, S.F., Caughey, W.S., Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy (1991) Biochemistry, 30, pp. 7672-7680; Caughey, W.S., Raymond, L.D., Horiuchi, M., Caughey, B., Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines (1998) Proc. Natl. Acad. Sci. U.S.A., 95, pp. 12117-12122; Coustou, V., Deleu, C., Saupe, S., Bégueret, J., The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog (1997) Proc. Natl. Acad. Sci. U.S.A., 94, pp. 9773-9778; Dos Reis, S., Coulary-Salin, B., Forge, V., Lascu, I., Begueret, J., Saupe, S.J., The HET-s prion protein of the filamentous fungus Podospora anserina aggregates in vitro into amyloid-like fibrils (2002) J. Biol. Chem., 277, pp. 5703-5706; Glenner, G.G., Eanes, E.D., Bladen, H.A., Linke, R.P., Termine, J.D., A comparison of native amyloid with synthetic protein fibrils (1974) J. Histochem. Cytochem., 22, pp. 1141-1158; Glover, J.R., Kowal, A.S., Schirmer, E.C., Patino, M.M., Liu, J.J., Lindquist, S., Self-seeded fibers formed by Sup35, the protein determinant of [PSI+], a heritable prion-like factor of S. cerevisiae (1997) Cell, 89, pp. 811-819; Legname, G., Baskakov, I.V., Nguyen, H.O., Riesner, D., Cohen, F.E., DeArmond, S.J., Prusiner, S.B., Synthetic mammalian prions (2004) Science, 305, pp. 673-676; Liu, Y., Schubert, D., Steroid hormones block amyloid fibril-induced MTT formazan exocytosis: relationship to neurotoxicity (1998) J. Neurochem., 71, pp. 2322-2329; Liu, Y., Understanding the biological activity of amyloid proteins in vitro: from inhibited cellular MTT reduction to altered cellular cholesterol homeostasis (1999) Prog. Neuro-Psychopharmacol. & Psychiat., 23, pp. 377-395; Liu, Y., Dargusch, D., Banh, C., Miller, C.A., Schubert, D., Detecting bioactive amyloid β peptide species in Alzheimer's disease (2004) J. Neurochem., 91, pp. 648-656; Liu, Y., Peterson, D., Schubert, D., Amyloid β peptide alters intracellular vesicle trafficking and cholesterol homeostasis (1998) Proc. Natl. Acad. Sci. U.S.A., 95, pp. 13266-13271; Liu, Y., Peterson, D., Kimura, H., Schubert, D., The mechanism of cellular MTT reduction (1997) J. Neurochem., 69, pp. 581-593; Liu, Y., Piasecki, D., A cell-based method for the detection of nanomolar concentrations of bioactive amyloid (2001) Anal. Biochem., 289, pp. 130-136; Liu, Y., Schubert, D., Cytotoxic amyloid peptides inhibit cellular MTT reduction by enhancing MTT formazan exocytosis (1997) J. Neurochem., 69, pp. 2285-2293; Maddelein, M.L., Dos Reis, S., Duvezin-Caubet, S., Coulary-Salin, B., Saupe, S.J., Amyloid aggregates of the Het-s prion protein are infectious (2002) Proc. Natl. Acad. Sci., 91, pp. 648-656; Prusiner, S.B., McKinley, M.P., Bowman, K.A., Bolton, D.C., Bendheim, P.E., Groth, D.F., Glenner, G.G., Scrapie prions aggregate to form amyloid-like birefringent rods (1983) Cell, 35, pp. 349-358; Ritter, C., Maddelein, M.L., Siemer, A.B., Luhrs, T., Ernst, M., Meier, B.H., Saupe, S.J., Riek, R., Correlation of structural elements and infectivity of the HET-s prion (2005) Nature, 435, pp. 844-848; Schubert, D., Heinemann, S., Carlisle, W., Tarika, H., Kimes, B., Steinbach, J.H., Culp, W., Brandt, B.L., Clonal cell lines from the rat central nervous system (1974) Nature, 249, pp. 224-227; Sipe, J.D., Amyloidosis (1992) Ann. Rev. Biochem., 61, pp. 947-975; Wickner, R.B., Taylor, K.L., Edskes, H.K., Maddeleein, M.L., Moriyama, H., Roberts, T., Yeast prions act as genes composed of self-propagating protein amyloids (2001) Adv. Prot. Chem., 57, pp. 313-334","Schubert, D.; Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, La Jolla, CA 92037-1099, United States; email: schubert@salk.edu",,,,,,,,03043940,,NELED,16916580,"English","Neurosci. Lett.",Article,Scopus,2-s2.0-33748146884
"Diambra, L., Cintra, L.C., Chen, Q., Schubert, D., Costa, L.d.F.","Cell adhesion protein decreases cell motion: Statistical characterization of locomotion activity",2006,"Physica A: Statistical Mechanics and its Applications","365","2",,"481","490",,4,10.1016/j.physa.2005.10.006,"http://www.scopus.com/inward/record.url?eid=2-s2.0-33646110740&partnerID=40&md5=b11ef3ba4782a9633e342599cd47e3a4","Instituto de Física de São Carlos, Universidade de São Paulo, Caixa Postal: 369, cep, 13560-970 São Carlos, SP, Brazil; The Salk Institute, 10010 N. Torrey Pines Road, La Jolla, CA 92037, United States","Diambra, L., Instituto de Física de São Carlos, Universidade de São Paulo, Caixa Postal: 369, cep, 13560-970 São Carlos, SP, Brazil; Cintra, L.C., Instituto de Física de São Carlos, Universidade de São Paulo, Caixa Postal: 369, cep, 13560-970 São Carlos, SP, Brazil; Chen, Q., The Salk Institute, 10010 N. Torrey Pines Road, La Jolla, CA 92037, United States; Schubert, D., The Salk Institute, 10010 N. Torrey Pines Road, La Jolla, CA 92037, United States; Costa, L.d.F., Instituto de Física de São Carlos, Universidade de São Paulo, Caixa Postal: 369, cep, 13560-970 São Carlos, SP, Brazil","This manuscript uses a statistical-mechanical approach to study the effect of the adhesion, caused by the modifier of cell adhesion (MOCA) protein on cell locomotion. The MOCA protein regulates cell-cell adhesion, and we explore its potential role in cell movement. We present a series of statistical descriptions to characterize cell movement, and find that MOCA affects the statistical scenario of cell locomotion. In particular, MOCA enhances the tendency of joint motion and decreases overall cell motion. Furthermore, we observe that non-interacting cells that express the MOCA protein have smaller mean velocities than interacting cells, and seem to exhibit normal diffusion. In contrast, control cells exhibit anomalous diffusion independent of interactions with other cells. Furthermore, we observe that in many cases the velocity distribution tails are longer than those predicted by the Maxwell-Boltzmann distribution, indicating that cell movement is more complex than molecules. © 2005 Elsevier B.V. All rights reserved.","Anomalous diffusion; Cell adhesion; Cell motion","Biped locomotion; Cell culture; Computational complexity; Maxwell equations; Statistical mechanics; Statistics; Anomalous diffusion; Cell adhesion; Cell motion; Proteins",,,,,,"Abercrombie, M., Heaysman, J.E., Pegrum, S.M., (1970) Exp. Cell Res., 59, p. 393; Revenu, C., Athman, R., Robine, S., Louvard, D., (2004) Nat. Rev. Mol. Cell Biol., 5, p. 635; Welch, M.D., Iwamatsu, A., Mitchison, T.J., (1997) Nature, 385, p. 265; Santos Da Silva, J., Dotti, C.G., (2002) Nat. Rev. Neurosci., 3, p. 694; McNeill, H., Ryan, T.A., Smith, S.J., Nelson, W.J., (1993) J. Cell Biol., 120, p. 1217; Kobielak, A., Fuchs, E., (2004) Nat. Rev. Mol. Cell Biol., 5, p. 614; Negulescu, P.A., Krasieva, T.B., Khan, A., Kerschbaum, H., Cahalan, M.D., (1996) Immunity, 4, p. 421; Chicoine, M.R., Silbergeld, D.L., (1995) Cancer, 75, p. 2904; Rieu, J.P., Kataoka, N., Sawada, Y., (1998) Phys. Rev. E, 57, p. 924; Beysens, D.A., Forgacs, G., Glazier, J.A., (2000) Proc. Natl. Acad. Sci. USA, 97, p. 9467; O'Rourke, N.A., Dailey, M.E., Smith, S.J., McConnell, S.K., (1992) Science, 258, p. 299; Bray, D., (1992) Cell Movements, , Garland, New York; Upadhyaya, A., Rieu, J.P., Glazier, J.A., Sawada, Y., (2001) Physica A, 293, pp. 549-558; Glazier, J.A., Graner, F., (1993) Phys. Rev. E, 47, p. 2128; Mombach, J.C.M., Glazier, J.A., (1996) Phys. Rev. Lett., 76, p. 3032; Czirók, A., Schlett, K., Madarász, E., Vicsek, T., (1998) Phys. Rev. Lett., 81, p. 3038; Rieu, J.P., Upadhyaya, A., Glazier, J.A., Ouchi, B., Sawada, Y., (2000) Biophys. J., 79, p. 1903; Kashiwa, A., Yoshida, H., Lee, S., Paladino, T., Liu, Y., Chen, Q., Dargush, R., Kimura, H., (2000) J. Neurochem., 75, p. 109; Jalink, K., van Corven, E.J., Hengeveld, T., Morii, N., Narumiya, S., Moonlenauar, W.H., (1994) J. Cell Biol., 126, p. 801; Albert, M.L., Kim, J.L., Birge, R.B., (2000) Nat. Cell Biol., 2, p. 899; Namekata, K., Enokido, Y., Iwasawa, K., Kimura, K., (2004) J. Biol. Chem., 279, p. 14331; Chen, Q., Chen, T.-J., Letourneau, P.C., Costa, L.D., Schubert, D., (2005) J. Neurosci., 25, p. 281; Chen, Q., Kimura, H., Schubert, D., (2002) J. Cell Biol., 158, p. 79; Shreiber, D.I., Barocas, V.H., Tranquillo, R.T., (2003) Biophys. J., 84, p. 4102; Bouchaud, J.P., Georges, A., (1990) Phys. Rep., 195, p. 127; Tsallis, C., Bukman, D.J., (1996) Phys. Rev. E, 54, pp. R2197; Mogilner, A., Edelstein-Keshet, L., (2002) Biophys. J., 83, p. 1237","Diambra, L.; Instituto de Física de São Carlos, Universidade de São Paulo, Caixa Postal: 369, cep, 13560-970 São Carlos, SP, Brazil; email: diambra@univap.br",,,,,,,,03784371,,PHYAD,,"English","Phys A Stat Mech Appl",Article,Scopus,2-s2.0-33646110740
"Burdo, J., Dargusch, R., Schubert, D.","Distribution of the cystine/glutamate antiporter system xc - in the brain, kidney, and duodenum",2006,"Journal of Histochemistry and Cytochemistry","54","5",,"549","557",,74,10.1369/jhc.5A6840.2006,"http://www.scopus.com/inward/record.url?eid=2-s2.0-33646018919&partnerID=40&md5=93771b0ee8e88ace8122eb8b3079297a","Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; Salk Institute for Biological Studies, 10010 N. Torrey Pines Rd., San Diego, CA 92037, United States","Burdo, J., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; Dargusch, R., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; Schubert, D., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States, Salk Institute for Biological Studies, 10010 N. Torrey Pines Rd., San Diego, CA 92037, United States","System xc -, one of the main transporters responsible for central nervous system cystine transport, is comprised of two subunits, xCT and 4F2hc. The transport of cystine into cells is rate limiting for glutathione synthesis, the major antioxidant and redox cofactor in the brain. Alterations in glutathione status are prevalent in numerous neurodegenerative diseases, emphasizing the importance of proper cystine homeostasis. However, the distribution of xCT and 4F2hc within the brain and other areas has not been described. Using specific antibodies, both xCT and 4F2hc were localized predominantly to neurons in the mouse and human brain, but some glial cells were labeled as well. Border areas between the brain proper and periphery including the vascular endothelial cells, ependymal cells, choroid plexus, and leptomeninges were also highly positive for the system xc - components. xCT and 4F2hc are also present at the brush border membranes in the kidney and duodenum. These results indicate that system xc - is likely to play a role in cellular health throughout many areas of the brain as well as other organs by maintaining intracellular cystine levels, thereby resulting in low levels of oxidative stress. © The Histochemical Society, Inc.","4F2hc; Brain; Cystine; Cystinuria; Duodenum; Glutathione; Kidney; System xc -; xCT","antioxidant; antiporter; cystine; glutamate transporter; glutamate transporter system Xc; glutathione; protein subunit; unclassified drug; adolescent; animal cell; animal tissue; article; brain; brush border; central nervous system; choroid plexus; controlled study; degenerative disease; duodenum; ependyma cell; glia cell; glutathione metabolism; homeostasis; kidney; meninx; mouse; nonhuman; oxidation reduction reaction; oxidative stress; priority journal; protein localization; vascular endothelium; Amino Acid Transport System y+; Animals; Antigens, CD98 Heavy Chain; Brain; Cell Line; Duodenum; Haplorhini; Humans; Immunoblotting; Immunohistochemistry; Kidney; Mice; Mice, Inbred C57BL; Neuroglia; Neurons; Oxidative Stress; RNA Interference; Animalia",,"cystine, 24645-67-8, 56-89-3, 6020-39-9; glutathione, 70-18-8; Amino Acid Transport System y+; Antigens, CD98 Heavy Chain; SLC7A11 protein, human; Slc7a11 protein, mouse",,,,"Adams Jr., J.D., Klaidman, L.K., Odunze, I.N., Shen, H.C., Miller, C.A., Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E (1991) Mol Chem Neuropathol, 14, pp. 213-226; Awapara, J., Wingo, W.J., On the mechanism of taurine formation from cysteine in the rat (1953) J Biol Chem, 203, pp. 189-194; Bannai, S., Transport of cystine and cysteine in mammalian cells (1984) Biochim Biophys Acta, 779, pp. 289-306; Bannai, S., Kitamura, E., Transport interaction of L-cystine and L-glutamate in human diploid fibroblasts in culture (1980) J Biol Chem, 255, pp. 2372-2376; Bannai, S., Takada, A., Kasuga, H., Tateishi, N., Induction of cystine transport activity in isolated rat hepatocytes by sulfobromophthalein and other electrophilic agents (1986) Hepatology, 6, pp. 1361-1368; Bassi, M.T., Gasol, E., Manzoni, M., Pineda, M., Riboni, M., Martin, R., Zorzano, A., Identification and characterisation of human xCT that co-expresses, with 4F2 heavy chain, the amino acid transport activity system xc (2001) Pflugers Arch, 442, pp. 286-296; Benrabh, H., Lefauconnier, J.M., Glutamate is transported across the rat blood-brain barrier by a sodium-independent system (1996) Neurosci Lett, 210, pp. 9-12; Blasco, T., Aramayona, J.J., Alcalde, A.I., Catalan, J., Sarasa, M., Sorribas, V., Rat kidney MAP17 induces cotransport of Na-mannose and Na-glucose in Xenopus laevis oocytes (2003) Am J Physiol Renal Physiol, 285, pp. F799-F810; Chen, C.J., Liao, S.L., Kuo, J.S., Gliotoxic action of glutamate on cultured astrocytes (2000) J Neurochem, 75, pp. 1557-1565; Cho, Y., Bannai, S., Uptake of glutamate and cysteine in C-6 glioma cells and in cultured astrocytes (1990) J Neurochem, 55, pp. 2091-2097; Cooper, A.J., Biochemistry of sulfur-containing amino acids (1983) Annu Rev Biochem, 52, pp. 187-222; Davis, J.B., Maher, P., Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line (1994) Brain Res, 652, pp. 169-173; Dringen, R., Glutathione metabolism and oxidative stress in neurodegeneration (2000) Eur J Biochem, 267, p. 4903; Droge, W., Eck, H.P., Gmunder, H., Mihm, S., Modulation of lymphocyte functions and immune responses by cysteine and cysteine derivatives (1991) Am J Med, 91, pp. 140-1445; Froissard, P., Monrocq, H., Duval, D., Role of glutathione metabolism in the glutamate-induced programmed cell death of neuronal-like PC12 cells (1997) Eur J Pharmacol, 326, pp. 93-99; Furlong, T.J., Stiel, D., Decreased uptake of L-cystine by duodenal brush border membrane vesicles from patients with cystinuria (1993) Aust NZ J Med, 23, pp. 258-263; Gochenauer, G.E., Robinson, M.B., Dibutyryl-cAMP (dbcAMP) up-regulates astrocytic chloride-dependent L-[3H]glutamate transport and expression of both system xc(-) subunits (2001) J Neurochem, 78, pp. 276-286; Helboe, L., Egebjerg, J., Moller, M., Thomsen, C., Distribution and pharmacology of alanine-serine-cysteine transporter 1 (asc-1) in rodent brain (2003) Eur J Neurosci, 18, pp. 2227-2238; Hemler, M.E., Strominger, J.L., Characterization of antigen recognized by the monoclonal antibody (4F2): Different molecular forms on human T and B lymphoblastoid cell lines (1982) J Immunol, 129, pp. 623-628; Hosoya, K., Tomi, M., Ohtsuki, S., Takanaga, H., Saeki, S., Kanai, Y., Endou, H., Enhancement of L-cystine transport activity and its relation to xCT gene induction at the blood-brain barrier by diethyl maleate treatment (2002) J Pharmacol Exp Ther, 302, pp. 225-231; Kim, J.Y., Kanai, Y., Chairoungdua, A., Cha, S.H., Matsuo, H., Kim, D.K., Inatomi, J., Human cystine/glutamate transporter: CDNA cloning and upregulation by oxidative stress in glioma cells (2001) Biochim Biophys Acta, 1512, pp. 335-344; Kolesnikova, T.V., Mannion, B.A., Berditchevski, F., Hemler, M.E., Beta1 integrins show specific association with CD98 protein in low density membranes (2001) BMC Biochem, 2, p. 10. , Published online October 15, 2001; Lewerenz, J., Letz, J., Methner, A., Activation of stimulatory heterotrimeric G proteins increases glutathione and protects neuronal cells against oxidative stress (2003) J Neurochem, 87, pp. 522-531; Li, Y., Maher, P., Schubert, D., Requirement for cGMP in nerve cell death caused by glutathione depletion (1997) J Cell Biol, 139, pp. 1317-1324; Li, Y., Maher, P., Schubert, D., A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion (1997) Neuron, 19, pp. 453-463; Lim, J., Lam, Y.C., Kistler, J., Donaldson, P.J., Molecular characterization of the cystine/glutamate exchanger and the excitatory amino acid transporters in the rat lens (2005) Invest Ophthalmol Vis Sci, 46, pp. 2869-2877; Maher, P., Davis, J.B., The role of monoamine metabolism in oxidative glutamate toxicity (1996) J Neurosci, 16, pp. 6394-6401; Murphy, T.H., Baraban, J.M., Glutamate toxicity in immature cortical neurons precedes development of glutamate receptor currents (1990) Brain Res Dev Brain Res, 57, pp. 146-150; Murphy, T.H., Miyamoto, M., Sastre, A., Schnaar, R.L., Coyle, J.T., Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress (1989) Neuron, 2, pp. 1547-1558; Murphy, T.H., Schnaar, R.L., Coyle, J.T., Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake (1990) FASEB J, 4, pp. 1624-1633; Nawashiro, H., Otani, N., Shinomiya, N., Fukui, S., Nomura, N., Yano, A., Shima, K., The role of CD98 in astrocytic neoplasms (2002) Hum Cell, 15, pp. 25-31; Oka, A., Belliveau, M.J., Rosenberg, P.A., Volpe, J.J., Vulnerability of oligodendroglia to glutamate: Pharmacology, mechanisms, and prevention (1993) J Neurosci, 13, pp. 1441-1453; Orrenius, S., Ormstad, K., Thor, H., Jewell, S.A., Turnover and functions of glutathione studied with isolated hepatic and renal cells (1983) Fed Proc, 42, pp. 3177-3188; Overvoorde, P.J., Chao, W.S., Grimes, H.D., A plasma membrane sucrose-binding protein that mediates sucrose uptake shares structural and sequence similarity with seed storage proteins but remains functionally distinct (1997) J Biol Chem, 272, pp. 15898-15904; Piani, D., Fontana, A., Involvement of the cystine transport system xc- in the macrophage-induced glutamate-dependent cytotoxicity to neurons (1994) J Immunol, 152, pp. 3578-3585; Quackenbush, E.J., Linsley, P., Letarte, M., Mouse L cells express a molecular complex carrying the human epitopes recognized by monoclonal antibodies 44D7 and 44H7 after DNA-mediated gene transfer (1986) J Immunol, 137, pp. 234-239; Sagara, J., Miura, K., Bannai, S., Cystine uptake and glutathione level in fetal brain cells in primary culture and in suspension (1993) J Neurochem, 61, pp. 1667-1671; Sagara, Y., Schubert, D., The activation of metabotropic glutamate receptors protects nerve cells from oxidative stress (1998) J Neurosci, 18, pp. 6662-6671; Sato, H., Tamba, M., Ishii, T., Bannai, S., Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins (1999) J Biol Chem, 274, pp. 11455-11458; Sato, H., Tamba, M., Okuno, S., Sato, K., Keino-Masu, K., Masu, M., Bannai, S., Distribution of cystine/glutamate exchange transporter, system x(c)-, in the mouse brain (2002) J Neurosci, 22, pp. 8028-8033; Satoh, T., Ishige, K., Sagara, Y., Protective effects on neuronal cells of mouse afforded by ebselen against oxidative stress at multiple steps (2004) Neurosci Lett, 371, pp. 1-5; Shih, A.Y., Johnson, D.A., Wong, G., Kraft, A.D., Jiang, L., Erb, H., Johnson, J.A., Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress (2003) J Neurosci, 23, pp. 3394-3406; Sian, J., Dexter, D.T., Lees, A.J., Daniel, S., Agid, Y., Javoy-Agid, F., Jenner, P., Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia (1994) Ann Neurol, 36, pp. 348-355; Sticht, H., Rosch, P., The structure of iron-sulfur proteins (1998) Prog Biophys Mol Biol, 70, pp. 95-136; Tan, S., Schubert, D., Maher, P., Oxytosis: A novel form of programmed cell death (2001) Curr Top Med Chem, 1, pp. 497-506; Tan, S., Wood, M., Maher, P., Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells (1998) J Neurochem, 71, pp. 95-105; Tetsuka, K., Hosoya, K.I., Ohtsuki, S., Takanag, H., Yanai, N., Ueda, M., Obinata, M., Acidic amino acid transport characteristics of a newly developed conditionally immortalized rat type 2 astrocyte cell line (TR-AST) (2001) Cell Struct Funct, 26, pp. 197-203; Tomi, M., Funaki, T., Abukawa, H., Katayama, K., Kondo, T., Ohtsuki, S., Ueda, M., Expression and regulation of L-cystine transporter, system xc-, in the newly developed rat retinal Muller cell line (TR-MUL) (2003) Glia, 43, pp. 208-217; Tomi, M., Hosoya, K., Takanaga, H., Ohtsuki, S., Terasaki, T., Induction of xCT gene expression and L-cystine transport activity by diethyl maleate at the inner blood-retinal barrier (2002) Invest Ophthalmol Vis Sci, 43, pp. 774-779; Wang, H., Tamba, M., Kimata, M., Sakamoto, K., Bannai, S., Sato, H., Expression of the activity of cystine/glutamate exchange transporter, system x(c)(-), by xCT and rBAT (2003) Biochem Biophys Res Commun, 305, pp. 611-618; Wang, X.F., Cynader, M.S., Astrocytes provide cysteine to neurons by releasing glutathione (2000) J Neurochem, 74, pp. 1434-1442; Watanabe, H., Bannai, S., Induction of cystine transport activity in mouse peritoneal macrophages (1987) J Exp Med, 165, pp. 628-640; Zolotarev, A.S., Shmukler, B.E., Alper, S.L., AE2 anion exchanger polypeptide is a homooligomer in pig gastric membranes: A chemical cross-linking study (1999) Biochemistry, 38, pp. 8521-8531","Schubert, D.; Salk Institute for Biological Studies, 10010 N. Torrey Pines Rd., San Diego, CA 92037, United States; email: Schubert@salk.edu",,,,,,,,00221554,,JHCYA,16399997,"English","J. Histochem. Cytochem.",Article,Scopus,2-s2.0-33646018919
"Liu, Y., Schubert, D.","Treating Alzheimer's disease by inactivating bioactive amyloid β peptide",2006,"Current Alzheimer Research","3","2",,"129","135",,7,10.2174/156720506776383077,"http://www.scopus.com/inward/record.url?eid=2-s2.0-33645813416&partnerID=40&md5=b32f5e878c447b1f906302f7b41fa3e8","Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037-1099, United States","Liu, Y., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037-1099, United States; Schubert, D., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037-1099, United States","Treating Alzheimer's disease (AD) is one of today's biggest unmet medical needs. The drugs currently available transiently relieve some symptoms but have no significant effects on the progression of the disease. Progress in the past decade suggests that the amyloidogenesis of the inactive monomeric amyloid β peptide (Aβ) into a subset of toxic Aβ polymers is responsible for neurodegeneration in AD. Not all forms of Aβ aggregates are damaging, for there are patients whose brains accumulated large amounts of Aβ in the form of plaques, but they had no obvious neurodegeneration and symptoms of dementia. Since Aβ can polymerize into many types of polymers or aggregates, the form of Aβ that induces neurodegeneration in AD, defined here as bioactive Aβ, is not clear. Preventing the formation of bioactive Aβ or inactivating previously formed bioactive Aβ is a promising approach for treating AD. This review describes our efforts to develop a cell-based assay for detecting bioactive Aβ, to verify the concept of bioactive Aβ in an animal model of AD and in post mortem brain tissue from AD patients, and to use this assay to screen for drugs that can inactivate bioactive Aβ. These studies show the proof in principle that inactivating bioactive Aβ is a promising approach to treat AD. Several promising compounds that can inactivate bioactive Aβ species are also described. ©2006 Bentham Science Publishers Ltd.","Alzheimer's disease; Amyloid β peptide; Amyloidogenesis; Bioactive amyloid species; Drug screening; MTT","amyloid beta protein; chlorpromazine; congo red; iron deuteroporphyrin 2,4 diethylene glycol; mepacrine; protein inhibitor; unclassified drug; Alzheimer disease; animal cell; cell assay; controlled study; degenerative disease; dementia; disease course; drug potency; drug screening; nonhuman; pathophysiology; peptide synthesis; priority journal; protein aggregation; protein defect; protein polymerization; protein targeting; rat; review; senile plaque; Alzheimer Disease; Amyloid beta-Protein; Animals; Cells, Cultured; Humans; Peptide Fragments",,"amyloid beta protein, 109770-29-8; chlorpromazine, 50-53-3, 69-09-0; congo red, 573-58-0, 80701-77-5; mepacrine, 69-05-6, 83-89-6; Amyloid beta-Protein; Peptide Fragments",,,,"Travis, J., Saving the mind faces high hurdles (2005) Science, 309, pp. 731-734; Hardy, J., Selkoe, D.J., The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics (2002) Science, 297, pp. 353-356; Citron, M., Strategies for disease modification in Alzheimer's disease (2004) Nat Rev Neurosci, 5, pp. 677-685; Sipe, J.D., Amyloidosis (1992) Ann Rev Biochem, 61, pp. 947-975; Glenner, G.G., Eanes, E.D., Bladen, H.A., Linke, R.P., Termine, J.D., A comparison of native amyloid with synthetic protein fibrils (1974) J Histochem Cytochem, 22, pp. 1141-1158; Crystal, H., Dickson, D., Fuld, P., Masur, D., Scott, R., Mehler, M., Clinico-pathologic studies in dementia: Nondemented subjects with pathologically confirmed Alzheimer's disease (1988) Neurology, 38, pp. 1682-1687; Delaere, P., Duyckaerts, C., Masters, C., Beyreuther, K., Piette, F., Hauw, J.J., Large amounts of neocortical beta A4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person (1990) Neurosci Lett, 116, pp. 87-93; Dickson, D.W., Crystal, H.A., Mattiace, L.A., Masur, D.M., Blau, A.D., Davies, P., Identification of normal and pathological aging in prospectively studied nondemented elderly humans (1992) Neurobiol Aging, 13, pp. 179-189; Delaere, P., He, Y., Fayet, G., Duyckaerts, C., Hauw, J.J., Beta A4 deposits are constant in the brain of the oldest old: An immunocytochemical study of 20 French centenarians (1993) Neurobiol. Aging, 14, pp. 191-194; Berr, C., Hauw, J.J., Delaere, P., Duyckaerts, C., Amouyel, P., Apolipoprotein E allele epsilon 4 is linked to increased deposition of the amyloid beta-peptide (A-beta) in cases with or without Alzheimer's disease (1994) Neurosci Lett, 178, pp. 221-224; Harper, J.D., Lansbury Jr., P.T., Models of amyloid seeding in Alzheimer's disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins (1997) Annu Rev Biochem, 66, pp. 385-407; Borchelt, D.R., Ratovitski, T., Van Lare, J., Lee, M.K., Gonzales, V., Jenkins, N.A., Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins (1997) Neuron, 19, pp. 939-945; Holcomb, L., Gordon, M.N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes (1998) Nature Med, 4, pp. 97-100; Lorenzo, A., Yankner, B.A., β-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red (1994) Proc Natl Acad Sci, 91, pp. 12243-12247. , USA; Liu, Y., Piasecki, D., A cell-based method for the detection of nanomolar concentrations of bioactive amyloid (2001) Anal Biochem, 289, pp. 130-136; Klein, W.L., Krafft, G.A., Finch, C.E., Targeting small Abeta oligomers: The solution to an Alzheimer's disease conundrum? (2001) Trends Neurosci, 24, pp. 219-224; Caughey, B., Lansbury Jr., P.T., Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders (2003) Annu Rev Neurosci, 26, pp. 267-298; Meda, L., Cassatella, M.A., Szendrel, G.I., Otvos Jr., L., Baron, P., Villalba, M., Activation of microglial cells by β-amyloid protein and interferon-γ (1995) Nature, 374, pp. 647-650; Hu, J., Akama, K.T., Krafft, G.A., Chromy, B.A., Van Eldik, L.J., Amyloid-beta peptide activates cultured astrocytes: Morphological alterations, cytokine induction and nitric oxide release (1998) Brain Res, 785, pp. 195-206; Behl, C., Davis, J.B., Lesley, R., Schubert, D., Hydrogen peroxide mediate amyloid β protein toxicity (1994) Cell, 77, pp. 817-827; Shearman, M.S., Ragan, C.I., Iversen, L.L., Inhibition of PC-12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death (1994) Proc Natl Acad Sci, 91, pp. 1470-1474. , USA; Mosmann, T., Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity (1983) J Immunol Methods, 65, pp. 55-63; Liu, Y., Peterson, D., Kimura, H., Schubert, D., The mechanism of cellular MTT reduction (1997) J Neurochem, 69, pp. 581-593; Liu, Y., Schubert, D., Cytotoxic amyloid peptides inhibit cellular MTT reduction by enhancing MTT formazan exocytosis (1997) J Neurochem, 69, pp. 2285-2293; Liu, Y., Schubert, D., Steroid hormones block amyloid fibrilinduced MTT formazan exocytosis: Relationship to neurotoxicity (1998) J Neurochem, 71, pp. 2322-2329; Liu, Y., Peterson, D., Schubert, D., Amyloid β peptide alters intracellular vesicle trafficking and cholesterol homeostasis (1998) Proc Natl Acad Sci, 95, pp. 13266-13271. , USA; Liu, Y., Understanding the biological activity of amyloid proteins in vitro: From inhibited cellular MTT reduction to altered cellular cholesterol homeostasis (1999) Prog Neuro-Psychopharmacol & Psychiat, 23, pp. 377-395; Liu, Y., Dargusch, R., Banh, C., Miller, C.A., Schubert, D., Detecting bioactive amyloid β peptide species in Alzheimer's disease (2004) J Neurochem, 91, pp. 648-656; Davis II, J.N., Chisholm, J.C., The 'amyloid hypothesis' of AD: Decoy or real McCoy? (1997) Trends Neurosci, 20, pp. 558-559; Price, D.L., Sisodis, S.S., Mutant genes in familial Alzheimer's disease and transgenic models (1998) Annu Rev Neurosci, 21, pp. 479-505; Lewis, J., Dickson, D.W., Lin, W.L., Chisholm, L., Corral, A., Jones, G., Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP (2001) Science, 293, pp. 1487-1491; Versijpt, J.J., Dumont, F., Van Laere, K.J., Decoo, D., Santens, P., Audenaert, K., Assessment of neuroinflammation and microglial activation in Alzheimer's disease with radiolabelled PK11195 and single photon emission computed tomography. A pilot study (2003) Eur Neurol, 50, pp. 39-47; Mueller, S.G., Weiner, M.W., Thal, L.J., Peterson, R.C., Jack, C.R., Jagust, W., Ways toward an early diagnosis in Alzheimer's disease: The Alzheimer's Disease Neuroiamging Initiative (ADNI) (2005) Alzheimer's & Dementia, 1, pp. 55-66; Findeis, M.A., Approaches to discovery and characterization of inhibitors of amyloid β-peptide polymerization (2000) Biochim Biophys Acta, 1502, pp. 76-84; Caughey, W.S., Raymond, L.D., Horiuchi, M., Caughey, B., Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines (1998) Proc Natl Acad Sci, 95, pp. 12117-12122. , USA; Doh-Ura, K., Iwaki, T., Caughey, B., Lysosomotropic agents and cysteine protease inhibitors inhibit scrapie-associated prion protein accumulation (2000) J Virol, 74, pp. 4894-4897; Korth, C., May, B.C., Cohen, F.E., Prusiner, S.B., Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease (2001) Proc Natl Acad Sci, 98, pp. 9836-9841. , USA; Prusiner, S.B., McKinley, M.P., Bowman, K.A., Bolton, D.C., Bendheim, P.E., Groth, D.F., Scrapie prions aggregate to form amyloid-like birefringent rods (1983) Cell, 35, pp. 349-358; Caughey, B.W., Dong, A., Bhat, S., Ernst, D., Hayes, S.F., Caughey, W.S., Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy (1991) Biochemistry, 30, pp. 7672-7680; Caughey, B., Race, R.E., Potent inhibition of scrapie-associated PrP accumulation by Congo red (1992) J Neurochem, 59, pp. 768-771; Schubert, D., Heinemann, S., Carlisle, W., Tarika, H., Kimes, B., Steinbach, J.H., Culp, W., Brandt, B.L., Clonal cell lines from the rat central nervous system (1974) Nature, 249, pp. 224-227; Levison, S.W., McCarthy, K.D., Astroglia in culture (1992) Culturing Nerve Cells, pp. 309-336. , Banker G. and Goslin K., Eds., MIT Press, Cambridge, MA; Day, B.J., Shawen, S., Liochev, S.I., Crapro, J.D., A metalloporpgyrin superoxide dismutase mimetic protects against paraquat-induced endothelial cell injury, in vitro (1995) J Pharmacol Exp Ther, 275, pp. 1227-1232","Liu, Y.; Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037-1099, United States; email: yliu@salk.edu",,,,,,,,15672050,,,16611013,"English","Curr. Alzheimer Res.",Review,Scopus,2-s2.0-33645813416
"Schubert, D., Dargusch, R., Raitano, J., Chan, S.-W.","Cerium and yttrium oxide nanoparticles are neuroprotective",2006,"Biochemical and Biophysical Research Communications","342","1",,"86","91",,318,10.1016/j.bbrc.2006.01.129,"http://www.scopus.com/inward/record.url?eid=2-s2.0-32644468773&partnerID=40&md5=c6c02970cfca96f8a481f1c1977cc4b1","Salk Institute, 10010 N. Torrey Pines Rd., San Diego, CA 92037, United States; Columbia University, Departments of Applied Physics and Applied Mathematics, MC 4701, 1136 Mudd, New York, NY 10027, United States","Schubert, D., Salk Institute, 10010 N. Torrey Pines Rd., San Diego, CA 92037, United States; Dargusch, R., Salk Institute, 10010 N. Torrey Pines Rd., San Diego, CA 92037, United States; Raitano, J., Columbia University, Departments of Applied Physics and Applied Mathematics, MC 4701, 1136 Mudd, New York, NY 10027, United States; Chan, S.-W., Columbia University, Departments of Applied Physics and Applied Mathematics, MC 4701, 1136 Mudd, New York, NY 10027, United States","The responses of cells exposed to nanoparticles have been studied with regard to toxicity, but very little attention has been paid to the possibility that some types of particles can protect cells from various forms of lethal stress. It is shown here that nanoparticles composed of cerium oxide or yttrium oxide protect nerve cells from oxidative stress and that the neuroprotection is independent of particle size. The ceria and yttria nanoparticles act as direct antioxidants to limit the amount of reactive oxygen species required to kill the cells. It follows that this group of nanoparticles could be used to modulate oxidative stress in biological systems. © 2006 Elsevier Inc. All rights reserved.","Antioxidant; Ceria; Nanoparticle; Neuroprotection; Oxytosis; Yttria","cerium; nanoparticle; reactive oxygen metabolite; yttrium; antioxidant activity; article; cell killing; controlled study; human; human cell; neuromodulation; neuroprotection; oxidative stress; particle size; priority journal; Aluminum Oxide; Antioxidants; Cell Line, Tumor; Cell Survival; Cerium; Humans; Nanomedicine; Nanostructures; Neurons; Neuroprotective Agents; Oxidative Stress; Yttrium",,"cerium, 7440-45-1; yttrium, 7440-65-5; Aluminum Oxide, 1344-28-1; Antioxidants; ceric oxide, 1306-38-3; Cerium, 7440-45-1; Neuroprotective Agents; yttria, 1314-36-9; Yttrium, 7440-65-5",,,,"D'Amato, G., Urban air pollution and plant-derived respiratory allergy (2000) Clin. Exp. Allergy, 30, pp. 628-636; Brumfiel, G., Nanotechnology: A little knowledge (2003) Nature, 424, pp. 246-248; (2003) Green Peace Report, Future Technologies, Today's Choices, , Green Peace Environmental Trust, London, July; Gaidos, S., Time to regulate nanoparticle safety? (2005) The Scientist, 19, p. 29; Warheit, D.B., Nanoparticles: Health impacts? (2004) Mater. Today, pp. 32-35; Lam, C.W., James, J.T., McCluskey, R., Hunter, R.L., Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation (2004) Toxicol. Sci., 77, pp. 126-134; Soto, K.F., Carrasco, A., Powell, T.G., Garza, K.M., Murr, L.E., Comparative in vitro cytotoxicity assessment of some manufactured nanoparticulate materials characterized by transmission electron microscopy (2005) J. Nanoparticle Res., 7, pp. 145-169; Sayes, C.M., Fortner, J.D., Guo, W., Lyon, D., Boyd, A.M., Ausman, K.D., Tao, Y.J., Colvin, V.L., The differential cytotoxicity of water-soluble fullerenes (2004) Nano Lett., 4, pp. 1881-1887; Becker, S., Soukup, J.M., Gallagher, J.E., Differential particulate air pollution induced oxidant stress in human granulocytes, monocytes and alveolar macrophages (2002) Toxicol. in Vitro, 16, pp. 209-218; Boldogh, I., Bacsi, A., Choudhury, B.K., Dharajiya, N., Alam, R., Hazra, T.K., Mitra, S., Sur, S., ROS generated by pollen NADPH oxidase provide a signal that augments antigen-induced allergic airway inflammation (2005) J. Clin. Invest., 115, pp. 2169-2179; Kumar, P., Khanna, M., Srivastava, V., Tyagi, Y.K., Raj, H.G., Ravi, K., Effect of quercetin supplementation on lung antioxidants after experimental influenza virus infection (2005) Exp. Lung Res., 31, pp. 449-459; Gensch, E., Gallup, M., Sucher, A., Li, D., Gebremichael, A., Lemjabbar, H., Mengistab, A., Basbaum, C., Tobacco smoke control of mucin production in lung cells requires oxygen radicals AP-1 and JNK (2004) J. Biol. Chem., 279, pp. 39085-39093; Tan, S., Schubert, D., Maher, P., Oxytosis: A novel form of programmed cell death (2001) Curr. Top. Med. Chem., 1, pp. 497-506; Oberdorster, E., Manufactured nanomaterials (Fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass (2004) Environ. Health Perspect., 112, pp. 1058-1062; Chung, D., Nanoparticles have health benefits too (2003) New Scientist, 179, pp. 2410-2416; Zhang, F., Chan, S.-W., Spanier, J.F., Apak, F., Jin, Q., Robinson, R., Herman, I.P., Cerium oxide nanoparticles: Size-selective formation and structure analysis (2002) Appl. Phys. Lett., 80, pp. 127-129; Perebeinos, V., Chan, S.-W., Zhang, F., Madelung-Model prediction for the lattice constant scaling with the sizes of ionic nanocrystals of CeO2 and BaTiQ3 (2002) Solid State Commun., 123, pp. 295-297; Zhang, F., Wang, P., Koberstein, J., Khalid, S., Chan, S.-W., Cerium oxidation state in ceria nanoparticles studied with x-ray photoelectron spectroscopy and absorption near edge spectroscopy (2004) Surf. Sci., 563, pp. 74-82; Robinson, R.D., Spanier, J.E., Zhang, F., Chan, S.-W., Herman, I.P., Visible thermal emission from sub-band-gap laser excited cerium dioxide particles (2002) J. Appl. Phys., 92, pp. 1936-1941; Kingery, W.D., Bowen, H.K., Uhlman, D.R., (1976) Introduction to Ceramics, , second ed. John Wiley New York; Kilbourn, B.T., Yttrium oxide (1994) The Encyclopedia of Advanced Materials, 4, pp. 2957-2959. , D. Bloor R.J. Brook M.C. Flemings S. Mahajan Pergamon Press, Ltd. Oxford; Kofstad, P., (1972) Nonstoichiometry, Diffusion, and Electrical Conductivity in Binary Metal Oxides., , Wiley Interscience New York; Kilbourn, B.T., Yttria (1986) Encyclopedia of Materials Science and Engineering, 7, pp. 5509-5510. , M.B. Bever Pergamon press, Ltd. Oxford; Atou, T., Kusaba, K., Fukuoka, K., Kikuchi, M., Syono, Y., Shock-induced phase transition of M203 (M = Sc, Y, Sm, Gd, and In)-type compounds (1990) J. Solid State Chem., 89, pp. 378-384; Ishige, K., Schubert, D., Sagara, Y., Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms (2001) Free Radic. Biol. Med., 30, pp. 433-446; Alivisatos, A.P., Semiconductor clusters, nanocrystals, and quantum dots (1996) Science, 271, pp. 933-937; Conesa, J.C., Computer modeling of surfaces and defects on cerium oxide (1995) Surf. Sci., 339, pp. 337-352; Thompson, L.C., Chapter 25: Complexes (1979) Handbook of Physics and Chemistry of Rare Earths, 3, pp. 209-297. , K.A. Gschneider, L. Eyring (Eds.), Elsevier B.V., North Holland; Weast, R.C., (1968) CRC Handbook of Chemistry and Physics, , Chemical Rubber Company Cleveland; Bevan, D.J., Kordis, J., Mixed oxides of the type Mo2 (fluorite)-M2O 3-I oxygen dissociation pressures and phase relationships in the system CeO2-Ce2O3 at high temperatures (1964) J. Inorg. Nucl. Chem., 26, pp. 1509-1523; Morimoto, B.H., Koshland Jr., D.E., Induction and expression of long- and short-term neurosecretory potentiation in a neural cell line (1990) Neuron, 5, pp. 875-880; Davis, J.B., Maher, P., Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line (1994) Brain Res., 652, pp. 169-173; Vogt, M., Dulbecco, R., Steps in the neoplastic transformation of hamster embryo cells by polyoma virus (1963) Proc. Natl. Acad. Sci. USA, 49, pp. 171-179; Schubert, D., Kimura, H., Maher, P., Growth factors and vitamin e modify neuronal glutamate toxicity (1992) Proc. Natl. Acad. Sci. (USA), 89, pp. 8264-8267; Zhang, F., Jin, Q., Chan, S.-W., Ceria nanoparticles: Size, size distribution, and shape (2004) J. Appl. Phys., 95, pp. 4319-4326; McCabe, W.L., Smith, J.C., Harriott, P., (1985) Unit Operations of Chemical Engineering, , fourth ed. McGraw-Hill New York","Schubert, D.; Salk Institute, 10010 N. Torrey Pines Rd., San Diego, CA 92037, United States; email: schubert@salk.edu",,,,,,,,0006291X,,BBRCA,16480682,"English","Biochem. Biophys. Res. Commun.",Article,Scopus,2-s2.0-32644468773
"Kimura, Y., Dargusch, R., Schubert, D., Kimura, H.","Hydrogen sulfide protects HT22 neuronal cells from oxidative stress",2006,"Antioxidants and Redox Signaling","8","3-4",,"661","670",,177,10.1089/ars.2006.8.661,"http://www.scopus.com/inward/record.url?eid=2-s2.0-33646680757&partnerID=40&md5=d9f0aa7595e7adb73076c3d9f672aeec","National Institute of Neuroscience, Tokyo, Japan; Salk Institute for Biological Studies, San Diego, CA, United States; National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8551, Japan","Kimura, Y., National Institute of Neuroscience, Tokyo, Japan; Dargusch, R., Salk Institute for Biological Studies, San Diego, CA, United States; Schubert, D., Salk Institute for Biological Studies, San Diego, CA, United States; Kimura, H., National Institute of Neuroscience, Tokyo, Japan, National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8551, Japan","Hydrogen sulfide (H2S) is a neuromodulator in the brain and a relaxant for smooth muscle. H2S protects primary cortical neurons from oxidative stress by increasing the intracellular concentrations of glutathione, the major antioxidant in cells. However, changes in glutathione alone are not sufficient to account for full protection in all types of nerve cells. H2S is here shown to protect an immortalized mouse hippocampal cell line from oxidative glutamate toxicity by activating ATP-dependent K + (KATP) and Cl- channels, in addition to increasing the levels of glutathione. The present study therefore identifies a novel pathway for H2S protection from oxidative stress. © Mary Ann Liebert, Inc.",,"adenosine triphosphate sensitive potassium channel; chloride channel; glutamic acid; glutathione; hydrogen sulfide; animal cell; antioxidant activity; article; brain cell; cell immortalization; cell level; cell line; controlled study; hippocampus; mouse; neuromodulation; neuroprotection; nonhuman; oxidative stress; priority journal; smooth muscle relaxation; Adenosine Triphosphate; Animals; Cell Line; Culture Media; Cysteine; Glutathione; Hydrogen Sulfide; L-Lactate Dehydrogenase; Mice; Neurons; Oxidative Stress; Potassium; Time Factors; Animalia",,"glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; glutathione, 70-18-8; hydrogen sulfide, 15035-72-0, 7783-06-4; Adenosine Triphosphate, 56-65-5; Culture Media; Cysteine, 52-90-4; Glutathione, 70-18-8; Hydrogen Sulfide, 7783-06-4; L-Lactate Dehydrogenase, EC 1.1.1.27; Potassium, 7440-09-7",,,,"Abe, K., Kimura, H., The possible role of hydrogen sulfide as an endogenous neuromodulator (1996) J Neurosci, 16, pp. 1066-1071; Abele, A.E., Miller, R.J., Potassium channel activators abolish excitotoxicity in cultured hippocampal pyramidal neurons (1990) Neurosci Lett, 115, pp. 195-200; Bajgar, R., Seetharaman, S., Kowaltowski, A.J., Garlid, K.D., Paucek, P., Identification and properties of a novel intracellular (mitochondrial) ATP-sensitive potassium channel in brain (2001) J Biol Chem, 276, pp. 33369-33374; Becq, F., Verrier, B., Chang, X.-B., Riordan, J.R., Hanrahan, J., CAMP- and Ca2+-independent activation of cystic fibrosis transmembrane conductance regulator channels by phenylimidazothiazole drugs (1996) J Biol Chem, 271, pp. 16171-16179; Cheng, Y., Ndisang, J.F., Tang, G., Cao, K., Wang, R., Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats (2004) Am J Physiol Heart Circ Physiol, 287, pp. H2316-H2323; Choi, D.W., Glutamate neurotoxicity and diseases of the nervous system (1988) Neuron, 1, pp. 623-634; Coyle, J.T., Puttfarcken, P., Oxidative stress, glutamate, and neurodegenerative disorders (1993) Science, 262, pp. 689-695; Davis, J.B., Maher, P., Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line (1994) Brain Res, 652, pp. 169-173; Du, J., Hui, Y., Cheung, Y., Bin, G., Jiang, H., Chen, X., Tang, C., The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cells (2004) Heart Vessels, 19, pp. 75-80; Fischbach, P.S., White, A., Barrett, T.D., Lucchesi, B.R., Risk of ventricular proarryhythmia with selective opening of the myocardial sarcolemmal versus mitochondrial ATP-gated potassium channels (2004) J Pharmacol Exp Ther, 309, pp. 554-559; Goodman, Y., Mattson, M.P., K+ channel openers protect hippocampal neurons against oxidative injury and amyloid β-peptide toxicity (1996) Brain Res, 706, pp. 328-332; Haddad, P.R., Heckenberg, A.L., Trace determination of sulfide by reversed-phase ion-interaction chromatography using pre-column derivatization (1988) J Chromatogr, 447, pp. 415-420; Hernandez-Sanchez, C., Wood, T.L., Le Roith, D., Developmental and tissue-specific sulfonylurea receptor gene expression (1997) Endocrinology, 138, pp. 705-711; Heurteaux, C., Bertaina, V., Widmann, C., Lazdunski, M., K+ channel openers prevent global ischemia-induced expression of c-fos, c-jun, heat shock protein, and amyloid β-protein precursor genes and neuronal death in rat hippocampus (1993) Proc Natl Acad Sci USA, 90, pp. 9431-9435; Higgins, C.F., The ABC of channel regulation (1995) Cell, 82, pp. 693-696; Hosoki, R., Matsuki, N., Kimura, H., The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide (1997) Biochem Biophys Res Commun, 237, pp. 527-531; Inagaki, N., Gonoi, T., Clement IV, J.P., Namba, N., Inazawa, J., Gonzalez, G., Aguilar-Bryan, L., Bryan, J., Reconstitution of IKATP: An inward rectifier subunit plus the sulfonylurea receptor (1995) Science, 270, pp. 1166-1170; Islam, M.S., Berggren, P.-O., Larsson, O., Sulfhydryl oxidation induces rapid and reversible closure of the ATP-regulated K+ channel in the pancreatic beta-cell (1993) FEBS Lett, 319, pp. 128-132; Jentsch, T.J., Stein, V., Weinreich, F., Zdebik, A.A., Molecular structure and physiological function of chloride channels (2002) Physiol Rev, 82, pp. 503-568; Johannesson, M., Bogdanovic, N., Nordqvist, A.C., Hjelte, L., Schalling, M., Cystic fibrosis mRNA expression in rat brain: Cerebral cortex and medial preoptic area (1997) Neuroreport, 8, pp. 535-539; Kim, J.A., Kang, Y.S., Lee, S.H., Lee, E.H., Yoo, B.H., Lee, Y.S., Glibenclamide induces apoptosis through inhibition of cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channels and intracellular Ca2+ release in HepG2 human hepatoblastoma cells (1999) Biochem Biophys Res Commun, 261, pp. 682-688; Kimura, Y., Kimura, H., Hydrogen sulfide protects neurons from oxidative stress (2004) FASEB J, 18, pp. 1165-1167; Lahousse, S.A., Stopa, E.G., Mulberg, A.E., De La Monte, S.M., Reduced expression of the cystic fibrosis transmembrane conductance regulator gene in the hypothalamus of patients with Alzheimer's disease (2003) J Alzheimers Dis, 5, pp. 455-462; Lauritzen, I., De Weille, J.R., Lazdunski, M., The potassium channel opener (-)-cromakalim prevents glutamate-induced cell death in hippocampal neurons (1997) J Neurochem, 69, pp. 1570-1579; Liss, B., Bruns, R., Roeper, J., Alternative sulfonylurea receptor expression defines metabolic sensitivity of K-ATP channels in dopaminergic midbrain neurons (1999) EMBO J, 18, pp. 833-846; Maher, P., How protein kinase C activation protects nerve cells from oxidative stress-induced cell death (2001) J Neurosci, 2, pp. 2929-2938; Miyamoto, M., Murphy, T.H., Schnaar, R.L., Coyle, J.T., Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line (1989) J Pharmacol Exp Ther, 250, pp. 1132-1140; Mulberg, A.E., Resta, L.P., Wiedner, E.B., Altschuler, S.M., Jefferson, D.M., Broussard, D.L., Expression and localization of the cystic fibrosis transmembrane conductance regulator mRNA and its protein in rat brain (1995) J Clin Invest, 96, pp. 646-652; Murphy, T.H., Malouf, A.T., Sastre, A., Schnaar, R.L., Coyle, J.T., Calcium-dependent glutamate cytotoxicity in a neuronal cell line (1988) Brain Res, 444, pp. 325-332; Murphy, T.H., Miyamoto, M., Sastre, A., Schnaar, R.L., Coyle, J.T., Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress (1989) Neuron, 2, pp. 1547-1558; Nagai, Y., Tsugane, M., Oka, J., Kimura, H., Hydrogen sulfide induced calcium waves in astrocytes (2004) FASEB J, 18, pp. 557-559; Oka, A., Belliveau, M.J., Rosenberg, P.A., Volpe, J.J., Vulnerability of oligodendroglia to glutamate: Pharmacology, mechanisms, and prevention (1992) J Neurosci, 13, pp. 1441-1453; Perry, G., Cash, A.D., Smith, M.A., Alzheimer disease and oxidative stress (2002) J Biomed Biotechnol, 2, pp. 120-123; Reiffenstein, R.J., Toxicology of hydrogen sulfide (1992) Annu Rev Pharmacol Toxicol, pp. 109-134; Riordan, J.R., Rommens, J.M., Kerem, B., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Tsui, L.-C., Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA (1989) Science, 245, pp. 1066-1073; Sah, R., Schwartz-Bloom, R.D., Optical imaging reveals elevated intracellular chloride in hippocampal pyramidal neurons after oxidative stress (1999) J Neurosci, 19, pp. 9209-9217; Sheppard, D., Robinson, K.A., Mechanism of glibenclamide inhibition of cystic fibrosis transmembrane conductance regulator Cl- Channels expressed in a murine cell line (1997) J Physiol, 503, pp. 333-346; Tan, S., Sagara, Y., Liu, Y., Maher, P., Schubert, D., The regulation of reactive oxygen species production during programmed cell death (1998) J Cell Biol, 141, pp. 1423-1432; Tan, S., Schubert, D., Maher, P., Oxytosis: A novel form of programmed cell death (2001) Curr Top Med Chem, 1, pp. 497-506; Tang, D., Santshi, P.H., Sensitive determination of dissolved sulfide in estuarine water by solid-phase extraction and high-performance liquid chromatography of methylene blue (2000) J Chromatogr a, 883, pp. 305-309; Vornov, J.J., Coyle, J.T., Glutamate neurotoxicity and the inhibition of protein synthesis in the hippocampal slice (1991) J Neurochem, 56, pp. 996-1006; Wang, W., Oliva, C., Li, G., Holmgren, A., Lillig, C.H., Kirk, K.L., Reversible silencing of CFTR chloride channels by glutathionylation (2005) J Gen Physiol, 125, pp. 127-141","Kimura, H.; National Institute of Neuroscience, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8551, Japan; email: kimura@ncnp.go.jp",,,,,,,,15230864,,ARSIF,16677109,"English","Antioxid. Redox Signal.",Article,Scopus,2-s2.0-33646680757
"Schubert, D., Klar, A., Park, M., Dargusch, R., Fischer, W.H.","F-spondin promotes nerve precursor differentiation",2006,"Journal of Neurochemistry","96","2",,"444","453",,19,10.1111/j.1471-4159.2005.03563.x,"http://www.scopus.com/inward/record.url?eid=2-s2.0-33644875964&partnerID=40&md5=46c71af7ac45d0b65231e7e6d6fcd5d1","Salk Institute, San Diego, CA, United States; Hebrew University, Jerusalem, Israel; Salk Institute, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States","Schubert, D., Salk Institute, San Diego, CA, United States, Salk Institute, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States; Klar, A., Hebrew University, Jerusalem, Israel; Park, M., Salk Institute, San Diego, CA, United States; Dargusch, R., Salk Institute, San Diego, CA, United States; Fischer, W.H., Salk Institute, San Diego, CA, United States","Cells in the developing nervous system secrete a large number of proteins that regulate the migration and differentiation of their neighbors. It is shown here that a clonal central nervous system cell line secretes a protein that causes both a rat hippocampal progenitor cell line and primary cortical neural cells to differentiate into cells with the morphological and biochemical features of neurons. This protein was identified as F-spondin. Analysis of F-spondin isoforms secreted from transfected cells shows that the core protein without the thrombospondin type 1 repeats is sufficient to promote neuronal differentiation when adsorbed to a surface. F-spondin can also inhibit neurite outgrowth while allowing the expression of nerve-specific proteins when present in a soluble form at high concentrations. Therefore, F-spondin can alter cell differentiation in multiple ways, depending upon its concentration and distribution between substrate-attached and soluble forms. © 2005 International Society for Neurochemistry.","Differentiation; F-spondin; Nerve; Neural precursor","F spondin; isoprotein; scleroprotein; thrombospondin 1; unclassified drug; nerve protein; peptide; Sponf protein, rat; adolescent; adsorption; animal cell; article; cell differentiation; cell migration; genetic transfection; nerve cell differentiation; nerve fiber growth; nervous system development; neural stem cell; nonhuman; priority journal; protein analysis; protein function; protein secretion; rat; animal; brain cortex; cell culture; cell line; central nervous system; cytology; hippocampus; metabolism; nerve cell; nerve cell inhibition; neurite; physiology; stem cell; Animalia; Animals; Cell Differentiation; Cell Line, Transformed; Cells, Cultured; Central Nervous System; Cerebral Cortex; Hippocampus; Nerve Tissue Proteins; Neural Inhibition; Neurites; Neurons; Peptides; Rats; Stem Cells; Transfection",,"thrombospondin 1, 343987-56-4; Nerve Tissue Proteins; Peptides; Sponf protein, rat",,,,"Alvarez-Buylla, A., Garcia-Verdugo, J.M., Tramontin, A.D., A unified hypothesis on the lineage of neural stem cells (2001) Nat. Rev. Neurosci, 2, pp. 287-293; Bernfield, M., Kokenyesi, R., Kato, M., Hinkes, M.T., Spring, J., Gallo, R.L., Lose, E.J., Biology of the syndecans: A family of transmembrane heparan sulfate proteoglycans (1992) Annu. Rev. Cell Biol, 8, pp. 365-393; Burstyn-Cohen, T., Frumkin, A., Xu, Y.T., Scherer, S.S., Klar, A., Accumulation of F-spondin in injured peripheral nerve promotes the outgrowth of sensory axons (1998) J. Neurosci, 18, pp. 8875-8885; Burstyn-Cohen, T., Tzarfaty, V., Frumkin, A., Feinstein, Y., Stoeckli, E., Klar, A., F-spondin is required for accurate pathfinding of commissural axons at the floor plate (1999) Neuron, 23, pp. 233-246; Campos, L.S., Neurospheres: Insights into neural stem cell biology (2004) J. Neurosci. Res, 78, pp. 761-769; Chen, Q., Chen, X., Costa, L., Letourneau, P., Schubert, D., MOCA modulates N-cadherin-mediated adhesion and neurite outgrowth (2005) J. Neurosci, 25, pp. 281-290; Cumming, R.C., Andon, N.L., Haynes, P.A., Park, M., Fischer, W.H., Schubert, D., Disulfide bond formation occurs in the cytoplasm during oxidative stress (2004) J. Biol. Chem, 279, pp. 21749-21758; D'Arcangelo, G., Miao, G.G., Chen, S.C., Soares, H.D., Morgan, J.I., Curran, T., A protein related to extracellular matrix proteins deleted in the mouse mutant reeler (1995) Nature, 374, pp. 719-723; Engele, J., Schubert, D., Bohn, M.C., Conditioned media derived from glial cell lines promote survival and differentiation of dopaminergic neurons in vitro; Role of mesencephalic glia (1991) J. Neurosci. Res, 30, pp. 359-371; Engstrom, C.M., Demers, D., Dooner, M., A method for clonal analysis of epidermal growth factor-responsive neural progenitors (2002) J. Neurosci. Meth, 117, pp. 111-121; Feinstein, Y., Klar, A., The neuronal class 2 TSR proteins F-spondin and mindin: A small family with divergent biological activities (2004) IntJBiochemCell Biol, 36, pp. 975-980; Feinstein, Y., Borrell, V., Garcia, C., F-spondin and mindin: Two structurally and functionally related genes expressed in the hippocampus that promote outgrowth of embryonic hippocampal neurons (1999) Development, 126, pp. 3637-3648; Fischer, W.H., Schubert, D., Purification and microsequencing of neurotrophic proteins (1993) Neuromethods, pp. 1-23. , , in. , eds). Butterworth R. Baker G. Boulton A. Humana Press Inc. New York , pp; Fischer, W.H., Schubert, D., Characterization of a novel PDGF associated protein (1996) JNeurochem, 66, pp. 2213-2216; Higashijima, S., Nose, A., Eguchi, G., Hotta, Y., Okamoto, H., Mindin/F-spondin family: Novel ECM proteins expressed in the zebrafish embryonic axis (1997) DevBiol, 192, pp. 211-227; Ho, A., Sudhof, T., Binding of F-spondin to amyloid-β precursor protein: A candidate amyloid-β precursor protein ligand that modulates amyloid-β precursor protein cleavage (2004) ProcNatl AcadSciUSA, 101, pp. 2548-2553; Kimura, H., Fischer, W.H., Schubert, D., Structure, expression and function of a schwannoma-derived growth factor (1990) Nature, 348, pp. 257-260; Klar, A., Baldassare, M., Jessell, T.M., F-spondin: A gene expressed at high levels in the floor plate encodes a secreted protein that promotes neural cell adhesion and neurite extension (1992) Cell, 69, pp. 95-110; Lennon, V.A., Peterson, S., Schubert, D., Neuroectoderm markers retained in phenotypical skeletal muscle cells arising from a glial cell line (1979) Nature, 281, pp. 586-588; Palmer, T.D., Takahashi, J., Gage, F.H., The adult rat hippocampus contains primordial neural stem cells (1997) MolCell Neurosci, 8, pp. 389-404; Ray, J., Peterson, D.A., Schinstine, M., Gage, F.H., Proliferation, differentiation, and long-term culture of primary hippocampal neurons (1993) ProcNatl AcadSciUSA, 90, pp. 3602-3606; Salie, R., Niederkofler, V., Arber, S., Patterning molecules; Multitasking in the nervous system (2005) Neuron, 45, pp. 189-192; Schubert, D., Heinemann, S., Carlisle, W., Tarikas, H., Kimes, B., Steinbach, J.H., Culp, W., Brandt, B.L., Clonal cell lines from the rat central nervous system (1974) Nature, 249, pp. 224-227; Schubert, D., Carlisle, W., Look, C., Putative neurotransmitters in clonal cell lines (1975) Nature, 254, pp. 341-343; Schubert, D., Jin, L.-W., Saitoh, T., Cole, G., The regulation of amyloid β protein precursor secretion and its modulatory role in cell adhesion (1989) Neuron, 3, pp. 689-694; Schubert, D., Kimura, H., Lacorbiere, M., Vaughan, J., Karr, D., Fischer, W.H., Activin is a nerve cell survival molecule (1990) Nature, 344, pp. 868-870; Takahashi, J., Palmer, T.D., Gage, F.H., Retinoic acid and neurotrophins collaborate to regulate neurogenesis in adult-derived neural stem cell cultures (1999) J. Neurobiol, 38, pp. 65-81; Taupin, P., Ray, J., Fischer, W.H., Suhr, S.T., Hakansson, K., Grubb, A., Gage, F.H., FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor (2000) Neuron, 28, pp. 385-397; Tzarfati-Majar, V., Burstyn-Cohen, T., Klar, A., F-spondin is a contact-repellent molecule for embryonic motor neurons (2001) Proc. Natl. Acad. Sci. (USA), 98, pp. 4722-4727; Tzarfaty-Majarq, V., Lopez-Alemany, R., Feinstein, Y., Gombau, L., Goldshmidt, O., Soriano, E., Munoz-Canoves, P., Klar, A., Plasmin-mediated release of the guidance molecule F-spondin from the extracellular matrix (2001) J. Biol. Chem, 276, pp. 28233-28241","Schubert, D.; Salk Institute, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States; email: Schubert@salk.edu",,,,,,,,00223042,,JONRA,,"English","J. Neurochem.",Article,Scopus,2-s2.0-33644875964
"Schubert, D.","Regulatory regimes for transgenic crops [2]",2005,"Nature Biotechnology","23","7",,"785","786",,5,10.1038/nbt0705-785b,"http://www.scopus.com/inward/record.url?eid=2-s2.0-24944591026&partnerID=40&md5=3db0db6b70a33437a4499a825a0249e4","Cellular Neurobiology Laboratory, Salk Institute, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States","Schubert, D., Cellular Neurobiology Laboratory, Salk Institute, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States",[No abstract available],,"flavonoid; genomic DNA; isoflavonoid; lignin; methylglyoxal; plant medicinal product; plasmid DNA; retinoic acid; retinol; rotenone; shikimic acid; small molecule transport agent; sucrose; virus DNA; cell transformation; crop; DNA sequence; food; gene deletion; gene expression; gene insertion; genetic engineering; genetic variability; letter; morphological trait; nonhuman; Parkinson disease; phenotype; ploidy; priority journal; retroposon; Rhizobium radiobacter; risk assessment; sucrose metabolism; transgene; agriculture; Europe; genetics; law; legal aspect; mutation; note; safety; transgenic plant; United States; Agrobacterium tumefaciens; Agriculture; Consumer Product Safety; Crops, Agricultural; Europe; Legislation, Food; Mutation; Phenotype; Plants, Genetically Modified; United States; Genetic Engineering",,"lignin, 9005-53-2; methylglyoxal, 78-98-8; retinoic acid, 302-79-4; retinol, 68-26-8, 82445-97-4; rotenone, 83-79-4; shikimic acid, 138-59-0; sucrose, 122880-25-5, 57-50-1",,,,"Freese, W., Schubert, D., (2004) Biotechnol. Genet. Eng. Rev., 21, pp. 299-1225; Szabados, L., (2002) Plant J., 32, pp. 233-242; Forsbach, A., Schubert, D., Lechtenberg, B., Gils, M., Schmidt, R., (2003) Plant Mol. Biol., 52, pp. 161-176; Wilson, A., Latham, J., Steinbrecher, R., (2004) Genome Scrambling-Myth or Reality. Transformation-Induced Mutations in Plants, , EcoNexus, Brighton, UK; Tax, F.E., Vernon, D.M., (2001) Plant Physiol., 126, pp. 1527-1538; Makarevitch, I., Svitashev, S.K., Somers, D.A., (2003) Plant Mol. Biol., 52, pp. 421-432; Kaya, H., (2000) Plant Cell Physiol., 41, pp. 1055-1066; Kim, S.R., (2003) Plant Mol. Biol., 52, pp. 761-1173; Weigel, D., (2000) Plant Physiol., 122, pp. 1003-1013; Hirochika, H., Sugimoto, K., Otsuki, Y., Tsugawa, H., Kanda, M., (1996) Proc. Natl. Acad. Sci. USA, 93, pp. 7783-7788; Ahloowalia, B.S., Maluszynski, M., Nichterlein, K., (2004) Euphytica, 135, pp. 187-204; Feschotte, C., Jiang, N., Wessler, S.R., (2002) Nat. Rev. Genet., 3, pp. 329-341; Brunner, S., Fengler, K., Morgante, M., Tingey, S., Rafalski, A., (2005) Plant Cell, 17, pp. 343-360; Korpan, Y.I., (2004) Trends Biotechnol., 22, pp. 147-151; Ewen, S.W., Pusztai, A., (1999) Lancet, 354, pp. 1353-1354; Verpoorte, R., (2000) Metabolic Engineering of Plant Secondary Metabolism, pp. 1-29. , (eds. Verpoorte, R. & Alfermann, A.W.) (Kluwer Academic Publishers, Dordrecht, The Netherlands); Roessner, U., (2001) Plant Cell, 13, pp. 11-29; Schwab, W., (2003) Phytochemistry, 62, pp. 837-849; Zubieta, C., (2003) Plant Cell, 15, pp. 1704-1716; Johnson, E.T., (2001) Plant J., 25, pp. 325-333; Inose, T., Murata, K., (1995) Intl. J. Food Sci. Technol., 30, pp. 141-146; Grotewold, E., (2005) Trends Plant Sci., 10, pp. 57-62; Kuiper, H.A., Kleter, G.A., Noteborn, H.P., Kok, E.J., (2001) Plant J., 27, pp. 503-528; Saxena, D., Stotzky, G., (2001) Am. J Botany, 88, pp. 1704-1706; Gertz, J.M., Vencill, W.K., Hill, N.S., (1999) Proceedings of the 1999 Brighton Crop Protection Conference: Weeds, pp. 835-840. , British Crop Protection Council, Farnham, UK; Betarbet, R., (2000) Nat. Neurosci., 3, pp. 1301-1306; Morgan, E.D., Wilson, I.D., (1999) Comprehensive Natural Products Chemistry, pp. 363-375. , (ed. Mori, K.) (Pergamon Press/Elsevier Science, Oxford); Lappe, M.A., Bailey, E.B., Childress, C., Setchell, K.D.R., (1999) J. Med. Foods, 1, pp. 241-245; (1998) Manual for Assessing Ecological and Human Health Effects of Genetically Engineered Organisms, , http://www.edmonds-institute.org/manual.html, Edmonds Institute, Edmonds, Washington; (2001) Evaluation of Allergenicity of Genetically Modified Foods. Report of a Joint FAO/WHO Expert Consultation on Allergenicity of Foods Derived from Biotechnology, January 22-25, 2001, , http://www.fao.org/es/ESN/food/pd/allergygm.pdf, FAO-WHO, Rome; Maron, D.M., Ames, B.N., (1983) Mutat. Res., 113, pp. 173-215; McCaffery, P.J., Adams, J., Maden, M., Rosa-Molinar, E., (2003) Eur. J. Neurosci., 18, pp. 457-472; Kessler, D.A., Taylor, M.R., Maryanski, J.H., Flamm, E.L., Kahl, L.S., (1992) Science, 256, pp. 1747-1749","Schubert, D.; Cellular Neurobiology Laboratory, Salk Institute, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States; email: schubert@salk.edu",,,,,,,,10870156,,NABIF,16003351,"English","Nat. Biotechnol.",Letter,Scopus,2-s2.0-24944591026
"Cumming, R.C., Schubert, D.","Amyloid-β induces disulfide bonding and aggregation of GAPDH in Alzheimer's disease",2005,"FASEB Journal","19","14",,"2060","2062",,78,10.1096/fj.05-4195fje,"http://www.scopus.com/inward/record.url?eid=2-s2.0-28744448949&partnerID=40&md5=5d48f7d0de22cbb7ea2c9140aace7453","Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, 10010 N. Torrey Pines Rd., San Diego, CA 92037, United States","Cumming, R.C., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; Schubert, D., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States, Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, 10010 N. Torrey Pines Rd., San Diego, CA 92037, United States",[No abstract available],,"amyloid beta protein; glyceraldehyde 3 phosphate dehydrogenase; Alzheimer disease; animal cell; animal tissue; article; cell immortalization; cell nucleus; cellular distribution; controlled study; cytosol; disulfide bond; enzyme activity; human; immunofluorescence; mouse; nerve cell necrosis; nonhuman; oxidative stress; polyacrylamide gel electrophoresis; priority journal; protein aggregation; transgenic mouse; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Protein; Animals; Cell Line; Cell Nucleus; Cysteine; Cytoplasm; Cytosol; Detergents; Digitonin; Disulfides; Dithiothreitol; Electrophoresis, Gel, Two-Dimensional; Electrophoresis, Polyacrylamide Gel; Female; Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating); Glycolysis; Humans; Hydrogen Peroxide; Immunoblotting; Male; Mice; Mice, Transgenic; Models, Biological; Neurodegenerative Diseases; Neurons; Oxidants; Oxidation-Reduction; Polymorphism, Genetic; Protein Isoforms; Rats; Reactive Oxygen Species; Risk; Time Factors; Animalia; Mus musculus",,"amyloid beta protein, 109770-29-8; glyceraldehyde 3 phosphate dehydrogenase, 9001-50-7; Amyloid beta-Protein; Cysteine, 52-90-4; Detergents; Digitonin, 11024-24-1; Disulfides; Dithiothreitol, 3483-12-3; Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating), EC 1.2.1.12; Hydrogen Peroxide, 7722-84-1; Oxidants; Protein Isoforms; Reactive Oxygen Species",,,,,"Schubert, D.; Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, 10010 N. Torrey Pines Rd., San Diego, CA 92037, United States; email: Schubert@salk.edu",,,,,,,,08926638,,FAJOE,16186172,"English","FASEB J.",Article,Scopus,2-s2.0-28744448949
"Costa, L.D.F., Cintra, L.C., Schubert, D.","An integrated approach to the characterization of cell movement",2005,"Cytometry Part A","68","2",,"92","100",,8,10.1002/cyto.a.20191,"http://www.scopus.com/inward/record.url?eid=2-s2.0-28244469568&partnerID=40&md5=d73249ed324ee39cbede223858447639","Institute of Physics at São Carlos (IFSC), University of São Paulo (USP), Sao Carlos, Brazil; Salk Institute, San Diego, CA, United States; Institute of Physics at São Carlos, University of São Paulo, Caixa Postal 369, 13560-97 São Carlos, SP, Brazil","Costa, L.D.F., Institute of Physics at São Carlos (IFSC), University of São Paulo (USP), Sao Carlos, Brazil, Institute of Physics at São Carlos, University of São Paulo, Caixa Postal 369, 13560-97 São Carlos, SP, Brazil; Cintra, L.C., Institute of Physics at São Carlos (IFSC), University of São Paulo (USP), Sao Carlos, Brazil; Schubert, D., Salk Institute, San Diego, CA, United States","Background: Most phenomena in developmental biology involve or depend upon cell migration. This article describes a comprehensive framework for the characterization and analysis of trajectories defined by cell movement. The following two perspectives are considered: (a) the behavior of each individual cell and (b) interactions between neighboring pairs of cells. Methods: The measurements considered for individual trajectories include the velocity magnitude and orientation, maximum spatial dispersion, displacement effectiveness, and displacement entropies. Interactions between two trajectories are characterized by comparing the respective velocities. Results: The potential of the overall framework is illustrated using data of moving cells in different biological environments. The work shows that it is possible to use the new algorithm presented here to characterize cell motility. Conclusions: The features of the algorithm were successful in determining the motility changes under different experimental conditions. © 2005 International Society for Analytical Cytology.","Cell displacement; Cell interaction; Trajectory analysis","algorithm; analytic method; animal cell; article; cell culture; cell interaction; cell migration; cell motion; developmental biology; image analysis; kidney cell; nonhuman; priority journal; velocity; Algorithms; Cell Communication; Cell Line; Cell Movement; Cytological Techniques; Entropy; Humans; Image Processing, Computer-Assisted; Kidney; Microscopy, Video; Models, Biological; Nerve Tissue Proteins",,"Nerve Tissue Proteins",,,,"Chicurel, M., Cell migration research is on the move (2002) Science, 295, pp. 606-609; Berg, H., How to track bacteria (1971) Rev Sci Instrum, 42, pp. 868-871; Berg, H., Brown, D., Chemotaxis in Escherichia coli analysed by three-dimensional tracking (1972) Nature, 239, pp. 500-504; Krull, C., Collazo, A., Fraser, S., Bronner-Fraser, M., Segmental migration of trunk neural crest: Time-lapse analysis reveals a role for PNA-binding molecules (1995) Development, 121, pp. 3733-3743; Ruthazer, E., Cline, H., Multiphoton imaging of neurons in living tissue: Acquisition and analysis of time-lapse morphological data (2002) J R Time Imag, 8, pp. 175-188; Distasi, C., Ariano, P., Zamburlin, P., Ferraro, M., In vitro analysis of neuron-glial cell interactions during cellular migration (2002) Eur Biophys J, 31, pp. 81-88; Turner, L., Ryu, W., Berg, H., Real-time imaging of fluorescent flagellar filaments (2000) J Bacteriol, 182, pp. 2793-2801; Pettet, G., Please, C., Tindall, M., McElwain, D., The migration of cells in multicell tumor spheroids (2001) Bull Math Biol, 63, pp. 231-257; Fenchel, T., Blackburn, N., Motile chemosensory behavior of phagotrophic protests: Mechanisms for and efficiency in congregating at food patches (1999) Protist, 150, pp. 325-336; Yundt, A., Schack, W., Lardner, T., Applicability of hydrodynamic analyses of spermatozoan motion (1975) J Exp Biol, 62, pp. 27-41; Katz, D., Pedrotti, L., Geotaxis by motile spermatozoa: Hydrodynamic reorientation (1977) J Theor Biol, 67, pp. 723-732; Dresdmer, R., Katz, D., Relationships of mammalian sperm motility and morphology to hydrodynamic aspects of cell function (1981) Biol Represent, 25, pp. 920-930; Molyneaux, K., Stalllock, J., Schaible, K., Wylie, C., Time-lapse analysis of living mouse germ cell migration (2001) Dev Biol, 240, pp. 488-498; Woolley, D., Studies on the eel sperm flagellum. 2. The Kinematics of normal motility (1998) Cell Motil Cytoskeleton, 39, pp. 233-245; Woolley, D., Studies on the eel sperm flagellum. 3. Vibratile motility and rotary bending (1998) Cell Motil Cytoskeleton, 39, pp. 246-255; Yang, L., Albregtsen, F., Lonnestad, R., Grottum, P., Iversen, J., Rotnes, J., Rottingen, J., Measuring shape and motion of white blood cells from sequences of fluorescence microscopy images (1995) Theory and Applications of Image Analysis 11, pp. 305-316. , G. Borgefors, editor. Singapore: World Scientific; Thomann, D., Rines, D., Sorger, P., Danuser, G., Automatic fluorescent tag detection in 3D with super-resolution: Application to the analysis of chromosome movement (2002) LFB Technical Report LFB-TR-2003; Czirók, A., Schlett, K., Madarász, E., Vicsek, T., Exponential distribution of locomotion activity in cell cultures (1998) Phys Rev Lett, 81, pp. 3038-3041; Crenshaw, H., A new look at locomotion in microorganisms: Rotating and translating (1996) Am Zool, 36, pp. 608-618; Bretschneider, T., Vasiev, B., Weijer, C., A model for Dictyostelium slug movement (1999) J Theor Biol, 199, pp. 125-136; Collett, M., Collett, T., Bisch, S., Wehner, R., Local and global vectors in desert ant navigation (1998) Nature, 394, pp. 269-271; Dickinson, R., Tranquillo, R., Optimal estimation of cell movement indices from the statistical analysis of cell tracking data (1993) Bioeng Food Nat Prod, 39, pp. 1995-2010; Zygourakis, K., Quantification and regulation of cell migration (1996) Tissue Eng, 2, pp. 1-26; Ware, M., Wells, A., Lauffenburger, D., Epidermal growth factor alters fibroblast migration speed and directional persistence reciprocally and in a matrix-dependent manner (1998) J Cell Sci, 111, pp. 2423-2432; DiMilla, P., Quinn, J., Albelda, S., Lauffenburger, D., Measurement of individual cell migration parameters for human tissue cells (1992) AlChE J, 38, pp. 1092-1104; Maheshwari, G., Lauffenburger, D., Deconstructing (and reconstructing) cell migration (1998) Microsc Res Tech, 43, pp. 358-368; Holly, S., Larson, M., Parise, L., Multiple roles of integrins in cell motility (2000) Exp Cell Res, 261, pp. 69-74; Fang, K., Ionides, E., Oster, G., Nuccitelly, R., Isseroff, R., Epidermal growth factor receptor relocalization and kinase activity are necessary for directional migration of keratinocytes in DC electric fields (1999) J Cell Sci, 112, pp. 1967-1978; Murray, J., (2002) Mathematical Biology, , New York: Springer-Verlag; Dunn, G., Characterizing a kinesis response: Time averaged measures of cell speed and directional persistence (1983) Agents Actions Suppl, 12, pp. 14-33; Zigmond, S., Ability of polymorphonuclear leukocytes to orient in gradients of chemotactic factors (1977) J Cell Biol, 75, pp. 600-616; Therrien, C., (1992) Discrete Random Signals and Statistical Signal Processing, , Englewood Cliffs, NJ: Prentice Hall; Costa, L., Cesar, R., (2001) Shape Analysis and Classification: Theory and Practice, , Boca Raton, FL: CRC Press; Kashiwa, A., Yoshida, H., Lee, S., Paladino, T., Liu, Y., Chen, Q., Dargush, R., Kimura, H., Isolation and characterization of novel presenilin binding protein (2000) J Neurochem, 75, pp. 109-116; Albert, M., Kim, J., Birge, R., Alphavbeta5 integrin recruits the Crk11-Dock180-rac1 complex for phagocytosis of apoptotic cells (2000) Nature Cell Biol, 2, pp. 899-905; Fukunaga, K., (1990) Introduction to Statistical Pattern Recognition, 2nd Edition, , New York: Academic Press; Chen, Q., Chen, T.J., Letcumean, P.C., Costa, L., Schubert, D., Modifier of cell adhesion regulates Ak:adeherin mediated cell-cell adhesion and neurite outgrowth (2005) J Neurosci, 25, pp. 281-290; Schubert, D., The possible role of adhesion in synaptic modification (1991) Trends Neurosci, 14, pp. 127-130; Redies, C., Cadherins in the central nervous system (2000) Prog Neurobiol, 61, pp. 611-688; Costa, L., Veite, T., Automatic characterization and classification of ganglion cells from the salamander retina (1999) J Comp Neurol, 404, pp. 33-51","Costa, L.D.F.; Institute of Physics at São Carlos, University of São Paulo, Caixa Postal 369, 13560-97 São Carlos, SP, Brazil; email: luciano@if.sc.usp.br",,,,,,,,15524922,,CPAYA,16237685,"English","Cytometry Part A",Article,Scopus,2-s2.0-28244469568
"Lührs, T., Ritter, C., Adrian, M., Riek-Loher, D., Bohrmann, B., Döbeli, H., Schubert, D., Riek, R.","3D structure of Alzheimer's amyloid-β(1-42) fibrils",2005,"Proceedings of the National Academy of Sciences of the United States of America","102","48",,"17342","17347",,947,10.1073/pnas.0506723102,"http://www.scopus.com/inward/record.url?eid=2-s2.0-28444442999&partnerID=40&md5=4e927a2ba86999f9329cbf586b1254a8","Salk Institute for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; Laboratoire d'Analyse Ultrastructurelle, Université de Lausanne, 1015 Lausanne, Switzerland; F. Hoffmann-La Roche, 4070 Basel, Switzerland","Lührs, T., Salk Institute for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; Ritter, C., Salk Institute for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; Adrian, M., Laboratoire d'Analyse Ultrastructurelle, Université de Lausanne, 1015 Lausanne, Switzerland; Riek-Loher, D., Salk Institute for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; Bohrmann, B., F. Hoffmann-La Roche, 4070 Basel, Switzerland; Döbeli, H., F. Hoffmann-La Roche, 4070 Basel, Switzerland; Schubert, D., Salk Institute for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; Riek, R., Salk Institute for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States","Alzheimer's disease is the most fatal neurodegenerative disorder wherein the process of amyloid-β (Aβ) amyloidogenesis appears causative. Here, we present the 3D structure of the fibrils comprising Aβ(1-42), which was obtained by using hydrogen-bonding constraints from quenched hydrogen/deuterium-exchange NMR, side-chain packing constraints from pairwise mutagenesis studies, and parallel, in-register β-sheet arrangement from previous solid-state NMR studies. Although residues 1-17 are disordered, residues 18-42 form a β-strand-turn-β-strand motif that contains two intermolecular, parallel, in-register β-sheets that are formed by residues 18-26 (β1) and 31-42 (β2). At least two molecules of Aβ(1-42) are required to achieve the repeating structure of a protofilament. Intermolecular side-chain contacts are formed between the odd-numbered residues of strand β1 of the nth molecule and the even-numbered residues of strand β2 of the (n - 1)th molecule. This interaction pattern leads to partially unpaired β-strands at the fibrillar ends, which explains the sequence selectivity, the cooperativity, and the apparent unidirectionality of Aβ fibril growth. It also provides a structural basis for fibrillization inhibitors. © 2005 by The National Academy of Sciences of the USA.","Hydrogen/deuterium exchange; NMR","amyloid beta protein[1-42]; Alzheimer disease; amino acid sequence; article; beta sheet; degenerative disease; deuterium hydrogen exchange; hydrogen bond; molecular interaction; mutagenesis; nuclear magnetic resonance spectroscopy; priority journal; protein structure; Alzheimer Disease; Amino Acid Sequence; Amyloid; Deuterium; Humans; Hydrogen; Models, Molecular; Molecular Sequence Data; Mutagenesis; Nitrogen Isotopes; Nuclear Magnetic Resonance, Biomolecular; Protein Conformation",,"Amyloid; Deuterium, 7782-39-0; Hydrogen, 1333-74-0; Nitrogen Isotopes",,,,"Selkoe, D.J., (2003) Nature, 426, pp. 900-904; Tycko, R., (2004) Curr. Opin. Struct. Biol., 14, pp. 96-103; Ritter, C., Maddelein, M.L., Siemer, A.B., Luhrs, T., Ernst, M., Meier, B.H., Saupe, S.J., Riek, R., (2005) Nature, 435, pp. 844-848; Nelson, R., Sawaya, M.R., Balbirnie, M., Madsen, A.O., Riekel, C., Grothe, R., Eisenberg, D., (2005) Nature, 435, pp. 773-778; Masters, C.L., Simms, G., Weinman, N.A., Multhaup, G., McDonald, B.L., Beyreuther, K., (1985) Proc. Natl. Acad. Sci. USA, 82, pp. 4245-4249; Kang, J., Lemaire, H.G., Unterbeck, A., Salbaum, J.M., Masters, C.L., Grzeschik, K.H., Multhaup, G., Muller-Hill, B., (1987) Nature, 325, pp. 733-736; Jarrett, J.T., Berger, E.P., Lansbury Jr., P.T., (1993) Biochemistry, 32, pp. 4693-4697; Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Glabe, C., (1992) J. Biol. Chem., 267, pp. 546-554; Riek, R., Guntert, P., Dobeli, H., Wipf, B., Wuthrich, K., (2001) Eur. J. Biochem., 268, pp. 5930-5936; Kirschner, D.A., Abraham, C., Selkoe, D.J., (1986) Proc. Natl. Acad. Sci. USA, 83, pp. 503-507; Balbach, J.J., Petkova, A.T., Oyler, N.A., Antzutkin, O.N., Gordon, D.J., Meredith, S.C., Tycko, R., (2002) Biophys. J., 83, pp. 1205-1216; Alexandrescu, A.T., (2001) Pac. Symp. Biocomput., pp. 67-78; Hoshino, M., Katou, H., Hagihara, Y., Hasegawa, K., Naiki, H., Goto, Y., (2002) Nat. Struct. Biol., 9, pp. 332-336; Kheterpal, I., Zhou, S., Cook, K.D., Wetzel, R., (2000) Proc. Natl. Acad. Sci. USA, 97, pp. 13597-13601; Wang, S.S., Tobler, S.A., Good, T.A., Fernandez, E.J., (2003) Biochemistry, 42, pp. 9507-9514; Torok, M., Milton, S., Kayed, R., Wu, P., McIntire, T., Glabe, C.G., Langen, R., (2002) J. Biol. Chem., 277, pp. 40810-40815; Kheterpal, I., Williams, A., Murphy, C., Bledsoe, B., Wetzel, R., (2001) Biochemistry, 40, pp. 11757-11767; Egnaczyk, G.F., Greis, K.D., Stimson, E.R., Maggio, J.E., (2001) Biochemistry, 40, pp. 11706-11714; Petkova, A.T., Ishii, Y., Balbach, J.J., Antzutkin, O.N., Leapman, R.D., Delaglio, F., Tycko, R., (2002) Proc. Natl. Acad. Sci. USA, 99, pp. 16742-16747; Dobeli, H., Draeger, N., Huber, G., Jakob, P., Schmidt, D., Seilheimer, B., Stuber, D., Zulauf, M., (1995) Bio/Technology, 13, pp. 988-993; Seilheimer, B., Bohrmann, B., Bondolfi, L., Muller, F., Stuber, D., Dobeli, H., (1997) J. Struct. Biol., 119, pp. 59-71; Bohrmann, B., Adrian, M., Dubochet, J., Kuner, P., Muller, F., Huber, W., Nordstedt, C., Dobeli, H., (2000) J. Struct. Biol., 130, pp. 232-246; Levine III, H., (1999) Methods Enzymol., 309, pp. 274-284; Gordon, D.J., Sciarretta, K.L., Meredith, S.C., (2001) Biochemistry, 40, pp. 8237-8245; Wuthrich, K., (1986) NMR of Proteins and Nucleic Acids, , Wiley, New York; Koradi, R., Billeter, M., Wuthrich, K., (1996) J. Mol. Graphics, 14, pp. 51-55; Ban, T., Hoshino, M., Takahashi, S., Hamada, D., Hasegawa, K., Naiki, H., Goto, Y., (2004) J. Mol. Biol., 344, pp. 757-767; Bieler, S., Soto, C., (2004) Curr. Drug Targets, 5, pp. 553-558; Behl, C., Davis, J.B., Lesley, R., Schubert, D., (1994) Cell, 77, pp. 817-827; Hardy, J., Selkoe, D.J., (2002) Science, 297, pp. 353-356; Lambert, M.P., Barlow, A.K., Chromy, B.A., Edwards, C., Freed, R., Liosatos, M., Morgan, T.E., Viola, K.L., (1998) Proc. Natl. Acad. Sci. USA, 95, pp. 6448-6453; Hartley, D.M., Walsh, D.M., Ye, C.P., Diehl, T., Vasquez, S., Vassilev, P.M., Teplow, D.B., Selkoe, D.J., (1999) J. Neurosci., 19, pp. 8876-8884; Kayed, R., Head, E., Thompson, J.L., McIntire, T.M., Milton, S.C., Cotman, C.W., Glabe, C.G., (2003) Science, 300, pp. 486-489","Riek, R.; Salk Institute for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; email: riek@salk.edu",,,,,,,,00278424,,PNASA,16293696,"English","Proc. Natl. Acad. Sci. U. S. A.",Article,Scopus,2-s2.0-28444442999
"Schubert, D.","Glucose metabolism and Alzheimer's disease",2005,"Ageing Research Reviews","4","2",,"240","257",,63,10.1016/j.arr.2005.02.003,"http://www.scopus.com/inward/record.url?eid=2-s2.0-23444461417&partnerID=40&md5=a25c37e98333f36e51617f84dda3d5e5","Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, 10010 N, Torrey Pines Road, San Diego, CA 92037, United States","Schubert, D., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, 10010 N, Torrey Pines Road, San Diego, CA 92037, United States","The brain is the organ with the highest basal rate of glucose consumption. Most of the energy generated by the oxidation of glucose is used for the work necessary to maintain the ionic balances associated with synaptic transmission. When the nervous system is subjected to the oxidative stress of age-associated disease, there is a redistribution of glucose breakdown to pathways that more efficiently produce molecules involved in antioxidant metabolism. This shift is at least in part mediated by the transcription factor HIF-1. The clinical implications of this change in glucose metabolism are discussed in the context of aging and Alzheimer's disease. © 2005 Elsevier Ireland Ltd. All rights reserved.","Alzheimer's; Brain; Glucose; HIF-1; Metabolism; Nerve","1,2,3,6 tetrahydro 1 methyl 4 phenylpyridine; 6 phosphofructokinase isoenzyme L; adenosine phosphate; adenosine triphosphate; amyloid beta protein; enolase; fructose 2,6 bisphosphatase; fructose bisphosphate aldolase; glucose; glucose 6 phosphatase; glucose 6 phosphate; glucose 6 phosphate dehydrogenase; glucose transporter; glucose transporter 1; glucose transporter 3; glucose transporter 4; glucose transporter 5; glyceraldehyde 3 phosphate dehydrogenase; hexokinase; hypoxia inducible factor 1; lactate dehydrogenase; lactic acid; pentose phosphate; phosphoglycerate kinase; protein glutamine gamma glutamyltransferase; reduced nicotinamide adenine dinucleotide phosphate; ribulose phosphate; transcription factor; triosephosphate isomerase; actin polymerization; Alzheimer disease; blood brain barrier; brain oxygen consumption; computer assisted emission tomography; dehydrogenation; electron transport; energy metabolism; functional magnetic resonance imaging; genetic transcription; glia cell; glucose brain level; glucose intake; glucose metabolism; glucose transport; glucose utilization; glycolysis; human; lactate blood level; lactic acidosis; neurofibrillary tangle; neuroprotection; oxidative phosphorylation; oxidative stress; Parkinson disease; pentose phosphate cycle; protein phosphorylation; review; signal transduction; upregulation; Aging; Alzheimer Disease; Brain; Glucose; Humans",,"1,2,3,6 tetrahydro 1 methyl 4 phenylpyridine, 28289-54-5; adenosine phosphate, 61-19-8, 8063-98-7; adenosine triphosphate, 15237-44-2, 56-65-5, 987-65-5; amyloid beta protein, 109770-29-8; enolase, 9014-08-8; fructose 2,6 bisphosphatase, 81611-75-8; fructose bisphosphate aldolase, 9024-52-6; glucose 6 phosphatase, 9001-39-2; glucose 6 phosphate dehydrogenase, 37259-83-9, 9001-40-5; glucose 6 phosphate, 56-73-5; glucose transporter 1, 172077-08-6; glucose transporter 3, 174958-52-2; glucose transporter 4, 188071-24-1; glucose transporter 5, 130456-74-5; glucose, 50-99-7, 84778-64-3; glyceraldehyde 3 phosphate dehydrogenase, 9001-50-7; hexokinase, 9001-51-8; lactate dehydrogenase, 9001-60-9; lactic acid, 113-21-3, 50-21-5; pentose phosphate, 27710-24-3; phosphoglycerate kinase, 9001-83-6; protein glutamine gamma glutamyltransferase, 80146-85-6; reduced nicotinamide adenine dinucleotide phosphate, 53-57-6; ribulose phosphate, 26264-33-5, 4151-19-3; triosephosphate isomerase, 9023-78-3; Glucose, 50-99-7",,,,"Attwell, D., Iadecola, C., The neural basis of functional brain imaging signals (2002) Trends Neurosci., 25, pp. 621-625; Behl, C., Davis, J., Cole, G.M., Schubert, D., Vitamin e protects nerve cells from amyloid b protein toxicity (1992) Biochem. Biophys Res. Comm., 186, pp. 944-950; Behl, C., Davis, J.B., Lesley, R., Schubert, D., Hydrogen peroxide mediates amyloid beta protein toxicity (1994) Cell, 77, pp. 817-827; Behl, C., Schubert, D., Heat shock partially protects rat pheochromocytoma PC12 cells from amyloid b peptide toxicity (1993) Neurosci. Lett., 154, pp. 1-4; Bernstein, B.W., Bamburg, J.R., Actin-ATP hydrolysis is a major energy drain for neurons (2003) J. Neurosci., 23, pp. 1-6; Blass, J.P., Brain metabolism and brain disease: Is metabolic deficiency the proximate cause of Alzheimer dementia? (2001) J. Neurosci. Res., 66, pp. 851-856; Bowen, D.M., White, P., Spillane, J.A., Goodhardt, M.J., Curzon, G., Iwangoff, P., Meier-Ruge, W., Davison, A.N., Accelerated ageing or selective neuronal loss as an important cause of dementia (1979) Lancet, 1, pp. 11-14; Brand, K., Aerobic glycolysis by proliferating cells (1997) J. Bioenerg. Biomembr., 29, pp. 355-364; Bruce-Keller, A.J., Umberger, G., McFall, R., Mattson, M.P., Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults (1999) Ann. Neurol., 45, pp. 8-15; Carling, D., The AMP-activated protein kinase cascade - A unifying system for energy control (2004) Trends Biochem. Sci., 29, pp. 18-24; Chandel, N.S., McClintock, D.S., Feliciano, C.E., Wood, T.M., Melendez, J.A., Rodriguez, A.M., Schumacker, P.T., Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: A mechanism of O2 sensing (2000) J. Biol. Chem., 275, pp. 25130-25138; Chang, L.K., Schmidt, R.E., Johnson Jr., E.M., Alternating metabolic pathways in NGF-deprived sympathetic neurons affect caspase-independent death (2003) J. Cell Biol., 162, pp. 245-256; Chavez, J.C., Lamanna, J.C., Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: Potential role of insulin-like growth factor-1 (2002) J. Neurosci., 22, pp. 8922-8931; Cherny, R.A., Atwood, C.S., Xilinas, M.E., Gray, D.N., Jones, W.D., McLean, C.A., Barnham, K.J., Kim, Y., Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice (2001) Neuron, 30, pp. 641-642; Chih, C.P., Lipton, P., Roberts Jr., E.L., Do active cerebral neurons really use lactate rather than glucose? (2001) Trends Neurosci., 24, pp. 573-578; Craft, S., Newcomer, J., Kanne, S., Dagogo-Jack, S., Cryer, P., Sheline, Y., Luby, J., Alderson, A., Memory improvement following induced hyperinsulinemia in Alzheimer's disease (1996) Neurobiol. Aging, 17, pp. 123-130; Duyndam, M.C., Hulscher, T.M., Fontijn, D., Pinedo, H.M., Boven, E., Induction of vascular endothelial growth factor expression and hypoxia-inducible factor 1alpha protein by the oxidative stressor arsenite (2001) J. Biol. Chem., 276, pp. 48066-48076; Dwyer, D.S., Vannucci, S.J., Simpson, I.A., Expression, regulation, and functional role of glucose transporters (GLUTs) in brain (2002) Int. Rev. Neurobiol., 51, pp. 159-188; Fingar, D.C., Blenis, J., Target of rapamycin (TOR): An integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression (2004) Oncogene, 23, pp. 3151-3171; Hardie, D.G., Scott, J.W., Pan, D.A., Hudson, E.R., Management of cellular energy by the AMP-activated protein kinase system (2003) FEBS Lett., 546, pp. 113-120; Hoet, P.H., Roesems, G., Demedts, M.G., Nemery, B., Activation of the hexose monophosphate shunt in rat type II pneumocytes as an early marker of oxidative stress caused by cobalt particles (2002) Arch. Toxicol., 76, pp. 1-7; Horwood, N., Davies, D.C., Immunolabelling of hippocampal microvessel glucose transporter protein is reduced in Alzheimer's disease (1994) Virchows Arch., 425, pp. 69-72; Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J.Q., Boonplueang, R., Viswanath, V., Beal, M.F., Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: A novel therapy for Parkinson's disease (2003) Neuron, 37, pp. 899-909; Klein, W.L., Krafft, G.A., Finch, C.E., Targeting small a beta oligomers: The solution to an Alzheimer's disease conundrum? (2001) Trends Neurosci., 24, pp. 219-224; Lehnen-Beyel, I., Groot, H.D., Rauen, U., Enhancement of iron toxicity in L929 cells by d-glucose: Accelerated(re-)reduction (2002) Biochem. J., 368, pp. 517-526; Lehninger, A.L., (1971) Bioenergetics, , Menlo Park, Ca Benjamin, W.A; Lemay, D.R., Gehua, L., Zelenock, G.B., D'Alecy, L.G., Insulin administration protects neurologic function in cerebral ischemia in rats (1988) Stroke, 19, pp. 1411-1419; Liu, Y., Fiskum, G., Schubert, D., Generation of reactive oxygen species by the mitochondrial electron transport chain (2002) J. Neurochem., 80, pp. 780-787; Manning, C.A., Ragozzino, M.E., Gold, P.E., Glucose enhancement of memory in patients with probable senile dementia of the Alzheimer's type (1993) Neurobiol. Aging, 14, pp. 523-528; Martini, G., Ursini, M.V., A new lease of life for an old enzyme (1996) Bioassays, 18, pp. 631-637; Ott, A., Stolk, R.P., Van Harskamp, F., Pols, H.A., Hofman, A., Bretele, R.M.M., Diabetes mellitus and the risk of dementia: The Rotterdam study (1999) Neurology, 53, pp. 1937-1942; Palmer, A.M., The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease (1999) J. Neural Trans., 106, pp. 317-328; Pandolfi, P.P., Sonati, F., Rivi, R., Mason, P., Grosveld, F., Luzzatto, L., Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress (1995) EMBO J., 14, pp. 5209-5215; Parpura-Gill, A., Beitz, D., Uemura, E., The inhibitory effects of b-amyloid on glutamate and glucose uptakes by cultured astrocytes (1997) Brain Res., 754, pp. 65-71; Plas, D.R., Thompson, C.B., Cell metabolism in the regulation of programmed cell death (2002) Trends Endocrinol. Metab., 13, pp. 74-78; Prass, K., Ruscher, K., Karsch, M., Isaev, N., Megow, D., Priller, J., Scharff, A., Meisel, A., Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro (2002) J. Cereb. Blood Flow Metab., 22, pp. 520-525; Puskas, F., Gergely Jr., P., Banki, K., Perl, A., Stimulation of the pentose phosphate pathway and glutathione levels by dehydroascorbate, the oxidized form of vitamin C (2000) Faseb J., 14, pp. 1352-1361; Raichle, M.E., Gusnard, D.A., Appraising the brain's energy budget (2002) Proc. Natl. Acad. Sci. U.S.A., 99, pp. 10237-10239; Rodriguez-Enriquez, S., Moreno-Sanchez, R., Intermediary metabolism of fast-growth tumor cells (1998) Arch. Med. Res., 29, pp. 1-12; Russell, R.L., Siedlak, S.L., Raina, A.K., Bautista, J.M., Smith, M.A., Perry, G., Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease (1999) Arch. Biochem. Biophys., 370, pp. 236-239; Ryan, C.M., Geckle, M., Why is learning and memory dysfunction in Type 2 diabetes limited to older adults? (2000) Diabetes Metab. Res. Rev., 16, pp. 308-315; Sagara, Y., Dargusch, R., Klier, F.G., Schubert, D., Behl, C., Increased antioxidant enzyme activity in amyloid beta protein-resistant cells (1996) J. Neurosci., 16, pp. 497-505; Salvemini, F., Franze, A., Iervolino, A., Filosa, S., Salzano, S., Ursini, M.V., Enhanced glutathione levels and oxidoresistance mediated by increased glucose-6-phosphate dehydrogenase expression (1999) J. Biol. Chem., 274, pp. 2750-2757; Sano, M., Ernesto, C., Thomas, R.G., Klauber, M.R., Schafer, K., Grundman, M., Woodbury, P., Pfeiffer, E., A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease (1997) New Eng. J. Med., 336, pp. 1216-1222; Sapolsky, R.M., Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders (2000) Arch. Gen. Psychiatr., 57, pp. 925-935; Schubert, D., Behl, C., Lesley, R., Brack, A., Dargusch, R., Sagara, Y., Kimura, H., Amyloid peptides are toxic via a common oxidative mechanism (1995) Proc. Natl. Acad Sci. U.S.A., 92, pp. 1989-1993; Schubert, D., Chevion, M., The role of iron in beta amyloid toxicity (1995) Biochem. Biophys Res. Commun., 216, pp. 702-707; Seagroves, T.N., Ryan, H.E., Lu, H., Wouters, B.G., Knapp, M., Thibault, P., Laderoute, K., Johnson, R.S., Transcription factor HIF-1 is a necessary mediator of the Pasteur effect in mammalian cells (2001) Mol. Cell Biol., 21, pp. 3436-3444; Semenza, G., Signal transduction to hypoxia-inducible factor 1 (2002) Biochem. Pharmacol., 64, pp. 993-998; Shulman, R.G., Rothman, D.L., Behar, K.L., Hyder, F., Energetic basis of brain activity: Implications for neuroimaging (2004) Trends Neurosci., 27, pp. 489-495; Sims, N.R., Bowen, D.M., Davison, A.N., [14C]Acetylcholine synthesis and [14C]carbon dioxide production from [U-14C]glucose by tissue prisms from human neocortex (1981) Biochem. J., 196, pp. 867-876; Sims, N.R., Finegan, J.M., Blass, J.P., Bowen, D.M., Neary, D., Mitochondrial function in brain tissue in primary degenerative dementia (1987) Brain Res., 436, pp. 30-38; Soucek, T., Cumming, R., Dargusch, R., Maher, P., Schubert, D., The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide (2003) Neuron, 39, pp. 43-56; Svrzic, D., Schubert, D., Insulin-like growth factor 1 supports embryonic nerve cell survival (1990) Biochem. Biophys. Res. Commun., 172, pp. 54-60; Tan, S., Sagara, Y., Liu, Y., Maher, P., Schubert, D., The regulation of reactive oxygen species production during programmed cell death (1998) J. Cell Biol., 141, pp. 1423-1432; Terry, R.D., Masliah, E., Hansen, L.A., (1994) Structural Basis of the Cognitive Alterations in Alzheimer Disease, pp. 179-196. , R.D. Terry R. Katzman K.L. Bick Raven Press New York; Wang, X.F., Cynader, M.S., Pyruvate released by astrocytes protects neurons from copper-catalyzed cysteine neurotoxicity (2001) J. Neurosci., 21, pp. 3322-3331; Watson, G.S., Craft, S., The role of insulin resistance in the pathogenesis of Alzheimer's disease: Implications for treatment (2003) CNS Drugs, 17, pp. 27-45; Wenger, R.H., Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2- regulated gene expression (2002) FASEB J., 16, pp. 1151-1162; Wilson, W.J., Poellinger, L., The dietary flavonoid quercetin modulates HIF-1a activity in endothelial cells (2002) Biochem. Biophys. Res. Comm., 293, pp. 446-450; Yankner, B.A., Duffy, L.K., Kirschner, D.A., Neurotrophic and neurotoxic effects of amyloid beta protein: Reversal by tachykinin neuropeptides (1990) Science, 250, pp. 279-282; Zakzanis, K.K., Graham, S.J., Campbell, Z., A meta-analysis of structural and functional brain imaging in dementia of the Alzheimer's type: A neuroimaging profile (2003) Neuropsychol. Rev., 13, pp. 1-18; Zaman, K., Ryu, H., Hall, D., O'Donovan, K., Lin, K.I., Miller, M.P., Marquis, J.C., Ratan, R.R., Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin (1999) J. Neurosci., 19, pp. 9821-9830; Zhang, B., Tanaka, J., Yang, L., Sakanaka, M., Hata, R., Maeda, N., Mitsuda, N., Protective effect of vitamin e against focal brain ischemia and neuronal death through induction of target genes of hypoxia-inducible factor-1 (2004) Neuroscience, 126, pp. 433-440","Schubert, D.; Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, 10010 N, Torrey Pines Road, San Diego, CA 92037, United States; email: schubert@salk.edu",,,,,,,,15681637,,ARRGA,15950548,"English","Ageing Res. Rev.",Review,Scopus,2-s2.0-23444461417
"Chen, Q., Chen, T.-J., Letourneau, P.C., Costa, L.D.F., Schubert, D.","Modifier of cell adhesion regulates N-cadherin-mediated cell-cell adhesion and neurite outgrowth",2005,"Journal of Neuroscience","25","2",,"281","290",,36,10.1523/JNEUROSCI.3692-04.2005,"http://www.scopus.com/inward/record.url?eid=2-s2.0-12144266320&partnerID=40&md5=f896a13d46657737f8592fc7e1948924","Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA 92037, United States; Department of Neuroscience, University of Minnesota, Minneapolis, MN 55455, United States; Inst. of Physics at São Carlos, São Carlos, São Paulo, Brazil; Salk Institute, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; Department of Physiology, Kaohsiung Medical University, Kaohsiung, Taiwan","Chen, Q., Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA 92037, United States; Chen, T.-J., Department of Neuroscience, University of Minnesota, Minneapolis, MN 55455, United States, Department of Physiology, Kaohsiung Medical University, Kaohsiung, Taiwan; Letourneau, P.C., Department of Neuroscience, University of Minnesota, Minneapolis, MN 55455, United States; Costa, L.D.F., Inst. of Physics at São Carlos, São Carlos, São Paulo, Brazil; Schubert, D., Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA 92037, United States, Salk Institute, 10010 North Torrey Pines Road, San Diego, CA 92037, United States","Modifier of cell adhesion (MOCA) is a member of the dedicator of cytokinesis 180 family of proteins and is highly expressed in CNS neurons. MOCA is associated with Alzheimer's disease tangles and regulates the accumulation of amyloid precursor protein and β-amyloid. Here, we report that MOCA modulates cell-cell adhesion and morphology. MOCA increases the accumulation of adherens junction proteins, including N-cadherin and β-catenin, whereas reducing endogenous MOCA expression lowers cell-cell aggregation and N-cadherin expression. MOCA colocalizes with N-cadherin and actin in areas of cell-cell and cell substratum contact and is expressed in neuronal processes. MOCA accumulates during neuronal differentiation, and its expression enhances NGF-induced neurite outgrowth and morphological complexity. We conclude that MOCA regulates N-cadherin-mediated cell-cell adhesion and neurite outgrowth.","Adhesion; Cadherin; Differentiation; MOCA; Nerve; Neurite outgrowth","actin; beta catenin; docking protein; nerve cell adhesion molecule; nerve growth factor; protein modifier of cell adhesion; unclassified drug; animal cell; article; cell adhesion; cell interaction; cell structure; cellular distribution; cytokinesis; human; morphological adaptation; nerve cell; nerve cell differentiation; nerve fiber growth; nonhuman; nucleotide sequence; priority journal; protein expression; protein localization; rat; Animals; beta Catenin; Cadherins; Cell Adhesion; Cell Aggregation; Cell Line; Cytoskeletal Proteins; Guanine Nucleotide Exchange Factors; Humans; Molecular Sequence Data; Nerve Tissue Proteins; Neurites; PC12 Cells; Rats; RNA, Small Interfering; Trans-Activators; Transfection","GENBANK: AY145302, AY145303, NM_001792, XM_236616","nerve growth factor, 9061-61-4; beta Catenin; Cadherins; Catnb protein, rat; CTNNB1 protein, human; Cytoskeletal Proteins; DOCK3 protein, human; Guanine Nucleotide Exchange Factors; Nerve Tissue Proteins; RNA, Small Interfering; Trans-Activators",,,,"Beesley, P.W., Mummery, R., Tibaldi, J., N-cadherin is a major glycoprotein component of isolated rat forebrain postsynaptic densities (1995) J Neurochem, 64, pp. 2288-2294; Benson, D.L., Tanaka, H., N-cadherin redistribution during synapto-genesis in hippocampal neurons (1998) J Neurosci, 18, pp. 6892-6904; Brugnera, E., Haney, L., Grimsley, C., Lu, M., Walk, S.F., Tosello-Trampont, A.C., Macara, I.G., Ravichandran, K.S., Unconventional Rac-GEF activity is mediated through the Dock180-ELMO complex (2002) Nat Cell Biol, 4, pp. 574-582; Charrasse, S., Comunale, F., Gilbert, E., Delattre, O., Gauthier-Rouviere, C., Variation in cadherins and catenins expression is linked to both proliferation and transformation of rhabdomyosarcoma (2004) Oncogene, 23, pp. 2420-2430; Chen, Q., Yoshida, H., Schubert, D., Maher, P., Mallory, M., Masliah, E., Presenilin binding protein is associated with neurofibrillary alterations in Alzheimer's disease and stimulates tau phosphorylation (2001) Am J Pathol, 159, pp. 1597-1602; Chen, Q., Kimura, H., Schubert, D., A novel mechanism for the regulation of amyloid precursor protein metabolism (2002) J Cell Biol, 158, pp. 79-89; Chen, Y.T., Stewart, D.B., Nelson, W.J., Coupling assembly of the E-cadherin/beta-catenin complex to efficient endoplasmic reticulum exit and basal-lateral membrane targeting of E-cadherin in polarized MDCK cells (1999) J Cell Biol, 144, pp. 687-699; Cole, G.J., Schubert, D., Glaser, L., Cell-substratum adhesion in chick neuronal retina depends upon protein-heparan sulfate interactions (1985) J Cell Biol, 100, pp. 1192-1199; Costa, Ld.F., Enhanced multiscale skeletons (2003) J Real-Time Imaging, 9, pp. 315-319; Costa, Ld.F., Cesar Jr., R.M., (2001) Shape Analysis and Classification: Theory and Practice, , Boca Raton, FL: CRC; Costa, Ld.F., Campos, A.G., Estrozi, L.F., Filho, L.G.R., Bosco, A., A biologically motivated approach to image representation and its application to neuromorphology (2000) Biol Motiv Comput Vis, 1811, pp. 407-416; Costa, Ld.F., Manoel, E.T., Faucereau, F., Chelly, J., Van Pelt, J., Ramakers, G., A shape analysis framework for neuromorphometry (2002) Network, 13, pp. 283-310; Cote, J.F., Vuori, K., Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity (2002) J Cell Sci, 115, pp. 4901-4913; Silva, M.G., Elliott, K., Dahl, H.H., Fitzpatrick, E., Wilcox, S., Delatycki, M., Williamson, R., Forrest, S., Disruption of a novel member of a sodium/hydrogen exchanger family and DOCK3 is associated with an attention deficit hyperactivity disorder-like phenotype (2003) J Med Genet, 40, pp. 733-740; Dietrich, C., Scherwat, J., Faust, D., Oesch, F., Subcellular localization of beta-catenin is regulated by cell density (2002) Biochem Biophys Res Commun, 292, pp. 195-199; Doherty, P., Smith, P., Walsh, F.S., Shared cell adhesion molecule (CAM) homology domains point to CAMs signalling via FGF receptors (1996) Perspect Dev Neurobiol, 4, pp. 157-168; Fannon, A.M., Colman, D.R., A model for central synaptic functional complex formation based on the differential adhesive specificities of the cadherins (1996) Neuron, 17, pp. 423-434; Gallo, G., Letourneau, P.C., Regulation of growth cone actin filaments by guidance cues (2004) J Neurobiol, 58, pp. 92-102; Garcia-Castro, M., Vielmetler, E., Bonner-Fraser, M., N-cadherin, an adhesion molecule involved in establishment of left-right asymmetry (2000) Science, 288, pp. 1047-1051; Geiger, B., Ayalon, O., Cadherins (1992) Annu Rev Cell Biol, 8, pp. 307-332; Grimsley, C.M., Kinchen, J.M., Tosello-Trampont, A.C., Brugnera, E., Haney, L.B., Lu, M., Chen, Q., Ravichandran, K.S., Dock180 and ELMO1 proteins cooperate to promote evolutionarily conserved Rac-dependent cell migration (2004) J Biol Chem, 279, pp. 6087-6097; Huber, A.H., Weis, W.I., The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin (2001) Cell, 105, pp. 391-402; Huber, A.H., Stewart, D.B., Laurents, D.V., Nelson, W.J., Weis, W.I., The cadherin cytoplasmic domain is unstructured in the absence of beta-catenin. A possible mechanism for regulating cadherin turnover (2001) J Biol Chem, 276, pp. 12301-12309; Inoue, A., Sanes, J.R., Lamina-specific connectivity in the brain: Regulation by N-cadherin, neurotrophins, and glycoconjugates (1997) Science, 276, pp. 1428-1431; Iwai, Y., Usui, T., Hirano, S., Steward, R., Takeichi, M., Uemura, T., Axon patterning requires DN-cadherin, a novel neuronal adhesion receptor, in the Drosophila embryonic CNS (1997) Neuron, 19, pp. 77-89; Kashiwa, A., Yoshida, H., Lee, S., Paladino, T., Liu, Y., Chen, Q., Dargusch, R., Kimura, H., Isolation and characterization of novel presenilin binding protein (2000) J Neurochem, 75, pp. 109-116; Miyatani, S., Shimamura, K., Hatta, M., Hatta, N., Nose, A., Matsunaga, M., Hatta, K., Takeichi, M., Neural cadherin: Role in selective cell-cell adhesion (1989) Science, 245, pp. 631-635; Muller, T., Choidas, A., Reichmann, E., Ullrich, A., Phosphorylation and free pool of beta-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration (1999) J Biol Chem, 274, pp. 10173-10183; Namekata, K., Enokido, Y., Iwasawa, K., Kimura, H., MOCA induces membrane spreading by activating Rac1 (2004) J Biol Chem, 279, pp. 14331-14337; Piedra, J., Martinez, D., Castano, J., Miravet, S., Dunach, M., De Herreros, A.G., Regulation of beta-catenin structure and activity by tyrosine phosphorylation (2001) J Biol Chem, 276, pp. 20436-20443; Ramsby, M.L., Makowski, G.S., Differential detergent fractionation of eukaryotic cells. Analysis by two-dimensional gel electrophoresis (1999) Methods Mol Biol, 112, pp. 53-66; Redies, C., Cadherins in the central nervous system (2000) Prog Neurobiol, 61, pp. 611-648; Redies, C., Takeichi, M., Cadherins in the developing central nervous system: An adhesive code for segmental and functional subdivisions (1996) Dev Biol, 180, pp. 413-423; Roura, S., Miravet, S., Piedra, J., Garcia De Herreros, A., Dunach, M., Regulation of E-cadherin/Catenin association by tyrosine phosphorylation (1999) J Biol Chem, 274, pp. 36734-36740; Schubert, D., Heinemann, S., Carlisle, W., Tarikas, H., Kimes, B., Patrick, J., Steinbach, J.H., Brandt, B.L., Clonal cell lines from the rat central nervous system (1974) Nature, 249, pp. 224-227; Schubert, D., Jin, L.W., Saitoh, T., Cole, G., The regulation of amyloid beta protein precursor secretion and its modulatory role in cell adhesion (1989) Neuron, 3, pp. 689-694; Sommers, C.L., Gelmann, E.P., Kemler, R., Cowin, P., Byers, S.W., Alterations in beta-catenin phosphorylation and plakoglobin expression in human breast cancer cells (1994) Cancer Res, 54, pp. 3544-3552; Steinberg, M.S., Takeichi, M., Experimental specification of cell sorting, tissue spreading, and specific spatial patterning by quantitative differences in cadherin expression (1994) Proc Natl Acad Sci USA, 91, pp. 206-209; Stewart, D.B., Barth, A.I., Nelson, W.J., Differential regulation of endogenous cadherin expression in Madin-Darby canine kidney cells by cell-cell adhesion and activation of beta-catenin signaling (2000) J Biol Chem, 275, pp. 20707-20716; Takeichi, M., Cadherin cell adhesion receptors as a morphogenetic regulator (1991) Science, 251, pp. 1451-1455; Takeichi, M., Morphogenetic roles of classic cadherins (1995) Curr Opin Cell Biol, 7, pp. 619-627; Tanaka, H., Shan, W., Phillips, G.R., Arndt, K., Bozdagi, O., Shapiro, L., Huntley, G.W., Colman, D.R., Molecular modification of N-cadherin in response to synaptic activity (2000) Neuron, 25, pp. 93-107; Tang, L., Hung, C.P., Schuman, E.M., A role for the cadherin family of cell adhesion molecules in hippocampal long-term potentiation (1998) Neuron, 20, pp. 1165-1175; Taupin, P., Ray, J., Fischer, W.H., Suhr, S.T., Hakansson, K., Grubb, A., Gage, F.H., FGF-2-responsive neural stem cell proliferation requires CCg, a novel autocrine/paracrine cofactor (2000) Neuron, 28, pp. 385-397; Tomschy, A., Fauser, C., Landwehr, R., Engel, J., Homophilic adhesion of E-cadherin occurs by a co-operative two-step interaction of N-terminal domains (1996) EMBO J, 15, pp. 3507-3514; Uchida, N., Honjo, Y., Johnson, K.R., Wheelock, M.J., Takeichi, M., The catenin/cadherin adhesion system is localized in synaptic junctions bordering transmitter release zones (1996) J Cell Biol, 135, pp. 767-779; Utton, M.A., Eickholt, B., Howell, F.V., Wallis, J., Doherty, P., Soluble N-cadherin stimulates fibroblast growth factor receptor dependent neurite outgrowth and N-cadherin and fibroblast growth factor receptor co-cluster in cells (2001) J Neurochem, 76, pp. 1421-1430; Yagi, T., Takeichi, M., Cadherin superfamily genes: Functions, genomic organization, and neurologic diversity (2000) Genes Dev, 14, pp. 1169-1180; Yajnik, V., Paulding, C., Sordella, R., McClatchey, A.I., Saito, M., Wahrer, D.C., Reynolds, P., Haber, D.A., DOCK4, a GTPase activator, is disrupted during tumorigenesis (2003) Cell, 112, pp. 673-684; Yap, A.S., Brieher, W.M., Gumbiner, B.M., Molecular and functional analysis of cadherin-based adherens junctions (1997) Annu Rev Cell Dev Biol, 13, pp. 119-146","Schubert, D.; Salk Institute, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; email: schubert@salk.edu",,,,,,,,02706474,,JNRSD,15647471,"English","J. Neurosci.",Article,Scopus,2-s2.0-12144266320
"Freese, W., Schubert, D.","Safety testing and regulation of genetically engineered foods",2004,"Biotechnology and Genetic Engineering Reviews","21",,,"299","324",,34,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-10644254759&partnerID=40&md5=c4949794a7d09638b2f1b877df94e14b","Friends of the Earth U.S., 1717 Massachusetts Ave., NW, Washington, DC 20036, United States; Salk Inst. for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States","Freese, W., Friends of the Earth U.S., 1717 Massachusetts Ave., NW, Washington, DC 20036, United States; Schubert, D., Salk Inst. for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States",[No abstract available],,"protein; allergenicity; Ames test; Bacillus thuringiensis; corn; environmental protection; food and drug administration; food safety; genetically modified crop; government; policy; recombinant DNA technology; review; United States; world health organization; Agriculture; Consumer Product Safety; Food Inspection; Food Technology; Food, Genetically Modified; Genetic Engineering; Government Regulation; Nutrition Policy; Plants, Genetically Modified; United States; Bacillus thuringiensis; Zea mays",,"protein, 67254-75-5",,,,"Alibhai, M.F., Stallings, W.C., Closing down on glyphosate inhibition - With a new structure for drug discovery (2001) Proceedings of the National Academy of Sciences of the United States of America, 98 (6), pp. 2944-2946; Ames, B.N., Profet, M., Gold, L.S., Dietary pesticides (99.99% all natural) (1990) Proceedings of the National Academy of Sciences of the United States of America, 87, pp. 7777-7781; Behle, R.W., Mcguire, M.R., Shasha, B.S., Effects of sunlight and simulated rain on residual activity of Bacillus thuringiensis formulations (1997) Journal of Economic Entomology, 90, pp. 1560-1566; Benbrook, C., Troubled times amid commercial success for Roundup Ready soybeans (2001) AgBiotech InfoNet Technical Paper, 4. , http://www.biotech-info.net/troubledtimes.html, May 3, 2001; Benbrook, C., Impacts of genetically engineered crops on pesticide use in the United States: The first eight years (2003) Biotech InfoNet Technical Paper, 6. , http://www.biotech-info.net/technicalpaper6.html, November 2003; Bernstein, I.L., Bernstein, J.A., Miller, M., Immune responses in farm workers after exposure to Bacillus thuringiensis pesticides (1999) Environmental Health Perspectives, 107 (7), pp. 575-582; Caplan, R., Raising risk: Field testing of genetically engineered crops in the United States (2003) US PIRG Education Fund, , http://www.uspirg.org/reports/RaisingRisk2003.pdf, June 2003; (1991) Report on National Biotechnology Policy 11, , The President's Council on Competitiveness, Washington, DC, USA; Courtial, B., Feuerbach, F., Eberhard, S., Tnt1 transposition events are induced by in vitro transformation of Arabidopsis thaliana, and transposed copies integrate into genes (2001) Molecular Genetics and Genomics, 265, pp. 32-42; Biotech battle takes shape in capital (2003) Daily Democrat, 23, p. 2003. , Woodland, CA, USA, June; Dalton, R., Superweed study falters as seed firms deny access to transgene (2002) Nature, 419 (6908), p. 655; (2000) Risk Assessment in a Rapidly Evolving Field: The Case of Genetically Modified Plants (GMP), p. 9. , Scientific Opinion of the Scientific Steering Committee, Health and Consumer Protection Directorate-General, European Commission, October 26-27, 2000; (2003) European Legislative Framework for GMOs Is Now in Place, , http://europa.eu.int/rapid/start/cgi/guesten.ksh?p_action.gettxt= gt&doc=IP/03/1056|0|RAPID&lg=EN, Press Release IP/03/1056, European Commission, July 22, 2003; (1998) Manual for Assessing Ecological and Human Health Effects of Genetically Engineered Organisms, , http://www.edmonds-institute.org/manual.html; Eichenwald, K., Kolata, G., Petersen, M., Biotechnology food: From the lab to a debacle (2001) New York Times, pp. A1. , January 25, 2001; Elgorashi, E.E., Taylor, J.L.S., Maes, A., Van Staden, J., De Kimpe, N., Verschaeve, L., Screening of medicinal plants used in South African traditional medicine for genotoxic effects (2003) Toxicology Letters, 143, pp. 195-207; Glufosinate-ammonium; pesticide tolerance (2003) Federal Register, 68 (188), pp. 55833-55849. , 29th September, 2003; (2001) Biopesticides Registration Action Document (BRAD)-Bacillus thuringiensis Plant-incorporated Protectants: Environmental Assessment, pp. IIC34. , http://www.epa.gov/pesticides/biopesticides/pips/bt_brad2/3-ecological. pdf, October 15, 2001; (2001) Biopesticides Registration Action Document (BRAD)-Bacillus thuringiensis Plant-incorporated Protectants: Product Characterization and Human Health Assessment, , http://www.epa.gov/pesticides/biopesticides/pips/bt_brad2/2-id_health.pdf, October 15, 2001; (2001) Biopesticides Registration Action Document (BRAD)-Bacillus thuringiensis Cry1F Corn, p. 9. , http://www.epa.gov/pesticides/biopesticides/ingredients/tech_docs/ brad_006481.pdf, August 2001; (2001) Biopesticides Registration Action Document (BRAD)-Bacillus thuringiensis Plant-incorporated Protectants: Overview, , http://www.epa.gov/pesticides/biopesticides/pips/bt_brad2/1-overview.pdf, October 15, 2001; (2001) Biopesticides Registration Action Document (BRAD)-Bacillus thuringiensis Plant-incorporated Protectants: Insect Resistance Management, pp. IID2. , http://www.epa.gov/pesticides/biopesticides/pips/bt_brad2/4-irm.pdf, October 15, 2001; Regulations under the Federal Insecticide, Fungicide, and Rodenticide Act for plant-incorporated protectants (formerly plant-pesticides) (2001) Federal Register, 66 (139), pp. 37771-37817. , http://www.epa.gov/scipoly/pips.htm, 19th July, 2001; Pesticide tolerances and food and feed additive regulations for glyphosate: Final rule (1992) Federal Register, 57, p. 42700; Proposed policy; plant-pesticides subject to the Federal Insecticide, Fungicide, and Rodenticide Act and the Federal Food, Drug, and Cosmetic Act (1994) Federal Register, 59 (225). , http://www.pestlaw.com/x/fedreg/1994/EPA-19941123A.html, 23rd November, 1994; (2001) Evaluation of Allergenicity of Genetically Modified Foods. Report of a Joint FAO/WHO Expert Consultation on Allergenicity of Foods Derived from Biotechnology, , http://www.fao.org/es/ESN/food/pdf/allergygm.pdf, January 22-25, 2001; (1996) Letter from Alan M. Rulis, Office of Premarket Approval, Center for Food Safety and Applied Nutrition, , http://www.cfsan.fda.gov/~lrd/biocon.html, FDA to Dr. Kent Croon, Regulatory Affairs Manager, Monsanto Company, September 25, 1996. See Letter for BNF No. 34; (1991) Points to Consider for Safety Evaluation of Genetically Modified Foods. Supplemental Information, , http://www.bio-integrity.org/FDAdocs/10/10.pdf, Memo from Division of Food Chemistry and Technology and Division of Contaminants Chemistry, FDA, to James Maryanski, Biotechnology Coordinator. November 1, 1991; (1992) Revision of Toxicology Section of the Statement of Policy: Foods Derived from Genetically Modified Plants, , http://www.bio-integrity.org/FDAdocs/03/03.pdf, Memo from Samuel I. Shibko, Director, Division of Toxicological Review and Evaluation, FDA to James Maryanski, Biotechnology Coordinator. January 31, 1992; (1992) Comments on Biotechnology Draft Document, 2/27/92, , http://www.bio-integrity.org/FDAdocs/04/04.pdf, Draft memo from Dr. Louis J. Pribyl (recipient not cited). 3/6/92; FDA Memos 1991, 1992a and 1992b above Are 3 of 24 Internal FDA Documents Obtained in a Freedom of Information Act Request by the Alliance for Bio-Integrity, , http://www.bio-integrity.org/list.html; (1996) FDA Consultation Note on Monsanto's MON809 and MON810 Bt Corn Events, , http://www.cfsan.fda.gov/~lrd/biocon.html, September 18, 1996. See memo for BNF No. 34; (1998) FDA Consultation Note on Monsanto/Novartis' Glyphosate-tolerant Sugar Beet Line 77, , http://www.cfsan.fda.gov/~lrd/biocon.html, September 28, 1998. See memo for BNF No. 56; FDA consultation noteon Aventis' male-sterile corn (2000) MS6 Line, , http://www.cfsan.fda.gov/~lrd/biocon.html, April 4, 2000. See memo for BNF No. 66; Statement of policy: Foods derived from new plant varieties; notice (1992) Federal Register, 57 (104), pp. 22983-23005. , 29th May, 1992; Ferber, D., Something funny down on the pharm (2003) Popular Science, pp. 78-84. , April 2003; Freese, B., (2001) A Critique of the EPA's Decision to Reregister Bt Crops and an Examination of the Potential Allergenicity of Bt Proteins, , www.foe.org/safefood/comments.pdf, Adapted from comments of Friends of the Earth to the EPA, Docket No. OOP-00678B, Dec. 9, 2001; Freese, B., (2002) Suggestions for Improvement of the FDA's Assessment of Genetically Engineered Crops, Including Assessment of the Potential Allergenicity of Novel, Recombinant Proteins, , http://www.foe.org/camps/comm/safefood/gefood/index.html, Presentation to FDA's Food Biotechnology Subcommittee by Friends of the Earth, August 14, 2002; Freese, B., (2003) Genetically Engineered Crop Health Impacts Evaluation - GAPS Analysis, , http://www.foe.org/safefood/gapseval.pdf, Washington, DC, USA; Gendel, S., The use of amino acid sequence alignments to assess potential allergenicity of proteins used in genetically modifiedfoods (1998) Advances in Food and Nutrition Research, 42, pp. 45-62; Gepts, P., A comparison between crop domestication, classical plant breeding, and genetic engineering (2002) Crop Science, 42, pp. 1780-1790; Gurian-Sherman, D., (2003) Holes in the Biotech Safety Net: FDA Policy Does Not Assure the Safety of Genetically Engineered Foods, pp. 4-5. , http://www.cspinet.org/new/pdf/fda_report_final.pdf, January 2003; Harrison, L.A., Bailey, M.R., Naylor, M.W., The expressed protein in glyphosate-tolerant soybean, 5-enolpyruvylshikimate-3-phosphate synthase from Agrobacterium sp. Strain CP4, is rapidly digested in vitro and is not toxic to acutely gavaged mice (1996) The Journal of Nutrition, 126, pp. 728-740; Haslberger, A.G., Codex guidelines for GM foods include the analysis of unintended effects (2003) Nature Biotechnology, 21 (7), pp. 739-741; Hilbeck, A., Meier, M.S., (2002) Critique of Monsanto's Environmental Safety Assessment for Cry3Bb Bt Corn, , http://www.ucsusa.org/publication.cfm?publicationID=480, Ecostrat GmbH. Submitted to EPA on behalf of the Union of Concerned Scientists; Hilbeck, A., Meier, M.S., Raps, A., (2000) Non-target Organisms and Bt Plants: Report to Greenpeace International, , http://www.greenpeaceusa.org/media/press_releases/gmo-report-complete.pdf, EcoStrat GmbH, April 2000; Howitz, K.T., Bitterman, K.J., Cohen, H.Y., Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan (2003) Nature, 425, pp. 191-196; Humphreys, J.M., Chapple, C., Rewriting the lignin roadmap (2002) Current Opinions in Plant Biology, 5, pp. 224-229; Ignoffo, C.M., Garcia, C., UV-photoinactivation of cells and spores of Bacillus thuringiensis and effects of peroxidase on inactivation (1978) Environmental Entomology, 7, pp. 270-272; Ilinskaya, O.N., Vamvakas, S., Nephrotoxic effects of bacterial ribonucleases in the isolated perfused rat kidney (1997) Toxicology, 120 (1), pp. 55-63; James, C., (2002) Global Status of Commercialized Transgenic Crops: 2002, , ISAAA Briefs No. 27: The International Service for the Acquisition of Agri-biotech Applications, Ithaca, NY, USA; Kilman, S., McDonald's other fast-food chains pull Monsanto's bio-engineered potato (2000) Wall Street Journal, , April 28, 2000; Kleter, G.A., Peijnenburg, Ad.A.C.M., Screening of transgenic proteins expressed in transgenic food crops for the presence of short amino acid sequences identical to potential, IgE-binding linear epitopes of allergens (2002) BMC Structural Biology, 2 (8), pp. 1-11. , http://www.biomedcentral.com/1472-6807/2/8; Kok, E.J., Kuiper, H.A., Comparative safety assessment for biotech crops (2003) Trends in Biotechnology, 21, pp. 439-444; Kota, M., Daniell, H., Varma, S., Garczynski, S.F., Gould, F., Moar, W.J., Overexpression of the Bacillus thuringiensis (Bt) Cry2Aa2 protein in chloroplasts confers resistance to plants against susceptible and Bt-resistant insects (1999) Proceedings of the National Academy of Sciences of the United States of America, 96, pp. 1840-1845; Kuiper, H.A., Kleter, G.A., Noteborn, H.P.J.M., Kok, E.J., Assessment of the food safety issues related to genetically modified foods (2001) The Plant Journal, 27 (6), pp. 503-528; Lappé, M., Bailey, B., (1998) Against the Grain: Biotechnology and the Corporate Takeover of Your Food, pp. 75-76. , Monroe, ME, USA: Common Courage Press; Lappé, M.A., Bailey, E.B., Childress, C., Setchell, K.D.R., Alterations in clinically important phytoestrogens in genetically modified, herbicide-tolerant soybeans (1998) Journal of Medicinal Food, 1, pp. 241-245; Lee, T.C., Bailey, M., (1995) Assessment of the Equivalence of B.t.k. HD-1 Protein Produced in Several Insect Protected Corn Lines and Escherichia coli, , Unpublished study submitted to the EPA by Monsanto. EPA MRID No. 436655-03; Lee, T.C., Bailey, M., Sims, S., (1995) Assessment of the Equivalence of the Bacillus thuringiensis subsp. Kurstaki HD-1 Protein Produced in Escherichia coli and European Corn Borer Resistant Corn, , Unpublished study submitted to the EPA by Monsanto. EPA MRID No. 435332-04; Levine, E., Groth, M., Kania, J., (1995) Molecular Characterization of Insect Protected Corn Line MON 810, , Unpublished study submitted to the EPA by Monsanto, EPA MRID No-01CC; Maggi, V.L., Sims, S.R., (1994) Evaluation of the Dietary Effects of Purified B.t.k. Endotoxin Proteins on Honey Bee Adults, , California Agricultural Research, Inc. Unpublished study submitted to the EPA by Monsanto, EPA MRID No. 434392-03; Maron, D.M., Ames, B.N., Revised methods for the Salmonella mutagenicity test (1983) Mutation Research, 113, pp. 173-215; Meldrum, B., Amino acids as dietary excitotoxins: A contribution to understanding neurodegenerative disorders (1993) Brain Research, 18, pp. 293-314; Mendelsohn, M., Kough, J., Vattuzis, Z., Matthews, K., Are Bt Crops Safe? (2003) Nature Biotechnology, 21 (9), pp. 1003-1009; Metcalfe, D.D., Astwood, J.D., Townsend, R., Sampson, H.A., Taylor, S.L., Fuchs, R.L., Assessment of the allergenic potential of foods derived from genetically engineered crop plants (1996) Critical Reviews in Food Science and Nutrition, 36 (S), pp. S165-186; Meyer, P., The role of chromatin remodelling in transgene silencing and plant development (1999) In Vitro Cellular and Developmental Biology - Plant, 35, pp. 29-36; (2000) Genetically Modified Pest-protected Plants: Science and Regulation, , http://books.nap.edu/catalog/9795.html, Committee on Genetically Modified Pest-Protected Plants, National Research Council, National Academy of Sciences, Washington, DC, USA: National Academy Press; (2002) Environmental Effects of Transgenic Plants: The Scope and Adequacy of Regulation, , http://books.nap.edu/catalog/10258.html, Committee on Environmental Impacts associated with Commercialization of Transgenic Plants, National Research Council, National Academy of Sciences, Washington, DC, USA: National Academy Press; (2003) Acreage, , http://usda.mannlib.cornell.edu/reports/nassr/field/pcp-bba/acrg0603.pdf, Economic Research Service, US Department of Agriculture, June 30, 2003; Noteborn, H.P.J.M., (1998) Assessment of the Stability to Digestion and Bioavailability of the LYS Mutant Cry9C Protein from Bacillus thuringiensis Serovar Tolworthi, , Unpublished study submitted to the EPA by AgrEvo, EPA MRID No. 447343-05; Noteborn, H.P.J.M., Bienenmann-Ploum, M.E., Van Den Berg, J.H.J., Safety assessment of the Bacillus thuringiensis insecticidal crystal protein CRY1A(b) expressed in transgenic tomatoes (1995) Genetically Modified Foods: Safety Issues, pp. 134-147. , Eds. K.-H. Engel, G.R. Takeoka and R. Teranishi. Washington, DC, USA: American Chemical Society Symposium Series 605; Coordinated framework for regulation of biotechnology (1986) Federal Register, 51 (123). , Office of Science and Technology Policy, 26th June, 1986, 23302 ff; Ream, J.E., (1994) Assessment of the in Vitro Digestive Fate of Bacillus thuringiensis subsp. kurstaki HD-1 Protein, , Unpublished study submitted to the EPA by Monsanto. EPA MRID No. 434392-01; Roessner, U., Luedemann, A., Brust, D., Metabolic profiling allows comprehensive phenotyping of genetically or environmentally modified plant systems (2001) The Plant Cell, 13, pp. 11-29; (2001) Elements of Precaution: Recommendations for the Regulation of Food Biotechnology in Canada, an Expert Panel Report on the Future of Food Biotechnology, p. 122. , http://www.rsc.ca/foodbiotechnology/index/EN.html; (2000) Bt Plant-pesticides Risk and Benefit Assessments, , http://www.epa.gov/scipoly/sap/2000/october/octoberfinal.pdf, FIFRA Scientific Advisory Panel. SAP Report No. 2000-07; (2000) Mammalian Toxicity Assessment Guidelines for Protein Plant Pesticides, , http://www.epa.gov/scipoly/sap/2000/june/finbtmamtox.pdf, FIFRA Scientific Advisory Panel. SAP Report No. 2000-03B; (2001) Assessment of Additional Scientific Information Concerning StarLink Corn, p. 29. , http://www.epa.gov/oscpmont/sap/2001/july/julyfinal.pdf, FTPRA Scientific Advisory Panel. SAP Report No. 2001-09; Saxena, D., Stotzky, G., Bt corn has a higher lignin content than non-fif corn (2001) American Journal of Botany, 88 (9), pp. 1704-1706; Schmelz, E.A., Engelberth, J., Alborn, H.T., Simultaneous analysis of phytohormones, phytotoxins, and volatile organic compounds in plants (2003) Proceedings of the National Academy of Sciences of the United States of America, 100, pp. 109552-109557; Schubert, D., A different perspective on GM food (2002) Nature Biotechnology, 20, p. 969; Smith, N., Kilpatrick, J.B., Whitelam, G.C., Superfluous transgene integration in plants (2001) Critical Reviews in Plant Sciences, 20, pp. 215-249; Trethewey, R.N., Krotzky, A.J., Willmitzer, L., Metabolic profiling: A Rosetta Stone for genomics? (1999) Current Opinion in Plant Biology, 2, pp. 83-85; (2003) What Is the Compliance History with APHIS' Biotechnology Regulations?, , http://www.aphis.usda.gov/brs/compliance9.html, posted October 2003; (2003) Crops No Longer Regulated by USDA, , http://www.nbiap.vt.edu/cfdocs/biopetitions1.cfm, Information system for biotechnology, downloaded 24th September, 2003; (1998) Determination of Non-regulated Status for Glufosinate-tolerant Rice, , http://www.aphis.usda.gov/biotech/dec_docs/9832901p_det_ea.HTM, response to AgrEvo's petition for deregulation of Liberty Link rice, Petition 98-329-301p; (1996) Environmental Assessment and Finding of No Significant Impact for Permit No. 96-355-01 Granted to Applied Phytologics, Inc. for a Field Trial of Biopharmaceutical Rice Conducted in California in 1997, , http://www.isb.vt.edu/biomon/relea/9635501r.eaa; Information Systems for Biotechnology, Field Test Releases in the US, , http://www.nbiap.vt.edu/cfdocs/fieldtests1.cfm, Searchable database of GE crop field trials; Field testing of plants engineered to produce pharmaceutical and industrial compounds (2003) Federal Register, 68 (46), pp. 11337-11340. , 10th March, 2003; (2001) Meeting the Performance Standards in 7 CFR 340.3(c), , www.aphis.usda.gov/bbep/bp/perstds.htm; Vázquez-Padrón, R.I., Moreno-Fierros, L., Neri-Bazán, L., De La Riva, G.A., López-Revilla, R., Intragastric and intraperitoneal administration of Cry1Ac protoxin from Bacillus thuringiensis induces systemic and mucosal antibody responses in mice (1999) Life Sciences, 64 (21), pp. 1897-1912; Vázquez, R.I., Moreno-Fierros, L., Neri-Bazán, L., De La Riva, G.A., López-Revilla, R., Bacillus thuringiensis Cry1Ac protoxin is a potent systemic and mucosal adjuvant (1999) Scandinavian Journal of Immunology, 49, pp. 578-584; Vázquez-Padrón, R.I., Moreno-Fierros, L., Neri-Bazán, L., De La Riva, G.A., López-Revilla, R., Characterization of the mucosal and systemic immune response induced by Cry1Ac protein from Bacillus thuringiensis HD 73 in mice (2000) Brazilian Journal of Medical and Biological Research, 33, pp. 147-155; Vázquez-Padrón, R.I., Gonzales-Cabrera, J., Garcia-Tovar, C., Cry1Ac protoxin from Bacillus thuringiensis sp. kurstaki HD73 binds to surface proteins in the mouse small intestine (2000) Biochemical and Biophysical Research Communications, 271, pp. 54-58; Wal, J.M., Strategies for assessment and identification of allergenicity in (novel) foods (1998) International Dairy Journal, 8, pp. 413-423","Schubert, D.; Salk Inst. for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States; email: schubert@salk.edu",,,,,,,,02648725,,BGERE,17017038,"English","Biotechnol. Genet. Eng. Rev.",Review,Scopus,2-s2.0-10644254759
"Liu, Y., Dargusch, R., Banh, C., Miller, C.A., Schubert, D.","Detecting bioactive amyloid β peptide species in Alzheimer's disease",2004,"Journal of Neurochemistry","91","3",,"648","656",,12,10.1111/j.1471-4159.2004.02751.x,"http://www.scopus.com/inward/record.url?eid=2-s2.0-7244225197&partnerID=40&md5=ad6383a237c496430a3f87ed346fbae7","Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA, United States; Department of Pathology, University of Southern California, Keck School of Medicine, Los Angeles, CA, United States; Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037-1099, United States","Liu, Y., Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA, United States, Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037-1099, United States; Dargusch, R., Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA, United States; Banh, C., Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA, United States; Miller, C.A., Department of Pathology, University of Southern California, Keck School of Medicine, Los Angeles, CA, United States; Schubert, D., Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA, United States","Amyloid β peptide (Aβ) is believed to play a central role in the pathogenesis of Alzheimer's disease (AD). However, the form of Aβ that induces neurodegeneration in AD, defined here as bioactive Aβ, is not clear. Preventing the formation of bioactive Aβ or inactivating previously formed bioactive Aβ should be a promising approach to treat AD. We have previously developed a cell-based assay for the detection of bioactive Aβ species. The assay is based upon the correlation between the ability of an Aβ sample to induce a unique form of cellular MTT [3-(4,5-dimethylthiazol- 2-yl)-2,5-diphenyltetrazolium bromide] formazan exocytosis, and its ability to activate glia and induce neurotoxicity. Here, we show that this cell-based assay is not only useful for a cellular model of Aβ amyloidogenesis but is also able to detect bioactive Aβ species in a transgenic mouse model of AD, as well as in post-mortem cortex samples from AD patients. There is a good correlation between the extent of glia activation and the level of bioactive Aβ species in the mouse brain. A promising deuteroporphyrin that can inactivate bioactive Aβ species was also identified using this assay. These novel insights and findings should have important implications for the treatment of AD.","3-(4, 5-dimethylthiazol-2-yl)-2; 5-diphenyltetrazolium bromide; Alzheimer's disease; Amyloid β peptide; Amyloid fibrillogenesis; Bioactive amyloid species; Drug screening","amyloid beta protein; congo red; deuteroporphyrin IX; iron deuteroporphyrin ix 2,4 bisethylene glycol; thioflavine; unclassified drug; aged; Alzheimer disease; animal cell; animal model; animal tissue; article; brain cortex; cadaver; cell assay; correlation analysis; female; glia; human; human tissue; male; mouse; nonhuman; priority journal; protein analysis; rat; sample; transgenic mouse; Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Amyloid beta-Protein; Animals; Astrocytes; Brain Chemistry; Cells, Cultured; Deuteroporphyrins; Disease Models, Animal; Exocytosis; Female; Formazans; Frontal Lobe; Humans; Male; Mice; Mice, Transgenic; Peptide Fragments; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Stem Cells; Tetrazolium Salts; Animalia; Mus musculus",,"amyloid beta protein, 109770-29-8; congo red, 573-58-0, 80701-77-5; deuteroporphyrin IX, 448-65-7; thioflavine, 2390-54-7; amyloid beta-protein (1-40); amyloid beta-protein (1-42); amyloid beta-protein (25-35); Amyloid beta-Protein; Amyloid; Deuteroporphyrins; Formazans; MTT formazan, 23305-68-2; Peptide Fragments; Tetrazolium Salts",,"porpyrin products, United States",,"Berr, C., Hauw, J.J., Delaere, P., Duyckaerts, C., Amouyel, P., Apolipoprotein e allele epsilon 4 is linked to increased deposition of the amyloid beta-peptide (A-beta) in cases with or without Alzheimer's disease (1994) Neurosci. Lett., 178, pp. 221-224; Borchelt, D.R., Ratovitski, T., Van Lare, J., Lee, M.K., Gonzales, V., Jenkins, N.A., Copeland, N.G., Sisodia, S.S., Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins (1997) Neuron, 19, pp. 939-945; Braak, H., Braak, E., Neuropathological stageing of Alzheimer-related changes (1991) Acta Neuropathol., 82, pp. 239-259; Caughey, B., Lansbury Jr., P.T., Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders (2003) Annu. Rev. Neurosci., 26, pp. 267-298; Caughey, W.S., Raymond, L.D., Horiuchi, M., Caughey, B., Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines (1998) Proc. Natl. Acad. Sci. USA, 95, pp. 12117-12122; Choo-Smith, L.P., Garzon-Rodriguez, W., Glabe, C.G., Surewicz, W.K., Acceleration of amyloid fibril formation by specific binding of Abeta-(1-40) peptide to ganglioside-containing membrane vesicles (1997) J. Biol. Chem., 272, pp. 22987-22990; Crystal, H., Dickson, D., Fuld, P., Masur, D., Scott, R., Mehler, M., Masdeu, J., Wolfson, L., Clinico-pathologic studies in dementia: Nondemented subjects with pathologically confirmed Alzheimer's disease (1988) Neurology, 38, pp. 1682-1687; Davis II, J.N., Chisholm, J.C., The 'amyloid hypothesis' of AD: Decoy or real McCoy? (1997) Trends Neurosci., 20, pp. 558-559; Delaere, P., Duyckaerts, C., Masters, C., Beyreuther, K., Piette, F., Hauw, J.J., Large amounts of neocortical beta A4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person (1990) Neurosci. Lett., 116, pp. 87-93; Delaere, P., He, Y., Fayet, G., Duyckaerts, C., Hauw, J.J., Beta A4 deposits are constant in the brain of the oldest old: An immunocytochemical study of 20 French centenarians (1993) Neurobiol. Aging, 14, pp. 191-194; Dickson, D.W., Crystal, H.A., Mattiace, L.A., Masur, D.M., Blau, A.D., Davies, P., Yen, S.H., Aronson, M.K., Identification of normal and pathological aging in prospectively studied nondemented elderly humans (1992) Neurobiol. Aging, 13, pp. 179-189; Findeis, M.A., Approaches to discovery and characterization of inhibitors of amyloid β-peptide polymerization (2000) Biochim. Biophys. Acta, 1502, pp. 76-84; Hardy, J., Selkoe, D.J., The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics (2002) Science, 297, pp. 353-356; Harper, J.D., Lansbury Jr., P.T., Models of amyloid seeding in Alzheimer's disease and scrapie: Mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins (1997) Annu. Rev. Biochem., 66, pp. 385-407; Holcomb, L., Gordon, M.N., McGowan, E., Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes (1998) Nature Med., 4, pp. 97-100; Hu, J., Akama, K.T., Krafft, G.A., Chromy, B.A., Van Eldik, L.J., Amyloid-beta peptide activates cultured astrocytes: Morphological alterations, cytokine induction and nitric oxide release (1998) Brain Res., 785, pp. 195-206; Jankowsky, J.L., Slunt, H.H., Ratovitski, T., Jenkins, N.A., Copland, N.G., Borchelt, D.R., Co-expression of multiple transgenes in mouse CNS: A comparison of strategies (2001) Biomol. Eng., 17, pp. 157-165; Klein, W.L., Krafft, G.A., Finch, C.E., Targeting small Abeta oligomers: The solution to an Alzheimer's disease conundrum? (2001) Trends Neurosci., 24, pp. 219-224; Levison, S.W., McCarthy, K.D., Astroglia in culture (1991) Culturing Nerve Cells, pp. 309-336. , Banker, G. and Goslin, K., eds, MIT Press, Cambridge, MA; Lewis, J., Dickson, D.W., Lin, W.L., Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP (2001) Science, 293, pp. 1487-1491; Liu, Y., Understanding the biological activity of amyloid proteins in vitro: From inhibited cellular MTT reduction to altered cellular cholesterol homeostasis (1999) Prog. Neuro-Psychopharmacol. Psychiat., 23, pp. 377-395; Liu, Y., Piasecki, D., A cell-based method for the detection of nanomolar concentrations of bioactive amyloid (2001) Anal. Biochem., 289, pp. 130-136; Liu, Y., Schubert, D., Cytotoxic amyloid peptides inhibit cellular MTT reduction by enhancing MTT formazan exocytosis (1997) J. Neurochem., 69, pp. 2285-2293; Liu, Y., Schubert, D., Steroid hormones block amyloid fibril-induced MTT formazan exocytosis: Relationship to neurotoxicity (1998) J. Neurochem., 71, pp. 2322-2329; Liu, Y., Peterson, D., Kimura, H., Schubert, D., The mechanism of cellular MTT reduction (1997) J. Neurochem., 69, pp. 581-593; Liu, Y., Peterson, D., Schubert, D., Amyloid β peptide alters intracellular vesicle trafficking and cholesterol homeostasis (1998) Proc. Natl. Acad. Sci. USA, 95, pp. 13266-13271; Lorenzo, A., Yankner, B.A., Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red (1994) Proc. Natl. Acad. Sci. USA, 91, pp. 12243-12247; McLaurin, J., Franklin, T., Zhang, X., Deng, J., Fraser, P.E., Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth (1999) Eur. J. Biochem., 266, pp. 1101-1110; Price, D.L., Sisodia, S.S., Mutant genes in familial Alzheimer's disease and transgenic models (1998) Annu. Rev. Neurosci., 21, pp. 479-505; Schubert, D., Heinemann, S., Carlisle, W., Tarika, H., Kimes, B., Steinbach, J.H., Culp, W., Brandt, B.L., Clonal cell lines from the rat central nervous system (1974) Nature, 249, pp. 224-227; Wood, S.J., Maleeff, B., Hart, T., Wetzel, R., Physical, morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Aβ (1996) J. Mol. Biol., 256, pp. 870-877","Liu, Y.; Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037-1099, United States; email: yliu@salk.edu",,,,,,,,00223042,,JONRA,15485495,"English","J. Neurochem.",Article,Scopus,2-s2.0-7244225197
"Cumming, R.C., Andon, N.L., Haynes, P.A., Park, M., Fischer, W.H., Schubert, D.","Protein disulfide bond formation in the cytoplasm during oxidative stress",2004,"Journal of Biological Chemistry","279","21",,"21749","21758",,258,10.1074/jbc.M312267200,"http://www.scopus.com/inward/record.url?eid=2-s2.0-2542469551&partnerID=40&md5=814a0f77ecc1b3350ace6ab35b2a0b21","Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA 92037, United States; Peptide Biology Laboratory, Salk Inst. for Biological Studies, San Diego, CA 92037, United States; Protein and Metabolite Dynam. Dept., Torrey Mesa Research Institute, San Diego, CA 92121, United States; Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, 10010 N. Torrey Pines Rd., San Diego, CA 92037, United States","Cumming, R.C., Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA 92037, United States; Andon, N.L., Protein and Metabolite Dynam. Dept., Torrey Mesa Research Institute, San Diego, CA 92121, United States; Haynes, P.A., Protein and Metabolite Dynam. Dept., Torrey Mesa Research Institute, San Diego, CA 92121, United States; Park, M., Peptide Biology Laboratory, Salk Inst. for Biological Studies, San Diego, CA 92037, United States; Fischer, W.H., Peptide Biology Laboratory, Salk Inst. for Biological Studies, San Diego, CA 92037, United States; Schubert, D., Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA 92037, United States, Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, 10010 N. Torrey Pines Rd., San Diego, CA 92037, United States","The majority of disulfide-linked cytosolic proteins are thought to be enzymes that transiently form disulfide bonds while catalyzing oxidation-reduction (redox) processes. Recent evidence indicates that reactive oxygen species can act as signaling molecules by promoting the formation of disulfide bonds within or between select redox-sensitive proteins. However, few studies have attempted to examine global changes in disulfide bond formation following reactive oxygen species exposure. Here we isolate and identify disulfide-bonded proteins (DSBP) in a mammalian neuronal cell line (HT22) exposed to various oxidative insults by sequential nonreducing/reducing two-dimensional SDS-PAGE combined with mass spectrometry. By using this strategy, several known cytosolic DSBP, such as peroxiredoxins, thioredoxin reductase, nucleoside-diphosphate kinase, and ribonucleotide-diphosphate reductase, were identified. Unexpectedly, a large number of previously unknown DSBP were also found, including those involved in molecular chaperoning, translation, glycolysis, cytoskeletal structure, cell growth, and signal transduction. Treatment of cells with a wide range of hydrogen peroxide concentrations either promoted or inhibited disulfide bonding of select DSBP in a concentration-dependent manner. Decreasing the ratio of reduced to oxidized glutathione also promoted select disulfide bond formation within proteins from cytoplasmic extracts. In addition, an epitope-tagged version of the molecular chaperone HSP70 forms mixed disulfides with both β4-spectrin and adenomatous polyposis coli protein in the cytosol. Our findings indicate that disulfide bond formation within families of cytoplasmic proteins is dependent on the nature of the oxidative insult and may provide a common mechanism used to control multiple physiological processes.",,"Chemical bonds; Concentration (process); Proteins; Redox reactions; Reduction; Signaling; Cell growth; Signal transduction; Biochemistry; APC protein; beta4 spectrin; disulfide; epitope; glutathione disulfide; heat shock protein 70; hydrogen peroxide; protein; reactive oxygen metabolite; spectrin; unclassified drug; article; cell growth; cell structure; concentration response; controlled study; cytoplasm; cytoskeleton; disulfide bond; glycolysis; human; human cell; mass spectrometry; nucleotide sequence; oxidation reduction reaction; oxidative stress; polyacrylamide gel electrophoresis; priority journal; RNA translation; signal transduction; Adenomatous Polyposis Coli Protein; Animals; Biotin; Cell Division; Cytoplasm; Cytosol; Disulfides; Dose-Response Relationship, Drug; Electrophoresis, Gel, Two-Dimensional; Electrophoresis, Polyacrylamide Gel; Epitopes; Genetic Vectors; Glutathione; HSP70 Heat-Shock Proteins; Humans; Hydrogen Peroxide; Immunoblotting; Iodoacetamide; Mass Spectrometry; Mice; Neurons; Nucleoside-Diphosphate Kinase; Oxidation-Reduction; Oxidative Stress; Oxygen; Peroxidases; Precipitin Tests; Reactive Oxygen Species; Ribonucleotide Reductases; Signal Transduction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Thioredoxin Reductase (NADPH); Mammalia","GENBANK: AAB94793, CAA06329, CAC43228, NP_038770, O08651, P02551, P04642, P05217, P05218, P07742, P07901, P08109, P09456, P10126, P11499, P11983, P14211, P16858, P17182, P17879, P20029, P24547, P26040, P26041, P29341, P35700, P42932, P52480, P56399, P80314, P80315, P80316, Q01768, Q60973, Q61035, Q61171, Q64303, Q92973","disulfide, 16734-12-6; glutathione disulfide, 27025-41-8; hydrogen peroxide, 7722-84-1; protein, 67254-75-5; spectrin, 12634-43-4; Adenomatous Polyposis Coli Protein; Biotin, 58-85-5; Disulfides; Epitopes; Glutathione, 70-18-8; HSP70 Heat-Shock Proteins; Hydrogen Peroxide, 7722-84-1; Iodoacetamide, 144-48-9; Nucleoside-Diphosphate Kinase, EC 2.7.4.6; Oxygen, 7782-44-7; Peroxidases, EC 1.11.1.-; peroxiredoxin, EC 1.11.1.15; Reactive Oxygen Species; Ribonucleotide Reductases, EC 1.17.4.-; Thioredoxin Reductase (NADPH), EC 1.8.1.9",,,,"Maher, P., Schubert, D., (2000) Cell. Mol. Life Sci., 57, pp. 1287-1305; Finkel, T., Holbrook, N.J., (2000) Nature, 408, pp. 239-247; Stadtman, E.R., Levine, R.L., (2000) Ann. N. Y. Acad. Sci., 899, pp. 191-208; Thomas, J.A., Mallis, R.J., (2001) Exp. Gerontol., 36, pp. 1519-1526; Sevier, C.S., Kaiser, C.A., (2002) Nat. Rev. Mol. Cell. Biol., 3, pp. 836-847; Rietsch, A., Beckwith, J., (1998) Annu. Rev. Genet., 32, pp. 163-184; Mannervik, B., Axelsson, K., Sundewall, A.C., Holmgren, A., (1983) Biochem. J., 213, pp. 519-523; Arner, E.S., Holmgren, A., (2000) Eur. J. Biochem., 267, pp. 6102-6109; Linke, K., Jakob, U., (2003) Antioxid. Redox. Signal., 5, pp. 425-434; Rhee, S.G., Bae, Y.S., Lee, S.R., Kwon, J., (2000) Science's STKE, , http://www.stke.org/cgi/content/full/OC_sigtrans;2000/53/pel; Denu, J.M., Tanner, K.G., (1998) Biochemistry, 37, pp. 5633-5642; Chiarugi, P., Cirri, P., (2003) Trends Biochem. Sci., 28, pp. 509-514; Liu, H., Nishitoh, H., Ichijo, H., Kyriakis, J.M., (2000) Mol. Cell. Biol., 20, pp. 2198-2208; Sommer, A., Traut, R.R., (1974) Proc. Natl. Acad. Sci. U. S. A., 71, pp. 3946-3950; Molinari, M., Helenius, A., (1999) Nature, 402, pp. 90-93; Molinari, M., Helenius, A., (2000) Science, 288, pp. 331-333; Li, Y., Maher, P., Schubert, D., (1997) Neuron, 19, pp. 453-463; Griffith, O.W., (1980) Anal. Biochem., 106, pp. 207-212; Ramsby, M.L., Makowski, G.S., (1999) Methods Mol. Biol., 112, pp. 53-66; Laemmli, U.K., (1970) Nature, 227, pp. 680-685; Shevchenko, A., Wilm, M., Vorm, O., Mann, M., (1996) Anal. Chem., 68, pp. 850-858; Andon, N.L., Hollingworth, S., Koller, A., Greenland, A.J., Yates III, J.R., Haynes, P.A., (2002) Proteomics, 2, pp. 1156-1168; Tan, S., Sagara, Y., Liu, Y., Maher, P., Schubert, D., (1998) J. Cell Biol., 141, pp. 1423-1432; Sagara, Y., Dargusch, R., Chambers, D., Davis, J., Schubert, D., Maher, P., (1998) Free Radic. Biol. Med., 24, pp. 1375-1389; Ishige, K., Schubert, D., Sagara, Y., (2001) Free Radic. Biol. Med., 30, pp. 433-446; Tan, S., Somia, N., Maher, P., Schubert, D., (2001) J. Cell Biol., 152, pp. 997-1006; Tan, S., Schubert, D., Maher, P., (2001) Curr. Top. Med. Chem., 1, pp. 497-506; Kosower, N.S., Kosower, E.M., (1995) Methods Enzymol., 251, pp. 123-133; Gilbert, H.F., (1995) Methods Enzymol., 251, pp. 8-28; Cumming, R.C., Lightfoot, J., Beard, K., Youssoufian, H., O'Brien, P.J., Buchwald, M., (2001) Nat. Med., 7, pp. 814-820; Delaunay, A., Pflieger, D., Barrault, M.B., Vinh, J., Toledano, M.B., (2002) Cell, 111, pp. 471-481; Manalo, D.J., Lin, Z., Liu, A.Y., (2002) Biochemistry, 41, pp. 2580-2588; Yang, K.S., Kang, S.W., Woo, H.A., Hwang, S.C., Chae, H.Z., Kim, K., Rhee, S.G., (2002) J. Biol. Chem., 277, pp. 38029-38036; Woo, H.A., Chae, H.Z., Hwang, S.C., Yang, K.S., Kang, S.W., Kim, K., Rhee, S.G., (2003) Science, 300, pp. 653-656; Song, E.J., Kim, Y.S., Chung, J.Y., Kim, E., Chae, S.K., Lee, K.J., (2000) Biochemistry, 39, pp. 10090-10097; Hartl, F.U., Hayer-Hartl, M., (2002) Science, 295, pp. 1852-1858; Brodie, A.E., Reed, D.J., (1990) Arch. Biochem. Biophys., 276, pp. 212-218; Chaudhuri, A.R., Khan, I.A., Luduena, R.F., (2001) Biochemistry, 40, pp. 8834-8841; Hwang, C., Sinskey, A.J., Lodish, H.F., (1992) Science, 257, pp. 1496-1502; Hampton, M.B., Kettle, A.J., Winterbourn, C.C., (1998) Blood, 92, pp. 3007-3017; Halliwell, B., Clement, M.V., Long, L.H., (2000) FEBS Lett., 488, pp. 10-13; Klatt, P., Lamas, S., (2000) Eur. J. Biochem., 267, pp. 4928-4944; Coan, C., Ji, J.Y., Hideg, K., Mehlhorn, R.J., (1992) Arch. Biochem. Biophys., 295, pp. 369-378; Gasdaska, J.R., Kirkpatrick, D.L., Montfort, W., Kuperus, M., Hill, S.R., Berggren, M., Powis, G., (1996) Biochem. Pharmacol., 52, pp. 1741-1747; Casagrande, S., Bonetto, V., Fratelli, M., Gianazza, E., Eberini, I., Massignan, T., Salmona, M., Ghezzi, P., (2002) Proc. Natl. Acad. Sci. U. S. A., 99, pp. 9745-9749; Fratelli, M., Fratelli, M., Demol, H., Puype, M., Casagrande, S., Eberini, I., Salmona, M., Ghezzi, P., (2002) Proc. Natl. Acad. Sci. U. S. A., 99, pp. 3505-3510; Lind, C., Gerdes, R., Hamnell, Y., Schuppe-Koistinen, I., Von Lowenhielm, H.B., Holmgren, A., Cotgreave, I.A., (2002) Arch. Biochem. Biophys., 406, pp. 229-240; Eaton, P., Byers, H.L., Leeds, N., Ward, M.A., Shattock, M.J., (2002) J. Biol. Chem., 277, pp. 9806-9811; Shenton, D., Grant, C.M., (2003) Biochem. J., 374, pp. 513-519; Nystrom, T., (2002) Ageing Res. Rev., 1, pp. 693-703; Davies, K.J., (1999) IUBMB Life, 48, pp. 41-47; Antunes, F., Cadenas, E., (2000) FEBS Lett., 475, pp. 121-126; Vignols, F., Mouaheb, N., Thomas, D., Meyer, Y., (2003) J. Biol. Chem., 278, pp. 4516-4523; Beal, M.F., (2002) Free Radic. Biol. Med., 32, pp. 797-803; Butterfield, D.A., Lauderback, C.M., (2002) Free Radic. Biol. Med., 32, pp. 1050-1060; Ischiropoulos, H., Beckman, J.S., (2003) J. Clin. Investig., 111, pp. 163-169; Saadatzadeh, M.R., Bijangi-Vishehsaraei, K., Hong, P., Bergmann, H., Haneline, L.S., (2004) J. Biol. Chem., 279. , in press","Schubert, D.; Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, 10010 N. Torrey Pines Rd., San Diego, CA 92037, United States; email: schubert@salk.edu",,,,,,,,00219258,,JBCHA,15031298,"English","J. Biol. Chem.",Article,Scopus,2-s2.0-2542469551
"Da Fontoura Costa, L., Schubert, D.","A framework for cell movement image analysis",2003,"Proceedings - 12th International Conference on Image Analysis and Processing, ICIAP 2003",,, 1234062,"271","276",,,10.1109/ICIAP.2003.1234062,"http://www.scopus.com/inward/record.url?eid=2-s2.0-84890541498&partnerID=40&md5=3abacfc012d573eeacff1333db93d96b","Cybernetic Vision Research Group, IFSC-USP, Brazil; Salk Institute, San Diego, CA, United States","Da Fontoura Costa, L., Cybernetic Vision Research Group, IFSC-USP, Brazil; Schubert, D., Salk Institute, San Diego, CA, United States","This article describes an image analysis framework for the characterization and analysis of cell trajectories considering the following three biologically relevant parameters: (a) the behavior of each individual cell; (b) interactions between each pair of cells; and (c) interactions between each cell and its environment. The potential of the overall framework is illustrated with respect to real cell displacement data. © 2003 IEEE.",,"Analysis frameworks; Cell movement; Individual cells; Cytology; Image analysis; Cells",,,,,,"Chicurel, M., Cell migration research is on the move (2002) Science, 295, pp. 606-609; Berg, H.C., How to track bacteria (1971) Review of Scientific Instruments, 42, pp. 868-871; Berg, H.C., Brown, D.A., Chemotaxis in Escherichia coli analysed by three-dimensional tracking (1972) Nature, 239, pp. 500-504; Krull, C.E., Collazo, A., Fraser, S.A., Bronner-Fraser, M., Segmental migration of trunk neural crest: Time-lapse analysis reveals a role for PNA-binding molecules (1995) Development, 121, pp. 3733-3743; Ruthazer, E.S., Cline, H.T., Multiphoton imaging of neurons in living tissue: Acquisition and analysis of time-lapse morphological data (2002) Journal of Real-time Imaging, 8, pp. 175-188; Turner, L., Ryu, W.S., Berg, H.C., Real-time imaging of fluorescent flagellar filaments (2000) Journal of Bacteriology, 182 (10), pp. 2793-2801; Pettet, G.J., Please, C.P., Tindall, M.J., McElwain, D.L.S., The migration of cells in multicell tumor spheroids (2001) Bull. of Mathematical Biology, 63, pp. 231-257; Fenchel, T., Blackburn, N., Motile chemosensory behavior of phagotrophic protests: Mechanisms for and efficiency in congregating at food patches (1999) Protist, 150, pp. 325-336; Yundt, A.P., Schack, W.J., Lardner, T.J., Applicability of hydrodynamic analyses of spermatozoan motion (1975) Journal of Experimental Biology, 62, pp. 27-41; Molyneaux, K.A., Stalllock, J., Schaible, K., Wylie, C., Timelapse analysis of living mouse germ cell migration (2001) Developmental Biology, 240, pp. 488-498; Yang, L., Albregtsen, F., Lonnestad, R., Grottum, P., Iversen, J.G., Rotnes, J.S., Rottingen, J.A., Measuring shape and motion of white blood cells from sequences of fluorescence microscopy Images (1995) Theory and Applications of Image Analysis II, World Scientific, pp. 305-316; Thomann, D., Rines, D.R., Sorger, P.K., Danuser, G., (2002) Automatic Fluorescent Tag Detection in 3D with Super-resolution: Application to the Analysis of Chromosome Movement, , LFB-Technical-Report LFB-TR-2003; Czirók, A., Schlett, K., Madarász, E., Vicsek, T., Exponential distribution of locomotion activity in cell cultures (1998) Phisical Review Letters, 81 (14), pp. 3038-3041; Crenshaw, H.C., A new look at locomotion in microorganisms: Rotating and translating (1996) American Zoology, 36, pp. 608-618; Bretschneider, T., Vasiev, B., Weijer, C.J., A model for Dictyostelium slug movement (1999) Journal of Theoretical Biology, 199, pp. 125-136; Collett, M., Collett, T.S., Bisch, S., Wehner, R., Local and global vectors in desert ant navigation (1998) Nature, 394, pp. 269-271; Therrien, C.W., (1992) Discrete Random Signals and Statistical Signal Processing, , Prentice Hall., Englewood Cliffs; Costa, L.F., Cesar Jr., R.M., (2001) Shape Analysis and Classification: Theory and Practice, , CRC Press, Boca Raton; Duda, R.O., Hart, P.E., Stork, D.G., (2001) Pattern Classification, , 2nd edition, Wiley-Interscience, New York; Holly, S.P., Larson, M.K., Parise, L.V., Multiple roles of integrins in cell motility (2000) Exp Cell Res, 261, pp. 69-74; Fang, K.S., Ionides, E., Oster, G., Nuccitelly, R., Isseroff, R.R., Epidermal growth factor receptor relocalization and kinase activity are necessary for directional migration of keratinocytes in DC electric fields (1999) Journal of Cell Science, 112, pp. 1967-1978; Costa, L.F., Velte, T.J., Automatic characterization and classification of ganglion cells from the salamander retina (1999) Journal of Comparative Neurology, 404, pp. 33-51","Cybernetic Vision Research Group, IFSC-USPBrazil",,,,"12th International Conference on Image Analysis and Processing, ICIAP 2003","17 September 2003 through 19 September 2003","Mantova",101350,,0769519482; 9780769519487,,,"English","Proc. - Int. Conf. Image Anal. Process., ICIAP",Conference Paper,Scopus,2-s2.0-84890541498
"Da Costa, L.F., Mutinari, G., Schubert, D.","Characterizing width uniformity by wave propagation",2003,"Physical Review E - Statistical, Nonlinear, and Soft Matter Physics","68","5 2", 056704,"567041","567047",,1,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0942267606&partnerID=40&md5=dbeeef9398ace19c8f95d006add51d3b","Cybernetic Vision Research Group, IFSC, University of Sao Paulo, Caixa Postal 369, Sao Carlos, SP 13560-970, Brazil; Salk Institute, 10010N Torrey Pines Road, San Diego, CA 92037, United States","Da Costa, L.F., Cybernetic Vision Research Group, IFSC, University of Sao Paulo, Caixa Postal 369, Sao Carlos, SP 13560-970, Brazil; Mutinari, G., Cybernetic Vision Research Group, IFSC, University of Sao Paulo, Caixa Postal 369, Sao Carlos, SP 13560-970, Brazil; Schubert, D., Salk Institute, 10010N Torrey Pines Road, San Diego, CA 92037, United States","An image analysis approach to characterize the uniformity of objects in agglomerates by using the propagation of normal wave fronts was described. The problem of width uniformity and its importance for characterization of composite structures found in physics and biology was also highlighted. The medial axes were estimated by using a wave front propagation approach. The distance value along such axes and their mean and standard deviation values were also obtained. Some aspects of cell-matrix adhesions and their relationship to cell shape were studied by plating nerve cells derived from a single common precursor cell (clonal cell) on different surfaces.",,"Cells; Composite structures; Dimensional stability; Image analysis; Neurology; Proteins; Structural analysis; Wave propagation; Cell agglomeration; Wave fronts; Agglomeration",,,,,,"Einstein, A.J., Wu, H.S., Gil, J., (1998) Phys. Rev. Lett., 80, p. 397; Hovi, J.P., Aharony, A., Stauffer, D., Mandelbrot, B.B., (1996) Phys. Rev. Lett., 77, p. 877; Mandelbrot, B.B., (1983) The Fractal Geometry of Nature, , Freeman, New York; Plotnick, R.E., Gardner, R.H., Hargrove, W.W., Prestegaard, K., Perlmutter, M., (1996) Phys. Rev. E, 53, p. 5461; Dickson, B.J., (2002) Science, 298, p. 1959; Osher, S., Sethian, J.A., (1988) J. Comput. Phys., 79, p. 12; Sethian, J.A., (1999) Level Set Methods and Fast Marching Methods: Evolving Interfaces in Computational Geometry, , Cambridge University Press, Cambridge; Ogniewicz, R.L., Kubler, O., (1995) Pattern Recogn., 28, p. 343; Costa, L.F., (1999) Proceedings of the International Workshop on Synthetic-Natural Hibrid Coding and Three Dimensional Imaging, pp. 214-217. , edited by M. G. Strintzis and F. Lavagetto (Aristotle University, Santorini; Costa, L.F., Estrozi, L.F., (1999) Electron. Lett., 35, p. 1829; Costa, L.F., Junior, R.M.C., (2001) Shape Analysis and Classification, Theory and Practice, , CRC Press, Boca Raton, FL; Danielsson, P.E., (1980) Comput. Graph. Image Process., 14, p. 227; Attali, P., Bertolino, D., Montanvert, A., (1994) Proceedings of the International Conference on Pattern Recognition, pp. 626-628. , edited by L. Shapiro and S. Tanimoto (IEEE, Seattle); Falcao, A.X., Costa, L.D., Da Cunha, B.S., (2002) Pattern Recogn., 35, p. 1571; Schubert, D., Klier, F.G., (1991) Fasciculation Brain, 549, p. 305; Verroust, A., Lazarus, F., (2000) Visual Comput., 16, p. 15","Da Costa, L.F.; Cybernetic Vision Research Group, IFSC, University of Sao Paulo, Caixa Postal 369, Sao Carlos, SP 13560-970, Brazil; email: luciano@if.sc.usp.br",,,,,,,,1063651X,,PLEEE,,"English","Phys. Rev. E Stat. Nonlinear Soft Matter Phys.",Article,Scopus,2-s2.0-0942267606
"Soucek, T., Cumming, R., Dargusch, R., Maher, P., Schubert, D.","The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide",2003,"Neuron","39","1",,"43","56",,113,10.1016/S0896-6273(03)00367-2,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0038644221&partnerID=40&md5=fad3687642d61ef47ac387a4e2b440bc","Salk Inst. for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; Scripps Research Institute, 10550 North Torrey Pines Road, San Diego, CA 92037, United States","Soucek, T., Salk Inst. for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; Cumming, R., Salk Inst. for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; Dargusch, R., Salk Inst. for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; Maher, P., Scripps Research Institute, 10550 North Torrey Pines Road, San Diego, CA 92037, United States; Schubert, D., Salk Inst. for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States","It is frequently argued that both amyloid beta (Aβ) and oxidative stress are involved in the pathogenesis of Alzheimer's disease (AD). We show here that clonal nerve cell lines and primary cortical neurons that are resistant to Aβ toxicity have an enhanced flux of glucose through both the glycolytic pathway and the hexose monophosphate shunt. AD brain also has increased enzymatic activities in both pathways relative to age-matched controls. The Aβ-induced changes in glucose metabolism are due to the activation of the transcription factor hypoxia inducible factor 1 (HIF-1). As a result of Aβ-induced changes in glucose metabolism, Aβ-resistant cells are more readily killed by glucose starvation and by classes of antipsychotic drugs that inhibit glucose uptake.",,"amyloid beta protein; clozapine; fluphenazine; glucose; glyceraldehyde 3 phosphate dehydrogenase; glycolytic enzyme; hexokinase; hexose phosphate; hypoxia inducible factor 1; neuroleptic agent; pyruvate kinase; age; Alzheimer disease; animal cell; animal model; animal tissue; article; brain cell; cell cloning; cell killing; cell line; controlled study; drug effect; enzyme activity; glucose metabolism; glucose transport; glycolysis; hypoglycemia; mouse; neuroprotection; nonhuman; priority journal; protein function; Alzheimer Disease; Amyloid beta-Protein; Animals; Antipsychotic Agents; Brain; DNA-Binding Proteins; Drug Resistance; Glucose; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Mice; Neurons; Neuroprotective Agents; Nuclear Proteins; PC12 Cells; Pentose Phosphate Pathway; Rats; Reactive Oxygen Species; Transcription Factors; Up-Regulation",,"amyloid beta protein, 109770-29-8; clozapine, 5786-21-0; fluphenazine, 146-56-5, 69-23-8; glucose, 50-99-7, 84778-64-3; glyceraldehyde 3 phosphate dehydrogenase, 9001-50-7; hexokinase, 9001-51-8; pyruvate kinase, 9001-59-6; Amyloid beta-Protein; Antipsychotic Agents; DNA-Binding Proteins; Glucose, 50-99-7; HIF1A protein, human; Hif1a protein, mouse; Hif1a protein, rat; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Neuroprotective Agents; Nuclear Proteins; Reactive Oxygen Species; Transcription Factors",,,,"Ardizzone, T.D., Bradley, R.J., Freeman A.M. III, Dwyer, D.S., Inhibition of glucose transport in PC12 cells by the atypical antipsychotic drugs risperidone and clozapine, and structural analogs of clozapine (2001) Brain Res., 923, pp. 82-90; Ashcroft, S.J.H., Weerasinghe, L.C.C., Bassett, J.M., Randle, P.J., The pentose cycle and insulin release in mouse pancreatic islets (1972) Biochem. J., 126, pp. 525-532; Behl, C., Schubert, D., Heat shock partially protects rat pheochromocytoma PC12 cells from amyloid β peptide toxicity (1993) Neurosci. Lett., 154, pp. 1-4; Behl, C., Davis, J.B., Lesley, R., Schubert, D., Hydrogen peroxide mediates amyloid beta protein toxicity (1994) Cell, 77, pp. 817-827; Bernaudin, M., Tang, Y., Reilly, M., Petit, E., Sharp, F.R., Brain genomic response following hypoxia and re-oxygenation in the neonatal rat (2002) J. Biol. Chem., 277, pp. 39728-39738; Blass, J.P., Brain metabolism and brain disease: Is metabolic deficiency the proximate cause of Alzheimer dementia? (2001) J. Neurosci. Res., 66, pp. 851-856; Bowen, D.M., White, P., Spillane, J.A., Goodhardt, M.J., Curzon, G., Iwangoff, P., Meier-Ruge, W., Davison, A.N., Accelerated ageing or selective neuronal loss as an important cause of dementia (1979) Lancet, 1, pp. 11-14; Brand, K., Aerobic glycolysis by proliferating cells (1997) J. Bioenerg. Biomembr., 29, pp. 355-364; Cherny, R.A., Atwood, C.S., Xilinas, M.E., Gray, D.N., Jones, W.D., McLean, C.A., Barnham, K.J., Kim, Y., Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice (2001) Neuron, 30, pp. 641-642; Craft, S., Newcomer, J., Kanne, S., Dagogo-Jack, S., Cryer, P., Sheline, Y., Luby, J., Alderson, A., Memory improvement following induced hyperinsulinemia in Alzheimer's disease (1996) Neurobiol. Aging, 17, pp. 123-130; Dargusch, R., Schubert, D., Specificity of resistance to oxidative stress (2002) J. Neurochem., 81, pp. 1394-1400; Drutel, G., Kathmann, M., Heron, A., Gros, C., Mace, S., Schwartz, H.C., Arrang, J.M., Two splice variants of the hypoxia-inducible factor HIF-1α as potential dimerization partners of ARNT2 in neurons (2000) Eur. J. Neurosci., 12, pp. 3701-3708; Dufour, E., Boulay, J., Rincheval, V., Sainsard-Chanet, A., A causal link between respiration and senescence in Podospora anserina (2000) Proc. Natl. Acad. Sci. USA, 97, pp. 4138-4143; Duyndam, M.C., Hulscher, T.M., Fontijn, D., Pinedo, H.M., Boven, E., Induction of vascular endothelial growth factor expression and hypoxia-inducible factor 1alpha protein by the oxidative stressor arsenite (2001) J. Biol. Chem., 276, pp. 48066-48076; Dwyer, D.S., Pinkofsky, H.B., Liu, Y., Bradley, R.J., Antipsychotic drugs affect glucose uptake and the expression of glucose transporters in PC12 cells (1999) Prog. Neuropsychopharmacol. Biol. Psychiatry, 23, pp. 69-80; Esmann, V., (1978) Regulatory Mechanisms of Carbohydrate Metabolism, , New York: Pergamon Press; Gibson, G.E., Interactions of oxidative stress with cellular calcium dynamics and glucose metabolism in Alzheimer's disease (2002) Free Radic. Biol. Med., 32, pp. 1061-1070; Hiles, B.W., Hyperglycemia and glycosuria following chlorpromazine therapy (1956) JAMA, 162, p. 1651; Honegger, P., Braissant, O., Henry, H., Boulat, O., Bachmann, C., Zurich, M.-G., Pardo, B., Alteration of amino acid metabolism in neuronal aggregate cultures exposed to hypoglycaemic conditions (2002) J. Neurochem., 81, pp. 1141-1151; Horwood, N., Davies, D.C., Immunolabelling of hippocampal microvessel glucose transporter protein is reduced in Alzheimer's disease (1994) Virchows Arch., 425, pp. 69-72; Hyslop, P.A., Hinshaw, D.B., Halsey W.A., Jr., Schraufstatter, I.U., Sauerhebet, R.D., Spragg, R.G., Jackson, J.H., Cochrane, C.G., Mechanisms of oxidant-mediated cell injury (1988) J. Biol. Chem., 263, pp. 1665-1675; Katschinski, D.M., Le, L., Heinrich, D., Wagner, K.F., Hofer, T., Schindler, S.G., Wenger, R.H., Heat induction of the unphosphorylated form of hypoxia-inducible factor-1α is dependent on heat shock protein-90 activity (2002) J. Biol. Chem., 277, pp. 9262-9267; Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J.Q., Boonplueang, R., Viswanath, V., Beal, M.F., Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: A novel therapy for Parkinson's disease (2003) Neuron, 37, pp. 899-909; Klein, W.L., Krafft, G.A., Finch, C.E., Targeting small Abeta oligomers: The solution to an Alzheimer's disease conundrum? (2001) Trends Neurosci., 24, pp. 219-224; Li, Y., Maher, P., Schubert, D., A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion (1997) Neuron, 19, pp. 453-463; Lim, G.P., Chu, T., Yang, F., Beech, W., Frautschy, S.A., Cole, G.M., The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse (2001) J. Neurosci., 21, pp. 8370-8377; Lin, S.-J., Kaeberlein, M., Andalis, A.A., Sturtz, L.A., Defossez, P.-A., Culotta, V.C., Fink, G.R., Guarente, L., Calorie restriction extends Saccharomyces cerevisiae lifespan by increasing respiration (2002) Nature, 418, pp. 344-348; Liu, Y., Peterson, D.A., Kimura, H., Schubert, D., Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) reduction (1997) J. Neurochem., 69, pp. 581-593; Maher, F., Davies-Hill, T.M., Lysko, P.G., Henneberry, R.C., Simpson, I.A., Expression of two glucose transporters, GLUT1 and GLUT3 in cultured cerebellar cells (1991) Mol. Cell. Neurosci., 2, pp. 351-360; Manning, C.A., Ragozzino, M.E., Gold, P.E., Glucose enhancement of memory in patients with probable senile dementia of the Alzheimer's type (1993) Neurobiol. Aging, 14, pp. 523-528; Maxwell, P.H., Wiesener, M.S., Chang, G.W., Clifford, S.C., Vaux, E.C., Cockman, M.E., Wykoff, C.C., Ratcliffe, P.J., The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis (1999) Nature, 399, pp. 203-204; McLachlan, D.R.C., Kruck, T.P., Lukiw, W.J., Krishnan, S.S., Would decreased aluminum ingestion reduce the incidence of Alzheimer's disease? (1991) Can. Med. Assoc. J., 145, pp. 793-804; Michiels, C., Minet, E., Mottet, D., Raes, M., Regulation of gene expression by oxygen: NF-κB and HIF-1, two extremes (2002) Free Radic. Biol. Med., 33, pp. 1231-1242; Mielke, R., Herholz, K., Grond, M., Kessler, J., Heiss, W.D., Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type (1991) Neurobiol. Aging, 13, pp. 93-98; Ott, A., Stolk, R.P., Van Harskamp, F., Pols, H.A., Hofman, A., Bretele, R.M.M., Diabetes mellitus and the risk of dementia: The Rotterdam study (1999) Neurology, 53, pp. 1937-1942; Palmer, A.M., The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease (1999) J. Neural Transm., 106, pp. 317-328; Parpura-Gill, A., Beitz, D., Uemura, E., The inhibitory effects of β-amyloid on glutamate and glucose uptakes by cultured astrocytes (1997) Brain Res., 754, pp. 65-71; Piret, J.P., Mottet, D., Raes, M., Michiels, C., Is HIF-1alpha a pro- or an anti-apoptotic protein? (2002) Biochem. Pharmacol., 64, pp. 889-892; Russell, R.L., Siedlak, S.L., Raina, A.K., Bautista, J.M., Smith, M.A., Perry, G., Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease (1999) Arch. Biochem. Biophys., 370, pp. 236-239; Sagara, Y., Dargusch, R., Klier, F.G., Schubert, D., Behl, C., Increased antioxidant enzyme activity in amyloid beta protein-resistant cells (1996) J. Neurosci., 16, pp. 497-505; Salvemini, F., Franze, A., Iervolino, A., Filosa, S., Salzano, S., Ursini, M.V., Enhanced glutathione levels and oxidoresistance mediated by increased glucose-6-phosphate dehydrogenase expression (1999) J. Biol. Chem., 274, pp. 2750-2757; Schubert, D., Chevion, M., The role of iron in beta amyloid toxicity (1995) Biochem. Biophys. Res. Commun., 216, pp. 702-707; Schulingkamp, R.J., Pagano, T.C., Hung, D., Raffa, R.B., Insulin receptors and insulin action in the brain: Review and clinical implications (2000) Neurosci. Biobehav. Rev., 24, pp. 855-872; Schwartz, M., Duara, R., Haxby, J., Grady, C., White, B.J., Kessler, R.M., Kay, A.D., Rapoport, S.I., Down's syndrome in adults: Brain metabolism (1983) Science, 221, pp. 781-783; Semenza, G.L., Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1 (1999) Annu. Rev. Cell Dev. Biol., 15, pp. 551-578; Sims, N.R., Bowen, D.M., Davison, A.N., [14C]Acetylcholine synthesis and [14C]carbon dioxide production from [U-14C]glucose by tissue prisms from human neocortex (1981) Biochem. J., 196, pp. 867-876; Sims, N.R., Bowen, D.M., Neary, D., Davison, A.N., Metabolic processes in Alzheimer's disease: Adenine nucleotide content and production of 14CO2 from [U-14C]glucose in vitro in human neocortex (1983) J. Neurochem., 41, pp. 1329-1334; Sims, N.R., Finegan, J.M., Blass, J.P., Bowen, D.M., Neary, D., Mitochondrial function in brain tissue in primary degenerative dementia (1987) Brain Res., 436, pp. 30-38; Smith, M.A., Harris, P.L.R., Sayre, L.M., Beckman, J.S., Perry, G., Widespread peroxynitrite-mediated damage in Alzheimer's Disease (1997) J. Neurosci., 17, pp. 2653-2657; Srinivas, V., Zhang, L., Shu, X., Caro, J., Characterization of an oxygen/redox-dependent degradation domain of hypoxia-inducible factor alpha (HIF-a) proteins (1999) Biochem. Biophys. Res. Commun., 260, pp. 557-561; Strohman, R., Maneuvering in the complex path from genotype to phenotype (2002) Science, 296, pp. 701-703; Tan, S., Somia, N., Maher, P., Schubert, D., Regulation of antioxidant metabolism by translation initiation factor-2 alpha (2001) J. Cell Biol., 152, pp. 997-1006; Terry, R.D., Cell death or synaptic loss in Alzheimer disease (2000) J. Neuropathol. Exp. Neurol., 59, pp. 1118-1119; Terry, R.D., Masliah, E., Hansen, L.A., Structural basis of the cognitive alterations in Alzheimer disease (1994) Alzheimer Disease, , R.D. Terry, R. Katzman, & K.L. Bick. New York: Raven Press. 179-196.pp; Thonnard-Neumann, E., Phenothiazines and diabetes in hospitalized women (1968) Am. J. Psychiatry, 124, pp. 978-982; Wang, G.L., Jiang, B.H., Rue, E.A., Semenza, G.L., Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension (1995) Proc. Natl. Acad. Sci. USA, 92, pp. 5510-5514; Webster, K.A., Gunning, P., Hardeman, E., Wallace, D.C., Kedes, L., Coordinate reciprocal trends in glycolytic and mitochondrial transcript accumulations during the in vitro differentiation of human myoblasts (1990) J. Cell. Physiol., 142, pp. 566-573; Wisniewski, K.E., Dalton, A.J., McLachlan, C., Wen, G.Y., Wisniewski, H.M., Alzheimer's disease in Down's syndrome: Clinicopathological studies (1985) Neurology, 35, pp. 957-961; Wong, W.L., Brostrom, M.A., Kuznetsov, G., Gmitter-Yellen, D., Brostrom, C.O., Inhibition of protein synthesis and early protein processing by thapsigargin in cultured cells (1993) Biochem. J., 289, pp. 71-79; Worthington, C., (1947) Worthington Enzyme Manual, , Freehold, NJ: Worthington Biochemical Corporation; Yankner, B.A., Duffy, L.K., Kirschner, D.A., Neurotrophic and neurotoxic effects of amyloid beta protein: Reversal by tachykinin neuropeptides (1990) Science, 250, pp. 279-282; Zhang, Z., Yu, J., Stanton, R.C., A method for determination of pyridine nucleotides using a single extract (2000) Anal. Biochem., 285, pp. 163-167","Schubert, D.; Salk Inst. for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; email: schubert@salk.edu",,,,,,,,08966273,,NERNE,12848931,"English","Neuron",Article,Scopus,2-s2.0-0038644221
"Borghi, R., Venè, R., Arena, G., Schubert, D., Albini, A., Tosetti, F.","Transient modulation of cytoplasmic and nuclear retinoid receptors expression in differentiating human teratocarcinoma NT2 cells",2003,"Journal of Neurochemistry","84","1",,"94","104",,10,10.1046/j.1471-4159.2003.01501.x,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0037269384&partnerID=40&md5=431f8af56cd53e31346abd4e701e610d","Laboratory of Molecular Biology, Natl. Cancer Res. Institute (IST), Genova, Italy; Department of Experimental Medicine, Human Anatomy Section, University of Genova, Genova, Italy; Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA, United States; Laboratory of Molecular Biology, Natl. Cancer Res. Institute (IST), c/o Adv. Biotechnology Center (CBA), Largo Rosanna Benzi, 10, 16132 Genova, Italy","Borghi, R., Laboratory of Molecular Biology, Natl. Cancer Res. Institute (IST), Genova, Italy, Department of Experimental Medicine, Human Anatomy Section, University of Genova, Genova, Italy; Venè, R., Laboratory of Molecular Biology, Natl. Cancer Res. Institute (IST), Genova, Italy; Arena, G., Laboratory of Molecular Biology, Natl. Cancer Res. Institute (IST), Genova, Italy; Schubert, D., Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA, United States; Albini, A., Laboratory of Molecular Biology, Natl. Cancer Res. Institute (IST), Genova, Italy; Tosetti, F., Laboratory of Molecular Biology, Natl. Cancer Res. Institute (IST), Genova, Italy, Laboratory of Molecular Biology, Natl. Cancer Res. Institute (IST), c/o Adv. Biotechnology Center (CBA), Largo Rosanna Benzi, 10, 16132 Genova, Italy","Human embryonal carcinoma Ntera2/D1 (NT2) cells treated with retinoic acid (RA) differentiate into several cell types including post-mitotic neurons. In this study we asked if RA-induced differentiation alters the expression of RA and retinol (ROL) binding proteins. The regulation of the intracellular carrier proteins for ROL and RA, cellular retinol binding protein I (CRBP-I), and cellular retinoic acid binding protein I and II (CRABP-I, CRABP-II) were studied along with the nuclear RA receptors RARα, RARβ and RARγ2. PCR analysis of total mRNA from RA-treated cells showed a biphasic early induction of CRBP-I, CRABP-II, and RARγ2 genes. The immediate early gene Krox-24, a zinc finger transcription factor which is up-regulated during neuronal differentiation, was also induced, but after 1 week of treatment. The induction of CRBP-I protein synthesis in differentiating NT2 cells was confirmed by western blotting and immunofluorescence experiments. Conversely, the synthetic retinoid N-(4-hydroxyphenyl)retinamide, which induces cell death, but not differentiation in different tumour cell types, did not produce the same modulation on gene expression in NT2 cells. These data suggest that the RA-specific induction of CRBP-I and CRABP-II could be an early event in the process leading to neuronal differentiation of NT2 cells.","4HPR; Neuronal differentiation; Ntera2/D1; Retinoic acid; Retinoid binding proteins; Teratocarcinoma","cell nucleus receptor; cellular retinol binding protein; cellular retinol binding protein 1; cellular retinol binding protein 2; retinoic acid receptor alpha; retinoic acid receptor beta; retinoic acid receptor gamma; retinol binding protein; unclassified drug; article; cell death; cell differentiation; cell type; controlled study; cytoplasm; genetic transcription; human; human cell; immunofluorescence; mitosis; modulation; nerve cell; polymerase chain reaction; priority journal; protein expression; protein synthesis; regulatory mechanism; upregulation; Western blotting; Cell Differentiation; Cell Nucleus; Cytoplasm; DNA-Binding Proteins; Early Growth Response Protein 1; Humans; Immediate-Early Proteins; Protein Isoforms; Receptors, Retinoic Acid; Retinol-Binding Proteins; RNA, Messenger; Teratocarcinoma; Time Factors; Transcription Factors; Tumor Cells, Cultured",,"CRBP I; DNA-Binding Proteins; Early Growth Response Protein 1; EGR1 protein, human; Immediate-Early Proteins; Protein Isoforms; Receptors, Retinoic Acid; retinoic acid binding protein I, cellular; retinoic acid binding protein II, cellular; retinoic acid receptor gamma; Retinol-Binding Proteins; RNA, Messenger; Transcription Factors",,,,"Andrews, P.W., Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro (1984) Dev. Biol., 103, pp. 285-293; Avantaggiato, V., Acampora, D., Tuorto, F., Simeone, A., Retinoic acid induces stage-specific repatteming of the rostral central nervous system (1996) Dev. Biol., 175, pp. 347-357; Baldassarre, G., Barone, M., Belletti, B., Sandomenico, C., Bruni, P., Spiezia, S., Boccia, A., Viglietto, G., Key role of the cyclin-dependent kinase inhibitor p27kip? for embryonal carcinoma cell survival and differentiation (1999) Oncogene, 18, pp. 6241-6251; Balsalobre, A., Damiola, F., Schibler, U., A serum shock induces circadian gene expression in mammalian tissue culture cells (1998) Cell, 93, pp. 929-937; Bani-Yaghoub, M., Felker, J., Naus, C., Human NT2/D1 cells differentiate into functional astrocytes (1999) Neuroreport, 10, pp. 3843-3846; Bavik, C., Ward, S.J., Chambon, P., Developmental abnormalities in cultured mouse embryos deprived of retinoic by inhibition of yolk-sac retinol binding protein synthesis (1996) Proc. Natl. Acad. Sci. USA, 93, pp. 3110-3114; Boylan, J.F., Gudas, L.J., Overexpression of the cellular retinoic acid binding protein-I (CRABP-I) results in a reduction in differentiation-specific gene expression in F9 teratocarcinoma cells (1991) J. Cell Biol., 112, pp. 965-979; Boylan, J.F., Lufkin, T., Achkar, C.C., Taneja, R., Chambon, P., Gudas, L.J., Targeted disruption of retinoic acid receptor alpha (RAR alpha) and RAR gamma results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism (1995) Mol. Cell Biol., 15, pp. 843-851; De Bruijn, D., Oerlemans, F., Hendriks, W., Baats, E., Ploemacher, R., Wieringa, B., Geurts van Kessel, A., Normal development, growth and reproduction in cellular retinoic acid binding protein-I (CRABPI) null mutant mice (1994) Differentiation, 58, pp. 141-148; Chang, B., Broude, E., Dokmanovic, M., Zhu, H., Ruth, A., Xuan, Y., Kandel, E., Roninson, I., A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents (1999) Cancer Res., 59, pp. 3761-3767; Cheung, W.M., Chu, P.W., Lung, C.H., Ip, N.Y., Expression of retinoid receptors during the retinoic acid-induced neuronal differentiation of human embryonal carcinoma cells (2000) J. Neurochem., 75, pp. 34-40; Chomienne, C., Fenaux, P., Degos, L., Retinoid differentiation therapy in promyelocytic leukemia (1996) FASEB J., 10, pp. 1025-1030; Chrousos, G., Ultradian, circadian, and stress-related hypothalamic-pituitary-adrenal axis activity - A dynamic digital-to-analog modulation (1998) Endocrinology, 139, pp. 437-440; Clagett-Dame, M., Plum, L.A., Retinoid-regulated gene expression in neural development (1998) Crit. Rev. Eukaryot. Gene Expr., 7, pp. 299-342; Clifford, J.L., Menter, D.G., Wang, M., Lotan, R., Lippman, S.M., Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl) retinamide in F9 embryonal carcinoma cells (1999) Cancer Res., 59, pp. 14-18; D'Onofrio, C., Colantuoni, V., Cortese, R., Structure and cellspecific expression of a cloned human retinol binding protein gene: The 5′-flanking region contains hepatoma specific transcriptional signals (1985) EMBO J., 4, pp. 1981-1989; Delva, L., Bastie, J., Rochette-Egly, C., Kraiba, R., Balitrand, N., Despouy, G., Chambon, P., Chomienne, C., Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complex (1999) Mol. Cell Biol., 19, pp. 7158-7167; Dodd, J., Morton, S., Karagogeos, D., Yamamoto, M., Jessell, T., Spatial regulation of axonal glycoprotein expression on embryonic spinal neurons (1988) Neuron, 1, pp. 105-116; Durston, A.J., Timmermans, J.P., Hage, W.J., Hendriks, H.F., De Vries, N.J., Heideveld, M., Nieuwkoop, P.D., Retinoic acid causes an anteroposterior transformation in the developing central nervous system (1989) Nature, 340, pp. 140-144; Eskild, W., Oyen, O., Beebe, S., Jahnsen, T., Hansson, V., Regulation of mRNA levels for cellular retinol binding protein in rat Sertoli cells by cyclic AMP and retinol (1988) Biochem. Biophys. Res. Commun., 152, pp. 1504-1510; Fawcett, D., Pasceri, P., Fraser, R., Colbert, M., Rossant, J., Giguere, V., Postaxial polydactyly in forelimbs of CRABP-II mutant mice (1995) Development, 121, pp. 671-679; Ferrari, N., Vidali, G., Pfeffer, U., Use of quantitative polymerase chain reaction to study retinoid receptor expression (1997) Meth. Enzymol., 282, pp. 48-64; Galdieri, M., Faraonio, R., Colantuoni, V., Detection of cellular retinol-binding protein messenger RNA in the somatic cells of the rat seminiferous tubules (1988) Biochem. Biophys. Res. Commun., 154, pp. 1174-1181; Ghyselinck, N., Bavik, C., Sapin, V., Mark, M., Bonnier, D., Hindelang, C., Dierich, A., Chambon, P., Cellular retinolbinding protein I is essential for vitamin A homeostasis (1999) EMBO J., 18, pp. 4903-4914; Giguere, V., Lyn, S., Yip, P., Siu, C.H., Amin, S., Molecular cloning of cDNA encoding a second cellular retinoic acid-binding protein (1990) Proc. Natl. Acad. Sci. USA, 87, pp. 6233-6237; Gorry, P., Lufkin, T., Dierich, A., Rochette-Egly, C., Decimo, D., Dolle, P., Mark, M., Chambon, P., The cellular retinoic acid binding protein I is dispensable (1994) Proc. Natl. Acad. Sci. USA, 91, pp. 9032-9036; Haq, R., Chytil, F., Retinoic acid rapidly induces lung cellular retinol-binding protein mRNA levels in retinol deficient rats (1988) Biochem. Biophys. Res. Commun., 156, pp. 712-716; Harnish, D.C., Soprano, K.J., Soprano, D.R., Mouse conceptuses have a limited capacity to elevate the mRNA level of cellular retinoid binding proteins in response to teratogenic doses of retinoic acid (1992) Teratology, 46, pp. 137-146; Horton, C., Maden, M., Endogenous distribution of retinoids during normal development and teratogenesis in the mouse embryo (1995) Dev. Dyn., 202, pp. 312-323; Kitareewan, S., Spinella, M.J., Allopenna, J., Reczek, P.R., Dmitrovsky, E., 4HPR triggers apoptosis but not differentiation in retinoid sensitive and resistant human embryonal carcinoma cells through an RARgamma independent pathway (1999) Oncogene, 18, pp. 5747-5755; Kleinjan, D.A., Dekker, S., Vaessen, M.J., Grosveld, F., Regulation of the CRABP-I gene during mouse embryogenesis (1997) Mech. Dev., 67, pp. 157-169; Kurlandsky, S.B., Gamble, M.V., Ramakrishnan, R., Blaner, W.S., Plasma delivery of retinoic acid to tissues in the rat (1995) J. Biol. Chem., 270, pp. 17850-17857; Laemmli, U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4 (1970) Nature, 227, pp. 680-685; Lampron, C., Rochette-Egly, C., Gorry, P., Dolle, P., Mark, M., Lufkin, T., LeMeur, M., Chambon, P., Mice deficient in cellular retinoic acid binding protein II (CRABPII) or in both CRABPI and CRABPII are essentially normal (1995) Development, 121, pp. 539-548; Lotan, R., Retinoids and apoptosis: Implications for cancer chemoprevention and therapy (1995) J. Natl Cancer Inst., 87, pp. 1655-1657; MacDonald, P.N., Bok, D., Ong, D.E., Localization of cellular retinol-binding protein and retinol-binding protein in cells comprising the blood-brain barrier of rat and human (1990) Proc. Natl. Acad. Sci. USA, 87, pp. 4265-4269; Maden, M., Holder, N., Retinoic acid and the development of the central nervous system (1992) Bioessays, 14, pp. 431-438; Maden, M., Ong, D.E., Chytil, F., Retinoid-binding protein distribution in the developing mammalian nervous system (1990) Development, 109, pp. 75-80; Maden, M., Gale, E., Zile, M., The role of vitamin A in the development of the central nervous system (1998) J. Nutr., 128, pp. 471S-475S; McCaffery, P., Drager, U., Regulation of retinoic acid signaling in the embryonic nervous system: A master differentiation factor (2000) Cytokine Growth Factor Rev., 11, pp. 233-249; McNamara, P., Seo, S.P., Rudic, R.D., Sehgal, A., Chakravarti, D., FitzGerald, G.A., Regulation of CLOCK and MOP4 by nuclear hormone receptors in the vasculature: A humoral mechanism to reset a peripheral clock (2001) Cell, 105, pp. 877-889; Means, A.L., Gudas, L.J., The CRABP-I gene contains two separable, redundant regulatory regions active in neural tissue in transgenic mouse embryos (1997) Dev. Dyn., 209, pp. 59-69; Miller, W.H.J., Moy, D., Li, A., Grippo, J.F., Dmitrovsky, E., Retinoic acid induces down-regulation of several growth factors and proto-oncogenes in a human embryonal cancer cell line (1990) Oncogene, 5, pp. 511-517; Moasser, M.M., Reuter, V.E., Dmitrovsky, E., Overexpression of the retinoic acid receptor gamma directly induces terminal differentiation of human embryonal carcinoma cells (1995) Oncogene, 10, pp. 1537-1543; Morriss-Kay, G.M., Ward, S.J., Retinoids and mammalian development (1999) Int. Rev. Cytol., 188, pp. 73-131; Muller, A., Nakagawa, H., Rustgi, A., Retinoic acid and N-(4-hydroxy-phenyl) retinamide suppress growth of esophageal squamous carcinoma cell lines (1997) Cancer Lett., 113, pp. 95-101; Noy, N., Retinoid-binding proteins: Mediators of retinoid action (2000) Biochem. J., 348, pp. 481-495; Ong, D.E., Purification and partial characterization of cellular retinol-binding protein from human liver (1982) Cancer Res., 42, pp. 1033-1037; Ong, D.E., Newcomer, M.E., Chytil, F., Cellular retinoid-binding proteins (1994) The Retinoids. Biology, Chemistry, and Medicine, 2nd Edn., pp. 283-317. , Sporn M. B., Roberts A. B. and Goodman D. S., eds. Raven Press, New York; Perez-Castro, A.V., Toth-Rogler, L.E., Wei, L.N., Nguyen-Huu, M.C., Spatial and temporal pattern of expression of the cellular retinoic acid-binding protein and the cellular retinol-binding protein during mouse embryogenesis (1989) Proc. Natl. Acad. Sci. USA, 86, pp. 8813-8817; Qu, Z., Wolfraim, L.A., Svaren, J., Ehrengruber, M.U., Davidson, N., Milbrandt, J., The transcriptional corepressor NAB2 inhibits NGF-induced differentiation of PC12 cells (1998) J. Cell Biol., 142, pp. 1075-1082; Ruberte, E., Friederich, V., Chambon, P., Morriss-Kay, G., Retinoic acid receptors and cellular retinoid binding proteins. III. Their differential transcript distribution during mouse nervous system development (1993) Development, 118, pp. 267-282; Sabichi, A., Hendricks, D., Bober, M., Birrer, M., Retinoic acid receptor beta expression and growth inhibition of gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenyl) retinamide (1998) J. Natl Cancer Inst., 90, pp. 597-605; Sandhu, J., Sikorska, M., Walker, P., Characterization of astrocytes derived from human NTera-2/D1 embryonal carcinoma cells (2002) J. Neurosci. Res., 68, pp. 604-614; Schindler, J., Matthaei, K., Sherman, M., Isolation and characterization of mouse mutant embryonal carcinoma cells which fail to differentiate in response to retinoic acid (1981) Proc. Natl. Acad. Sci. USA, 78, pp. 1077-1080; Smith, W.C., Nakshatri, H., Leroy, P., Rees, J., Chambon, P., A retinoic acid response element is present in the mouse cellula retinol binding protein I (mCRBPI) promoter (1991) EMBO J., 10, pp. 2223-2230; Spinella, M.J., Kitareewan, S., Mellado, B., Sekula, D., Khoo, K.S., Dmitrovsky, E., Specific retinoid receptors cooperate to signal growth suppression and maturation of human embryonal carcinoma cells (1998) Oncogene, 16, pp. 3471-3480; Sukhatme, V.P., Cao, X.M., Chang, L.C., Tsai-Morris, C.H., Stamenkovich, D., Ferreira, P.C., Cohen, D.R., Adamson, E.D., A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization (1988) Cell, 53, pp. 37-43; De The, H., Vivanco-Ruiz, M.M., Tiollais, P., Stunnenberg, H., Dejean, A., Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene (1990) Nature, 343, pp. 177-180; Vo, H.P., Crowe, D.L., Transcriptional regulation of retinoic acid responsive genes by cellular retinoic acid binding protein-II modulates RA mediated tumor cell proliferation and invasion (1998) Anticancer Res., 18, pp. 217-224; Wagner, M., Han, B., Jessell, T.M., Regional differences in retinoid release from embryonic neural tissue detected by an in vitro reporter assay (1992) Development, 116, pp. 55-66; Wagner, E., McCaffery, P., Mey, J., Farhangfar, F., Applebury, M.L., Drager, U.C., Retinoic acid increases arrest in mRNA levels in the mouse retina (1997) FASEB J., 11, pp. 271-275; Wainwright, L., Lasorella, A., Iavarone, A., Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells (2001) Proc. Natl. Acad. Sci. USA, 98, pp. 9396-9400; Wan, H., Dawson, M., Hong, W., Lotan, R., Enhancement of Caluhuman lung carcinoma cell growth in serum-free medium by retinoids: Dependence on AP-activation, but not on retinoid response element activation (1997) Oncogene, 15, pp. 2109-2118; Wang, S.Y., Gudas, L.J., Selection and characterization of F9 teratocarcinoma stem cell mutants with altered responses to retinoic acid (1984) J. Biol. Chem., 259, pp. 5899-5906; Wei, L., Blaner, W., Goodman, D., Nguyen-Huu, M., Regulation of the cellular retinoid-binding proteins and their messenger ribonucleic acids during P19 embryonal carcinoma cell differentiation induced by retinoic acid (1989) Mol. Endocrinol., 3, pp. 454-463; Wei, L., Chang, L., Hu, X., Studies of the type I cellular retinoic acid-binding protein mutants and their biological activities (1999) Mol. Cell Biochem., 200, pp. 69-76; Yamamoto, M., Drager, U., Ong, D., McCaffery, P., Retinoid-binding proteins in the cerebellum and choroid plexus and their relationship to regionalized retinoic acid synthesis and degradation (1998) Eur. J. Biochem., 257, pp. 344-350; Zetterstrom, R.H., Simon, A., Giacobini, M.M., Eriksson, U., Olson, L., Localization of cellular retinoid-binding proteins suggests specific roles for retinoids in the adult central nervous system (1994) Neuroscience, 62, pp. 899-918; Zile, M.H., Vitamin A and embryonic development: An overview (1998) J. Nutr., 128, pp. 455S-458S","Tosetti, F.; Laboratory of Molecular Biology, Natl. Cancer Res. Institute (IST), c/o Adv. Biotechnology Center (CBA), Largo Rosanna Benzi, 10, 16132 Genova, Italy; email: tosetti@cba.unige.it",,,,,,,,00223042,,JONRA,12485405,"English","J. Neurochem.",Article,Scopus,2-s2.0-0037269384
"Schubert, D.","A different perspective on GM food",2002,"Nature Biotechnology","20","10",,"969","",,32,10.1038/nbt1002-969,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0036788484&partnerID=40&md5=03cf138a0a8acc95472b633695538586","Salk Institute, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States","Schubert, D., Salk Institute, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States",[No abstract available],,"bacterial toxin; flavonoid; retinoic acid; retinol; tryptophan; carcinogenicity; diet supplementation; DNA microarray; food biotechnology; food poisoning; gene control; gene expression; genetically modified crop; note; plant product; priority journal; protein function; protein modification; RNA splicing; California; Consumer Product Safety; Environment; Food, Genetically Modified; Gene Expression Regulation, Plant; Genetic Engineering; Health Knowledge, Attitudes, Practice; Plants, Genetically Modified; Protein Engineering; Public Opinion; Bacteria (microorganisms)",,,,,,"Shioi, J., (1995) J. Biol. Chem., 270, pp. 11839-11844; Salinero, O., Moreno-Flores, M.T., Wandosell, F.J., (2000) Neurosci. Res., 60, pp. 87-97; Srivastava, M., Eidelman, O., Pollard, H.B., (1999) Mol. Med., 5, pp. 753-767; Atkinson, R.G., Schroder, R., Hallett, I.C., Cohen, D., MacRae, E.A., (2002) Plant Physiol., 129, pp. 122-133; Gronemeyer, H., Miturski, R., (2001) Cell Mol. Biol. Lett., 6, pp. 3-52; Kilbourne, E.M., Philen, R.M., Kamb, M.L., Falk, H.J., (1996) Rheumatol. Suppl., 46, pp. 81-88; Middleton, E., Kandaswami, C., Theoharides, T.C., (2000) Pharmacol. Rev., 52, pp. 673-751; Lappe, M.A., Bailey, E.B., Childress, C., Setchell, K.D.R., (1999) J. Med. Food, 1, pp. 241-245","Schubert, D.; Salk Institute, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States; email: schubert@salk.edu",,,,,,,,10870156,,NABIF,12355105,"English","Nat. Biotechnol.",Note,Scopus,2-s2.0-0036788484
"Chen, Q., Schubert, D.","Presenilin-interacting proteins.",2002,"Expert reviews in molecular medicine [electronic resource]","4",,,"1","18",,31,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-1542438695&partnerID=40&md5=d6e81b80540454826def2106e5ff8e5e","Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA.","Chen, Q., Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA.; Schubert, D., Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA.","Familial Alzheimer's disease (FAD) accounts for 5-10% of deaths from Alzheimer's disease (AD), and approximately 50% of these cases have been definitely linked to missense mutations in three genes, encoding the amyloid precursor protein (APP), presenilin 1 (PS1) and presenilin 2 (PS2). Of these, the vast majority of FAD-linked mutations are within PS1. There has been an extensive effort to identify proteins that functionally interact with PS1 and PS2 because of their clear roles in FAD. The goal of this review is to describe these proteins and to discuss in more detail the probable biological functions of a subset of the better-studied interacting proteins. In particular, the review examines APP, Notch, nicastrin, modifier of cellular adhesion (MOCA), beta-catenin, and the group of proteins involved in cell death, calcium metabolism and cell adhesion. We argue that, although a few of the interacting proteins are unambiguously involved in well-studied cellular pathways, their exact roles within these pathways have not been clearly defined, and indeed might vary between cell types. We also question the physiological relevance of some of the work linking PS to cell death pathways. Finally, we point out the value of using flies and worms to sort out the often contradictory work in the PS field, and we mention how knowledge of PS-interacting pathways will contribute to the development of new therapeutic strategies in AD.",,"membrane protein; presenilin 1; presenilin 2; PSEN1 protein, human; PSEN2 protein, human; Alzheimer disease; animal; human; metabolism; protein analysis; review; Alzheimer Disease; Animals; Humans; Membrane Proteins; Presenilin-1; Presenilin-2; Protein Interaction Mapping",,"presenilin 1, 186986-30-1; presenilin 2, 172593-10-1; Membrane Proteins; Presenilin-1; Presenilin-2; PSEN1 protein, human; PSEN2 protein, human",,,,,"Chen, Q.email: qchen@salk.edu",,,,,,,,14623994,,,14585160,"English","Expert Rev Mol Med",Review,Scopus,2-s2.0-1542438695
"Liu, Y., Fiskum, G., Schubert, D.","Generation of reactive oxygen species by the mitochondrial electron transport chain",2002,"Journal of Neurochemistry","80","5",,"780","787",,591,10.1046/j.0022-3042.2002.00744.x,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0036319021&partnerID=40&md5=a964b38a6abfd1c6a4fe739e69f59aa9","Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; Department of Anesthesiology, University of Maryland, School of Medicine, Baltimore, MD, United States; Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037-9062, United States","Liu, Y., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States, Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037-9062, United States; Fiskum, G., Department of Anesthesiology, University of Maryland, School of Medicine, Baltimore, MD, United States; Schubert, D., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States","Generation of reactive oxygen species (ROS) by the mitochondrial electron transport chain (ETC), which is composed of four multiprotein complexes named complex I-IV, is believed to be important in the aging process and in the pathogenesis of neurodegenerative diseases such as Parkinson's disease. Previous studies have identified the ubiquinone of complex III and an unknown component of complex I as the major sites of ROS generation. Here we show that the physiologically relevant ROS generation supported by the complex II substrate succinate occurs at the flavin mononucleotide group (FMN) of complex I through reversed electron transfer, not at the ubiquinone of complex III as commonly believed. Indirect evidence indicates that the unknown ROS-generating site within complex I is also likely to be the FMN group. It is therefore suggested that the major physiologically and pathologically relevant ROS-generating site in mitochondria is limited to the FMN group of complex I. These new insights clarify an elusive target for intervening mitochondrial ROS-related processes or diseases.","Aging; Electron transport chain; Mitochondria; Parkinson's disease; Reactive oxygen species","flavine mononucleotide; hydrogen peroxide; protein; reactive oxygen metabolite; reduced nicotinamide adenine dinucleotide phosphate; succinic acid; superoxide; ubiquinone; aging; animal tissue; article; electron transport; fluorescence; mitochondrion; nonhuman; Parkinson disease; priority journal; rat; Aging; Animals; Brain Chemistry; Electron Transport; Electron Transport Complex I; Electron Transport Complex III; Flavin Mononucleotide; Hydrogen Peroxide; Mitochondria; NADH, NADPH Oxidoreductases; Oxidation-Reduction; Rats; Reactive Oxygen Species; Subcellular Fractions; Ubiquinone; Animalia",,"Electron Transport Complex I, EC 1.6.5.3; Electron Transport Complex III, EC 1.10.2.2; Flavin Mononucleotide, 146-17-8; Hydrogen Peroxide, 7722-84-1; NADH, NADPH Oxidoreductases, EC 1.6.-; Reactive Oxygen Species; Ubiquinone, 1339-63-5",,,,"Betarbet, R., Sherer, T.B., MacKenzie, G., Garcia-Osuna, M., Panov, A.V., Greenamyre, J.T., Chronic systemic pesticide exposure reproduces features of Parkinson's disease (2000) Nat. Neurosci., 3, pp. 1301-1306; Boveris, A., Determination of the production of superoxide radicals and hydrogen peroxide in mitochondria (1984) Meth. Enzymol., 105, pp. 429-435; Boveris, A., Cadenas, E., Mitochondrial production of superoxide anions and its relationship to antimycin insensitive respiration (1975) FEBS Lett., 54, pp. 311-314; Boveris, A., Oshino, N., Chance, B., Cellular production of hydrogen peroxide (1972) Biochem. J., 128, pp. 617-630; Cadenas, E., Boveris, A., Ragan, C.I., Stoppani, A.O.M., Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria (1977) Arch. Biochem. Biophys., 180, pp. 248-257; Chance, B., Hollunger, G., The interaction of energy and electron transfer reactions in mitochondria. I. General properties and nature of the products of succinate-linked reduction of pyridine nucleotide (1961) J. Biol. Chem., 236, pp. 1534-1543; Chance, B., Hollunger, G., The interaction of energy and electron transfer reactions in mitochondria. IV. The pathway of electron transfer (1961) J. Biol. Chem., 236, pp. 1562-1568; Chance, B., Sies, H., Boveris, A., Hydroperoxide metabolism in mammlian organs (1979) Physiol. Rev., 59, pp. 527-605; Cino, M., Del Maestro, R.F., Generation of hydrogen peroxide by brain mitochondria: The effect of reoxygenation following postdecapitative ischemia (1989) Arch. Biochem. Biophys., 269, pp. 623-638; Cross, A.R., Jones, O.T., The effect of the inhibitor diphenylene iodonium on the superoxide-generating system of neutrophils. Specific labeling of a component polypeptide of the oxidase (1986) Biochem. J., 237, pp. 111-116; Forman, H.J., Azzi, A., On the virtual existence of superoxide anions in mitochondria: Thoughts regarding its role in pathophysiology (1997) FASEB J., 11, pp. 374-375; Guilbaut, G.G., Brigac, Jr., Juneau, M., New substrates for the fluorometric determination of oxidative enzymes (1968) Anal. Chem., 40, pp. 1256-1263; Hinkle, P.C., Butow, R.A., Racker, E., Chance, B., Partial resolution of the enzymes catalyzing oxidative phosphorylation. XV. Reverse electron transfer in the flavin-cytochrome b region of the respiratory chain of beef heart submitochondrial particles (1967) J. Biol. Chem., 242, p. 5169; Holland, P.C., Clark, M.G., Bloxham, D.P., Lardy, H.A., Mechanism of action of the hypoglycemic agent diphenyleneiodonium (1973) J. Biol. Chem., 248, pp. 6050-6056; Jocelyn, P.C., Cronshaw, A., Properties of mitochondria treated with 1-chloro-2,4-dinitrobenzene (1985) Biochem. Pharmacol., 34, pp. 1588-1590; Kwong, L.K., Sohal, R.S., Substrate and site specificity of hydrogen peroxide generation in mouse mitochondria (1998) Arch. Biochem. Biophys., 350, pp. 118-126; Lebovitz, R.M., Zhang, H., Vogel, H., Cartwright J., Jr., Dionne, L., Lu, N., Huang, S., Matzuk, M.M., Neurodegeneration, myocardial injury, and perinatal death in mitochondrial dismutase-deficient mice (1996) Proc. Natl. Acad. Sci. USA, 93, pp. 9782-9787; Li, Y., Huang, T.T., Carlson, E.J., Melov, S., Ursell, P.C., Olson, J.L., Noble, L.J., Epstein, C.J., Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase (1995) Nat. Genet., 11, pp. 376-381; Liu, Y., Rosenthal, R.E., Fiskum, G., H2O2 release by isolated brain mitochondria in a canine cerebral ischemia/reperfusion model (1993) FASEB J., 7, pp. A424; Loschen, G., Flohe, L., Chance, B., Respiratory chain linked production in pigeon heart mitochondria (1971) FEBS Lett., 18, pp. 261-264; Loschen, G., Azzi, A., Flohe, L., Superoxide radicals as precursors of mitochondrial hydrogen peroxide (1974) FEBS Lett., 42, pp. 68-72; Ragan, C.I., Bloxham, D.P., Specific labelling of a constituent polypeptide of bovine heart mitochondrial reduced nicotinamideadenine dinucleotide-ubiquinone reductase by the inhibitor diphenyleneiodonium (1977) Biochem. J., 163, pp. 605-615; Robinson, B.H., Human complex I deficiency: Clinical spectrum and involvement of oxygen free radicals in the pathogenicity of the defect (1998) Biochim. Biophys. Acta, 1364, pp. 271-286; Shigenaga, M.K., Hagen, T.M., Ames, B.N., Oxidative damage and mitochondrial decay in aging (1994) Proc. Natl. Acad. Sci. USA, 91, pp. 10771-10778; Tan, S., Sagara, Y., Liu, Y., Maher, P., Schubert, D., The regulation of reactive oxygen species production during programmed cell death (1998) J. Cell Biol., 141, pp. 1423-1432; Turrens, J.F., Boveris, A., Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria (1980) Biochem. J., 191, pp. 421-427; Turrens, J.F., Alexandre, A., Lehninger, A.L., Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria (1985) Arch. Biochem. Biophys., 237, pp. 408-414; Tyler, D.D., Gonze, J., The preparation of heart mitochondria from laboratory animals (1967) Meth. Enzymol., 10, pp. 75-77; Votyakova, T.V., Reynolds, I.J., δψm-dependent and -independent production of reactive oxygen species by rat brain mitochondria (2001) J. Neurochem., 79, pp. 266-277; Wallace, D.C., Mitochondrial diseases in man and mouse (1999) Science, 283, pp. 1482-1488; Wilson, D.F., Erecinska, M., Dutton, P.L., Thermodynamic relationships in mitochondrial oxidative phosphorylation (1974) Annu. Rev. Biophys. Bioeng., 3, pp. 203-230; Zoccarato, F., Cavallini, L., Deana, R., Alexandre, A., Pathways of hydrogen peroxide generation in guinea pig cerebral cortex mitochondria (1988) Biochem. Biophys. Res. Commun., 154, pp. 727-734","Liu, Y.; Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037-9062, United States; email: liu@salk.edu",,,,,,,,00223042,,JONRA,11948241,"English","J. Neurochem.",Article,Scopus,2-s2.0-0036319021
"Dargusch, R., Schubert, D.","Specificity of resistance to oxidative stress",2002,"Journal of Neurochemistry","81","6",,"1394","1400",,36,10.1046/j.1471-4159.2002.00950.x,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0036316323&partnerID=40&md5=d3a5db796478431225c5d54f27f811fc","Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States","Dargusch, R., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; Schubert, D., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States, Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States","Two clonal nerve-like cell lines derived from HT22 and PC12 have been selected for resistance to glutamate toxicity and amyloid toxicity, respectively. In the following experiments it was asked if these cell lines show cross-resistance toward amyloid beta peptide (Aβ) and glutamate as well as toward a variety of additional neurotoxins. Conversely, it was determined if inhibitors of oxytosis, a well-defined oxidative stress pathway, also protect cells from the neurotoxins. It is shown that both glutamate and amyloid resistant cells are cross resistant to most of the other toxins or toxic conditions, while inhibitors of oxytosis protect from glutathione and cystine depletion and H2O2 toxicity, but not from the toxic effects of nitric oxide, rotenone, arsenite or cisplatin. It is concluded that while there is a great deal of cross-resistance to neurotoxins, the components of the cell death pathway which has been defined for oxytosis are not used by many of the neurotoxins.","Amyloid; Glutamate; Oxidative stress; Oxytosis; Programmed cell death; Resistance","amyloid; amyloid beta protein; arsenic trioxide; cisplatin; cystine; glutamic acid; glutathione; neurotoxin; nitric oxide; rotenone; animal cell; article; cell clone; cell death; cell protection; cross resistance; human; human cell; inhibition kinetics; nerve cell; neuroprotection; neurotoxicity; nonhuman; oxidation kinetics; oxidative stress; priority journal; tissue specificity; Amyloid beta-Protein; Animals; Apoptosis; Cell Line; Cystine; Drug Resistance; Glutamic Acid; Hydrogen Peroxide; Mice; Neurons; Neurotoxins; Oxidants; Oxidative Stress; Animalia",,"Amyloid beta-Protein; Cystine, 56-89-3; Glutamic Acid, 56-86-0; Hydrogen Peroxide, 7722-84-1; Neurotoxins; Oxidants",,,,"Abernathy, C.O., Liu, Y.P., Longfellow, D., Aposhian, H.V., Beck, B., Fowler, B., Goyer, R., Thompson, C., Arsenic: Health effects, mechanisms of actions, and research issues (1999) Environ. Health Perspect., 107, pp. 593-597; Andersen, J.K., Does neuronal loss in Parkinson's disease involve programmed cell death? (2001) Bioessays, 23, pp. 640-646; Bannai, S., Kitamura, E., Transport interaction of 1-cystine and 1-glutamate in human diploid fibroblasts in culture (1980) J. Biol. Neurochem., 255, pp. 2372-2376; Behl, C., Davis, J.B., Lesley, R., Schubert, D., Hydrogen peroxide mediates amyloid beta protein toxicity (1994) Cell, 77, pp. 817-827; Bredt, D.S., Endogenous nitric oxide synthesis: Biological functions and pathophysiology (1999) Free Radic. Res., 31, pp. 577-596; Dargusch, R., Piasecki, D., Tan, S., Liu, Y., Schubert, D., The role of Bax in glutamate-induced nerve cell death (2000) J. Neurochem., 76, pp. 295-301; Davis, J.B., Maher, P., Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line (1994) Brain Res., 652, pp. 169-173; Gurr, J.R., Bau, D.T., Liu, F., Lynn, S., Jan, K.Y., Dithiothreitol enhances arsenic trioxide-induced apoptosis in NB4 cells (1999) Mol. Pharmacol., 56, pp. 102-109; Hannemann, J., Baumann, K., Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: Different effects of antioxidants and radical scavengers (1988) Toxicology, 51, pp. 119-132; Ishige, K., Chen, Q., Sagara, Y., Schubert, D., The activation of dopamine D4 receptors inhibits oxidative stress-induced nerve cell death (2001) J. Neurosci., 21, pp. 6069-6076; Kim, D.K., Cho, E.S., Lee, B.R., Um, H.D., NF-KB mediates the adaptation of human U937 cells to hydrogen peroxide (2001) Free Rad. Biol. Med., 30, pp. 563-571; Li, Y., Maher, P., Schubert, D., Requirement for cGMP in nerve cell death caused by glutathione depletion (1997) J. Cell Biol., 139, pp. 1317-1324; Liu, J., Chen, H., Miller, D.S., Saavedra, J.E., Keefer, L.K., Johnson, D.R., Klaassen, C.D., Waalkes, M.P., Overexpression of glutathione S-transferase II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic (2001) Molec. Pharmacol., 60, pp. 302-309; Liu, Y., Peterson, D.A., Kimura, H., Schubert, D., Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction (1997) J. Neurochem., 69, pp. 581-593; Liu, Y., Schubert, D., Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis (1997) J. Neurochem., 69, pp. 2285-2293; Mello-Filho, A.C., Chubatsu, L.S., Meneghini, R., V79 Chinese-hamster cells rendered resistant to high cadmium concentration also become resistant to oxidative stress (1988) Biochem. J., 256, pp. 475-479; Murphy, T.H., Miyamoto, M., Sastre, A., Schnaar, R.L., Coyle, J.T., Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress (1989) Neuron, 2, pp. 1547-1558; Romach, E.H., Zhao, C.Q., Del Razo, L.M., Cebrian, M.E., Waalkes, M.P., Studies on the mechanism of arsenic-induced self tolerance in liver epithelial cells through continuous low-level arsenite exposure (2000) Toxicol. Sci., 54, pp. 500-508; Sagara, Y., Dargusch, R., Chambers, D., Davis, J., Schubert, D., Maher, P., Cellular mechanisms of resistance to chronic oxidative stress (1998) Free Radic. Biol. Med., 24, pp. 1375-1389; Sagara, Y., Dargusch, R., Klier, F.G., Schubert, D., Behl, C., Increased antioxidant enzyme activity in amyloid beta protein-resistant cells (1996) J. Neurosci., 16, pp. 497-505; Sagara, Y., Schubert, D., The activation of metabotropic glutamate receptors protects nerve cells from oxidative stress (1998) J. Neurosci., 18, pp. 6662-6671; Salnikow, K., Gao, M., Voitkun, V., Huang, X., Costa, M., Altered oxidative stress responses in nickel-resistant mammalian cells (1994) Cancer Res., 54, pp. 6407-6412; Sato, H., Tamba, M., Ishii, T., Bannai, S., Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins (1999) J. Biol. Chem., 274, pp. 11455-11458; Schubert, D., Kimura, H., Maher, P., Growth factors and vitamin E modify neuronal glutamate toxicity (1992) Proc. Natl. Acad. Sci. (USA), 89, pp. 8264-8267; Spitz, D.R., Kinter, M.T., Roberts, R.J., Contribution of increased glutathione content to mechanisms of oxidative stress resistance in hydrogen peroxide resistant hamster fibroblasts (1995) J. Cell. Physiol., 165, pp. 600-609; Spitz, D.R., Phillips, J.W., Adams, D.T., Sherman, C.M., Deen, D.F., Li, G.C., Cellular resistance to oxidative stress is accompanied by resistance to cisplatin: The significance of increased catalase activity and total glutathione in hydrogen peroxide-resistant fibroblasts (1993) J. Cell. Physiol., 156, pp. 72-79; Sugiyama, M., Tsuzuki, K., Haramaki, N., DNA single-strand breaks and cytotoxicity induced by sodium chromate (VI) in hydrogen peroxide-resistant cell lines (1993) Mutat. Res., 299, pp. 95-102; Tan, S., Schubert, D., Maher, P., Oxytosis: A novel form of programmed cell death (2002) Curr. Topics Med. Chem., 1, pp. 497-506; Tan, S., Somia, N., Maher, P., Schubert, D., Regulation of antioxidant metabolism by translation initiation factor-2 alpha (2001) J. Cell Biol., 152, pp. 997-1006; Tan, S., Wood, M., Maher, P., Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells (1998) J. Neurochem., 71, pp. 95-105; Vogt, M., Dulbecco, R., Steps in the neoplastic transformation of hamster embryo cells by polyoma virus (1963) Proc. Natl. Acad. Sci. USA, 49, pp. 171-179; Wang, T.-S., Hsu, T.-Y., Chung, C.-H., Wang, A.S.S., Bau, D.T., Jan, K.-Y., Arsenite induces oxidative DNA adducts and DNA-protein cross-links in mammalian cells (2001) Free Rad. Biol. Med., 31, pp. 321-330; Yamanaka, K., Takabayashi, F., Mizoi, M., An, Y., Hasegawa, A., Okada, S., Oral exposure of dimethylarsinic acid, a main metabolite of inorganic arsenics, in mice leads to an increase in 8-oxo-2′-deoxyguanosine level, specifically in the target organs for arsenic carcinogenesis (2001) Biochem. Biophys. Res. Comm., 287, pp. 66-70","Schubert, D.; Salk Inst. for Biological Studies, 10010 N. Torrey Pines Road, San Diefo, CA 92037, United States; email: schubert@salk.edu",,,,,,,,00223042,,JONRA,12068086,"English","J. Neurochem.",Article,Scopus,2-s2.0-0036316323
"Chen, Q., Kimura, H., Schubert, D.","A novel mechanism for the regulation of amyloid precursor protein metabolism",2002,"Journal of Cell Biology","158","1",,"79","89",,39,10.1083/jcb.200110151,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0037043330&partnerID=40&md5=f0ed6d8df01c9dcdf5519b80a1e4487e","Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037, United States; National Institute of Neuroscience, Kodaira, Tokyo 187-8551, Japan; Salk Institute, 10010 N. Torrey Pines Rd., San Diego, CA 92037, United States","Chen, Q., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037, United States; Kimura, H., National Institute of Neuroscience, Kodaira, Tokyo 187-8551, Japan; Schubert, D., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037, United States, Salk Institute, 10010 N. Torrey Pines Rd., San Diego, CA 92037, United States","Modifier of cell adhesion protein (MOCA; previously called presenilin [PS] binding protein) is a DOCK180-related molecule, which interacts with PS1 and PS2, is localized to brain areas involved in Alzheimer's disease (AD) pathology, and is lost from the soluble fraction of sporadic Alzheimer's disease (AD) brains. Because PS1 has been associated with γ-secretase activity, MOCA may be involved in the regulation of β-amyloid precursor protein (APP) processing. Here we show that the expression of MOCA decreases both APP and amyloid β-peptide secretion and lowers the rate of cell-substratum adhesion. In contrast, MOCA does not lower the secretion of amyloid precursor-like protein (APLP) or several additional type 1 membrane proteins. The phenotypic changes caused by MOCA are due to an acceleration in the rate of intracellular APP degradation. The effect of MOCA expression on the secretion of APP and cellular adhesion is reversed by proteasome inhibitors, suggesting that MOCA directs nascent APP to proteasomes for destruction. It is concluded that MOCA plays a major role in APP metabolism and that the effect of MOCA On APP secretion and cell adhesion is a downstream consequence of MOCA-directed APP catabolism. This is a new mechanism by which the expression of APP is regulated.","Amyloid precursor protein; Beta amyloid; MOCA; Proteasome; Secretion","amyloid precursor protein; membrane protein; presenilin 1; presenilin 2; proteasome inhibitor; Alzheimer disease; animal cell; article; catabolism; cell adhesion; controlled study; enzyme activity; nonhuman; phenotype; priority journal; protein degradation; protein expression; protein localization; protein metabolism; protein protein interaction; protein secretion; rat; Amyloid beta-Protein; Amyloid beta-Protein Precursor; Animals; Bacterial Proteins; Blotting, Northern; Blotting, Western; Cell Adhesion; Cell Line; Cysteine Endopeptidases; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Laminin; Microscopy, Confocal; Microscopy, Fluorescence; Multienzyme Complexes; Neurons; Phenotype; Proteasome Endopeptidase Complex; Rats; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Transfection; Tumor Cells, Cultured; Animalia",,"Amyloid beta-Protein Precursor; Amyloid beta-Protein; Bacterial Proteins; Cysteine Endopeptidases, EC 3.4.22.-; Laminin; MocA protein, Bacteroides fragilis; Multienzyme Complexes; Proteasome Endopeptidase Complex, EC 3.4.25.1",,,,"Beher, D., Hesse, L., Masters, C.L., Beyreuther, K., Regulation of amyloid precursor protein (APP)-binding to collagen and mapping of the binding sites on APP and collagen type I (1996) J. Biol. Chem., 271, pp. 1613-1620; Berezovska, O., Jack, C., McLean, P., Aster, J.C., Hicks, C., Xia, W., Wolfe, M.S., Kimberly, W.T., Aspartate mutations in presenilin and gamma-secretase inhibitors both impair Notch1 proteolysis and nuclear translocation with relative preservation of Notch1 signaling (2000) J. Neurochem., 75, pp. 583-593; Borchelt, D.R., Lee, M.K., Thinakaran, G., Rarovitsky, T., Prada, C.M., Kim, G., Seeger, M., Copeland, N.G., Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo (1996) Neuron, 17, pp. 1005-1013; Bunnell, W.L., Pham, H.V., Glabe, C.G., Gamma-secretase cleavage is distinct from endoplasmic reticulum degradation of the transmembrane domain of the amyloid precursor protein (1998) J. Biol. Chem., 273, pp. 31947-31955; Capell, A., Steiner, H., Romig, H., Keck, S., Baadeer, M., Grim, M.G., Baumeister, R., Haass, C., Presenilin-1 differentially facilitates endoproteolysis of the beta-amyloid precursor protein and Notch (2000) Nat. Cell Biol., 2, pp. 205-211; Caporaso, G.L., Gandy, S.E., Buxbaum, J.D., Greengard, P., Chloroquine inhibits intracellular degradation but not secretion of Alzheimer β/A4 amyloid precursor protein (1992) Proc. Natl. Acad. Sci. USA, 89, pp. 2252-2256; Checler, F., Da Costa, C.A., Ancolio, K., Chevallier, N., Lopez-Perez, E., Marambaud, P., Role of the proteasome in Alzheimer's disease (2000) Biochem. Biophys. Acta, 1502, pp. 133-138; Chen, M., Yankner, B.A., An antibody to β amyloid and the amyloid precursor protein inhibits cell-substratum adhesion in many mammalian cell types (1991) Neurosci. Lett., 125, pp. 223-226; Chen, Q., Yoshida, H., Schubert, D., Maher, P., Mallory, M., Masliah, E., Presenilin binding protein is associated with neurofibrillary alterations in Alzheimer's disease and stimulates tau phosphorylation (2001) Am. J. Pathol., 159, pp. 1597-1602; Ciallella, J.R., Rangnekar, V.V., McGillis, J.P., Heat shock alters Alzheimer's β-amyloid precursor protein expression in human endothelial cells (1994) J. Neurosci. Res., 37, pp. 769-776; Cook, D.G., Forman, M.S., Sung, J.C., Leight, S., Kolson, D.L., Iwatsubo, T., Lee, V.M., Doms, R.W., Alzheimer's Aβ(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells (1997) Nat. Med., 3, pp. 1021-1023; Coulson, E.J., Barrett, G.L., Storey, E., Bartlett, P.F., Beyreuther, K., Masters, C.L., Down-regulation of the amyloid protein precursor of Alzheimer's disease by antisense oligonucleotides reduces neuronal adhesion to specific substrata (1997) Brain Res., 770, pp. 72-80; Craiu, A., Gaczynska, M., Akopian, T., Gramm, C.F., Fenteany, G., Goldberg, A.L., Rock, K.L., Lacracystin and clasto-lacracystin β-lactone modify multiple proteasome β-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation (1997) J. Biol. Chem., 272, pp. 13437-13445; De Strooper, B., Annaert, W., Proteolytic processing and cell biological functions of the amyloid precursor protein (2000) J. Cell Sci., 113, pp. 1857-1870; De Strooper, B., Annaert, W., Cupers, P., Saftig, P., Craessaerts, K., Mumm, J.S., Schroeter, E.H., Ray, W.J., A presenilin-1-dependent γ-secrerase-like protease mediates release of Notch intracellular domain (1999) Nature, 398, pp. 518-522; Doan, A., Thinakaran, G., Botchelt, D.R., Protein topology of presenilin 1 (1996) Neuron, 17, pp. 1023-1030; Esler, W.P., Kimberly, W.T., Ostaszewski, B.L., Diehl, T.S., Moore, C.L., Tsai, J.-Y., Rahmati, T., Wolfe, M.S., Transition-state analogue inhibitors of gamma-secretase bind directly to presenilin 1 (2000) Nat. Cell Biol., 2, pp. 428-434; Evin, G., Le Brocque, D., Culvenor, J.G., Galatis, D., Weidemann, A., Beyreuther, K., Masters, C.L., Cappai, R., Presenilin I expression in yeast lowers secretion of the amyloid precursor protein (2000) Neuroreport, 11, pp. 405-408; Fenteany, G., Schreiber, S.L., Lactacystin, proteasome function, and cell fate (1998) J. Biol. Chem., 273, pp. 8545-8548; Figueiredo-Pereira, M.E., Efthimiopoulos, S., Tezapsidis, N., Buku, A., Ghiso, J., Mehta, P., Robakis, N.K., Distinct secretases, a cysteine protease and a serine protease, generate the C-terminal of amyloid beta-proteins Aβ1-40 and Aβ1-42, respectively (1999) J. Neurochem., 72, pp. 1417-1422; Galbete, J.L., Martin, T.R., Peressini, E., Modena, P., Bianchi, R., Forloni, G., Cholesterol decreases secretion of the secreted form of amyloid precursor protein by interfering with glycosylation in the protein secretory pathway (2000) Biochem. J., 348, pp. 307-313; Gower, H.J., Barton, C.H., Eelsom, V.L., Thompson, J., Moore, S.E., Dickson, G.G., Walsh, F.S., Alternative splicing generates a secreted form of N-CAM in muscle and brain (1988) Cell, 55, pp. 955-964; Greenwald, I., Lin-12/Notch signaling lessons from worms and flies (1998) Genes Dev., 12, pp. 1751-1762; Haass, C., Schlossmacher, M.G., Hung, A.Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B.L., Lieberburg, I., Selkoe, D.J., Amyloid β-peptide is produced by cultured cells during normal metabolism (1992) Nature, 359, pp. 322-325; Hare, J.F., Protease inhibitors divert amyloid precursor protein to the secretory pathway (2001) Biochem. Biophys. Res. Commun., 281, pp. 1298-1303; Higaki, J., Quon, D., Zhong, Z., Cordell, B., Inhibition of β-amyloid formation identifies proteolytic precursors and subcellular site of catabolism (1995) Neuron, 14, pp. 651-659; Hurtley, S.M., Helenius, A., Protein oligomerization in the endoplasmic reticulum (1989) Annu. Rev. Cell Biol., 5, pp. 277-307; Jin, L.-W., Ninomiya, H., Roch, J.-M., Schubert, D., Masliah, E., Otero, D.A.C., Saitoh, T., Peptides containing RERMS sequence of amyloid β/A4 protein precursor bind cell surface and promote neurite extension (1994) J. Neurosci., 14, pp. 5461-5470; Kashiwa, A., Yoshida, H., Lee, S., Paladino, T., Liu, Y., Chen, Q., Dargusch, R., Kimura, H., Isolation and characterization of a novel presenilin binding protein (2000) J. Neurochem., 75, pp. 109-116; Katayama, T., Imaizumi, K., Sato, N., Miyoshi, K., Kudo, T., Hitomi, J., Morihara, T., Gomi, F., Presenilin-1 mutations down-regulate the signalling pathway of the unfolded protein response (2000) Nat. Cell Biol., 1, pp. 479-485; Kim, K.S., Wen, G.Y., Bancher, C., Chen, C.M.J., Sapienza, V.J., Hong, H., Wisniewski, H.M., Detection and quantitation of amyloid β-peptide with 2 monoclonal antibodies (1990) Neurosci. Res. Comm., 7, pp. 113-122; Klausner, R.D., Sitia, R., Protein degradation in the endoplasmic reticulum (1990) Cell, 62, pp. 611-614; Kouchi, Z., Sorimachi, H., Suzukui, K., Ishiura, S., Proteasome inhibitors induce the association of Alzheimer's amyloid precursor with Hsc73 (1999) Biochem. Biophys. Res. Commun., 254, pp. 804-810; Marambaud, P., Shioi, J., Georgakopoulos, A., Satner, S., Nagy, V., Baki, L., Wen, P., Wishiewski, T., A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions (2002) EMBO J., 21, pp. 1948-1956; Meng, L., Mohan, R., Kwok, B.H.B., Elofsson, M., Sin, N., Crews, C., Expoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity (1999) Proc. Natl. Acad. Sci., 96, pp. 10403-10408; Mills, J., Reiner, P.B., Regulation of amyloid precursor protein cleavage (1999) J. Neurochem., 72, pp. 443-460; Naruse, S., Thinakaran, G., Luo, J.J., Kusiak, J.W., Tomita, T., Iwatsubo, T., Qian, X., Borchelt, D.R., Effects of PS1 deficiency on membrane protein trafficking in neurons (1998) Neuron, 21, pp. 1213-1221; Niwa, M., Sidrauski, C., Kaufman, R.J., Walter, P., A role for presenilin-1 in nuclear accumulation of IRE1 fragments and induction of the mammalian unfolded protein response (1999) Cell, 99, pp. 691-702; Parvathy, S., Hussain, I., Karran, E.H., Turner, A.J., Hooper, N.M., Alzheimer's amyloid precursor protein α-secretase is inhibited by hydroxamic acid-based zinc metalloprotease inhibitors: Similarities to the angiotensin converting enzyme secretase (1998) J. Biochem., 37, pp. 1680-1685; Rogaev, E.I., Sherrington, R., Rogaeva, E.A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Tsuda, T., Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome I related to the Alzheimer's disease type 3 gene (1995) Nature, 376, pp. 775-778; Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T.D., Kukull, W., Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease (1996) Nat. Med., 2, pp. 864-870; Schubert, D., Behl, C., The expression of amyloid beta protein precursor protects nerve cells from β-amyloid and glutamate toxicity and alters their interaction with the extracellular matrix (1993) Brain Res., 629, pp. 275-282; Schubert, D., Heinemann, S., Carlisle, W., Tarikas, H., Kimes, B., Patrick, J., Steinbach, J.H., Brandt, B.L., Clonal cell lines from the rat central nervous system (1974) Nature, 249, pp. 224-227; Schubert, D., Jin, L.-W., Saitoh, T., Cole, G., The regulation of amyloid β protein precursor secretion and its modulatory role in cell adhesion (1989) Neuron, 3, pp. 689-694; Schubert, U., Anton, L.C., Gibbs, J., Norbury, C.C., Yewdell, J.W., Bennink, J.R., Rapid degradation of a large fraction of newly synthesized proteins by proteasomes (2000) Nature, 404, pp. 770-774; Shepherd, C.E., Bowes, S., Parkinson, D., Cambray-Deakin, M., Pearson, R.C., Expression of amyloid precursor protein in human astrocytes in vitro: Isoform-specific increases following heat shock (2000) Neuroscience, 99, pp. 317-325; Sherrington, R., Rogaev, E.I., Liang, Y., Rogaeva, E.A., Levesque, G., Ikeda, M., Chi, H., Holman, K., Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease (1995) Nature, 375, pp. 754-760; Sherwood, S.W., Kung, A.L., Roitelman, J., Simoni, R.D., Schimke, R.T., In vivo inhibition of cyclin B degradation and induction of cell-cycle arrest in mammalian cells by the neutral cysteine protease inhibitor N-acetylleucylleucylnorleucinal (1993) Proc. Natl. Acad. Sci. USA, 90, pp. 3353-3357; Sinha, S., Lieberburg, I., Cellular mechanisms of β-amyloid production and secretion (1999) Proc. Natl. Acad. Sci. USA, 96, pp. 11049-11053; Sisodia, S.S., An accomplice for γ-secretase brought into focus (2000) Science, 289, pp. 2296-2297; Soriano, S., Chyung, A.S.C., Chen, X., Stokin, G.B., Lee, V.M.Y., Koo, E.H., Expression of β-amyloid precursor protein-CD3g chimeras to demonstrate the selective generation of β1-40 and amyloid β1-42 peptides within secretory and endocytic compartments (1999) J. Biol. Chem., 274, pp. 32295-32300; Struhl, G., Greenwald, I., Presenilin is required for activity and nuclear access of Notch in Drosophila (1999) Nature, 398, pp. 522-525; Suzuki, T., Yan, Q., Lennarz, W.J., Complex, two-way traffic of molecules across the membrane of the endoplasmic reticulum (1998) J. Biol. Chem., 273, pp. 10083-10086; Tavella, S., Raffo, P., Tacchetti, C., Cancedda, R., Castagnola, P., N-CAM and N-cadherin expression during in vitro chondrogenesis (1994) Exp. Cell Res., 215, pp. 354-362; Van Gassen, G., Annaert, W., Van Broeckhoven, C., Binding partners of Alzheimer's disease proteins: Are they physiologically relevant? (2000) Neurobiol. Dis., 7, pp. 135-151; Wolfe, M.S., Haass, C., The role of presenilins in γ-secretase activity (2001) J. Biol. Chem., 276, pp. 5413-5416; Wolfe, M.S., Citron, M., Diehl, T.S., Xia, W., Donkor, I.O., Selkoe, D.J., A substrate-based difluoroketone selectively inhibits Alzheimer's γ-secretase activity (1998) J. Med. Chem., 41, pp. 6-9; Wolfe, M.S., Xia, W., Moore, C.L., Leatherwood, D.D., Ostaszewski, B.B., Rahmati, T.T., Donkor, I.O., Selkoe, D.J., Peptidomimetic probes and molecular modeling suggest that Alzheimer's γ-secretase is an intramembrane-cleaving asparty protease (1999) Biochemistry, 38, pp. 4720-4727; Wu, A., Pangalos, M.N., Efthimiopoulos, S., Shioi, J., Robakis, N.K., Appican expression induces morphological changes in C6 glioma cells and promotes adhesion of neural cells to the extracellular matrix (1997) J. Neurosci., 17, pp. 4987-4993; Xia, W., Ray, W.J., Ostaszewski, B.L., Rahmati, T., Kimberly, W.T., Wolfe, M.S., Zhang, J., Selkoe, D.J., Presenilin complexes with the C-terminal fragments of amyloid precursor protein at the sites of amyloid β-protein generation (2000) Proc. Natl. Acad. Sci. USA, 97, pp. 9299-9304; Xu, H., Sweeney, D., Wang, R., Thinakaran, G., Lo, A.C., Sisodia, S.S., Greengard, P., Gandy, S., Generation of Alzheimer beta-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation (1997) Proc. Natl. Acad. Sci. USA, 94, pp. 3748-3752; Xu, X., Yang, D., Wyss-Coray, T., Yan, J., Gan, L., Sun, Y., Mucke, L., Wild-type but not Alzheimer-mutant amyloid precursor protein confers resistance against p53-mediated apoptosis (1999) Proc. Natl. Acad. Sci. USA, 96, pp. 7547-7552; Yang, Y., Turner, R.S., Gaut, J.R., The chaperone BiP/GRP78 binds to amyloid precursor protein and decreases Aβ40-42 secretion (1998) J. Biol. Chem., 273, pp. 25552-25555; Ye, Y., Lukinova, N., Fortini, M.E., Neurogenic phenotypes and altered Notch processing in Drosophila presenilin mutants (1999) Nature, 398, pp. 525-529; Yu, C., Kim, S.H., Ikeuchi, T., Xu, H., Gasparini, L., Wang, R., Sisodia, S.S., Characterization of a presenilin-mediated amyloid precursor protein carboxyl-terminal fragment gamma. Evidence for distinct mechanisms involved in gamma-secretase processing of the APP and Notchl transmembrane domains (2001) J. Biol. Chem., 276, pp. 43756-43760; Zhang, L., Song, L., Parker, E.M., Calpain inhibitor I increases β-amyloid peptide production by inhibiting the degradation of the substrate of gamma-secretase: Evidence that substrate availability limits β-amyloid peptide production (1999) J. Biol. Chem., 274, pp. 8966-8972","Schubert, D.; Salk Institute, 10010 N. Torrey Pines Rd., San Diego, CA 92037, United States; email: schubert@salk.edu",,,,,,,,00219525,,JCLBA,12093789,"English","J. Cell Biol.",Article,Scopus,2-s2.0-0037043330
"Tan, S., Schubert, D., Maher, P.","Oxytosis: A novel form of programmed cell death.",2001,"Current topics in medicinal chemistry","1","6",,"497","506",,152,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0035756761&partnerID=40&md5=40e7bf120a0a75b8c3908305418f5954","The Salk Institute for Biological Studies, Cellular Neurobiology Lab, La Jolla, CA 92037, USA.","Tan, S., The Salk Institute for Biological Studies, Cellular Neurobiology Lab, La Jolla, CA 92037, USA.; Schubert, D., The Salk Institute for Biological Studies, Cellular Neurobiology Lab, La Jolla, CA 92037, USA.; Maher, P., The Salk Institute for Biological Studies, Cellular Neurobiology Lab, La Jolla, CA 92037, USA.","Extensive nerve cell death occurs during the development of the central nervous system as well as in episodes of trauma and in neurodegenerative disease. The mechanistic details of how these cells die are poorly understood. Here we describe a unique oxidative stress-induced programmed cell death pathway called oxytosis, and outline pharmacological approaches which interfere with its execution. Oxidative glutamate toxicity, in which exogenous glutamate inhibits cystine uptake through the cystine/glutamate antiporter leading to a depletion of glutathione, is used as an example of oxytosis. It is shown that there is a sequential requirement for de novo macromolecular synthesis, lipoxygenase activation, reactive oxygen species production, and the opening of cGMP-gated channels which allow the influx of extracellular calcium. The translation initiation factor elF2alpha plays a central role in this pathway by regulating the levels of glutathione. Finally, examples are given in which the reduction in glutathione, the production of reactive oxygen species, and calcium influx can be experimentally manipulated to prevent cell death. Data are reviewed which suggest that oxytosis may be involved in nerve cell death associated with nervous system trauma and disease.",,"calcium; glutamic acid; reactive oxygen metabolite; apoptosis; cell death; drug effect; human; metabolism; nerve cell; oxidative stress; pathology; physiology; review; Apoptosis; Calcium; Cell Death; Glutamic Acid; Humans; Neurons; Oxidative Stress; Reactive Oxygen Species",,"Calcium, 7440-70-2; Glutamic Acid, 56-86-0; Reactive Oxygen Species",,,,,"Tan, S.",,,,,,,,15680266,,,11895126,"English","Curr Top Med Chem",Review,Scopus,2-s2.0-0035756761
"Chen, Q., Yoshida, H., Schubert, D., Maher, P., Mallory, M., Masliah, E.","Presenilin binding protein is associated with neurofibrillary alterations in Alzheimer's disease and stimulates tau phosphorylation",2001,"American Journal of Pathology","159","5",,"1597","1602",,23,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0035155597&partnerID=40&md5=f43d76db36ff44983fe26d5a70962d37","Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; Department of Cell Biology, Scripps Research Institute, San Diego, CA, United States; Department of Neurosciences, University of California, San Diego, CA, United States; Salk Institute, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States","Chen, Q., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; Yoshida, H., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States; Schubert, D., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA, United States, Salk Institute, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States; Maher, P., Department of Cell Biology, Scripps Research Institute, San Diego, CA, United States; Mallory, M., Department of Neurosciences, University of California, San Diego, CA, United States; Masliah, E., Department of Neurosciences, University of California, San Diego, CA, United States","A novel presenilin binding protein, PBP, has recently been identified. PBP is localized to the particulate fraction of extracts of Alzheimer's disease brain but is found in the soluble fractions of brain from age matched normal controls. It is shown here that PBP is associated with neurofibrillary tangles in Alzheimer's disease brain. In addition, the expression of PBP increases the phosphorylation of tau in cultured cells. Therefore PBP may have a regulatory role in tau phosphorylation and in the genesis of neurofibrillary tangles.",,"binding protein; presenilin binding protein; tau protein; unclassified drug; aged; Alzheimer disease; article; cell culture; clinical article; controlled study; human; human tissue; neurofibrillary tangle; pathogenesis; priority journal; protein expression; protein localization; protein phosphorylation; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Ca(2+)-Calmodulin Dependent Protein Kinase; Carrier Proteins; Enzyme Activation; Glycogen Synthase Kinase 3; Guanine Nucleotide Exchange Factors; Humans; Intracellular Membranes; Middle Aged; Nerve Tissue Proteins; Neurofibrillary Tangles; Phosphorylation; Reference Values; tau Proteins",,"Ca(2+)-Calmodulin Dependent Protein Kinase, EC 2.7.1.123; Carrier Proteins; DOCK3 protein, human; Glycogen Synthase Kinase 3, EC 2.7.1.37; Guanine Nucleotide Exchange Factors; Nerve Tissue Proteins; tau Proteins",,,,"Perry, E.K., Perry, R.H., Blessed, G., Tomlinson, B.E., Neurotransmitter enzyme abnormalities in senile dementia: CAT and GAD activities in necropsy tissue (1977) J Neurol Sci, 34, pp. 247-265; Hyman, B.T., VanHoesen, G.W., Damasio, A.R., Barnes, C.L., Alzheimer's disease: Cell-specific pathology isolates the hippocampal formation (1984) Science, 225, pp. 1168-1170; Wilcock, G.K., Esiri, M.M., Bowen, D.M., Hughes, A.O., The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type (1988) J Neurol Neurosurg Psychiatry, 51, pp. 842-849; Hof, P.R., Cox, K., Morrison, J.H., Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex (1990) J Comp Neurol, 301, pp. 44-54; Palmer, A.M., Gershon, S., Is the neuronal basis of Alzheimer's disease cholinergic or glutamatergic? (1990) FASEB J, 4, pp. 2745-2752; Masliah, E., Mallory, M., Hansen, L., DeTeresa, R., Terry, R.D., Quantitative synaptic alterations in the human neocortex during normal aging (1993) Neurology, 43, pp. 192-197; Fraser, P.E., Yang, S.-S., Yu, G., Levesque, L., Nishimura, M., Arawaka, S., Serpell, L.C., St. George-Hyslop, P., Presenilin structure, function, and role in Alzheimer's disease (2000) Biochim Biophys Acta, 1502, pp. 1-15; Van Gassen, G., Annaert, W., Van Broeckhoven, C., Binding partners of Alzheimer's disease proteins: Are they physiologically relevant? (2000) Neurobiol Dis, 7, pp. 135-151; Takashima, A., Murayama, M., Murayama, O., Kohno, T., Honda, T., Yasutake, K., Nihonmatsu, N., Wolozin, B., Presenilin 1 associates with glycogen synthase kinase-3β and its substrate tau (1998) Proc Natl Acad Sci USA, 95, pp. 9637-9641; Kashiwa, A., Yoshida, H., Lee, S., Paladino, T., Liu, Y., Chen, Q., Dargusch, R., Kimura, H., Isolation and characterization of a novel presenilin binding protein (2000) J Neurochem, 75, pp. 109-116; Hanger, D.P., Hughes, K., Woodgett, J.R., Brion, J.-P., Anderton, B.H., Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase (1992) Neurosci Lett, 147, pp. 58-62; Shackelford, D.A., Nelson, K.E., Changes in phosphorylation of tau during ischemia and reperfusion in the rabbit spinal cord (1996) J Neurochem, 66, pp. 286-295; Binder, L.I., Frankfurter, A., Rebhun, L., The distribution of tau in the mammalian central nervous system J Cell Biol (1985), 101, pp. 1371-1378Crowder, R.J., Freeman, R.S., Glycogen synthase kinase-3 beta activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal (2000) J Biol Chem, 275, pp. 34266-34271; Terry, R.D., The fine structure of neurofibrillary tangles in Alzheimer's disease (1963) J Neuropathol Exp Neurol, 22, pp. 629-641; Terry, R.D., Gonatas, N.K., Weiss, M., Ultrastructural studies in Alzheimer's presenile dementia (1964) Am J Pathol, 44, pp. 269-297; Terry, R.D., Wisniewski, H.M., The ultrastructure of the neurofibrillary tangle and the senile plaque (1970) Ciba Foundation Symposium on Alzheimer's Disease and Related Conditions, pp. 145-168. , Edited by G Wolstenholme and M O'Connor. London, J & A Churchill; Masliah, E., Ellisman, M., Carragher, B., Mallory, M., Young, S., Hansen, L., Three-dimensional analysis of the relationship between synaptic pathology and neuropil threads in Alzheimer's disease (1992) J Neuropathol Exp Neurol, 51, pp. 404-414; Braak, H., Braak, E., Grundke-Iqbal, I., Iqbal, K., Occurrence of neuropil threads in the senile brain and in Alzheimer's disease: A third location of paired helical filaments outside the neurofibrillary tangles and neuritic plaques (1986) Neurosci Lett, 65, pp. 351-355; Braak, H., Braak, E., Neuropil threads occur in dendrites of tangle-bearing nerve cells (1988) Neuropathol Appl Neurobiol, 14, pp. 39-44; Masliah, E., Mallory, M., Deerinck, T., DeTeresa, R., Lamont, S., Miller, A., Re-evaluation of the structural organization of neuritic plaques in Alzheimer's disease (1993) J Neuropathol Exp Neurol, 52, pp. 619-632; Trojanowski, J.Q., Schmidt, M.L., Shin, R.-W., Bramblett, G.T., Rao, D., Lee, V.-Y., Altered Tau and neurofilament proteins in neurodegenerative diseases: Diagnostic implications for Alzheimer's disease and Lewy body dementias (1993) Brain Pathol, 3, pp. 45-54; Grundke-Iqbal, I., Iqbal, K., Tung, Y.-C., Quinlan, M., Wisniewski, H.M., Binder, L., Abnormal phosphorylation of the microtubule associated protein tau in Alzheimer cytoskeletal pathology (1986) Proc Natl Acad Sci USA, 83, pp. 4913-4917; Bancher, C., Grundke-Iqbal, I., Iqbal, K., Fried, V.A., Smith, H.T., Wisniewski, H.M., Abnormal phosphorylation of tau precedes ubiquitination in neurofibrillary pathology of Alzheimer disease (1991) Brain Res, 539, pp. 11-18; Brion, J., Passareiro, H., Nunez, J., Flament-Durand, J., Immunological determinants of tau proteins are present in neurofibrillary tangles of Alzheimer's disease (1985) Arch Biol (Liege), 95, pp. 229-235; Goedert, M., Spillantini, M.G., Jakes, R., Rutheford, D., Crowther, R.A., Multiple isoforms of human microtubule-associated protein tau: Sequences and localization in neurofibrillary tangles of Alzheimer's disease (1989) Neuron, 3, pp. 519-526; Mandelkow, E.M., Mandelkow, E., Tau in Alzheimer's disease (1998) Trends Cell Biol, 8, pp. 125-127; Lee, V.-Y., Balin, B.J., Otvos, L.J., Trojanowski, J.Q., A68: A major subunit of paired helical filaments and derivatized forms of normal Tau (1991) Science, 251, pp. 675-678; Van Leeuwen, F.W., De Klein, D.P., Van den Hurk, H.H., Neubauer, A., Sonnemans, M.A., Sluijs, J.A., Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients (1998) Science, 279, pp. 242-247; Hutton, M., Lendon, C.L., Rizzu, P., Baker, M., Forelich, S., Houlden, H., Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 (1998) Nature, 393, pp. 702-705; Clark, L.N., Poorkaj, P., Wszolek, Z., Geschwind, D.H., Nasreddine, Z.S., Miller, B., Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17 (1998) Proc Natl Acad Sci USA, 95, pp. 13103-13107; Spillantini, M.G., Murrell, J.R., Goedert, M., Farlow, M.R., Klug, A., Ghetti, B., Mutation in the tau gene in familiar multiple system tauopathy with presenile dementia (1998) Proc Natl Acad Sci USA, 95, pp. 7737-7741; Hong, M., Zhukareva, V., Vogelsberg-Ragagalia, V., Wszolek, Z., Reed, L., Miller, B., Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17 (1998) Science, 282, pp. 1914-1917; Hasegawa, M., Smith, M.J., Goedert, M., Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly (1998) FEBS Lett, 437, pp. 207-210; Hasegawa, M., Smith, M.J., Iijima, M., Tabira, T., Goedert, M., FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10 (1999) FEBS Lett, 443, pp. 93-96; Ferreira, A., Lu, Q., Orecchio, L., Kosik, K.S., Selective phosphorylation of adult tau isoforms in mature hippocampal neurons exposed to fibrillar A beta (1997) Mol Cell Neurosci, 9, pp. 220-234; Busciglio, J., Lorenzo, A., Yeh, J., Yankner, B.A., Beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding (1995) Neuron, 14, pp. 879-888; Smith, D.H., Chen, X.H., Nonaka, M., Trojanowski, J.Q., Lee, V.M., Saatman, K.E., Accumulation of amyloid beta and tau and the formation of neurofilament inclusions following diffuse brain injury in the pig (1999) J Neuropathol Exp Neurol, 58, pp. 982-992; Chambers, C.B., Sigurdsson, E.M., Hejna, M.J., Lorens, S.A., Lee, J.M., Muma, N.A., Amyloid-beta injection in rat amygdala alters tau protein but not mRNA expression (2000) Exp Neurol, 162, pp. 158-170; Geula, C., Wu, C.-K., Saroff, D., Lorenzo, A., Yuan, M., Yankner, B., Aging renders the brain vulnerable to amyloid C-protein neurotoxicity (1998) Nat Med, 4, pp. 827-831; Kiyokawa, E., Mochizuki, N., Kurata, T., Matsuda, M., Role of Crk oncogene product in physiologic signaling (1997) Crit Rev Oncog, 8, pp. 329-342; Buee, L., Bussiere, T., Buee-Scherrer, V., Delacourte, A., Hof, P.R., Tau protein isoforms, phosphorylation, and role in neurodegenerative disorders (2000) Brain Res Rev, 33, pp. 95-130","Schubert, D.; Salk Institute, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States; email: schubert@salk.edu",,,,,,,,00029440,,AJPAA,11696419,"English","Am. J. Pathol.",Article,Scopus,2-s2.0-0035155597
"Schubert, D., Piasecki, D.","Oxidative glutamate toxicity can be a component of the excitotoxicity cascade",2001,"Journal of Neuroscience","21","19",,"7455","7462",,136,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0035478598&partnerID=40&md5=876b3eda8c66afdd455ff1778265c4d5","Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037, United States; Salk Institute for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States","Schubert, D., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037, United States, Salk Institute for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; Piasecki, D., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037, United States","Along with ionotropic and metabotropic glutamate receptors, the cystine/glutamate antiporter xc- may play a critical role in CNS pathology. High levels of extracellular glutamate inhibit the import of cystine, resulting in the depletion of glutathione and a form of cell injury called oxidative glutamate toxicity. Here we show that a portion of the cell death associated with NMDA receptor-initiated excitotoxicity can be caused by oxidative glutamate toxicity. In primary mouse cortical neurons the cell death resulting from the short-term application of 10 μM glutamate can be divided into NMDA and NMDA receptor-independent phases. The NMDA receptor-independent component is associated with high extracellular glutamate and is inhibited by a variety of reagents that block oxidative glutamate toxicity. These results suggest that oxidative glutamate toxicity toward neurons lacking functional NMDA receptors can be a component of the excitotoxicity-initiated cell death pathway.","Brain; Death; Excitotoxicity; Nerve; Non-NMDA; Oxidative stress","1 (4 aminophenyl) 4 methyl 7,8 methylenedioxy 5h 2,3 benzodiazepine; 2 amino 5 phosphonovaleric acid; 6 cyano 7 nitro 2,3 quinoxalinedione; alpha amino 3 hydroxy 5 methyl 4 isoxazolepropionic acid; AMPA receptor antagonist; dizocilpine; glutamic acid; kainic acid; kainic acid receptor antagonist; n methyl dextro aspartic acid; n methyl dextro aspartic acid receptor; n methyl dextro aspartic acid receptor blocking agent; animal cell; article; brain cortex; embryo; mouse; nerve cell culture; nerve cell necrosis; neurotoxicity; neurotransmission; nonhuman; oxidative stress; priority journal; 2-Amino-5-phosphonovalerate; Amino Acid Transport System y+; Animals; Carrier Proteins; Cell Count; Cell Death; Cell Survival; Cells, Cultured; Cerebral Cortex; Culture Media, Conditioned; Cystine; Excitatory Amino Acid Antagonists; Glutamic Acid; Glutathione; Mice; Mice, Inbred BALB C; Neurons; Oxidative Stress; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Time Factors",,"2-Amino-5-phosphonovalerate, 76726-92-6; Amino Acid Transport System y+; Carrier Proteins; Culture Media, Conditioned; Cystine, 56-89-3; Excitatory Amino Acid Antagonists; Glutamic Acid, 56-86-0; Glutathione, 70-18-8; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Slc7a11 protein, mouse",,,,"Akazawa, C., Shigemoto, R., Bessho, Y., Nakanishi, S., Mizuno, N., Differential expression of five N-methyl-D-aspartate receptor subunit mRNAs in the cerebellum of developing and adult rats (1994) J Comp Neurol, 347, pp. 150-160; Ankacrona, M., Dypbukt, J.M., Bonfoco, E., Zhivotovsky, B., Orrenius, S., Lipton, S.A., Nicotera, P., Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function (1995) Neuron, 15, pp. 961-973; Brewer, G.J., Torricelli, J.R., Evege, E.K., Price, P.J., Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination (1993) J Neurosci Res, 35, pp. 567-576; Carriedo, S.G., Yin, H.Z., Sensi, S.L., Weiss, J.H., Rapid Ca2+ entry through Ca2+-permeable AMPA/kainate channels triggers marked intracellular Ca2+ rises and consequent oxygen radical production (1998) J Neurosci, 18, pp. 7727-7738; Choi, D.W., Ionic dependence of glutamate neurotoxicity in cortical cell culture (1987) J Neurosci, 7, pp. 369-379; Choi, D.W., Excitotoxic cell death (1992) J Neurobiol, 23, pp. 1261-1275; Choi, D.W., Rothman, S.M., The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death (1990) Annu Rev Neurosci, 13, pp. 171-182; Choi, D.W., Viseskul, V., Amirthanayagam, M., Monyer, H., Aspartate neurotoxicity on cultured cortical neurons (1989) J Neurosci Res, 23, pp. 116-121; Coyle, J.T., Bird, S.J., Evans, R.H., Gulley, R.L., Nadler, J.V., Nicklas, W.J., Olney, J.W., Excitatory amino acid neurotoxins: Selectivity, specificity, and mechanisms of action (1981) Neurosci Res Program Bull, 19, pp. 331-427; Davis, J.B., Maher, P., Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line (1994) Brain Res, 652, pp. 169-173; Dugan, L.L., Bruno, V.M.G., Amagasu, S.M., Giffard, R.G., Glia modulate the response of murine cortical neurons to excitotoxicity: Glia exacerbate AMPA neurotoxicity (1995) J Neurosci, 15, pp. 4545-4555; Frandsen, A., Drejer, J., Schousboe, A., Direct evidence that excitotoxicity in cultured neurons is mediated via N-methyl-D-aspartate (NMDA) as well as non-NMDA receptors (1989) J Neurochem, 53, pp. 297-299; Gwag, B.J., Lobner, D., Koh, J.Y., Wie, M.B., Choi, D.W., Blockade of glutamate receptors unmasks neuronal apoptosis after oxygen-glucose deprivation in vitro (1995) Neuroscience, 68, pp. 615-619; Hartley, D.M., Choi, D.W., Delayed rescue of N-methyl-D-aspartate receptor-mediated neuronal injury in cortical culture (1989) J Pharmacol Exp Ther, 250, pp. 752-758; Iwabuchi, Y., Kitazawa, E., Kobayashi, N., Watanabe, H., Kanai, M., Nakamura, K., Studies of drug metabolism using liquid chromatography/mass spectrometry: Comparison of three liquid chromatographic/mass spectrometric interfaces (1994) Biol Mass Spectrom, 23, pp. 540-546; Kanai, Y., Segawa, H., Miyamoto, K., Uchino, H., Takeda, E., Endou, H., Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (1998) J Biol Chem, 273, pp. 23629-23632; Koh, J.-Y., Palmer, E., Cotman, C.W., Activation of the metabotropic glutamate receptor attenuates N-methyl-D-aspartate neurotoxicity in cortical cultures (1991) Proc Natl Acad Sci USA, 88, pp. 9431-9435; Kure, S., Tominaga, T., Yoshimoto, T., Tada, K., Narisawa, K., Glutamate triggers internucleosomal DNA cleavage in neuronal cells (1991) Biochem Biophys Res Commun, 179, pp. 39-45; Laemmli, U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4 (1970) Nature, 227, pp. 680-685; Li, Y., Maher, P., Schubert, D., A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion (1997) Neuron, 19, pp. 453-463; Li, Y., Maher, P., Schubert, D., Requirement for cGMP in nerve cell death caused by glutathione depletion (1997) J Cell Biol, 139, pp. 1317-1324; Linnik, M.D., Zobrist, R.H., Hatfield, M.D., Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats (1993) Stroke, 24, pp. 2002-2009; Liu, Y., Peterson, D.A., Kimura, H., Schubert, D., Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction (1997) J Neurochem, 69, pp. 581-593; MacManus, J.P., Buchan, A.M., Hill, I.E., Rasquinha, I., Preston, E., Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain (1993) Neurosci Lett, 164, pp. 89-92; Maher, P., Davis, J., The role of monoamine metabolism in oxidative glutamate toxicity (1996) J Neurosci, 16, pp. 6394-6401; Manev, H., Favaron, M., Guidotti, A., Costa, E., Delayed increase of Ca2+ influx elicited by glutamate: Role in neuronal death (1989) Mol Pharmacol, 36, pp. 106-112; Matsumoto, K., Lo, E., Pierce, A.R., Halpern, E.F., Newcomb, R., Secondary elevation of extracellular neurotransmitter amino acids in the reperfusion phase following focal cerebral ischemia (1996) J Cereb Blood Flow Metab, 16, pp. 114-124; Matthews, C.C., Zielke, H.R., Wollack, J.B., Fishman, P.S., Enzymatic degradation protects neurons from glutamate excitotoxicity (2000) J Neurochem, 75, pp. 1045-1052; McAdoo, D.J., Xu, G.-Y., Robak, G., Hughes, M.G., Changes in amino acid concentrations over time and space around an impact injury and their diffusion through the rat spinal cord (1999) Exp Neurol, 159, pp. 538-544; Meldrum, B., Garthwaite, J., Excitatory amino acid neurotoxicity and neurodegenerative disease (1990) Trends Pharmacol Sci, 11, pp. 379-387; Murphy, T.H., Miyamoto, M., Sastre, A., Schnaar, R.L., Coyle, J.T., Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress (1989) Neuron, 2, pp. 1547-1558; Nakanishi, S., Metabotropic glutamate receptors: Synaptic transmission, modulation, and plasticity (1994) Neuron, 13, pp. 1031-1037; Newcomb, R., Sun, X., Taylor, L., Curthoys, N., Giffard, R.G., Increased production of extracellular glutamate by the mitochondrial glutaminase following neuronal death (1997) J Biol Chem, 272, pp. 11276-11282; Newell, D., Barth, A., Papermaster, V., Malouf, A.T., Glutamate and nonglutamate receptor-mediated toxicity caused by oxygen and glucose deprivation in organotypic hippocampal cultures (1995) J Neurosci, 15, pp. 7702-7711; Okamoto, M., Matsumoto, M., Ohtsuki, T., Taguchi, A., Mikoshica, K., Yanagihara, T., Kamada, T., Internucleosomal DNA cleavage involved in ischemia-induced neuronal death (1993) Biochem Biophys Res Commun, 196, pp. 1356-1362; Olney, J.W., Inciting excitotoxic cytocide among central neurons (1986), pp. 632-645. , Advances in experimental medicine and biology (Schwarcz R, Ben-Ari Y, eds), New York: PlenumOppenheim, R.W., Flavell, R.A., Vinsant, S., Prevette, D., Kuan, C.-Y., Rakic, P., Programmed cell death of developing mammalian neurons after genetic deletion of caspases (2001) J Neurosci, 21, pp. 4752-4760; Rose, K., Goldberg, M.P., Choi, D.W., Cytotoxicity in murine neocortical cell culture (1993) Methods Toxicol, 1 (A), pp. 46-60; Rothman, S.M., The neurotoxicity of excitatory amino acids is produced by passive chloride influx (1985) J Neurosci, 5, pp. 1483-1489; Rothman, S.M., Olney, J.W., Glutamate and the pathophysiology of hypoxic-ischemic brain damage (1986) Ann Neurol, 19, pp. 105-111; Rothman, S.M., Thurston, J.H., Hauhart, R.E., Delayed neurotoxicity of excitatory amino acids in vitro (1987) Neuroscience, 22, pp. 471-480; Sagara, Y., Schubert, D., The activation of metabotropic glutamate receptors protects nerve cells from oxidative stress (1998) J Neurosci, 18, pp. 6662-6671; Sato, H., Tamba, M., Ishii, T., Bannai, S., Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins (1999) J Biol Chem, 274, pp. 11455-11458; Schubert, D., Kimura, H., Maher, P., Growth factors and vitamin E modify neuronal glutamate toxicity (1992) Proc Natl Acad Sci USA, 89, pp. 8264-8267; Shigeno, T., Yamasaki, Y., Kato, G., Kusaka, K., Mama, T., Takakura, K., Graham, D.I., Furukawa, S., Reduction of delayed neuronal death by inhibition of protein synthesis (1990) Neurosci Lett, 120, pp. 117-119; Siesjo, B.K., Pathophysiology and treatment of focal cerebral ischemia. I. Pathophysiology (1992) J Neurosurg, 77, pp. 169-184; Strijbos, P.J., Leach, M.J., Garthwaite, J., Vicious cycle involving Na+ channels, glutamate release, and NMDA receptors mediates delayed neurodegeneration through nitric oxide formation (1996) J Neurosci, 16, pp. 5004-5013; Tan, S., Sagara, Y., Liu, Y., Maher, P., Schubert, D., The regulation of peroxide production during programmed cell death (1998) J Cell Biol, 141, pp. 1423-1432; Tan, S., Wood, M., Maher, P., Oxidative stress in nerve cells induces a form of cell death with characteristics of both apoptosis and necrosis (1998) J Neurochem, 71, pp. 95-105; Trotti, D., Danbolt, N.C., Volterra, A., Glutamate transporters are oxidant-vulnerable: A molecular link between oxidative and excitotoxic neurodegeneration? (1998) Trends Pharmacol Sci, 19, pp. 328-334","Schubert, D.; Salk Inst. for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; email: schubert@salk.edu",,,,,,,,02706474,,JNRSD,11567035,"English","J. Neurosci.",Article,Scopus,2-s2.0-0035478598
"Ishige, K., Chen, Q., Sagara, Y., Schubert, D.","The activation of dopamine D4 receptors inhibits oxidative stress-induced nerve cell death",2001,"Journal of Neuroscience","21","16",,"6069","6076",,51,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0035882457&partnerID=40&md5=8176cba7bc6060160b66cfa4c1184b6e","Cellular Neurobiobgy Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037, United States; Salk Institute for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States","Ishige, K., Cellular Neurobiobgy Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037, United States; Chen, Q., Cellular Neurobiobgy Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037, United States; Sagara, Y., Cellular Neurobiobgy Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037, United States; Schubert, D., Cellular Neurobiobgy Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037, United States, Salk Institute for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States","Oxidative stress is thought to be the cause of nerve cell death in many CNS pathologies, including ischemia, trauma, and neurodegenerative disease. Glutamate kills nerve cells that lack ionotropic glutamate receptors via the inhibition of the cystine-glutamate antiporter xc -, resulting in the inhibition of cystine uptake, the loss of glutathione, and the initiation of an oxidative stress cell death pathway. A number of catecholamines were found to block this pathway. Specifically, dopamine and related ligands inhibit glutamate-induced cell death in both clonal nerve cell lines and rat cortical neurons. The protective effects of dopamine, apomorphine, and apocodeine, but not epinephrine and norepinephrine, are antagonized by dopamine D4 antagonists. A dopamine D4 agonist also protects, and this protective effect is inhibited by U101958, a dopamine D4 antagonist. Although the protective effects of some of the catecholamines are correlated with their antioxidant activities, there is no correlation between the protective and antioxidant activities of several other ligands. Normally, glutamate causes an increase in reactive oxygen species (ROS) and intracellular Ca2+. Apomorphine partially inhibits glutamate-induced ROS production and blocks the opening of cGMP-operated Ca2+ channels that lead to Ca2+ elevation in the late part of the cell death pathway. These data suggest that the protective effects of apomorphine on oxidative stress-induced cell death are, at least in part, mediated by dopamine D4 receptors via the regulation of cGMP-operated Ca2+ channels.","Apocodeine; Apomorphine; Cell death; CGMP; Dopamine D4 receptors; Glutamate; HT22 cells","2 dipropylamino 7 hydroxytetralin; 2,3,4,5 tetrahydro 7,8 dihydroxy 1 phenyl 1h 3 benzazepine; adrenalin; antiporter; apocodeine; apomorphine; calcium; calcium channel; cyclic GMP; dopamine; dopamine 4 receptor; glutamic acid; glutathione; n (1 benzyl 4 piperidinyl) n (3 isopropoxy 2 pyridinyl) n methylamine; noradrenalin; reactive oxygen metabolite; serotonin; animal cell; antioxidant activity; article; brain injury; brain ischemia; calcium cell level; controlled study; degenerative disease; human; human cell; nerve cell necrosis; neuroprotection; nonhuman; oxidative stress; priority journal; rat; receptor upregulation; Animals; Antioxidants; Apomorphine; Binding, Competitive; Calcium; Cell Death; Cell Line; Cyclic GMP; Dopamine; Dopamine Agonists; Dopamine Antagonists; Epinephrine; Glutamic Acid; Hippocampus; Mice; Neurons; Neuroprotective Agents; Norepinephrine; Oxidative Stress; Rats; Reactive Oxygen Species; Receptors, Dopamine D2; Receptors, Dopamine D4",,"Antioxidants; apocodeine, 641-36-1; Apomorphine, 58-00-4; Calcium, 7440-70-2; Cyclic GMP, 7665-99-8; Dopamine Agonists; Dopamine Antagonists; Dopamine, 51-61-6; Drd4 protein, mouse; Drd4 protein, rat; Epinephrine, 51-43-4; Glutamic Acid, 56-86-0; Neuroprotective Agents; Norepinephrine, 51-41-2; Reactive Oxygen Species; Receptors, Dopamine D2; Receptors, Dopamine D4, 137750-34-6",,,,"Ferger, B., Eberhardt, O., Teismann, P., De Groote, C., Schulz, J.B., Malonate-induced generation of reactive oxygen species in rat striatum depends on dopamine release but not on NMDA receptor activation (1999) J Neurochem, 73, pp. 1329-1332; Fishburn, C.S., Carmon, S., Fuchs, S., Molecular cloning and characterization of the gene encoding the murine D4 dopamine receptor (1995) FEBS Lett, 361, pp. 215-219; Grünblatt, E., Mandel, S., Gassen, M., Youdim, M.B.H., Potent neuroprotective and antioxidant activity of apomorphine in MPTP and 6-hydroxydopamine induced neurotoxicity (1999) J Neural Transm [Suppl], 55, pp. 57-70; Lanau, F., Brockhans, M., Pink, J.R.L., Franchet, C., Wildet-Perinie, D., Goepfert, C., Probst, A., Hartman, D.S., Development and characterization of antibodies against the N terminus of the human dopamine D4 receptor (1997) J Neurochem, 69, pp. 2169-2178; Li, Y., Maher, P., Schubert, D., A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion (1997) Neuron, 19, pp. 453-463; Li, Y., Maher, P., Schubert, D., Requirement for cGMP in nerve cell death caused by glutathione depletion (1997) J Cell Biol, 139, pp. 1317-1324; Liu, Y., Peterson, D.A., Kimura, H., Schubert, D., Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction (1997) J Neurochem, 69, pp. 581-593; Maher, P., Davis, J., The role of monoamine metabolism in oxidative glutamate toxicity (1996) J Neurosci, 16, pp. 6394-6401; Maher, P., Schubert, D., Signaling by reactive oxygen species in the nervous system (2000) Cell Mol Life Sci, 57, pp. 1287-1305; Maroto, R., Lopez, M.G., Del Valle, M., Naranjo, J.R., Mellstrom, B., Garcia, A.G., Expression of the bovine striatal D2 receptor, but not the D1 receptor, in bovine adrenal medulla (1995) Mol Pharmacol, 47, pp. 40-50; Miller, N.J., Rice-Evans, C.A., Davies, M.J., Gopinathan, V., Miller, A., A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates (1993) Clin Sci, 84, pp. 407-4122; Murphy, T.H., Miyamoto, M., Sastre, A., Schnaar, R.L., Coyle, J.T., Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress (1989) Neuron, 2, pp. 1547-1558; Noh, J.S., Kim, E.Y., Kang, J.S., Kim, H.R., Oh, Y.J., Gwag, B.J., Neurotoxic and neuroprotective actions of catecholamines in cortical neurons (1999) Exp Neurol, 159, pp. 217-224; Reynolds, D.S., Carter, R.J., Morton, A.J., Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease (1998) J Neurosci, 18, pp. 10116-10127; Sagara, Y., Induction of reactive oxygen species in neurons by haloperidol (1998) J Neurochem, 71, pp. 1002-1012; Sagara, Y., Schubert, D., The activation of metabotropic glutamate receptors protects nerve cells from oxidative stress (1998) J Neurosci, 18, pp. 6662-6671; Sam, E.E., Verbeke, N., Free radical scavenging properties of apomorphine enantiomers and dopamine: Possible implication in their mechanism of action in Parkinsonism (1995) J Neural Transm, 10, pp. 115-127; Seeman, P., Van Tol, H.H.M., Dopamine receptor pharmacology (1994) Trends Pharmacol Sci, 15, pp. 264-270; Sethy, V.H., Wu, H., Oosveen, J.A., Hall, E.D., Neuroprotective effects of the dopamine agonists pramipexole and bromocriptine in 3-acetylpyridine-treated rats (1997) Brain Res, 754, pp. 181-186; Sokoloff, P., Schwartz, J.C., Novel dopamine receptors half a decade later (1995) Trends Pharmacol Sci, 16, pp. 270-275; Suzuki, T., Kobayashi, K., Nagatsu, T., Genomic structure and tissue distribution of the mouse dopamine D4 receptor (1995) Neurosci Lett, 199, pp. 69-72; Takashima, H., Tsujihara, M., Kishikawa, M., Freed, W.J., Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D2 receptors (1999) Exp Neurol, 159, pp. 98-104; Tan, S., Sagara, Y., Liu, Y., Maher, P., Schubert, D., The regulation of reactive oxygen species production during programmed cell death (1998) J Cell Biol, 141, pp. 1423-1432; Tan, S., Wood, M., Maher, P., Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells (1998) J Neurochem, 71, pp. 95-105; Van Tol, H.H.M., Bunzow, J.R., Guan, H.-C., Sunahara, R.K., Seeman, P., Niznik, H.B., Civelli, O., Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine (1991) Nature, 350, pp. 610-614; Vaughan, P.J., Pike, C.J., Cotman, C.W., Cunningham, D.D., Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults (1995) J Neurosci, 15, pp. 5389-5401; Yoshikawa, T., Minamiyama, Y., Naito, Y., Kondo, M., Antioxidant properties of bromocriptine, a dopamine agonist (1994) J Neurochem, 62, pp. 1034-1038","Schubert, D.; Salk Institute for Biological Studs., 10010 North Torrey Pines Road, La Jolla, CA 92037, United States; email: schubert@salk.edu",,,,,,,,02706474,,JNRSD,11487630,"English","J. Neurosci.",Article,Scopus,2-s2.0-0035882457
"Tan, S., Somia, N., Maher, P., Schubert, D.","Regulation of antioxidant metabolism by translation initiation factor 2α",2001,"Journal of Cell Biology","152","5",,"997","1006",,54,10.1083/jcb.152.5.997,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0035809930&partnerID=40&md5=301c40b3e937b6fa1e7ff6d831905191","Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037, United States; Department of Cell Biology, Scripps Research Institute, San Diego, CA 92037, United States; Salk Institute for Biological Studies, 10010 N. Torrey Pines Rd., San Diego, CA 92037, United States","Tan, S., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037, United States; Somia, N., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037, United States; Maher, P., Department of Cell Biology, Scripps Research Institute, San Diego, CA 92037, United States; Schubert, D., Cellular Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92037, United States, Salk Institute for Biological Studies, 10010 N. Torrey Pines Rd., San Diego, CA 92037, United States","Oxidative stress and highly specific decreases in glutathione (GSH) are associated with nerve cell death in Parkinson's disease. Using an experimental nerve cell model for oxidative stress and an expression cloning strategy, a gene involved in oxidative stress-induced programmed cell death was identified which both mediates the cell death program and regulates GSH levels. Two stress-resistant clones were isolated which contain antisense gene fragments of the translation initiation factor (eIF)2α and express a low amount of eIF2α. Sensitivity is restored when the clones are transfected with full-length eIF2α transcription of wild-type cells with the truncated eIF2α gene confers resistance. The phosphorylation of eIF2α also results in resistance to oxidative stress. In wild-type cells, oxidative stress results in rapid GSH depletion, a large increase in peroxide levels, and an influx of Ca2+. In contrast, the resistant clones maintain high GSH levels and show no elevation in peroxides or Ca2+ when stressed, and the GSH synthetic enzyme γ-glutamyl cysteine synthetase (γGCS) is elevated. The change in γGCS is regulated by a translational mechanism. Therefore, eIF2α is a critical regulatory factor in the response of nerve cells to oxidative stress and in the control of the major intracellular antioxidant, GSH, and may play a central role in the many neurodegenerative diseases associated with oxidative stress.","eIF2α; Glutamate; Glutathione; Oxidative stress; Resistance","antioxidant; glutamate cysteine ligase; glutamic acid; initiation factor; initiation factor 2; initiation factor 2alpha; unclassified drug; animal cell; animal experiment; animal model; antioxidant activity; article; calcium transport; cell specificity; controlled study; degenerative disease; disease association; enzyme synthesis; experimental model; gene expression regulation; gene insertion; genetic resistance; genetic transfection; glutathione metabolism; metabolic regulation; molecular cloning; mouse; nerve cell; nerve cell necrosis; nonhuman; oxidative stress; Parkinson disease; peroxidation; priority journal; protein phosphorylation; regulatory mechanism; stress; translation initiation; wild type; Antioxidants; Apoptosis; Calcium; Cell Division; Cell Line; Cytotoxins; DNA, Antisense; Down-Regulation; Enzyme Induction; Eukaryotic Initiation Factor-2; Glutamate-Cysteine Ligase; Glutamic Acid; Glutathione; Humans; Kinetics; Mutation; Neurons; Oxidative Stress; Peroxides; Phosphorylation; Protein Biosynthesis; Reactive Oxygen Species; Transfection; Animalia; insertion sequences",,"Antioxidants; Calcium, 7440-70-2; Cytotoxins; DNA, Antisense; Eukaryotic Initiation Factor-2; Glutamate-Cysteine Ligase, EC 6.3.2.2; Glutamic Acid, 56-86-0; Glutathione, 70-18-8; Peroxides; Reactive Oxygen Species",,,,"Bannai, S., Kitamura, E., Transport interaction of L-cysteine and L-glutamate in human diploid fibrolasts in culture (1980) J. Biol. Chem., 255, pp. 2372-2376; Burda, J., Martin, M., Gottlieb, M., Chavko, M., Marsala, J., Alcázar, A., Pavón, M., Salinas, M., The intraischemic and early reperfusion changes of protein synthesis in the rat brain. eIF-2α kinase activity and role of initiation factors eIF-2α and eIF-4E (1998) J. Cereb. Blood Flow Metab., 18, pp. 59-66; DeGracia, D., Sullivan, J., Neumar, R., Alousi, S., Hikade, K., Pittman, J., White, B., Krause, G., Effect of brain ischemia and reperfusion on the localization of phosphorylated eukaryotic initiation factor 2 α (1997) J. Cereb. Blood Flow Metab., 17, pp. 1291-1302; Dexter, D.T., Sian, J., Rose, S., Hindmarsh, J.G., Mann, V.M., Copper, J.M., Wells, F.R., Schapira, A.H., Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease (1994) Ann. Neurol., 35, pp. 38-44; Ernst, H., Duncan, R., Hershey, J., Cloning and sequencing of complementary DNAs encoding the α-sub-unit of translation factor eIF-2 (1987) J. Biol. Chem., 262, pp. 1206-1212; Gipp, J.J., Chang, C., Mulcahy, R.T., Cloning and nucleotide sequence of a full-length cDNA for human liver γ-glutamylcysteine synthetase (1992) Biochem. Biophys. Res. Commun., 185, pp. 29-35; Gudkov, A.V., Roninson, I.B., Isolation of genetic suppressor elements (GSEs) from fragment cDNA libraries in retroviral vectors (1997) Methods Mol. Biol., 69, pp. 221-240; Harding, H.P., Novoa, I., Zhang, Y., Zeng, H., Wek, R., Schapira, M., Ron, D., Regulated translation initiation controls stress-induced gene expression in mammalian cells (2000) Mol. Cell., 6, pp. 1099-1108; Hershey, J., Translational control in mammalian cells (1991) Annu. Rev. Biochem., 60, pp. 717-755; Jenner, P., Olanow, C.W., Oxidative stress and the pathogenesis of Parkinson's disease (1996) Neurology, 47, pp. s161-s170; Kaufman, R.J., Davies, M.V., Pathak, V.K., Hershey, J.W., The phosphorylation state of eucaryotic initiation factor 2 alters translational efficiency of specific mRNAs (1989) Mol. Cell. Biol., 9, pp. 946-958; Li, Y., Maher, P., Schubert, D., Requirement for cGMP in nerve cell death caused by glutathione depletion (1997) J. Cell Biol., 139, pp. 1317-1324; Li, Y., Maher, P., Schubert, D., A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion (1997) Neuron, 19, pp. 453-463; Maher, P., Schubert, D., Signaling by reactive oxygen species in the nervous system (2000) Cell. Mol. Life Sci., 57, pp. 1287-1305; Miller, A., Miller, D., Garcia, J., Lynch, C., Use of retroviral vectors for gene transfer and expression (1993) Methods Enzymol., 217, pp. 581-599; Miyamoto, M., Murphy, T.H., Schnaar, R.L., Coyle, J.T., Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line (1989) J. Pharmacol. Exp. Ther., 250, pp. 1132-1140; Mochizuki, H., Goto, K., Mori, H., Mizuno, Y., Histochemical detection of apoptosis in Parkinson's disease (1996) J. Neurol. Sci., 137, pp. 120-123; Morgenstern, J.P., Land, H., Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line (1990) Nucleic Acids Res., 18, pp. 3587-3596; Murphy, T.H., Baraban, J.M., Glutamate toxicity in immature cortical neurons precedes development of glutamate receptor currents (1990) Brain Res., 57, pp. 146-150; Murphy, T.H., Miyamoto, M., Sastre, A., Schnaar, R.L., Coyle, J.T., Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress (1989) Neuron, 2, pp. 1547-1558; Oka, A., Belliveau, M.J., Rosenberg, P.A., Volpe, J.J., Vulnerability of oligodendroglia to glutamate: Pharmacology, mechanisms, and prevention (1993) J. Neurosci., 13, pp. 1441-1453; Pain, V., Initiation of protein synthesis in eukaryotic cells (1996) Eur. J. Biochem., 236, pp. 747-771; Pathak, V.K., Nielsen, P.J., Trachsel, H., Hershey, J.W., Structure of the beta subunit of translational initiation factor eIF-2 (1988) Cell, 54, pp. 633-639; Perry, T.L., Godin, D.V., Hansen, S., Parkinson's disease: A disorder due to nigral glutathione deficiency? (1982) Neurosci. Lett., 33, pp. 305-310; Prostko, C., Dholakia, J., Brostrom, M., Brostrom, C., Activation of the double-stranded RNA-regulated protein kinase by depletion of endoplasmic reticular calcium stores (1995) J. Biol. Chem., 270, pp. 6211-6215; Reilly, B., Brostrom, M., Brostrom, C., Regulation of protein synthesis in ventricular myocytes by vasopressin. The role of sarcoplasmic/endoplasmic reticulum (1998) J. Biol. Chem., 273, pp. 3747-3755; Sagara, Y., Schubert, D., The activation of metabotropic glutamate receptors protects nerve cells from oxidative stress (1998) J. Neurosci., 18, pp. 6662-6671; Samuel, C., The eIF-2α protein kinases, regulators of translation in eukaryotes from yeasts to humans (1993) J. Biol. Chem., 269, pp. 7603-7606; Sato, H., Tamba, M., Ishii, T., Bannai, S., Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins (1999) J. Biol. Chem., 274, pp. 11455-11458; Satoh, S., Hijikata, M., Handa, H., Shimotohno, K., Caspase-mediated cleavage of eukaryotic translation initiation factor subunit 2α (1999) Biochem. J., 342, pp. 65-70; Sian, J., Dexter, D.T., Lees, A.J., Daniel, S., Agid, Y., Javoy-Agid, F., Jenner, P., Marsden, C.D., Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia (1994) Ann. Neurol., 36, pp. 348-355; Simonian, N.A., Coyle, J.T., Oxidative stress in neurodegenerative diseases (1996) Annu. Rev. Pharmacol. Toxicol., 36, pp. 83-106; Sofic, E., Lange, K.W., Riederer, P., Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease (1992) Neurosci. Lett., 142, pp. 128-130; Somia, N., Schmitt, M., Vetter, D., Van Antwerp, D., Heinemann, S., Verma, I., LFG: An anti-apoptotic gene that provides protection from Fas-mediated cell death (1999) Proc. Natl Acad. Sci. USA, 96, pp. 12667-12672; Soucek, T., Yeung, R.S., Hengstschlager, M., Inactivation of the cyclin-dependent kinase inhibitor p27 upon loss of the tuberous sclerosis complex gene-2 (1998) Proc. Natl. Acad. Sci. USA, 95, pp. 15653-15658; Srivastava, S., Davies, M., Kaufman, R., Calcium depletion from the endoplasmic reticulum activates the double-stranded RNA-dependent protein kinase (PKR) to inhibit protein synthesis (1995) J. Biol. Chem., 270, pp. 16619-16624; Srivastava, S., Kumar, K., Kaufman, R., Phosphorylation of eukaryotic translation initiation factor 2 mediates apoptosis in response to activation of the double-stranded RNA-dependent protein kinase (1998) J. Biol. Chem., 273, pp. 2416-2423; Tan, S., Wood, M., Maher, P., Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells (1998) J. Neurochem., 71, pp. 95-105; Tan, S., Sagara, Y., Liu, Y., Maher, P., Schubert, D., The regulation of reactive oxygen species production during programmed cell death (1998) J. Cell Biol., 141, pp. 1423-1432; Vornov, J.J., Coyle, J.T., Glutamate neurotoxicity and the inhibition of protein synthesis in the hippocampal slice (1991) J. Neurochem., 56, pp. 996-1006; Wek, R.C., eIF-2 kinases: Regulators of general and gene-specific translation initiation (1994) Trends Biochem. Sci., 19, pp. 491-496; Yankner, B.A., Mechanisms of neuronal degeneration in Alzheimer's disease (1996) Neuron, 16, pp. 921-932","Schubert, D.; Salk Inst. for Biological Studies, 10010 N. Torrey Pines Rd., San Diego, CA 92037, United States; email: schubert@salk.edu",,,,,,,,00219525,,JCLBA,11238455,"English","J. Cell Biol.",Article,Scopus,2-s2.0-0035809930
"Ishige, K., Schubert, D., Sagara, Y.","Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms",2001,"Free Radical Biology and Medicine","30","4",,"433","446",,477,10.1016/S0891-5849(00)00498-6,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0035865819&partnerID=40&md5=2cf98b7ea2ec821977a876a65c7cf9cb","The Salk Institute for Biological Studies, La Jolla, CA, United States; Department of Neurosciences, University of California, San Diego La Jolla, CA, United States; The Salk Institute, 10010 N. Torrey Pines Road, La Jolla, CA 92037, United States","Ishige, K., The Salk Institute for Biological Studies, La Jolla, CA, United States; Schubert, D., The Salk Institute for Biological Studies, La Jolla, CA, United States, The Salk Institute, 10010 N. Torrey Pines Road, La Jolla, CA 92037, United States; Sagara, Y., Department of Neurosciences, University of California, San Diego La Jolla, CA, United States","Flavonoids are a family of antioxidants found in fruits and vegetables as well as in popular beverages such as red wine and tea. Although the physiological benefits of flavonoids have been largely attributed to their antioxidant properties in plasma, flavonoids may also protect cells from various insults. Nerve cell death from oxidative stress has been implicated in a variety of pathologies, including stroke, trauma, and diseases such as Alzheimer's and Parkinson's. To determine the potential protective mechanisms of flavonoids in cell death, the mouse hippocampal cell line HT-22, a model system for oxidative stress, was used. In this system, exogenous glutamate inhibits cystine uptake and depletes intracellular glutathione (GSH), leading to the accumulation of reactive oxygen species (ROS) and an increase in Ca2+ influx, which ultimately causes neuronal death. Many, but not all, flavonoids protect HT-22 cells and rat primary neurons from glutamate toxicity as well as from five other oxidative injuries. Three structural requirements of flavonoids for protection from glutamate are the hydroxylated C3, an unsaturated C ring, and hydrophobicity. We also found three distinct mechanisms of protection. These include increasing intracellular GSH, directly lowering levels of ROS, and preventing the influx of Ca2+ despite high levels of ROS. These data show that the mechanism of protection from oxidative insults by flavonoids is highly specific for each compound. © 2001 Elsevier Science Inc.","Apoptosis; Buthionine sulfoximine; Flavonoids; Free radicals; Glutamate toxicity; Glutathione; Mitochondria; Neuronal cells; Oxidative stress; Quercetin; Reactive oxygen species; Vitamin E","alpha tocopherol; antioxidant; caffeic acid; cyanidin; cystine; flavanoid; flavanol; flavanone; flavone; gallic acid; glutamic acid; glutathione; reactive oxygen metabolite; trolox C; unclassified drug; Alzheimer disease; animal cell; article; calcium transport; cell line; cell protection; cell viability; chemical structure; controlled study; cytotoxicity; drug effect; drug efficacy; hydrophobicity; mouse; nerve cell necrosis; neuroprotection; nonhuman; oxidative stress; Parkinson disease; perikaryon; priority journal; stroke; structure analysis; Animals; Antioxidants; Calcium; Cell Death; Cell Line; Flavonoids; Free Radicals; Glutamic Acid; Glutathione; Hippocampus; Mice; Neurons; Oxidative Stress; Reactive Oxygen Species; Vitamin E",,"Antioxidants; Calcium, 7440-70-2; Flavonoids; Free Radicals; Glutamic Acid, 56-86-0; Glutathione, 70-18-8; Reactive Oxygen Species; Vitamin E, 1406-18-4",,"Aldrich, United States; Alexis, United States; Calbiochem, United States",,"Herrmann, K., Flavonoids and flavones in food plants: A review (1976) J. Food Technol., 11, pp. 433-448; Hertog, M.G.L., Hollman, P.C.H., Katan, M.B., Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands (1992) J. Agric. Food Chem., 40, pp. 2379-2383; Hertog, M.G.L., Hollman, P.C.H., Van der Putte, B., Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruits juices (1993) J. Agric. Food Chem., 41, pp. 1242-1246; Hertog, M.G.L., Katan, M.B., Quercetin in foods, cardiovascular disease, and cancer (1998), pp. 447-467. , Rice-Evans, C. A.; Packer, L., eds. Flavonoids in health and disease. New York: Marcel Dekker, IncWollenweber, E., Occurrence of flavonoid aglycones in medicinal plants (1988) Prog. Clin. Biol. Res., 280, pp. 45-55; Pietta, P., Flavonoids in medicinal plants (1998), pp. 61-110. , Rice-Evans, C. A.; Packer, L., eds. Flavonoids in health and disease. New York: Marcel Dekker, IncManach, C., Régérat, F., Texier, O., Agullo, G., Demigne, C., Rémésy, C., Bioavailability, metabolism and physiological impact of 4-oxo-flavonoids (1996) Nutr. Res., 16, pp. 517-544; Manach, C., Morand, C., Crespy, V., Demigne, C., Texier, O., Régérat, F., Rémésy, C., Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties (1998) FEBS Lett., 426, pp. 331-336; Paganga, G., Rice-Evans, C.A., The identification of flavonoids as glycosides in human plasma (1997) FEBS Lett., 401, pp. 78-82; Shimoi, K., Okada, H., Furugori, M., Goda, T., Takase, S., Suzuki, M., Hara, Y., Kinae, N., Intestinal absorption of luteolin and luteolin 7-O-beta-glucoside in rats and humans (1998) FEBS Lett., 438, pp. 220-224; Maxwell, S., Cruickshank, A., Thorpe, G., Red wine and antioxidant activity in serum (1994) Lancet, 344, pp. 193-194; Morand, C., Crespy, V., Manach, C., Besson, C., Demigne, C., Remesy, C., Plasma metabolites of quercetin and their antioxidant properties (1998) Am. J. Physiol., 275, pp. R212-R219; Block, G., A role for antioxidants in reducing cancer risk (1992) Nutr. Rev., 50, pp. 207-213; Hertog, M.G.L., Feskens, E.J.M., Hollman, P.C.H., Katan, M.B., Kromhout, D., Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study (1993) Lancet, 342, pp. 1007-1011; Renaud, S., De Lorgeril, M., Wine, alcohol, platelets and the French paradox for coronary heart disease (1992) Lancet, 339, pp. 1523-1526; Rusznyak, S., Szent-György, A., Vitamin nature of flavones (1936) Nature, 138, p. 798; Richardson, G.A., El-Rafey, M.S., Long, M.L., Flavones and flavone derivatives as antioxidants (1947) J. Dairy Sci., 30, pp. 397-411; Cody, V., Middleton, E., Harborne, J.B., Beretz, A., (1988) Plant flavonoids in biology and medicine II - Biochemical, cellular and medicinal properties, , New York: Alan R. Liss; Wayner, D.D., Burton, G.W., Ingold, K.U., Barclay, L.R., Locke, S.J., The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma (1987) Biochim. Biophys. Acta, 924, pp. 408-419; Miller, N.J., Rice-Evans, C., Davies, M.J., Gopinathan, V., Milner, A., A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates (1993) Clin. Sci. (Colch.), 84, pp. 407-412; Bors, W., Heller, W., Michel, C., Saran, M., Flavonoids as antioxidants: Determination of radical-scavenging efficiencies (1990) Methods Enzymol., 186, pp. 343-355; Afanas'ev, I.B., Dorozhko, A.I., Brodskii, A.V., Kostyuk, V.A., Potapovitch, A.I., Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation (1989) Biochem. Pharmacol., 38, pp. 1763-1769; Jan, C.-Y., Takahama, U., Kimura, M., Inhibition of photooxidation of α-tocopherol by quercetin in human blood cell membranes in the presence of hematoporphyrin as a photosensitizer (1989) Biochim. Biophys. Acta, 1086, pp. 7-14; Terao, J., Piskula, M.K., Flavonoids as inhibitors of lipid peroxidation in membranes (1998), pp. 277-293. , Rice-Evans, C. A.; Packer, L., eds. Flavonoids in health and disease. New York: Marcel Dekker, IncLeake, D.S., Effects of flavonoids on the oxidation of low-density lipoproteins (1998), pp. 253-276. , Rice-Evans, C. A.; Packer, L., eds. Flavonoids in health and disease. New York: Marcel Dekker, IncRice-Evans, C.A., Miller, N.J., Paganga, G., Structure-antioxidant activity relationships of flavonoids and phenolic acids (1996) Free Radic. Biol. Med., 20, pp. 933-956. , published erratum appears in Free Radic. Biol. Med. 1996; 21:417; Ames, B.N., Shigenaga, M.K., Hagen, T.M., Oxidants, antioxidants, and the degenerative diseases of aging (1993) Proc. Natl. Acad. Sci. USA, 90, pp. 7915-7922; Dugan, L.L., Sensi, S.L., Canzoniero, L.M., Handran, S.D., Rothman, S.M., Lin, T.S., Goldberg, M.P., Choi, D.W., Mitochondrial production of reactive oxygen species in cortical neurons following exposure to NMDA (1995) J. Neurosci., 15, pp. 6377-6388; Reynolds, I.J., Hastings, T.G., Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation (1995) J. Neurosci., 15, pp. 3318-3327; Tan, S., Sagara, Y., Liu, Y., Maher, P., Schubert, D., Peroxide production in oxidative glutamate toxicity (1998) J. Cell Biol., 141, pp. 1423-1432; Esposti, M.D., Hatzinisiriou, I., McLennan, H., Ralph, S., Bcl-2 and mitochondrial oxygen radicals. New approaches with reactive oxygen species-sensitive probes (1999) J. Biol. Chem., 274, pp. 29831-29837; May, P.C., Gray, P.N., The mechanism of glutamate-induced degeneration of cultured Huntington's disease and control fibroblasts (1985) J. Neurol. Sci., 70, pp. 101-112; Murphy, T.H., Miyamoto, M., Sastre, A., Schnaar, R.L., Coyle, J.T., Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress (1989) Neuron, 2, pp. 1547-1558; Kato, S., Negishi, K., Mawatari, K., Kuo, C.-H., A mechanism for glutamate toxicity in the C6 glioma cells involving inhibition of cystine uptake leading to glutathione depletion (1992) Neuroscience, 48, pp. 903-914; Schubert, D., Kimura, H., Maher, P., Growth factors and vitamin E modify neuronal glutamate toxicity (1992) Proc. Natl. Acad. Sci. USA, 89, pp. 8264-8267; Oka, A., Belliveau, M.J., Rosenberg, P.A., Volpe, J.J., Vulnerability of oligodendroglia to glutamate: Pharmacology, mechanism, and prevention (1993) J. Neurosci., 13, pp. 1441-1453; Froissard, P., Monrocq, H., Duval, D., Role of glutathione metabolism in the glutamate-induced programmed cell death of neuronal-like PC12 cells (1997) Eur. J. Pharmacol., 326, pp. 93-99; Davis, J.B., Maher, P., Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line (1994) Brain Res., 652, pp. 169-173; Maher, P., Davis, J.B., The role of monoamine metabolism in oxidative glutamate toxicity (1996) J. Neurosci., 16, pp. 6394-6401; Li, Y., Maher, P., Schubert, D., Requirement for cGMP in nerve cell death caused by glutathione depletion (1997) J. Cell Biol., 139, pp. 1317-1324; Li, Y., Maher, P., Schubert, D.A., Role for 12-lipoxygenase in nerve cell death caused by glutathione depletion (1997) Neuron, 19, pp. 453-463; Sagara, Y., Dargusch, R., Chambers, D., Davis, J., Schubert, D., Maher, P., Cellular mechanisms of resistance to chronic oxidative stress (1998) Free Radic. Biol. Med., 24, pp. 1375-1389; Tan, S., Wood, M., Maher, P., Oxidative stress in nerve cells induces a form of cell death with characteristics of both apoptosis and necrosis (1998) J. Neurochem., 71, pp. 95-105; Vogt, M., Dulbecco, R., Steps in the neoplastic transformation of hamster embryo cells by polyoma virus (1963) Proc. Natl. Acad. Sci. USA, 49, pp. 171-179; Morimoto, B.H., Koshland D.E., Jr., Induction and expression of long- and short-term neurosecretory potentiation in a neural cell line (1990) Neuron, 5, pp. 875-880; Abe, K., Kimura, H., Amyloid beta toxicity consists of a Ca(2+)-independent early phase and a Ca(2+)-dependent late phase (1996) J. Neurochem., 67, pp. 2074-2078; Hansen, M.B., Nielsen, S.E., Berg, K., Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill (1989) J. Immunol. Methods, 119, pp. 203-210; Liu, Y., Peterson, D.A., Kimura, H., Schubert, D., Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction (1997) J. Neurochem., 69, pp. 581-593; Sagara, Y., Schubert, D., The activation of metabotropic glutamate receptors protects nerve cells from oxidative stress (1998) J. Neurosci., 18, pp. 6662-6671; Tietze, F., Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues (1969) Anal. Biochem., 27, pp. 502-522; Griffith, O.W., Determination of glutathione and glutathione disulfide using glucose reductase and 2-vinyl pyridine (1980) Anal. Biochem., 106, pp. 207-212; Sagara, Y., Induction of reactive oxygen species in neurons by haloperidol (1998) J. Neurochem., 71, pp. 1002-1012; Bass, D.A., Parce, J.W., Dechatelet, L.R., Szejda, P., Seeds, M.C., Thomas, M., Flow cytometric studies of oxidative product formation by neutrophils: A graded response to membrane stimulation (1983) J. Immunol., 130, pp. 1910-1917; Novak, E.J., Rabinovitch, P.S., Improved sensitivity in flow cytometric intracellular ionized calcium measurement using fluo-3/Fura Red fluorescence ratios (1994) Cytometry, 17, pp. 135-141; Rice-Evans, C., Miller, N.J., Total antioxidant status in plasma and body fluids (1994) Methods Enzymol., 234, pp. 279-293; Griffith, O.W., Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis (1982) J. Biol. Chem., 257, pp. 13704-13712; Ikeda, J., Ma, L., Morita, L., Murota, S., Involvement of nitric oxide and free radical (O2-) in neuronal injury induced by deprivation of oxygen and glucose in vivo (1994) Acta Neurochir. Suppl. (Wien), 60, pp. 94-97; Papadopoulos, M.C., Koumenis, I.L., Dugan, L.L., Giffard, R.G., Vulnerability to glucose deprivation injury correlates with glutathione levels in astrocytes (1997) Brain Res., 748, pp. 151-156; Sagara, Y., Hendler, S., Khoh-Reiter, S., Gillenwater, G., Carlo, D., Schubert, D., Chang, J., Propofol hemisuccinate protects neuronal cells from oxidative injury (1999) J. Neurochem., 73, pp. 2524-2530; Wolfbeis, O.S., Knierzinger, A., Schipfer, R., pH-Dependent fluorescence spectroscopy XVII: First excited singlet state dissociation constants, phototautomersim and dual fluorescence of flavonol (1983) J. Photochem., 21, pp. 67-79; Hodnick, W.F., Pardini, R.S., Inhibition of mitochondrial function by flavonoids (1998), pp. 179-197. , Rice-Evans, C. A.; Packer, L., eds. Flavonoids in health and disease. New York: Marcel Dekker, IncSogawa, S., Nihro, Y., Ueda, H., Izumi, A., Miki, T., Matsumoto, H., Satoh, T., 3,4-Dihydroxychalcones as potent 5-lipoxygenase and cyclooxygenase inhibitors (1993) J. Med. Chem., 36, pp. 3904-3909; Agrawal, P.K., Schneider, H.-J., Deprotonation induced 13C NMR shifts in phenols and flavonoids (1983) Tetrahedron Lett., 24, pp. 177-180; Behl, C., Skutella, T., Lezoualc'h, F., Post, A., Widmann, M., Newton, C.J., Holsboer, F., Neuroprotection against oxidative stress by estrogens: Structure-activity relationship (1997) Mol. Pharmacol., 51, pp. 535-541; Van Acker, S.A.B.E., Bast, A., Van der Vijgh, W.J.F., Structural aspects of antioxidant activity of flavonoids (1998), pp. 221-251. , Rice-Evans, C. A.; Packer, L., eds. Flavonoids in health and disease. New York: Marcel Dekker, IncMorel, I., Cillard, P., Cillard, J., Flavonoid-metal interactions in biological systems (1998), pp. 163-177. , Rice-Evans, C. A.; Packer, L., eds. Flavonoids in health and disease. New York: Marcel Dekker, IncLu, S.C., Regulation of hepatic glutathione synthesis: Current concepts and controversies (1999) FASEB J., 13, pp. 1169-1183; Mulcahy, R.T., Wartman, M.A., Bailey, H.H., Gipp, J.J., Constitutive and beta-naphthoflavone-induced expression of the human gamma-glutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence (1997) J. Biol. Chem., 272, pp. 7445-7454; Moinova, H.R., Mulcahy, R.T., An electrophile responsive element (EpRE) regulates beta-naphthoflavone induction of the human gamma-glutamylcysteine synthetase regulatory subunit gene. Constitutive expression is mediated by an adjacent AP-1 site (1998) J. Biol. Chem., 273, pp. 14683-14689; Hayek, T., Fuhrman, B., Vaya, J., Rosenblat, M., Belinky, P., Coleman, R., Elis, A., Aviram, M., Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation (1997) Arterioscler. Thromb. Vasc. Biol., 17, pp. 2744-2752; Halliwell, B., Oxidants and human disease: Some new concepts (1987) FASEB J., 1, pp. 358-364","Schubert, D.; Salk Institute, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States; email: schubert@salk.edu",,,,,,,,08915849,,FRBME,11182299,"English","Free Radic. Biol. Med.",Article,Scopus,2-s2.0-0035865819
"Dargusch, R., Piasecki, D., Tan, S., Liu, Y., Schubert, D.","The role of Bax in glutamate-induced nerve cell death",2001,"Journal of Neurochemistry","76","1",,"295","301",,36,10.1046/j.1471-4159.2001.00035.x,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0035167270&partnerID=40&md5=db7ece319ac20864e4d3054f604900ab","Laboratory of Cellular Neurobiology, Salk Institute for Biological Studies, San Diego, CA, United States; Salk Institute, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States","Dargusch, R., Laboratory of Cellular Neurobiology, Salk Institute for Biological Studies, San Diego, CA, United States; Piasecki, D., Laboratory of Cellular Neurobiology, Salk Institute for Biological Studies, San Diego, CA, United States; Tan, S., Laboratory of Cellular Neurobiology, Salk Institute for Biological Studies, San Diego, CA, United States; Liu, Y., Laboratory of Cellular Neurobiology, Salk Institute for Biological Studies, San Diego, CA, United States; Schubert, D., Laboratory of Cellular Neurobiology, Salk Institute for Biological Studies, San Diego, CA, United States, Salk Institute, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States","The role of the Bax gene product was examined in three forms of cortical nerve cell death in primary cultures. These include spontaneous cell death, oxidative glutamate toxicity, in which exogenous glutamate inhibits cystine uptake resulting in toxic oxidative stress, and ionotropic glutamate receptor-mediated excitotoxicity following a brief exposure to 10 μM glutamate. Primary cortical and hippocampal neuron cultures were established from embryos of Bax-/+ x Bax-/+ matings and the embryos genotyped and assayed for cell death in the three experimental paradigms. Cell death induced by oxidative glutamate toxicity and glutamate-mediated excitotoxicity was not altered in the Bax-/- homozygous knockout animals. In contrast, there was an approximately 50% inhibition of spontaneous cell death. These results suggest that a classical Bax-dependent apoptotic pathway contributes to the spontaneous cell death that takes place when nerve cells are initially exposed to cell culture conditions. A Bax-dependent programed cell death pathway is not, however, utilized in oxidative glutamate toxicity and NMDA receptor-mediated excitotoxicity following a brief exposure to low concentrations of glutamate.","Bax; Knockout; Oxidative glutamate toxicity","gene product; glutamic acid; ionotropic receptor; protein Bax; staurosporine; animal cell; animal experiment; animal tissue; article; brain cell; cell death; controlled study; cytotoxicity; embryo; gene deletion; gene expression; hippocampus; knockout mouse; mouse; nerve cell; nerve cell necrosis; nonhuman; oxidative stress; priority journal; protein analysis; protein expression; protein transport; Animals; Apoptosis; bcl-2-Associated X Protein; Cell Death; Cell Survival; Cells, Cultured; Enzyme Inhibitors; Glutamic Acid; Heterozygote; Homozygote; Mice; Mice, Inbred BALB C; Mice, Knockout; Neurons; Oxidative Stress; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Staurosporine; Animalia",,"Bax protein, mouse; bcl-2-Associated X Protein; Enzyme Inhibitors; Glutamic Acid, 56-86-0; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Staurosporine, 62996-74-1",,,,"Ackermann, E.J., Taylor, J.K., Narayana, R., Bennett, C.F., The role of antiapoptotic Bcl-2 family members in endothelial apoptosis elucidated with antisense oligonucleotides (1999) J. Biol. Chem., 274, pp. 11245-11252; Ankacrona, M., Dypbukt, J.M., Bonfoco, E., Zhivotovsky, B., Orrenius, S., Lipton, S.A., Nicotera, P., Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function (1995) Neuron, 15, pp. 961-973; Behl, C., Hovey, L., Krajewski, S., Schubert, D., Reed, J.C., BCL-2 prevents killing of neuronal cells by glutamate but not by amyloid beta protein (1993) Biochem. Biophys. Res. Comm., 197, pp. 949-956; Bernard, R., Dieni, S., Rees, S., Bernard, O., Physiological and induced neuronal death are not affected in NSE-bax transgenic mice (1998) J. Neurosci. Res., 52, pp. 247-259; Brewer, G.J., Torricelli, J.R., Evege, E.K., Price, P.J., Optimized survival of hippocampal neurons in B27-supplemented neurobasal, a new serum-free medium combination (1993) J. Neurosci. Res., 35, pp. 567-576; Chao, D.T., Korsmeyer, S.J., BCL-2 family: Regulators of cell death (1998) Annu. Rev. Immunol., 16, pp. 395-419; Choi, D.W., Ionic dependence of glutamate neurotoxicity in cortical cell culture (1987) J. Neurosci., 7, pp. 369-379; Choi, D.W., Excitotoxic cell death (1992) J. Neurobiol., 23, pp. 1261-1275; Chong, M.J., Murray, M.R., Gosink, E.C., Russell, H.R., Srinivasan, A., Kapsetaki, M., Korsmeyer, S.J., McKinnon, P.J., Atm and Bax cooperate in ionizing radiation-induced apoptosis in the central nervous system (2000) Proc. Natl Acad. Sci. USA, 97, pp. 889-894; Connor, J.A., Tseng, H.Y., Hockberger, P.E., Depolartizationand transmitter-induced changes in intracellular Ca2+ of rat cerebellar granule cells in explant cultures (1987) J. Neurosci., 7, pp. 1384-1400; Coyle, J.T., Puttfarcken, P., Oxidative stress, glutamate, and neurodegenerative disorders (1993) Science, 262, pp. 689-695; Cregan, S.P., MacLaurin, J.G., Craig, C.G., Robertson, G.S., Nicholson, D.W., Park, D.S., Slack, R.S., Bax-dependent caspase-3 activation is a key determinant in p53-induced apoptosis in neurons (1999) J. Neurosci., 19, pp. 7860-7869; Davis, J.B., Maher, P., Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line (1994) Brain Res., 652, pp. 169-173; Deckwerth, T.L., Elliott, J.L., Knudson, C.M., Johnson E.M., Jr., Snider, W.D., Korsmeyer, S.J., BAX is required for neuronal death after trophic factor deprivation and during development (1996) Neuron, 17, pp. 401-411; Deckwerth, T.L., Easton, R.M., Knudson, C.M., Korsmeyer, S.J., Johnson E.M., Jr., Placement of the BCL2 family member BAX in the death pathway of sympathetic neurons activated by trophic factor deprivation (1998) Exp. Neurol., 152, pp. 150-162; Dugan, L.L., Bruno, V.M.G., Amagasu, S.M., Giffard, R.G., Glia modulate the response of murine cortical neurons to excitotoxicity: Glia exacerbate AMPA neurotoxicity (1995) J. Neurosci., 15, pp. 4545-4555; Dugan, L.L., Sensi, S.L., Canzoniero, L.M.T., Handran, S.D., Rothman, S.M., Lin, T.-S., Goldberg, M.P., Choi, D.W., Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate (1995) J. Neurosci., 15, pp. 6377-6388; Farlie, P.G., Dringen, R., Rees, S.M., Kannourakis, G., Bernard, O., Bcl-2 transgene expression can protect neurons against developmental and induced cell death (1995) Proc. Natl Acad. Sci. USA, 92, pp. 4397-4401; Garthwaite, G., Garthwaite, J., Neurotoxicity of excitatory amino acid receptor agonists in rat cerebellar slices: Dependence on calcium concentration (1986) Neurosci. Lett., 66, pp. 193-198; Gasic, G.P., Hollmann, M., Molecular neurobiology of glutamate receptors (1992) Annu. Rev. Physiol., 54, pp. 507-536; Hyrc, K., Handran, S.D., Rothman, S.M., Goldberg, M.P., Ionized intracellular calcium concentration predicts excitotoxic neuronal death: Observations with low-affinity fluorescent calcium indicators (1997) J. Neurosci., 17, pp. 6669-6677; Knudson, C.M., Korsmeyer, S.J., Bcl-2 and Bax function independently to regulate cell death (1997) Nat. Genet., 16, pp. 358-363; Korsmeyer, S.J., BCL-2 gene family and the regulation of programmed cell death (1999) Cancer Res., 59 (SUPPL.), pp. 1693-1700; Laemmli, U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4 (1970) Nature, 227, pp. 680-685; Liu, Y., Peterson, D.A., Kimura, H., Schubert, D., Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction (1997) J. Neurochem., 69, pp. 581-593; Maher, P., Schubert, D., Signaling by reactive oxygen species in the nervous system (2000) Cell. Mol. Biol., 57, pp. 1287-1305; Miller, T.M., Moulder, K.L., Knudson, C.M., Creedon, D.J., Desmukh, M., Korsmeyer, S.J., Johnson E.M., Jr., Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway to cell death (1997) J. Cell Biol., 139, pp. 205-217; Murphy, T.H., Miyamoto, M., Sastre, A., Schnaar, R.L., Coyle, J.T., Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress (1989) Neuron, 2, pp. 1547-1558; Olney, J.W., Inciting excitotoxic cytocide among central neurons (1986), pp. 632-645. , Advances in Experimental Medicine and Biology (Schwarcz R. and Ben-Ari Y., eds). Plenum Press, New YorkPatel, M., Day, B.J., Crapo, J.D., Fridovich, I., McNamara, J.O., Requirement for superoxide in excitotoxic cell death (1996) Neuron, 16, pp. 345-355; Rodriguez, I., Matsuura, K., Khatib, K., Reed, J.C., Nagata, S., Vassalli, P., A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection (1996) J. Exp. Med., 183, pp. 1031-1036; Rose, K., Goldberg, M.P., Choi, D.W., Cytotoxicity in murine neocortical cell culture (1993) Meth. Toxicol., 1 A, pp. 46-60; Rothman, S.M., The neurotoxicity of excitatory amino acids is produced by passive chloride influx (1985) J. Neurosci., 5, pp. 1483-1489; Rothman, S.M., Olney, J.W., Glutamate and the pathophysiology of hypoxic-ischemic brain damage (1986) Ann. Neurol., 19, pp. 105-111; Sato, H., Tamba, M., Ishii, T., Bannai, S., Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins (1999) J. Biol. Chem., 274, pp. 11455-11458; Schinder, A.F., Olson, E.C., Spitzer, N.C., Montal, M., Mitochondrial dysfunction is a primary event in glutamate neurotoxicity (1996) J. Neurosci., 16, pp. 6125-6133; Steinman, H.M., The Bcl-2 oncoprotein functions as a prooxidant (1995) J. Biol. Chem., 270, pp. 3487-3490; Tan, S., Sagara, Y., Liu, Y., Maher, P., Schubert, D., The regulation of reactive oxygen species production during programmed cell death (1998) J. Cell Biol., 141, pp. 1423-1432; Tan, S., Wood, M., Maher, P., Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells (1998) J. Neurochem., 71, pp. 95-105; Xiang, H., Kinoshita, Y., Knudson, C.M., Korsmeyer, S.J., Schwartzkroin, P.A., Morrison, R.S., Bax involvement in p53-mediated neuronal cell death (1998) J. Neurosci., 18, pp. 1363-1373; Yankner, B.A., Duffy, L.K., Kirschner, D.A., Neurotrophic and neurotoxic effects of amyloid beta protein: Reversal by tachykinin neuropeptides (1990) Science, 250, pp. 279-282","Schubert, D.; Salk Institute, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States; email: schubert@salk.edu",,,,,,,,00223042,,JONRA,11146002,"English","J. Neurochem.",Article,Scopus,2-s2.0-0035167270
"Maher, P., Schubert, D.","Signaling by reactive oxygen species in the nervous system",2000,"Cellular and Molecular Life Sciences","57","8-9",,"1287","1305",,120,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0033836908&partnerID=40&md5=19f8fb92a0a5acb92e90f7af0d750ace","Scripps Research Institute, Department of Cell Biology, 10550 N. Torrey Pines Rd., San Diego, CA 92037, United States; Salk Inst. for Biological Studies, Cellular Neurobiology Lab., 10010 N. Torrey Pines Rd., San Diego, CA 92037, United States","Maher, P., Scripps Research Institute, Department of Cell Biology, 10550 N. Torrey Pines Rd., San Diego, CA 92037, United States; Schubert, D., Salk Inst. for Biological Studies, Cellular Neurobiology Lab., 10010 N. Torrey Pines Rd., San Diego, CA 92037, United States","Free radicals and reactive oxygen species (ROS) are involved in a variety of different cellular processes ranging from apoptosis and necrosis to cell proliferation and carcinogenesis. Cells contain multiple sites for ROS production and a few mechanisms for their degradation. Which of these sites is activated by a given stimulus may play a role in dictating the subsequent downstream effects of the ROS generated on cellular function. Even when the ultimate outcome is similar, such as when ROS production leads to cell death, the specific cellular changes can be quite different depending on the initial stimulus and the type of cell involved. These data, along with the evidence that ROS can modify a number of intracellular signaling pathways including protein phosphatases, protein kinases and transcription factors, suggest that the majority of the effects of ROS on cells are through their actions on signaling pathways rather than via nonspecific damage of intracellular macromolecules.","Apoptosis; Glutathione; H2O2; Necrosis; Protein kinases; ROS; Transcription factors; Tyrosine phosphatases","reactive oxygen metabolite; apoptosis; cell death; cell proliferation; chemical reaction; human; nervous system; nonhuman; review; signal transduction; Animals; Apoptosis; Free Radicals; Humans; Necrosis; Nervous System Physiology; Oxidative Stress; Reactive Oxygen Species; Signal Transduction",,"Free Radicals; Reactive Oxygen Species",,,,"Gerschman, R., Gilbert, D.L., Nye, S.W., Dwyer, P., Fenn, W.O., Oxygen poisoning and X-irradiation: A mechanism in common (1954) Science, 119, pp. 623-626; Babior, B.M., Kipnes, R.S., Curnutte, J.T., Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent (1973) J. Clin. Invest., 52, pp. 741-744; Mercurio, F., Manning, A.M., NF-κB as a primary regulator of the stress response (1999) Oncogene, 18, pp. 6163-6171; Sionov, R.V., Haupt, Y., The cellular response to p53: The decision between life and death (1999) Oncogene, 18, pp. 6145-6157; Gilbert, D.L., Colton, C.A., (1999) Reactive Oxygen Species in Biological Systems, , Kluwer Academic, New York; Halliwell, B., Gutteridge, J.M.C., (1993) Free Radicals in Biology and Medicine, , Oxford, New York; Brand, M.D., Murphy, M.P., Control of electron flux through the respiratory chain in mitochondria and cells (1987) Biol. Rev., 62, pp. 141-193; Boveris, A., Chance, B., The mitochondrial generation of hydrogen peroxide (1973) Biochem. J., 134, pp. 707-716; Boveris, A., Cadenas, E., Stoppani, A.O.M., Role of ubiquinone in the mitochondrial generation of hydrogen peroxide (1976) Biochem. J., 156, pp. 435-444; Nohl, H., Generation of superoxide radicals as byproduct of cellular respiration (1994) Ann. Biol. Clin., 52, pp. 199-204; Turrens, J.F., Boveris, A., Generation of superoxide anion by NADH dehydrogenase of bovine heart mitochondria (1980) Biochem. J., 191, pp. 421-427; Babior, B.M., The production and use of reactive oxidants in phagocytes (1999) Reactive Oxygen Species in Biological Systems, pp. 503-526. , Gilbert D. L. and Colton C. A. (eds), Kluwer Academic, New York; Krieger-Brauer, H.I., Kather, H., Human fat cells possess a plasma membrane-bound H2O2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase (1992) J. Clin. Invest., 89, pp. 1006-1013; Krieger-Brauer, H.I., Kather, H., Antagonistic-effects of different members of the fibroblast and platelet-derived growth factor families on adipose conversion and NADPH-dependent H2O2 generation in 3T3 Ll-cells (1995) Biochem. J., 307, pp. 549-556; Thannickal, V.J., Hassoun, P.M., White, A.C., Fanburg, B.L., Enhanced rate of H2O2 release from bovine pulmonary artery endothelial cells induced by TGF-β1 (1993) Am. J. Physiol., 265, pp. L622-L626; Tammariello, S.T., Quinn, M.T., Estus, S., NADPH oxidase contributes directly to oxidative stress and apoptosis in nerve growth factor-deprived sympathetic neurons (2000) J. Neurosci., 20, pp. 1-5; De Rey-Pailhade, J., Nouvelle recherche physiologique sur la substance organique hydrogenant le soufre à froid (1888) C. R. Acad. Sci. Paris, 107, pp. 43-44; Sies, H., (1991) Oxidative Stress, Oxidants and Antioxidants, , Academic Press, San Diego; Hidalgo, E., Demple, B., Adaptive responses to oxidative stress: The soxRS and oxyR regulons (1996) Regulation of Gene Expression in E. Coli., pp. 435-452. , Lin E. C. C. and Lynch A. G. (eds), R. Landis, Austin, TX; Esposti, M.D., Hatzinisiriou, I., McLennan, H., Ralph, S., Bcl-2 and mitochondrial oxygen radicals (1999) J. Biol. Chem., 274, pp. 29831-29837; Steinman, H.M., The Bcl-2 oncoprotein functions as a pro-oxidant (1995) J. Biol. Chem., 270, pp. 3487-3490; Ellerby, L.M., Ellerby, H.M., Park, S.M., Holleran, A.L., Murphy, A.N., Fiskum, G., Shift of the cellular oxidation-reduction potential in neural cells expressing Bcl-2 (1996) J. Neurochem., 67, pp. 1259-1267; Sagara, Y., Dargusch, R., Chambers, D., Davis, J., Schubert, D., Maher, P., Cellular mechanisms of resistance to chronic oxidative stress (1998) Free Rad. Biol. Med., 24, pp. 1375-1389; Sagara, Y., Dargusch, R., Klier, F.G., Schubert, D., Behl, C., Increased antioxidant enzyme activity in amyloid β protein resistant cells (1996) J. Neurosci., 16, pp. 497-505; Hockenbery, D.M., Oltvai, Z.N., Yin, X.M., Milliman, C.L., Korsmeyer, S.J., Bcl-2 functions in an antioxidant pathway to prevent apoptosis (1993) Cell, 75, pp. 241-251; Kerr, J.F.R., Wyllie, A.H., Currie, A.R., Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics (1972) Br. J. Cancer, 26, pp. 239-257; Wyllie, A.H., Cell death: The significance of apoptosis (1980) Int. Rev. Cytol., 68, pp. 251-306; Kane, D.J., Ord, T., Anton, R., Bredesen, D.E., Expression of bcl-2 inhibits necrotic neural cell death (1995) J. Neurosci. Res., 40, pp. 269-275; Tan, S., Sagara, Y., Liu, Y., Maher, P., Schubert, D., The regulation of reactive oxygen species production during programmed cell death (1998) J. Cell Biol., 141, pp. 1423-1432; Tan, S., Wood, M., Maher, P., Oxidative stress in nerve cells induces a form of cell death with characteristics of both apoptosis and necrosis (1998) J. Neurochem., 71, pp. 95-105; Majno, G., Joris, I., Apoptosis, oncosis and necrosis (1995) Am. J. Pathol., 146, pp. 3-15; Lipton, S.A., Rosenberg, P.A., Excitatory amino acids as a final common pathway in neurological disorders (1994) N. Engl. J. Med., 330, pp. 613-622; Trotti, D., Danbolt, C., Volterra, A., Glutamate transporters are oxidant-vulnerable: A molecular link between oxidative and excitotoxic neurodegeneration? (1998) Trends Pharmacol. Sci., 19, pp. 328-334; Olney, J.W., Inciting excitotoxic cytocide among central neurons (1986) Advances in Experimental Medicine and Biology, pp. 632-645. , Schwarcz R. and Ben-Ari Y. (eds), Plenum Press, New York; Ankarcrona, M., Kypbukt, J.M., Bonfoco, E., Zhivotovsky, B., Orrenius, S., Lipton, S.A., Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function (1995) Neuron, 15, pp. 961-973; Carriedo, S.G., Yin, H.Z., Sensi, S.L., Weiss, J.H., Rapid Ca2+ entry through Ca2+ permeable AMPA/kainate channels triggers marked intracellular Ca2+ rises and consequent oxygen radical production (1998) J. Neurosci., 18, pp. 7727-7738; Coyle, J.T., Puttfarcken, P., Oxidative stress, glutamate and neurodegenerative disorders (1993) Science, 262, pp. 689-695; Castilho, R.F., Ward, M.W., Nicholls, D.G., Oxidative stress, mitochondrial function and acute glutamate excitotoxicity in cultured cerebellar granule cells (1999) J. Neurochem., 72, pp. 1394-1401; Dykens, J.A., Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated Ca+2 and Na+ : Implications for neurodegeneration (1994) J. Neurochem., 63, pp. 584-591; Schinder, A.F., Olson, E.C., Spitzer, N.C., Montal, M., Mitochondrial dysfunction is a primary event in glutamate neurotoxicity (1996) J. Neurosci., 16, pp. 6125-6133; Bannai, S., Kitamura, E., Role of proton dissociation in the transport of cystine and glutamate in human diploid fibroblasts in culture (1981) J. Biol. Chem, 256, pp. 5770-5772; Sato, H., Tamba, M., Ishii, T., Bannai, S., Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins (1999) J. Biol. Chem., 274, pp. 11455-11458; Murphy, T.H., Miyamoto, M., Sastre, A., Schnaar, R.L., Coyle, J.T., Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress (1989) Neuron, 2, pp. 1547-1558; Meldrum, B., Garthwaite, J., Excitatory amino acid neurotoxicity and neurodegenerative disease (1990) Trends Pharmacol. Sci., 11, pp. 379-387; Beal, M.F., Aging, energy and oxidative stress in neurodegenerative diseases (1995) Ann. Neurol., 38, pp. 357-366; Behl, C., Davis, J.B., Klier, F.G., Schubert, D., Amyloid β peptide induces necrosis rather than apoptosis (1994) Brain Res., 645, pp. 253-264; Li, Y., Maher, P., Schubert, D., A role of 12-lipoxygenase in nerve cell death caused by glutathione depletion (1997) Neuron, 19, pp. 453-463; Maher, P., Davis, J.B., The role of monoamine metabolism in oxidative glutamate toxicity (1996) J. Neurosci., 16, pp. 6394-6401; Li, Y., Maher, P., Schubert, D., Requirement for cGMP in nerve cell death caused by glutathione depletion (1997) J. Cell Biol., 139, pp. 1317-1324; Montal, M., Mitochondria, glutamate neurotoxicity and the death cascade (1998) Biochem. Biophys. Res. Commun., 1366, pp. 113-126; Kroemer, G., Zamzami, N., Susin, S.A., Mitochondrial control of apoptosis (1997) Immunol. Today, 18, pp. 44-52; Palmer, H.J., Paulson, K.E., Reactive oxygen species and antioxidants in signal transduction and gene expression (1997) Nutrition Rev., 55, pp. 353-361; Suzuki, Y.J., Forman, H.J., Sevanian, A., Oxidants as stimulators of signal transduction (1997) Free Rad. Biol. Med., 22, pp. 269-285; Rhee, S.G., Redox signaling: Hydrogen peroxide as intracellular messenger (1999) Exp. Mol. Med., 31, pp. 53-59; Kamata, H., Hirata, H., Redox regulation of cellular signalling (1999) Cell. Signal., 11, pp. 1-14; Gamaley, I.A., Klyubin, I.V., Roles of reactive oxygen species: Signaling and regulation of cellular functions (1999) Int. Rev. Cytol., 188, pp. 203-255; Gupta, A., Rosenberger, S.F., Bowden, G.T., Increased ROS levels contribute to elevated transcription factor and MAP kinase activities in malignantly progressed mouse keratinocyte cell lines (1999) Free Rad. Res., 20, pp. 2063-2073; Sunderesan, M., Yu, Z.-X., Ferrans, V.J., Irani, K., Finkel, T., Requirement for generation of H2O2 for platelet-derived growth factor signal transduction (1995) Science, 270, pp. 296-299; Irani, K., Xia, Y., Zweier, J.L., Sollott, S.J., Der, C.J., Fearson, E.R., Mitogenic signaling mediated by oxidants in ras-transformed fibroblasts (1997) Science, 275, pp. 1649-1652; Bae, Y.S., Kang, S.W., Seo, M.S., Baines, I.C., Tekle, E., Chock, P.B., Epidermal growth factor (EGF)-induced generation of hydrogen peroxide (1997) J. Biol. Chem., 272, pp. 217-221; Adler, V., Yin, Z., Ronai, Z., Role of redox potential and reactive oxygen species in stress signaling (1999) Oncogene, 18, pp. 6104-6111; Knebel, A., Rahmsdorf, H.J., Ullrich, A., Herrlich, P., Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents (1996) EMBO J., 15, pp. 5314-5325; Gamou, S., Shimizu, N., Hydrogen peroxide preferentially enhances the tyrosine phosphorylation of epidermal growth factor receptor (1995) FEBS Lett., 357, pp. 161-164; Devary, Y., Gottlieb, R.A., Smeal, T., Karin, M., The mammalian ultraviolet response is triggered by activation of Src tyrosine kinases (1992) Cell, 71, pp. 1081-1091; Hardwick, J.S., Sefton, B.M., Activation of the Lck tyrosine protein kinase by hydrogen peroxide requires the phosphorylation of Tyr-394 (1995) Proc. Natl. Acad. Sci. USA, 92, pp. 4527-4531; Nakamura, K., Hori, T., Sato, N., Sugie, K., Kawakami, T., Yodoi, J., Redox regulation of a src family protein tyrosine kinase p56lck in T cells (1993) Oncogene, 8, pp. 3133-3139; Bauskin, A.R., Alkalay, I., Ben-Neriah, Y., Redox regulation of a protein tyrosine kinase in the endoplasmic reticulum (1991) Cell, 66, pp. 685-696; Rigacci, S., Iantomasi, T., Marraccini, P., Berti, A., Vincenzini, M.T., Ramponi, G., Evidence for glutathione involvement in platelet-derived growth-factor-mediated signal transduction (1997) Biochem. J., 324, pp. 792-796; Schieven, G.L., Kirihara, J.M., Burg, D.L., Geahlen, R.L., Ledbetter, J.A., p72syk Tyrosine kinase is activated by oxidizing conditions that induce lymphocyte tyrosine phosphorylation and Ca2+ signals (1993) J. Biol. Chem., 268, pp. 16688-16692; Vepa, S., Scribner, W.M., Parinandi, N.L., English, D., Garcia, J.G.N., Natarajan, V., Hydrogen peroxide stimulates tyrosine phosphorylation of focal adhesion kinase in vascular endothelial cells (1999) Am. J. Physiol., 277, pp. L150-L158; Robinson, M.J., Cobb, M.H., Mitogen-activated protein kinase pathways (1997) Curr. Opin. Cell Biol., 9, pp. 180-186; Kyriakis, J.M., Avruch, J., Protein kinase cascades activated by stress and inflammatory cytokines (1996) Bioessays, 18, pp. 567-577; Cohen, P., The search for physiological substrates of MAO and SAP kinases in mammalian cells (1998) Trends Cell Biol., 7, pp. 353-361; Schaeffer, H.J., Weber, M.J., Mitogen-activated protein kinases: Specific messages from ubiquitous messengers (1999) Mol. Cell. Biol., 19, pp. 2435-2444; Guyton, K.Z., Liu, Y., Gorospe, M., Xy, Q., Holbrook, N.J., Activation of mitogen-activated protein kinase by H2O2 (1996) J. Biol. Chem., 271, pp. 4138-4142; Baas, A.S., Berk, B.C., Differential activation of mitogen-activated protein kinases by H2O2 and O-2 in vascular smooth muscle cells (1995) Circ. Res., 77, pp. 29-36; Lander, H.M., Ogiste, J.S., Teng, K.K., Novogroksky, A., p21ras As a common signaling target of reactive free radicals and cellular redox stress (1995) J. Biol. Chem., 270, pp. 21195-21198; Lander, H.M., Milbank, A.J., Tauras, J.M., Hajjar, D.P., Hempstead, B.L., Schwartz, G.D., Redox regulation of cell signaling (1996) Nature, 381, pp. 380-381; Xia, Z., Dickens, M., Raingeaud, J., Davis, R.J., Greenberg, M.E., Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis (1995) Science, 270, pp. 1326-1331; Guvillier, O., Pirianov, G., Kleuser, B., Vanek, P.G., Coso, O.A., Gutkind, J.S., Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate (1996) Nature, 381, pp. 800-803; Singer, C.A., Figueroa-Masot, A., Batchelor, R.H., Dorsa, D.M., The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons (1999) J. Neurosci., 19, pp. 2455-42463; Wang, X., Martindale, J.L., Liu, Y., Holbrook, N.J., The cellular response to oxidative stress: Influences of mitogen-activaled protein kinase signalling pathways on cell survival (1998) Biochem. J., 333, pp. 291-300; Abe, J., Takahashi, M., Ishida, M., Lee, J., Berk, B.C., cSrc is required for oxidative stress-mediated activation of big mitogen-activated protein kinase 1 (BMK1) (1997) J. Biol. Chem., 272, pp. 20389-20394; Meriin, A.B., Yaglom, J.A., Gabai, V.L., Mosser, D.D., Zon, L., Sherman, M.Y., Protein-damaging stresses activate c-Jun N-terminal kinase via inhibition of its dephosphorylation: A novel pathway controlled by HSP72 (1999) Mol. Cell. Biol., 19, pp. 2547-2555; Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1 (1998) EMBO J., 17, pp. 2596-2606; Gotoh, Y., Cooper, J.A., Reactive oxygen species and dimerization-induced activation of apoptosis signal-regulating kinase 1 in tumor necrosis factor-α signal transduction (1998) J. Biol. Chem., 273, pp. 17477-17482; Nakamura, H., Nakamura, K., Yodio, J., Redox regulation of cellular activation (1997) Annu. Rev. Immunol., 15, pp. 351-369; Adler, V., Yin, Z., Fuchs, S.Y., Benezra, M., Rosario, L., Tew, K.D., Regulation of JNK signaling by GSTp (1999) EMBO J., 18, pp. 1321-1334; Sanna, M.G., Duckett, C.S., Richter, B.W.M., Thompson, C.B., Ulevitch, R.J., Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP (1998) Proc. Natl. Acad. Sci. USA, 98, pp. 6015-6020; Roulston, A., Reinhard, C., Amiri, P., Williams, L.T., Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor α (1998) J. Biol. Chem., 273, pp. 10232-10239; Kuan, C.Y., Yang, D.D., Roy, D.R.S., Davis, R.J., Pakic, P., Flavell, R.A., The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development (1999) Neuron, 22, pp. 667-676; Kawsaski, H., Morooka, T., Shimohama, S., Kimura, J., Hirano, T., Gotoh, Y., Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells (1997) J. Biol. Chem., 272, pp. 18518-18521; Horstmann, S., Kahle, P.J., Borasio, G.D., Inhibitors of p38 mitogen-activated protein kinase promote neuronal survival in vitro (1998) J. Neurosci. Res., 52, pp. 483-490; Ma, X.L., Kumar, S., Gao, F., Louden, C.S., Lopez, B.L., Christopher, T.A., Inhibition of p38 mitogen-aclivated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion (1999) Circulation, 99, pp. 1685-1691; Mackay, K., Mochly-Rosen, D., An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia (1998) J. Biol. Chem., 274, pp. 6272-6279; Nishizuka, Y., Protein kinase C and lipid signaling for sustained cellular responses (1995) Faseb J., 9, pp. 484-496; Mochly-Rosen, D., Kauvar, M., Modulating protein kinase C signal transduction (1998) Adv. Neurol., 44, pp. 91-145; Jaken, S., Protein kinase C isozymes and substrates (1996) Curr. Opin. Cell Biol., 8, pp. 168-178; Hug, H., Sarre, T.F., Protein kinase C isoenzymes: Divergence in signal transduction? (1993) Biochem. J., 291, pp. 329-343; Konishi, H., Tanaka, M., Takemura, Y., Matsuzaki, H., Ono, Y., Kikkawa, U., Activation of protein kinase C by tyrosine phosphorylation in response to H2O2 (1997) Proc. Natl. Acad. Sci. USA, 94, pp. 11233-11237; Denu, J.M., Stuckey, J.A., Saper, M.A., Dixon, J.E., Form and function in protein dephosphorylation (1996) Cell, 87, pp. 361-364; Sullivan, S.G., Chiu, D.T.Y., Errasfa, M., Wang, J.M., Qi, J.S., Stern, A., Effects of H2O2 on protein tyrosine phosphatase activity in her14 cells (1994) Free Rad. Biol. Med., 16, pp. 399-403; Denu, J.M., Tanner, K.G., Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: Evidence for a sulfenic acid intermediate and implications for redox regulation (1998) Biochemistry, 37, pp. 5633-5642; Keyse, S.M., The role of protein phosphatases in the regulation of mitogen and stress-activated protein kinases (1999) Free Rad. Res., 31, pp. 341-349; Robinson, K.A., Stewart, C.A., Pye, Q.N., Nguyen, X., Kenney, L., Salzman, S., Redox-sensitive protein phosphatase activity regulates the phosphorylation state of p38 protein kinase in primary astrocyte culture (1999) J. Neurosci. Res., 55, pp. 724-732; Wang, W., Culotta, V.C., Klee, C.B., Superoxide dismutase protects calcineurin from inactivation (1996) Nature, 383, pp. 434-437; Bogumil, R., Namgaladze, D., Schaarschmidt, D., Schmachtel, T., Hellstern, S., Mutzel, R., Inactivation of calcineurin by hydrogen peroxide and phenylarsine oxide (2000) Eur. J. Biochem., 267, pp. 1407-1415; Nemani, R., Lee, E.Y.C., Reactivity of sulfhydryl groups of the catalytic subnunits of rabbit skeletal muscle protein phosphatases 1 and 2A (1993) Arch. Biochem. Biophys., 300, pp. 24-29; Hayes, J.D., McLellan, L.I., Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress (1999) Free Rad. Res., 31, pp. 273-300; Thomas, J.A., Poland, B., Honzatko, R., Protein sulfhydryls and their role in the antioxidant function of protein S-thiolation (1995) Arch. Biochem. Biophys., 319, pp. 1-9; Cotgreave, I.A., Gerdes, R.G., Recent trends in giutathione biochemistry: Glutathione-protein interactions: A molecular link between oxidative stress and cell proliferation? (1998) Biochem. Biophys. Res. Commun., 242, pp. 1-9; Schindler, C., Cytokines and JAK-STAT signaling (1999) Exp. Cell Res., 253, pp. 7-14; Darnell, J.E., STATs and gene regulation (1997) Science, 277, pp. 1630-1635; Carballo, M., Conde, M., Bekay, R.E., Martin-Nieto, J., Camacho, M.J., Monteseirin, J., Oxidative stress triggers STAT3 tyrosine phosphorylation and nuclear translocation in human lymphocytes (1999) J. Biol. Chem., 274, pp. 17580-17586; Simon, A.R., Rai, U., Fanburg, B.L., Cochran, B.H., Activation of the JAK-STAT pathway by reactive oxygen species (1998) Am. J. Physiol., 275, pp. C1640-C1652; Hayes, J.D., Ellis, E.M., Neal, G.E., Harrison, D.J., Manson, M.M., Cellular response to cancer chemopreventive agents: Contribution of the antioxidant responsive element to the adaptive response to oxidative and chemical stress (1999) Biochem. Soc. Symp., 64, pp. 141-168; Itoh, K., Wakabyashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J.D., Keapl represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain (1999) Genes Dev., 13, pp. 76-86; Sun, Y., Oberley, L.W., Redox regulation of transcriptional activators (1996) Free Rad. Biol. Med., 21, pp. 335-348; Sen, C.K., Packer, L., Antioxidant and redox regulation of gene transcription (1996) Faseb J., 10, pp. 709-720; Herdegen, T., Skene, P., Bahr, M., The c-Jun transcription factor: Bipotential mediator of neuronal death, survival and regeneration (1997) Trends Neurosci., 20, pp. 227-231; Leppa, S., Bohmann, D., Diverse functions of JNK signaling and c-Jun in stress response and apoptosis (1999) Oncogene, 18, pp. 6158-6162; Wisdom, R., AP-1: One switch for many signals (1999) Exp. Cell Res., 253, pp. 180-185; Arrigo, A.P., Gene expression and the thiol redox state (1999) Free Rad. Biol. Med., 27, pp. 936-944; Abate, C., Patel, L., Rauscher, F.J., Curran, T., Redox regulation of fos and jun DNA-binding activity in vitro (1990) Science, 249, pp. 1157-1161; Klatt, P., Molina, E.P., Garcia De Lacoba, M., Padilla, C.A., Martinez-Galisteo, E., Barcena, J.A., Redox regulation of c-Jun DNA binding by reversible S-glutathiolation (1999) FASEB J., 13, pp. 1481-1490; Flohe, L., Brigelius-Flohe, R., Saliou, C., Traber, M.G., Packer, L., Redox regulation of NF-κB activation (1997) Free Rad. Biol. Med., 22, pp. 1115-1126; Lezoualc'h, F., Sagara, Y., Holsboer, F., Behl, C., High constitutive NF-κB activity mediates resistance to oxidative stress in neuronal cells (1998) J. Neurosci., 18, pp. 3224-3232; Schmidt, K.N., Amstad, P., Cerutti, P., Baeuerle, P.A., The roles of hydrogen peroxide and Superoxide as messengers in the activation of transcription factor NF-κB (1995) Chem. Biol., 2, pp. 13-22; Imbert, V., Rupec, R.A., Livolsi, A., Pahl, H.L., Traenckner, E.B.M., Mueller-Kieckmann, C., Tyrosine phosphorylation of IκB-α activates NF-κB without proteolytic degradation of IκB-α (1996) Cell, 86, pp. 787-798; Canty, T.G., Boyle, E.M., Farr, A., Morgan, E.N., Verrier, E.D., Pohlman, T.H., Oxidative stress induces NF-κB nuclear translocation without degradation of IκBα (1999) Circulation, 100, pp. 361-364; Morel, Y., Barouki, R., Repression of gene expression by oxidative stress (1999) Biochem. J., 342, pp. 481-496","Maher, P.; Scripps Research Institute, Department of Cell Biology, 10550 N. Torrey Pines Rd., San Diego, CA 92037, United States; email: pmaher@scripps.edu",,,,,,,,1420682X,,CMLSF,11028919,"English","Cell. Mol. Life Sci.",Review,Scopus,2-s2.0-0033836908
"Kashiwa, A., Yoshida, H., Lee, S., Paladino, T., Liu, Y., Chen, Q., Dargusch, R., Schubert, D., Kimura, H.","Isolation and characterization of a novel presenilin binding protein",2000,"Journal of Neurochemistry","75","1",,"109","116",,48,10.1046/j.1471-4159.2000.0750109.x,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0034047739&partnerID=40&md5=0484774eba2244b04c0f20a0bf2ece3b","Salk Inst. for Biological Studies, University of California, San Diego, CA, United States; Department of Pathology, University of California, San Diego, CA, United States; Salk Inst. for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; National Institute of Neuroscience, NCNP, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8551, Japan","Kashiwa, A., Salk Inst. for Biological Studies, University of California, San Diego, CA, United States; Yoshida, H., Salk Inst. for Biological Studies, University of California, San Diego, CA, United States; Lee, S., Salk Inst. for Biological Studies, University of California, San Diego, CA, United States; Paladino, T., Department of Pathology, University of California, San Diego, CA, United States; Liu, Y., Salk Inst. for Biological Studies, University of California, San Diego, CA, United States; Chen, Q., Salk Inst. for Biological Studies, University of California, San Diego, CA, United States; Dargusch, R., Salk Inst. for Biological Studies, University of California, San Diego, CA, United States; Schubert, D., Salk Inst. for Biological Studies, University of California, San Diego, CA, United States, Salk Inst. for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; Kimura, H., Salk Inst. for Biological Studies, University of California, San Diego, CA, United States, National Institute of Neuroscience, NCNP, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8551, Japan","Approximately 50% of familial Alzheimer's disease (AD) cases are linked to the presenilin (PS) gene. This suggests that an altered function of mutated PSs accounts for a fundamental process leading to AD. Here we identify a new PS binding protein, PBP, which is highly expressed cerebral cortex and hippocampus. Immunohistochemical studies and cell fractionation analysis show that PBP redistributes from cytoplasm to membranes in the presence of PS. In addition, PBP is deficient in the soluble fraction of sporadic AD brains.","Alzheimer's disease; Presenilin; Presenilin binding protein","binding protein; presenilin 1; Alzheimer disease; amino acid sequence; animal cell; article; brain cortex; controlled study; hippocampus; human; human cell; nonhuman; priority journal; protein analysis; protein domain; protein expression; protein interaction; protein isolation; protein localization; protein structure; Alzheimer Disease; Amino Acid Sequence; Animals; Blotting, Northern; Blotting, Western; Carrier Proteins; Cell Fractionation; Cell Line; Cell Membrane; Cerebral Cortex; COS Cells; Cytoplasm; DNA, Complementary; Guanine Nucleotide Exchange Factors; Hippocampus; Humans; Immunohistochemistry; In Situ Hybridization; Kidney; Membrane Proteins; Mice; Molecular Sequence Data; Nerve Tissue Proteins; Peptide Fragments; Presenilin-1; Saccharomyces cerevisiae; Transfection; Animalia",,"Carrier Proteins; DNA, Complementary; DOCK3 protein, human; Dock3 protein, mouse; Guanine Nucleotide Exchange Factors; Membrane Proteins; Nerve Tissue Proteins; Peptide Fragments; Presenilin-1; PSEN1 protein, human",,,,"Bancher, C., Lassmann, H., Budka, H., Grundke-Iqbal, K., Iqbal, K., Wiche, G., Seitelberger, F., Wisniewski, H.M., Neurofibrillary tangles in Alzheimer's disease and progressive supranuclear palsy: Antigenic similarities and differences. Microtubule-associated protein tau antigenicity is prominent in all types of tangles (1987) Acta Neuropathol. (Berl.), 74, pp. 39-46; Busciglio, J., Hartmann, H., Lorenzo, A., Wong, C., Baumann, K., Sommer, B., Staufenbiel, M., Yankner, B.A., Neuronal localization of presenilin-1 and association with amyloid plaques and neurofibrillary tangles in Alzheimer's disease (1997) J. Neurosci., 17, pp. 5010-5107; Buxbaum, J.D., Choi, E.K., Luo, Y., Lilliehook, C., Crowley, A.C., Merriam, D.E., Wasco, W., Calsenilin: A calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment (1998) Nat. Med., 4, pp. 1177-1181; Chui, D.H., Tanahashi, J., Ozawa, K., Ikeda, S., Checler, F., Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation (1999) Nat. Med., 5, pp. 560-564; Doan, A., Thinakaran, G., Borchelt, D.R., Protein topology of presenilin I (1996) Neuron, 17, pp. 1023-1030; Hasegawa, H., Kiyokawa, E., Tanaka, S., Nagashima, K., Gotoh, N., Shibuya, M., Kurata, T., Matsuda, M., DOCK180, a major CRK-binding protein, alters cell morphology upon translocation to the cell membrane (1996) Mol. Cell. Biol., 16, pp. 1770-1776; Hempstead, B.L., Birge, R.B., Fajardo, J.E., Glassman, R., Mahadeo, D., Kraemer, R., Hanafusa, H., Expression of the v-crk oncogene product in PC12 cells results in rapid differentiation by both nerve growth factor-and epidermal growth factor-dependent pathways (1994) Mol. Cell. Biol., 14, pp. 1964-1971; Katzman, R., Saitoh, T., Advances in Alzheimer's disease (1991) FASEB J., 5, pp. 278-286; Keller, J.N., Guo, Q., Holtsberg, F.W., Bruce-Keller, A.J., Mattson, M.P., Increased sensitivity to mitochondrial toxin-induced apoptosis in neural cells expressing mutant presenilin-1 is linked to perturbed calcium homeostasis and enhanced oxyradical production (1998) J. Neurosci., 18, pp. 4439-4450; Kimura, H., Schwannoma-derived growth factor must be transported into the nucleus to exert its mitogenic activity (1993) Proc. Natl. Acad. Sci. USA, 90, pp. 2165-2169; Kimura, H., Fischer, W.H., Schubert, D., Structure, expression and function of a Schwannoma-derived growth factor (1990) Nature, 348, pp. 257-260; Kovacs, D.M., Fausett, H.J., Page, K.J., Kim, T.W., Moir, R.D., Merriam, D.E., Hollister, R.D., Wasco, W., Alzheimer-associated presenilins 1 and 2: Neuronal expression in brain and localization to intracellular membranes in mammalian cells (1996) Nat. Med., 2, pp. 224-229; Leissring, M.A., Paul, B.A., Parker, I., Cotman, C.W., LaFerla, F.M., Alzheimer's presenilin-1 mutation potentiates inositol 1,4,5-trisphosphate-mediated calcium signaling in Xenopus oocytes (1999) J. Neurochem., 72, pp. 1061-1068; Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D.M., Oshima, J., Pettingell, W.H., Yu, C.E., Wang, K., Candidate gene for the chromosome 1 familial Alzheimer's disease locus (1995) Science, 269, pp. 973-977; Nagase, T., Ishikawa, K., Nakajima, D., Ohira, M., Seki, N., Miyajima, N., Tanaka, A., Ohara, O., Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro (1997) DNA Res., 4, pp. 141-150; Sherrington, R., Rogaev, E.I., Liang, Y., Rogaeva, E.A., Levesque, G., Ikeda, M., Chi, H., Holman, K., Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease (1995) Nature, 375, pp. 754-760; Stabler, S.M., Ostrowski, L.L., Janicki, S.M., Monteiro, M.J., A myristoylated calcium-binding protein that preferentially interacts with the Alzheimer's disease presenilin 2 protein (1999) J. Cell Biol., 145, pp. 1277-1292; Tanzi, R.E., Kovacs, D.M., Kim, T.W., Moir, R.D., The gene defects responsible for familial Alzheimer's disease (1996) Neurobiol. Dis., 3, pp. 159-168; Yoshida, H., Watanabe, A., Ihara, Y., Collapsin response mediator protein-2 is associated with neurofibrillary tangles in Alzheimer's disease (1998) J. Biol. Chem., 273, pp. 9761-9768","Schubert, D.; Salk Inst. for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; email: schubert@salk.edu",,,,,,,,00223042,,JONRA,10854253,"English","J. Neurochem.",Article,Scopus,2-s2.0-0034047739
"Sagara, Y., Hendler, S., Khoh-Reiter, S., Gillenwater, G., Carlo, D., Schubert, D., Chang, J.","Propofol hemisuccinate protects neuronal cells from oxidative injury",1999,"Journal of Neurochemistry","73","6",,"2524","2530",,55,10.1046/j.1471-4159.1999.0732524.x,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0032733142&partnerID=40&md5=f760d08013f14f47c0d26ebaf47ae72c","Salk Inst. for Biological Studies, La Jolla, CA, United States; Vyrex Corporation, La Jolla, CA, United States; Immune Response Corporation, Carlsbad, CA, United States; Cellular Neurobiology, Salk Inst. for Biological Studies, 10010 N. Torrey Pines Rd., San Diego, CA 92037, United States","Sagara, Y., Salk Inst. for Biological Studies, La Jolla, CA, United States, Cellular Neurobiology, Salk Inst. for Biological Studies, 10010 N. Torrey Pines Rd., San Diego, CA 92037, United States; Hendler, S., Vyrex Corporation, La Jolla, CA, United States; Khoh-Reiter, S., Immune Response Corporation, Carlsbad, CA, United States; Gillenwater, G., Vyrex Corporation, La Jolla, CA, United States; Carlo, D., Immune Response Corporation, Carlsbad, CA, United States; Schubert, D., Salk Inst. for Biological Studies, La Jolla, CA, United States; Chang, J., Immune Response Corporation, Carlsbad, CA, United States","Oxidative stress contributes to the neuronal death observed in neurodegenerative disorders and neurotrauma. Some antioxidants for CNS injuries, however, have yet to show mitigating effects in clinical trials, possibly due to the impermeability of antioxidants across the blood-brain barrier (BBB). Propofol (2,6-diisopropylphenol), the active ingredient of a commonly used anesthetic, acts as an antioxidant, but it is insoluble in water. Therefore, we synthesized its water-soluble prodrug, propofol hemisuccinate sodium salt (PHS), and tested for its protective efficacy in neuronal death caused by non-receptor-mediated, oxidative glutamate toxicity. Glutamate induces apoptotic death in rat cortical neurons and the mouse hippocampal cell line HT-22 by blocking cystine uptake and causing the depletion of intracellular glutathione, resulting in the accumulation of reactive oxygen species (ROS). PHS has minimal toxicity and protects both cortical neurons and HT-22 cells from glutamate. The mechanism of protection is attributable to the anti-oxidative property of PHS because PHS decreases the ROS accumulation caused by glutamate. Furthermore, PHS protects HT-22 cells from oxidative injury induced by homocysteic acid, buthionine sulfoximine, and hydrogen peroxide. For comparison, we also tested α- tocopherol succinate (TS) and methylprednisolone succinate (MPS) in the glutamate assay. Although TS is protective against glutamate at lower concentrations than PHS, TS is toxic to HT-22 cells. In contrast, MPS is nontoxic but also nonprotective against glutamate. Taken together, PHS, a water-soluble prodrug of propofol, is a candidate drug to treat CNS injuries owing to its antioxidative properties, low toxicity, and permeability across the BBB.","Antioxidant; Glutamate; Neuronal cells; Neurotrauma; Oxidative injury; Propofol","glutamic acid; propofol; propofol hemisuccinic acid; succinic acid derivative; unclassified drug; animal cell; antioxidant activity; apoptosis; article; blood brain barrier; cell protection; mouse; nerve cell necrosis; neuroprotection; nonhuman; oxidative stress; priority journal; rat; Animals; Apoptosis; Buthionine Sulfoximine; Glutamic Acid; Hippocampus; Homocysteine; Hydrogen Peroxide; Methylprednisolone; Mice; Neurons; Neuroprotective Agents; Neurotoxins; Oxidative Stress; Propofol; Rats; Reactive Oxygen Species; Vitamin E; Animalia",,"Buthionine Sulfoximine, 5072-26-4; Glutamic Acid, 56-86-0; homocysteic acid, 1001-13-4; Homocysteine, 454-28-4; Hydrogen Peroxide, 7722-84-1; Methylprednisolone, 83-43-2; Neuroprotective Agents; Neurotoxins; Propofol, 2078-54-8; Reactive Oxygen Species; vitamin E succinate, 17407-37-3; Vitamin E, 1406-18-4",,,,"Abe, K., Kimura, H., Amyloid β toxicity consists of a Ca2+-independent early phase and a Ca2+-dependent late phase (1996) J. Neurochem., 67, pp. 2074-2078; Bågenholm, R., Nilsson, E.A., Kjellmer, I., Formation of free radicals in hypoxic ischemic brain damage in the neonatal rat, assessed by an endogenous spin trap and lipid peroxidation (1997) Brain Res., 773, pp. 132-138; Baldwin, S.A., Broderick, R., Osbourne, D., Waeg, G., Blades, D., Scheff, S.W., The presence of 4-hydroxynonenal/protein complex as an indicator of oxidative stress after experimental spinal cord contusion in a rat model (1998) J. Neurosurg., 88, pp. 874-883; Bao, Y.P., Williamson, G., Tew, D., Pllumb, G.W., Lambert, N., Jones, J.G., Menon, D.K., Antioxidant effects of propofol in human hepatic microsomes: Concentration effects and clinical relevance (1998) Br. J. Anaesth., 81, pp. 584-589; Bass, D.A., Parce, J.W., Dechatelet, L.R., Szejda, P., Seeds, M.C., Thomas, M., Flow cytometric studies of oxidative product formation by neutrophils: A graded response to membrane stimulation (1983) J. Immunol., 130, pp. 1910-1917; Beck, T., Bielenberg, G.W., Failure of the lipid peroxidation inhibitor U-74006F to improve neurologic outcome after transient forebrain ischemia in the rat (1990) Brain Res., 532, pp. 336-338; Bhat, N.R., Zhang, P., Hydrogen peroxide activation of multiple mitogen-activated protein kinases in an oligodendrocyte cell line: Role of extracellular signal-regulated kinase in hydrogen peroxide-induced cell death (1999) J. Neurochem., 72, pp. 112-119; Bracken, M.B., Shepard, M.J., Collins, W.F., Holford, T.R., Young, W., Baskin, D.S., Eisenberg, H.M., Maroon, J., A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the second national acute spinal cord Injury study (1990) N. Engl. J. Med, 322, pp. 1405-1411; Bracken, M.B., Shepard, M.J., Holford, T.R., Leo-Summers, L., Aldrich, E.F., Fazl, M., Fehlings, M.G., Young, W., Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the third National Acute Spinal Cord Injury randomized controlled trial. National Acute Spinal Cord Injury Study (1997) JAMA, 277, pp. 1597-1604; Bracken, M.B., Shepard, M.J., Holford, T.R., Leo-Summers, L., Aldrich, E.F., Fazl, M., Fehlings, M.G., Young, W., Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial (1998) J. Neurosurg., 89, pp. 699-706; Braughler, J.M., Lipid peroxidation-induced inhibition of γ-aminobutyric acid uptake in rat brain synaptosomes: Protection by glucocorticoids (1985) J. Neurochem., 44, pp. 1282-1288; Braughler, J.M., Hall, E.D., Correlation of methylprednisolone levels in cat spinal cord with its effects on (Na+ + K+)-ATPase, lipid peroxidation, and alpha motor neuron function (1982) J. Neurosurg., 56, pp. 838-844; Braughler, J.M., Hall, E.D., Central nervous system trauma and stroke. I. Biochemical considerations for oxygen radical formation and lipid peroxidation (1989) Free Radic. Biol. Med., 6, pp. 289-301; Coyle, J.T., Puttfarcken, P., Oxidative stress, glutamate, and neurodegenerative disorders (1993) Science, 262, pp. 689-695; Davis, J.B., Maher, P., Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line (1994) Brain Res., 652, pp. 169-173; De La Cruz, J.P., Sedeno, G., Carmona, J.A., Sanchez De La Cuesta, F., The in vitro effects of propofol on tissular oxidative stress in the rat (1998) Anesth. Analg., 87, pp. 1141-1146; Eriksson, O., Pollesello, P., Saris, N.E., Inhibition of lipid peroxidation in isolated rat liver mitochondria by the general anesthetic propofol (1992) Biochem. Pharmacol., 44, pp. 391-393; Froissard, P., Monrocq, H., Duval, D., Role of glutathione metabolism in the glutamate-induced programmed cell death of neuronal-like PC12 cells (1997) Eur. J. Pharmacol., 326, pp. 93-99; Griffith, O.W., Determination of glutathione and glutathione disulfide using glucose reductase and 2-vinyl pyridine (1980) Anal. Biochem., 106, pp. 207-212; Griffith, O.W., Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis (1982) J. Biol. Chem., 258, pp. 1591-1598; Hall, E.D., The neuroprotective pharmacology of methylprednisolone (1992) J. Neurosurg., 76, pp. 13-22; Hall, E.D., Braughler, J.M., Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation (1989) Free Radic. Biol. Med., 6, pp. 303-313; Hall, E.D., Braughler, J.M., McCall, J.M., Antioxidant effects in brain and spinal cord injury (1992) J. Neurotrauma, 9 (SUPPL. 1), pp. S165-S172; Hall, E.D., Yonkers, P.A., Taylor, B.M., Sun, F.F., Lack of effect of postinjury treatment with methylprednisolone or tirilazad mesylate on the increase in eicosanoid levels in the acutely injured cat spinal cord (1995) J. Neurotrauma, 12, pp. 245-256; Halliwell, B., Oxidants and human disease: Some new concepts (1987) FASEB J., 1, pp. 358-364; Hansen, M.B., Nielsen, S.E., Berg, K., Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill (1989) J. Immunol. Methods, 119, pp. 203-210; Kato, S., Negishi, K., Mawatari, K., Kuo, C.-H., A mechanism for glutamate toxicity in the C6 glioma cells involving inhibition of cystine uptake leading to glutathione depletion (1992) Neuroscience, 48, pp. 903-914; Katoh, D., Ikata, T., Katoh, S., Hamada, Y., Fukuzawa, K., Effects of dietary vitamin C on compression injury of the spinal cord in a rat mutant unable to synthesize ascorbic acid and its correlation with that of vitamin E (1996) Spinal Cord, 34, pp. 234-238; Kokita, N., Hara, A., Propofol attenuates hydrogen peroxide-induced mechanical and metabolic derangements in the isolated rat heart (1996) Anesthesiology, 84, pp. 117-127; Kvam, C., Granese, D., Flaibani, A., Pollesello, P., Paoletti, S., Hyaluronan can be protected from free-radical depolymerisation by 2,6-diisopropylphenol, a novel radical scavenger (1993) Biochem. Biophys. Res. Commun., 193, pp. 927-933; Lemke, M., Frei, B., Ames, B.N., Faden, A.I., Decreases in tissue levels of ubiquinol-9 and -10, ascorbate and α-tocopherol following spinal cord impact trauma in rats (1990) Neurosci. Lett., 108, pp. 201-206; Li, G.L., Farooque, M., Holtz, A., Olsson, Y., Effects of alpha-phenyl-N-tert-butyl nitrone (PBN) on compression injury of rat spinal cord (1997) Free Radic. Res., 27, pp. 187-196; Liu, Y., Peterson, D.A., Kimura, H., Schubert, D., Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction (1997) J. Neurochem., 69, pp. 581-593; Machlin, L.J., Gabriel, E., Kinetics of tissue alpha tocopherol uptake and depletion following administration of high levels of vitamin E (1982) Ann. NY Acad. Sci., 393, pp. 48-59; Maher, P., Davis, J., The role of monoamine metabolism in oxidative glutamate toxicity (1996) J. Neurosci., 16, pp. 6394-6401; Marshall, L.F., Maas, A.I., Marshall, S.B., Bricolo, A., Fearnside, M., Iannotti, F., Klauber, M.R., Musch, B., A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury (1998) J. Neurosurg., 89, pp. 519-525; May, P.C., Gray, P.N., The mechanism of glutamate-induced degeneration of cultured Huntington's disease and control fibroblasts (1985) J. Neurol. Sci., 70, pp. 101-112; Miyamoto, M., Murphy, T.H., Schnaar, R.L., Coyle, J.T., Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line (1989) J. Pharmacol. Exp. Ther., 250, pp. 1132-1140; Morimoto, B.H., Koshland D.E., Jr., Induction and expression of long- and short-term neurosecretory potentiation in a neural cell line (1990) Neuron, 5, pp. 875-880; Murphy, P.G., Myers, D.S., Davies, M.J., Webster, N.R., Jones, J.G., The antioxidant potential of propofol (2,6-diisopropylphenol) (1992) Br. J. Anaesth., 68, pp. 613-618; Murphy, T.H., Miyamoto, M., Sastre, A., Schnaar, R.L., Coyle, J.T., Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress (1989) Neuron, 2, pp. 1547-1558; Musacchio, E., Rizzoli, V., Bianchi, M., Bindoli, A., Galzigna, L., Antioxidant action of propofol on liver microsomes, mitochondria and brain synaptosomes in the rat (1991) Pharmacol. Toxicol., 69, pp. 75-77; Oka, A., Belliveau, M.J., Rosenberg, P.A., Volpe, J.J., Vulnerability of oligodendroglia to glutamate: Pharmacology, mechanism, and prevention (1993) J. Neurosci., 13, pp. 1441-1453; Oliver, C.N., Starke-Reed, P.E., Stadtman, E.R., Liu, G.J., Carney, J.M., Floyd, R.A., Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain (1990) Proc. Natl. Acad. Sci. USA, 87, pp. 5144-5147; Pietronigro, D.D., Hovsepian, M., Demopoulos, H.B., Flamm, E.S., Loss of ascorbic acid from injured feline spinal cord (1983) J. Neurochem., 41, pp. 1072-1076; Ratan, R., Murphy, T.H., Baraban, J.M., Macromolecular synthesis inhibitors prevent oxidative stress-induced apoptosis in embryonic cortical neurons by shunting cysteine from protein synthesis to glutathione (1994) J. Neurosci., 14, pp. 4385-4392; Sagara, Y., Induction of reactive oxygen species in neurons by haloperidol (1998) J. Neurochem., 71, pp. 1002-1012; Sagara, Y., Schubert, D., The activation of metabotropic glutamate receptors protects nerve cells from oxidative stress (1998) J. Neurosci., 18, pp. 6662-6671; Sagara, Y., Dargusch, R., Chambers, D., Davis, J., Schubert, D., Maher, P., Cellular mechanisms of resistance to chronic oxidative stress (1998) Free Radic. Biol. Med., 24, pp. 1375-1389; Salah, N., Miller, N.J., Paganga, G., Tijiburg, L., Bolwell, G.P., Rice-Evans, C., Polyphenolic flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants (1995) Arch. Biochem. Biophys., 322, pp. 339-346; Saunders, R.D., Dugan, L.L., Demediuk, P., Means, E.D., Horrocks, L.A., Anderson, D.K., Effects of methylprednisolone and the combination of α-tocopherol and selenium on arachidonic acid metabolism and lipid peroxidation in traumatized spinal cord tissue (1987) J. Neurochem., 49, pp. 24-31; Schubert, D., Kimura, H., Maher, P., Growth factors and vitamin E modify neuronal glutamate toxicity (1992) Proc. Natl. Acad. Sci. USA, 89, pp. 8264-8267; Springer, J.E., Azbill, R.D., Mark, R.J., Begley, J.G., Waeg, G., Mattson, M.P., 4-hydroxynonenal, a lipid peroxidation product, rapidly accumulates following traumatic spinal cord injury and inhibits glutamate uptake (1997) J. Neurochem., 68, pp. 2469-2476; Tan, S., Sagara, Y., Liu, Y., Maher, P., Schubert, D., Peroxide production in oxidative glutamate toxicity (1998) J. Cell Biol., 141, pp. 1423-1432; Tan, S., Wood, M., Maher, P., Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells (1998) J. Neurochem., 71, pp. 95-105; Tietze, F., Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues (1969) Anal. Biochem., 27, pp. 502-522; Vogt, M., Dulbecco, R., Steps in the neoplastic transformation of hamster embryo cells by polyoma virus (1963) Proc. Natl. Acad. Sci. USA, 49, pp. 171-179; Young, Y., Menon, D.K., Tisavipat, N., Matta, B.F., Jones, J.G., Propofol neuroprotection in a rat model of ischemia reperfusion injury (1997) Eur. J. Anaesthesiol., 14, pp. 320-326","Sagara, Y.; Cellular Neurobiology, Salk Inst. for Biological Studies, 10010 N. Torrey Pines Rd., San Diego, CA 92037, United States",,,,,,,,00223042,,JONRA,10582614,"English","J. Neurochem.",Article,Scopus,2-s2.0-0032733142
"Li, Y., Xu, C., Schubert, D.","The up-regulation of endosomal-lysosomal components in amyloid β- resistant cells",1999,"Journal of Neurochemistry","73","4",,"1477","1482",,17,10.1046/j.1471-4159.1999.0731477.x,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0032848122&partnerID=40&md5=cf833d3541a675b8ba3d6e5fa2efcc94","Salk Institute, San Diego, CA, United States; Burnham Institute, San Diego, CA, United States; Salk Inst. for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States","Li, Y., Salk Institute, San Diego, CA, United States; Xu, C., Burnham Institute, San Diego, CA, United States; Schubert, D., Salk Institute, San Diego, CA, United States, Salk Inst. for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States","The abundance of amyloid β peptide (Aβ) and the selective loss of neurons are characteristics of Alzheimer's disease. However, subpopulations of brain cells survive, including neurons near Aβ-rich plaques. The surviving neurons may have gene expression profiles that allow them to be resistant to Aβ toxicity. Here we use the differential display technique to compare the profiles of gene expression in an Aβ-resistant cell line with its parental cells. Prominent among the changes are two components of the endosomal-lysosomal system, insulin growth factor II receptor/mannose-6- phosphate receptor and arylsulfatase B. Both are more highly expressed in the Aβ-resistant clone, and arylsulfatase is inducible by Aβ and hydrogen peroxide. Another lysosomal enzyme, β-glucuronidase, is also up-regulated in Aβ-resistant cells. These results are consistent with the observation that the endosomal-lysosomal system is highly activated in Alzheimer's disease brains, and they raise the possibility that the high expression of endosomal- lysosomal components is important for neuronal survival in the presence of Aβ.","β-Glucuronidase; Alzheimer's disease; Amyloid β; Arylsulfatase; Differential display; Lysosome; Mannose-6-phosphate receptor","amyloid beta protein; beta glucuronidase; hydrogen peroxide; n acetylgalactosamine 4 sulfatase; somatomedin b receptor; animal cell; article; cell survival; controlled study; endosome; lysosome; nonhuman; pheochromocytoma cell; priority journal; protein expression; rat; Amyloid beta-Protein; Animals; Cell Survival; Clone Cells; Drug Resistance; Endosomes; Gene Expression Regulation; Glucuronidase; Hydrogen Peroxide; Lysosomes; N-Acetylgalactosamine-4-Sulfatase; PC12 Cells; Rats; Receptor, IGF Type 2; RNA, Messenger; Transcription, Genetic",,"Amyloid beta-Protein; Glucuronidase, EC 3.2.1.31; Hydrogen Peroxide, 7722-84-1; N-Acetylgalactosamine-4-Sulfatase, EC 3.1.6.12; Receptor, IGF Type 2; RNA, Messenger",,,,"Behl, C., Davis, J.B., Lesley, R., Schubert, D., Hydrogen peroxide mediates amyloid beta protein toxicity (1994) Cell, 77, pp. 817-827; Cataldo, A.M., Paskevich, P.A., Kominami, E., Nixon, R.A., Lysosomal hydrolases of different classes are abnormally distributed in Alzheimer brain (1991) Proc. Natl Acad. Sci. USA, 88, pp. 10988-11002; Cataldo, A.M., Hamilton, D.J., Barnett, J.L., Paskevich, P.A., Nixon, R.A., Properties of the endosomal-lysosomal system in the human central nervous system: Disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease (1996) J. Neurosci., 16, pp. 186-199; Choi, B.H., Oxidative stress and Alzheimer's disease (1995) Neurobiol. Aging, 16, pp. 675-678; Evers, M., Saftig, P., Schmidt, P., Hafner, A., McLoghlin, D.B., Schmal, W., Hess, B., Peters, C., Targeted disruption of the arylsulfatase B gene results in mice resembling the phenotype of mucopolysaccharidosis VI (1996) Proc. Natl. Acad. Sci. USA, 93, pp. 8214-8219; Geula, C., Wu, C.K., Saroff, D., Lorenzo, A., Yuan, M., Yankner, B.A., Aging renders the brain vulnerable to amyloid β-protein neurotoxicity (1998) Nat. Med., 4, pp. 827-831; Hardy, J., Amyloid, the presenilins and Alzheimer's disease (1997) Trends Neurosci., 20, pp. 154-159; Iversen, L.L., Mortishire-Smith, R.J., Pollack, S.J., Shearman, M.S., The toxicity in vitro of beta-amyloid protein (1995) Biochem. J., 311, pp. 1-16; Kanamori, S., Waguri, S., Shibata, M., Isahara, K., Ohsawa, Y., Konishi, A., Kametaka, S., Uchiyama, Y., Overexpression of cation-dependent mannose 6-phosphate receptor prevents cell death induced by serum deprivation in PC12 cells (1998) Biochem. Biophys. Res. Commun., 251, pp. 204-208; Kang, J.X., Li, Y., Leaf, A., Mannose-6-phosphate/insulin-like growth factor-II receptor is a receptor for retinoic acid (1997) Proc. Natl. Acad. Sci. USA, 94, pp. 13671-13676; Kunieda, T., Simonaro C, M., Yoshida, M., Ikadai, H., Levan, G., Desnick, R.J., Schuchman, E.H., Mucopolysaccharidosis type VI in rats: Isolation of cDNAs encoding arylsulfatase B, chromosomal localization of the gene, and identification of the mutation (1995) Genomics, 29, pp. 582-587; Kurtin, W.E., Schwesinger, W.H., Assay of β-glucuronidase in bile following ion-pair extraction of pigments and bile acids (1985) Anal. Biochem., 147, pp. 511-516; Li, Y., Maher, P., Schubert, D., A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion (1997) Neuron, 19, pp. 453-463; Liang, P., Pardee, A.B., Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction (1992) Science, 257, pp. 967-971; Ludwig, T., Munier-Lehmann, H., Bauer, U., Hollinshead, M., Ovitt, C., Lobel, P., Hoflack, B., Differential sorting of lysosomal enzymes in mannose 6-phosphate receptor-deficient fibroblasts (1994) EMBO J., 13, pp. 3430-3437; Mattson, M.P., Goodman, Y., Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium (1995) Brain Res., 676, pp. 219-224; Mukhopadhyay, S., Schellhorn, H.E., Identification and characterization of hydrogen peroxide-sensitive mutants of Escherichia coli: Genes that require OxyR for expression (1997) J. Bacteriol., 179, pp. 330-338; Neuwelt, E., Use of antibodies and the primary enzyme immunoassay (PE1A) to study enzymes: The arylsulfatase A-anti-arylsulfatase A system (1981) Methods Enzymol., 73, pp. 550-578; Nixon, R.A., Cataldo, A.M., The lysosomal system in neuronal cell death: A review (1993) Ann. NY Acad. Sci., 679, pp. 87-109; Oshima, A., Nolan, C.M., Kyle, J.W., Grubb, J.H., Sly, W.S., The human cation-independent mannose 6-phosphate receptor: Cloning and sequence of the full length cDNA and expression of functional receptor in COS cells (1988) J. Biol. Chem., 263, pp. 2553-2562; Pratico, D., Lee, V.M.-Y., Trojanowski, J.Q., Rokach, J., Fitzgerald, G.A., Increased F2-isoprostanes in Alzheimer's disease: Evidence for enhanced lipid peroxidation in vivo (1998) FASEB J., 12, pp. 1777-1783; Sagara, Y., Dargusch, R., Klier, F.G., Schubert, D., Behl, C., Increased antioxidant enzyme activity in amyloid beta protein-resistant cells (1996) J. Neurosci., 16, pp. 497-505; Schubert, D., Kimura, H., Maher, P.A., Growth factors and vitamin E modify neuronal glutamate toxicity (1992) Proc. Natl. Acad. Sci. USA, 89, pp. 8264-8267; Welsh, J., Chada, K., Dalal, S.S., Cheng, R., Ralph, D., McClelland, M., Arbitrarily primed PCR fingerprinting of RNA (1992) Nucleic Acids Res., 20, pp. 4965-4970; Yankner, B.A., Mechanisms of neuronal degeneration in Alzheimer's disease (1996) Neuron, 16, pp. 921-932; Yoshida, M., Noguchi, J., Ikadai, H., Takahashi, M., Nagase, S., Arylsulfatase B-deficient mucopolysaccharidosis in rats (1993) J. Clin. Invest., 91, pp. 1099-1104","Schubert, D.; Salk Inst. for Biological Studies, P O Box 85800, San Diego, CA 92186-5800, United States",,,,,,,,00223042,,JONRA,10501192,"English","J. Neurochem.",Article,Scopus,2-s2.0-0032848122
"Liu, Y., Schubert, D.","Steroid hormones block amyloid fibril-induced 3-(4,5-dimethylthiazol-2- yl)-2,5-diphenyltetrazolium bromide (MTT) formazan exocytosis: Relationship to neurotoxicity",1998,"Journal of Neurochemistry","71","6",,"2322","2329",,43,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0031741751&partnerID=40&md5=65cfd429a981333a5f8a23e962d9b0c1","Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA, United States; Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, 10010 N. Torrey Pines Rd., San Diego, CA 92037-1099, United States","Liu, Y., Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA, United States, Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, 10010 N. Torrey Pines Rd., San Diego, CA 92037-1099, United States; Schubert, D., Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA, United States","Perhaps the most reproducible early event induced by the interaction of amyloid β peptide (Aβ) with the cell is the inhibition of cellular 3-(4,5- dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. We recently demonstrated that cytotoxic amyloid peptides such as Aβ and human amylin inhibit cellular MTT reduction by dramatically enhancing MTT formazan exocytosis: We now show the following: (a) Insulin and glucagon, when converted to fibrils with β-pleated sheet structure, induce MTT formazan exocytosis that is indistinguishable from that induced by Aβ. NAC35, an amyloidogenic fragment of α-synuclein (or NACP), also induces MTT formazan exocytosis. (b) All protein fibrils with the β-pleated sheet structure examined are toxic to rat hippocampal neurons. (c) Many sterol sex hormones (e.g., estradiol and progesterone) block amyloid fibril-enhanced MTT formazan exocytosis as well as MTT formazan exocytosis in control cells by acting at a common late step in the exocytic pathway. Steroids fail, however, to protect hippocampal neurons from acute amyloid fibril toxicity. These findings suggest that the ability to enhance MTT-formazan exocytosis and to induce neurotoxicity are common biological activities of protein fibrils with β- pleated sheet structure but that enhanced MTT formazan exocytosis is not sufficient for acute Aβ neurotoxicity.","β-Pleated sheet; 3- (4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; Alzheimer's disease; Amyloid fibrils; Amyloidosis; Steroid sex hormones","3 (4,5 dimethyl 2 thiazolyl) 2,5 diphenyltetrazolium bromide; amyloid; estradiol; formazan; glucagon; insulin; progesterone; sex hormone; amyloidosis; animal tissue; article; chronology; controlled study; drug mechanism; exocytosis; hippocampus; intracellular transport; membrane vesicle; neurotoxicity; nonhuman; priority journal; protein secondary structure; rat; signal transduction; structure activity relation; Amyloid; Animals; Cell Line; Exocytosis; Formazans; Glucagon; Gonadal Steroid Hormones; Hippocampus; Insulin; Neurons; Neurotoxins; Peptide Fragments; Rats; Rats, Sprague-Dawley; Sterols; Swine; Tetrazolium Salts; Time Factors",,"Amyloid; Formazans; Glucagon, 9007-92-5; Gonadal Steroid Hormones; Insulin, 11061-68-0; MTT formazan, 23305-68-2; Neurotoxins; Peptide Fragments; Sterols; Tetrazolium Salts",,,,"Abe, K., Kimura, H., Amyloid β toxicity consists of a Ca2+-independent early phase and a Ca2+-dependent late phase (1996) J. Neurochem., 67, pp. 2074-2078; Altman, F.P., Tetrazolium salts and formazans (1976) Prog. Histochem. Cytochem., 9, pp. 1-56; Beaven, G.H., Gratzer, W.B., Davies, H.G., Formation and structure of gels and fibrils from glucagon (1969) Eur. J. Biochem., 11, pp. 37-42; Behl, C., Davis, J.B., Cole, G.M., Schubert, D., Vitamin E protects nerve cells from amyloid β protein toxicity (1992) Biochem. Biophys. Res. Commun., 186, pp. 944-952; Behl, C., Davis, J.B., Lesley, R., Schubert, D., Hydrogen peroxide mediates amyloid β protein toxicity (1994) Cell, 77, pp. 817-827; Behl, C., Widmann, M., Trapp, T., Holsboer, F., 17-β estradiol protects neurons from oxidative stress-induced cell death in vitro (1995) Biochem. Biophys. Res. Commun., 216, pp. 473-482; Booth, D.R., Sunde, M., Bellotti, V., Robinson, C.V., Hutchinson, W.L., Fraser, P.E., Hawkins, P.N., Pepys, M.B., Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis (1997) Nature, 385, pp. 787-793; Burke, M.J., Rougvie, M.A., Cross-β protein structures. I. Insulin fibrils (1972) Biochemistry, 11, pp. 2435-2439; Caughey, B.W., Dong, A., Bhat, K.S., Ernst, D., Hayes, S.F., Caughey, W.S., Secondary structure analysis of the scrapie-associated protein PrP27-30 in water by infrared spectroscopy (1991) Biochemistry, 30, pp. 7672-7680; Glenner, G.G., Amyloid deposits and amyloidosis: The beta-fibrilloses (1980) N. Engl. J. Med., 302 (1 PART), pp. 1283-1292; N. Engl. J. Med., (2 PART), pp. 1333-1343; Glenner, G.G., Page, D.L., Amyloid, amyloidosis, and amyloidogenesis (1976) Int. Rev. Exp. Pathol., 15, pp. 1-92; Glenner, G.G., Eanes, E.D., Bladen, H.A., Linke, R.P., Termine, J.D., A comparison of native amyloid with synthetic protein fibrils (1974) J. Histochem. Cytochem., 22, pp. 1141-1158; Han, H., Weinreb, P.H., Lansbury Jr., P.T., The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: Is NAC a common trigger or target in neurodegenerative diseases? (1995) Chem. Biol., 2, pp. 163-169; Iwai, A., Yoshimoto, M., Masliah, E., Saitoh, T., Non-A beta component of Alzheimer's disease amyloid (NAC) is amyloidogenic (1995) Biochemistry, 34, pp. 10139-10145; Kawas, C., Resnick, R., Morrison, A., Brookmeyer, R., Corrada, M., Zonderman, A., Bacal, C., Metter, E., A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease (1997) Neurology, 48, pp. 1517-1521; Klunk, W.E., Pettegrew, J.W., Abraham, D.J., Two simple methods for quantifying low-affinity dye-substrate binding (1989) J. Histochem. Cytochem., 37, pp. 1293-1297; Lai, Z., Colón, W., Kelly, J.W., The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid (1995) Biochemistry, 35, pp. 6470-6482; Liu, Y., Schubert, D., Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis (1997) J. Neurochem., 69, pp. 2285-2293; Liu, Y., Peterson, D.A., Kimura, H., Schubert, D., The mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction (1997) J. Neurochem., 69, pp. 581-593; Liu, Y., Dargusch, R., Schubert, D., Beta amyloid toxicity does not require RAGE protein (1997) Biochem. Biophys. Res. Commun., 237, pp. 37-40; Lorenzo, A., Yankner, B.A., β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red (1994) Proc. Natl. Acad. Sci. USA, 91, pp. 12243-12247; May, P.C., Boggs, L.N., Fuson, K.S., Neurotoxicity of human amylin in rat primary hippocampal cultures: Similarity to Alzheimer's disease amyloid-β neurotoxicity (1993) J. Neurochem., 61, pp. 2330-2333; Mosmann, T., Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity (1983) J. Immunol. Methods, 65, pp. 55-63; Nussbaum, R.L., Polymeropoulos, M.H., Genetics of Parkinson's disease (1997) Hum. Mol. Genet, 6, pp. 1687-1691; Paganini-Hill, A., Henderson, V.W., Estrogen deficiency and risk of Alzheimer's disease (1994) Am. J. Epidemiol., 140, pp. 256-261; Perutz, M.F., Johnson, T., Suzuki, M., Finch, J.T., Glutamine repeats as polar zippers: Their possible role in inherited neurodegenerative diseases (1994) Proc. Natl. Acad. Sci. USA, 91, pp. 5355-5358; Pike, C.J., Cummings, B.J., Cotman, C.W., In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity (1991) Brain Res., 563, pp. 311-314; Prusiner, S.B., McKinley, M.P., Bowman, K.A., Bendheim, P.E., Bolton, D.C., Groth, D.F., Glenner, G.G., Scrapie prions aggregate to form amyloid-like birefringent rods (1983) Cell, 35, pp. 349-358; Scherzinger, E., Lurz, R., Turmaine, M., Mangiarini, L., Hollenbach, B., Hasenbank, R., Bates, G.P., Wanker, E.E., Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo (1997) Cell, 90, pp. 549-558; Schubert, D., Heinemann, S., Carlisle, W., Tarika, H., Kimes, B., Steinbach, J.H., Culp, W., Brandt, B.L., Clonal cell lines from the rat central nervous system (1974) Nature, 249, pp. 224-227; Schubert, D., Behl, C., Lesley, R., Brack, A., Dargusch, R., Sagara, Y., Kimura, H., Amyloid peptides are toxic via a common oxidative mechanism (1995) Proc. Natl. Acad. Sci. USA, 92, pp. 1989-1993; Shearman, M.S., Ragan, C.I., Iversen, L.L., Inhibition of PC-12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death (1994) Proc. Natl. Acad. Sci. USA, 91, pp. 1470-1474; Sipe, J.D., Amyloidosis (1992) Annu. Rev. Biochem., 61, pp. 947-975; Tang, M., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B., Andrews, H., Mayeux, R., Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease (1996) Lancet, 348, pp. 429-432; Ueda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D.A., Saitoh, T., Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer's disease (1993) Proc. Natl. Acad. Sci. USA, 90, pp. 11282-11286; Yankner, B.A., Mechanism of neuronal degeneration in Alzheimer's disease (1996) Neuron, 16, pp. 921-932; Yankner, B.A., Duffy, L.K., Kirscher, D.A., Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides (1990) Science, 250, pp. 279-282","Schubert, D.; Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, 10010 N. Torrey Pines Rd., San Diego, CA 92037-1099, United States",,,,,,,,00223042,,JONRA,9832130,"English","J. Neurochem.",Article,Scopus,2-s2.0-0031741751
"Liu, Y., Peterson, D.A., Schubert, D.","Amyloid β peptide alters intracellular vesicle trafficking and cholesterol homeostasis",1998,"Proceedings of the National Academy of Sciences of the United States of America","95","22",,"13266","13271",,101,10.1073/pnas.95.22.13266,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0032573097&partnerID=40&md5=76200074ebc824a9740f17f561178c21","Salk Inst. for Biological Studies, San Diego, CA 92037, United States; Salk Inst. for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037-1099, United States","Liu, Y., Salk Inst. for Biological Studies, San Diego, CA 92037, United States; Peterson, D.A., Salk Inst. for Biological Studies, San Diego, CA 92037, United States; Schubert, D., Salk Inst. for Biological Studies, San Diego, CA 92037, United States, Salk Inst. for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037-1099, United States","Amyloid β peptide (Aβ) is thought to play a central role in the pathogenesis of Alzheimer disease (AD). How Aβ induces neurodegeneration in AD is not known. A connection between AD and cholesterol metabolism is suggested by the finding that people with the apolipoprotein E4 allele, a locus coding for a cholesterol-transporting lipoprotein, have a modified risk for both late-onset AD and cardiovascular disease. In the present study we show that both Aβ and submieromolar concentrations of free cholesterol alter the trafficking of a population of intracellular vesicles that are involved in the transport of the reduced form of the tetrazolium dye 3-(4,5- dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT formazan), the formation of which is a widely used cell viability assay. Treatments that change Cellular free cholesterol levels also modulate the trafficking of the MTT formazan-containing vesicles, suggesting that the trafficking of these vesicles may be regulated by free cholesterol under physiological conditions. In addition, Aβ decreases cholesterol esterification and changes the distribution of free cholesterol in neurons. These results suggest that the MTT formazan-transporting vesicles may be involved in cellular cholesterol homeostasis and that the alteration of vesicle transport by Aβ may be relevant to the chronic neurodegeneration observed in AD.",,"amyloid beta protein; cholesterol; lipoprotein; tetrazolium; alzheimer disease; animal cell; article; cell level; cholesterol esterification; cholesterol metabolism; cholesterol synthesis; cholesterol transport; disease association; nerve cell; nonhuman; pathogenesis; priority journal; rat; Amyloid beta-Protein; Animals; Cell Line; Cells, Cultured; Cholesterol; Cholesterol Esters; Embryo; Exocytosis; Formazans; Hippocampus; Homeostasis; Mice; Mice, Knockout; Neurons; Oleic Acid; Rats; Sterol O-Acyltransferase; Tetrazolium Salts; Animalia",,"Amyloid beta-Protein; Cholesterol Esters; Cholesterol, 57-88-5; Formazans; MTT formazan, 23305-68-2; Oleic Acid, 112-80-1; Sterol O-Acyltransferase, EC 2.3.1.26; Tetrazolium Salts",,,,"Yankner, B.A., (1996) Neuron, 16, pp. 921-932; Hardy, J., (1997) Trends Neurosci., 20, pp. 154-159; Pike, C.J., Cummings, B.J., Cotman, C.W., (1991) Brain Res., 563, pp. 311-314; Yankner, B.A., Duffy, L.K., Kirscher, D.A., (1990) Science, 250, pp. 279-282; Behl, C., Davis, J.B., Cole, G.M., Schubert, D., (1992) Biochem. Biophys. Res. Commun., 186, pp. 944-952; Behl, C., Davis, J.B., Lesley, R., Schubert, D., (1994) Cell, 77, pp. 817-827; Shearman, M.S., Ragan, C.I., Iversen, L.L., (1994) Proc. Natl. Acad. Sci. USA, 91, pp. 1470-1474; Mosmann, T., (1983) J. Immunol. Methods, 65, pp. 55-63; Liu, Y., Peterson, D., Kimura, H., Schubert, D., (1997) J. Neurochem., 69, pp. 581-593; Liu, Y., Schubert, D., (1997) J. Neurochem., 69, pp. 2285-2293; Schubert, D., Heinemann, S., Carlisle, W., Tarika, H., Kimes, B., Steinbach, J.H., Culp, W., Brandt, B.L., (1974) Nature (London), 249, pp. 224-227; Meiner, V.L., Cases, S., Myers, H.M., Sande, E.R., Bellosta, S., Schambelan, M., Pitas, R.E., Farese, R.V., (1996) Proc. Natl. Acad. Sci. USA, 93, pp. 14041-14046; Goldstein, J., Dana, S.E., Brown, M.S., (1974) Proc. Natl. Acad. Sci. USA, 71, pp. 4288-4292; Gamble, W., Vaughan, M., Kruth, H.S., Avigan, J., (1978) J. Lipid Res., 19, pp. 1068-1070; Abe, K., Kimura, H., (1996) J. Neurochem., 67, pp. 2074-2078; Neufeld, E.B., Cooney, A.M., Pitha, J., Dawidowicz, E.A., Dwyer, N.K., Pentchev, P.G., Blanchette-Mackie, E.J., (1996) J. Biol. Chem., 271, pp. 21604-21613; Glenner, G.G., (1980) N. Engl. J. Med., 302, pp. 1283-1292; Brown, M.S., Faust, J.R., Goldstein, J.L., Kaneko, I., Endo, A., (1978) J. Biol. Chem., 253, pp. 1121-1128; Kandutsch, A.A., Chen, H.W., (1978) Lipids, 13, pp. 704-707; Lorenzo, A., Yankner, B.A., (1994) Proc. Natl. Acad. Sci. USA, 91, pp. 12243-12247; Avdulov, N.A., Chochina, S.V., Igbavboa, U., Warden, C.S., Vassiliev, A.V., Wood, W.G., (1997) J. Neurochem., 69, pp. 1746-1752; Robinson, M., Watt, C., Zerial, M., (1996) Cell, 69, pp. 129-138; Brown, M.S., Goldstein, J.L., (1987) Science, 232, pp. 34-47; Futerman, A.H., Banker, G.A., (1996) Trends Neurosci., 19, pp. 144-149; Crews, F.T., Camacho, A., Phillips, M.I., (1983) Brain Res., 261, pp. 155-158; Ginsberg, L., Atack, J.R., Rapoport, S.I., Gershfeld, N.L., (1993) Brain Res., 625, pp. 355-357; Pentchev, P.G., Brady, R.O., Blanchette-Mackie, E.J., Vanier, M.T., Carstea, G., Parker, C.C., Goldin, E., Roff, C.F., (1994) Biochim. Biophys. Acta, 1225, pp. 235-243; Strittmatter, W.J., Saunders, A.M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G.S., Roses, A.D., (1993) Proc. Natl. Acad. Sci. USA, 90, pp. 1977-1981; Stengard, J.H., Zerba, K.E., Pekkanen, J., Ehnholm, C., Nissinen, A., Sing, C.F., (1995) Circulation, 91, pp. 265-269; Simons, M., Keller, P., De Strooper, B., Beyreuther, K., Dotti, C.G., Simons, K., (1998) Proc. Natl. Acad. Sci. USA, 95, pp. 6460-6464","Schubert, D.; Salk Inst. for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037-1099, United States; email: Schubert@salk.edu",,,,,,,,00278424,,PNASA,9789077,"English","Proc. Natl. Acad. Sci. U. S. A.",Article,Scopus,2-s2.0-0032573097
"Sagara, Y., Schubert, D.","The activation of metabotropic glutamate receptors protects nerve cells from oxidative stress",1998,"Journal of Neuroscience","18","17",,"6662","6671",,111,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0032171182&partnerID=40&md5=ef0b99d2878a7beab560119d36d2f1f2","Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA 92037, United States; Salk Inst. for Biological Studies, San Diego, CA 92037, United States","Sagara, Y., Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA 92037, United States; Schubert, D., Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA 92037, United States, Salk Inst. for Biological Studies, San Diego, CA 92037, United States","Metabotropic glutamate receptors (mGluRs) have been implicated in a variety of cellular responses to glutamic acid. The work described in this manuscript extends the role of mGluRs to include protection from oxidative stress-induced programmed cell death. Glutamate analogs regulate inositol- 1,4,5 triphosphate mass accumulation in accordance with their ability to protect cells from oxidative glutamate toxicity, and protection appears to take place at the level of glutathione metabolism. Short-term exposure of cells to low concentrations of glutamate desensitizes cells to a subsequent challenge from glutamate. Glutamate exposure upregulates the expression of mGluR5 in hippocampal HT-22 cells and mGluR1 in cortical primary cultures. Finally, group I mGluR agonists also protect cells from death programs initiated by glucose starvation and cystine deprivation.","Cell death; Cystine; Glutamate; Metabotropic receptors; Oxidative stress; Toxicity","antiporter; cyclic amp; glutamic acid; metabotropic receptor; reactive oxygen metabolite; amino acid sequence; animal cell; apoptosis; article; cell culture; cell viability; desensitization; glutathione metabolism; mouse; neuroprotection; nonhuman; oxidative stress; priority journal; receptor binding; starvation; Animals; Cell Survival; Cells, Cultured; Cerebral Cortex; Glutathione; Neurons; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Signal Transduction",,"Glutathione, 70-18-8; Receptors, Metabotropic Glutamate",,,,"Abe, K., Takayanagi, M., Saito, H., Effects of recombinant human basic FGF and its modified protein CS23 on survival of primary cultured neurons from various regions of fetal rat brain (1990) Jpn J Pharmacol, 53, pp. 221-227; Alaluf, S., Mulvihill, E.R., McIlhinney, R.A.J., Rapid agonist mediated phosphorylation of the metabotropic glutamate receptor 1α by protein kinase C in permanently transfected BHK cells (1995) FEBS Lett, 367, pp. 301-305; Bading, B., Hardingham, G.E., Johnson, C.M., Chawla, S., Gene regulation by nuclear and cytoplasmic calcium signals (1997) Biochem Biophys Res Commun, 236, pp. 541-543; Bashir, Z.I., Bortolotto, Z.A., Davies, C.H., Berretta, N., Irving, A.J., Seal, A.J., Henley, J.M., Collingridge, G.L., Induction of LTP in the hippocampus needs synaptic activation of glutamate metabotropic receptors (1993) Nature, 363, pp. 347-350; Bass, D.A., Parce, J.W., Dechatelet, L.R., Szejda, P., Seeds, M.C., Thomas, M., Flow cytometric studies of oxidative product formation by neutrophils: A graded response to membrane stimulation (1983) J Immunol, 130, pp. 1910-1917; Bleasdale, J.E., Thakur, N.R., Gremban, R.S., Bundy, G.L., Fitzpatrick, F.A., Smith, R.J., Bunting, S., Selective inhibition of receptor-coupled phospholipase C-dependent processes in human neutrophils (1990) J Pharmacol Exp Ther, 255, pp. 756-768; Bruno, V., Battaglia, G., Copani, A., Giffard, R.G., Raciti, G., Raffaele, R., Shinozaki, H., Nicoletti, F., Activation of class II or III metabotropic glutamate receptors protects cultured cortical neurons against excitotoxic degeneration (1995) Eur J Neurosci, 7, pp. 1906-1913; Bruno, V., Copani, A., Knopfel, T., Kuhn, R., Casabona, G., Dell'Albani, P., Condorelli, D.F., Nicoletti, F., Activation of metabotropic glutamate receptors coupled to inositol phospholipid hydrolysis amplifies NMDA-induced neuronal degeneration in cultured cortical cells (1995) Neuropharmacology, 34, pp. 1089-1098; Buisson, A., Choi, D.W., The inhibitory mGluR agonist, S-4-carboxy-3-hydroxy-phenylglycine selectively attenuates NMDA neurotoxicity and oxygen-glucose deprivation-induced neuronal death (1995) Neuropharmacology, 34, pp. 1081-1087; Catania, M.V., Aronica, E., Sortino, M.A., Canocio, P.L., Nicoletti, F., Desensitization of metabotrophic glutamate receptors in neuronal cultures (1991) J Neurochem, 56, pp. 1329-1335; Challiss, R.A.J., Jenkinson, S., Mistry, R., Batty, I.H., Nahorski, S.R., Assessment of neuronal phosphoinositide turnover and its disruption by lithium (1993) Neuroprotocols, 3, pp. 135-144; Chen, C.K., Silverstein, F.S., Fisher, S.K., Statman, D., Johnston, M.V., Perinatal hypoxic-ischemic brain injury enhances quisqualic acid-stimulated phosphoinositide turnover (1988) J Neurochem, 51, pp. 353-359; Conn, P.J., Pin, J.-P., Pharmacology and functions of metabotropic glutamate receptors (1997) Annu Rev Pharmacol Toxicol, 37, pp. 205-237; Coyle, J.T., Puttfarcken, P., Oxidative stress, glutamate, and neurodegenerative disorders (1993) Science, 262, pp. 689-695; Davis, J.B., Maher, P., Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line (1994) Brain Res, 652, pp. 169-173; Dowson, A.P., Calcium signalling: How do IP3 receptors work? (1997) Curr Biol, 7, pp. R544-R547; Fisher, S.K., Homologous and heterologous regulation of receptor-stimulated phosphoinositide hydrolysis (1995) Eur J Pharmacol, 288, pp. 231-250; Gereau IV, R.W., Heinemann, S.F., Role of protein kinase C phosphorylation in rapid desensitization of metabotropic glutamate receptor 5 (1998) Neuron, 20, pp. 143-151; Griffith, O.W., Determination of glutathione and glutathione disulfide using glucose reductase and 2-vinyl pyridine (1980) Anal Biochem, 106, pp. 207-212; Ikeda, J., Morita, L., Murota, S., Involvement of nitric oxide and free radical (02-) in neuronal injury induced by deprivation of oxygen and glucose in vitro (1994) Acta Neurochir Suppl, 60, pp. 94-97; Ito, I., Kohda, A., Tanabe, S., Hirose, E., Hayashi, M., Mitsunaga, S., Sugiyama, H., 3,5-Dihydroxyphenyl-glycine: A potent agonist of metabotropic glutamate receptors (1992) NeuroReport, 3, pp. 1013-1016; Joly, C., Gomeza, J., Brabet, I., Curry, K., Bockaert, J., Pin, J.-P., Molecular, functional, and pharmacological characterization of the metabotropic glutamate receptor type 5 splice variants: Comparison with mGluR1 (1995) J Neurosci, 15, pp. 3970-3981; Laemmli, U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4 (1970) Nature, 227, pp. 680-685","Schubert, D.; Salk Inst. for Biological Studies, San Diego, CA 92037, United States",,,,,,,,02706474,,JNRSD,9712638,"English","J. Neurosci.",Article,Scopus,2-s2.0-0032171182
"Sagara, Y., Tan, S., Maher, P., Schubert, D.","Mechanisms of resistance to oxidative stress in Alzheimer's disease",1998,"BioFactors","8","1-2",,"45","50",,8,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0031873849&partnerID=40&md5=dff983288bc0722a332f7795b11c804a","Salk Institute for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; Scripps Research Institute, 10666 North Torrey Pines Road, San Diego, CA 92037, United States; Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States","Sagara, Y., Salk Institute for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; Tan, S., Salk Institute for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; Maher, P., Scripps Research Institute, 10666 North Torrey Pines Road, San Diego, CA 92037, United States; Schubert, D., Salk Institute for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States, Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States","It is likely that amyloid β-protein (Aβ) mediates nerve cell death in Alzheimer's disease (AD). Some nerve cell populations, however, remain undamaged in AD brain. To understand the biochemical basis for resistance to Aβ toxicity, a series of cell lines were isolated which are resistant to Aβ toxicity. It is shown that a major component of the resistance mechanism is the transcriptional elevation of two H 2O 2 degrading enzymes, glutathione peroxidase arid catalase. These data support other evidence for the role of oxidative damage in Aβ toxicity, and suggest strategies for clinical approaches to the disease.",,"amyloid beta protein; catalase; glutathione peroxidase; aerobic metabolism; alzheimer disease; conference paper; cytotoxicity; enzyme inactivation; nonhuman; oxidative stress; priority journal; Alzheimer Disease; Amyloid beta-Protein; Animals; Brain; Cell Line; Humans; Neurons; Oxidative Stress",,"Amyloid beta-Protein",,,,"Anderson, A.J., Su, J.H., Cotman, C.W., DNA damage and apoptosis in Alzheimer's disease: Colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay (1996) J. Neurosci., 16, pp. 1710-1719; Balazs, L., Leon, M., Evidence of an oxidative challenge in the Alzheimer's brain (1994) Neurochem. Res., 19, pp. 1131-1137; Behl, C., Davis, J., Cole, G.M., Schubert, D., Vitamin E protects nerve cells from amyloid β-protein toxicity (1992) Biochem. Biophys. Res. Comm., 186, pp. 944-950; Behl, C., Davis, J.B., Klier, F.G., Schubert, D., Amyloid β-peptide induces necrosis rather than apoptosis (1994) Brain Res., 645, pp. 253-264; Behl, C., Davis, J.B., Lesley, R., Schubert, D., Hydrogen peroxide mediates amyloid β-protein toxicity (1994) Cell, 77, pp. 817-827; Cai, X.-D., Golde, T., Younkin, S., Release of excess amyloid β-protein from a mutant amyloid beta-protein precursor (1993) Science, 259, pp. 514-516; Chartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Mullan, M., Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene (1991) Nature, 353, pp. 844-846; Citron, M., Oltersorf, T., Haass, C., McConlogue, L., Hung, A.Y., Seubert, P., Vigo-Pelfrey, C., Selkoe, D.J., Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production (1992) Nature, 360, pp. 672-674; Connor, J.R., Menzies, S.L., St.-Martin, S.M., Mufson, E.J., A histochemical study of iron, transferrin and ferritin in Alzheimer's diseased brains (1992) J. Neurosci. Res., 31, pp. 75-83; Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Perez-Tur, J., Hutton, M., Younkin, S., Increased amyloid-β 42 (43) in brains of mice expressing mutant presenilin 1 (1996) Nature, 383, pp. 710-713; Eikelenboom, P., Zhan, S.-S., Van Gool, W.A., Allsop, D., Inflammatory mechanisms in Alzheimer's disease (1994) TIPS, 15, pp. 447-450; Friedlich, A.L., Butcher, L.L., Involvement of free oxygen radicals in beta-amyloidosis: An hypothesis (1994) Neurobiol. Ageing, 15, pp. 443-455; Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Hardy, J., Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease (1991) Nature, 349, pp. 704-706; Hof, P.R., Nimchinsky, E.A., Celio, M.R., Bouras, C., Morrison, J.H., Calretinin-immunorreactive neocortical interneurons are unaffected in Alzheimer's disease (1993) Neurosci. Lett., 152, pp. 145-149; Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., Cole, G., Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice (1996) Science, 274, pp. 99-102; Jackson, G.R., Sampath, D., Werrbach-Perez, K., Perez-Polo, R., Effects of nerve growth factor on catalase and glutathione peroxidase in a hydrogen peroxide-resistant pheochromocytoma subclone (1994) Brain Res., 634, pp. 69-76; Lovell, M.A., Ehmann, W.D., Butler, S.M., Markesbury, W.R., Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease (1995) Neurology, 45, pp. 1594-1601; Lyras, L., Cairns, N.J., Jenner, A., Jenner, P., Halliwell, B., An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease (1997) J. Neurochem., 68, pp. 2061-2069; McGeer, P.L., McGeer, E.G., The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases (1995) Brain Res. Rev., 21, pp. 195-218; Mecocci, P., MacGarvey, U., Geal, M., Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease (1994) Ann. Neurol., 36, pp. 747-751; Mortimer, J.A., French, L.R., Hutton, J.T., Schuman, L.M., Head injury as a risk factor for Alzheimer's disease (1985) Neurology, 35, pp. 264-267; Murrell, J., Farlow, M., Ghetti, B., Benson, M.D., A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease (1991) Science, 254, pp. 97-99; Pappolla, M.A., Omar, R.A., Kim, K.S., Robakis, N.K., Immunohistochemical evidence of antioxidant stress in Alzheimer's disease (1992) Am. J. Pathol., 140, pp. 621-628; Pike, C.J., Burdick, D., Walencewicz, A.J., Glabe, C.G., Cotman, C.W., Neuro-degeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state (1993) J. Neurosci., 13, pp. 1676-1687; Sagara, Y., Dargusch, R., Schubert, D., Behl, C., Increased antioxidant enzyme activity Aβ-resistant cells (1996) J. Neurosci., 16, pp. 497-505; Sano, M., Ernesto, C., Thomas, R.G., Klauber, M.R., Schafer, K., Grundman, M., Woodbury, P., Thal, L.J., A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease (1997) New Engl. J. Med., 336, pp. 1216-1222; Schubert, D., Chevion, M., The role of iron in beta amyloid toxicity (1995) Biochem. Biophys. Res. Comm., 216, pp. 702-707; Shearman, M.S., Ragan, C.I., Iversen, L.L., Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death (1994) Proc. Natl. Acad. Sci. USA, 91, pp. 1470-1474; Smith, M.A., Harris, P.L.R., Sayre, L.M., Beckman, J.S., Perry, G., Widespread peroxynitrite-mediated damage in Alzheimer's disease (1997) J. Neurosci., 17, pp. 2653-2657; Smith, M.A., Perry, G., Richey, P.L., Sayre, L.M., Anderson, V.E., Beal, M.F., Kowall, N., Oxidative damage in Alzheimer's (1996) Nature, 382, pp. 120-121; Subarao, K.V., Richardson, S., Ang, L.C., Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro (1990) J. Neurochem., 55, pp. 342-345; Tan, S., Maher, P., Schubert, D., The role of protein phosphorylation in beta amyloid toxicity (1997) Brain Res., 765, pp. 159-163; Tomita, T., Maruyama, K., Saido, T.C., Kume, H., Shinozaki, K., Tokuhiro, S., Capell, A., Obata, K., The presenilin 2 mutation (N141I) linked to familial Alzheimer's disease (Volga German families) increases the secretion of amyloid β-protein ending at the 42nd (or 43rd) residue (1997) Proc. Natl. Acad. Sci. USA, 94, pp. 2025-2030; Yan, S.D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Schmidt, A.M., RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease (1996) Nature, 382, pp. 685-719; Yankner, B.A., Duffy, L.K., Kirschner, D.A., Neurotrophic and neurotoxic effects of amyloid β-protein: Reversal by tachykinin neuropeptides (1990) Science, 25, pp. 279-282","Schubert, D.; Salk Inst. for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States",,,,,,,,09516433,,BIFAE,9699008,"English","BioFactors",Conference Paper,Scopus,2-s2.0-0031873849
"Li, Y., Maher, P., Schubert, D.","Phosphatidylcholine-specific phospholipase C regulates glutamate- induced nerve cell death",1998,"Proceedings of the National Academy of Sciences of the United States of America","95","13",,"7748","7753",,79,10.1073/pnas.95.13.7748,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0032560471&partnerID=40&md5=1a2b7e3c003a63cc8c5d75919ee0058f","Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA 92037, United States","Li, Y., Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA 92037, United States; Maher, P., Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA 92037, United States; Schubert, D., Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA 92037, United States","Phosphatidylcholine-specific phospholipase C (PC-PLC) is a necessary intermediate in transducing apoptotic signals for tumor necrosis factor and Fas/Apo-1 ligands in nonneuronal cells. The data presented here show that PC- PLC also is required in oxidative glutamate-induced programmed cell death of both immature cortical neurons and a hippocampal nerve cell line, HT22. In oxidative glutamate toxicity, which is distinct from excitotoxicity, glutamate interferes with cystine uptake by blocking the cystine/glutamate antiporter, indirectly causing a depletion of intracellular glutathione. A PC-PLC inhibitor blocks oxidative glutamate toxicity, and exogenous PC-PLC potentiates glutamate toxicity. The inhibition of PC-PLC uncouples the cystine uptake from glutamate inhibition, allowing the maintenance of glutathione synthesis and cell viability. These data suggest that PC-PLC modulates neuronal cell death through a mechanism that is distinct from that involved in nonneuronal apoptosis.",,"cystine; glutamic acid; glutathione; phosphatidylcholine; phospholipase c; amino acid transport; animal cell; article; brain cell; cell line; cell viability; glutathione metabolism; hippocampus; nerve cell necrosis; neurotoxicity; nonhuman; priority journal; Animals; Antimetabolites; Apoptosis; Bridged Compounds; Buthionine Sulfoximine; Cell Line; Cystine; Glutamic Acid; Hippocampus; Mice; Neurons; Phosphodiesterase Inhibitors; Phospholipase C; Thiones; Animalia",,"Antimetabolites; Bridged Compounds; Buthionine Sulfoximine, 5072-26-4; Cystine, 56-89-3; Glutamic Acid, 56-86-0; phosphatidylcholine-specific phospholipase C, EC 3.1.4.-; Phosphodiesterase Inhibitors; Phospholipase C, EC 3.1.4.3; Thiones; tricyclodecane-9-yl-xanthogenate, 83373-60-8",,,,,"Schubert, D.; Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA 92037, United States",,,,,,,,00278424,,PNASA,9636222,"English","Proc. Natl. Acad. Sci. U. S. A.",Article,Scopus,2-s2.0-0032560471
"Tan, S., Sagara, Y., Liu, Y., Maher, P., Schubert, D.","The regulation of reactive oxygen species production during programmed cell death",1998,"Journal of Cell Biology","141","6",,"1423","1432",,502,10.1083/jcb.141.6.1423,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0032526940&partnerID=40&md5=9575baacd7adbcdcadfc3a4fe50618eb","Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA 92037, United States; Department of Cell Biology, Scripps Research Institute, San Diego, CA 92037, United States; Cellular Neurobiology Lab., Salk Inst. for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States","Tan, S., Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA 92037, United States; Sagara, Y., Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA 92037, United States; Liu, Y., Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA 92037, United States; Maher, P., Department of Cell Biology, Scripps Research Institute, San Diego, CA 92037, United States; Schubert, D., Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA 92037, United States, Cellular Neurobiology Lab., Salk Inst. for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States","Reactive oxygen species (ROS) are thought to be involved in many forms of programmed cell death. The role of ROS in cell death caused by oxidative glutamate toxicity was studied in an immortalized mouse hippocampal cell line (HT22). The causal relationship between ROS production and glutathione (GSH) levels, gene expression, caspase activity, and cytosolic Ca 2+ concentration was examined. An initial 5-10-fold increase in ROS after glutamate addition is temporally correlated with GSH depletion. This early increase is followed by an explosive burst of ROS production to 200-400-fold above control values. The source of this burst is the mitochondrial electron transport chain, while only 5-10% of the maximum ROS production is caused by GSH depletion. Macromolecular synthesis inhibitors as well as Ac-YVAD-cmk, an interleukin 1β-converting enzyme protease inhibitor, block the late burst of ROS production and protect HT22 cells from glutamate toxicity when added early in the death program. Inhibition of intracellular Ca 2+ cycling and the influx of extracellular Ca 2+ also blocks maximum ROS production and protects the cells. The conclusion is that GSH depletion is not sufficient to cause the maximal mitochondrial ROS production, and that there is an early requirement for protease activation, changes in gene expression, and a late requirement for Ca 2+ mobilization.",,"calcium ion; glutamic acid; glutathione; interleukin 1beta converting enzyme inhibitor; reactive oxygen metabolite; animal cell; apoptosis; article; brain ischemia; calcium mobilization; controlled study; electron transport; enzyme activity; hippocampus; mitochondrial respiration; mouse; nerve degeneration; neurotoxicity; nonhuman; oxidative stress; priority journal; Animals; Apoptosis; Calcium; Caspase 1; Cell Line; Cysteine Endopeptidases; Cytosol; Dactinomycin; Electron Transport; Gene Expression; Glutathione Transferase; Mice; Mitochondria; Protein Synthesis Inhibitors; Reactive Oxygen Species; Animalia",,"Calcium, 7440-70-2; Caspase 1, EC 3.4.22.36; Cysteine Endopeptidases, EC 3.4.22.-; Dactinomycin, 50-76-0; Glutathione Transferase, EC 2.5.1.18; Protein Synthesis Inhibitors; Reactive Oxygen Species",,,,"Abe, J., Takahashi, M., Ishida, M., Lee, J.-D., Berk, B.C., C-Src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase 1 (BMK1) (1997) J. Biol. Chem., 272, pp. 20389-20394; Ames, B.N., Shigenaga, M.K., Hagen, T.M., Oxidants, antioxidants, and the degenerative diseases of aging (1993) Proc. Natl. Acad. Sci. USA, 90, pp. 7915-7922; Bass, D.A., Parce, J.W., Dechatelet, L.R., Szejda, P., Seeds, M.C., Thomas, M., Flow cytometric studies of oxidative product formation by neutrophils: A graded response to membrane stimulation (1983) J. Immunol., 130, pp. 1910-1917; Boveris, A., Chance, B., The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen (1973) Biochem. J., 134, pp. 707-716; Boveris, A., Oshino, N., Chance, B., The cellular production of hydrogen peroxide (1972) Biochem. J., 128, pp. 617-630; Budd, S.L., Nicholls, D.G., Mitochondria, calcium regulation, and acute glutamate excitotoxicity in cultured cerebellar granule cells (1996) J. Neurochem., 67, pp. 2282-2291; Budd, S.L., Nicholls, D.G., A reevaluation of the role of mitochondria in neuronal Ca 2+ homeostasis (1996) J. Neurochem., 66, pp. 403-411; Cathcart, R., Schwiers, E., Ames, B.N., Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay (1983) Anal. Biochem., 134, pp. 111-116; Chaudhri, G., Clark, I.A., Hunt, N.H., Cowden, W.B., Ceredig, R., Effect of antioxidants on primary alloantigen-induced T cell activation and proliferation (1986) J. Immunol., 137, pp. 2646-2652; Chaudhri, G., Hunt, N.H., Clark, I.A., Ceredig, R., Antioxidants inhibit proliferation and cell surface expression of receptors for interleukin-2 and transferrin in T lymphocytes stimulated with phorhol myristate acetate and ionomycin (1988) Cell. Immunol., 115, pp. 204-213; Choi, D.W., Glutamate neurotoxicity and diseases of the nervous system (1988) Neuron, 1, pp. 623-634; Cino, M., Del Maestro, R.F., Generation of hydrogen peroxide by brain mitochondria: The effect of reoxygenation following postdecapitative ischemia (1989) Arch. Biochem. Biophys., 269, pp. 623-638; Coyle, J.T., Puttfarcken, P., Oxidative stress, glutamate, and neurodegenerative disorders (1993) Science, 262, pp. 689-695; Davis, J.B., Maher, P., Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line (1994) Brain Res., 652, pp. 169-173; Dessi, F., Ben-Ari, Y., Charriaut-Marlangue, C., Ruthenium red protects against glutamate-induced neuronal death in cerebellar culture (1995) Neurosci. Lett., 201, pp. 53-56; Esposito, F., Cuccovillo, F., Vanoni, M., Cimino, F., Anderson, C.W., Appella, E., Russo, T., Redox-mediated regulation of p21 waf/cip1 expression involves a post-transcriptional mechanism and activation of the mitogen-activated protein kinase pathway (1997) Eur. J. Biochem., 245, pp. 730-737; Goldstone, S.D., Hunt, N.H., Redox regulation of the mitogen-activated protein kinase pathway during lymphocyte activation (1997) Biochim. Biophys. Acta., 1355, pp. 353-360; Griffith, O.W., Determination of glutathione and glutathione disulfide using glutathione reduclase and 2-vinylpyridine (1980) Anal. Biochem., 106, pp. 207-212; Guilbault, G.G., J. Brignac, P.I., Juneau, M., New substrates for the fluorometric determination of oxidative enzymes (1968) Anal. Chem., 40, pp. 1256-1263; Gunter, T.E., Pfeiffer, D.R., Mechanisms by which mitochondria transport calcium (1990) Am. J. Physiol., 258, pp. C755-C786; Halliwell, B., Reactive oxygen species and the central nervous system (1992) J. Neurochem., 59, pp. 1609-1623; He, H., Lam, M., McCormick, T.S., Distelhorst, C.W., Maintenance of calcium homeostasis in the endoplasmic reticulum by Bcl-2 (1997) J. Cell Biol., 138, pp. 1219-1228; Hirabayashi, Y., Taniuchi, S., Kobayashi, Y., A quantitative assay of oxidative metabolism by neutrophils in whole blood using flow cytometry (1985) J. Immunol. Methods, 82, pp. 253-259; Isaev, N.K., Zorov, D.B., Stelmashook, E.V., Uzbekov, R.E., Kozhemyakin, M.B., Victorov, I.V., Neurotoxic glutamate treatment of cultured cerebellar granule cells induces Ca 2+-dependent collapse of mitochondrial membrane potential and ultrastructural alterations of mitochondria (1996) FEBS Lett., 392, pp. 143-147; Jenner, P., Oxidative damage in neurodegenerative disease (1994) Lancet, 344, pp. 796-798; Jocelyn, P.C., Some properties of mitochondrial glutathione (1975) Biochim. Biophys. Acta., 396, pp. 427-436; Kazzaz, J.A., Xu, J., Palaia, T.A., Mantell, L., Fein, A.M., Horowitz, S., Cellular oxygen toxicity. Oxidant injury without apoptosis (1996) J. Biol. Chem., 271, pp. 15182-15186; Kohda, K., Inoue, T., Mikoshiba, K., Ca 2+ release from Ca 2+ stores, particularly from ryanodine-sensitivc Ca 2+ stores, is required for the induction of LTD in cultured cerebellar Purkinje cells (1995) J. Neurophysiol., 74, pp. 2184-2188; Korkotian, E., Segal, M., Lasting effects of glutamate on nuclear calcium concentration in cultured rat hippocampal neurons: Regulation by calcium stores (1996) J. Physiol. (Lond.), 496, pp. 39-48; LeBel, C.P., Ischiropoulos, H., Bondy, S.C., Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress (1992) Chem. Res. Toxicol., 5, pp. 227-231; Li, Y., Maher, P., Schubert, D., A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion (1997) Neuron, 19, pp. 453-463; Li, Y., Maher, P., Schubert, D., Requirement for cGMP in nerve cell death caused by glutathione depletion (1997) J. Cell Biol., 139, pp. 1-8; Liu, Y., Rosenthal, R.E., Fiskum, G., H 2O 2 release by brain mitochondria in a canine cerebral ischemia/reperfusion model (1993) FASEB (Fed. Am. Soc. Exp. Biol.) J., 7, pp. A424; Luo, X., Bond, J.D., Ingram, V.M., Compromised mitochondrial function leads to increased cytosolic calcium and to activation of MAP kinases (1997) Proc. Natl. Acad. Sci. USA, 94, pp. 9705-9710; Macho, A., Hirsch, T., Marzo, I., Marchetti, P.D., Dallaporta, B., Susin, S.A., Zamzami, N., Kroemer, G., Glutathione depletion is an early and calcium elevation is a late event of thymocyte apoptosis (1997) J. Immunol., 158, pp. 4612-4619; Maher, P., Davis, J.B., The role of monoamine metabolism in oxidative glutamate toxicity (1996) J. Neurosci., 16, pp. 6394-6401; McConkey, D.J., Orrenius, S., The role of calcium in the regulation of apoptosis (1997) Biochem. Biophys. Res. Commun., 239, pp. 357-366; McFarlane, M.B., Bruhn, T.O., Jackson, I.M., Postsomatostatin hypersecretion of growth hormone from perfused rat anterior pituitary cells is dependent on calcium influx (1993) Neuroendocrinology., 57, pp. 496-502; McPherson, P.S., Campbell, K.P., Characterization of the major brain form of the ryanodine receptor/Ca 2+ release channel (1993) J. Biol. Chem., 268, pp. 19785-19790; Miyamoto, M., Murphy, T.H., Schnaar, R.L., Coyle, J.T., Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line (1989) J. Pharmacol. Exp. Ther., 250, pp. 1132-1140; Moreadith, R.W., Fiskum, G., Isolation of mitochondria from ascites tumor cells permeabilized with digitonin (1984) Anal. Biochem., 137, pp. 360-367; Murphy, T.H., Miyamoto, M., Sastre, A., Schnaar, R.L., Coyle, J.T., Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress (1989) Neuron, 2, pp. 1547-1558; Murphy, T.H., Schnaar, R.L., Coyle, J.T., Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake (1990) FASEB (Fed. Am. Soc. Exp. Biol.) J., 4, pp. 1624-1633; Nakamura, K., Hori, T., Sato, N., Sugie, K., Kawakami, T., Yodoi, J., Redox regulation of a src family protein tyrosine kinase p56 lck in T cells (1993) Oncogene, 8, pp. 3133-3139; Oka, A., Belliveau, M.J., Rosenberg, P.A., Volpe, J.J., Vulnerability of oligodendroglia to glutamate: Pharmacology, mechanisms, and prevention (1993) J. Neurosci., 13, pp. 1441-1453; Park, Y.B., Herrington, J., Babcock, D.F., Hille, B., Ca 2+ clearance mechanisms in isolated rat adrenal chromaffin cells (1996) J. Phys. (Lond.), 492, pp. 329-346; Randall, R.D., Thayer, S.A., Glutamate-induced calcium transient triggers delayed calcium overload and neurotoxicity in rat hippocampal neurons (1992) J. Neurosci., 12, pp. 1882-1895; Ravindranath, V., Reed, D.J., Glutathione depletion and formation of glutathione-protein mixed disulfide following exposure of brain mitochondria to oxidative stress (1990) Biochem. Biophys. Res. Commun., 169, pp. 1075-1079; Reed, D.J., Savage, M.K., Influence of metabolic inhibitors on mitochondrial permeability transition and glutathione status (1995) Biochim. Biophys. Acta., 1271, pp. 43-50; Reynolds, I.J., Hastings, T.G., Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation (1995) J. Neurosci., 15, pp. 3318-3327; Richter, C., Gogvadze, V., Laffranchi, R., Schlapbach, R., Schweizer, M., Suter, M., Walter, P., Yaffee, M., Oxidants in mitochondria: From physiology to diseases (1995) Biochim. Biophys. Acta., 1271, pp. 67-74; Russo, T., Zambrano, N., Esposito, F., Ammendola, R., Cimino, F., Fiscella, M., Jackman, J., Appella, E., A p53-independent pathway for activation of WAF1/CIP1 expression following oxidative stress (1995) J. Biol. Chem., 270, pp. 29386-29391; Sagara, Y., Dargusch, R., Chambers, D., Davis, J., Schubert, D., Maher, P., Cellular mechanisms of resistance to chronic oxidative stress (1998) Free Radical Biol. Med., , In press; Shigenaga, M.K., Hagen, T.M., Ames, B.N., Oxidative damage and mitochondrial decay in aging (1994) Proc. Natl. Acad. Sci. USA, 91, pp. 10771-10778; Slater, A.F., Nobel, C.S., Maellaro, E., Bustamante, J., Kimland, M., Orrenius, S., Nitrone spin traps and a nitroxide antioxidant inhibit a common pathway of thymocyte apoptosis (1995) Biochem. J., 306, pp. 771-778; Staal, F.J., Anderson, M.T., Staal, G.E., Herzenberg, L.A., Gitler, C., Herzenberg, L.A., Redox regulation of signal transduction: Tyrosine phosphorylation and calcium influx (1994) Proc. Natl. Acad. Sci. USA, 91, pp. 3619-3622; Suzuki, Y.S., Forman, H.J., Sevanian, A., Oxidants as stimulators of signal transduction (1997) Free Radical Biol. Med., 22, pp. 269-285; Tan, S., Wood, M., Maher, P., Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells (1998) J. Neurochem., , In press; Thayer, S.A., Wang, G.J., Glutamate-induced calcium loads: Effects on energy metabolism and neuronal viability (1995) Clin. Exp. Pharmacol. Physiol., 22, pp. 303-304; Tietze, F., Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues (1969) Anal. Biochem., 27, pp. 502-522; Voet, D., Voet, J.G., (1990) Biochemistry, 1223p. , Wiley Liss, New York; Vornov, J.J., Coyle, J.T., Glutamate neurotoxicity and the inhibition of protein synthesis in the hippocampal slice (1991) J. Neurochem., 56, pp. 996-1006","Schubert, D.; Cellular Neurobiology Lab, Salk Inst. for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States",,,,,,,,00219525,,JCLBA,9628898,"English","J. Cell Biol.",Article,Scopus,2-s2.0-0032526940
"Sagara, Y., Dargusch, R., Chambers, D., Davis, J., Schubert, D., Maher, P.","Cellular mechanisms of resistance to chronic oxidative stress",1998,"Free Radical Biology and Medicine","24","9",,"1375","1389",,132,10.1016/S0891-5849(97)00457-7,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0031866530&partnerID=40&md5=68c31be2871b68e567c50303f33112fb","The Salk Inst. for Biol. Studies, San Diego, CA, United States; The Scripps Research Institute, San Diego, CA, United States","Sagara, Y., The Salk Inst. for Biol. Studies, San Diego, CA, United States; Dargusch, R., The Salk Inst. for Biol. Studies, San Diego, CA, United States; Chambers, D., The Salk Inst. for Biol. Studies, San Diego, CA, United States; Davis, J., The Salk Inst. for Biol. Studies, San Diego, CA, United States; Schubert, D., The Salk Inst. for Biol. Studies, San Diego, CA, United States; Maher, P., The Scripps Research Institute, San Diego, CA, United States","Oxidative stress is implicated in several pathologies such as AIDS, Alzheimer's disease, and Parkinson's disease, as well as in normal aging. As a model system to study the response of cells to oxidative insults, glutamate toxicity on a mouse nerve cell line, HT-22, was examined. Glutamate exposure kills HT-22 via a nonreceptor-mediated oxidative pathway by blocking cystine uptake and causing depletion of intracellular glutathione (GSH), leading to the accumulation of reactive oxygen species and, ultimately, apoptotic cell death. Several HT-22 subclones that are 10-fold resistant to exogenous glutamate were isolated and the mechanisms involved in resistance characterized. The expression levels of neither heat shock proteins nor apoptosis-related proteins are changed in the resistant cells. In contrast, the antioxidant enzyme catalase, but not glutathione peroxidase nor superoxide dismutase, is more highly expressed in the resistant than in the parental cells. In addition, the resistant cells have enhanced rates of GSH regeneration due to higher activities of the GSH metabolic enzymes γ- glutamylcysteine synthetase and GSH reductase, and GSH S-transferases activities are also elevated. As a consequence of these alterations, the glutamate resistant cells are also more resistant to organic hydroperoxides and anticancer drugs that affect these GSH enzymes. These results indicate that resistance to apoptotic oxidative stress may be acquired by coordinated changes in multiple antioxidant pathways.","Apoptosis; Free radical; Glutamate toxicity; Glutathione metabolism; Oxidative stress; Reactive oxygen species","free radical; glutathione peroxidase; acquired immune deficiency syndrome; aging; alzheimer disease; animal cell; antioxidant activity; article; mouse; nonhuman; oxidative stress; parkinson disease; pathophysiology; priority journal; Animals; Antioxidants; bcl-2-Associated X Protein; Biological Transport; Catalase; Cell Line; Cell Survival; Cystathionine; Cystine; Drug Resistance; Glutamate-Cysteine Ligase; Glutamic Acid; Glutathione; Heat-Shock Proteins; Homocysteine; Mice; Neoplasm Proteins; Oxidative Stress; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Time Factors; Up-Regulation; Animalia",,"Antioxidants; bcl-2-Associated X Protein; biliverdin reductase, EC 1.3.1.24; Catalase, EC 1.11.1.6; Cystathionine, 56-88-2; Cystine, 56-89-3; Glutamate-Cysteine Ligase, EC 6.3.2.2; Glutamic Acid, 56-86-0; Glutathione, 70-18-8; Heat-Shock Proteins; homocysteic acid, 1001-13-4; Homocysteine, 454-28-4; MCL1 protein; Neoplasm Proteins; Oxidoreductases Acting on CH-CH Group Donors, EC 1.3.-; Oxidoreductases, EC 1.-; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins",,,,"Halliwell, B., Oxidants and human disease: Some new concepts (1987) FASEB J., 1, pp. 358-364; Ames, B.N., Shigenaga, M.K., Hagen, T.M., Oxidants, antioxidants, and the degenerative diseases of aging (1993) Proc. Natl. Acad. Sci. USA, 90, pp. 7915-7922; Halliwell, B., Gutteridge, J.M.C., (1993) Free Radicals in Biology and Medicine, , Oxford, UK: Clarendon; Keaney J.F., Jr., Vita, J.A., Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action (1995) Prog. Cardiovascular Dis., 38, pp. 129-154; Adelman, R., Saul, R.L., Ames, B.N., Oxidative damage to DNA: Relation to species metabolic rate and life span (1988) Proc. Natl. Acad. Sci. USA, 85, pp. 2706-2710; Muehlmatter, D., Larsson, R., Cerutti, P., Active oxygen induced strand breakage and poly ADP-ribosylation in promotable and nonpromotable JB6 mouse epidermal cells (1988) Carcinogenesis, 9, pp. 239-247; Coyle, J.T., Puttfarcken, P., Oxidative stress, glutamate, and neurodegenerative disorders (1993) Science, 262, pp. 689-695; Riederer, P., Sofic, E., Rausch, W.D., Schmidt, B., Reynolds, G.P., Jellinger, K., Youdim, M.B.H., Transition metals, ferritin, glutathione and ascorbic acid in Parkinsonian brains (1989) J. Neurochem., 52, pp. 515-520; Bergeron, C., Oxidative stress: Its role in the pathogenesis of amyotrophic lateral sclerosis (1995) J. Neurol. Sci., 129, pp. 81-S84; Williams, L.R., Oxidative stress, age-related neuro-degeneration, and the potential for neurotrophic treatment (1995) Cerebro. Brain Metab. Rev., 7, pp. 55-73; Benzi, G., Moretti, A., Are reactive oxygen species involved in Alzheimer's disease? (1995) Neurobiol. Aging, 16, pp. 661-674; Beal, M.F., Aging, energy, and oxidative stress in neurodegenerative diseases (1995) Ann. Neurol., 38, pp. 357-366; Jenner, P., Oxidative stress as a cause of Parkinson's disease (1991) Acta Neurol. Scand., 136 (SUPPL.), pp. 6-15; Gerlach, M., Ben-Shachar, D., Riederer, P., Youdim, M.B.H., Altered brain metabolism of iron as a cause of neurodegenerative diseases? (1994) J. Neurochem., 63, pp. 793-807; Hall, E.D., Braughler, J.M., Central nervous system trauma and stroke. II. physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation (1989) Free Radic. Biol. Med., 6, pp. 303-313; Meister, A., Glutathione metabolism (1995) Meth. Enzymol., 251, pp. 3-7; Meister, A., Glutathione deficiency produced by inhibition of its synthesis, and its reversal: Applications in research and therapy (1991) Pharmacol. Ther., 51, pp. 155-194; Bast, A., Haenen, G.R., Regulation of lipid peroxidation by glutathione and lipoic acid: Involvement of liver microsomal vitamin E free radical reductase (1990) Adv. Exp. Med. Biol., 264, pp. 111-116; Fahey, R.C., Sundquist, A.R., Evolution of glutathione metabolism (1991) Adv. Enzymol., 64, pp. 1-53; Mårtensson, J., Jain, A., Frayer, W., Meister, A., Glutathione metabolism in the lung: Inhibition of its synthesis leads to lamellar body and mitochondrial defects (1989) Proc. Natl. Acad. Sci. USA, 86, pp. 5296-5300; Bannai, S., Ishii, T., Transport of cystine and cysteine and cell growth in cultured human diploid fibroblasts: Effect of glutamate and homocysteate (1982) J. Cell. Physiol., 112, pp. 265-272; Christensen, H.N., Role of amino acid transport and countertransport in nutrition and metabolism (1990) Physiol. Rev., 70, pp. 43-77; Makowske, M., Christensen, H.N., Contrasts in transport systems for anionic amino acids in hepatocytes and a hepatoma cell line HTC (1982) J. Biol. Chem., 257, pp. 5663-5670; Bannai, S., Transport of cystine and cysteine in mammalian cells (1984) Biochim. Biophys. Acta, 779, pp. 289-306; Murphy, T.H., Miyamoto, M., Sastre, A., Schnaar, R.L., Coyle, J.T., Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress (1989) Neuron, 2, pp. 1547-1558; Cho, Y., Bannai, S., Uptake of glutamate and cystine in C6 glioma cells and in cultured astrocytes (1990) J. Neurochem., 55, pp. 2091-2097; Murphy, T.H., Schnaar, R.L., Coyle, J.T., Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake (1990) FASEB J., 4, pp. 1624-1633; Sagara, J., Miura, K., Bannai, S., Cystine uptake and glutathione level in fetal brain cells in primary culture and in suspension (1993) J. Neurochem., 61, pp. 1667-1671; Oka, A., Belliveau, M.J., Rosenberg, P.A., Volpe, J.J., Vulnerability of oligodendroglia to glutamate: Pharmacology, mechanisms, and prevention (1993) J. Neurosci., 13, pp. 1441-1453; Davis, J.B., Maher, P., Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line (1994) Brain Res., 652, pp. 169-173; Maher, P., Davis, J.B., The role of monoamine metabolism in oxidative glutamate toxicity (1996) J. Neurosci., 16, pp. 6394-6401; Ratan, R.R., Murphy, T.H., Baraban, J.M., Oxidative stress induces apoptosis in embryonic cortical neurons (1994) J. Neurochem., 62, pp. 376-379; Vogt, M., Dulbecco, R., Steps in the neoplastic transformation of hamster embryo cells by polyoma virus (1963) Proc. Natl. Acad. Sci. USA, 49, pp. 171-179; Morimoto, B.H., Koshland, D.E., Induction and expression of long and short term neourosecretory potentiation in a neural cell line (1990) Neuron, 5, pp. 875-880; Schubert, D., Heinemann, S., Carlisle, W., Tarikas, H., Kimes, B., Steinbach, J.H., Culp, W., Brandt, B.L., Clonal cell lines from the rat central nervous system (1974) Nature, 249, pp. 224-227; Sagara, Y., Dargusch, R., Klier, F.G., Schubert, D., Behl, C., Increased antioxidant enzyme activity in amyloid β protein resistant cells (1996) J. Neurosci., 16, pp. 497-505; Hansen, M.B., Nielsen, S.E., Berg, K., Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell killing (1989) J. Immunol. Meth., 119, pp. 203-210; Behl, C., Davis, J.B., Lesley, R., Schubert, D., Hydrogen peroxide mediates amyloid β protein toxicity (1994) Cell, 77, pp. 817-827; Abe, K., Kimura, H., Amyloid β toxicity consists of a Ca-independent early phase and a Ca-dependent late phase (1996) J. Neurochem., 67, pp. 2074-2078; Chomczynski, P., Sacchi, N., Single step method of RNA isolation by acid-thiocyanate phenol-chloroform extraction (1987) Anal. Biochem., 162, pp. 156-159; Kimura, H., Fischer, W.H., Schubert, D., Structure, expression and function of a Schwannoma-derived growth factor (1990) Nature, 348, pp. 257-260; Tietze, F., Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues (1969) Anal. Biochem., 27, pp. 502-522; Griffith, O.W., Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine (1980) Anal. Biochem., 106, pp. 207-212; Aebi, H., Methods of enzymatic analysis (1974) Catalase. I, pp. 673-684. , H. Bergmeyer. New York: Academic Press; Günzler, W., Flohe, L., Glutathione peroxidase (1985) Handbook of Methods for Oxygen Radical Research, pp. 285-290. , R. Greenwald. Boca Raton, FL: CRC Press; McCord, J.M., Fridovich, I., Superoxide dismutase: An enzymic function for erythrocuperin (hemocuperin) (1969) J. Biol. Chem., 244, pp. 6049-6055; Seelig, G.F., Meister, A., Glutamyl biosynthesis: Γ-glutamylcysteine synthetase from rat kidney (1985) Meth. Enzymol., 113, pp. 379-392; Carlberg, I., Mannervik, B., Glutathione reductase (1985) Meth. Enzymol., 113, pp. 484-490; Warholm, M., Guthenberg, C., Von Bahr, C., Mannervik, B., Glutathione transferases from human liver (1985) Meth. Enzymol., 113, pp. 499-504; Bass, D.A., Parce, J.W., Dechatelet, L.R., Szejda, P., Seeds, M.C., Thomas, M., Flow cytometric studies of oxidative product formation by neutrophils: A graded response to membrane stimulation (1983) J. Immunol., 130, pp. 1910-1917; Hedley, D.W., Chow, S., Evaluation of methods for measuring cellular glutathione content using flow cytometry (1994) Cytometry, 15, pp. 349-358; Schubert, D., Kimura, H., Maher, P., Growth factors and vitamin E modify neuronal glutamate toxicity (1992) Proc. Natl. Acad. Sci. USA, 89, pp. 8264-8267; Behl, C., Hovey, L., Krajewski, S., Schubert, D., Reed, J.C., BCL-2 prevents killing of neuronal cells by glutamate but not by amyloid beta protein (1993) Biochem. Biophys. Res. Comm., 197, pp. 949-956; Froissard, P., Monrocq, H., Duval, D., Role of glutathione metabolism in the glutamate-induced programmed cell death of neuronal-like PC12 cells (1997) Eur. J. Pharmacol., 326, pp. 93-99; Bridges, R.J., Stanley, M.S., Anderson, M.W., Cotman, C.W., Chamberlin, A.R., Conformationally defined neurotransmitter analogues. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereomer (1991) J. Med. Chem., 34, pp. 717-725; Reed, D.J., Cystathionine (1995) Meth. Enzymol., 252, pp. 92-102; Kane, D.J., Ord, T., Anton, R., Bredesen, D.E., Expression of bcl-2 inhibits necrotic neural cell death (1995) J. Neurosci. Res., 40, pp. 269-275; Lindquist, S., Craig, E.A., The heat shock proteins (1988) Ann. Rev. Genet., 22, pp. 631-637; Barbe, M., Tytell, M., Gower, D., Welch, W., Hyperthermia protects against light damage in the rat retina (1988) Science, 241, pp. 1817-1820; Chopp, M., Chen, H., Ho K., -L., Dereski, M.O., Brown, E., Hetzel, F.W., Welch, K.M., Transient hyperthermia protects against subsequent forebrain ischemic cell damage in the rat (1989) Neurol., 39, pp. 1396-1398; Rordorf, G., Koroshetz, W.J., Bonventre, J.V., Heat shock protects cultured neurons from glutamate toxicity (1991) Neuron, 7, pp. 1043-1051; Lowenstein, D.H., Chan, P.H., Miles, M.F., The stress protein response in cultured neurons: Characterization and evidence for a protective role in excitotoxicity (1991) Neuron, 7, pp. 1053-1060; Simon, M.M., Reikerstorfer, A., Schwarz, A., Krone, C., Luger, T.A., Jäättelä, M., Schwarz, T., Heat shock protein 70 overexpression affects the response to ultraviolet light in murine fibroblasts (1995) J. Clin. Invest., 95, pp. 926-933; Saunders, E.L., Maines, M.D., Meredith, M.J., Freeman, M.L., Enhancement of heme oxygenase-1 synthesis by glutathione depletion in Chinese hamster ovary cells (1991) Arch. Biochem. Biophys., 288, pp. 368-373; Ewing, J.F., Maines, M.D., Glutathione depletion induces heme oxygenase-1 (HSP32) mRNA and protein in rat brain (1993) J. Neurochem., 60, pp. 1512-1519; Maines, M.D., Heme oxygenase: Function, multiplicity, regulatory mechanisms, and clinical applications (1988) FASEB J., 2, pp. 2557-2568; Stocker, P., Glazer, A.N., Ames, B.N., Antioxidant activity of albumin bound bilirubin (1987) Proc. Natl. Acad. Sci. USA, 84, pp. 5918-5923; Stocker, P., Yamamoto, Y., McDonagh, A.F., Glazer, A.N., Ames, B.N., Bilirubin is an antioxidant of possible physiological importance (1987) Science, 235, pp. 1043-1047; Meister, A., Anderson, M.E., Glutathione (1983) Ann. Rev. Biochem., 52, pp. 711-760; Bailey, H.H., Gipp, J.J., Ripple, M., Wilding, G., Mulcahy, R.T., Increase in γ-glutamylcysteine synthetase activity and steady-state messenger RNA levels in melphalan-resistant DU-145 human prostate carcinoma cells expressing elevated glutathione levels (1992) Cancer Res., 52, pp. 5115-5118; Spitz, D.R., Kinter, M.T., Roberts, R.J., Contribution of increased glutathione content to mechanisms of oxidative stress resistance in hydrogen peroxide resistant hamster fibroblasts (1995) J. Cell. Physiol., 165, pp. 600-609; Godwin, A.K., Meister, A., O'Dwyer, P.J., Huang, C.S., Hamilton, T.C., Anderson, M.E., High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis (1992) Proc. Natl. Acad. Sci. USA, 89, pp. 3070-3074; Meister, A., Methods for the selective modification of glutathione metabolism and study of glutathione transport (1985) Meth. Enzymol., 113, pp. 571-585; Griffith, O.W., Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis (1982) J. Biol. Chem., 258, pp. 1591-1598; Moore, W.R., Anderson, M.E., Meister, A., Murata, K., Kimura, A., Increased capacity for glutathione synthesis enhances resistance to radiation in Escherichia coli: A possible model for mammalian cell protection (1989) Proc. Natl. Acad. Sci. USA, 86, pp. 1461-1464; (1988) Glutathione Coenzymes and Cofactors, , D. Dolphin, R. Poulson, & O. Avramovic. New York: Wiley; Yokomizo, A., Kohno, K., Wada, M., Ono, M., Morrow, C.S., Cowan, K.H., Kuwano, M., Markedly decreased expression of glutathione S-transferase π gene in human cancer cell lines resistant to buthionine sulfoximine, an inhibitor of cellular glutathione synthesis (1995) J. Biol. Chem., 270, pp. 19451-19457; Liebmann, J., Fisher, J., Lipschultz, C., Kuno, R., Kaufman, D.C., Enhanced glutathione peroxidase expression protects cells from hydroperoxides but not from radiation or doxorubicin (1995) Cancer Res., 55, pp. 4465-4470; Mulcahy, R.T., Bailey, H.H., Gipp, J.J., Transfection of complementary DNAs for the heavy and light subunits of human γ-glutamylcysteine synthetase results in an elevation of intracellular glutathione and resistance to melphalan (1995) Cancer Res., 55, pp. 4771-4775; Srivastava, S.K., Beutler, E., The transport of oxidized glutathione from human erythrocytes (1969) J. Biol. Chem., 244, pp. 9-16; Becker, K., Shirmer, R.H., 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) as thiol-carbamoylating agent in biological systems (1995) Meth. Enzymol., 251, pp. 173-188; Anderson, M.E., Meister, A., Transport and direct utilization of γ-glutamylcyst(e)ine for glutathione synthesis (1983) Proc. Natl. Acad. Sci. USA, 80, pp. 707-711; Forman, H.J., Shi, M.M., Iwamoto, T., Liu, R.-M., Robinson, T.W., Measurement of γ-glutamyl transpeptidase and γ-glutamylcysteine synthetase activities in cells (1995) Meth. Enzymol., 252, pp. 66-71; Sweiry, J.H., Sastre, J., Viã, J., Elss̈ser, H.P., Mann, G.E., A role for γ-glutamyl transpeptidase and the amino acid transport system x c- In cystine transport by a human pancreatic duct cell line (1995) J. Physiol., 485, pp. 167-177; Kugelman, A., Choy, H.A., Liu, R., Shi, M.M., Gozal, E., Forman, H.J., γ-glutamyl transpeptidase is increased by oxidative stress in rat alveolar L2 epithelial cells (1994) Am. J. Cell Molec. Biol., 11, pp. 586-592; Pickett, C.B., Lu, A.Y., Glutathione S-transferases: Gene structure, regulation, and biological function (1989) Ann. Rev. Biochem., 58, pp. 743-764; Nicholson, D.W., Ali, A., Vaillancourt, J.P., Calaycay, J.R., Mumford, R.A., Zamboni, R.J., Ford-Hutchinson, A.W., Purification to homogeneity and the N-terminal sequence of a human leukotriene C4 synthase: A homodimeric glutathione S-transferase composed of 18-kDa subunits (1993) Proc. Natl. Acad. Sci. USA, 90, pp. 2015-2019; Cagen, L.M., Pisano, J.J., Ketley, J.N., Habig, W.H., Jakoby, W.B., The conjugation of prostaglandin A1 and glutathione catalyzed by homogeneous glutathione S-transferases from human and rat liver (1975) Biochim. Biophys. Acta, 398, pp. 205-208; Mannervik, B., The isoenzymes of glutathione transferase (1985) Adv. Enzymol. Relat. Areas Molec. Biol., 57, pp. 357-417; Ketterer, B., Tan, K.H., Meyer, D.J., Coles, B., Glutathione transferases: A possible role in the detoxification of DNA and lipid hydroperoxides (1987) Glutathione S-transferases and Carcinogenesis, pp. 149-164. , T.J. Mantle, C.B. Pickett, & J.D. Hayes. London: Taylor & Francis; Beckett, G.J., Hayes, J.D., Glutathione S-transferases: Biomedical applications (1993) Adv. Clin. Chem., 30, pp. 281-380; Tew, K.D., Glutathione-associated enzymes in anticancer drug resistance (1994) Cancer Res., 54, pp. 4313-4320; Colvin, O.M., Mechanisms of resistance to alkylating agents (1994) Anticancer Drug Resistance: Advances in Molecular and Clinical Research, pp. 249-262. , L.J. Goldstein, & R.F. Ozols. New York: Academic Press; Ploemen, J.H.T.M., Van Schanke, A.V., Van Ommen, B.V., Van Bladeren, P.J., Reversible conjugation of ethacrynic acid with glutathione and human glutathione S-transferase P1-1 (1994) Cancer Res., 54, pp. 915-919; Phillips, M.F., Mantle, T.J., Inactivation of mouse liver glutathione S-transferase YfYf (Pi class) by ethacrynic acid and 5,5′-dithiobis-(2-nitrobenzoic acid) (1991) Biochem. J., 275, pp. 703-709; Bolton, M.G., Colvin, O.M., Hilton, J., Specificity of isozymes of murine hepatic glutathione S-transferase for the conjugation of glutathione with L-phenylalanine mustard (1991) Cancer Res., 51, pp. 2410-2415; Muller, J.G., Bucheler, U.S., Kayser, K., Schirmer, R.H., Werner, D., Krauth-Siegel, R.L., Glutathione reductase in human and murine lung tumors: High levels of mRNA and enzymatic activity (1993) Cell. Molec. Biol., 39, pp. 389-396; Hart, B.A., Gong, Q., Eneman, J.D., Durieux-Lu, C.C., Kimberly, P., Hacker, M.P., Increased oxidant resistance of alveolar macrophages isolated from rats repeatedly exposed to cadmium aerosols (1996) Toxicol., 107, pp. 163-175; Rickman, P., Meister, A., Regulation of γ-glutamylcysteine synthetase by nonallosteric feedback inhibition by glutathione (1975) J. Biol. Chem., 254, pp. 7558-7560; Woods, J.S., Ellis, M.E., Up-regulation of glutathione synthesis in rat kidney by methyl mercury. Relationship to mercury-induced oxidative stress (1995) Biochem. Pharmacol., 50, pp. 1719-1724; Miyamoto, M., Murphy, T.H., Schnaar, R.L., Coyle, J.T., Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line (1989) J. Pharmacol. Exp. Ther., 250, pp. 1132-1140; Greenlund, L.J.S., Deckwerth, T.L., Johnson E.M., Jr., Superoxide dismutase delays neuronal apoptosis: A role for reactive oxygen species in programmed neuronal death (1995) Neuron, 14, pp. 303-315; Prehn, J.H., Bindokas, V.P., Jordan, J., Galindo, M.F., Protective effect of transforming growth factor-beta 1 on beta-amyloid neurotoxicity in rat hippocampal neurons (1996) Molec. Pharmacol., 49, pp. 319-328; Bar-Peled, O., Korkotian, E., Segal, M., Groner, Y., Constitutive overexpression of Cu/Zn superoxide dismutase exacerbates kainic acid-induced apoptosis of transgenic-Cu/Zn superoxide dismutase neurons (1996) Proc. Natl. Acad. Sci. USA, 93, pp. 8530-8535; Tan, K.H., Meyer, D.J., Coles, B., Ketterer, B., Thymine hydroperoxide, a substrate for rat Se-dependent glutathione peroxidase and glutathione transferase isoenzymes (1986) FEBS, 207, pp. 231-233; Tan, K.H., Meyer, D.J., Gillies, N., Ketterer, B., Detoxification of DNA hydroperoxide by glutathione transferases and the purification and characterization of glutathione transferases of the rat liver nucleus (1988) Biochem. J., 254, pp. 841-845; Johnson, J.A., El Barbary, A., Kornguth, S.E., Brugge, J.F., Glutathione S-transferase isoenzymes in rat brain neurons and glia (1993) J. Neurosci., 13, pp. 2013-2023; Philbert, M.A., Beiswanger, C.M., Manson, M.M., Green, J.A., Novak, R.F., Primiano, T., Reuhl, K.R., Lowndes, H.E., Glutathione S-transferases and γ-glutamyl transpeptidase in the rat nervous system: A basis for differential susceptibility to neurotoxicants (1995) NeuroToxicol., 16, pp. 349-362; Perry, T.L., Godin, D.V., Hansen, S., Parkinson's disease: A disorder due to nigral glutathione deficiency? (1982) Neurosci. Lett., 33, pp. 305-310; Sian, J., Dexter, D.T., Lees, A.J., Daniels, S., Agid, Y., Javoy-Agid, F., Jenner, P., Marsden, C.D., Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia (1994) Ann. Neurol., 36, pp. 348-355; Shivakumar, B.R., Kolluri, S.V.R., Ravindranath, V., Glutathione and protein thiol homeostasis in brain during reperfusion after cerebral ischemia (1995) J. Pharmacol. Exp. Ther., 274, pp. 1167-1173; Chen, T.S., Richie J.P., Jr., Lang, C.A., The effect of aging on glutathione and cysteine levels in different regions of the mouse brain (1989) Proc. Soc. Exp. Biol. Med., 190, pp. 399-402; Benzi, G., Pastoris, O., Gorini, A., Marzatico, F., Villa, R.F., Curti, D., Influence of aging on the acute depletion of reduced glutathione induced by electrophilic agents (1991) Neurobiol. Aging, 12, pp. 227-231; Adams J.D., Jr., Klaidman, L.K., Odunze, I.N., Shen, H.C., Miller, C.A., Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E (1991) Molec. Chem. Neuropathol., 14, pp. 213-225; Lovell, M.A., Ehmann, W.D., Butler, S.M., Markesbery, W.R., Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease (1995) Neurol., 45, pp. 1594-1601; Meredith, M.J., Reed, D.J., Depletion in vitro of mitochondrial glutathione in rat hepatocyte and enhancement of lipid peroxidation by adriamycin and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) (1983) Biochem. Pharmacol., 32, pp. 1383-1388; Fahey, R.C., Newton, G.L., Arrick, B., Overdank-Bogart, T., Aley, S.B., Entamoeba histolytica: A eukaryote without glutathione metabolism (1984) Science, 224, pp. 70-72","Sagara, Y.; Salk Inst. for Biological Studies, P.O. Box 85800, San Diego, CA 92186 5800, United States; email: sagara@salk.edu",,,,,,,,08915849,,FRBME,9641255,"English","Free Radic. Biol. Med.",Article,Scopus,2-s2.0-0031866530
"Li, Y., Maher, P., Schubert, D.","Requirement for cGMP in nerve cell death caused by glutathione depletion",1997,"Journal of Cell Biology","139","5",,"1317","1324",,92,10.1083/jcb.139.5.1317,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0030782430&partnerID=40&md5=d7020de20056d87bbf8ab01bad30fab1","Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA 92037, United States; Department of Cell Biology, Scripps Research Institute, San Diego, CA 92037, United States; Cellular Neurobiology Lab., Salk Inst. for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States","Li, Y., Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA 92037, United States; Maher, P., Department of Cell Biology, Scripps Research Institute, San Diego, CA 92037, United States; Schubert, D., Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA 92037, United States, Cellular Neurobiology Lab., Salk Inst. for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States","Glutathione depletion occurs in several forms of apoptosis and is associated with Parkinson's disease and HIV toxicity. The neurotransmitter glutamate kills immature cortical neurons and a hippocampal nerve cell line via an oxidative pathway associated with glutathione depletion. It is shown here that soluble guanylyl cyclase (sGC) activity is required for nerve cell death caused by glutathione depletion. Inhibitors of sGC block glutamate toxicity and a cGMP analogue potentiates cell death. Glutamate also induces an elevation of cGMP that occurs late in the cell death pathway. The resultant cGMP modulates the increase in intracellular calcium that precedes cell death because sGC inhibitors prevent calcium elevation and the cGMP analogue potentiates the increase in intracellular calcium. These results suggest that the final pathway of glutamate induced nerve cell death is through a cGMP-modulated calcium channel.",,"calcium channel; cyclic GMP; cyclic GMP derivative; glutamic acid; glutathione; guanylate cyclase; neurotransmitter; animal cell; article; brain cell; calcium cell level; controlled study; embryo; enzyme activity; glutathione metabolism; hippocampus; mouse; nerve cell necrosis; nonhuman; oxidative stress; Parkinson disease; priority journal; rat; Animals; Apoptosis; Buthionine Sulfoximine; Calcium; Carbon Monoxide; Cell Line; Cell Membrane Permeability; Cerebral Cortex; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Enzyme Activation; Enzyme Inhibitors; Glutamic Acid; Glutathione; Guanylate Cyclase; Hippocampus; Mice; Neurons; Nitric Oxide; Signal Transduction; Animalia",,"Buthionine Sulfoximine, 5072-26-4; Calcium, 7440-70-2; Carbon Monoxide, 630-08-0; Cyclic GMP, 7665-99-8; Cyclic GMP-Dependent Protein Kinases, EC 2.7.1.37; Enzyme Inhibitors; Glutamic Acid, 56-86-0; Glutathione, 70-18-8; Guanylate Cyclase, EC 4.6.1.2; Nitric Oxide, 10102-43-9",,,,"Abe, K., Takayanagi, M., Saito, H., Effects of recombinant human basic FGF and its modified protein CS23 on survival of primary cultured neurons from various regions of fetal rat brain (1990) Jpn. J. Pharmacol., 53, pp. 221-227; Ameisen, J.C., Estaquier, J., Idziorek, T., De Bels, F., Programmed cell death and AIDS: Significance, perspectives and unanswered questions (1995) Cell Death Diff., 2, pp. 9-22; Barger, S.W., Fiscus, R.R., Ruth, P., Hofmann, F., Mattson, M.P., Role of cyclic GMP in the regulation of neuronal calcium and survival by secreted forms of β-amyloid precursor (1995) J. Neurochem., 64, pp. 2087-2096; Beaver, J.P., Waring, P., A decrease in intracellular glutathione concentration precedes the onset of apoptosis in murine thymocytes (1995) Eur. J. Cell Biol., 68, pp. 47-54; Bowes, C., Li, T., Danciger, M., Baxter, L.C., Applebury, M.L., Farber, D.B., Retinal degeneration in the rd mouse is caused by a defect in the β subunit of rod cGMP-phosphodiesterase (1990) Nature, 347, pp. 677-681; Brune, B., Ullrich, V., 12-Hydroperoxyeicosatetraenoic acid inhibits main platelet functions by activation of soluble guanylate cyclase (1991) Mol. Pharmacol., 39, pp. 671-678; Davis, J.B., Maher, P., Protein kinase C activation inhibits glutamate-induced cytoxicity in a neuronal cell line (1994) Brain Res., 652, pp. 169-173; Deguchi, T., Saito, M., Kono, M., Blockade by N-methylhydroxylamine of activator of guanylate cyclase and elevations of guanosine 3′,5′-monophosphate levels in nervous tissues (1978) Biochem. Biophys. Acta, 544, pp. 8-19; Farinelli, S.E., Park, D.S., Greene, L.A., Nitric oxide delays the death of trophic factor-deprived PC12 cells and sympathetic neurons by a cGMP-mediated mechanism (1996) J. Neurosci., 16, pp. 2325-2334; Finn, J.T., Grunwald, M.E., Yau, K.W., Cyclic nuclcotide-gated ion channels: An extended family with diverse functions (1996) Annu. Rev. Physiol., 58, pp. 395-426; Frandsen, A., Anderson, C.F., Schousboe, A., Possible role of cGMP in excitatory amino acid induced cytotoxicity in cultured cerebral cortical neurons (1992) Neurochem. Res., 17, pp. 35-43; Frey II, W.H., Senogles, S.E., Heston, L.L., Tuason, V.B., Nicol, S.E., Catecholamine-sensitive guanylate cyclase from human caudate nucleus (1980) J. Neurochem., 35, pp. 1418-1430; Garthwaite, G., Garthwaite, J., Cyclic GMP and cell death in rat cerebellar slices (1988) Neuroscience, 26, pp. 321-326; Ghibelli, L., Coppola, S., Rotilio, G., Lafavia, E., Maresca, V., Ciriolo, M.R., Non-oxidative loss of glutathione in apoptosis via GSH extrusion (1995) Biochem. Biophys. Res. Commun., 216, pp. 313-320; Goy, M.F., cGMP: The wayward child of the cyclic nucleotide family (1991) Trends Neurosci., 14, pp. 293-299; Graff, G., Stephenson, J.H., Glass, D.B., Haddox, M.K., Goldberg, N.D., Activation of soluble splenic cell guanylate cyclase by prostaglandin endoperoxides and fatty acid hydroperoxides (1978) J. Biol. Chem., 253, pp. 7662-7676; Gruetter, C.A., Gruitter, D.Y., Lyon, J.E., Kadowitz, P.J., Ignarro, L.J., Relationship between cyclic guanosine 3′:5′-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: Effects of methylene blue and methomoglobin (1981) J. Pharmacol. Exp. Ther., 219, pp. 181-186; Grynkiewicz, G., Poenie, M., Tisen, R.Y., A new generation of Ca++ indicators with greatly improved fluorescence properties (1985) J. Biol. Chem., 260, pp. 3440-3450; Herzenberg, L.A., De Rosa, S.C., Dubs, J.G., Roederer, M., Anderson, M.T., Ela, S.W., Dercsinski, S.C., Herzenberg, L.A., Glutathione deficiency is associated with impaired survival in HIV disease (1997) Proc. Natl. Acad. Sci. USA, 94, pp. 1967-1972; Ito, M., Karachot, L., Messengers mediating long-term desensitization in cerebellar Purkinje cells (1990) Neuroreport, 1, pp. 129-132; Jenner, P., Olanow, C.W., Oxidative stress and the pathogenesis of Parkinson's disease (1996) Neurology, 47, pp. s161-s170; Kaupp, U.B., Family of cyclic nucleotide gated ion channels (1995) Curr. Opin. Neurobiol., 5, pp. 434-442; Khan, A.A., Soloski, M.J., Sharp, A.H., Schiling, G., Sabatini, D.M., Li, S.H., Ross, C.A., Snyder, S.H., Lymphocyte apoptosis: Mediation by increased type 3 inositol 1,4,5-trisphosphate receptor (1996) Science, 273, pp. 503-507; Li, Y., Maher, P., Schubert, D., A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion (1997) Neuron., 19, pp. 453-463; Lolley, R.N., Farber, D.B., Rayborn, M.E., Hollyfield, J.G., Cyclic GMP accumulation causes degeneration of photoreceptor cells: Stimulation of an inherited disease (1977) Science, 196, pp. 664-666; Luond, R.M., McKie, J.H., Douglas, K.T., A direct link between LY83583, a selective repressor of cyclic GMP formation, and glutathione metabolism (1993) Biochem. Pharmacol., 45, pp. 2547-2549; Lustig, H.S., Von Brauchitsch, K.L., Chan, J., Greenberg, D.A., Cyclic GMP modulators and excitoxic injury in cerebral cortical cultures (1992) Brain Res., 577, pp. 343-346; Mayer, B., Schrammel, A., Klatt, P., Koesling, D., Schmidt, K., Peroxynitrite-induced accumulation of cyclic GMP in endothelial cells and stimulation of purified soluble guanylyl cyclase (1995) J. Biol. Chem., 270, pp. 17355-17360; McConkey, D.J., Orrenius, S., Signal transduction pathway to apoptosis (1994) Trends Cell Biol., 4, pp. 370-375; Meister, A., Anderson, M.E., Glutathione (1983) Annu. Rev. Biochem., 52, pp. 711-760; Morimoto, B.H., Koshland, D.E., Induction and expression of long-and short-term neurosecretory potentiation in a neural cell line (1989) Neuron., 5, pp. 875-880; Mosmann, T., Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays (1983) J. Immunol. Methods., 65, pp. 55-63; Mulsch, A., Busse, R., Liebau, S., Forstermainn, U., LY83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase (1988) J. Pharmacol. Exp. Ther., 247, pp. 283-288; Murphy, T.H., Baraban, J.M., Glutamate toxicity in immature cortical neurons precedes development of glutamate receptor currents (1990) Dev. Brain Res., 57, pp. 146-150; Murphy, T.H., Miyamoto, M., Sastre, A., Schnaar, R.L., Coyle, J.T., Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress (1989) Neuron., 2, pp. 1547-1558; Murphy, T.H., Schnaar, R.L., Coyle, J.T., Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake (1990) FASEB (Fed. Am. Soc. Exp. Biol.) J., 4, pp. 1624-1633; Oka, A., Belliveau, M.J., Rosenberg, P.A., Volpe, J.J., Vulnerability of oligodendroglia to glutamate: Pharmacology, mechanisms, and prevention (1993) J. Neurosci., 13, pp. 1441-1453; Palluy, O., Rigaud, M., Nitric oxide induces cultured cortical neuron apoptosis (1996) Neurosci. Lett., 208, pp. 1-4; Perry, T.L., Godin, D.V., Hansen, S., Parkinson's disease: A disorder due to nigral glutathionc deficiency (1982) Neurosci. Lett., 33, pp. 305-310; Pileblad, E., Magnusson, T., Fornstedt, B., Reduction of brain glutathione by L-buthionine sulfoximine potentiates the dopamine-depleting action of 6-hydroxydopamine in rat striatum (1989) J. Neuochem., 52, pp. 978-984; Ratan, R.R., Murphy, T.M., Baraban, J.M., Oxidative stress induces apoptosis in embryonic cortical neurons (1994) J. Neurochem., 62, pp. 376-379; Schmidt, M.J., Sawyer, B.D., Truex, L.L., Marshall, W.S., Fleisch, J.H., LY83583: An agent that lowers intracellular levels of cyclic guanosine 3′.5′-monophosphate (1985) J. Pharmacol. Exp. Ther., 232, pp. 764-769; Sian, J., Dexter, D.T., Lees, A.J., Daniel, S., Agid, Y., Javoy-Agid, F., Jenner, P., Marsden, C.D., Alterations in glutathione levels in Parkinson's divease and other neurodegenerative disorders affecting basal ganglia (1994) Ann. Neurol., 36, pp. 348-355; Slater, A.F., Nobel, C.S., Maellaro, E., Bustamante, J., Kimland, M., Orrenius, S., Nitrone spin traps and a nitroxide antioxidant inhibit a common pathway of thymocyte apoptosis (1995) Biochem. J., 306, pp. 771-778; Snider, R.M., McKinney, M., Forray, C., Rechelson, E., Neurotransmitter receptors mediate cyclic GMP formation by involvement of arachidonic acid and lipoxygenase (1984) Proc. Natl. Acad. Sci. USA, 81, pp. 3905-3909; Sofic, E., Lange, K.W., Riederer, P., Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease (1992) Neurosci. Lett., 142, pp. 128-130; Staal, F.J.T., Ela, S.W., Roederer, M., Anderson, M.T., Herzenberg, L.A., Herzenberg, L.A., Glutathione deficiency and human immunodeli ciency virus infection (1992) Lancet, 339, pp. 909-912; Tietze, F., Enzymatic method for quantification of total and oxidized glutathione: Applications to mammalian blood and other tissues (1969) Anal. Biochem., 27, pp. 502-522; Van Den Dobbelsteen, D.J., Nobel, C.S.I., Schlegel, J., Cotgreave, I.A., Orrenius, S., Slater, A.F.G., Rapid and specific efflux of reduced glutathione during apoptosis induced by anti-Fas/APO-1 antibody (1996) J. Biol. Chem., 271, pp. 15420-15427; Vogt, M., Dulbecco, R., Steps in the neoplastic transformation of hamster embryo cells by polyoma virus (1963) Proc. Natl. Acad. Sci. USA, 49, pp. 171-179; Weill, C.L., Greene, D.P., Prevention of natural motoneurone cell death by dibutyryl cyclic GMP (1984) Nature (Lond.), 308, pp. 452-454; Wu, X.-B., Brune, B., Von Appen, F., Ullrich, V., Reversible activation of soluble guanylate cyclase by oxidizing agents (1992) Arch. Biochem. Biophys., 294, pp. 75-82; Wullner, U., Loschmann, P.A., Schulz, J.B., Schmid, A., Dringen, R., Eblen, F., Turski, L., Klockgether, T., Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurons (1996) Neuroreport, 7, pp. 921-923; Yau, K.W., Cyclic nucleotide-gated channels: An expanding new family of ion channels (1994) Proc. Natl. Acad. Sci. USA, 91, pp. 3481-3483","Schubert, D.; Cellular Neurobiology Lab., Salk Inst. for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States",,,,,,,,00219525,,JCLBA,9382876,"English","J. CELL BIOL.",Article,Scopus,2-s2.0-0030782430
"Liu, Y., Schubert, D.","Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2- yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis",1997,"Journal of Neurochemistry","69","6",,"2285","2293",,145,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0030695856&partnerID=40&md5=104148d29fd9f10c43c45a9a159412cb","Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA, United States; Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, 10010 N. Torrey Pines Rd., San Diego, CA 92037-1099, United States","Liu, Y., Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA, United States, Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, 10010 N. Torrey Pines Rd., San Diego, CA 92037-1099, United States; Schubert, D., Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA, United States","Amyloid β peptide (Aβ) neurotoxicity is believed to play a central role in the pathogenesis of Alzheimer's disease. An early indicator of Aβ toxicity is the inhibition of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) reduction to MTT formazan, a widely used assay for measuring cell viability. In this report we show that Aβ and other cytotoxic-amyloid peptides such as human amylin dramatically enhance MTT formazan exocytosis, resulting in the inhibition of cellular MTT reduction. Only the amyloid peptides that are known to be cytotoxic enhanced MTT formazan exocytosis. Basal MTT formazan exocytosis and amyloid peptide- enhanced MTT formazan exocytosis are blocked by several drugs with diverse known effects. These and other data suggest that MTT formazan exocytosis is a multistep process and that cytotoxic amyloid peptides enhance MTT formazan exocytosis through an intracellular signal transduction pathway.","3-(4,5-Dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide; Alzheimer's disease; Amyloid peptides; Cytotoxicity; Exocytosis","3 (4,5 dimethyl 2 thiazolyl) 2,5 diphenyltetrazolium bromide; amylin; amyloid; calcitonin; formazan; transferrin; alzheimer disease; article; cell viability; cytotoxicity; endocytosis; exocytosis; immunoblotting; microscopy; neurotoxicity; pathogenesis; peptide synthesis; priority journal; signal transduction; Amyloid; Amyloid beta-Protein; Animals; Cell Membrane; Cytotoxins; Exocytosis; Formazans; Humans; Oxidation-Reduction; PC12 Cells; Peptide Fragments; Rats; Signal Transduction; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured",,"amylin, 106602-62-4; Amyloid beta-Protein; Amyloid; Cytotoxins; Formazans; MTT formazan, 23305-68-2; Peptide Fragments; Tetrazolium Salts; Thiazoles; thiazolyl blue, 298-93-1",,,,"Behl, C., Davis, J.B., Cole, G.M., Schubert, D., Vitamin E protects nerve cells from amyloid β protein toxicity (1992) Biochem. Biophys. Res. Commun., 186, pp. 944-952; Behl, C., Davis, J.B., Lesley, R., Schubert, D., Hydrogen peroxide mediates amyloid β protein toxicity (1994) Cell, 77, pp. 817-827; Greene, L.A., Rein, G., Release of [ 3H]norepinephrine from a clonal line of pheochromocytoma cells (PC12) by nicotinic cholinergic stimulation (1977) Brain Res., 137, pp. 521-528; Greene, L.A., Tischler, A.S., Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor (1976) Proc. Natl. Acad. Sci. USA, 73, pp. 2424-2428; Hertel, C., Hauser, N., Schubenel, R., Seilheimer, B., Kemp, J.A., β-Amyloid-induced cell toxicity: Enhancement of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide-dependent cell death (1996) J. Neurochem., 67, pp. 272-276; Kaneko, I., Yamada, N., Sakuraba, Y., Kamenosono, M., Tutumi, S., Suppression of mitochondrial succinate dehydrogenase, a primary target of β-amyloid, and its derivative racemized at Ser residue (1995) J. Neurochem., 65, pp. 2585-2593; Klausner, R.D., Van Renswoude, J., Kempf, C., Rao, K., Bateman, J.L., Robbins, A.R., Failure to release iron from transferrin in a Chinese hamster ovary cell mutant pleiotropically defective in endocytosis (1984) J. Cell Biol., 98, pp. 1098-1101; Knauer, M.F., Soreghan, B., Burdick, D., Kosmoski, J., Glabe, C.G., Intracellular accumulation and resistance to degradation of the Alzheimer's amyloid A4/β protein (1992) Proc. Natl. Acad. Sci. USA, 89, pp. 7437-7441; Liu, Y., Schubert, D., Beta amyloid toxicity does not require RAGE protein (1997) Biochem. Biophys. Res. Commun., , in press; Liu, Y., Peterson, D.A., Kimura, H., Schubert, D., The mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction (1997) J. Neurochem., 69, pp. 581-593; Lorenzo, A., Yankner, B.A., β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red (1994) Proc. Natl. Acad. Sci. USA, 91, pp. 12243-12247; Lorenzo, A., Razzaboni, B., Weir, G.C., Yankner, B.A., Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus (1994) Nature, 368, pp. 756-760; Mosmann, T., Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity (1983) J. Immunol. Methods, 65, pp. 55-63; Pike, C.J., Cummings, B.J., Cotman, C.W., In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity (1991) Brain Res., 563, pp. 311-314; Pollack, S.J., Sadler, I.I.J., Hawtin, S.R., Tailor, V.J., Shearman, M.S., Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of β-amyloid in rat PC12 cells (1995) Neurosci. Lett., 184, pp. 113-116; Pollack, S.J., Sadler, I.I.J., Hawtin, S.R., Tailor, V.J., Shearman, M.S., Sulfonated dyes attenuate the toxic effects of β-amyloid in a structure-specific fashion (1995) Neurosci. Lett., 197, pp. 211-214; Schubert, D., Heinemann, S., Carlisle, W., Tarika, H., Kimes, B., Steinbach, J.H., Culp, W., Brandt, B.L., Clonal cell lines from the rat central nervous system (1974) Nature, 249, pp. 224-227; Schubert, D., Behl, C., Lesley, R., Brack, A., Dargusch, R., Sagara, Y., Kimura, H., Amyloid peptides are toxic via a common oxidative mechanism (1995) Proc. Natl. Acad. Sci. USA, 92, pp. 1989-1993; Shearman, M.S., Ragan, C.I., Iversen, L.L., Inhibition of PC-12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death (1994) Proc. Natl. Acad. Sci. USA, 91, pp. 1470-1474; Shearman, M.S., Hawtin, S.R., Tailor, V.J., The intracellular component of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by β-amyloid peptides (1995) J. Neurochem., 65, pp. 218-227; West, M.A., Bretscher, M.S., Watts, C., Distinct endocytic pathways in epidermal growth factor-stimulated human carcinoma A431 cells (1989) J. Cell Biol., 109, pp. 2731-2739; Yan, S.U., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Schmidt, A.M., RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease (1996) Nature, 382, pp. 685-691; Yankner, B.A., Mechanism of neuronal degeneration in Alzheimer's disease (1996) Neuron, 16, pp. 921-932; Yankner, B.A., Duffy, L.K., Kirschner, D.A., Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides (1990) Science, 250, pp. 279-282","Liu, Y.; Cellular Neurobiology Laboratory, SIBS, 10010 N. Torrey Pines Rd., San Diego, CA 92037-1099, United States",,,,,,,,00223042,,JONRA,9375659,"English","J. NEUROCHEM.",Article,Scopus,2-s2.0-0030695856
"Tan, S., Maher, P., Schubert, D.","The role of protein phosphorylation in beta amyloid toxicity",1997,"Brain Research","765","1",,"159","163",,6,10.1016/S0006-8993(97)00477-0,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0030809628&partnerID=40&md5=373f332da64e5ec820493405b6fe8ace","The Salk Inst. for Biol. Studies, San Diego, CA 92037, United States; Scripps Research Institute, San Diego, CA 92037, United States","Tan, S., The Salk Inst. for Biol. Studies, San Diego, CA 92037, United States; Maher, P., Scripps Research Institute, San Diego, CA 92037, United States; Schubert, D., The Salk Inst. for Biol. Studies, San Diego, CA 92037, United States","Recent evidence suggests that amyloid beta protein (Aβ) mediates the neurotoxicity observed in Alzheimer's disease (AD). Little is known, however, about the cytotoxic pathway leading to nerve cell death. Using a rat brain cell line which is sensitive to Aβ, it is shown that a 50-60 kDa protein becomes more phosphorylated when cells are exposed to Aβ. Several kinase and phosphatase inhibitors block both the increase in phosphorylation of the 50- 60 kDa protein and Aβ toxicity. In contrast, a tyrosine kinase inhibitor blocks toxicity at a step which is distinct from the phosphorylation of this protein. A β also causes a general increase in overall phosphatase activity. It is therefore likely that a protein phosphorylation cascade is involved in Aβ toxicity.","Alzheimer's disease; Amyloid beta (Aβ); Cytotoxicity; Phosphorylation","amyloid beta protein; alzheimer disease; animal cell; article; cell death; enzyme activity; neurotoxicity; nonhuman; pathophysiology; priority journal; protein phosphorylation; rat; Amyloid beta-Protein; Animals; Biotransformation; Cells, Cultured; Cerebral Cortex; Clone Cells; Enzyme Inhibitors; Kinetics; Neurotoxins; Phosphoric Monoester Hydrolases; Phosphorylation; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Rats",,"Amyloid beta-Protein; Enzyme Inhibitors; Neurotoxins; Phosphoric Monoester Hydrolases, EC 3.1.3.-; Protein Kinase Inhibitors; Protein-Tyrosine Kinases, EC 2.7.1.112",,,,"Ahn, N.G., Krebs, E.G., Evidence for an epidermal growth factor-stimulated protein kinase activity by myelin basic protein kinases in vitro (1990) J. Biol. Chem., 265, pp. 11495-11501; Behl, C., Davis, J.B., Lesley, R., Schubert, D., Hydrogen peroxide mediates amyloid β protein toxicity (1994) Cell, 77, pp. 817-827; Busciglio, J., Lorenzo, A., Yeh, J., Yankner, B.A., Beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding (1995) Neuron, 14, pp. 879-888; Cohen, P., The subunit structure of rabbit-skeletal-muscle phosphorylase kinase, and the molecular basis of its activation reactions (1973) Eur. J. Biochem., 34, pp. 453-508; Cohen, P., The structure and regulation of protein phosphatases (1989) Ann. Rev. Biochem., 58, pp. 453-508; Enan, E., Matsumura, F., Specific inhibition of calcineurin by type II synthetic pyrethroid insecticides (1992) Biochem. Pharmacol., 43, pp. 1777-1784; Garver, T.D., Harris, K.A., Lehman, R.A., Lee, V.M., Trojanowski, J.Q., Billingsley, M.L., Tau phosphorylation in human, primate, and rat brain: Evidence that a pool of tau is highly phosphorylated in vivo and is rapidly dephosphorylated in vitro (1994) J. Neurochem., 63, pp. 2279-2287; Glenn, G., Mutation of a cysteine residue in polyomavirus middle T antigen abolishes interactions with protein phosphatase 2A, pp60c-src, and phosphatidylinositol-3 kinase, activation of c-fos expression, and cellular transformation (1993) J. Virol., 67, pp. 1945-1952; Gong, C.-X., Singh, T.J., Grundke-Iqbal, I., Iqbal, K., Phosphoprotein phosphatase activities in Alzheimer disease brain (1993) J. Neurochem., 61, pp. 921-927; Goodman, E.B., Tenner, A.J., Signal transduction mechanisms of C1q-mediated superoxide production. Evidence for the involvement of temporally distinct staurosporine-insensitive and sensitive pathways (1992) J. Immuno., 148, pp. 3920-3928; Goodman, Y., Mattson, M.P., Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid beta-peptide toxicity (1996) J. Neurochem., 66, pp. 869-872; Honkanen, R.E., Dukelow, M., Zwiller, J., Moore, R.E., Khatra, B.S., Boynton, A.L., Cyanobacterial nodularin is a potent inhibitor of type 1 and type 2A protein phosphatases (1991) Molec. Pharm., 40, pp. 577-583; Knauer, M.F., Soreghan, B., Burdick, D., Kosmoski, J., Glabe, C.G., Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein (1992) Proc. Natl. Acad. Sci. USA, 89, pp. 7437-7441; Kopke, E., Tung, Y.-C., Shaikh, S., Alonso, A., Del, C., Iqbal, K., Grundke, I.-I., Microtubule associated protein Tau: Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer's disease (1993) J. Biol. Chem., 268, pp. 24374-24384; Lambert, M.P., Stevens, G., Sabo, S., Barber, K., Wang, G.W., Krafft, G., Snyder, S., Klein, W.L., Beta/A4-evoked degeneration of differentiated SH-SY5Y human neuroblastoma cells (1994) J. Neurosci. Res., 39, pp. 377-385; Lee, V.M., Disruption of the cytoskeleton in Alzheimer's disease (1995) Cur. Opin. Neurobiol., 5, pp. 663-668; Luo, Y.Q., Hirashima, N., Li, Y.H., Alkon, D.L., Sunderland, T., Etcheberrigaray, R., Wolozin, B., Physiological levels of beta-amyloid increase tyrosine phosphorylation and cytosolic calcium (1995) Brain Res., 681, pp. 65-74; Maher, P., Activation of phosphotyrosine phosphatase activity by reduction of cell-substrate adhesion (1993) Proc. Natl. Acad. Sci. USA, 90, pp. 11177-11181; Sagara, Y., Dargusch, R., Schubert, D., Behl, C., Increased antioxidant enzyme activity Aβ resistant cells (1996) J. Neurosci., 16, pp. 497-505; Schubert, D., Behl, C., Lesley, R., Brack, A., Dargusch, R., Sagara, Y., Kimura, H., Amyloid peptides are toxic via a common oxidative mechanism (1995) Proc. Natl. Acad. Sci. USA, 92, pp. 1989-1993; Schubert, D., Heinemann, S., Carlisle, W., Tarikas, H., Kimes, B., Steinbach, J.H., Culp, W., Brandt, B.L., Clonal cell lines from the rat central nervous system (1974) Nature, 249, pp. 224-227; Shearman, M.S., Ragan, C.I., Iversen, L.L., Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death (1994) Proc. Natl. Acad. Sci. USA, 91, pp. 1470-1474; Takashima, A., Noguchi, K., Sato, K., Hoshino, T., Imahori, K., Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity (1993) Proc. Natl. Acad. Sci. USA, 90, pp. 7789-7793; Yan, S.D., Chan, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Schmidt, A.M., RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease (1996) Nature, 382, pp. 685-719; Yankner, B.A., Mechanisms of neuronal degeneration in Alzheimer's disease (1996) Neuron, 16, pp. 921-932; Yankner, B.A., Duffy, L.K., Kirschner, D.A., Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides (1990) Science, 25, pp. 279-282; Zhang, C., Lambert, M.P., Bunch, J.C., Barber, K., Wade, W.S., Krafft, G.A., Klein, W.L., Focal adhesion kinase expressed by nerve cell lines shows increased tyrosine phosphorylation in response to Alzheimer's A-beta peptide (1994) J. Biol. Chem., 269, pp. 25247-25250","Schubert, D.; Salk Institute, P.O. Box 85800, San Diego, CA 92186-5800, United States",,,,,,,,00068993,,BRREA,9310407,"English","Brain Res.",Article,Scopus,2-s2.0-0030809628
"Liu, Y., Dargusch, R., Schubert, D.","Beta amyloid toxicity does not require RAGE protein",1997,"Biochemical and Biophysical Research Communications","237","1",,"37","40",,29,10.1006/bbrc.1997.7068,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0031559566&partnerID=40&md5=16c5d689bdf0ce94df5a19624c925436","Salk Inst. for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States","Liu, Y., Salk Inst. for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; Dargusch, R., Salk Inst. for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States; Schubert, D., Salk Inst. for Biological Studies, 10010 North Torrey Pines Road, San Diego, CA 92037, United States","It has been suggested that a receptor for advanced glycation end products (RAGE) is the nerve cell receptor for amyloid β protein (Aβ). To determine if this is indeed the case, two neural cell lines as well as rat cortical neurons were examined for the presence of the mRNA for RAGE by PCR and northern blot analysis. Although lung was strongly positive, in no case was RAGE mRNA detected in the cultured neural cells. Glycated albumin is a major ligand for RAGE and the cell surface RAGE protein is trypsin sensitive. In agreement with the mRNA data, trypsin treatment did not alter Aβ toxicity, nor did glycated albumin modify the Aβ response. It follows that RAGE is not the neural receptor for Aβ.",,"amyloid beta protein; cell surface receptor; glycosylated albumin; glycosylated protein; messenger rna; trypsin; animal cell; animal tissue; article; brain cell; cell culture; cell line; controlled study; embryo; lung; nerve cell; neurotoxicity; nonhuman; northern blotting; polymerase chain reaction; priority journal; rat; tissue distribution; Amyloid beta-Protein; Animals; Blotting, Northern; Brain Neoplasms; Cell Survival; Cells, Cultured; Cerebral Cortex; Glycosylation End Products, Advanced; Neurons; PC12 Cells; Peptide Fragments; Polymerase Chain Reaction; Rats; Receptors, Immunologic; Serum Albumin, Bovine; Trypsin; Tumor Cells, Cultured; Animalia",,"advanced glycation end products-bovine serum albumin; advanced glycosylation end-product receptor; Amyloid beta-Protein; Glycosylation End Products, Advanced; Peptide Fragments; Receptors, Immunologic; Serum Albumin, Bovine; Trypsin, EC 3.4.21.4",,,,"Yankner, B.A., (1996) Neuron, 16, pp. 921-932; Joslin, G., Krause, J.E., Hershey, A.D., Adams, S.P., Fallon, R.J., Perlmutter, D.H., (1991) J. Biol. Chem., 266, pp. 21897-21902; Kimura, H., Schubert, D., (1993) Proc. Natl. Acad. Sci. (USA), 90, pp. 7508-7512; Yankner, B.A., Duffy, L.K., Kirschner, D.A., (1990) Science, 25, pp. 279-282; Schubert, D., Behl, C., Lesley, R., Brack, A., Dargusch, R., Sagara, Y., Kimura, H., (1995) Proc. Natl. Acad. Sci. USA, 92, pp. 1989-1993; Arispe, N., Rojas, E., Pollard, H.B., (1993) Proc. Nat. Acad. Sci. USA, 90, pp. 567-571; Knauer, M.F., Soreghan, B., Burdick, D., Kosmoski, J., Glabe, C.G., (1992) Proc. Natl. Acad. Sci. USA, 89, pp. 7437-7441; Yan, S.D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Schmidt, A.M., (1996) Nature, 382, pp. 685-719; Behl, C., Davis, J.B., Lesley, R., Schubert, D., (1994) Cell, 77, pp. 817-827; Behl, C., Davis, J., Cole, G.M., Schubert, D., (1992) Biochem. Biophys. Res. Comm., 186, pp. 944-950; Shearman, M.S., Ragan, C.I., Iversen, L.L., (1994) Proc. Natl. Acad. Sci. USA, 91, pp. 1470-1474; Abe, K., Takayanagi, M., Saito, H., (1990) Japan J. Pharmacol., 53, pp. 221-227; Chomczynski, P., Sacchi, N., (1987) Anal. Biochem., 162, pp. 156-159; Kimura, H., Fischer, W.H., Schubert, D., (1990) Nature, 348, pp. 257-260; Ernst, H., Duncan, R.F., Hershey, J.W.B., (1987) J. Biol. Chem., 262, pp. 1206-1212; Schmidt, A.M., Vianna, M., Gerlach, M., Brett, J., Ryan, J., Kao, J., Esposito, C., Stern, D., (1992) J. Biol. Chem., 267, pp. 14987-14997; Neeper, M., Schmidt, A.M., Brett, J., Yan, S.D., Wang, F., Pan Y.-C., E., Elliston, K., Shaw, A., (1992) J. Biol. Chem., 267, pp. 14998-15004; Boland, K., Behrens, M., Choi, D., Manias, K., Perlmutter, D.H., (1996) J. Biol. Chem., 271, pp. 18032-18044; Schubert, D., (1997) European J. Neurosci., 9, pp. 770-777; May, P.C., Boggs, L.N., Fuson, K.S., (1993) J. Neurochem., 61, pp. 2330-2333; Lorenzo, A., Razzaboni, B., Weir, G.C., Yankner, B.A., (1994) Nature, 368, pp. 756-760","Schubert, D.; Salk Institute Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037, United States",,,,,,,,0006291X,,BBRCA,9266825,"English","BIOCHEM. BIOPHYS. RES. COMMUN.",Article,Scopus,2-s2.0-0031559566
"Liu, Y., Peterson, D.A., Kimura, H., Schubert, D.","Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) reduction",1997,"Journal of Neurochemistry","69","2",,"581","593",,528,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0030852948&partnerID=40&md5=894a16ea291a9cbbbaaccb8767530ee1","Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA, United States; Laboratory of Genetics, Salk Inst. for Biological Studies, San Diego, CA, United States; Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States","Liu, Y., Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA, United States, Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States; Peterson, D.A., Laboratory of Genetics, Salk Inst. for Biological Studies, San Diego, CA, United States; Kimura, H., Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA, United States; Schubert, D., Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, San Diego, CA, United States","3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction is one of the most frequently used methods for measuring cell proliferation and neural cytotoxicity. It is widely assumed that MTT is reduced by active mitochondria in living cells. By using isolated mitochondria from rat brain and B12 cells, we indeed found that malate, glutamate, and succinate support MTT reduction by isolated mitochondria. However, the data presented in this study do not support the exclusive role of mitoohondria in MTT reduction by intact cells. Using a variety of approaches, we found that MTT reduction by B12 cells is confined to intracellular vesicles that later give rise to the needle-like MTT formazan at the cell surface. Some of these vesicles were identified as endosomes or lysosomes. In addition, MTT was found to be membrane impermeable. These and other results suggest that MTT is taken up by cells through endocytosis and that reduced MTT formazan accumulates in the endosomal/lysosomal compartment and is then transported to the cell surface through exocytosis.","3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; Endocytosis; Exocytosis; Oxidoreductase; Viability assay","3 (4,5 dimethyl 2 thiazolyl) 2,5 diphenyltetrazolium bromide; oxidoreductase; animal cell; article; brain mitochondrion; cell proliferation; cell viability; controlled study; endocytosis; enzyme assay; exocytosis; membrane permeability; nerve cell; neurotoxicity; nonhuman; priority journal; rat; Animals; Brain; Cell Division; Cell Membrane Permeability; Coloring Agents; Endocytosis; Endosomes; Ethylmaleimide; Exocytosis; Lysosomes; Membrane Lipids; Mitochondria; NAD; NADP; Oxidation-Reduction; Oxidoreductases; Rats; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Animalia",,"Coloring Agents; Ethylmaleimide, 128-53-0; Membrane Lipids; NAD, 53-84-9; NADP, 53-59-8; Oxidoreductases, EC 1.-; Tetrazolium Salts; Thiazoles; thiazolyl blue, 298-93-1",,,,"Aebi, H., Catalase in vitro (1984) Methods Enzymol., 105, pp. 121-126; Altman, F.P., Tetrazolium salts and formazans (1976) Prog. Histochem. Cytochem., 9, pp. 1-56; Beaufay, H., Amar-Costesec, A., Feytmans, E., Thines-Sempoux, D., Wibo, M., Robbi, M., Berthet, J., Analytical study of microsomes and isolated subcellular membranes from rat liver: I. Biochemical methods (1974) J. Cell Biol., 61, pp. 88-200; Behl, C., Davis, J.B., Cole, G.M., Schubert, D., Vitamin e protects nerve cells from amyloid β protein toxicity (1992) Biochem. Biophys. Res. Commun., 186, pp. 944-950; Behl, C., Davis, J.B., Lesley, R., Schubert, D., Hydrogen peroxide mediates amyloid β protein toxicity (1994) Cell, 77, pp. 817-827; Berridge, M.V., Tan, A.N., Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-yl)-2,5-diphenyltetrazolium bromide (MTT): Subcellular localization, substrate dependence and involvement of mitochondrial electron transport in MTT reduction (1993) Arch. Biochem. Biophys., 303, pp. 474-482; Beutler, E., West, C., The removal of leukocytes and platelets from whole blood (1976) J. Clin. Lab. Res., 88, pp. 328-333; Bowman, E.J., Siebers, A., Altendorf, K., Bafilomycins: A class of inhibitors of membrane ATPases from microorganism, animal cells, and plant cells (1988) Proc. Natl. Acad. Sci. USA, 85, pp. 7972-7976; Burdon, R.H., Gill, V., Rice-Evens, C., Reduction of a tetrazolium salt and superoxide generation in human tumor cells (HeLa) (1993) Free Radic. Res. Commun., 18, pp. 369-380; Crane, F.L., Sun, I.L., Clark, M.G., Grebing, C., Löw, H., Transplasma-membrane redox systems in growth and development (1985) Biochim. Biophys. Acta, 811, pp. 233-264; Damke, H., Baba, T., Van Der Bliek, A.M., Schmid, S.L., Clathrin-independent pinocytosis is induced in cells overexpressing a temperature-sensitive mutant of dynamin (1995) J. Cell Biol., 131, pp. 69-80; Dunn Jr., W.A., Studies on the mechanisms of autophagy (1990) J. Cell Biol., 110, pp. 1923-1945; Gordon, P.B., Høyvik, H., Seglen, P.O., Prelysosomal and lysosomal connections between autophagy and endocytosis (1992) Biochem. J., 283, pp. 361-369; Jabber, S.A.B., Twentyman, P.R., Watson, J.V., The MTT assay underestimates the growth inhibitory effects of interferon (1989) Br. J. Cancer, 60, pp. 523-528; Johnson, L.V., Walsh, M.L., Chen, L.B., Localization of mitochondria in living cells with rhodamine 123 (1980) Proc. Natl. Acad. Sci. USA, 77, pp. 990-994; King, M.P., Attardi, G., Human cells lacking mtDNA: Repopulation with exogenous mitochondria by complementation (1989) Science, 246, pp. 500-503; Kopitz, J., Kisen, G.Ø., Gorden, P.B., Bohley, P., Seglen, P.O., Nonselective autophagy of cytosolic enzymes by isolated rat hepatocytes (1990) J. Cell Biol., 111, pp. 941-953; Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., Protein measurement with the Folin phenol reagent (1951) J. Biol. Chem., 193, pp. 265-275; Mellman, I., Fuchs, R., Helenius, A., Acidification of the endocytic and exocytic pathways (1986) Annu. Rev. Biochem., 55, pp. 663-700; Moreadith, R.W., Fiskum, G., Isolation of mitochondria from ascites tumor cells permeabilized with digitonin (1984) Anal. Biochem., 137, pp. 360-367; Mosmann, T., Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity (1983) J. Immunol. Methods, 65, pp. 55-63; Myers, M.K., Fiskum, G., Liu, Y., Simmens, S.J., Bredesen, D.E., Murphy, A.N., Bcl-2 protects neural cells from cyanide/ aglycemia-induced lipid oxidation, mitochondrial injury, and loss of viability (1995) J. Neurochem., 65, pp. 2432-2440; Nikkhah, G., Tonn, J.C., Hoffmann, O., Kraemer, H.-P., Darling, J.L., Schönmayr, R., Schachenmayr, W., The MTT assay for chemosensitivity testing of human tumors of the central nervous system (1992) J. Neurooncol., 13, pp. 1-11; Orci, L., Tagaya, M., Amherdt, M., Perrelet, A., Donaldson, J.G., Lippincott-Schwartz, J., Klausner, R.D., Rothman, J.E., Brefeldin A, a drug that blocks secretion, prevents the assembly of non-clathrin-coated buds on Golgi cisternae (1991) Cell, 64, pp. 1183-1195; Pagano, R.E., Martin, O.C., Kang, H.C., Haugland, R.P., A novel fluorescent ceramide analogue for studying membrane traffic in animal cells: Accumulation at the Golgi apparatus results in altered spectral properties of the sphingolipid precursor (1991) J. Cell Biol., 113, pp. 1267-1279; Peterson, D.A., Lucidi-Phillipi, C.A., Murphy, D.P., Ray, J., Gage, F.H., Fibroblast growth factor-2 protects entorhinal layer II glutamatergic neurons from axotomy-induced cell death (1996) J. Neurosci., 16, pp. 886-898; Robinson, M.S., Kreis, T.E., Recruitment of coat proteins onto Golgi membranes in intact and permeabilized cells: Effects of brefeldin A and G protein activators (1992) Cell, 69, pp. 129-138; Robinson, M.S., Watts, C., Zerial, M., Membrane dynamics in endocytosis (1996) Cell, 84, pp. 13-21; Rosenthal, R.E., Hamud, F., Fiskum, G., Varghese, P.J., Sharpe, S., Cerebral ischemia and reperfusion: Prevention of brain mitochondrial injury by lidoflazize (1987) J. Cereb. Blood Flow Metab., 7, pp. 752-758; Schubert, D., Heinemann, S., Carlisle, W., Tarika, H., Kimes, B., Steinbach, J.H., Culp, W., Brandt, B.L., Clonal cell lines from the rat central nervous system (1974) Nature, 249, pp. 224-227; Shearman, M.S., Hawtin, S.R., Tailor, V.J., The intracellular component of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by β-amyloid peptides (1995) J. Neurochem., 65, pp. 218-227; Slater, T.F., Sawyer, B., Sträuli, U., Studies on succinatetetrazolium reductase system. III. Points of coupling of four different tetrazolium salts (1963) Biochim. Biophys. Acta, 77, pp. 383-393; Steinman, R.M., Mellman, I., Muller, W.A., Cohn, Z.A., Endocytosis and the recycling of plasma membrane (1983) J. Cell Biol., 96, pp. 1-27; Swanson, J.A., Yirinec, B.D., Silverstein, S.C., Phorbol esters and horseradish peroxidase stimulate pinocytosis and redirect the flow of pinocytosed fluid in macrophages (1985) J. Cell Biol., 100, pp. 851-859; Szoka, F., Papahadjopoulos, D., Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation (1978) Proc. Natl. Acad. Sci. USA, 75, pp. 4194-4198; Terasaki, M., Song, J., Wong, J.R., Weiss, M.J., Chen, L.B., Localization of endoplasmic reticulum in living and glutaraldehyde-fixed cells with fluorescent dyes (1984) Cell, 38, pp. 101-108; Vistica, D.T., Skehan, P., Scudiero, D., Monks, A., Boyd, M.R., Tetrazolium-based assays for cellular viability: A critical examination of selected parameters affecting formazan production (1991) Cancer Res., 51, pp. 2515-2520; Yoshimori, T., Yamamoto, A., Moriyama, Y., Futai, M., Tashiro, Y., Bafilomycin Al, a specific inhibitor of vacuolar-type H+-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells (1991) J. Biol. Chem., 266, pp. 17707-17712","Liu, Y.; Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States",,,,,,,,00223042,,JONRA,9231715,"English","J. NEUROCHEM.",Article,Scopus,2-s2.0-0030852948
"Li, Y., Maher, P., Schubert, D.","A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion",1997,"Neuron","19","2",,"453","463",,299,10.1016/S0896-6273(00)80953-8,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0030867994&partnerID=40&md5=64b708eb3899a530829e3d145f74368c","Department of Cell Biology, Scripps Research Institute, San Diego, CA 92037, United States","Li, Y.; Maher, P., Department of Cell Biology, Scripps Research Institute, San Diego, CA 92037, United States; Schubert, D.","An early and highly specific decrease in glutathione (GSH) in the substantia nigra is associated with Parkinson's disease, and low levels of GSH lead to the degeneration of cultured dopaminergic neurons. Using immature cortical neurons and a clonal nerve cell line, it is shown that a decrease in GSH triggers the activation of neuronal 12-lipoxygenase (12-LOX), which leads to the production of peroxides, the influx of Ca2+, and ultimately to cell death. The supporting evidence includes: 1) inhibitors of arachidonate metabolism and 12-LOX block cell death induced by GSH depletion; 2) there is an increase in 12-LOX activity and a membrane translocation in HT22 cells, and an induction of the enzyme in primary cortical neurons following the reduction of GSH; 3) 12-LOX is directly inhibited by GSH; and 4) exogenous arachidonic acid potentiates cell death. These data show that the LOX pathway is a critical intermediate in at least some forms of neuronal degeneration.",,"arachidonate 12 lipoxygenase; glutathione; peroxide; animal cell; animal tissue; article; cell death; cell degeneration; controlled study; embryo; enzyme mechanism; glutathione metabolism; nerve cell; nonhuman; parkinson disease; priority journal; rat; Animals; Arachidonate 12-Lipoxygenase; Cell Death; Cell Line; Cerebral Cortex; Glutamic Acid; Glutathione; Neurons; Rats; Rats, Sprague-Dawley",,"Arachidonate 12-Lipoxygenase, EC 1.13.11.31; Glutamic Acid, 56-86-0; Glutathione, 70-18-8",,,,"Abe, K., Takayanagi, M., Saito, H., Effects of recombinant human basic FGF and its modified protein CS23 on survival of primary cultured neurons from various regions of fetal rat brain (1990) Jpn. J. Pharmacol., 53, pp. 221-227; Baba, A., Sakuma, S., Okamoto, H., Inoue, T., Iwata, H., Calcium induces membrane translocation of 12-lipoxygenase in rat platelets (1989) J. Biol. Chem., 262, pp. 15790-15795; Behl, C., Hovey L. III, Krajewske, S., Schubert, D., Reed, J.C., Bcl-2 prevents killing of neuronal cells by glutamate but not by amyloid beta protein (1993) Biochem. Biophys. Res. Commun., 197, pp. 949-956; Bendani, M.K., Palluy, O., Cook-Moreau, J., Beneytout, J.L., Rigaud, M., Vallat, J.-M., Localization of 12-lipoxygenase mRNA in cultured oligodendrocytes and astrocytes by in situ reverse transcriptase and polymerase chain reaction (1995) Neurosci. Lett., 189, pp. 159-162; Buttner, N., Siegelbaum, S.A., Volterra, A., Direct modulation of Aplysia S-K+ channels by a 12-lipoxygenase metabolite of arachidonic acid (1989) Nature, 342, pp. 553-555; Cho, H., Ueda, M., Tamaoka, M., Hamaguchi, M., Aisaka, K., Kiso, Y., Inoue, T., Murota, S., Novel caffeic acid derivatives: Extremely potent inhibitors of 12-lipoxygenase (1991) J. Med. Chem., 34, pp. 1503-1505; Davis, J.B., Maher, P., Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line (1994) Brain Res., 652, pp. 169-173; Dexter, D.T., Sian, J., Rose, S., Hindmarsh, J.G., Mann, V.M., Copper, J.M., Wells, F.M., Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease (1994) Ann. Neurol., 35, pp. 38-44; Dumuis, A., Sebben, M., Hayes, L., Pin, J.-P., Bockaert, J., NMDA receptors activate the arachidonic acid cascade system in striatal neurons (1988) Nature, 336, pp. 68-70; Dumuis, A., Sebben, M., Fagni, L., Prezeau, L., Manzoni, O., Cragoe, E.J., Bockaert, J., Stimulation by glutamate receptors of arachidonic acid release depends on the Na+/Ca2+ exchanger in neuronal cells (1993) Mol. Pharmacol., 43, pp. 976-981; Grynkiewicz, G., Poenie, M., Tsien, R.Y., A new generation of Ca++ indicators with greatly improved fluorescence properties (1985) J. Biol. Chem., 260, pp. 3440-3450; Hagmann, W., Kagawa, D., Renaud, C., Honn, K.V., Activity and protein distribution of 12-lipoxygenase in HEL cells: Induction of membrane-association by phorbol ester TPA, modulation of activity by glutathione and 13-HPODE, and Ca2+-dependent translocation to membranes (1993) Prostaglandins, 46, pp. 471-477; Hale, A.J., Smith, C.A., Sutherland, L.C., Stoneman, V.E., Longthorne, V.L., Culhane, A.C., Williams, G.T., Apoptosis: Molecular regulation of cell death (1996) Eur. J. Biochem., 236, pp. 1-26; Halliwell, B., Gutteridge, J.M.C., (1989) Free Radicals in Biology and Medicine, p. 93. , Oxford: Clarendon Press; Hannun, Y.A., Functions of ceramide in coordinating cellular responses to stress (1996) Science, 274, pp. 1855-1859; Jenner, P., Olanow, C.W., Oxidative stress and the pathogenesis of Parkinson's disease (1996) Neurology, 47, pp. s161-s170; June, C.H., Rabinovitch, P.S., Measurement of intracellular ions by flow cytometry (1991) Curr. Prot. Immunol., pp. 551-5515; Kinzig, A., Furstenberger, G., Burger, F., Vogel, S., Muller-Decker, K., Mincheva, A., Lichter, P., Krieg, P., Murine epidermal lipoxygenase (Aloxe)encodes a 12-lipoxygenase isoform (1997) FEBS Lett., 402, pp. 162-166; Korystov, Y.N., Dobrovinskaya, O.R., Shaposhnikova, V.V., Edius, L.K., Role of arachidonic acid metabolism in thymocyte apoptosis after irradiation (1996) FEBS Lett., 388, pp. 238-241; Koshihara, Y., Neichi, T., Murota, S., Lao, A., Fujimoto, Y., Tatsuno, T., Caffeic acid is a selective inhibitor for leukotriene biosynthesis (1984) Biochem. Biophys. Acta, 792, pp. 92-97; Laemmli, U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4 (1970) Nature, 227, pp. 680-685; Maher, P., Davis, J.B., The role of monamine metabolism in glutamate toxicity (1996) J. Neurosci., 16, pp. 6394-6401; Mayer, M., Noble, M., N-acetyl-L-cysteine is a pluripotent protector against cell death and enhancer of trophic factor-mediated cell survival in vitro (1994) Proc. Natl. Acad. Sci. USA, 91, pp. 7496-7500; McConkey, D.J., Orrenius, S., Signal transduction pathway to apoptosis (1994) Trends Cell Biol., 4, pp. 370-375; Meister, A., Anderson, M.E., Glutathione (1983) Annu. Rev. Biochem., 52, pp. 711-760; Mochizuki, H., Goto, K., Mori, H., Mizuno, Y., Histochemical detection of apoptosis in Parkinson's disease (1996) J. Neurol. Sci., 137, pp. 120-123; Morimoto, B.H., Koshland, D.E., Induction and expression of long-and short-term neurosecretory potentiation in a neural cell line (1989) Neuron, 5, pp. 875-880; Mosmann, T., Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays (1983) J. Immunol. Methods, 65, pp. 55-63; Murphy, T.H., Baraban, J.M., Glutamate toxicity in immature cortical neurons precedes development of glutamate receptor currents (1990) Dev. Brain Res., 57, pp. 146-150; Murphy, T., Parikh, A., Schnaar, R., Coyle, J., Arachidonic acid metabolism in glutamate neurotoxicity (1989) Ann. N. Y. Acad. Sci., 559, pp. 474-477; Murphy, T.H., Miyamoto, M., Sastre, A., Schnaar, R.L., Coyle, J.T., Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress (1989) Neuron, 2, pp. 1547-1558; Murphy, T.H., Schnaar, R.L., Coyle, J.T., Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake (1990) FASEB J., 4, pp. 1624-1633; Natarajan, R., Gu, J.-L., Ross, J., Gonzales, N., Lanting, L., Xu, L., Nadler, J., Elevated glucose and angiotensin II increase 12-lipoxygenase activity and expression in porcine aortic smooth muscle cells (1993) Proc. Natl. Acad. Sci. USA, 90, pp. 4947-4951; Perry, T.L., Godin, D.V., Hansen, S., Parkinson's disease: A disorder due to nigral glutathione deficiency? (1982) Neurosci. Lett., 33, pp. 305-310; Pileblad, E., Magnusson, T., Fornstedt, B., Reduction of brain glutathione by L-buthionine sulfoximine potentiates the dopamine-depleting action of 6-hydroxydopamine in rat striatum (1989) J. Neurochem., 52, pp. 978-980; Piomelli, D., Eicosanoids in synaptic transmission (1994) Crit. Rev. Neurobiol., 8, pp. 65-83; Piomelli, D., Volterra, A., Dale, N., Siegelbaum, S.A., Kandel, E.R., Schwartz, J.H., Belardetti, F., Lipoxygenase metabolites of arachidonic acid as second messenger for presynaptic inhibition of Aplysia sensory cell (1987) Nature, 328, pp. 39-43; Rao, G.N., Lassegue, B., Griendling, K., Alexander, R.W., Berk, B.C., Hydrogen peroxide-induced c-fos expression is mediated by arachidonic acid release: Role of protein kinase C (1993) Nucleic Acids Res., 21, pp. 1259-1263; Ratan, R.R., Murphy, T.H., Baraban, J.M., Macromolecular synthesis inhibitors prevent oxidative stress-induced apoptosis in embryonic cortical neurons by shunting cysteine from protein synthesis to glutathione (1994) J. Neurosci., 14, pp. 4385-4392; Ratan, R.R., Murphy, T.M., Baraban, J.M., Oxidative stress induces apoptosis in embryonic cortical neurons (1994) J. Neurochem., 62, pp. 376-379; Royall, J.A., Ischiropoulos, H., Evaluation of 2′,7′ dichlorofluorescin and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells (1993) Arch. Biochem. Biophys., 302, pp. 348-355; Sautebin, L., Spagnuolo, C., Galli, C., Galli, G., A mass fragmentographic procedure for the simultaneous determination of HETE and PGF2α in the central nervous system (1978) Prostaglandins, 16, pp. 985-988; Schubert, D., Behl, C., The expression of amyloid β protein precursor protects nerve cells from β-amyloid and glutamate toxicity and alters their interaction with the extracellular matrix (1993) Brain Res., 629, pp. 275-282; Schubert, D., Kimura, H., Maher, P., Growth factors and vitamin E modify neuronal glutamate toxicity (1992) Proc. Natl. Acad. Sci. USA, 89, pp. 8264-8267; Sekiya, K., Okuda, H., Selective inhibition of platelet lipoxygenase by baicalein (1982) Biochem. Biophys. Res. Commun., 105, pp. 1090-1095; Shimizu, T., Wolfe, L.S., Arachidonic acid cascade and signal transduction (1990) J. Neurochem., 55, pp. 1-15; Shimizu, T., Takusagawa, Y., Isumi, T., Ohishi, N., Seyama, Y., Enzymic synthesis of leukotriene B4 in the guinea pig brain (1987) J. Neurochem., 48, pp. 1541-1546; Shornick, L.P., Holtzman, M.J., A cryptic, microsomaltype arachidonate 12-lipoxygenase is tonically inactivated by oxidation-reduction conditions in culture epithelial cells (1993) J. Biol. Chem., 268, pp. 371-376; Sian, J., Dexter, D.T., Lees, A.J., Daniel, S., Agid, Y., Javoy-Agid, F., Jenner, P., Marsden, C.D., Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia (1994) Ann. Neurol., 36, pp. 348-355; Simonian, N.A., Coyle, J.T., Oxidative stress in neurodegenerative diseases (1996) Annu. Rev. Pharmacol. Toxicol., 36, pp. 83-106; Smale, G., Nichols, N.R., Brady, D.R., Finch, C.E., Horton, W.E.J., Evidence for apoptotic cell death in Alzheimer's disease (1995) Exp. Neurol., 133, pp. 225-230; Snider, R.M., McKinney, M., Forray, C., Richelson, E., Neurotransmitter receptors mediate cyclic GMP formation by involvement of arachidonic acid and lipoxygenase (1984) Proc. Natl. Acad. Sci. USA, 81, pp. 3905-3909; Sofic, E., Lange, K.W., Riederer, P., Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease (1992) Neurosci. Lett., 142, pp. 128-130; Sok, D.E., Man, C.Q., Pai, J.K., Sih, C.J., Inhibition of leukotriene biosynthesis by acetylenic analogs (1982) Biochem. Biophys. Res. Commun., 107, pp. 101-108; Stern, N., Yanagawa, N., Saito, F., Hori, M., Natarajan, R., Nadler, J., Tuch, M., Potential role of 12 hydroxyeicosatetraenoic acid in angiotensin II-induced calcium signal in rat glomerulosa cells (1993) Endocrinology, 133, pp. 843-847; Su, J.H., Anderson, A.J., Cummings, B.J., Cotman, C.W., Immuno-histochemical evidence for apoptosis in Alzheimer's disease (1994) Neuroreport, 5, pp. 2529-2533; Tang, D.G., Chen, Y.Q., Honn, K.V., Arachidonate lipoxygenase as essential regulators of cell survival and apoptosis (1996) Proc. Natl. Acad. Sci. USA, 93, pp. 5241-5246; Tietze, F., Enzymatic method for quantitation of total and oxidized glutathione: Applications to mammalian blood and other tissues (1969) Anal. Biochem., 27, pp. 502-522; Vogt, M., Dulbecco, R., Steps in the neoplastic transformation of hamster embryo cells by polyoma virus (1963) Proc. Natl. Acad. Sci. USA, 49, pp. 171-179; Watanabe, T., Medina, J.F., Haeggstrom, J.Z., Radmark, O., Samuelsson, B., Molecular cloning of a 12-lipoxygenase cDNA from rat brain (1993) Eur. J. Biochem., 212, pp. 605-612; Wullner, U., Loschmann, P.A., Schulz, J.B., Schmid, A., Dringen, R., Eblen, F., Turski, L., Klockgether, T., Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurons (1996) Neuroreport, 7, pp. 921-923; Yoshimoto, T., Yokoyama, C., Ochi, K., Yamamoto, S., Maki, Y., Ashida, Y., Terao, S., Shiraishi, M., 2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-ben zoquinone (AA861), a selective inhibitor of the 5-lipoxygenase reaction and the biosynthesis of slow-reacting substance of anaphylaxis (1982) Biochem. Biophys. Acta, 713, pp. 470-473","Li, Y.; Cellular Neurobiology Laboratory, Salk Inst. for Biological Studies, Department of Cell Biology, San Diego, CA 92037, United States",,,,,,,,08966273,,NERNE,9292733,"English","NEURON",Article,Scopus,2-s2.0-0030867994
"Schubert, D.","Serpins inhibit the toxicity of amyloid peptides",1997,"European Journal of Neuroscience","9","4",,"770","777",,12,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0030936558&partnerID=40&md5=487051b32c15e2939e53cad5498bbe75","Cellular Neurobiology Laboratory, Salk Institute, PO Box 85800, San Diego, CA 92186, United States","Schubert, D., Cellular Neurobiology Laboratory, Salk Institute, PO Box 85800, San Diego, CA 92186, United States","The amyloid plaque in Alzheimer's disease (AD) contains numerous proteins, some of which may be relevant to the pathogenesis of the disease. The serine protease inhibitor α1-antichymotrypsin is specifically localized in AD plaques. It is shown here that α1-antichymotrypsin and several other serine protease inhibitors (serpins) inhibit the toxicity of amyloid peptides on primary cortical nerve cell cultures as well as a clonal cell line. This inhibition of toxicity is not mediated via the serpin enzyme complex receptor, the transferrin receptor, or by interference with the polymerization of amyloid fibrils. Since a variety of synthetic serine protease inhibitors mimic the effects of serpins on amyloid toxicity, it is likely that the antiprotease activities of serpins are responsible for their biological effects.","Alzheimer's disease; Cell culture; Protease inhibitors","alpha 1 antichymotrypsin; amyloid; serine proteinase inhibitor; article; brain cell; cell line; cytotoxicity; nerve cell culture; priority journal; Adenoma, Islet Cell; alpha 1-Antichymotrypsin; Amyloid; Amyloid beta-Protein; Animals; Cell Division; Cell Survival; Clone Cells; Humans; Kinetics; Pancreatic Neoplasms; Platelet Aggregation; Rats; Serine Proteinase Inhibitors; Serpins; Tumor Cells, Cultured",,"alpha 1-Antichymotrypsin; amylin, 106602-62-4; Amyloid beta-Protein; Amyloid; Serine Proteinase Inhibitors; Serpins",,,,"Abraham, C.A., Selkoe, D.J., Potter, H., Immunochemical identification of the serine protease inhibitor α1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease (1988) Cell, 52, pp. 487-501; Abraham, C.R., Shirahama, T., Potter, H., The protease inhibitor α1-antichymotrypsin is associated solely with amyloid deposits containing the β-protein and is localized in specific cells of both normal and diseased brain (1990) Neurobiol. Aging, 11, pp. 123-129; Behl, C., Davis, J., Cole, G.M., Schubert, D., Vitamin e protects nerve cells from amyloid β protein toxicity (1992) Biochem. Biophys. Res. Commun., 186, pp. 944-950","Schubert, D.; Cellular Neurobiology Laboratory, The Salk Institute, PO Box 85800, San Diego, CA 92186, United States",,,,,,,,0953816X,,EJONE,9153583,"English","EUR. J. NEUROSCI.",Article,Scopus,2-s2.0-0030936558
"Fischer, W.H., Schubert, D.","Characterization of a novel platelet-derived growth factor-associated protein",1996,"Journal of Neurochemistry","66","5",,"2213","2216",,12,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0029913291&partnerID=40&md5=e093460e8d04a3bacc626f529e8e111b","Salk Inst. for Biological Studies, San Diego, CA, United States; Salk Inst. for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States","Fischer, W.H., Salk Inst. for Biological Studies, San Diego, CA, United States, Salk Inst. for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States; Schubert, D., Salk Inst. for Biological Studies, San Diego, CA, United States","A novel mitogen-associated protein was isolated from a rat neural retina cell line. The protein copurified with platelet-derived growth factor (PDGF)- A and was therefore termed PDGF-associated protein (PAP). cDNAs corresponding to the protein were characterized from both rat and human cDNA libraries. PAP binds to PDGF with low affinity and enhances the mitogenic effect of PDGF-A but lowers the mitogenic activity of PDGF-B. PAP mRNA is abundant in the brain of newborn rats and is found in several other tissues.","Binding protein; cDNA; Mitogen; Platelet-derived growth factor; Secreted protein","platelet derived growth factor; animal cell; article; cell growth; cell immortalization; cell survival; dna library; mitogenesis; nonhuman; priority journal; protein analysis; protein isolation; retina cell; schwann cell; sensory ganglion; 3T3 Cells; Amino Acid Sequence; Animals; Carrier Proteins; Dose-Response Relationship, Drug; Drug Interactions; Humans; Intercellular Signaling Peptides and Proteins; Mice; Molecular Sequence Data; Nerve Tissue Proteins; Phosphoproteins; Platelet-Derived Growth Factor; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-sis; Rats; RNA, Messenger; Thymidine; Tissue Distribution; Tumor Cells, Cultured","GENBANK: U41744, U41745","Carrier Proteins; HASPP28 protein, rat; Intercellular Signaling Peptides and Proteins; Nerve Tissue Proteins; PDAP1 protein, human; Phosphoproteins; platelet-derived growth factor A; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Proto-Oncogene Proteins; RNA, Messenger; Thymidine, 50-89-5",,,,"Antoniades, H.N., PDGF: A multifactorial growth factor (1991) Baillieres Clin. Endocrinol. Metab., 5, pp. 595-613; Bonner, J.C., Badgett, A., Hoffman, M., Lindroos, P.M., Inhibition of platelet-derived growth factor-BB-induced fibroblast proliferation by plasmin-activated alpha2-macroglobulin is mediated via an alpha2-macroglobulin receptor/low density lipoprotein receptor-related protein-dependent mechanism (1995) J. Biol. Chem., 270, pp. 6389-6395; Bowen-Pope, D.F., Van Koppen, A., Schatteman, G., Is PDGF really important? (1991) Trends Genet., 7, pp. 413-418; Chomczynski, P., Sacchi, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction (1987) Anal. Biochem., 162, pp. 156-159; Crookston, K.P., Webb, D.J., Lamarre, J., Gonias, S.L., Binding of the platelet-derived growth factor-BB and transforming growth factor-beta1 to alpha2-macroglobulin in vitro and in vivo: Comparison of receptor-recognized and non-recognized alpha2-macroglobulin conformations (1993) Biochem. J., 293, pp. 443-450; Crookston, K.P., Webb, D.J., Wolf, B.B., Gonias, S.L., Classification of alpha2-macroglobulin-cytokine interactions based on affinity of noncovalent association in solution under apparent equilibrium conditions (1994) J. Biol. Chem., 269, pp. 1533-1540; Deuel, T.F., Structural and functional diversity of the platelet-derived growth factor (1991) Curr. Opin. Biotechnol., 2, pp. 802-806; Fischer, W.H., Schubert, D., Purification and microsequencing of neurotrophic proteins (1993) Neuromethods, 25, pp. 1-23. , (Boulton A., Baker G., and Hefti F., eds), Humana Press, Totowa, New Jersey; Florkiewicz, R.Z., Majack, R.A., Buechler, R.D., Florkiewicz, E., Quantitative export of FGF-2 occurs through an alternative, energy dependent, non-ER/Golgi pathway (1995) J. Cell. Physiol., 162, pp. 388-399; Heldin, C.-H., Bachstrom, C., Ostman, A., Hammacher, A., Ronnstrand, L., Rubin, K., Nister, M., Westermark, B., Binding of different dimeric forms of PDGF to human fibroblasts: Evidence for two separate receptor types (1988) EMBO J., 7, pp. 1387-1393; Horwitz, A., Duggan, K., Greggs, R., Decker, C., Buck, C., The cell substrate attachment (CSAT) antigen has properties of a receptor for laminin and fibronectin (1985) J. Cell Biol., 101, pp. 2134-2144; Horwitz, A., Duggan, K., Buck, C., Beckerle, M.C., Burridge, K., Interaction of plasma membrane fibronectin receptor with talin - A transmembrane linkage (1986) Nature, 320, pp. 531-533; Hummel, J.P., Dreyer, W.J., Measurement of protein binding phenomena by gel filtration (1962) Biochim. Biophys. Acta, 63, pp. 530-532; Hutchins, J.B., Jefferson, V.E., Developmental distribution of platelet-derived growth factor in the mouse central nervous system (1992) Dev. Brain Res., 67, pp. 121-135; Hutchins, J.B., Zhang, X., Platelet-derived growth factor receptors in the developing mouse optic pathway (1994) Vis. Neurosci., 11, pp. 33-40; Kimura, H., Fischer, W.H., Schubert, D., Structure, expression and function of a schwannoma-derived growth factor (1990) Nature, 348, pp. 257-260; Lin, L.F.H., Doherty, D.H., Lile, J.D., Bektesh, S., Collins, F., GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons (1993) Science, 260, pp. 1130-1132; Maniatis, T., Fritsch, E.F., Sambrook, J., (1982) Molecular Cloning, a Laboratory Manual, , Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York; Mudhar, H.S., Pollock, R.A., Wang, C., Stiles, C.D., Richardson, W.D., PDGF and its receptors in the developing rodent retina and optic nerve (1993) Development, 118, pp. 539-552; Raines, E.W., Lane, T.F., Iruela-Arispe, M.L., Ross, R., Sage, E.H., The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors (1992) Proc. Natl. Acad. Sci. USA, 89, pp. 1281-1285; Reddy, U.R., Pleasure, D., Expression of platelet-derived growth factor (PDGF) and PDGF receptor genes in the developing rat brain (1992) J. Neurosci. Res., 31, pp. 670-677; Saiki, R.K., Scharf, S., Faloona, F., Mullis, K.B., Horn, G.T., Erlich, H.A., Arnheim, N., Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia (1985) Science, 230, pp. 1350-1354; Schubert, D., Kimura, H., Lacorbiere, M., Vaughan, J., Karr, D., Fischer, W.H., Activin is a nerve cell survival molecule (1990) Nature, 344, pp. 868-870; Seifert, R.A., Hart, C.E., Phillips, P.E., Forstrom, J.W., Ross, R., Marray, M.J., Bowen-Pope, D.F., Two different subunits associate to create isoform-specific platelet-derived growth factor receptors (1989) J. Biol. Chem., 264, pp. 8771-8778; Stüber, D., Matile, H., Garotta, G., System for high level production in E. coli and rapid purification of recombinant proteins (1990) Immunological Methods, 4, pp. 121-152. , (Lefkovits I. and Pernis B., eds), Academic Press, San Diego; Westermark, B., Heldin, C.H., Platelet-derived growth factor. Structure, function and implications in normal and malignant cell growth (1993) Acta Oncol., 32, pp. 101-105; Yeh, H.-J., Ruit, K.G., Wang, Y.-X., Pards, W.C., Snider, W.D., Deuel, T.F., PDGF A-chain gene is expressed by mammalian neurons during development and in maturity (1991) Cell, 64, pp. 209-216","Fischer, W.H.; Salk Biological Studies Institute, P.O. Box 85800, San Diego, CA 92186-5800, United States",,,,,,,,00223042,,JONRA,8780057,"English","J. NEUROCHEM.",Article,Scopus,2-s2.0-0029913291
"Sagara, Y., Dargusch, R., Klier, F.G., Schubert, D., Behl, C.","Increased antioxidant enzyme activity in amyloid β protein-resistant cells",1996,"Journal of Neuroscience","16","2",,"497","505",,106,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0030030030&partnerID=40&md5=4b35dacb38390d3da3d75e76f9d6ee11","Salk Inst. for Biological Studies, San Diego, CA 92186, United States; Scripps Research Institute, San Diego, CA 92037, United States; Salk Inst. for Biological Studies, P.O. Box 85800, San Diego, CA 92186, United States; Max Planck Inst. Psychiat. Clin. I., 80804 Munich, Germany","Sagara, Y., Salk Inst. for Biological Studies, San Diego, CA 92186, United States; Dargusch, R., Salk Inst. for Biological Studies, San Diego, CA 92186, United States; Klier, F.G., Scripps Research Institute, San Diego, CA 92037, United States; Schubert, D., Salk Inst. for Biological Studies, San Diego, CA 92186, United States, Salk Inst. for Biological Studies, P.O. Box 85800, San Diego, CA 92186, United States; Behl, C., Salk Inst. for Biological Studies, San Diego, CA 92186, United States, Max Planck Inst. Psychiat. Clin. I., 80804 Munich, Germany","Clones of the rat pheochromocytoma cell line PC12 were selected for their resistance to amyloid β protein (Aβ). These Aβ-resistant cells also survive higher concentrations of exogenously applied peroxides than the parent cells. Aβ triggers intracellular H2O2 accumulation in the parent PC12 cells but not in the Aβ-resistant cells. The absence of H2O2 accumulation in Aβ-resistant cells is not attributable to differences in Aβ binding to the cell surface. However, the mRNA and protein levels of catalase and glutathione peroxidase, as well as the corresponding enzyme activities, are highly elevated in Aβ-resistant clones. These activities correlate well with the increased resistance of cells to Aβ or peroxides. Finally, cells transfected with catalase and glutathione peroxidase are also more resistant to Aβ toxicity. These results indicate that increased antioxidant enzyme activities in Aβ-resistant cells account for at least part of their resistance to Aβ and substantiate further the role of H2O2 in Aβ toxicity.","Alzheimer's disease; amyloid β toxicity; catalase; glutathione peroxidase; oxidative stress; PC12","amyloid beta protein; catalase; enzyme; glutathione peroxidase; hydrogen peroxide; messenger rna; protein; alzheimer disease; animal cell; article; controlled study; cytotoxicity; enzyme activity; nonhuman; oxidative stress; priority journal; rat; transmission electron microscopy; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Antioxidants; Catalase; Cells, Cultured; Glutathione Peroxidase; Microscopy, Electron; PC12 Cells; Rats",,"Amyloid beta-Protein Precursor; Antioxidants; Catalase, EC 1.11.1.6; Glutathione Peroxidase, EC 1.11.1.9",,,,"Aebi, H., Methods of enzymatic analysis (1974) Catalase, 1, pp. 673-684. , Bergmeyer H, ed, New York: Academic; Ames, B.N., Shigenaga, M.K., Hagen, T.M., Oxidants, antioxidants, and the degenerative diseases of aging (1993) Proc Natl Acad Sci USA, 90, pp. 7915-7922; Bass, D.A., Parce, J.W., Dechatelet, L.R., Szejda, P., Seeds, M.C., Thomas, M., Flow cytometric studies of oxidative product formation by neutrphils: A graded response to membrane stimulation (1983) J Immunol, 130, pp. 1910-1917; Beauchamp, C., Fridovich, I., Superoxide dismutase: Improved assay and an assay application to acrylamide gels (1971) Anal Biochem, 44, pp. 276-287; Behl, C., Davis, J., Cole, G.M., Schubert, D., Vitamin E protects nerve cells from amyloid β protein toxicity (1992) Biochem Biophys Res Commun, 186, pp. 944-950; Behl, C., Davis, J.B., Klier, F.G., Schubert, D., Amyloid β peptide induces necrosis rather than apoptosis (1994) Brain Res, 645, pp. 253-264; Behl, C., Davis, J.B., Lesley, R., Schubert, D., Hydrogen peroxide mediates amyloid β protein toxicity (1994) Cell, 77, pp. 817-827; Bellomo, G., Jewell, S.A., Thor, H., Orrenius, S., Regulation of intracellular calcium compartmentation: Studies with isolated hepatocytes and t-butyl hydroperoxide (1982) Proc Natl Acad Sci USA, 79, pp. 6842-6846; Buckman, T.D., Sutphin, M.S., Mitrovic, B., Oxidative stress in a clonal cell line of neuronal origin: Effects of antioxidant enzyme modulation (1993) J Neurochem, 60, pp. 2046-2058; Cai, X.-D., Golde, T., Younkin, S., Release of excess amyloid beta-protein from a mutant amyloid beta-protein precursor (1993) Science, 259, pp. 514-516; Cathcart, R., Schwiers, E., Ames, B.N., Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay (1983) Anal Biochem, 134, pp. 111-116; Chartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Mullan, M., Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene (1991) Nature, 353, pp. 844-846; Chaudiere, J., Wilhelmsen, E.C., Tappel, A.L., Mechanism of selenium-glutathione peroxidase and its inhibition by mercaptocarboxylic acid and other mercaptans (1984) J Biol Chem, 259, pp. 1043-1050; Citron, M., Oltersorf, T., Haass, C., McConlogue, L., Hung, A.Y., Seubert, P., Vigo-Pelfrey, C., Selkoe, D.J., Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production (1992) Nature, 360, pp. 672-674; Cohen, J.J., Duke, R.C., Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death (1984) J Immunol, 132, pp. 38-42; Coyle, J.T., Puttfarcken, P., Oxidative stress, glutamate, and neurodegenerative disorders (1993) Science, 262, pp. 689-695; Darr, D., Fridovich, I., Irreversible inactivation of catalase by 3-amino-1,2,4-triazole (1986) Biochem Pharmacol, 35, p. 3642; Flohe, L., Loschen, G., Günzler, W., Eichele, E., Glutathione peroxidase V (1972) Hoppe Seyler's Z Physiol Chem, 353, pp. 987-999; Games, D., Adams, D., Alessandrini, R., Barbour, R., Berthelette, P., Blackwell, C., Carr, T., Zhao, J., Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein (1995) Nature, 373, pp. 523-527; Glenner, G.G., Alzheimer's disease: Its proteins and genes (1988) Cell, 52, pp. 307-308; Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Hardy, J., Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease (1991) Nature, 349, pp. 704-706; Goodman, Y., Mattson, M.P., Staurosporin and K-252 compound protect hippocampal neurons against amyloid beta-peptide toxicity and oxidative injury (1994) Brain Res, 650, pp. 170-174; Greene, L.A., Tischler, A.S., Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor (1976) Proc Natl Acad Sci USA, 73, pp. 2424-2428; Günzler, W., Flohe, L., Glutathione peroxidase (1985) Handbook of Methods for Oxygen Radical Research, pp. 285-290. , Greenwald R, ed, Boca Raton, FL: CRC; Hall, E.D., Braughler, J.M., Role of lipid peroxidation in post-traumatic spinal cord degeneration (1986) Central Nerv Sys Trauma, 3, pp. 281-294; Halliwell, B., Gutteridge, J.M.C., (1989) Free Radicals in Biology and Medicine, pp. 188-266. , Oxford: Clarendon; Hansen, M.B., Nielsen, S.E., Berg, K., Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell killing (1989) J Immunol Methods, 119, pp. 203-210; Harman, D., Free radical theory of aging: A hypothesis on pathogenesis of senile dementia of the Alzheimer's type (1993) Ageing, 16, pp. 23-30; Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R.D., Korsmeyer, S.J., Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death (1990) Nature, 348, pp. 334-336; Jackson, G.R., Sampath, D., Werrbach-Perez, K., Perez-Polo, R., Effects of nerve growth factor on catalase and glutathione peroxidase m a hydrogen peroxide-resistant pheochromocytoma subclone (1994) Brain Res, 634, pp. 69-76; Jenner, P., Dexter, D., Sian, J., Schapira, A.H.V., Marsden, C.D., Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease (1992) Ann Neurol, 32, pp. S82-S87; Jones, D.P., Eklow, L., Thor, H., Orrenius, S., Metabolism of hydrogen peroxide in isolated hepatocytes: Relative contribution of catalase and glutathione peroxidase in decomposition of endogenously generated H2O2 (1981) Arch Biochem Biophys, 210, pp. 505-516; Keston, A.S., Brandt, R., The fluorometric analysis of ultramicro quantities of hydrogen peroxide (1965) Anal Biochem, 11, pp. 1-5; Kimura, H., Fischer, W.H., Schubert, D., Structure, expression and function of a Schwannoma-derived growth factor (1990) Nature, 348, pp. 257-280; Kitagawa, K., Matsumoto, M., Oda, T., Niinobe, M., Hata, R., Handa, N., Fukunaga, R., Maeda, H., Free radical generation during brief period of cerebral ischemia may trigger delayed neuronal death (1990) Neuroscience, 35, pp. 551-558; Korneluk, R., Quan, F., Lewis, W., Guise, K., Willard, H., Holmes, M., Gravel, R., Isolation of human fibroblast catalase cDNA clones (1984) J Biol Chem, 259, pp. 13819-13823; Lindau-Shepard, B.A., Shaffer, J.B., Expression of human catalase in acatalasemic murine SV-B2 cells confers protection from oxidative damage (1993) Free Radical Biol Med, 15, pp. 581-588; Masaki, N., Kyle, M., Farber, J.L., t-Butyl hydroperoxide kills cultured hepatocytes by peroxidizing membrane lipids (1989) Arch Biochem Biophys.; McCord, J.M., Fridovich, I., Superoxide dismutase: An enzymic function for erythrocuperin (hemocuperin) (1969) J Biol Chem, 244, pp. 6049-6055; Murphy, T.H., Miyamoto, M., Sastre, A., Schnaar, R.L., Coyl, J.T., Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress (1989) Neuron, 2, pp. 1547-1558; Murrell, J., Farlow, M., Ghetti, B., Benson, M.D., A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease (1991) Science, 254, pp. 97-99; Olanow, C.W., A radical hypothesis for neurodegeneration (1993) Trends Neurosci, 16, pp. 439-444; Oyama, Y., Hayashi, A., Ueha, T., Maekawa, K., Characterization of 2′,7′-dichlorofluorescein fluorescence in dissociated mammalian brain neurons: Estimation on intracellular content of hydrogen peroxide (1994) Brain Res, 635, pp. 113-117; Pike, C.J., Burdick, D., Walencewicz, A.J., Glabe, C.G., Cotman, C.W., Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state (1993) J Neurosci, 13, pp. 1676-1687; Pind, S.N., Nuoffer, C., McCaffery, J.M., Plutner, H., Davidson, H.W., Farquhar, M.G., Balch, W.E., Rab1 and Ca2+ are required for the fusion of carrier vesicles mediating endoplasmic reticulum to Golgi transport (1994) J Cell Biol, 125, pp. 239-252; Rosen, D.R., Siddique, T., Patterson, D., Figlewicz, D.A., Sapp, P., Hentati, A., Donaldson, D., Brown Jr., R.H., Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis (1993) Nature, 362, pp. 59-62; Sandstrom, P.A., Buttke, T.M., Autocrine production of extracellular catalase prevents apoptosis of human CEM T-cell line in serum-free medium (1993) Proc Natl Acad Sci USA, 90, pp. 4708-4712; Shearman, M.S., Ragan, C.I., Iversen, L.L., Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death (1994) Proc Natl Acad Sci USA, 91, pp. 1470-1474; Slater, T.F., Sawyer, B., Strauli, U., Studies of succinate reductase systems. III. Points of coupling of four different tetrazolium salts (1963) Biochim Biophys Acta, 77, pp. 383-393; Slivka, A., Cohen, G., Hydroxyl radical attach on dopamine (1985) J Biol Chem, 260, pp. 15466-15472; Stark, G.R., Wahl, G.M., Gene amplification (1984) Annu Rev Biochem, 53, pp. 447-491; Tiffany-Castiglioni, E., Perez-Polo, J.R., Stimulation of resistance of 6-hydroxydopamine in a human neuroblastoma cell line by nerve growth factor (1981) Neurosci Lett, 26, pp. 157-161; Vogt, M., Dulbecco, R., Steps in the neoplastic transformation of hamster embryo cells by polyoma virus (1963) Proc Natl Acad Sci USA, 49, pp. 171-179; Yamamoto, M., Shima, T., Uozumi, T., Sogabe, T., Yamada, K., Kawasaki, T., A possible role of lipid peroxidation in cellular damage caused by cerebral ischemia and protective effects of alpha-tocopherol administration (1983) Stroke, 14, pp. 977-982; Yankner, B.A., Duffy, L.K., Kirschner, D.A., Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides (1990) Science, 25, pp. 279-282","Schubert, D.; Salk Inst. for Biological Studies, P.O. Box 85800, San Diego, CA 92186, United States",,,,,,,,02706474,,JNRSD,8551334,"English","J. NEUROSCI.",Article,Scopus,2-s2.0-0030030030
"Schubert, D., Chevion, M.","The role of iron in beta amyloid toxicity",1995,"Biochemical and Biophysical Research Communications","216","2",,"702","707",,102,10.1006/bbrc.1995.2678,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0028871735&partnerID=40&md5=bfc73634e0f2d3919d4dc60af889def8","Salk Institute, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States; Hebrew University, Hadassah Medical School, P.O. Box 12272, Jerusalem 91120, Israel","Schubert, D., Salk Institute, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States; Chevion, M., Hebrew University, Hadassah Medical School, P.O. Box 12272, Jerusalem 91120, Israel","There is evidence that oxidative damage plays a causative role in Alzheimer's disease and amyloid β protein (Aβ) toxicity. Iron is frequently a potent facilitator of free radical production due to its ability to mediate the conversion of H2O2 to hydroxyl radicals via the Fenton reaction or by virtue of hypervalent iron compounds. It is shown here that iron facilitates Aβ toxicity to cultured cells.",,"amyloid beta protein; free radical; hydrogen peroxide; hydroxyl radical; iron; alzheimer disease; animal cell; article; cell culture; chemical reaction; controlled study; cytotoxicity; nonhuman; oxidation; priority journal; rat; Alzheimer Disease; Amyloid beta-Protein; Animal; Cell Death; Cell Survival; Cells, Cultured; Cerebral Cortex; Clone Cells; Comparative Study; Deferoxamine; Drug Synergism; Human; Hydrogen Peroxide; Iron; Iron Chelating Agents; Neurons; Neurotoxins; Peptide Fragments; Support, U.S. Gov't, P.H.S.; Animalia",,"amyloid beta-protein (1-40); amyloid beta-protein (25-35); Amyloid beta-Protein; Deferoxamine, 70-51-9; Hydrogen Peroxide, 7722-84-1; Iron Chelating Agents; Iron, 7439-89-6; Neurotoxins; Peptide Fragments",,,,,"Schubert, D.; Salk Institute, 10010 N Torrey Pines Road, La Jolla, CA 92037, United States",,,,,,,,0006291X,,BBRCA,7488167,"English","BIOCHEM. BIOPHYS. RES. COMMUN.",Article,Scopus,2-s2.0-0028871735
"Schubert, D., Behl, C., Lesley, R., Brack, A., Dargusch, R., Sagara, Y., Kimura, H.","Amyloid peptides are toxic via a common oxidative mechanism",1995,"Proceedings of the National Academy of Sciences of the United States of America","92","6",,"1989","1993",,307,10.1073/pnas.92.6.1989,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0028957882&partnerID=40&md5=74acf6496d4afb06bef64c51cf4b9e21","Salk Inst. for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States; Centre de Biophysique Moleculaire, Ctr. Natl. de la Rech. Scientifique, 1A, Ave. de la Rech. Scientifique, 45071 Orleans, Cedex 2, France; Max Planck Institute of Psychiatry, Kraepelinstrasse 2-10, 80804 Munich, Germany","Schubert, D., Salk Inst. for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States; Behl, C., Salk Inst. for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States, Max Planck Institute of Psychiatry, Kraepelinstrasse 2-10, 80804 Munich, Germany; Lesley, R., Salk Inst. for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States; Brack, A., Centre de Biophysique Moleculaire, Ctr. Natl. de la Rech. Scientifique, 1A, Ave. de la Rech. Scientifique, 45071 Orleans, Cedex 2, France; Dargusch, R., Salk Inst. for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States; Sagara, Y., Salk Inst. for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States; Kimura, H., Salk Inst. for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States","β-Amyloid protein (Aβ) is a member of a small group of proteins that accumulate as amyloid deposits in various tissues. It has recently been demonstrated that the toxicity of Aβ toward some neural cells is caused by oxidative damage. Since all of the amyloid diseases are characterized by protein deposited in the antiparallel β-sheet conformation, it was asked whether there is a common toxic mechanism. It is shown here that the protein components of other human amyloidoses, including amylin, calcitonin, and atrial natriuretic peptide, are all toxic to clonal and primary cells. The toxicity is mediated via a free radical pathway indistinguishable from that of Aβ. Experiments with synthetic peptides suggest that it is the amphiphilic nature of the peptides generated by their β structure rather than their β structure per se that causes toxicity. These results tend to rule out the alternative that amyloid toxicity is exclusively mediated via specific cell surface receptors.",,"amyloid beta protein; cell surface receptor; aerobic metabolism; amyloidosis; animal cell; article; cell death; enzyme activation; flow cytometry; nonhuman; priority journal; protein conformation; protein structure; rat; Amino Acid Sequence; Amyloid; Amyloid beta-Protein; Animal; Atrial Natriuretic Factor; Brain Neoplasms; Calcitonin; Cell Line; Cell Survival; Comparative Study; Flow Cytometry; Human; Hydrogen Peroxide; Lactate Dehydrogenase; Melitten; Molecular Sequence Data; NADH, NADPH Oxidoreductases; Oligopeptides; Onium Compounds; p-Methoxy-N-methylphenethylamine; Peptide Fragments; Peptides; Protein Structure, Secondary; Rats; Structure-Activity Relationship; Support, U.S. Gov't, P.H.S.; Tumor Cells, Cultured; Wasp Venoms; Animalia",,"amylin, 106602-62-4; amyloid beta-protein (25-35); Amyloid beta-Protein; Amyloid; Atrial Natriuretic Factor, 85637-73-6; Calcitonin, 9007-12-9; diphenyleneiodonium, 244-54-2; Hydrogen Peroxide, 7722-84-1; Lactate Dehydrogenase, EC 1.1.1.27; mastoparan, 72093-21-1; Melitten, 20449-79-0; NADH, NADPH Oxidoreductases, EC 1.6.; Oligopeptides; Onium Compounds; p-Methoxy-N-methylphenethylamine, 4091-50-3; Peptide Fragments; Peptides; Wasp Venoms",,,,,"Behl, C.; Max Planck Institute of Psychiatry, Kraepelinstrasse 2-10, 80804 Munich, Germany",,,,,,,,00278424,,PNASA,7892213,"English","PROC. NATL. ACAD. SCI. U. S. A.",Article,Scopus,2-s2.0-0028957882
"Maher, P.A., Schubert, D.","Schwannoma-derived growth factor interacts with the epidermal growth factor receptor",1995,"Journal of Neurochemistry","65","4",,"1895","1898",,5,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0029157658&partnerID=40&md5=0bc9642bdfdbac1ca2f821e531830075","Salk Inst. for Biological Studies, San Diego, CA 92037, United States","Maher, P.A., Salk Inst. for Biological Studies, San Diego, CA 92037, United States; Schubert, D., Salk Inst. for Biological Studies, San Diego, CA 92037, United States","Schwannoma-derived growth factor (SDGF) is a potent mitogen and neuronal differentiation factor. Because of its relationship to epidermal growth factor (EGF) and the heregulins, it was asked if SDGF interacts with the EGF receptor or HER2/neu. SDGF binds to and causes the phosphorylation on tyrosine of the EGF receptor but not HER2/neu.","Epidermal growth factor; Growth factors; Phosphotyrosine","amphiregulin; epidermal growth factor; epidermal growth factor receptor; animal cell; antibody specificity; article; central nervous system; gene isolation; molecular interaction; nerve cell differentiation; neurilemoma; nonhuman; peptide analysis; priority journal; protein degradation; protein phosphorylation; protein synthesis; rat; 3T3 Cells; Animal; Binding, Competitive; Cell Line; Growth Substances; Mice; PC12 Cells; Phosphorylation; Rats; Receptor, Epidermal Growth Factor; Receptor, erbB-2; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Tyrosine",,"amphiregulin, 117147-70-3; epidermal growth factor, 62229-50-9; amphiregulin, 117147-70-3; Growth Substances; Receptor, Epidermal Growth Factor, EC 2.7.1.112; Receptor, erbB-2, EC 2.7.1.112; Tyrosine, 55520-40-6",,,,,"Schubert, D.; Salk Inst. for Biological Studies, San Diego, CA 92037, United States",,,,,,,,00223042,,JONRA,7561890,"English","J. NEUROCHEM.",Article,Scopus,2-s2.0-0029157658
"Jin, L.-W., Ninomiya, H., Roch, J.-M., Schubert, D., Masliah, E., Otero, D.A.C., Saitoh, T.","Peptides containing the RERMS sequence of amyloid β/A4 protein precursor bind cell surface and promote neurite extension",1994,"Journal of Neuroscience","14","9",,"5461","5470",,142,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0028136865&partnerID=40&md5=082d3178c1878ae83bd8e98e7f472221","Department of Neurosciences, School of Medicine, University of California, San Diego, San Diego, CA 92093-0624, United States; Salk Inst. for Biological Studies, San Diego, CA 92128, United States","Jin, L.-W., Department of Neurosciences, School of Medicine, University of California, San Diego, San Diego, CA 92093-0624, United States; Ninomiya, H., Department of Neurosciences, School of Medicine, University of California, San Diego, San Diego, CA 92093-0624, United States; Roch, J.-M., Department of Neurosciences, School of Medicine, University of California, San Diego, San Diego, CA 92093-0624, United States; Schubert, D., Salk Inst. for Biological Studies, San Diego, CA 92128, United States; Masliah, E., Department of Neurosciences, School of Medicine, University of California, San Diego, San Diego, CA 92093-0624, United States; Otero, D.A.C., Department of Neurosciences, School of Medicine, University of California, San Diego, San Diego, CA 92093-0624, United States; Saitoh, T., Department of Neurosciences, School of Medicine, University of California, San Diego, San Diego, CA 92093-0624, United States","Amyloid β/A4 protein precursor (APP) is secreted into medium by most cultured cells and can function as an autocrine factor. To study the biological function of secreted forms of APP (sAPP) on neurons, we used a clonal CNS neuronal line, B103, which does not synthesize detectable levels of APP. B103 cells transfected with APP construct developed neurites faster than the parent B103 cells when plated in a serum-free defined medium. Neurite outgrowth of B103 cells was promoted by the conditioned medium of APP-695-over-producing cells or by the bacteria-produced sAPP-695 (named KB75). A series of peptides having sequences between Ala-319 and Met-335 of APP-695 also stimulated neurite outgrowth of B103 cells. The sequence of five amino acids, RERMS (APP 328-332), within this stretch of sequence, was the shortest active peptide, although the concentration required for the neuritotropic activity was higher than that of KB75. Binding assay using 125I-labeled APP 17-mer peptide corresponding to Ala-319 to Met-335 of APP-695 as a ligand demonstrated specific and saturable cell-surface binding sites. The predicted K(D) value was 20 ± 5 nM and the B(max) value was 80 ± 8 fmol/106 cells. The binding could be displaced with KB75. A 17-mer peptide with reverse sequence neither induced neurite outgrowth nor competed for the binding. A bacteria-produced sAPP fragment lacking the active 17-mer sequence (named KB75δ) did not compete with 125I-labeled 17-mer for binding or stimulate neurite extension. A peptide of sequence RMSQ (APP 330-333), which partially overlaps the active sequence RERMS, could block the neuritotropic effects of both KB75 and the 17-mer at higher concentrations. APP 17-mer was also found to induce the accumulation of inositol polyphosphates, suggesting that the APP 17-mer effects involve activation of inositol phospholipid signal transduction systems. These data indicate that sAPP induces neurite extension through cell-surface binding and that the domain containing the RERMS sequence (APP 328-332) represents the active site responsible for this function.","Alzheimer's disease; amyloid β/A4 precursor protein; growth factor; receptor; signal transduction; trophic factor","amyloid precursor protein; amino acid sequence; article; cell culture; controlled study; kinetics; membrane binding; nerve cell growth; neurite; priority journal; protein binding; structure activity relation; Amino Acid Sequence; Amyloid beta-Protein Precursor; Cell Adhesion; Cell Line, Transformed; Cell Membrane; Central Nervous System; Detergents; Escherichia coli; Molecular Sequence Data; Neurites; Neurons; Peptide Fragments; Phosphatidylinositols; Plasmids; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Transfection",,"Amyloid beta-Protein Precursor; Detergents; Peptide Fragments; Phosphatidylinositols; Plasmids",,,,,"Saitoh, T.; Department of Neurosciences, School of Medicine, University of California, San Diego, CA 92093-0624, United States",,,,,,,,02706474,,JNRSD,8083748,"English","J. NEUROSCI.",Article,Scopus,2-s2.0-0028136865
"Behl, C., Davis, J.B., Lesley, R., Schubert, D.","Hydrogen peroxide mediates amyloid β protein toxicity",1994,"Cell","77","6",,"817","827",,1756,10.1016/0092-8674(94)90131-7,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0028233494&partnerID=40&md5=c4ff7dd1678078328118cca5c5c25cfb","The Salk Institute for Biological Studies San Diego, CA 92186-5800, United States","Behl, C., The Salk Institute for Biological Studies San Diego, CA 92186-5800, United States; Davis, J.B., The Salk Institute for Biological Studies San Diego, CA 92186-5800, United States; Lesley, R., The Salk Institute for Biological Studies San Diego, CA 92186-5800, United States; Schubert, D., The Salk Institute for Biological Studies San Diego, CA 92186-5800, United States","Amyloid β protein (Aβ) is a 40-43 amino acid peptide that is associated with plaques in the brains of Alzheimer's patients and is cytotoxic to cultured neurons. Using both primary central nervous system cultures and clonal cell lines, it is shown that a number of antioxidants protect cells from Aβ toxicity, suggesting that at least one pathway to Aβ cytotoxicity results in free radical damage. Aβ causes increased levels of H2O2 and lipid peroxides to accumulate in cells. The H2O2-degrading enzyme catalase protects cells from Aβ toxicity. Clonal cell lines selected for their resistance to Aβ toxicity also become resistant to the cytolytic action of H2O2. In addition, Aβ induces the activity of NF-βB, a transcription factor thought to be regulated by oxidative stress. Finally, Aβ-induced H2O2 production and Aβ toxicity are blocked by reagents that inhibit flavin oxidases, suggesting that Aβ activates a member of this class of enzymes. These results show that the cytotoxic action of Aβ on neurons results from free radical damage to susceptible cells. © 1994.",,"amyloid beta protein; catalase; free radical; hydrogen peroxide; alzheimer disease; animal cell; article; cell protection; cell strain; controlled study; cytolysis; cytotoxicity; enzyme activity; enzyme inhibition; flow cytometry; lipid peroxidation; neurotoxicity; nonhuman; priority journal; rat; Amino Acid Sequence; Amyloid beta-Protein; Animal; Antioxidants; Catalase; Cell Line; Clone Cells; Hydrogen Peroxide; Lipid Peroxidation; Molecular Sequence Data; Neurons; NF-kappa B; Oxidation-Reduction; PC12 Cells; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.",,"Amyloid beta-Protein; Antioxidants; Catalase, EC 1.11.1.6; Hydrogen Peroxide, 7722-84-1; NF-kappa B",,,,"Abe, Takayanagi, Saito, Effects of recombinant human basic FGF and its modified protein CS23 on survival of primary cultured neurons from various regions of fetal rat brain (1990) The Japanese Journal of Pharmacology, 53, pp. 221-227; Ames, Shigenaga, Hagen, Oxidants antioxidants and the degenerative diseases of aging (1993) Proceedings of the National Academy of Sciences, 90, pp. 7915-7922; Bakalkin, Yakovleva, Terenius, NF-κB-like factors in the murine brain (1993) Molecular Brain Research, 20, pp. 137-146; Behl, Davis, Cole, Schubert, Vitamin E protects nerve cells from amyloid β protein toxicity (1992) Biochemical and Biophysical Research Communications, 186, pp. 944-952; Behl, Davis, Klier, Schubert, Amyloid β protein induces necrosis rather than apoptosis (1994) Brain Research, 645, pp. 253-264; Brodie, Reed, Reversible oxidation of glyceraldehyde 3-phosphate dehydrogenase thiols in human lung carcinoma cells by hydrogen peroxide (1987) Biochemical and Biophysical Research Communications, 148, pp. 120-125; Burdon, Gill, Rice-Evans, Reduction of a tetrazolium salt and superoxide generation in human tumor cells (HeLa) (1993) Free Radical Research, 18, pp. 369-380; Cai, Golde, Younkin, Release of excess amyloid beta-protein from a mutant amyloid beta-protein precursor (1993) Science, 259, pp. 514-516; Cathcart, Schwiers, Ames, Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay (1983) Analytical Biochemistry, 134, pp. 111-116; Chartier-Harlin, Crawford, Houlden, Warren, Hughes, Fidani, Goate, Mullan, Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene (1991) Nature, 353, pp. 844-846; Choi, Ionic dependence of glutamate neurotoxicity (1987) J Neurosci, 7, pp. 369-379; Citron, Oltersorf, Haass, McConlogue, Hung, Seubert, Vigo-Pelfrey, Selkoe, Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production (1992) Nature, 360, pp. 672-674; Coyle, Puttfarcken, Oxidative stress glutamate and neurodegenerative disorders (1993) Science, 262, pp. 689-695; Cross, Inhibitors of leukocyte superoxide generating oxidase (1990) Free Radical Biology and Medicine, 8, pp. 71-93; Cross, Jones, Enzymatic mechanisms of superoxide production (1991) Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1057, pp. 281-298; Devary, Rosette, Didonato, Karin, NF-κB activation by ultraviolet light not dependent on a nuclear signal (1993) Science, 261, pp. 1442-1445; Glenner, Alzheimer's disease its proteins and genes (1988) Cell, 52, pp. 307-308; Goate, Chartier-Harlin, Mullan, Brown, Crawford, Fidani, Giuffra, Hardy, Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease (1991) Nature, 349, pp. 704-706; Greene, Tischler, Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor (1976) Proceedings of the National Academy of Sciences, 73, pp. 2424-2428; Halliwell, Gutteridge, (1989) Free Radicals in Biology and Medicine, pp. 188-266. , Oxford University Press, Oxford; Hansen, Nielsen, Berg, Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell killing (1989) Journal of Immunological Methods, 119, pp. 203-210; Hedley, Chow, Fluorocytometric measurement of lipid peroxidation in vital cells using parinaric acid (1992) Cytometry, 13, pp. 686-692; Hockenbery, Oltvai, Yin, Milliman, Korsmeyer, Bcl-2 functions in an antioxidant pathway to prevent apoptosis (1993) Cell, 75, pp. 241-251; Keston, Brandt, The fluorometric analysis of ultramicro quantities of hydrogen peroxide (1965) Analytical Biochemistry, 11, pp. 1-5; Kimura, Schubert, Schwannoma derived growth factor (SDGF) promotes PC12 cell differentiation (1992) The Journal of Cell Biology, 116, pp. 777-783; Kimura, Schubert, Amyloid β protein activates tackykinin receptors and IP3 accumulation by synergy with glutamate (1993) Proceedings of the National Academy of Sciences, 90, pp. 7508-7512; Koh, Yang, Cotman, β amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage (1990) Brain Research, 533, pp. 315-320; Kojima, Nomura, Icho, Kajiwara, Kitabatake, Kubota, Inhibitory effect of neopterin on NADPH-dependent superoxide-generating oxidase of rat peritoneal macrophages (1993) FEBS Letters, 329, pp. 125-128; Lees, Contributory mechanisms in the causation of neurodegenerative disorders (1993) Neuroscience, 4, pp. 287-322; Loo, Agata, Pike, Whittemore, Wulencewicz, Cotman, Apoptosis is induced by β-amyloid in cultured nervous system neurons (1993) Proceedings of the National Academy of Sciences, 90, pp. 7951-7955; Mattson, Cheng, Davis, Bryant, Lieberburg, Rydel, β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity (1992) J Neurosci, 12, pp. 376-389; Morel, Doussiere, Vignais, The superoxidegenerating oxidase of phagocytic cells (1991) European Journal of Biochemistry, 201, pp. 523-546; Murphy, Miyamoto, Sastre, Schnaar, Coyle, Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress (1989) Neuron, 2, pp. 1547-1558; Murrell, Farlow, Ghetti, Benson, A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease (1991) Science, 254, pp. 97-99; Nabel, Baltimore, An inducible transcription factor activates expression of human immunodeficiency virus in T cells (1987) Nature, 326, pp. 711-713; Olanow, An introduction to the free radical hypothesis in Parkinson's disease (1992) Annals of Neurology, 32, pp. 2-9; Olanow, A radical hypothesis for neurodegeneration (1993) Trends in Neurosciences, 16, pp. 439-444; Robberecht, Sapp, Viaene, Rosen, McKenna-Yasek, Haines, Horvitz, Brown, Jr., Cu/Zn superoxide dismutase activity in familial and sporadic amyotrophic lateral sclerosis (1994) Journal of Neurochemistry, 62, pp. 384-387; Rosen, Siddique, Patterson, Figlewicz, Sapp, Hentati, Donaldson, Brown, Jr., Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis (1993) Nature, 362, pp. 59-62; Royall, Ischiropoulos, Evaluation of 2′7′dichlorofluorescin and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells (1993) Archives of Biochemistry and Biophysics, 302, pp. 348-355; Sandstrom, Buttke, Autocrine production of extracellular catalase prevents apoptosis of human CEM T-cell line in serum-free medium (1993) Proceedings of the National Academy of Sciences, 90, pp. 4708-4712; Schreck, Baeuerle, A role of oxygen radicals as second messengers (1991) Trends Biochem., 1, pp. 39-42; Schreck, Rieber, Baeuerle, Reactive oxygen intermediates are apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1 (1991) EMBO J, 10, pp. 2247-2258; Schubert, (1984) Developmental Biology of Cultured Nerve, Muscle, and Glia, , First Edition, John Wiley and Sons, New York; Schubert, Behl, The expression of amyloid beta protein precursor protects nerve cells from glutamate toxicity and alters their interaction with the extracellular matrix (1993) Brain Research, 629, pp. 275-282; Schubert, Heinemann, Carlisle, Tarikas, Kimes, Steinbach, Culp, Brandt, Clonal cell lines from the rat central nervous system (1974) Nature, 249, pp. 224-227; Schubert, Kimura, Maher, Growth factors and vitamin E modify neuronal glutamate toxicity (1992) Proceedings of the National Academy of Sciences, 89, pp. 8264-8268; Slater, Sawyer, Strauli, Studies of succinate reductase systems III Points of coupling of four different tetrazolium salts (1963) Biochimica et Biophysica Acta, 77, pp. 383-393; Stuehr, Fasehun, Kwon, Gross, Gonzalez, Levi, Nathan, Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleniodonium and its analogs (1991) FASEB J, 5, pp. 98-103; Vogt, Dulbecco, Steps in the neoplastic transformation of hamster embryo cells by polyoma virus (1963) Proceedings of the National Academy of Sciences, 49, pp. 171-179; Wozniak, McLennan, Betts, Murphy, Scicchitano, Activation of human neutrophils by substance P (1989) Immunology, 68, pp. 359-364; Yankner, Duffy, Kirschner, Neurotrophic and neurotoxic effects of amyloid β protein reversal by tachykinin neuropeptides (1990) Science, 25, pp. 279-282","Behl, C.; The Salk Institute for Biological Studies San Diego, CA 92186-5800, United States",,,,,,,,00928674,,CELLB,8004671,"English","Cell",Article,Scopus,2-s2.0-0028233494
"Behl, C., Davis, J.B., Klier, F.G., Schubert, D.","Amyloid β peptide induces necrosis rather than apoptosis",1994,"Brain Research","645","1-2",,"253","264",,204,10.1016/0006-8993(94)91659-4,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0028207907&partnerID=40&md5=6e9d6359eff5a47b53b018a4864a2ae1","The Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States; Scripps Research Institute, 10666 N. Torrey Pines Road, La Jolla, CA 92037, United States","Behl, C., The Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States; Davis, J.B., The Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States; Klier, F.G., Scripps Research Institute, 10666 N. Torrey Pines Road, La Jolla, CA 92037, United States; Schubert, D., The Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States","Amyloid β peptide (AβP), a major component of Alzheimer's disease plaques, is toxic to rat pheochromocytoma PC12 cells and to rat cortical neurons. A reduction in cell survival could be detected after 24 h incubation with 0.01 to 20 μM of the 25-35 peptide fragment (β25-35) of AβP. To study the mechanism of cell death induced by AβP, the morphological as well as the biochemical features of neuronal cell death were analyzed. To distinguish between necrosis and apoptosis, PC12 cell death caused by β25-35 was compared to that induced by serum deprivation, a process known to be apoptotic in these cells. The DNA-degradation pattern of AβP treated cells appeared random rather than at distinct internucleosomal sites as with apoptosis. Electron microscopic studies of NGF-treated PC12 cells and cortical primary cultures exposed to 20 μM β25-35 revealed immediate cellular damage such as vacuolization of the cytoplasm, breakdown of Golgi-apparatus and other membrane systems, and neurite disintegration. This was followed by total collapse of the cytoplasm and cell lysis. These data show that AβP toxicity occurs via a necrotic rather than an apoptotic pathway. © 1994.","Amyloid β peptide; Apoptosis; Necrosis; Nerve growth factor; PC12 cell","amyloid; amyloid beta protein; nerve growth factor; animal cell; apoptosis; article; cell culture; controlled study; electron microscopy; necrosis; nonhuman; pheochromocytoma; priority journal; rat; Amyloid beta-Protein; Animal; Apoptosis; Cell Death; DNA Damage; Flow Cytometry; Microscopy, Electron; Necrosis; Nerve Growth Factors; PC12 Cells; Rats; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.",,"amyloid beta protein, 109770-29-8; amyloid, 11061-24-8; nerve growth factor, 9061-61-4; Amyloid beta-Protein; Nerve Growth Factors",,"bachem, United States; ubi, United States",,"Abe, Takayanagi, Saito, Effects of recombinant human basic FGF and its modified protein CS23 on survival of primary cultured neurons from various regions of fetal rat brain (1990) Jpn. J. Pharmacol., 53, pp. 221-227; Batistatou, Greene, Aurintricar☐ylic acid rescues PC12 cells and sympathetic neurons from cell death caused by nerve growth factor deprivation: correlation with suppression of endonuclease activity (1991) J. Cell Biol., 115, pp. 461-471; Behl, Davis, Cole, Schubert, Vitamin E protects nerve cells from amyloid β protein toxicity (1992) Biochem. Biophys. Res. Commun., 186, pp. 944-952; Behl, Schubert, Heat shock partially protects rat pheochromocytoma PC12 cells from amyloid β peptide toxicity (1993) Neurosci. Lett., 154, pp. 1-4; Behl, Hovey, Krajewski, Schubert, Reed, Bcl-2 prevents killing of neuronal cells by glutamate but not by amyloid beta protein (1993) Biochem. Biophys. Res. Commun., 197, pp. 949-956; Cai, Golde, Younkin, Release of excess amyloid beta-protein from a mutant amyloid beta-protein precursor (1993) Science, 259, pp. 514-516; Chartier-Harlin, Crawford, Houlden, Warren, Hughes, Fidani, Goate, Mullan, Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene (1991) Nature, 353, pp. 844-846; Citron, Oltersorf, Haass, McConlogue, Hung, Seubert, Vigo-Pelfrey, Selkoe, Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production (1992) Nature, 360, pp. 672-674; Cohen, Duke, Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death (1984) J. Immunol., 132, pp. 38-42; Davis, McMurray, Schubert, The amyloid β protein of Alzheimer's disease is chemotactic for mononuclear phagocytes (1992) Biochem. Biophys. Res. Commun., 189, pp. 1096-1100; Decker, Lohmann-Matthes, A quick and simple method for the quantitation of lactate dehydrogenase release in measurement of cellular cytotoxicity and tumor necrosis factor (TNF) activity (1988) J. Immunol. Methods, 15, pp. 61-69; Dickson, Lee, Mattiace, Yen, Brosnan, Microglia and cytokines in neurological disease (1993) Glia, 7, pp. 75-83; Dipasquale, Marini, Youle, Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons (1991) Biochem. Biophys. Res. Commun., 181, pp. 1442-1448; Dive, Gregory, Phipps, Evans, Milner, Wyllie, Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry (1992) Biochim. Biophys. Acta, 1133, pp. 275-285; Duvall, Wyllie, Death and the cell (1986) Immunol. Today, 7, pp. 115-119; Fesus, Davies, Piacentini, Apoptosis: molecular mechanisms in programmed cell death (1991) Eur. J. Cell Biol., 56, pp. 170-177; Frandsen, Schousboe, Dantrolene prevents glutamate cytoxicity and Ca2 + release from intracellular stores in cultured cerebral cortical neurons (1991) J. Neurochem., 56, pp. 1075-1078; Frautschy, Baird, Cole, Effects of injected Alzheimer β-amyloid cores in rat brain (1991) Proc. Natl. Acad. Sci. USA, 88, pp. 8362-8366. , 2nd. edn; Fukuchi, Kamino, Deeb, Smith, Dang, Martin, Overexpression of amyloid precursor protein alters its normal processing and is associated with neurotoxicity (1992) Biochem. Biophys. Res. Commun., 182, pp. 165-173; Gerschenson, Rotello, Apoptosis: a different type of cell death (1992) FASEB J., 6, pp. 2450-2455; Goate, Chartier-Harlin, Mullan, Brown, Crawford, Fidani, Giuffra, Hardy, Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease (1991) Nature, 349, pp. 704-706; Greene, Tischler, Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor (1976) Proc. Natl. Acad. Sci. USA, 73, pp. 2424-2428. , 2nd. edn; Greene, Tischler, PC12 pheochromocytoma cells in neurobiological research (1982) Adv. Cell Neurobiol., 3, pp. 373-414; Haga, Ikeda, Sato, Ishii, Synthetic Alzheimer amyloid β/A4 peptides enhance production of complement C3 component by cultured microglial cells (1993) Brain Res., 601, pp. 88-94; Hansen, Nielsen, Berg, Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell killing (1989) J. Immunol. Methods, 119, pp. 203-210; Hockenbery, Nunez, Milliman, Schreiber, Korsmeyer, Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death (1990) Nature, 348, pp. 334-336; Katzman, Saitoh, Advances in Alzheimer's disease (1991) FASEB J., 5, pp. 278-286; Kerr, Wyllie, Currie, Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics (1972) Br. J. Cancer, 26, pp. 239-257; Koh, Yang, Cotman, β amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage (1990) Brain Res., 533, pp. 315-320; Kowall, Beal, Busciglio, Duffy, Yankner, An in vivo model for the neurodegenerative effects of β amyloid and protection by substance P (1991) Proc. Natl. Acad. Sci. USA, 88, pp. 7247-7251. , 2nd. edn; Kure, Tominaga, Yoshimoto, Tada, Narisawa, Glutamate triggers internucleosomal DNA cleavage in neuronal cells (1991) Biochem. Biophys. Res. Commun., 179, pp. 39-45; Lockshin, Zakeri, Physiology and protein synthesis in programmed cell death (1992) Ann. N.Y. Acad. Sci., 663, pp. 234-249; Loo, Agata, Pike, Whittemore, Wulencewicz, Cotman, Apoptosis is induced by β-amyloid in cultured nervous system neurons (1993) Proc. Nat. Acad. Sci. USA, 90, pp. 7951-7955. , 2nd. edn; Martin, Schmidt, DiStefano, Lowry, Carter, Johnson, E, Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation (1988) J. Cell Biol., 106, pp. 829-844; Mattson, Cheng, Davis, Bryant, Lieberburg, Rydel, β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity (1992) J. Neurosci., 12, pp. 376-389; McConkey, Nicotera, Hartzell, Bellomo, Wyllie, Orrenius, Glucocorticoids activate a suicide process in thymocytes through an elevation of cytosolic Ca2+ concentration (1989) Arch. Biochem. Biophys., 269, pp. 365-370; Murrell, Farlow, Ghetti, Benson, A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease (1991) Science, 254, pp. 97-99; Oberhammer, Wilson, Dive, Morris, Hickman, Wakeling, Walker, Sikorska, Apoptotic death in epithelial cells (1993) EMBO J., 12, pp. 3679-3684; Oppenheim, Cell death during development of the nervous system (1991) Annu. Rev. Neurosci., 14, pp. 453-501; Oppenheim, Prevette, Tytell, Homma, Naturally occurring and induced neuronal death in vivo requires protein and RNA synthesis: evidence for the role of cell death genes (1990) Dev. Biol., 138, pp. 104-113; Pike, Burdick, Walencewicz, Glabe, Cotman, Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state (1993) J. Neurosci., 13, pp. 1676-1687; Samples, Dubinsky, Aurintricar☐ylic acid protects hippocampal neurons from glutamate excitotoxicity in vitro (1993) J. Neurochem., 61, pp. 382-385; Schwartz, Smith, Jones, Osborne, Do all programmed cell deaths occur via apoptosis? (1993) Proc. Natl. Acad. Sci. USA, 90, pp. 980-984. , 2nd. edn; Scott, Davies, Inhibition of protein synthesis prevents cell death in sensory and parasympathetic neurons deprived of neurotrophic factor in vitro (1990) J. Neurobiol., 21, pp. 630-638; Selkoe, The molecular pathology of Alzheimer's disease (1991) Neuron., 6, pp. 487-498; Sun, Snowden, Skilleter, Dinsdale, Ormerod, Cohen, A flow-cytometric method for the separation and quantitation of normal and apoptotic thymocytes (1992) Anal. Biochem., 204, pp. 351-356; Tomei, Shapiro, Cope, Apoptosis in C3H/10T1/2 mouse embryonic cells. Evidence for internucleosomal DNA modification in the absence of double strand cleavage (1993) Proc. Natl. Acad. Sci. USA, 90, pp. 853-857. , 2nd. edn; Van Gool, De Strooper, Van Leuven, Triau, Dom, Alpha 2 macroglobulin expression in neurite-type plaques in patients with Alzheimer's disease (1993) Neurobiol. Aging, 14, pp. 233-237; Vogt, Dulbecco, Steps in the neoplastic transformation of hamster embryo cells by polyoma virus (1963) Proc. Natl. Acad. Sci. USA, 49, pp. 171-179. , 2nd. edn; Williams, Smith, McCarthy, Grimes, Apoptosis: final control point in cell biology (1992) Trends Cell Biol., 2, pp. 263-267; Wyllie, Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation (1980) Nature, 284, pp. 555-556; Wyllie, Kerr, Currie, Cell death: the significance of apoptosis (1980) Int. Rev. Cytol., 68, pp. 251-306; Yankner, Duffy, Kirschner, Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides (1990) Science, 25, pp. 279-282; Zhong, Sarafani, Kane, Charles, Mah, Edwards, Bredesen, bcl,-2 inhibits death of central neural cells induced by multiple agents (1993) Proc. Natl. Acad. Sci. USA, 90, pp. 4533-4537. , 2nd. edn","Schubert, D.; The Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States",,,,,,,,00068993,,BRREA,8062088,"English","Brain Res.",Article,Scopus,2-s2.0-0028207907
"Roch, J.-M., Jin, L.-W., Ninomiya, H., Schubert, D., Saitoh, T.","Biologically active domain of the secreted form of the amyloid β/A4 protein precursor",1993,"Annals of the New York Academy of Sciences","695",,,"149","157",,16,10.1111/j.1749-6632.1993.tb23044.x,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0027381379&partnerID=40&md5=8184fb09f81bd782acef837ef7f323f4","Department of Neurosciences 0624, UC San Diego, La Jolla, CA 92093, United States","Roch, J.-M., Department of Neurosciences 0624, UC San Diego, La Jolla, CA 92093, United States; Jin, L.-W., Department of Neurosciences 0624, UC San Diego, La Jolla, CA 92093, United States; Ninomiya, H., Department of Neurosciences 0624, UC San Diego, La Jolla, CA 92093, United States; Schubert, D., Department of Neurosciences 0624, UC San Diego, La Jolla, CA 92093, United States; Saitoh, T., Department of Neurosciences 0624, UC San Diego, La Jolla, CA 92093, United States","The amyloid β/A4 protein precursor (APP), a large transmembrane protein, is expressed ubiquitously in many organisms, as well as in a variety of cultured cells. Studies of the synthesis and processing of APP have revealed several intricate metabolic pathways for this protein. One of these pathways involves the cleavage of APP in the middle of the β/A4 domain and results in the secretion of the large amino-terminal portion of the protein. The biological function of this secreted form of APP has been the subject of intense investigation by several groups and various activities have been described for the different domains of APP studied. Our initial approach was to create a fibroblast cell line in which APP expression is dramatically reduced. These fibroblasts, called A-l, have a very slow growth rate. Addition of exogenous APP in the medium of A-1 cells restores their growth to the level of normal parent fibroblasts demonstrating a growth factor-like activity for the secreted form of APP. Using APP fragments made in bacteria as well as synthetic peptides, we have been able to locate the active site of APP within a domain of 17 amino-acids (Ala319-Met335). This domain of APP can stimulate neurite extension of cultured neuroblastoma cells and it is proposed that APP mediates this effect through binding to a cell surface receptor, triggering intracellular transduction mechanisms. Thus, the secreted form of APP can function as a growth and/ or differentiation factor and the site involved in these activities is within a 17-mer domain in the middle of the molecule. Our current lines of research seek to further characterize the mechanisms of APP function as well as its activity in vivo.",,"amino acid; amyloid beta protein; cell surface receptor; differentiation inducing factor; growth factor; membrane protein; protein precursor; synthetic peptide; amino terminal sequence; cell differentiation; cell growth; conference paper; fibroblast; fibroblast culture; genetic transduction; human; human cell; neurite; neuroblastoma cell; priority journal; protein degradation; protein domain; protein processing; protein secretion; protein synthesis; receptor binding; Amino Acid Sequence; Amyloid beta-Protein; Amyloid beta-Protein Precursor; Animal; Brain; Cell Line; Human; Molecular Sequence Data; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Tumor Cells, Cultured",,"Amyloid beta-Protein Precursor; Amyloid beta-Protein",,,,,"Roch, J.-M.; Department of Neurosciences 0624, UC San Diego, La Jolla, CA 92093, United States",,,,,,,,00778923,,ANYAA,8239274,"English","ANN. NEW YORK ACAD. SCI.",Conference Paper,Scopus,2-s2.0-0027381379
"Schubert, D., Behl, C.","The expression of amyloid beta protein precursor protects nerve cells from β-amyloid and glutamate toxicity and alters their interaction with the extracellular matrix",1993,"Brain Research","629","2",,"275","282",,93,10.1016/0006-8993(93)91331-L,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0027421474&partnerID=40&md5=9e00a1c47c8e2e1196f973f78b63b292","The Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States","Schubert, D., The Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States; Behl, C., The Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States","The biological function of amyloid β protein precursor (ABPP) in nerve cells is examined by transfecting it into the B103 clonal nerve cell line which makes no ABPP and asking if a variety of biological activities are altered. Although ABPP is expressed by the transfected cells at high levels, there are no detectable differences between the ABPP negative control clones and the clones expressing ABPP with respect to growth rate in high serum medium, dibutyryl-cyclic AMP-induced differentiation, or morphology on plastic culture dishes. There are, however, significant differences in a number of properties between the two groups of cell lines. Cells expressing ABPP adhere more rapidly and have an enhanced rate of neurite outgrowth on collagen substrata. They also grow more rapidly in low serum medium. Finally, the expression of ABPP weakly but significantly protects the nerve cells from amyloid β protein and glutamate toxicity. © 1993.","Adhesion; Amyloid β-protein precursor; Cytotoxicity; Extracellular matrix","amyloid beta protein; bucladesine; glutamic acid; animal cell; article; cell culture; cell growth; controlled study; cytotoxicity; extracellular matrix; genetic transfection; neurite; nonhuman; priority journal; Amyloid beta-Protein; Amyloid beta-Protein Precursor; Blotting, Northern; Bucladesine; Cell Adhesion; Cell Line; Clone Cells; Collagen; Culture Media, Serum-Free; Electrophoresis, Polyacrylamide Gel; Extracellular Matrix; Glutamates; Glutamic Acid; Human; Neurites; Plasmids; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Transfection",,"Amyloid beta-Protein Precursor; Amyloid beta-Protein; Bucladesine, 362-74-3; Collagen, 9007-34-5; Culture Media, Serum-Free; Glutamates; Glutamic Acid, 56-86-0; Plasmids",,,,"Anderson, Buam, Geteland, Processing of adenovirus 2 proteins (1973) J. Virol., 12, pp. 241-248; Behl, Davis, Cole, Schubert, Vitamin E protects nerve cells from amyloid β protein toxicity (1992) BBRC, 186, pp. 944-950; Bernard, Oltersdorf, Seedorf, Expression of the human papillomavirus type 18 E7 gene by a cassette vector system for the transcription and translation of open reading frames in eukaryotic cells (1987) EMBO J., 6, pp. 133-138; Breen, Bruce, Anderson, β Amyloid precursor proteins mediates neuronal cell-cell and cell-surface adhesion (1991) J. Neurosci. Res., 28, pp. 90-100; Chen, Yankner, An antibody to β amyloid and the amyloid precursor protein inhibits cell-substratum adhesion (1991) Neurosci. Lett., 125, pp. 223-226; Esch, Keim, Beattie, Blacker, Culwell, Oltersdorf, McClure, Ward, Cleavage of amyloid β protein during constitutive processing of its precursor (1990) Science, 248, pp. 1122-1124; Glenner, Wong, Alzheimer's disease and Down's syndrome: sharing a unique cerebrovascular amyloid fibril protein (1984) Biochem. Biophys. Res. Commun., 222, pp. 1131-1136; Kang, Lemaire, Unterbeck, Salbaum, Masters, Grezeschik, Multhaup, Muller-Hill, The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor (1987) Nature, 325, pp. 733-736; Kimura, Fischer, Schubert, Structure, expression and function of a Schwannoma derived growth factor (1990) Nature, 348, pp. 257-260; Kitaguchi, Takahashi, Tokushima, Shiojiri, Ito, Novel precursor of Alzheimer's disease amyloid shows protease inhibitory activity (1988) Nature, 331, pp. 530-532; Klier, Cole, Stallcup, Schubert, Amyloid β-protein precursor is associated with extracellular matrix (1990) Brain Res., 515, pp. 336-342; Koh, Yang, Cotman, β Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage (1990) Brain Res., 533, pp. 315-320; Mattson, Cheng, Culwell, Esch, Lieberburg, Rydel, Evidence for excitoprotective and intraneuronal calcium regulating roles for secreted forms of the β-amyloid precursor protein (1993) Neuron, 10, pp. 243-254; Mattson, Cheng, Davis, Bryant, Lieberburg, Rydel, β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity (1992) J. Neurosci., 12, pp. 376-398; Milward, Papadopoulos, Fuller, Moir, Small, Beyreuther, Masters, The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth (1992) Neuron, 9, pp. 129-137; Ponte, Gonzalez-DeWhitt, Schilling, Miller, Hon, Greenberg, Davis, Cordell, A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors (1988) Nature, 331, pp. 525-528; Saitoh, Sundsmo, Roch, Kimura, Cole, Schubert, Oltersdorf, Schenk, Secreted form of amyloid β protein precursor is involved in the growth regulation of fibroblasts (1989) Cell, 58, pp. 615-622; Schubert, Induced differentiation of a rat nerve and glial cells (1974) Neurobiology, 4, pp. 376-387; Schubert, (1984) Developmental Biology of Cultured Nerve, Muscle and Glia, , John Wiley, New York; Schubert, The possible role of adhesion in synaptic modification (1991) Trends Neurosci., 14, pp. 127-131; Schubert, Cole, Saitoh, Oltersdorf, Amyloid β protein precursor is a mitogen (1989) Biochem. Biophys. Res. Commun., 162, pp. 83-88; Schubert, Heinemann, Carlisle, Tarikas, Kimes, Steinbach, Culp, Brandt, Clonal cell lines from the rat central nervous system (1974) Nature, 249, pp. 224-227; Schubert, Jin, Saitoh, Cole, The regulation of amyloid β protein precursor secretion and its modulatory role in cell adhesion (1989) Neuron, 3, pp. 689-694; Schubert, LaCorbiere, Saitoh, Cole, Characterization of an amyloid β protein precursor that binds heparin and contains tyrosine sulfate (1989) Proc. Natl. Acad. Sci. USA, 86, pp. 2066-2069; Schubert, Schroeder, LaCorbiere, Saitoh, Cole, Amyloid Î² protein precursor is possibly a heparan sulfate proteoglycan core protein (1988) Science, 241, pp. 223-226; Selkoe, Podisny, Joachim, Vickers, Lee, Fritz, Oltersdorf, β-Amyloid precursor protein occur as 110 to 135 kilodalton membrane-associated proteins in neural and non-neuronal tissues (1988) Proc. Natl. Acad. Sci. USA, 85, pp. 7341-7345; Shivers, Hilbich, Multhaup, Salbaum, Beyreuther, Seeburg, Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact (1988) EMBO J., 7, pp. 1365-1370; Tanzi, McClatchey, Lampert, Villa-Komaroff, Gusella, Neve, Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease (1988) Nature, 331, pp. 528-530; Ueda, Cole, Sundsmo, Katzman, Saitoh, Decreased adhesiveness of Alzheimer's disease fibroblasts: is amyloid β-protein precursor involved? (1989) Ann. Neurol., 25, pp. 246-251; Weidemann, Ko¨nig, Bunke, Fischer, Salbaum, Masters, Beyreuther, Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein (1989) Cell, 57, pp. 115-126; Yankner, Duffy, Kirschner, Neurotrophic and neurotoxic effects of amyloid β protein: reversal by Tachykinin neuropeptides (1990) Science, 250, pp. 279-282","Schubert, D.; The Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States",,,,,,,,00068993,,BRREA,7906601,"English","Brain Res.",Article,Scopus,2-s2.0-0027421474
"Behl, C., Hovey III, L., Krajewski, S., Schubert, D., Reed, J.C.","Bcl-2 prevents killing of neuronal cells by glutamate but not by amyloid beta protein",1993,"Biochemical and Biophysical Research Communications","197","2",,"949","956",,77,10.1006/bbrc.1993.2571,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0027787791&partnerID=40&md5=c0802ff0b998f18800b75b22b6ed47d1","Salk Inst. for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States","Behl, C., Salk Inst. for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States; Hovey III, L., Salk Inst. for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States; Krajewski, S., Salk Inst. for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States; Schubert, D., Salk Inst. for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States; Reed, J.C., Salk Inst. for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States","The 26-kDa protein encoded by the bcl-2 gene is a regulator of cell survival and blocks cell death induced by numerous stimuli. Amyloid beta protein (ABP) and glutamate are believed to play important roles in the neuronal cell death that occurs in Alzheimer's disease and stroke, respectively. Glutamate induces apoptosis in some neuronal cell systems, but it remains controversial whether ABP-mediated cell death occurs through apoptosis or necrosis. To further explore the pathways for cell death that are activated by these neurotoxins, we examined the effects of elevated levels of the p26-Bcl-2 protein on the susceptibility of neuronal cell lines to killing by glutamate and ABP. Gene transfer methods were used to elevate p26-Bcl-2 protein levels in the rat nerve lines PC-12 and B50 and the human neuroblastoma IMR-5. Bcl-2 protected all 3 cell lines from glutamate induced cell death but had no effect on killing mediated by ABP.",,"amyloid beta protein; glutamic acid; protein; animal cell; apoptosis; article; cell killing; controlled study; human; human cell; necrosis; nonhuman; oncogene; priority journal; rat; Amyloid beta-Protein; Animal; Apoptosis; Cell Death; Cell Line; Gene Transfer Techniques; Glutamates; Glutamic Acid; Human; Immunoblotting; Kinetics; Neuroblastoma; Neurons; Neurotoxins; PC12 Cells; Protein-Tyrosine Kinase; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Rats; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Tumor Cells, Cultured",,"amyloid beta protein, 109770-29-8; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; protein, 67254-75-5; Amyloid beta-Protein; Glutamates; Glutamic Acid, 56-86-0; Neurotoxins; Protein-Tyrosine Kinase, EC 2.7.1.112; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins",,,,,"Schubert, D.; Salk Inst. for Biological Studies, 10010 N. Torrey Pines Road, San Diego, CA 92037, United States",,,,,,,,0006291X,,BBRCA,7903532,"English","BIOCHEM. BIOPHYS. RES. COMMUN.",Article,Scopus,2-s2.0-0027787791
"Behl, C., Schubert, D.","Heat shock partially protects rat pheochromocytoma PC12 cells from amyloid β peptide toxicity",1993,"Neuroscience Letters","154","1-2",,"1","4",,19,10.1016/0304-3940(93)90156-F,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0027217527&partnerID=40&md5=9301e36ed7a5f835bce1b9ad49f4775f","The Salk Institute for Biological Studies, San Diego, CA 92186-5800, United States","Behl, C., The Salk Institute for Biological Studies, San Diego, CA 92186-5800, United States; Schubert, D., The Salk Institute for Biological Studies, San Diego, CA 92186-5800, United States","Rat pheochromocytoma PC12 cells are killed by amyloid β protein (ABP), a component of plaques and other amyloid deposits in Alzheimer's disease. To investigate the possibility of protection from ABP toxicity by induced heat shock proteins (hsps), PC12 cells were heat treated for 60 min at 42°C. The stress response of the PC12 cells was examined at the protein level using hsp72-specific monoclonal antibodies. Hsp72 immunoreactivity was highly induced following heat treatment. The toxic effect of the β 25-35 ABP peptide fragment, the major cytotoxic sequence within ABP, was reduced in heat pretreated PC12 cultures. These data indicate a protective role of hsps in neuronal cells exposed to ABP. © 1993.","Amyloid β protein toxicity; Heat shock; Neuronal protection","amyloid beta protein; alzheimer disease; animal cell; article; cell culture; controlled study; heat stroke; neurotoxicity; nonhuman; pheochromocytoma cell; priority journal; rat; Amyloid beta-Protein; Animal; Antibodies, Monoclonal; Blotting, Western; Heat; Heat-Shock Proteins; PC12 Cells; Rats; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.",,"amyloid beta protein, 109770-29-8; Amyloid beta-Protein; Antibodies, Monoclonal; Heat-Shock Proteins",,,,"Anderson, Buam, Geteland, Processing of adenovirus 2 proteins (1973) J. Virol., 12, pp. 241-248; Barbe, Tytell, Gower, Welch, Hyperthermia protects against light damage in the rat retina (1988) Science, 241, pp. 1817-1820; Behl, Davis, Cole, Schubert, Vitamin E protects nerve cells from amyloid beta protein toxicity (1992) Biochem. Biophys. Res. Commun., 186, pp. 944-950; Deshaies, Koch, Schekman, The role of stress proteins in membrane biogenesis (1988) Trends Biochem. Sci., 13, pp. 384-388; Gething, Sambrook, Protein folding in the cell (1992) Nature, 355, pp. 33-45; Greene, Tischler, Establishment of a noradrenergic clonal line of rat pheochromocytoma cells which respond to nerve growth factor (1976) Proc. Natl. Acad. Sci. USA, 73, pp. 2424-2432. , 2nd edn; Jaendel, Nicholas, DuBois, Nabet-Belleville, Penin, Cuny, Lipid peroxidation and free radical scavengers in Alzheimer's disease (1989) Gerontology, 35, pp. 275-282; Kirino, Tsujita, Tamura, Induced tolerance to ischemia in gerbil hippocampal neurons (1991) J. Cereb. Blood Flow Metab., 11, pp. 299-307; Kitagawa, Matsumoto, Tagaya, Hata, Ueda, Niinobe, Handa, Kamada, ‘Ischemic tolerance’ phenomenon found in the brain (1990) Brain Res., 528, pp. 21-24; Koh, Yang, Cotman, β Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage (1990) Brain Res., 533, pp. 315-320; Lowenstein, Chan, Miles, The stress protein response in cultured neurons: characterization and evidence for a protective role in excitotoxicity (1991) Neuron, 7, pp. 1053-1060; Marini, Kozuka, Lipsky, Nowak, 70-kilodalton heat shock protein induction in cerebellar astrocytes and cerebellar granule cells in vitro: comparison with immunocytochemical localization after hyperthermia in vitro (1990) J. Neurochem., 54, pp. 1509-1516; Mattson, Cheng, Davis, Bryant, Lieberburg, Rydel, β Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity (1992) J. Neurosci., 12, pp. 376-398; Miller, Raese, Morrison-Bogorad, Expression of heat shock protein 70 and heat shock cognate 70 messenger RNAs in rat cortex and cerebellum after heat shock or amphetamine treatment (1991) J. Neurochem., 56, pp. 2060-2071; Mosmann, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays (1983) J. Immunol. Methods, 65, pp. 55-63; Papolla, Omar, Kim, Robakis, Immunohistochemical evidence of antioxidant stress in Alzheimer's disease (1992) Am. J. Pathol., 140, pp. 621-628; Pelham, Heat shock and the sorting of luminal ER proteins (1989) EMBO J., 8, pp. 3171-3176; Rordorf, Koroshetz, Bonventre, Heat shock protects cultured neurons from glutamate toxicity (1991) Neuron, 7, pp. 1043-1051; Sambrook, Fritsch, Maniatis, (1989) Molecular Cloning: A laboratory manual, , 2nd edn., Cold Spring Harbor Laboratory, Cold Spring Harbor, New York; Schellenberg, Bird, Wijsman, Orr, Anderson, Nemens, White, Martin, Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14 (1992) Science, 258, pp. 668-671; Schlesinger, Heat shock proteins (1990) J. Biol. Chem., 265, pp. 12111-12114; Welch, Suhan, Cellular and biochemical events in mammalian cells during and after recovery from physiological stress (1986) J. Cell Biol., 103, pp. 2035-2052; Yankner, Duffy, Kirschner, Neurotrophic and neurotoxic effects of amyloid β protein: reversal by Tachykinin neuropeptides (1990) Science, 250, pp. 279-282","Behl, C.; The Salk Institute for Biological Studies, San Diego, CA 92186-5800, United States",,,,,,,,03043940,,NELED,8361618,"English","Neurosci. Lett.",Article,Scopus,2-s2.0-0027217527
"Kimura, H., Schubert, D.","Amyloid β-protein activates tachykinin receptors and inositol trisphosphate accumulation by synergy with glutamate",1993,"Proceedings of the National Academy of Sciences of the United States of America","90","16",,"7508","7512",,45,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0027182747&partnerID=40&md5=c9a12cc85233a9ad863e11e01756bae3","Salk Institute, P.O. Box 85800, San Diego, CA 92186-5800, United States","Kimura, H., Salk Institute, P.O. Box 85800, San Diego, CA 92186-5800, United States; Schubert, D., Salk Institute, P.O. Box 85800, San Diego, CA 92186-5800, United States","The biological function of the soluble form of the amyloid β-protein (ABP) was examined by assaying its interaction with neuronal receptors expressed in Xenopus oocytes. ABP weakly activated tachykinin receptors, but in the presence of N-methyl-D-aspartate and α-amino-3-hydroxy-5- methylisoxazole-4-propionate-type glutamate receptors ABP-induced responses were greatly enhanced. Glutamate and ABP together also induced accumulation of inositol trisphosphate and increases in intracellular Ca2+. These observations suggest that in the presence of glutamate, ABP can activate tachykinin receptors and phosphatidylinositol turnover. ABP may therefore act as a neuromodulatory peptide.","glutamate receptors; substance P receptor","alpha amino 3 hydroxy 5 methyl 4 isoxazolepropionic acid; amino acid receptor; amyloid beta protein; glutamate receptor; n methyl dextro aspartic acid; n methyl dextro aspartic acid receptor; tachykinin receptor; animal cell; animal tissue; article; calcium cell level; controlled study; nonhuman; oocyte; priority journal; rat; xenopus; 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Amino Acid Sequence; Amyloid beta-Protein; Analgesics; Animal; Calcium; Drug Synergism; Female; Glutamates; Glutamic Acid; Inositol 1,4,5-Trisphosphate; Kinetics; Molecular Sequence Data; Neurons; Oocytes; Quinoxalines; Receptors, AMPA; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Neurokinin-1; Receptors, Neurotransmitter; RNA, Messenger; Sodium; Substance P; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Xenopus",,"alpha amino 3 hydroxy 5 methyl 4 isoxazolepropionic acid, 77521-29-0; amyloid beta protein, 109770-29-8; n methyl dextro aspartic acid, 6384-92-5; 2-Amino-5-phosphonovalerate, 76726-92-6; 6-Cyano-7-nitroquinoxaline-2,3-dione, 115066-14-3; Amyloid beta-Protein; Analgesics; Calcium, 7440-70-2; Glutamates; Glutamic Acid, 56-86-0; Inositol 1,4,5-Trisphosphate, 85166-31-0; Quinoxalines; Receptors, AMPA; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Neurokinin-1; Receptors, Neurotransmitter; RNA, Messenger; Sodium, 7440-23-5; spantide, 91224-37-2; Substance P, 33507-63-0",,,,,"Kimura, H.; Salk Institute, P.O. Box 85800, San Diego, CA 92186-5800, United States",,,,,,,,00278424,,PNASA,7689220,"English","PROC. NATL. ACAD. SCI. U. S. A.",Article,Scopus,2-s2.0-0027182747
"Davis, J.B., McMurray, H.F., Schubert, D.","The amyloid beta-protein of Alzheimer's disease is chemotactic for mononuclear phagocytes",1992,"Biochemical and Biophysical Research Communications","189","2",,"1096","1100",,80,10.1016/0006-291X(92)92317-Q,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0027099863&partnerID=40&md5=2840945ba653116ab4b0e7e09102f115","The Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States; Dept. of Endocrinology and Metabolism, University of California, La Jolla, CA 92093, United States","Davis, J.B., The Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States; McMurray, H.F., Dept. of Endocrinology and Metabolism, University of California, La Jolla, CA 92093, United States; Schubert, D., The Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States","The cellular pathology of Alzheimer's disease includes an accumulation of microglia surrounding the amyloid plaques. We report that human amyloid beta-protein is chemotactic for murine resident peritoneal macrophages and rat microglia, which may account for the increased density of microglia in plaques. A maximal chemotactic response was observed at 1-10nM, with a 2.5 fold increase in activity over controls for both classes of mononuclear phagocytes. The neurotoxic peptide fragment (25-35) of amyloid beta-protein is similarly chemotactic, while a control scrambled version and the precursor protein are not chemotactic. These results indicate that beta-protein may influence plaque formation via the recruitment of phagocytes, with consequent implications for the future development of treatments for Alzheimer's disease. © 1992.",,"amyloid beta protein; alzheimer disease; animal cell; animal tissue; article; chemotaxis; human; mononuclear cell; mouse; nonhuman; phagocyte; priority journal; rat; Amino Acid Sequence; Amyloid beta-Protein; Animal; Chemotaxis; Comparative Study; Human; Macrophages; Mice; Molecular Sequence Data; Peptide Fragments; Poly I; Structure-Activity Relationship; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Animalia; Murinae",,"Amyloid beta-Protein; Peptide Fragments; Poly I, 25249-22-3",,,,"Bouman, (1934) Brain, 57, pp. 128-142; Perry, Hume, Gordon, (1985) Neurosci, 15, pp. 313-326; Schubert, Kimura, Maher, (1992) Proc. Natl. Acad. Sci. (USA), 89, pp. 8264-8267. , 2nd edition; Mortimer, French, Hutton, Schuman, (1985) Neurology, 35, pp. 264-267; Wright, Goedert, Hastie, (1991) Nature, 349, pp. 653-654; St. George-Hyslop, (1987) Science, 235, pp. 885-890; Yankner, Duffy, Kirschner, (1990) Science, 250, pp. 279-282; Koh, Yang, Cotman, (1990) Brain Res, 533, pp. 315-320; Behl, Davis, Cole, Schubert, (1992) Biochem Biophys Res. Commun, 186, pp. 944-950; Schubert, Jin, Saitoh, Cole, (1989) Neuron, 3, pp. 689-694; Guilian, Baker, (1986) J. Neurosci, 6, pp. 2163-2178; Joslin, Krause, Hershey, Adams, Fallon, Perlmutter, Amyloid-beta peptide, substance P, and bombesin bind to the serpin-enzyme complex receptor. (1991) J Biol Chem, 266, pp. 21897-21902; Banda, Rice, Griffin, Senior, (1988) J. Exp. Med, 167, pp. 1608-1615; Mehlhorn, Cole, (1985) Adv. Free Radical Biology and Med, 1, pp. 165-223; Davies, Bonney, (1979) J. Leukocyte Biol, 26, pp. 37-47","Davis, J.B.; The Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States",,,,,,,,0006291X,,BBRCA,1472019,"English","Biochem. Biophys. Res. Commun.",Article,Scopus,2-s2.0-0027099863
"Schubert, D.","Collaborative interactions between growth factors and the extracellular matrix",1992,"Trends in Cell Biology","2","3",,"63","66",,31,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0026578504&partnerID=40&md5=f6f3c368f934f716d4aae61d9a7974e5","Salk Institute, PO Box 85800, San Diego, CA 92186-5800, United States","Schubert, D., Salk Institute, PO Box 85800, San Diego, CA 92186-5800, United States","The contribution of extracellular matrix (ECM) components to the regulation of cell adhesion, proliferation and differentiation is receiving much attention. Recently, it has become evident that certain cellular responses require the combined action of ECM components and soluble growth factors. This article examines possible mechanisms underlying the synergistic interactions of growth factors and the ECM.",,"growth factor; cell adhesion; cell differentiation; cell growth; extracellular matrix; molecular interaction; short survey",,,,,,"Matsuyama, T., (1989) J. Exp. Med., 170, pp. 1133-1148; Davis, L.S., Marks, N., Bednarczyk, J.L., Mcintyre, B.W., Lipsky, P.E., (1990) Immunol., 145, pp. 785-793; Schubert, D., Kimura, H., (1991) J. Cell Biol., 114, pp. 841-846; Lilien, L.E., Sendtner, M., Raff, M., (1990) J. Cell Biol., 111, pp. 635-644; Berman, P., (1987) Cell, 51, pp. 135-142; Baird, A., Bohlen, P., (1990) Peptide Growth Factors and Their Receptors, pp. 197-225. , Sporn, M. B. and Robert, A., eds, Springer-Verlag; Andres, J.L., Stanley, K., Cheifetz, S., Massague, J.J., (1989) Cell Biol., 109, pp. 3137-3145; Paralkar, V.M., Vukicevic, S., Reddi, A.H., (1991) Dev. Biol., 143, pp. 303-308; Li, Y.S., (1990) Science, 250, pp. 1690-1694; Roberts, R., Gallagher, J., Spooncer, E., Allen, T.D., Bloomfield, F., Dexter, T.M., (1988) Nature, 332, pp. 376-378; Kimura, H., Fischer, W., Schubert, D., (1990) Nature, 348, pp. 257-260; Ingber, D.E., Folkman, J., (1989) Cell, 58, pp. 803-805; Breuer, D., Wagener, C., (1989) Exp. Cell Res., 182, pp. 659-663; Schwartz, M.A., Both, G., Lechene, C., (1989) Proc. Natl Acad. Sci. USA, 86, pp. 4525-4529; Lansman, J.B., Hallam, T.J., Rink, T.J., (1989) Nature, 325, pp. 811-813; Sutton, A.B., Canfield, A.E., Schor, S.L., Grant, M.E., Schor, A.M., (1991) J. Cell Sci., 99, pp. 777-787; Bixby, J.L., (1989) Neuron, 3, pp. 287-297; Halegoua, S., Armstrong, R.C., Kremer, N.E., (1991) Curr. Top. Microbiol. Immunol., 165, pp. 119-170; Ferrell, J.E., Martin, G.S., (1989) Proc. Natl Acad. Sci. USA, 86, pp. 2234-2238; Banga, H.S., Simons, E.R., Brass, L.F., Rittenhouse, S.E., (1980) Proc. Natl Acad. Sci. USA, 83, pp. 9197-9201; Panayotou, G., End, P., Aumailley, M., Timpl, R., Engel, J., (1989) Cell, 56, pp. 93-101; Piomelli, D., Pilon, C., Giros, B., Sokoloff, P., Martres, M.P., Schwartz, J.C., (1991) Nature, 353, pp. 164-166; Rossino, R., (1990) Exp. Cell Res., 189, pp. 100-108; Shimizu, Y., Shaw, S., (1991) FASEB J., 5, pp. 2292-2300; Schubert, D., Kimura, H., Lacorbiere, M., Vaughan, J., Karr, D., Fischer, W.H., (1990) Nature, 344, pp. 868-870; Green, J., Smith, J., (1990) Nature, 347, pp. 391-393; Lin, L., Armes, L., Sommer, A., Smith, D., Collins, F., (1990) J. Biol. Chem., 265, pp. 8942-8947; Kimura, H., Schubert, D., J. Cell Biol., , in press; Gordon, M.Y., (1991) Cancer Cells, 3, pp. 127-133","Schubert, D.; Salk Institute, PO Box 85800, San Diego, CA 92186-5800, United States",,,,,,,,09628924,,TCBIE,,"English","Trends Cell Biol.",Article,Scopus,2-s2.0-0026578504
"Behl, C., Davis, J., Cole, G.M., Schubert, D.","Vitamin E protects nerve cells from amyloid βprotein toxicity",1992,"Biochemical and Biophysical Research Communications","186","2",,"944","950",,509,10.1016/0006-291X(92)90837-B,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0027129818&partnerID=40&md5=2dc25c62fca483371d245c328ac9a160","The Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States; Department of Neurobiology, University of California, San Diego, Mail Code 0624, La Jolla, CA 92093, United States","Behl, C., The Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States; Davis, J., The Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States; Cole, G.M., Department of Neurobiology, University of California, San Diego, Mail Code 0624, La Jolla, CA 92093, United States; Schubert, D., The Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States","The amyloid βprotein (ABP) is a 40 to 42 amino acid peptide which accumulates in Alzheimer's disease plaques. It has been demonstrated that this peptide and a fragment derived from it are cytotoxic for cultured cortical nerve cells. It is shown here that ABP and an internal fragment encompassing residues 25 to 35(β25-35) are cytotoxic to a clone of PC12 cells at concentrations above 1×10-9M and to several other cell lines at higher concentrations. Between 10-9 and 10-11 Mβ25-35 protects PC12 cells from glutamate toxicity. The antioxidant and free radical scavenger vitamin E inhibits ABP induced cell death. These results have implications regarding the prevention and treatment of Alzheimer's disease. © 1992.",,"alpha tocopherol; amyloid beta protein; gallic acid propyl ester; nerve growth factor; peptide; peptide fragment; animal; article; cell line; cell strain; cell survival; central nervous system; dose response; drug effect; glioma; human; nerve cell; neuroblastoma; synthesis; Amyloid beta-Protein; Animal; Cell Line; Cell Survival; Central Nervous System; Dose-Response Relationship, Drug; Glioma; Human; Nerve Growth Factors; Neuroblastoma; Neurons; PC12 Cells; Peptide Fragments; Peptides; Propyl Gallate; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Vitamin E",,"Amyloid beta-Protein; Nerve Growth Factors; Peptide Fragments; Peptides; Propyl Gallate, 121-79-9; Vitamin E, 1406-18-4",,,,"Frautschy, Baird, Cole, (1991) Proc. Nat. Acad. Sci. (USA), 88, pp. 8362-8366. , 2nd ed; Kowall, Beal, Busciglio, Duffy, Yankner, (1991) Proc. Nat. Acad. Sci. (USA), 88, pp. 7247-7251. , 2nd ed; Marx, (1992) Science, 255, pp. 1200-1202; Fukuchi, Kamino, Deeb, Smith, Dang, Martin, (1992) Biochem Biophy/Res. Commun, 182, pp. 165-173; Yankner, Duffy, Kirschner, (1990) Science, 250, pp. 279-282; Koh, Yang, Cotman, (1990) Brain Res, 533, pp. 315-320; Mattson, Cheng, Davis, Bryant, Lieberburg, Rydel, (1992) J. Neurosci, 12, pp. 376-398; Greene, Tischler, (1976) Proc. Natl. Acad. Sci. (USA), 73, pp. 2424-2428. , 2nd ed; Schubert, Kimura, Maher, (1992) Proc. Natl. Acad. Sci. (USA), , in press; Manthorpe, Fagnani, Skaper, Varon, (1986) Brain Res, 25, pp. 191-198; Bannai, Ishii, (1982) J. Cell Physiol, 112, pp. 265-272; Murphy, Miyamoto, Sastre, Snaar, Coyle, (1989) Neuron, 2, pp. 1547-1558; Bannai, Tsukeda, Okumura, (1977) BBRC, 74, pp. 1582-1587; Kozlowski, Spanoyannis, Manly, Fidel, Neve, (1992) J. Neurosci, 12, pp. 1679-1687; Stuart, (1982) Ann. N.Y. Acad. Sci, 393, pp. 277-288; Adams, Klaidman, Odunze, Shen, Miller, (1991) Mol. Chem. Neuropathol, 14, pp. 213-226; Hall, Braughler, Yonkers, Smith, Linseman, Means, Scherch, Jacobsen, (1991) J. Pharmacol. Exp. Therapeutics, 258, pp. 688-694; Nakajima, Kashiwagi, Hayashi, Saito, Kawashima, Furukawa, Kobayashi, (1991) Neurosci. Lett, 133, pp. 49-52; Jeandel, Nicholas, DuBois, Nabet-Belleville, Penin, Cuny, (1989) Gerontology, 35, pp. 275-282; Pappolla, Omar, Kim, Robakis, (1992) Amer. J. Pathol, 140, pp. 622-628; Mehlhorn, Cole, (1985) Adv. Free Radical Biology and Medicine, 1, pp. 165-223; Hunter, Cashman, Morris-Valero, Bulock, Adams, Sanes, (1991) J. Neurosci, 11, pp. 3970-3971; Morimoto, Koshland, (1990) Proc. Nat. Acad. Sci. (USA), 87, pp. 3518-3521. , 2nd ed; Schubert, Brass, Dumas, (1986) J. Neurosci, 6, pp. 2829-2836","Behl, C.; The Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States",,,,,,,,0006291X,,BBRCA,1497677,"English","Biochem. Biophys. Res. Commun.",Article,Scopus,2-s2.0-0027129818
"Schubert, D.","Synergistic interactions between transforming growth factor beta and fibroblast growth factor regulate Schwann cell mitosis",1992,"Journal of Neurobiology","23","2",,"143","148",,38,10.1002/neu.480230205,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0026681090&partnerID=40&md5=560da9520829106c877deb7e736ff99e","Salk Institute, San Diego, CA 92186-5800, United States","Schubert, D., Salk Institute, San Diego, CA 92186-5800, United States","Cultured Schwann cells divide in response to a limited repertoire of mitogens. In addition to cyclic AMP analogs and reagents that raise intracellular cyclic AMP, the only purified mitogens for Schwann cells are transforming growth factor beta (TGFβ), acidic (a) and basic (b) fibroblast growth factor (FGF), and the BB and AB dimers of platelet-derived growth factor (PDGF). Although individually each one of these growth factors is only weakly mitogenic, it is shown here that when TGFβ and bFGF are added to Schwann cell cultures together, they interact to produce a mitogenic response that is much greater than that produced by either growth factor alone. Both the absolute concentration of each protein and the molar ratio of TGFβ to bFGF determines the magnitude of the Schwann cell response.","FGF; mitosis; Schwann cells; TGF","cyclic amp; fibroblast growth factor; platelet derived growth factor; transforming growth factor beta; animal cell; article; cell aggregation; cell culture; cell division; controlled study; dna synthesis; glia; mitogenesis; mitosis; nonhuman; priority journal; rat; schwann cell; Animal; Drug Synergism; Fibroblast Growth Factors; Mitosis; Rats; Schwann Cells; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Transforming Growth Factor beta",,"Fibroblast Growth Factors, 62031-54-3; Transforming Growth Factor beta",,,,,"Schubert, D.; Salk Institute, San Diego, CA 92186-5800, United States",,,,,,,,00223034,,JNEUB,1527524,"English","J. NEUROBIOL.",Article,Scopus,2-s2.0-0026681090
"Schubert, D., Kimura, H., Maher, P.","Growth factors and vitamin E modify neuronal glutamate toxicity",1992,"Proceedings of the National Academy of Sciences of the United States of America","89","17",,"8264","8267",,130,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0026644178&partnerID=40&md5=3e32a2da2ae706777df3fb79d6297b19","Salk Inst. for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States","Schubert, D., Salk Inst. for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States; Kimura, H., Salk Inst. for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States; Maher, P., Salk Inst. for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States","The sympathetic nerve cell line PC-12 is killed by glutamate in a concentration-dependent manner. Although glycine and the deletion of magnesium weakly potentiate glutamate toxicity and PC-12 cells express N- methyl-D-aspartate-receptor mRNA, most toxicity is mediated by means of a mechanism independent of typical N-methyl-D-aspartate receptors. Glutamate toxicity is, however, greatly enhanced by prior exposure to nerve growth factor or basic fibroblast growth factor. Glutamate killing is blocked by epidermal growth factor and, to a lesser extent, by vitamin E. These observations show that synergistic interactions between growth factors and excitotoxic amino acids may play critical roles in the developing nervous system and that antioxidants attenuate this toxicity.",,"alpha tocopherol; basic fibroblast growth factor; epidermal growth factor; glutamic acid; glutamic acid derivative; glycine; growth factor; magnesium ion; n methyl dextro aspartic acid; n methyl dextro aspartic acid receptor; nerve growth factor; quisqualic acid; animal cell; article; cell division; cell killing; controlled study; nerve cell growth; nervous system development; neurotoxicity; nonhuman; pheochromocytoma cell; priority journal; protein protein interaction; rat; sympathetic nerve cell; Animal; Calcium; Cell Division; Cell Survival; Gene Expression; Glutamates; Growth Substances; In Vitro; Magnesium; PC12 Cells; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Vitamin E",,"alpha tocopherol, 1406-18-4, 1406-70-8, 52225-20-4, 58-95-7, 59-02-9; basic fibroblast growth factor, 106096-93-9; epidermal growth factor, 62229-50-9; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; glycine, 56-40-6, 6000-43-7, 6000-44-8; magnesium ion, 22537-22-0; n methyl dextro aspartic acid, 6384-92-5; nerve growth factor, 9061-61-4; quisqualic acid, 52809-07-1; Calcium, 7440-70-2; Glutamates; Growth Substances; Magnesium, 7439-95-4; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Vitamin E, 1406-18-4",,,,,"Schubert, D.; Salk Inst. for Biological Studies, P.O. Box 85800, San Diego, CA 92186-5800, United States",,,,,,,,00278424,,PNASA,1387712,"English","PROC. NATL. ACAD. SCI. U. S. A.",Article,Scopus,2-s2.0-0026644178
"Kimura, H., Schubert, D.","Schwannoma-derived growth factor promotes the neuronal differentiation and survival of PC12 cells",1992,"Journal of Cell Biology","116","3",,"777","783",,23,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0026573229&partnerID=40&md5=104a786516489d6d99e32c596312ea59","The Salk Institute, P.O. Box 85800, San Diego, CA 92186-5800, United States","Kimura, H., The Salk Institute, P.O. Box 85800, San Diego, CA 92186-5800, United States; Schubert, D., The Salk Institute, P.O. Box 85800, San Diego, CA 92186-5800, United States","Schwannoma-derived growth factor (SDGF) was initially isolated from schwannoma cells as a mitogen for glial cells and fibroblasts. The present data show that SDGF causes the morphological and molecular differentiation of rat PC12 cells in a manner similar to, but distinguishable from nerve growth factor (NGF). It also promotes PC12 survival in serum-free conditions. SDGF induced changes include neurite outgrowth and the induction of the mRNAs for GAP-43 and transin, proteins which are highly expressed in axons. In addition, both SDGF and NGF induce the transcription factor, NGFI-A. The time course of the response to SDGF is similar to that for NGF. Gap-43 mRNA induction by both SDGF and NGF is inhibited by dexamethasone, but dexamethasone has no effect on NGFI-A mRNA synthesis. These observations show that SDGF has a differentiation and survival promoting effect on PC12 cells in addition to its mitogenic activity on glial cells and fibroblasts.",,"dexamethasone; messenger rna; nerve growth factor; neuromodulin; transcription factor; article; cell survival; fibroblast; gene expression; glia cell; mitogenicity; nerve cell differentiation; nerve fiber; nerve fiber growth; neurilemoma; nonhuman; pheochromocytoma cell; priority journal; Animal; Cell Differentiation; Cell Survival; Culture Media; Cycloheximide; Dexamethasone; DNA-Binding Proteins; GAP-43 Protein; Gene Expression Regulation; Growth Substances; Membrane Glycoproteins; Metalloendopeptidases; Nerve Growth Factors; Nerve Tissue Proteins; Neurites; Neurons; PC12 Cells; RNA, Messenger; Stromelysin 1; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Transcription Factors",,"dexamethasone, 50-02-2; nerve growth factor, 9061-61-4; amphiregulin, 117147-70-3; Culture Media; Cycloheximide, 66-81-9; Dexamethasone, 50-02-2; DNA-Binding Proteins; GAP-43 Protein; Growth Substances; Krox-24 protein; Membrane Glycoproteins; Metalloendopeptidases, EC 3.4.24; Nerve Growth Factors; Nerve Tissue Proteins; RNA, Messenger; Stromelysin 1, EC 3.4.24.17; Transcription Factors",,,,,"Kimura, H.; The Salk Institute, P.O. Box 85800, San Diego, CA 92186-5800, United States",,,,,,,,00219525,,JCLBA,1530950,"English","J. CELL BIOL.",Article,Scopus,2-s2.0-0026573229
"Schubert, D., Kimura, H.","Substratum-growth factor collaborations are required for the mitogenic activities of activin and FGF on embryonal carcinoma cells",1991,"Journal of Cell Biology","114","4",,"841","846",,36,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0025873272&partnerID=40&md5=4d101bc1770593c4e1146bc153047e14","The Salk Institute, San Diego, CA 92186-5800, United States","Schubert, D., The Salk Institute, San Diego, CA 92186-5800, United States; Kimura, H., The Salk Institute, San Diego, CA 92186-5800, United States","When P19 mouse embryonal carcinoma cells are grown in a serum-free N 2 medium on surfaces of tissue culture plastic, they die within two days. The death of these P19 cells is prevented by activin A and basic FGF (bFGF). The cells do not divide under these conditions. However, when P19 cells are cultured on substrata of extracellular matrix proteins such as laminin and fibronectin, activin A and bFGF are potent mitogens. These data show that the substratum to which cells are exposed can regulate their mitogenic response to growth factors.",,"activin; fibroblast growth factor; animal cell; article; culture medium; embryonal carcinoma; mitogenesis; mouse; nonhuman; priority journal; Activins; Animal; Cell Division; Cell Line; Cell Survival; Collagen; Comparative Study; Culture Media; Extracellular Matrix; Fibroblast Growth Factor 2; Fibronectins; Inhibins; Kinetics; Laminin; Mitogens; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Teratoma; Animalia",,"Activins, 104625-48-1; Collagen, 9007-34-5; Culture Media; Fibroblast Growth Factor 2, 103107-01-3; Fibronectins; Inhibins, 57285-09-3; Laminin; Mitogens",,,,,"Schubert, D.; The Salk Institute, San Diego, CA 92186-5800, United States",,,,,,,,00219525,,JCLBA,1869590,"English","J. CELL BIOL.",Article,Scopus,2-s2.0-0025873272
"Schubert, D., Klier, F.G.","Substratum regulation of neurite fasciculation",1991,"Brain Research","549","2",,"305","310",,3,10.1016/0006-8993(91)90472-8,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0025865858&partnerID=40&md5=c70f6bbd39c62412b68c0f0ed72b0792","The Salk Institute for Biological Studies, San Diego, CA 92138, United States","Schubert, D., The Salk Institute for Biological Studies, San Diego, CA 92138, United States; Klier, F.G., The Salk Institute for Biological Studies, San Diego, CA 92138, United States","A new clonal nerve-like cell line from the rat eye is used to show that cell-substratum adhesion can modulate neurite fasciculation. When cells are grown on a substratum of intermediate adhesiveness their neurites adhere to each other and form fascicles. In contrast, cells grown on more adhesive surfaces spread and extend individual neurites. The direct relationship between the initial rates of cell-substratum adhesion and neurite fasciculation shows that the extent of axon fasciculation which occurs in vivo may be determined by the extracellular environment through which the axons are growing. © 1991.","Adhesion; Clonal cell line; Fasciculation; Nerve; Substratum","animal cell; article; fasciculation; nerve; nonhuman; priority journal; rat; Animal; Axons; Cell Adhesion; Cell Line; Chemotaxis; Clone Cells; Eye; Leucine; Microscopy, Electron; Neurons; Rats; Support, U.S. Gov't, P.H.S.; Tumor Cells, Cultured",,"Leucine, 61-90-5",,,,"Albert, Gonder, Papale, Craft, Dohlman, Reid, Sunderman, Induction of ocular neoplasms in Fischer rats by intraocular injection of nickel subsulfide (1982) Invest. Opthalmol. Vis. Sci., 22, pp. 768-782; Al-Gaith, Lewis, Pioneer growth cones in virgin mesenchyme: an electron-microscope study in the developing chick wing (1982) J. Embryol. Exp. Morphol., 68, pp. 149-160; Chang, Rathjen, Raper, Extension of neurites on axons is impaired by antibodies against specific neural cell surface glycoproteins (1987) J. Cell Biol., 104, pp. 355-362; Cheresh, Klier, Disialoganglioside GD2 distributes preferentially into substrate-associated microprocesses on human melanoma cells during their attachment to fibronectin (1986) J. Cell Biol., 102, pp. 1887-1897; Collins, Garrett, Elongating nerve fibers are guided by a pathway of material released from embryonic nonneuronal cells (1980) Proc. Natl. Acad. Sci. U.S.A., 77, pp. 6226-6228. , 2nd edn; Edelman, Modulation of cell adhesion during induction, histogenesis, and perinatal development of the nervous system (1984) Annu. Rev. Neurosci., 7, pp. 339-377; Fischer, Kuenemund, Schachner, Neurite outgrowth patterns in cerebellar microexplant cultures are affected by antibodies to the cell surface glycoprotein L1 (1986) J. Neurosci., 6, pp. 605-612; Gundersen, Park, The effects of conditioned media on spinal neurites (1984) Dev. Biol., 104, pp. 18-27; Harrison, The outgrowth of the nerve fiber as a mode of protoplasmic movement (1910) Journal of Experimental Zoology, 9, pp. 787-846; Ho, Goodman, Peripheral pathways are pioneered by an array of central and peripheral neurones in grasshopper embryos (1982) Nature, 297, pp. 404-406; Holley, Silver, Growth pattern of pioneering chick spinal cord axons (1987) Dev. Biol., 123, pp. 375-388; Klier, Schubert, Heinemann, The ultrastructural differentiation of the clonal myogenic cell line L6 in normal and high K+ medium (1977) Dev. Biol., 57, pp. 440-449; Klier, Cole, Stallcup, Schubert, Amyloid beta protein precursor is associated with extracellular matrix (1990) Brain Research, 515, pp. 336-342; Kuwada, Cell recognition by neuronal growth cones in a simple vertebrate embryo (1986) Science, 233, pp. 740-746; Landmesser, Dahm, Schultz, Rutishauser, Distinct roles of adhesion molecules during innervation of embryonic chick muscle (1988) Dev. Biol., 130, pp. 645-670; Letourneau, Possible roles of cell-to-substratum adhesion in neural morphogenesis (1975) Dev. Biol., 44, pp. 77-91; Letourneau, Cell to substratum adhesion and guidance of axonal elongation (1975) Dev. Biol., 44, pp. 92-101; Levitt, Rakic, Immunoperoxidase localization of GFAP in radial cells and astrocytes of the developing monkey brain (1980) J. Comp. Neurol., 193, pp. 815-840; Lindner, Rathjen, Schachner, L1 mono-and polyclonal antibodies modify cell migration in early postnatal mouse cerebellum (1983) Nature, 305, pp. 427-430; Lopresti, Macagno, Levinthal, Structure and development of neuronal connections in isogenic organisms: cellular interactions and the development of the optic lamina of Daphnia (1973) Proc. Natl. Acad. Sci. U.S.A., 70, pp. 433-437. , 2nd edn; Nakajima, Selectivity in fasciculation in nerve fibers in vitro (1965) J. Comp. Neurol., 125, pp. 193-204; Newman, (1986) Astrocytes, , S. Fedoroff, A. Vernadakis, Academic Press, San Diego; Noble, Fol-Seang, Cohen, Glia are a unique substrate for the in vitro growth of CNS neurons (1984) J. Neurosci., 4, pp. 1892-1903; Rakic, Neuron-glia relationship during granule cell migration in developing cerebellar cortex (1971) J. Comp. Neurol., 141, pp. 283-312; Raper, Bastiani, Goodman, Pathfinding by neuronal growth cones in grasshopper embryos. II. Selective fasciculation on specific axonal pathways (1983) J. Neurosci., 3, pp. 31-41; Raper, Bastiani, Goodman, Pathfinding by neuronal growth in grasshopper embryos (1984) J. Neurosci., 4, pp. 2339-2348; Rathjen, Wolff, Frank, Bonhoeffer, Rutishauser, Membrane glycoproteins involved in a neurite fasciculation (1987) J. Cell Biol., 104, pp. 343-353; Roberts, Taylor, A scanning electron microscopic study of the development of a peripheral sensory neurite network (1982) J. Embryol. Exp. Morphol., 69, pp. 237-250; Ross, Arechiga, Nicholls, Influence of substrate on the distribution of calcium channels in identified leech neurons in culture (1988) Proc. Natl. Acad. Sci. U.S.A., 85, pp. 4075-4078. , 2nd edn; Rutishauser, Gall, Edelman, Adhesion among neural cells of the chick embryo. IV. Role of the cell surface molecule CAM in the formation of neurite bundles in cultures of spinal ganglia (1978) J. Cell Biol., 79, pp. 382-393; Rutishauser, Acheson, Hall, Mann, Sunshine, The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions (1988) Science, 240, pp. 53-57; Snow, Zinn, Harrelson, McAllister, Schilling, Bastiani, Makk, Goodman, Characterization and cloning of fasciclin I and fasciclin II glycoproteins in grasshopper (1988) Proc. Natl. Acad. Sci. U.S.A., 85, pp. 5291-5295. , 2nd edn; Stallcup, Beasley, Involvement of the nerve growth factor-inducible large external glycoprotein (NILE) in neurite fasciculation primary cultures of rat brain (1985) Proc. Natl. Acad. Sci. U.S.A., 82, pp. 1276-1280. , 2nd edn; Steinbach, Schubert, Multiple modes of dibutyryl cyclic AMP induced process formation by clonal and glial cells (1975) Exp. Cell Res., 91, pp. 449-453; Steinberg, Does differential adhesion govern self-assembly processes in histogenesis? Equilibrium configurations and the emergence of a hierarchy among populations of embryonic cells (1970) J. Exp. Zool., 173, pp. 395-433; Toran-Allerand, Neurite-like outgrowth from CNS explants may not always be of neuronal origin (1990) Brain Research, 513, pp. 353-357; Tosney, Landmesser, Development of the major pathways for neurite outgrowth in the chick hindlimb (1985) Dev. Biol., 109, pp. 193-214; Wolff, Rathjen, Frank, Roth, Biochemical characterization of polypeptide components involved in neurite fasciculation and elongation (1987) Eur. J. Biochem., 168, pp. 551-561","Schubert, D.; The Salk Institute for Biological Studies, San Diego, CA 92138, United States",,,,,,,,00068993,,BRREA,1884223,"English","Brain Res.",Article,Scopus,2-s2.0-0025865858
"Schubert, D.","The possible role of adhesion in synaptic modification",1991,"Trends in Neurosciences","14","4",,"127","130",,34,10.1016/0166-2236(91)90078-9,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0026089980&partnerID=40&md5=719c907b8db8e79e963d87e54c001356","The Salk Institute, PO Box 85800, San Diego, CA 92138-9216, United States","Schubert, D., The Salk Institute, PO Box 85800, San Diego, CA 92138-9216, United States","Alterations in the adhesive interactions at synapses caused by the neurosecretion of glycoproteins and transient changes in extracellular calcium might be involved in long-term synaptic modification. © 1991.",,"glycoprotein; animal experiment; animal tissue; article; calcium cell level; cell adhesion; extracellular matrix; hippocampus; long term potentiation; mammal; nonhuman; priority journal; Animal; Calcium; Cell Adhesion; Extracellular Matrix; Learning; Memory; Models, Biological; Neurotransmitters; Receptors, Neurotransmitter; Synapses; Synaptic Membranes; Synaptic Transmission; Synaptic Vesicles",,"Calcium, 7440-70-2; Neurotransmitters; Receptors, Neurotransmitter",,,,"Ramón y Cajal, (1911) Histologie du Systeme Nerveux de l'Homme et des Vertebres, 2. , Maloine; Hebb, (1944) The Organization of Behavior, , John Wiley & Sons; Bailey, Chen, (1988) Proc. Natl Acad. Sci. USA, 85, pp. 2373-2377; Desmond, Levy, (1988) Long-term Potentiation: From Biophysics to Behavior, pp. 265-305. , F.W. Landfield, S.A. Deadwyler, Liss; Desmond, Levy, (1988) Brain Res., 453, pp. 308-314; Shashoua, (1985) Cell. Mol. Neurobiol., 5, pp. 183-207; Kater, Mattson, Cohan, Connor, (1988) Trends Neurosci., 11, pp. 315-321; Kelly, Carlson, Caroni, (1987) Biology of Proteoglycans (Biology of Extracellular Matrix: A Series), pp. 247-265. , T.N. Wright, R.P. Mecham, Academic Press; Kelly, (1988) Neuron, 1, pp. 431-438; Castel, Gainer, Dellmann, (1984) Int. Rev. Cytol., 88, pp. 303-450; Winkler, (1984) Regulation of Transmitter Function, pp. 65-73. , E.S. Vizi, K. Magyar, Akademiai Kiad'o; Carlson, Caroni, Kelly, (1986) J. Cell Biol., 103, pp. 509-520; Kelly, (1983) Cold Spring Harbor Symp. Quant. Biol., 48, pp. 697-705; Giannattasio, Zanini, Meldolesi, (1979) Complex Carbohydrates of Nervous Tissue, pp. 327-345. , R.M. Margolis, R.K. Margolis, Plenum Press; Vila-Porcile, Oliver, (1980) Synthesis and Release of Adenohypophyseal Hormones, pp. 67-103. , M. Jutisz, K.W. McKerns, Plenum Press; Covault, Sanes, (1986) J. Cell Biol., 102, pp. 716-730; Peters, Palay, Webster, (1976) The Fine Structure of the Nervous System, pp. 135-142. , W.B. Saunders; Gordon, Bernfield, (1980) Dev. Biol., 74, pp. 118-135; MaCallum, (1982) Exp. Cell Res., 139, pp. 1-13; Berman, (1987) Cell, 51, pp. 135-142; Baird, Bohlen, (1990) Peptide Growth Factors and their Receptors, pp. 197-225. , M.B. Sporn, A. Robert, Springer-Verlag; Hammarback, McCarthy, Palm, Furcht, Letourneau, (1988) Dev. Biol., 126, pp. 29-39; Ross, Arechiga, Nicholls, (1988) Proc. Natl Acad. Sci. USA, 85, pp. 4075-4078; Bloch, Pumplin, Molecular events in synaptogenesis: nerve-muscle adhesion and postsynaptic differentiation. (1988) Am J Physiol, 254, pp. C345-C365; Barinaga, (1990) Science, 248, pp. 1603-1605; Reese, (1987) Encyclopedia of Neuroscience, 2, p. 1158. , G. Adelman, Birkhäuser; Faber, Funch, Korn, (1985) Proc. Natl Acad. Sci. USA, 82, pp. 3504-3508; Heath, Dunn, (1978) J. Cell Sci., 29, pp. 197-212; Trinkaus, (1980) Prog. Clin. Biol. Res., 41, pp. 887-906; Dike, Farmer, (1988) Proc. Natl Acad. Sci. USA, 85, pp. 6792-6796; Herman, Harrington, Vlashaw, Pledger, (1986) J. Cell Physiol., 126, pp. 115-125; Farmer, (1986) Cell and Molecular Biology of the Cytoskeleton, pp. 131-149. , J.W. Shay, Plenum Press; Vartanian, Sprinkle, Dawson, Szuchet, (1988) Proc. Natl Acad. Sci. USA, 85, pp. 939-943; Swaisgood, Schindler, (1989) Exp. Cell Res., 180, pp. 515-528; Takeichi, (1987) Trends Genet., 3, pp. 213-217; Ginsberg, Rahamimoff, (1986) Calcium, Neuronal Function and Transmitter Release, pp. 181-195. , R. Rahamimoff, S.B. Katz, Nijhoff; Schubert, LaCorbiere, Whitlock, Stallcup, (1978) Nature, 273, pp. 718-723; Gundersen, Barrett, (1980) J. Cell Biol., 87, pp. 546-554; Connor, (1986) Proc. Natl Acad. Sci. USA, 83, pp. 6179-6183; Cohan, Connor, Kater, (1987) J. Neurosci., 7, pp. 3588-3599; Schubert, (1984) Developmental Biology of Cultured Nerve, Muscle and Glia, pp. 84-116. , John Wiley & Sons; Schubert, LaCorbiere, Whitlock, Stallcup, (1978) Nature, 273, pp. 5665-5670; Purves, Hadley, (1985) Nature, 315, pp. 404-406; Staubli, Lynch, (1987) Brain Res., 435, pp. 227-234; Bliss, Lomo, (1973) J. Physiol., 232, pp. 331-356; Desmond, Levy, (1986) J. Comp. Neurol., 253, pp. 476-482; Greenough, (1984) Trends Neurosci., 7, pp. 229-233; Hirano, Ultrastructural study on the morphogenesis of the neuromuscular junction in the skeletal muscle of the chick (1967) Zeitschrift f�r Zellforschung und Mikroskopische Anatomie, 79, pp. 198-212; Turner, Baimbridge, Miller, (1982) Neuroscience, 7, pp. 1411-1416; Melchers, Pennartz, Lopes da Silva, (1987) Neurosci. Lett., 77, pp. 37-42; Melchers, Pennartz, Wadman, Lopes da Silva, (1988) Brain Res., 454, pp. 1-10; Andrews, Leapman, Landis, Reese, (1988) Proc. Natl Acad. Sci. USA, 85, pp. 1682-1685; Malenka, Kauer, Zucker, Nicoll, (1988) Science, 242, pp. 81-84; Carafoli, (1987) Biochemistry, 56, pp. 395-433; Schubert, Schroeder, LaCorbiere, Saitoh, Cole, Amyloid beta protein precursor is possibly a heparan sulfate proteoglycan core protein (1988) Science, 241, pp. 223-226; Esch, (1990) Science, 248, pp. 1122-1124; Klier, Cole, Stallcup, Schubert, (1990) Brain Res., 515, pp. 336-342","Schubert, D.; The Salk Institute, PO Box 85800, San Diego, CA 92138-9216, United States",,,,,,,,01662236,,TNSCD,1710846,"English","Trends Neurosci.",Article,Scopus,2-s2.0-0026089980
"Engele, J., Schubert, D., Bohn, M.C.","Conditioned media derived from glial cell lines promote survival and differentiation of dopaminergic neurons in vitro: Role of mesencephalic glia",1991,"Journal of Neuroscience Research","30","2",,"359","371",,105,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0026076380&partnerID=40&md5=637bc304894ec7540f9c46792a499250","Dept. of Neurobiology/Anatomy, Rochester Univ. Medical Center, Box 603, 601 Elmwood Ave., Rochester, NY 14642, United States","Engele, J., Dept. of Neurobiology/Anatomy, Rochester Univ. Medical Center, Box 603, 601 Elmwood Ave., Rochester, NY 14642, United States; Schubert, D., Dept. of Neurobiology/Anatomy, Rochester Univ. Medical Center, Box 603, 601 Elmwood Ave., Rochester, NY 14642, United States; Bohn, M.C., Dept. of Neurobiology/Anatomy, Rochester Univ. Medical Center, Box 603, 601 Elmwood Ave., Rochester, NY 14642, United States","Neuronal differentiation is influenced by extracellular factors; however, only a few such factors have been identified for central neurons. To address this issue, we have screened media conditioned (CM) by several glial cell lines for neurotrophic effects on dopaminergic neurons in dissociated cell cultures of the E14.5 rat mesencephalon grown in serum-free conditions. To establish culture conditions under which dopaminergic cell survival depends on the exogenous support from neurotrophic factors, cell suspensions were seeded at varying densities and the number of tyrosine hydroxylase-immunoreactive (TH-IR) neurons was determined. This number was maximal at plating densities greater than 175,000 cells/cm2 and was 10-fold lower at the plating density of 80,000 cells/cm2. Cell density had only a minimal effect on [3H]dopamine uptake per TH-IR neuron. Treatment of cultures plated at 80,000 cells/cm2 with CM derived from the glial cell line, B49, the neural retina glial cell line, R33, and the Schwannoma cell line JS1, increased the number of surviving TH-IR neurons 160-330%. These effects were dose dependent and heat sensitive. All CM stimulated neurite elongation of TH-IR neurons, while only the B49-CM increased [3H]dopamine uptake. The neurotrophic effects of these media were not confined to dopaminergic neurons but increased overall neuronal density in culture by 50-100%. Moreover, all three CM were mitogenic for mesencephalic glia as demonstrated by glial fibrillary acidic protein (GFAP)-immunocytochemistry in combination with [3H]thymidine-autoradiography. By contrast, medium conditioned by the pheochromocytoma cell line, PC12, did not increase the number of astrocytes or promote the survival of dopaminergic neurons. Inhibition of glial proliferation reduced the neurotrophic effects of the B49-, R33-, and JS1-CM by 40-80%. These observations suggest that the glial cell lines B49, R33, and JS1 secrete factors that promote the survival of dopaminergic neurons and induce proliferation of glial precursors. The partial decrease of the survival-promoting effects of these CM on dopaminergic neurons in glial-free mesencephalic cultures further suggests that the observed neurotrophic effects result from the combined action of cell line-derived substances directly on neurons and indirectly via effects on mesencephalic astrocytes or astrocyte precursors.","astrocytes; catecholamines; cell proliferation; glial fibrillary acidic protein; growth factors; neurotropism; tyrosine hydroxylase","catecholamine; glial fibrillary acidic protein; growth factor; thymidine; tyrosine 3 monooxygenase; animal tissue; article; astrocyte; autoradiography; controlled study; dopaminergic nerve cell; embryo; glia cell; immunocytochemistry; mesencephalon; morphometrics; nerve cell differentiation; nonhuman; priority journal; rat; Animal; Cell Differentiation; Cell Division; Cell Line; Cell Survival; Culture Media; Dopamine; Female; Glial Fibrillary Acidic Protein; Immunohistochemistry; Mesencephalon; Neurites; Neuroglia; Neurons; PC12 Cells; Pregnancy; Rats; Rats, Inbred Strains; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Thymidine; Tyrosine 3-Monooxygenase",,"thymidine, 50-89-5; tyrosine 3 monooxygenase, 9036-22-0; Culture Media; Dopamine, 51-61-6; Glial Fibrillary Acidic Protein; Thymidine, 50-89-5; Tyrosine 3-Monooxygenase, EC 1.14.16.2",,,,,"Bohn, M.C.; Dept. of Neurobiology/Anatomy, Rochester Univ. Medical Center, Box 603, 601 Elmwood Ave., Rochester, NY 14642, United States",,,,,,,,03604012,,JNRED,1686785,"English","J. NEUROSCI. RES.",Article,Scopus,2-s2.0-0026076380
"Kimura, H., Fischer, W.H., Schubert, D.","Structure, expression and function of a schwannoma-derived growth factor",1990,"Nature","348","6298",,"257","260",,94,10.1038/348257a0,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0025018165&partnerID=40&md5=d2f5ed3dc630a12c04670826070e2ffc","The Salk Institute for Biological Studies, PO Box 85800, San Diego, CA 92186-5800, United States","Kimura, H., The Salk Institute for Biological Studies, PO Box 85800, San Diego, CA 92186-5800, United States; Fischer, W.H., The Salk Institute for Biological Studies, PO Box 85800, San Diego, CA 92186-5800, United States; Schubert, D., The Salk Institute for Biological Studies, PO Box 85800, San Diego, CA 92186-5800, United States","During the development of the nervous system, cells require growth factors that regulate their division and survival. To identify new growth factors, serum-free growth-conditioned media from many clonal cells lines were screened for the presence of mitogens for central nervous system glial cells. A cell line secreting a potent glial mitogen was established from a tumour (or 'schwannoma') derived from the sheath of the sciatic nerve. The cells of the tumour, named JS1 cells, were adapted to clonal culture and identified as Schwann cells. Schwann cells secrete an autocrine mitogen and human schwannoma extracts have mitogenic activity on glial cells. Until now, neither mitogen has been purified. Here we report the purification and characterization of a mitogenic molecule, designated schwannoma-derived growth factor (SDGF), from the growth-conditioned medium of the JS1 Schwann cell line. SDGF belongs to the epidermal growth factor family, and is an autocrine growth factor as well as a mitogen for astrocytes, Schwann cells and fibroblasts.",,"nerve growth factor; article; cell culture; nervous system development; priority journal; schwann cell; Amino Acid Sequence; Animal; Astrocytes; Base Sequence; Cloning, Molecular; Culture Media; DNA; Epidermal Growth Factor; Fibroblasts; Gene Expression; Growth Substances; Human; Mice; Mitogens; Molecular Sequence Data; Molecular Weight; Neurilemmoma; Neuroglia; Rats; Schwann Cells; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Tumor Cells, Cultured",,"amphiregulin, 117147-70-3; Culture Media; DNA, 9007-49-2; Epidermal Growth Factor, 62229-50-9; Growth Substances; Mitogens",,,,,,,,,,,,,00280836,,NATUA,2234093,"English","NATURE",Article,Scopus,2-s2.0-0025018165
"Svrzic, D., Schubert, D.","Insulin-like growth factor 1 supports embryonic nerve cell survival",1990,"Biochemical and Biophysical Research Communications","172","1",,"54","60",,25,10.1016/S0006-291X(05)80172-X,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0025059645&partnerID=40&md5=8432f80552fcf43f057e10e861c34ae6","The Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92138-9216, United States; Institute for Biochemistry Department of Neurochemistry Pasterova 2, 11000 Beograd","Svrzic, D., Institute for Biochemistry Department of Neurochemistry Pasterova 2, 11000 Beograd; Schubert, D., The Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92138-9216, United States","Insulin-like growth factor 1 (IGF-1) is shown to support the long term survival of embryonic chicken central nervous system neurons cultured in a defined medium. This trophic activity for IGF-1 was discovered as the result of its presence as a contaminant in bovine serum albumin, a reagent frequently used in primary cultures of neuronal tissue. The observation that IGF-1 has cell survival activity may explain the high level of IGF-1 receptors found in embryonic brain. © 1990 Academic Press, Inc.",,"somatomedin c; animal cell; article; cell culture; cell survival; chicken; nerve cell; nonhuman; priority journal; Animal; Brain; Cell Survival; Cells, Cultured; Cerebral Cortex; Chick Embryo; Insulin-Like Growth Factor I; Kinetics; Nerve Tissue Proteins; Neurons; Recombinant Proteins; Serum Albumin, Bovine; Animalia; Bovinae; Gallus gallus",,"Insulin-Like Growth Factor I, 67763-96-6; Nerve Tissue Proteins; Recombinant Proteins; Serum Albumin, Bovine",,,,"Pacold, Blackard, (1979) Endocrinol., 105, pp. 1452-1457; Gammeltoft, Haselbacher, Humbel, Fehlmann, Obberghen, (1985) EMBO J., 4, pp. 3407-3412; Havrankova, Roth, Brownstein, (1978) Nature (Lond.), 272, pp. 827-829; Ocrant, Valentino, Eng, Hintz, Wilson, Rosenfeld, (1988) Endocrinol., 123, pp. 1023-1034; Pomerance, Gavaret, Jacquemin, Matricon, Torudelbauffe, Pierre, (1988) Dev. Brain Res., 42, pp. 77-83; Sara, Hall, Misaki, Fryklund, Christensen, Wetterberg, (1983) J. Clin. Inve st., 71, pp. 1084-1094; Caroni, Grandes, (1990) J. Cell Biol., 110, pp. 1307-1317; Pecio-Pinto, Ishii, (1984) Brain Res., 302, pp. 323-334; Pecio-Pinto, Rechler, Ishii, (1986) J. Neurosci., 6, pp. 1211-1219; Sendtner, Gnahn, Wakade, Thoenen, (1988) J. Neurosci., 8, pp. 458-462; Guthrie, Brenneman, Neale, (1987) Brain Res., 420, pp. 313-323; Vogt, Dulbecco, (1963) Proc. Natl. Acad. Sci., U.S.A., 49, pp. 171-178; Facci, Skaper, Varon, (1985) J. Neurochem., 45, pp. 926-934; Bottenstein, Sato, Growth of a rat neuroblastoma cell line in serum-free supplemented medium. (1979) Proceedings of the National Academy of Sciences, 76, pp. 417-514; Manthorpe, Fagnani, Skaper, Varon, (1986) Dev. Brain Res., 25, pp. 191-198; Anderson, Baum, Geteland, (1973) J. Virol., 12, pp. 241-248; Rudge, Davis, Manthorpe, Varon, (1987) Dev. Brain Res., 32, pp. 103-110; Russell, Van Wyk, Pledger, (1984) Proc. Natl. Acad. Sci., U.S.A., 81, pp. 2389-2392; Congote, Esch, (1987) Biochem. Biophys. Res. Comm., 149, pp. 1026-1032; Sara, Carlsson-Skwirut, (1988) Prog. Brain Res., 73, pp. 89-99; Orlowski, Chernausek, Akeson, (1989) J. Cell Physiol., 139, pp. 469-476; Dicicco-Bloom, Black, (1989) Brain Res., 491, pp. 403-406; McMorris, Smith, Desalvo, Furlanetto, (1986) Proc. Natl. Acad. Sci., U.S.A., 83, pp. 822-826; Aizenman, de Vellis, (1987) Brain Res., 406, pp. 32-42; Mill, Chao, Ishii, (1985) Proc. Natl. Acad. Sci. U.S.A., 82, pp. 7126-7130; Steele-Perkins, Turner, Edman, Haris, Pierce, Stover, Rutter, Roth, Expression and characterization of a functional human insulin-like growth factor I receptor. (1988) J Biol Chem, 263, pp. 11486-11492","Schubert, D.; The Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92138-9216, United States",,,,,,,,0006291X,,BBRCA,2222482,"English","Biochem. Biophys. Res. Commun.",Article,Scopus,2-s2.0-0025059645
"Schubert, D., Jin, L.-W., Saitoh, T., Cole, G.","Erratum: The regulation of amyloid β protein precursor secretion and its modulatory role in cell adhesion (Neuron 3, 689-694, 1989)",1990,"Neuron","4","5",,"813","",,,10.1016/0896-6273(90)90208-W,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0025364515&partnerID=40&md5=5e9d28d175f8057ff71dd90533b336c9",,"Schubert, D.; Jin, L.-W.; Saitoh, T.; Cole, G.",[No abstract available],,"amyloid; animal cell; cell adhesion; erratum; nonhuman; priority journal",,,,,,,,,,,,,,,08966273,,NERNE,,"English","NEURON",Erratum,Scopus,2-s2.0-0025364515
"Schubert, D., Kimura, H., LaCorbiere, M., Vaughan, J., Karr, D., Fischer, W.H.","Activin is a nerve cell survival molecule",1990,"Nature","344","6269",,"868","870",,204,10.1038/344868a0,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0025291340&partnerID=40&md5=581d9c5f463cdcca85456844f2068221","The Salk Institute, 10010 N. Torrey Pines Road, La Jolla, CA 92037, United States","Schubert, D., The Salk Institute, 10010 N. Torrey Pines Road, La Jolla, CA 92037, United States; Kimura, H., The Salk Institute, 10010 N. Torrey Pines Road, La Jolla, CA 92037, United States; LaCorbiere, M., The Salk Institute, 10010 N. Torrey Pines Road, La Jolla, CA 92037, United States; Vaughan, J., The Salk Institute, 10010 N. Torrey Pines Road, La Jolla, CA 92037, United States; Karr, D., The Salk Institute, 10010 N. Torrey Pines Road, La Jolla, CA 92037, United States; Fischer, W.H., The Salk Institute, 10010 N. Torrey Pines Road, La Jolla, CA 92037, United States","The structures of five neurotrophic molecules have so far been published. Nerve growth factor, fibroblast growth factor and purpurin, have been identified as nerve-cell survival molecules. More recently, brain-derived neurotrophic factor (BDNF) and ciliary neurotrophic factor have been cloned and sequenced. As all these proteins stimulate the survival of ciliary or sensory neurons, a new cell survival assay is required if novel neurotrophic molecules are to be discovered. P19 teratoma cells differentiate to nerve-like cells in the presence of 5 x 10-7 M retinoic acid (RA). But when P19 cells are plated in N2 synthetic medium without being exposed to RA, they die within 48 h. In an attempt to identify a molecule(s) that can substitute for RA in promoting P19 survival, we assayed serum-free growth-conditioned media for their ability to promote P19 survival. One cell line from the rat eye secreted a molecule that promoted the survival of P19 cells and some types of nerve cell. We identified this molecule as activin, better known for its role in hormone secretion.",,"activin; protein; amino acid sequence; animal cell; article; cell culture; cell survival; nerve cell; nonhuman; priority journal; Activins; Amino Acid Sequence; Animal; Cell Survival; Chromatography, High Pressure Liquid; Culture Media; Eye; Immunoblotting; Inhibins; Molecular Sequence Data; Neurons; Rats; Support, U.S. Gov't, P.H.S.; Teratoma; Tumor Cells, Cultured; Animalia",,"Activins, 104625-48-1; Culture Media; Inhibins, 57285-09-3",,,,,,,,,,,,,00280836,,NATUA,2330043,"English","NATURE",Article,Scopus,2-s2.0-0025291340
"Klier, F.G., Cole, G., Stallcup, W., Schubert, D.","Amyloid β-protein precursor is associated with extracellular matrix",1990,"Brain Research","515","1-2",,"336","342",,65,10.1016/0006-8993(90)90619-M,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0025360471&partnerID=40&md5=67973707f64458e0c1a911297feab34d","La Jolla Cancer Research Foundation, United States; The Salk Institute, La Jolla, CA 92037, United States; Department of Neurosciences, M-024 University of California at San Diego, La Jolla, CA 92093, United States","Klier, F.G., La Jolla Cancer Research Foundation, United States; Cole, G., Department of Neurosciences, M-024 University of California at San Diego, La Jolla, CA 92093, United States; Stallcup, W., La Jolla Cancer Research Foundation, United States; Schubert, D., The Salk Institute, La Jolla, CA 92037, United States","The ultrastructural distribution of the amyloid β-protein precursor (ABPP) in cultures of a neuronal cell line is examined. ABPP is associated with the extensive extracellular matrix (ECM) secreted by these cells. The possible role of matrix associated ABPP in the pathogenesis of Alzheimer's disease is discussed. © 1990.","Amyloid β-protein precursor; Extracellular matrix; NG2 proteoglycan","amyloid protein; radioisotope; alzheimer disease; animal cell; article; cell culture; cytochemistry; extracellular matrix; nerve cell; nonhuman; priority journal; ultrastructure; Amyloid; Amyloid beta-Protein Precursor; Animal; Cell Line; Extracellular Matrix; Neurons; Protein Precursors; Rats; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.",,"Amyloid beta-Protein Precursor; Amyloid; Protein Precursors",,,,"Baird, A. and Bohlen, P., Fibroblast growth factors. InPeptide Growth Factors and Their Receptors, Springer, Heidelberg, in pressBergman, Scott, Bajpai, Watts, Baker, Inhibition of tumor-cell-mediated ECM destruction by a fibroblast protease inhibitor, protease nexin I (1986) Proc. Natl. Acad. Sci. U.S.A., 83, pp. 996-1000; Bloch, Plumplin, Molecular events in synaptogenesis nerve-muscle adhesion and postsynaptic differentiation (1988) Am J Physiol, 254, pp. C345-C364; Cole, Masliah, Huynh, DeTeresa, Terry, Okuda, Saitoh, An antiserum against amyloid beta-protein precursor detects a unique peptide in Alzheimer brain (1989) Neurosci. Lett., 100, pp. 340-346; Cornwell, Westermark, Senile amyloidosis, a protein manifestation of the aging process (1980) J. Clin. Pathol., 33, pp. 1146-1152; Engvall, Bell, Carlsson, Miller, Ruoslahti, Nonhelical, fibronectin-binding basement-membrane collagen from endodermal cell culture (1982) Cell, 29, pp. 475-482; Engvall, Hessle, Klier, Molecular assembly, secretion, and matrix deposition of type VI collagen (1986) J. Cell Biol., 102, pp. 703-710; Giaccone, Taglivini, Linoli, Bouras, Frigerio, Frangione, Bugiani, Down patients: extracellular pre-amyloid deposits precede neuritic degeneration and senile plaques (1989) Neurosci. Lett., 97, pp. 232-238; Gray, Synapse morphology (1987) Encyclopedia of Neuroscience, pp. 1158-1162. , G. Edelman, Birkhauser, Boston, MA; Hantai, Rao, Kahler, Festoff, Decrease in plasminogen activator correlates with synapse elimination during neonatal development of mouse skeletal muscle (1989) Proc. Natl. Acad. Sci. U.S.A., 86, pp. 362-366; Inestrosa, Matthew, Reiness, Hall, Reichardt, A typical distribution of asymmetric acetylcholinesterase in mutant PC12 pheochromocytoma cells lacking a cell surface heparin sulfate proteoglycan (1985) J. Neurochem., 45, pp. 86-94; Ishii, Kametani, Haga, Sato, The immunohistochemical demonstration of subsequences of the precursor of the amyloid A4 protein in senile plaques in Alzheimer's disease (1988) Alzheimer Disease & Associated Disorders, 2, p. 270; Kang, Lemaire, Unterbeck, Salbaum, Masters, Grezeschik, Multhaup, Muller-Hill, The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor (1987) Nature (Lond.), 325, pp. 733-736; Kitaguchi, Takahashi, Tokushima, Shiojiri, Ito, Novel precursor of Alzheimer's disease amyloid shows proteas inhibitory activity (1988) Nature (Lond.), 331, pp. 530-532; Klier, Schubert, Heinemann, The ultrastructural differentiation of the clonal myogenic cell line L6 in normal and high K+ medium (1977) Dev. Biol., 57, pp. 440-449; Lander, Fudjii, Reichardt, Purification of a factor that promotes neurite outgrowth: isolation of laminin and associated molecules (1985) J. Cell Biol., 101, pp. 898-913; Levine, Stallcup, Plasticity of developing cerebellar cells in vitro studied with antibodies against the NG2 antigen (1987) J. Neurosci., 7, pp. 2721-2731; Palmert, Berman-Podlisny, Witker, Oltersdorf, Younkin, Selkoe, Younkin, Antisera to an amino-terminal peptide detect the amyloid protein precursor of Alzheimer's disease and recognize senile plaques (1988) Biochem. Biophys. Res. Commun., 156, pp. 432-437; Perry, Lipphardt, Mulvihill, Amyloid precursor protein in senile plaques of Alzheimer disease (1988) Lancet, 2, p. 746; Ponte, Gonzalez-DeWhitt, Schilling, Miller, Hon, Greenberg, Davis, Cordell, A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors (1988) Nature (Lond.), 331, pp. 525-528; Raff, Miller, Noble, A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium (1983) Nature (Lond.), 303, pp. 390-396; Ruoslahti, Hayman, Engvall, Cothran, Butler, Alignment of biologically active domains in the fibronectin molecule (1981) J. Biol. Chem., 256, pp. 7277-7281; Saitoh, Sundsmo, Roch, Kimura, Cole, Schubert, Oltersdorf, Schenk, Secreted form of amyloid β-protein precursor is involved in the growth regulation of fibroblasts (1989) Cell, 58, pp. 615-622; Sanes, Chin, The basal lamina of the neuromuscular junction (1983) Cold Spring Harbor Symposia on Quantitative Biology, 47, pp. 667-678; Schubert, Carlisle, Neuronal cells from rodent neoplasms (1978) Cell Culture (a volume of Methods in Enzymology), Neuronal Cells (III.II), 58, pp. 584-590. , Academic Press; Schubert, Schroeder, LaCorbiere, Saitoh, Cole, Amyloid Î²-protein precursor is possibly a heparin sulfate proteoglycan core protein (1988) Science, 241, pp. 223-226; Schubert, LaCorbiere, Saitoh, Cole, Characterization of an amyloid β-precursor protein that binds heparin and contains tyrosine sulfate (1989) Proc. Natl. Acad. Sci. U.S.A., 86, pp. 2066-2069; Schubert, Jin, Saitoh, Cole, The regulation of amyloid beta protein precursor secretion and its modulatory role in cell adhesion (1989) Neuron, 3, pp. 689-694; Schubert, Cole, Saitoh, Oltersdorf, Amyloid β-protein precursor protein is a mitogen (1989) Biochem. Biophys. Res. Commun., 162, pp. 83-88; Selkoe, Podlisny, Joachim, Vickers, Lee, Fritz, Oltersdorf, β-Amyloid precursor protein occur as 110 to 135 kilodalton membrane-associated proteins in neural and non-neuronal tissues (1988) Proc. Natl. Acad. Sci. U.S.A., 85, pp. 7341-7345; Shivers, Hillbich, Multhaup, Salbaum, Beyreuther, Seeburg, Alzheimer's disease amyloidogenic glycoprotein, expression pattern in rat brain suggests a role in cell contact (1988) EMBO J., 7, pp. 1365-1370; Stallcup, Beasley, Levine, Cell surface molecules that characterize different stages in the development of cerebellar interneurons (1983) Cold Spring Harbor Symp. Quant. Biol., 48, pp. 761-774; Stallcup, Beasley, Bipotential glial precursor cells of the optic nerve express the NG2 proteoglycan (1987) J. Neurosci., 7, pp. 2737-2744; Steinbach, Schubert, Multiple modes of dibutyryl cyclic AMP induced process formation by clonal nerve and glial cells (1975) Exp. Cell Res., 91, pp. 449-453; Storkel, Bohl, Schneider, Senile amyloidosis: principles of localization in a heterogeneous form of amyloidosis (1983) Virchow's Arch., 44, pp. 145-161; Tanzi, McClatchery, Lampert, Villa-Komaroff, Gusella, Neve, Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease (1988) Nature (Lond.), 331, pp. 528-530; Tate-Ostroff, Majocha, Marotta, Identification of cellular and extracellular sites of amyloid precursor protein extracytoplasmic domain in normal and Alzheimer disease brains (1989) Proc. Natl. Acad. Sci. U.S.A., 86, pp. 745-749; Ueda, Cole, Sundsmo, Katzman, Saitoh, Decreased adhesiveness of Alzheimer's disease fibroblasts: is amyloid β-protein precursor involved? (1989) Ann. Neurol., 25, pp. 246-251; Weidemann, Konig, Bunke, Fisher, Salbaum, Masters, Beyreuther, Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein (1989) Cell, 57, pp. 115-126; Yamada, Tsukagoshi, Otomo, Hayakawa, Systemic amyloid deposition in old age and dementia of Alzheimer type: the relationship of brain amyloid to other amyloids (1988) Acta Neuropathol., 17, pp. 136-141","Schubert, D.; The Salk Institute, La Jolla, CA 92037, United States",,,,,,,,00068993,,BRREA,2113416,"English","Brain Res.",Article,Scopus,2-s2.0-0025360471
"Cole, G.M., Schubert, D., Saitoh, T.","Cell biology of amyloid β-protein precursor",1990,"Molecular biology and genetics of Alzheimer's disease: proceedings of the International Symposium on Dementia: Molecular Biology and Genetics of Alzheimer's Disease. ICS884",,,,"113","122",,1,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0025041850&partnerID=40&md5=6bd5503772e12f25d7efebfb018b174b","University of California, School of Medicine, Department of Neurosciences, La Jolla, CA 92093, United States","Cole, G.M., University of California, School of Medicine, Department of Neurosciences, La Jolla, CA 92093, United States; Schubert, D., University of California, School of Medicine, Department of Neurosciences, La Jolla, CA 92093, United States; Saitoh, T., University of California, School of Medicine, Department of Neurosciences, La Jolla, CA 92093, United States",[No abstract available],,"amyloid protein; protein precursor; alzheimer disease; conference paper; female; human; human cell; male",,,,,,,,"Miyatake T.Selkoe D.J.Ihara Y.Miyatake T.Selkoe D.J.Ihara Y.",,"Elsevier Science Publishers B.V.","The International Symposium on Dementia: Molecular Biology and Genetics of Alzheimer's Disease","11 November 1989 through 14 November 1989",,,,0444811125,,,"English",,Conference Paper,Scopus,2-s2.0-0025041850
"Gowda, D.C., Margolis, R.K., Frangione, B., Ghiso, J., Larrondo-Lillo, M., Margolis, R.U., Schubert, D.","Relation of the amyloid β protein precursor to heparan sulfate proteoglycans",1989,"Science","244","4906",,"826","828",,6,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0024973839&partnerID=40&md5=7fdba5f86981a8354ceedd30e01b41bf","Department of Pharmacology, New York University Medical Center, 550 First Avenue, New York, NY 10016, United States; Department of Pharmacology, State University of New York, Health Science Center at Brooklyn, Brooklyn, NY 11203, United States; Department of Pathology, New York University Medical Center, New York, NY, United States; Department of Pharmacology, New York University Medical Center, New York, NY, United States; Salk Institute for Biological Studies, Post Office Box 85800, San Diego, CA 92138, United States","Gowda, D.C., Department of Pharmacology, New York University Medical Center, 550 First Avenue, New York, NY 10016, United States; Margolis, R.K., Department of Pharmacology, State University of New York, Health Science Center at Brooklyn, Brooklyn, NY 11203, United States; Frangione, B., Department of Pathology, New York University Medical Center, New York, NY, United States; Ghiso, J., Department of Pathology, New York University Medical Center, New York, NY, United States; Larrondo-Lillo, M., Department of Pathology, New York University Medical Center, New York, NY, United States; Margolis, R.U., Department of Pharmacology, New York University Medical Center, New York, NY, United States; Schubert, D., Salk Institute for Biological Studies, Post Office Box 85800, San Diego, CA 92138, United States",[No abstract available],,"amyloid; Amyloid beta Protein Precursor; amyloid precursor protein; drug derivative; heparin; heparin proteoglycan; protein precursor; proteoglycan; adrenal tumor; animal; article; cell culture; comparative study; pheochromocytoma; rat; Adrenal Gland Neoplasms; Amyloid; Amyloid beta-Protein Precursor; Animal; Comparative Study; Heparin; Pheochromocytoma; Protein Precursors; Proteoglycans; Rats; Tumor Cells, Cultured",,"amyloid, 11061-24-8; heparin, 37187-54-5, 8057-48-5, 8065-01-8, 9005-48-5; Amyloid beta-Protein Precursor; Amyloid; heparin proteoglycan; Heparin, 9005-49-6; Protein Precursors; Proteoglycans",,,,,"Gowda, D.C.; Department of Pharmacology, New York University Medical Center, 550 First Avenue, New York, NY 10016, United States",,,,,,,,00368075,,,2499044,"English",,Note,Scopus,2-s2.0-0024973839
"Saitoh, T., Sundsmo, M., Roch, J.-M., Kimura, N., Cole, G., Schubert, D., Oltersdorf, T., Schenk, D.B.","Secreted form of amyloid β protein precursor is involved in the growth regulation of fibroblasts",1989,"Cell","58","4",,"615","622",,303,10.1016/0092-8674(89)90096-2,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0024395366&partnerID=40&md5=273175157b2cf2388ba44a16379890f9","Department of Neurosciences School of Medicine (M-024), Center for Molecular Genetics University of California at San Diego, La Jolla, CA 92093, United States; Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92138, United States; Athena Neurosciences, Inc., 800F Gateway Boulevard, South San Francisco, CA 94080, United States","Saitoh, T., Department of Neurosciences School of Medicine (M-024), Center for Molecular Genetics University of California at San Diego, La Jolla, CA 92093, United States; Sundsmo, M., Department of Neurosciences School of Medicine (M-024), Center for Molecular Genetics University of California at San Diego, La Jolla, CA 92093, United States; Roch, J.-M., Department of Neurosciences School of Medicine (M-024), Center for Molecular Genetics University of California at San Diego, La Jolla, CA 92093, United States; Kimura, N., Department of Neurosciences School of Medicine (M-024), Center for Molecular Genetics University of California at San Diego, La Jolla, CA 92093, United States; Cole, G., Department of Neurosciences School of Medicine (M-024), Center for Molecular Genetics University of California at San Diego, La Jolla, CA 92093, United States; Schubert, D., Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92138, United States; Oltersdorf, T., Athena Neurosciences, Inc., 800F Gateway Boulevard, South San Francisco, CA 94080, United States; Schenk, D.B., Athena Neurosciences, Inc., 800F Gateway Boulevard, South San Francisco, CA 94080, United States","Fibroblasts that harbor an antisense construct of amyloid β protein precursor (ABPP) cDNA, A-2, produced less ABPP mRNA and ABPP and grew poorly. Normal growth was restored when either parent cell conditioned medium (CM) or purified ABPP was provided. The capacity of the CM to restore cell growth was abolished by passage through an anti-ABPP immunoaffinity column; the activity was in the bound fraction. A Mr 90,000 protein recognized by the anti-ABPP antibody was diminished in the CM of A-1. CM from ABPP cDNA-transfected cells expressing high levels of ABPP was more potent than that from non-transfected parent cells in restoring A-1 growth. These results indicate that ABPP is released from cells into the medium and has an autocrine function in growth regulation. © 1989.",,"amyloid beta protein; protein precursor; cell culture; cell growth; fibroblast; growth regulation; human; human cell; priority journal; protein secretion; Amyloid; Amyloid beta-Protein Precursor; Brain; Cell Compartmentation; Cell Division; Cell Line; Fibroblasts; Growth Substances; Human; In Vitro; Protein Precursors; RNA; RNA, Antisense; RNA, Messenger; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Transfection",,"amyloid beta protein, 109770-29-8; Amyloid beta-Protein Precursor; Amyloid; Growth Substances; Protein Precursors; RNA, 63231-63-0; RNA, Antisense; RNA, Messenger",,,,"Allsop, Wong, Ikeda, Landon, Kidd, Glenner, Immunohistochemical evidence for the derivation of a peptide ligand from the amyloid β-protein precursor of Alzheimer disease (1988) Proc. Natl. Acad. Sci. USA, 85, pp. 2790-2794; Bass, Weintraub, An unwinding activity that covalently modifies its double-stranded RNA substrate (1988) Cell, 55, pp. 1089-1098; Bernard, Oltersdorf, Seedorf, Expression of human papillomavirus type 18 E7 gene by a cassette-vector system for the transcription and translation of open reading frames in eukaryotic cells (1987) EMBO J., 6, pp. 133-138; Blake, Murakami, Miller, Inhibition of rabbit globin mRNA translation by sequence specific oligodeoxynucleotides (1985) Biochemistry, 24, pp. 6132-6138; Blessed, Tomlinson, Roth, The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects (1968) Br. J. Psychiatry, 114, pp. 797-811; Chomczynski, Sacchi, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction (1987) Anal. Biochem., 162, pp. 156-159; Cohen, Golde, Usiak, Younkin, Younkin, In situ hybridization of nucleus basalis neurons shows increased beta-amyloid mRNA in Alzheimer disease (1988) Proc. Natl. Acad. Sci. USA, 85, pp. 1227-1231; Cole, Masliah, Huynh, DeTeresa, Terry, Okuda, Saitoh, An antiserum against amyloid β-protein precursor detects a unique peptide in Alzheimer brain (1989) Neurosci. Lett., 100, pp. 340-346; Goldgaber, Lerman, McBride, Saffioti, Gajdusek, Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease (1987) Science, 235, pp. 877-880; Green, Pines, Inouye, The role of antisense RNA in gene regulation (1986) Annu. Rev. Biochem., 55, pp. 569-597; Inouye, Antisense RNA: its functions and application in gene regulation — a review (1988) Gene, 72, pp. 25-34; Kang, Lemaire, Unterbeck, Salbaum, Masters, Grzeschik, Multhaup, Müller-Hill, The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor (1987) Nature, 325, pp. 733-736; Katsuki, Sato, Kimura, Yokoyama, Kobayashi, Nomura, Conversion of normal behavior to shiverer by myelin basic protein antisense cDNA in transgenic mice (1988) Science, 241, pp. 593-595; Kitaguchi, Takahashi, Tokushima, Shiojiri, Ho, Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity (1988) Nature, 331, pp. 530-532; Knauer, Thompson, Cunningham, Protease nexins: cell-secreted proteins that mediate the binding, internalization, and degradation of regulatory serine proteases (1983) J. Cell. Physiol., 117, pp. 385-396; Laemmli, Cleavage of structural proteins during the assembly of the head of bacteriophage T4 (1970) Nature, 227, pp. 680-685; Lowry, Rosebrough, Farr, Randall, Protein measurement with the Folin phenol reagent (1951) J. Biol. Chem., 193, pp. 265-275; Okamoto, Freundlich, Mechanism for the autogenous control of the crp operon: transcriptional inhibition by a complementary RNA transcript (1986) Proc. Natl. Acad. Sci. USA, 83, pp. 5000-5004; Okano, Ikenaka, Mikoshiba, Recombination within the upstream gene of duplicated myelin basic protein genes of myelin deficient shimld mouse results in the production of antisense RNA (1988) EMBO J., 7, pp. 3407-3412; Palmert, Golde, Cohen, Kovacs, Tanzi, Gusella, Usiak, Younkin, Amyloid protein precursor messenger RNAs: differential expression in Alzheimer's disease (1988) Science, 241, pp. 1080-1084; Ponte, Gonzalez-DeWhitt, Shilling, Miller, Hsu, Greenberg, Davis, Cordell, A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors (1988) Nature, 331, pp. 525-527; Robakis, Ramakrishna, Wolfe, Wisniewski, Molecular cloning and characterization of a cDNA encoding the cerebrovascular, and the neuritic plaque amyloid peptides (1987) Proc. Natl. Acad. Sci. USA, 84, pp. 4190-4194; Saitoh, Hansen, Dobkins, Terry, Increased Mr 60,000 protein phosphorylation is correlated with neocortical neurofibrillary tangles in Alzheimer's disease (1988) J. Neuropathol. Exp. Neurol., 47, pp. 1-8; Schubert, Schroeder, LaCorbiere, Saitoh, Cole, Amyloid β protein precursor is possibly a heparan sulfate proteoglycan core protein (1988) Science, 241, pp. 223-226; Schubert, LaCorbiere, Saitoh, Cole, Characterization of an amyloid β precursor protein that binds heparin and contains tyrosine sulfate (1989) Proc. Natl. Acad. Sci. USA, 86, pp. 2066-2069; Selkoe, Aging amyloid and Alzheimer's disease (1989) New England Journal of Medicine, 320, pp. 1484-1487; Selkoe, Podlisny, Joachim, Vickers, Lee, Fritz, Oltersdorf, β-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues (1988) Proc. Natl. Acad. Sci. USA, 85, pp. 7341-7345; Simons, Kleckner, Translational control of IS10 transposition (1983) Cell, 34, pp. 683-691; Spandidos, Wilkie, Expression of exogenous DNA in mammalian cells (1984) Transcription and Translation, A Practical Approach, pp. 1-48. , B.D. Hames, S.J. Higgens, Oxford University Press, London; Tanaka, Nakamura, Uéda, Kameyama, Shiojiri, Takahashi, Kitaguchi, Ito, Three types of amyloid protein precursor mRNA in human brain: their differential expression in Alzheimer's disease (1988) Biochem. Biophys. Res. Commun., 157, pp. 472-479; Tanzi, Gusella, Watkins, Bruns, St. George-Hyslop, Van Keuren, Patterson, Neve, Amyloid β protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus (1987) Science, 235, pp. 880-884; Tanzi, McClatchey, Lamperti, Villa-Komaroff, Gusella, Neve, Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease (1988) Nature, 331, pp. 528-530; Teichman-Weinberg, Littauer, Ginzburg, The inhibition of neurite outgrowth in PC12 cells by tubulin antisense oligodeoxyribonucleotide (1988) Gene, 72, pp. 297-307; Terry, Wisniewski, The ultrastructure of the neurofibrillary tangle and the senile plaque (1970) Alzheimer's Disease and Related Conditions, pp. 145-168. , G. Wolstenholme, M. O'Connor, Churchill, London; Uchida, Ihara, Tomonaga, Alzheimer's disease brain extract stimulates the survival of cerebral cortical neurons from neonatal rats (1988) Biochem. Biophys. Res. Commun., 150, pp. 1263-1267; Uéda, Cole, Sundsmo, Katzman, Saitoh, Decreased adhesiveness of Alzheimer fibroblast: is β-protein precursor involved? (1989) Ann. Neurol., 25, pp. 246-251; Walicke, Novel neurotrophic factors, receptors and oncogenes (1989) Annu. Rev. Neurosci., 12, pp. 103-126; Whitson, Selkoe, Cotman, Amyloid β-protein enhances the survival of hippocampal neurons in vitro (1989) Science, 243, pp. 1488-1490; Wisniewski, Terry, Reexamination of the pathogenesis of the senile plaque (1973) Progress in Neuropathology, 2, pp. 1-26. , H.M. Zimmermann, Grune & Stratton, New York","Saitoh, T.; Department of Neurosciences School of Medicine (M-024), Center for Molecular Genetics University of California at San Diego, La Jolla, CA 92093, United States",,,,,,,,00928674,,CELLB,2475254,"English","Cell",Article,Scopus,2-s2.0-0024395366
"Schubert, D., Cole, G., Saitoh, T., Oltersdorf, T.","Amyloid beta protein precursor is a mitogen",1989,"Biochemical and Biophysical Research Communications","162","1",,"83","88",,67,10.1016/0006-291X(89)91965-7,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0024318406&partnerID=40&md5=b549ea1e012474f60c672d8e99ecd03c","The Salk Institute For Biological Studies, P.O. Box 85800, San Diego, CA 92138, United States; Department of Neurosciences, M-024 University of California at San Diego, La Jolla, CA 92093, United States; Athena Neurosciences 800 F Gateway Boulevard South San Francisco, California 94080 USA","Schubert, D., The Salk Institute For Biological Studies, P.O. Box 85800, San Diego, CA 92138, United States; Cole, G., Department of Neurosciences, M-024 University of California at San Diego, La Jolla, CA 92093, United States; Saitoh, T., Department of Neurosciences, M-024 University of California at San Diego, La Jolla, CA 92093, United States; Oltersdorf, T., Athena Neurosciences 800 F Gateway Boulevard South San Francisco, California 94080 USA","The form of the secreted amyloid β-protein precursor which contains the protease inhibitor sequence is mitogenic for Swiss 3T3 cells, while the precursor molecule lacking the protease inhibitor domain is not. A ten-fold stimulation of DNA synthesis occurs at 8 × 10-9M protein. © 1989.",,"amyloid protein; proteinase; cell culture; nonhuman; precursor; priority journal; Alzheimer Disease; Amyloid; Amyloid beta-Protein Precursor; Animal; Cell Division; Cell Line; Culture Media; Fibroblasts; Growth Substances; Human; Kidney; Mice; Protease Inhibitors; Protein Precursors; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Transfection",,"proteinase, 9001-92-7; Amyloid beta-Protein Precursor; Amyloid; Culture Media; Growth Substances; Protease Inhibitors; Protein Precursors",,,,"Katzman, (1983) Banbury Report 15, , (Cold Spring Harbor, N.Y.); Glenner, (1988) Cell, 52, pp. 307-308; Kang, Lemaire, Unterbeck, Salbaum, Masters, Grezeschik, Multhaup, Muller-Hill, (1987) Nature, 325, pp. 733-736; Selkoe, Podlisny, Joachim, Vickers, Lee, Fritz, Oltersdorf, (1988) Proc. Nat'l. Acad. Sci. USA, 85, pp. 7341-7345. , 2nd Edition; Autilio-Gambetti, Moranki, Tabaton, Schaetzle, Kovacs, Perry, Greenberg, Gambetti, (1988) FEBs. Lett, 241, pp. 94-98; Schubert, LaCorbiere, Saitoh, Cole, (1989) Proc. Natl. Acad. Sci. USA, 86, pp. 2066-2069. , 2nd Edition; Weidemann, Konig, Bunke, Fisher, Salbaum, Masters, Beyreuther, (1989) Cell, 57, pp. 115-126; Schubert, Schroeder, LaCorbiere, Saitoh, Cole, Amyloid beta protein precursor is possibly a heparan sulfate proteoglycan core protein (1988) Science, 241, pp. 223-226; Tanzi, McClatchey, Lampert, Villa-Komaroff, Gusella, Neve, (1988) Nature, 331, pp. 528-530; Ponte, Gonzalez-DeWhitt, Schilling, Miller, Hon, Greenberg, Davis, Cordell, (1988) Nature, 331, pp. 525-528; Kitaguchi, Takahashi, Tokushima, Shiojiri, Ito, (1988) Nature, 331, pp. 530-532; McKeehan, Sakagami, Hoshi, McKeehan, (1986) J. Biol. Chem, 261, pp. 5378-5383; Ueda, Cole, Sundsmo, Katzman, Saitoh, (1989) Ann. Neurol, 25, pp. 246-251; Bernard, Oltersdorf, Seedorf, (1987) EMBO J, 6, pp. 133-138; Baird, Schubert, Ling, Guillemin, (1988) Proc. Natl. Acad. Sci. USA, 85, pp. 2324-2328. , 2nd Edition; Pollack, Rifkin, (1975) Cell, 8, pp. 495-506","Schubert, D.; The Salk Institute For Biological Studies, P.O. Box 85800, San Diego, CA 92138, United States",,,,,,,,0006291X,,BBRCA,2502115,"English","Biochem. Biophys. Res. Commun.",Article,Scopus,2-s2.0-0024318406
"Schubert, D., LaCorbiere, M., Saitoh, T., Cole, G.","Characterization of an amyloid β precursor protein that binds heparin and contains tyrosine sulfate",1989,"Proceedings of the National Academy of Sciences of the United States of America","86","6",,"2066","2069",,123,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0024560146&partnerID=40&md5=d35162a71485cf48b04899acb0ec69e3","Salk Institute for Biological Studies, San Diego, CA 92138, United States","Schubert, D., Salk Institute for Biological Studies, San Diego, CA 92138, United States; LaCorbiere, M., Salk Institute for Biological Studies, San Diego, CA 92138, United States; Saitoh, T., Salk Institute for Biological Studies, San Diego, CA 92138, United States; Cole, G., Salk Institute for Biological Studies, San Diego, CA 92138, United States","A secreted form of the amyloid β protein precursor was isolated from the growth conditioned medium of the PC12 sympathetic nerve-like cell line. This protein is recognized by an antiserum that detects a protein of 140 kDa and a less abundant species of 115 kDa on NaDodSO4/acrylamide gels. The amyloid precursor proteins contain O-linked sugars and tyrosine sulfate and bind to the glycosaminoglycan heparin. These results suggest a role for extracellular sulfated glycoproteins in the pathogenesis of Alzheimer disease.",,"amyloid; heparan sulfate; heparin; protein precursor; alzheimer disease; cell culture; pheochromocytoma cell; priority journal; Adrenal Gland Neoplasms; Alzheimer Disease; Amyloid; Amyloid beta-Protein Precursor; Animal; Blotting, Western; Carbohydrates; Electrophoresis, Polyacrylamide Gel; Heparin; Immunoassay; Molecular Weight; Peptide Fragments; Pheochromocytoma; Protease Inhibitors; Protein Precursors; Rats; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Tumor Cells, Cultured; Tyrosine",,"amyloid, 11061-24-8; heparan sulfate, 9050-30-0; heparin, 37187-54-5, 8057-48-5, 8065-01-8, 9005-48-5; Amyloid beta-Protein Precursor; Amyloid; Carbohydrates; Heparin, 9005-49-6; Peptide Fragments; Protease Inhibitors; Protein Precursors; tyrosine O-sulfate, 956-46-7; Tyrosine, 55520-40-6",,,,,,,,,,,,,00278424,,PNASA,2494659,"English","PROC. NATL. ACAD. SCI. U. S. A.",Article,Scopus,2-s2.0-0024560146
"Schubert, D., Jin, L.-W., Saitoh, T., Cole, G.","The regulation of amyloid β protein precursor secretion and its modulatory role in cell adhesion",1989,"Neuron","3","6",,"689","694",,250,10.1016/0896-6273(89)90237-7,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0024810385&partnerID=40&md5=54e1ff0e8467f723826cda5b00f3a835","The Salk Institute For Biological Studies San Diego, CA 92138, United States; Department of Neurosciences University of California, San Diego La Jolla, CA 92093, United States","Schubert, D., The Salk Institute For Biological Studies San Diego, CA 92138, United States; Jin, L.-W., Department of Neurosciences University of California, San Diego La Jolla, CA 92093, United States; Saitoh, T., Department of Neurosciences University of California, San Diego La Jolla, CA 92093, United States; Cole, G., Department of Neurosciences University of California, San Diego La Jolla, CA 92093, United States","The regulation and function of two forms of the amyloid β protein precursor (ABPP) that are released into the growth-conditioned medium of the PC12 nerve cell line were examined. Nerve growth factor increases the release of the form of ABPP without the proteaseinhibitor domain relative to the protein containing the protease inhibitor and increases the overall rate of ABPP secretion 2-fold. In contrast, fibroblast growth factor increases the rate of ABPP secretion approximately 7-fold. Both forms of the secreted ABPP molecule are, in turn, able to stimulate adhesion of PC12 cells to substrata to which they are adsorbed about 10-fold more efficiently on a molar basis than laminin. © 1989.",,"amyloid; Amyloid beta Protein Precursor; amyloid precursor protein; fibroblast growth factor; nerve growth factor; protein precursor; proteinase inhibitor; animal; article; cell adhesion; cell line; drug effect; molecular weight; nerve cell; physiology; Amyloid; Amyloid beta-Protein Precursor; Animal; Cell Adhesion; Cell Line; Fibroblast Growth Factors; Molecular Weight; Nerve Growth Factors; Neurons; Protease Inhibitors; Protein Precursors; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.",,"Amyloid beta-Protein Precursor; Amyloid; Fibroblast Growth Factors, 62031-54-3; Nerve Growth Factors; Protease Inhibitors; Protein Precursors",,,,"Anderson, Buam, Geteland, Processing of adenovirus 2 proteins (1973) J. Virol., 12, pp. 241-248; Autilio-Gambetti, Moranki, Tabaton, Schaetzle, Kovacs, Perry, Greenberg, Gambetti, The amyloid precursor proteins of Alzheimer disease is expressed as a 130 kd polypeptide in various cultured cell types (1988) FEBS Lett., 241, pp. 94-98; Baird, Bohlen, (1989) Fibroblast growth factors in Peptide Growth Factors and Their Receptors, , Springer-Verlag, Heidelberg, in press; Bernard, Oltersdorf, Seedorf, Expression of the human papillomavirus type 18 E7 gene by a cassette vector system for the transcription and translation of open reading frames in eukaryotic cells (1987) EMBO J., 6, pp. 133-138; Bixby, Lilien, Reichardt, Identification of the major proteins that promote neuronal process outgrowth on Schwann cells in vivo (1988) J. Cell Biol., 107, pp. 353-361; Giaccone, Taglivini, Linoli, Bouras, Frigerio, Frangione, Bugiani, Down patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques (1989) Neurosci. Lett., 97, pp. 232-238; Glenner, Wong, Alzheimer's disease and Down's syndrome: sharing a unique cerebrovascular amyloid fibril protein (1984) Biochem. Biophys. Res. Commun., 222, pp. 1131-1136; Goldgaber, Lerman, McBride, Saffiotti, Gajdusek, Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease (1987) Science, 235, pp. 877-880; Kang, Lemaire, Unterbeck, Salbaum, Masters, Grezeschik, Multhaup, MullerHill, The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor (1987) Nature, 325, pp. 733-736; Kitaguchi, Takahashi, Tokushima, Shiojiri, Ito, Novel precursor of Alzheimer's disease amyloid shows protease inhibitory activity (1988) Nature, 331, pp. 530-532; Kjellen, Pettersson, Hook, Cell surface heparan sulfate: an intercalated membrane proteoglycan (1981) Proc. Natl. Acad. Sci. USA, 78, pp. 5371-5375; Masters, Simms, Weinman, Multhaup, McDonald, Beyreuther, Amyloid plaque core protein in Alzheimer disease and Down syndrome (1985) Proc. Natl. Acad. Sci. USA, 82, pp. 4245-4249; Oltersdorf, Fritz, Shenk, Lieberburg, JohnsonWood, Beattie, Ward, Sinha, The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II (1989) Nature, 341, pp. 144-147; Ponte, Gonzalez-DeWhitt, Schilling, Miller, Hon, Greenberg, Davis, Cordell, A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors (1988) Nature, 331, pp. 525-528; Probst, Brunnschweiler, Lauten-Schlager, Ulrich, A special type of senile plaque possibly an initial stage (1987) Acta Neuropathol., 74, pp. 133-141; Robakis, Ramakrishna, Wolfe, Wisniewski, Molecular cloning and characterization of a cDNA encoding the cerebrovascular and neuritic plaque amyloid peptides (1987) Proc. Natl. Acad. Sci. USA, 84, pp. 4190-4194; Schubert, Early events after the interaction of NGF with sympathetic nerve cells (1979) Trends Neurosci., 2, pp. 17-20; Schubert, Ling, Baird, Multiple influences of a heparin-binding growth factor on neuronal development (1987) J. Cell Biol., 104, pp. 635-643; Schubert, Schroeder, La Corbiere, Saitoh, Cole, Amyloid β protein precursor is possibly a heparan sulfate proteoglycan core protein (1988) Science, 241, pp. 223-226; Schubert, LaCorbiere, Saitoh, Cole, Characterization of an amyloid β protein precursor that binds heparin and contains tyrosine sulfate (1989) Proc. Natl. Acad. Sci. USA, 86, pp. 2066-2069; Schubert, Cole, Saitoh, Oltersdorf, Amyloid beta protein precursor is a mitogen (1989) Biochem. Biophys. Res. Commun., 162, pp. 83-88; Selkoe, Podlisny, Joachim, Vickers, Lee, Fritz, Oltersdorf, β-Amyloid precursor protein occur as 110 to 135 kilodalton membrane-associated proteins in neural and nonneuronal tissues (1988) Proc. Natl. Acad. Sci. USA, 85, pp. 7341-7345; Shivers, Hilbich, Multhaup, Salbaum, Beyreuther, Seeburg, Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact (1988) EMBO J., 7, pp. 1365-1370; Tagliavini, Giaccone, Frangione, Bugiani, Preamyloid deposits in the cerebral cortex of patients with Alzheimer's disease and nondemented individuals (1988) Neurosci. Lett., 93, pp. 191-196; Tanzi, Gusella, Watkins, Bruns, St, Hyslop, van Keuren, Neve, Amyloid β protein gene: cDNA mRNA distribution and genetic linkage near the Alzheimer locus (1987) Science, 235, pp. 880-884; Tanzi, McClatchey, Lampert, Villa-Komaroff, Gusella, Neve, Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease (1988) Nature, 331, pp. 528-530; Togari, Dickens, Ku-zyua, Guroff, The effect of fibroblast growth factor on PC12 cells (1985) J. Neurosci., 5, pp. 307-316; Tomaselli, Damsky, Reichardt, Interactions of a neuronal cell line (PC12) with laminin collagen IV and fibronectin: identification of integrin-related glycoproteins involved in attachment and process outgrowth (1987) J. Cell Biol., 105, pp. 2347-2358; Ueda, Cole, Sundsmo, Katzman, Saitoh, Decreased adhesiveness of Alzheimer's disease fibroblasts: is amyloid β-protein precursor involved? (1989) Ann. Neurol., 25, pp. 246-251; Wion, LeBert, Bracket, mRNAs of β amyloid precursor protein and prion protein are regulated by NGF in PC12 cells (1988) Int. J. Dev. Neurosci., 6, pp. 387-393; Weidemann, König, Bunke, Fischer, Salbaum, Masters, Beyreuther, Identification biogenesis and localization of precursors of Alzheimer's disease A4 amyloid protein (1989) Cell, 57, pp. 115-126","Schubert, D.; The Salk Institute For Biological Studies San Diego, CA 92138, United States",,,,,,,,08966273,,NERNE,2518372,"English","Neuron",Article,Scopus,2-s2.0-0024810385
"Schubert, D.","The biological roles of heparan sulfate proteoglycans in the nervous system",1989,"Neurobiology of Aging","10","5",,"504","506",,2,10.1016/0197-4580(89)90112-7,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0024404460&partnerID=40&md5=58c147983eeca3c0cf01a4f9e9e044b5","The Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92138-9216, United States","Schubert, D., The Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92138-9216, United States","The multiple species of HSPGs within the nervous system have a variety of functions. These include roles in ECM assembly and a contribution from synaptic vesicles to synaptic cleft matrix. Since the Alzheimer β-protein precursor is structurally very similar to a HSPG, it is most certainly an ECM-associated protein. An outstanding question then is what role ECM plays in the genesis of Alzheimer's plaques. © 1989.",,"heparan sulfate; proteoglycan; alzheimer disease; human; nervous system; short survey; Glycosaminoglycans; Heparitin Sulfate; Human; Nervous System; Proteoglycans",,"heparan sulfate, 9050-30-0; Glycosaminoglycans; Heparitin Sulfate, 9050-30-0; Proteoglycans",,,,"Baird, Bohlen, Fibroblast growth factors (1989) Peptide growth factors and their receptors, , M.B. Sporn, A. Robert, Springer-Verlag, New York, in press; Berman, Gray, Chen, Keyser, Ehrlich, Karten, LaCorbiere, Schubert, Sequence analysis, cellular localization, and expression of a neuroretina adhesion and cell survival molecule (1987) Cell, 51, pp. 135-142; Cole, Glaser, A heparin-binding domain from N-CAM is involved in neural cell-substratum adhesion (1986) J. Cell Biol., 102, pp. 403-412; Desmond, Levy, Anatomy of associative long-term synaptic modification (1988) Long-term potentiation: From biophysics to behavior, pp. 265-305. , Alan R. Liss, Inc, New York; Gray, Synapse morphology (1987) Encyclopedia of neuroscience, pp. 1158-1162. , G. Adelman, Birkhauser, Boston; Kelly, The cell biology of the nerve terminal (1988) Neuron, 1, pp. 431-438; MacCallum, Lillie, Scaletta, Occhino, Frederick, Ledbetter, Bovine corneal endothelium in vitro (1982) Elaboration and organization of a basement membrane, 139, pp. 1-13. , Exp. Cell Res; Mjaatvedt, Markwald, Induction of an epithelialmesenchymal transition by an in vivo adheron-like complex (1989) J. Cell Biol., , in press; Ross, Cossu, Herlyn, Bell, Steplewski, Koprowski, Isolation and chemical characterization of a melanoma-associated proteoglycan antigen (1983) Arch. Biochem. Biophys., 225, pp. 370-383; Schubert, LaCorbiere, Klier, Birdwell, The structure and function of myoblast adherons (1983) Cold Spring Harbor Symp. Quant. Biol., 48, pp. 539-549; Schubert, Schroeder, LaCorbiere, Saitoh, Cole, The Alzheimer's β-protein precursor is possibly a heparan sulfate proteoglycan core protein (1988) Science, 241, pp. 223-226; Schubert, LaCorbiere, Saitoh, Cole, Characterization of an amyloid β-protein precursor that binds heparin and contains tyrosine sulfate (1989) Proc. Natl. Acad. Sci. USA, 86, pp. 2066-2069","Schubert, D.; The Salk Institute for Biological Studies, P.O. Box 85800, San Diego, CA 92138-9216, United States",,,,,,,,01974580,,NEAGD,2530462,"English","Neurobiol. Aging",Article,Scopus,2-s2.0-0024404460
"Baird, A., Schubert, D., Ling, N., Guillemin, R.","Receptor- and heparin-binding domains of basic fibroblast growth factor",1988,"Proceedings of the National Academy of Sciences of the United States of America","85","7",,"2324","2328",,161,10.1073/pnas.85.7.2324,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0024121553&partnerID=40&md5=f5cbbf3dd1a45b26957c0204944f5df1","Laboratories for Neuroendocrinology, Salk Institute, 10010 North Torrey Pines Road, La Jolla, CA 92037, United States","Baird, A., Laboratories for Neuroendocrinology, Salk Institute, 10010 North Torrey Pines Road, La Jolla, CA 92037, United States; Schubert, D., Laboratories for Neuroendocrinology, Salk Institute, 10010 North Torrey Pines Road, La Jolla, CA 92037, United States; Ling, N., Laboratories for Neuroendocrinology, Salk Institute, 10010 North Torrey Pines Road, La Jolla, CA 92037, United States; Guillemin, R., Laboratories for Neuroendocrinology, Salk Institute, 10010 North Torrey Pines Road, La Jolla, CA 92037, United States","Two functional domains in the primary structure of basic fibroblast growth factor (FGF) have been identified on the basis of their ability to interact with the FGF receptor, bind radiolabeled heparin, and modulate the cellular response to FGF. Peptides derived from these two functional domains can act as partial agonists and antagonists in biological assays of FGF activity. Peptides related to the sequences of FGF-(24-68)-NH 2 and FGF-(106-115)-NH 2 inhibit thymidine incorporation into 3T3 fibroblasts when they are stimulated by FGF but have no effect when the cells are treated with either platelet-derived growth factor or epidermal growth factor. They also possess partial agonist activity and can stimulate DNA synthesis when tested in the absence of exogenous FGF. The active peptides have no effect on the binding of epidermal growth factor to its receptor on A431 cells and they can modulate the effects of FGF, but not fibronectin, on endothelial cell adhesion. The results suggest the possibility of designing specific analogs of FGF that are capable of inhibiting the biological effects of FGF.","adhesion; angiogenesis; endothelial cell; growth inhibition","basic fibroblast growth factor; drug analog; epidermal growth factor; fibroblast growth factor; fibroblast growth factor receptor; fibronectin; platelet derived growth factor; radioisotope; animal cell; article; cell adhesion; controlled study; drug antagonism; endothelium cell; fibroblast culture; nonhuman; priority journal; receptor binding; Amino Acid Sequence; Animal; Cell Adhesion; Cell Line; Endothelium, Vascular; Epidermal Growth Factor; Fibroblast Growth Factors; Fibroblasts; Fibronectins; Heparin; Mice; Molecular Sequence Data; Peptide Fragments; Platelet-Derived Growth Factor; Receptors, Cell Surface; Receptors, Fibroblast Growth Factor; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Animalia",,"Epidermal Growth Factor, 62229-50-9; Fibroblast Growth Factors, 62031-54-3; Fibronectins; Heparin, 9005-49-6; Peptide Fragments; Platelet-Derived Growth Factor; Receptors, Cell Surface; Receptors, Fibroblast Growth Factor",,,,,"Baird, A.; Laboratories for Neuroendocrinology, Salk Institute, 10010 North Torrey Pines Road, La Jolla, CA 92037, United States",,,,,,,,00278424,,PNASA,2832850,"English","PROC. NATL. ACAD. SCI. U. S. A.",Article,Scopus,2-s2.0-0024121553
"Le Beau, J.M., LaCorbiere, M., Powell, H.C., Ellisman, M.H., Schubert, D.","Extracellular fluid conditioned during peripheral nerve regeneration stimulates Schwann cell adhesion, migration and proliferation",1988,"Brain Research","459","1",,"93","104",,34,10.1016/0006-8993(88)90289-2,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0023715984&partnerID=40&md5=e82380216f2151681f40ea3dc7a9692b","Department of Neurosciences, University of California, San Diego, La Jolla, CA 92093, United States; The Veteran's Administration Medical Center San Diego, Department of Pathology, University of California, San Diego, La Jolla, CA 92093, United States; The Salk Institute, San Diego, CA 92138, United States","Le Beau, J.M., Department of Neurosciences, University of California, San Diego, La Jolla, CA 92093, United States; LaCorbiere, M., The Salk Institute, San Diego, CA 92138, United States; Powell, H.C., The Veteran's Administration Medical Center San Diego, Department of Pathology, University of California, San Diego, La Jolla, CA 92093, United States; Ellisman, M.H., Department of Neurosciences, University of California, San Diego, La Jolla, CA 92093, United States; Schubert, D., The Salk Institute, San Diego, CA 92138, United States","Schwann cell movement and proliferation occur during peripheral nerve regeneration and remyelination. We asked whether soluble factors promoting these activities were present in fluid surrounding rat sciatic nerves regenerating across a 10-mm gap bridged by a silicone tube. In this model, regenerated and remyelinated axons extend across the gap by 28 days following nerve transection and tube implantation. Fluid conditioned by cells participating in nerve regeneration (RCF) was assayed for its ability to promote Schwann cell adhesion, migration and proliferation in vitro. RCFs collected at post-transectional days 1-28 were equally effective in promoting Schwann cell-substratum adhesion. In contrast, the motility-promoting activity of RCF was minimal at 1-2 days following nerve-transection, peaked at 7 days and remained elevated through 21 days. The RCF peak response was 87-fold greater than control. Schwann cell proliferative activity of RCF exhibited peaks of activity at 1 and 14 days post-transection. The biological potency of this fluid for each activity assayed in vitro correlated well with the behavior of Schwann cells chronicled during nerve repair in vivo. These findings suggest that soluble factors promoting Schwann cell adhesion, migration, and proliferation accumulate extracellularly during peripheral nerve regeneration and remyelination. © 1988.","Adhesion; Growth; Migration; Peripheral nerve; Regeneration; Schwann cell factor","animal cell; animal experiment; nerve regeneration; nonhuman; priority journal; rat; schwann cell; sciatic nerve; Animal; Cell Adhesion; Cell Division; Cell Movement; Cells, Cultured; Culture Media; Extracellular Space; Female; Myelin Sheath; Nerve Growth Factors; Peripheral Nerves; Rats; Rats, Inbred Strains; Schwann Cells; Sciatic Nerve; Support, Non-U.S. Gov't; Support, U.S. Gov't, Non-P.H.S.; Support, U.S. Gov't, P.H.S.",,"Culture Media; Nerve Growth Factors",,,,"Abercrombie, Johnson, A quantitative histology of Wallerian degeneration: nuclear population in rabbit sciatic nerve (1946) J. Anat., 80, pp. 37-50; Baron-Van, Kleinman, Seppa, Rentier, Dubois-Dalcq, Fibronectin promotes rat Schwann cell growth and motility (1982) J. Cell Biol., 93, pp. 211-216; Beuche, Friede, The role of non-resident cells in Wallerian degeneration (1984) J. Neurocytol., 13, pp. 767-796; Bradley, Asbury, Duration of synthesis phase in neurilemma cells in the mouse sciatic nerve during degeneration (1970) Exp. Neurol., 26, pp. 275-282; Brockes, Fields, Raff, Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve (1979) Brain Research, 165, pp. 105-118; Brockes, Lemke, The neuron as a source of mitogen (1981) Development of the Nervous System, pp. 309-327. , D.R. Garrod, J.D. Feldman, Cambridge University Press, Cambridge; Brockes, Kintner, Glial growth factor and nerve-dependent proliferation in the regeneration blastema of urodele amphibians (1986) Cell, 45, pp. 301-306; Bunge, Bunge, Evidence that contact with connective tissue matrix is required for normal interaction between Schwann cells and nerve fibers (1978) J. Cell Biol., 78, pp. 943-950; Bunge, Bunge, Interrelationship between Schwann cell function and extracellular matrix production (1983) TINS, 6, pp. 499-505; Carter, Haptotaxis and the mechanisms of cell motility (1967) Nature (Lond.), 213, pp. 256-261; Cole, Glaser, Cell-substratum adhesion in embryonic chick central nervous system is mediated by a 170,000 mol. wt. neural-specific polypeptide (1984) J. Cell Biol., 99, pp. 1605-1612; Cole, Schubert, Glaser, Cell-substratum adhesion in chick neural retina depends upon protein-heparin sulfate interactions (1985) J. Cell Biol., 100, pp. 1192-1199; Cornbrooks, Carey, McDonald, Timpl, Bunge, In vivo and in vitro observations on laminin production by Schwann cells (1983) Proc. Natl. Acad. Sci. U.S.A., 80, pp. 3850-3854; Cravioto, The role of Schwann cells in the development of human peripheral nerves. An electron microscopic study (1965) J. Ultrastruct. Res., 12, pp. 634-651; Engvall, Ruoslahti, Binding of a soluble form of fibroblast surface protein, fibronectin, to collagen (1977) Int. J. Cancer, 20, pp. 1-5; Folkman, Moscona, Role of cell shape in growth control (1978) Nature (Lond.), 273, pp. 345-349; Friede, Samorajski, Myelin formation in the sciatic nerve of rat. A quantitative electron microscopic, histochemical, and radioautographic study (1968) J. Neuropathol. Exp. Neurol., 27, pp. 546-570; Gottlieb, Glaser, A novel assay of neuronal cell adhesion (1975) Biochem. Biophys. Res. Commun., 63, pp. 815-821; Grinnell, Fibronectin and wound healing (1984) J. Cell. Biochem., 26, pp. 107-116; Hall, Gregson, The effects of mitomycin C on the process of regeneration in the mammalian peripheral nervous system (1977) Neuropathol. Appl. Neurobiol., 3, pp. 65-78; Hall, Regeneration in cellular and acellular autografts in the peripheral nervous system (1986) Neuropathol. Appl. Neurobiol., 12, pp. 27-46; Heumann, Korsching, Bantlow, Thoenen, Changes in nerve growth factor synthesis in non-neuronal cells in response to sciatic nerve transection (1987) J. Cell Biol., 104, pp. 1623-1631; Keppel, (1973) Design and Analysis: A Researcher's Handbook, pp. 147-149. , Prentice Hall, Englewood Cliffs, NJ; Kjellen, Petterson, Hook, Cell-surface heparin sulfate: an intercalated membrane proteoglycan (1981) Proc. Natl. Acad. Sci. U.S.A., 78, pp. 5371-5375; Laemmli, Cleavage of structural proteins during the assembly of the head of the bacteriophage T4 (1970) Nature (Lond.), 227, pp. 680-682; Le Beau, Powell, Ellisman, Node of Ranvier formation along fibres regenerating through silicone tube implants: a freeze-fracture and thin-section electron microscopic study (1987) J. Neurocytol., 16, pp. 347-358; Le Beau, J.M., Ellisman, M.H. and Powell, H.C., Ultrastructural and morphometric analysis of long-term peripheral nerve regeneration through silicone tubes,J. Neurocytol., in pressLemke, Brockes, Glial growth factor: a mitogenic polypeptide of the brain and pituitary (1983) Fed. Proc., 42, pp. 2627-2629; Lemke, Brockes, Identification and purification of glial growth factor (1984) J. Neurosci., 4, pp. 75-83; Lisak, Sobue, Kuchmy, Burns, Pleasure, Products of activated lymphocytes stimulate Schwann cell mitosis in vitro (1985) Neurosci. Lett., 57, pp. 105-111; Longo, Hayman, Ruoslahti, Engvall, Manthorpe, Varon, Neurite-promoting factors and extracellular matrix components accumulating in vivo within nerve regeneration chambers (1984) Brain Research, 309, pp. 105-117; Love, An experimental study of peripheral nerve regeneration after X-irradiation (1983) Brain, 106, pp. 39-54; Lowry, Rosebrough, Farr, Randall, Protein measurement with the Folin phenol reagent (1951) J. Biol. Chem., 193, pp. 265-275; Lubinska, Sedentary and migratory states of Schwann cells (1961) Experimental Cell Research, 8, pp. 74-90; Lundborg, Gelberman, Longo, Powell, Varon, In vivo regeneration of cut nerves encased in silicone tubes: growth across a six-millimeter gap (1982) J. Neuropathol. Exp. Neurol., 4, pp. 412-422; McCarthy, Palm, Furcht, Migration by haptotaxis of a Schwann cell tumor line to the basement membrane glycoprotein laminin (1983) J. Cell Biol., 97, pp. 772-777; McGarvey, Baron-Van, Klienman, Dubois-Dalcq, Synthesis and effects of basement membrane components in cultured rat Schwann cells (1984) Dev. Biol., 105, pp. 18-28; Millis, Hoyle, Fibroblast-conditioned medium contains cell surface proteins required for cell attachement and spreading (1978) Nature (Lond.), 271, pp. 668-670; Moore, Cell to substratum adhesion-promoting activity released by normal and virus-transformed cells in culture (1976) J. Cell Biol., 70, pp. 634-642; Ohnishi, Dyck, Retardation of Schwann cell division and axonal regeneration following nerve crush in experimental lead neuropathy (1981) Ann. Neurol., 10, pp. 469-477; Palm, Furcht, Production of laminin and fibronectin by Schwanomma cells: cell-protein interactions in vitro and protein localization in peripheral nerve in vivo (1983) J. Cell Biol., 96, pp. 1218-1226; Pellegrino, Spencer, Schwann cell mitosis in response to regenerating peripheral axons in vivo (1985) Brain Research, 341, pp. 16-25; Pellegrino, Politis, Ritchie, Spencer, Events in degenerating cat peripheral nerve: induction of Schwann cell S phase and its relation to nerve fibre degeneration (1986) J. Neurocytol., 15, pp. 17-28; Peters, Muir, The relationship between axons and Schwann cells during development of peripheral nerves in the rat (1959) Q.J. Exp. Physiol., 44, pp. 117-130; Raff, Abney, Brockes, Hornby-Smith, Schwann cell growth factors (1978) Cell, 15, pp. 813-822; Ratner, Bunge, Glaser, A neuronal cell-surface heparin sulfate proteoglycan is required for dorsal root ganglion neuron stimulation of Schwann cell proliferation (1985) J. Cell Biol., 101, pp. 744-754; Rexed, U¨ber die Aktivita¨t der Schwannschen Zellen bei der Nervenregeneration. I. Dieu¨berbru¨cking neuritloser Nervenlu¨cken (1942) Z. Microskop. Anat. Forsch., 51, pp. 177-205; Salzer, Bunge, Studies on Schwann cell proliferation. I. An analysis in tissue cultures of proliferation during development, Wallerian degeneration, and direct injury (1980) J. Cell Biol., 84, pp. 739-752; Salzer, Williams, Glaser, Bunge, Studies on Schwann cell proliferation. II. Characterization of the stimulation and specificity of the response to a neurite membrane fraction (1980) J. Cell Biol., 84, pp. 753-766; Salzer, Bunge, Glaser, Studies on Schwann cell proliferation. III. Evidence for the surface localization of the neurite mitogen (1980) J. Cell Biol., 84, pp. 767-778; Scaravilli, Love, Myers, X-irradiation impairs regeneration of peripheral nerve across a gap (1986) J. Neurocytol., 15, pp. 439-449; Schubert, LaCorbiere, A role of glycosaminoglycans in cell-substratum adhesion (1980) J. Biol. Chem., 255, pp. 11564-11571; Schubert, LaCorbiere, Role of a 16S glycoprotein complex in cellular adhesion (1980) Proc. Natl. Acad. Sci. U.S.A., 77, pp. 4137-4141; Spencer, Politis, Pellegrino, Weinberg, Control of Schwann cell behavior during nerve degeneration and regeneration (1981) Posttraumatic Peripheral Nerve Regeneration: Experimental Basis and Clinical Implications, pp. 411-426. , A. Gorio, H. Millesi, S. Mingrino, Raven, New York; Taniuchi, Clark, Johnson, Induction of nerve growth factor receptor in Schwann cells after axotomy (1986) Proc. Natl. Acad. Sci. U.S.A., 83, pp. 4094-4098; Webster, Martin, O'Connell, The relationships between interphase Schwann cells and axons before myelination: a quantitative electron microscopic study (1973) Dev. Biol., 32, pp. 401-416; Williams, Longo, Powell, Lundborg, Varon, Spatial-temporal progress of peripheral nerve regeneration within a silicone chamber: parameters for a bioassay (1983) J. Comp. Neurol., 218, pp. 460-470; Windebank, Poduslo, Neuronal growth factors produced by adult peripheral nerve after injury (1986) Brain Research, 385, pp. 197-200; Wood, Bunge, Evidence that sensory axons are mitogenic for Schwann cells (1975) Nature (Lond.), 256, pp. 662-664; Yamada, Cell surface interactions with extracellular materials (1983) Annu. Rev. Biochem., 52, pp. 761-799","Le Beau, J.M.; Department of Neurosciences, University of California, San Diego, La Jolla, CA 92093, United States",,,,,,,,00068993,,BRREA,3167584,"English","Brain Res.",Article,Scopus,2-s2.0-0023715984
"Schubert, D., Schroeder, R., LaCorbiere, M., Saitoh, T., Cole, G.","Amyloid β protein precursor is possibly a heparan sulfate proteoglycan core protein",1988,"Science","241","4862",,"223","226",,108,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0023711257&partnerID=40&md5=b74e377b9d3c88c54b8af77dab09039d","Salk Institute for Biological Studies, San Diego, CA 92138, United States","Schubert, D., Salk Institute for Biological Studies, San Diego, CA 92138, United States; Schroeder, R., Salk Institute for Biological Studies, San Diego, CA 92138, United States; LaCorbiere, M., Salk Institute for Biological Studies, San Diego, CA 92138, United States; Saitoh, T., Salk Institute for Biological Studies, San Diego, CA 92138, United States; Cole, G., Salk Institute for Biological Studies, San Diego, CA 92138, United States","The amyloid β protein peptide is a major constituent of amyloid plaque cores in Alzheimer's disease and is apparently derived from a higher molecular weight precursor. It is now shown taht the core protein of a heparan sulfate proteoglycan secreted from a nerve cell line (PC12) has an amino acid sequence and a size very similar to those of the amyloid β protein precursor and that these molecules are antigenically related. This amyloid β protein precursor-related protein is not found in the conditioned medium of a variant cell line (F3 PC12) that does not secrete heparan sulfate proteoglycan. The synaptic localization and metabolism of this class of proteoglycans are consistent with its potential involvement in central nervous system dysfunction.",,"amyloid protein; proteoheparan sulfate; alzheimer disease; fetus; human; human cell; priority journal; Alzheimer Disease; Amino Acid Sequence; Amyloid; Amyloid beta-Protein; Animal; Cell Line; Chromatography, High Pressure Liquid; Glycosaminoglycans; Heparan Sulfate Proteoglycan; Heparitin Sulfate; Immunologic Techniques; Peptide Fragments; Proteochondroitin Sulfates; Proteoglycans; Rats; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Viral Core Proteins",,"Amyloid beta-Protein; Amyloid; Glycosaminoglycans; Heparan Sulfate Proteoglycan; Heparitin Sulfate, 9050-30-0; Peptide Fragments; Proteochondroitin Sulfates; Proteoglycans; Viral Core Proteins",,,,,,,,,,,,,00368075,,SCIEA,2968652,"English","SCIENCE",Article,Scopus,2-s2.0-0023711257
"Berman, P., Gray, P., Chen, E., Keyser, K., Ehrlich, D., Karten, H., LaCorbiere, M., Esch, F., Schubert, D.","Sequence analysis, cellular localization, and expression of a neuroretina adhesion and cell survival molecule",1987,"Cell","51","1",,"135","142",,39,10.1016/0092-8674(87)90018-3,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0023649185&partnerID=40&md5=9cedf62c2a4723005340101a226644a4","Department of Molecular Biology Genentech, Inc., 460 Point San Bruno Boulevard, South San Francisco, CA 94080, United States; Department of Neuroscience University of California, San Diego La Jolla, CA 92037, United States; The Salk Institute for Biological Studies P. O., Box 85800, San Diego, CA 92138, United States","Berman, P., Department of Molecular Biology Genentech, Inc., 460 Point San Bruno Boulevard, South San Francisco, CA 94080, United States; Gray, P., Department of Molecular Biology Genentech, Inc., 460 Point San Bruno Boulevard, South San Francisco, CA 94080, United States; Chen, E., Department of Molecular Biology Genentech, Inc., 460 Point San Bruno Boulevard, South San Francisco, CA 94080, United States; Keyser, K., Department of Neuroscience University of California, San Diego La Jolla, CA 92037, United States; Ehrlich, D., Department of Neuroscience University of California, San Diego La Jolla, CA 92037, United States; Karten, H., Department of Neuroscience University of California, San Diego La Jolla, CA 92037, United States; LaCorbiere, M., The Salk Institute for Biological Studies P. O., Box 85800, San Diego, CA 92138, United States; Esch, F., The Salk Institute for Biological Studies P. O., Box 85800, San Diego, CA 92138, United States; Schubert, D., The Salk Institute for Biological Studies P. O., Box 85800, San Diego, CA 92138, United States","A cDNA for purpurin, a secreted 20,000 dalton neural retina cell adhesion and survival protein, has been sequenced and expressed in mammalian cells. Purpurin mRNA is found in both embryonic and adult retina, but not the brain, heart, or liver. The protein is highly concentrated in the neural retina between the pigmented epithelium and the outer segments of the photoreceptor cells; it is synthesized by photoreceptor cells. The predicted purpurin sequence contains 196 residues, has approximately 50% sequence homology with serum retinol binding protein, and is a member of the α-2μ-globulin superfamily. Purpurin binds retinol and may play a major role in retinol transport across the interphotoreceptor cell matrix. © 1987.",,"1,2,4-trihydroxy-9,10-anthracenedione; DNA; lectin; peptide fragment; purpurin; recombinant DNA; recombinant protein; retinol; retinol binding protein; Retinol Binding Proteins; amino acid sequence; animal; article; biosynthesis; cell adhesion; cell line; cell survival; chick embryo; cytology; drug effect; embryology; genetic transfection; genetics; hamster; human; metabolism; molecular genetics; nucleotide sequence; pigment epithelium; retina; retina rod outer segment; sequence homology; Amino Acid Sequence; Animal; Base Sequence; Cell Adhesion; Cell Line; Cell Survival; Chick Embryo; DNA; DNA, Recombinant; Hamsters; Human; Lectins; Molecular Sequence Data; Peptide Fragments; Pigment Epithelium of Eye; Recombinant Proteins; Retina; Retinol-Binding Proteins; Rod Outer Segments; Sequence Homology, Nucleic Acid; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Transfection; Vitamin A","GENBANK: M17538","DNA, 9007-49-2; purpurin, 81-54-9; retinol, 68-26-8, 82445-97-4; 1,2,4-trihydroxy-9,10-anthracenedione, 81-54-9; DNA, 9007-49-2; DNA, Recombinant; Lectins; Peptide Fragments; Recombinant Proteins; Retinol-Binding Proteins; Vitamin A, 11103-57-4",,,,"Adler, Lindsey, Elsner, Expression of conelike properties by chick embryo neural retina cells in glial-free monolayer cultures (1984) J. Cell Biol., 99, pp. 1173-1178; Barbin, Manthrope, Varon, Purification of the chick eye ciliary neuronotrophic factor (1984) J. Neurochem., 43, pp. 1468-1478; Barde, Edgar, Thoenen, Purification of a new neurotrophic factor from mammalian brain (1982) EMBO J., 1, pp. 549-553; Benton, Davis, Screening larnbda recombinant clones by hybridization to single plaques in situ (1977) Science, 196, pp. 180-182; Berman, Bach, The acid mucopolysaccharides of cattle retina (1968) Biochem. J., 108, pp. 75-88; Berman, Simonsen, Dowbenko, Lasky, Detection of antibodies to herpes simplex virus with a continuous cell line expressing cloned glycoprotein D (1983) Science, 222, pp. 524-527; Bridges, The interphotoreceptor matrix—functions and possible role in hereditary retinal degenerations (1985) The Interphotoreceptor Matrix in Health and Disease, pp. 195-212. , Alan R. Liss, Inc, New York; Bunt-Milam, Saari, Immunocytochemical localization of two retinoid-binding proteins in vertebrate retina (1983) J. Cell Biol., 97, pp. 703-712; Chader, Retinoids in ocular tissues: binding proteins, transport, and mechanism of action (1982) Cell Biology of the Eye, pp. 377-433. , D.S. McDevitt, Academic Press, Inc, Orlando; Colantuino, Romano, Bensi, Santoro, Costanzo, Raugei, Cortese, Cloning and sequencing of a full length cDNA coding for human retinol-binding protein (1983) Nucleic Acids Research, 11, pp. 7769-7775; Cole, Glaser, Cell-substratum adhesion in embryonic chick central nervous system is mediated by a 170,000-mol-wt neural-specific polypeptide (1984) J. Cell Biol., 99, pp. 1605-1612; D'Onofrio, Colantuoni, Cortese, Structure and cell-specific expression of a cloned human retinol binding protein gene: the 5′-flanking region contains hepatoma specific transcriptional signals (1985) EMBO J., 4, pp. 1981-1989; Dowling, Chemistry of visual adaptation in the rat (1960) Nature, 188, pp. 114-118; Drayna, Fielding, McLean, Baer, Castro, Chen, Comstock, Lawn, Cloning and expression of human apolipoprotein D cDNA (1986) J. Biol. Chem., 261, pp. 16535-16539; Edelman, Cell adhesion molecules (1983) Science, 219, pp. 450-454; Esch, Polypeptide microsequence analysis with the commercially available gas-phase sequencer (1984) Anal. Biochem., 136, pp. 39-47; Hausman, Moscona, Isolation of retina-specific cell-aggregating factor from membranes of embryonic neural retina tissue (1976) Proc. Natl. Acad. Sci. USA, 73, pp. 3594-3598; Huynh, Young, Davis, Constructing and screening cDNA libraries in λgt10 and λgt11 (1985) DNA Cloning, Vol. 1, A Practical Approach, pp. 49-78. , 1RL Press, Oxford; Kozak, Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs (1984) Nucl. Acids Res., 12, pp. 857-871; Lai, Wiggert, Liu, Chader, Interphotoreceptor retinol-binding proteins: possible transport vehicles between compartments of the retina (1982) Nature, 298, pp. 848-849; Lasky, Dowbenko, Simonsen, Berman, Protection of mice from lethal herpes simplex virus infection by vaccination with a secreted form of cloned glycoprotein D (1984) Biotechnology, 2, pp. 527-532; Lasky, Croopman, Fennie, Bent, Capon, Dowbenko, Nakamura, Berman, Neutralization of the AIDS retrovirus by antibodies to a recombinant envelope of glycoprotein (1986) Science, 233, pp. 209-212; Laurent, Nilsson, Bavik, Jones, Sundelin, Peterson, Characterization of the rat retinol-binding protein gene and its comparison to the three-dimensional structure of the protein (1985) J. Biol. Chem., 260, pp. 11476-11480; Lehrach, Diamond, Wozney, Boedtker, RNA molecular weight determination by gel electrophoresis under denaturing conditions, a critical reexamination (1977) Biochemistry, 16, pp. 4743-4748; Liou, Bridges, Fong, Alvarez, Gonzalez-Fernandez, Vitamin A transport between retina and pigment epithelium—an interstitial protein carrying endogenous retinol (interstitial retinol-binding protein) (1982) Vision Res., 22, pp. 1457-1467; Liou, Fong, Beattie, Cook, Leone, Landers, Alvarez, Bridges, Bovine interstitial retinol-binding protein (IRBP)-isolation and sequence analysis of cDNA clones, characterization and in vitro translation of mRNA (1986) Vision Res., 26, pp. 1645-1653; Lopez, Grubb, Soriano, Mendez, The complete amino acids sequence of human complex-forming glycoprotein heterogeneous in charge (protein HC) (1981) Biochem. Biophys. Res. Comm., 103, pp. 919-925; Marchase, Harges, Jakoi, Ligatin from embryonic chick neural retina inhibits retinal cell adhesion (1981) Dev. Biol., 86, pp. 250-255; McGuire, Chytil, Three-step purification of retinol-binding protein from rat serum (1980) Biochim. Biophys. Acta, 621, pp. 324-331; Messing, Crea, Seeburg, A system for shotgun DNA sequencing (1981) Nucl. Acids Res., 9, pp. 309-321; Newcomer, Jones, Aqvist, Sundelin, Eriksson, Rask, Peterson, The three-dimensional structure of retinol-binding protein (1984) EMBO J., 3, pp. 1451-1454; Newcomer, Liljas, Sundelin, Rask, Peterson, Crystallization of and preliminary x-ray data for the plasma retinol-binding protein (1984) J. Biol. Chem., 259, pp. 5230-5231; Nishi, Berg, Two components from eye tissue that differentially stimulate the growth and development of ciliary ganglion neurons in cell culture (1981) J. Neurosci., 1, pp. 505-513; Pervaiz, Brew, Homology of beta-lactoglobulin, serum retinol-binding protein, and protein HC (1985) Science, 228, pp. 335-338; Sanger, Nickien, Coulson, DNA sequencing with chain-terminating inhibitors (1977) Proc. Natl. Acad. Sci. USA, 74, pp. 5463-5467; Schubert, LaCorbiere, Isolation of a cell-surface receptor for chick neural retina adherons (1985) J. Cell Biol., 100, pp. 56-63; Schubert, LaCorbiere, Isolation of an adhesionmediating protein from chick neural retina adherons (1985) J. Cell Biol., 101, pp. 1071-1077; Schubert, LaCorbiere, Role of purpurin in neural retina histogenesis (1986) Progress in Developmental Biology, Part B, pp. 3-16. , S.P. Hawks, J.L. Wang, Alan R. Liss, New York; Schubert, LaCorbiere, Esch, A chick neural retina adhesion and survival molecule is a retinol-binding protein (1986) J. Cell Biol., 102, pp. 2295-2302; Southern, Detection of specific sequences among DNA fragments separated by gel electrophoresis (1975) J. Mol. Biol., 98, pp. 503-517; Suggs, Wallace, Hirose, Kawashima, Itakura, Use of synthetic oligonucleotides as hybridization probes: isolation of cloned cDNA sequences for human beta 2-microglobulin (1981) Proc. Natl. Acad. Sci. USA, 78, pp. 6613-6616; Sundelin, Laurent, Anundi, Tragardh, Larhammer, Bjorck, Eriksson, Newcomer, Amino acid sequence homologies between rabbit, rat, and human serum retinol-binding proteins (1985) J. Biol. Chem., 260, pp. 6472-6480; Swanson, Simmons, Arriza, Hammer, Brinster, Rosenfeld, Evans, Novel developmental specificity in the nervous system of transgenic animals expressing growth hormone fusion genes (1985) Nature, 317, pp. 363-365; Takase, Ong, Chytil, Cellular retinol-binding protein allows specific interaction of retinol with the nucleus in vitro (1979) Proceedings of the National Academy of Sciences, 79, pp. 2204-2208; Urlaub, Chasin, Isolation of Chinese hamster cell mutants deficient in dihydrofolate reductase activity (1980) Proc. Natl. Acad. Sci. USA, 77, pp. 4216-4220; van Veen, Katial, Shinohara, Barrett, Wiggert, Chader, Nickerson, Retinal photoreceptor neurons and pinealocytes accumulate mRNA for interphotoreceptor retinoid-binding protein (IRBP) (1986) FEBS Lett., 208, pp. 133-138; Wood, Capon, Simonsen, Eaton, Gitschier, Keyt, Seeburg, Lawn, Expression of active human factor VIII from recombinant DNA clones (1984) Nature, 312, pp. 330-337","Berman, P.; Department of Molecular Biology Genentech, Inc., 460 Point San Bruno Boulevard, South San Francisco, CA 94080, United States",,,,,,,,00928674,,CELLB,3652208,"English","Cell",Article,Scopus,2-s2.0-0023649185
"Schubert, D., Ling, N., Baird, A.","Multiple influences of a heparin-binding growth factor on neuronal development",1987,"Journal of Cell Biology","104","3",,"635","643",,87,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0023116945&partnerID=40&md5=d96e45b0736397c87597b7f891ca1996","The Salk Institute for Biological Studies, San Diego, CA 92138 9216, United States","Schubert, D., The Salk Institute for Biological Studies, San Diego, CA 92138 9216, United States; Ling, N., The Salk Institute for Biological Studies, San Diego, CA 92138 9216, United States; Baird, A., The Salk Institute for Biological Studies, San Diego, CA 92138 9216, United States","Heparin-binding growth factor-2 (HBGF-2; also known as basic fibroblast growth factor) is mitogenic for most anchorage-dependent cells. It is shown here that HBGF-2 stimulates cell-substratum adhesion and neurite extension in the sympathetic nerve cell line PC12. When HBGF-2 is adsorbed to artificial extracellular matrices consisting of heparin or chondroitin sulfate, it causes the formation of cellular aggregates or circles of cells, respectively. HBGF-2 is also a nerve cell survival molecule, for it potentiates the survival of primary cultures of embryonic chick ciliary ganglion cells but not of embryonic neural retina cells. Finally, a series of synthetic peptides from the HBGF-2 sequence is described that selectively alter the biological effects of HBGF-2. The amphiphilic nature of one of these peptides is discussed with respect to its ability to stimulate cell adhesion.",,"basic fibroblast growth factor; chondroitin sulfate; fibroblast growth factor; heparin; heparin binding growth factor 2 derivative; heparin binding growth factor 2 i 125; radioisotope; unclassified drug; cell adhesion; cell culture; chicken; drug binding; drug comparison; drug mechanism; drug synthesis; heredity; histology; in vitro study; nerve cell differentiation; nerve fiber growth; nervous system; nonhuman; pharmacokinetics; priority journal; structure activity relation; Adrenal Gland Neoplasms; Amino Acid Sequence; Animal; Cell Adhesion; Cell Line; Fibroblast Growth Factor 2; Growth Substances; Heparin; Kinetics; Mitogens; Neurons; Peptide Fragments; Pheochromocytoma; Rats; Support, U.S. Gov't, P.H.S.",,"basic fibroblast growth factor, 106096-93-9; chondroitin sulfate, 9007-28-7, 9082-07-9; fibroblast growth factor, 62031-54-3; heparin, 37187-54-5, 8057-48-5, 8065-01-8, 9005-48-5; Fibroblast Growth Factor 2, 103107-01-3; Growth Substances; Heparin, 9005-49-6; Mitogens; Peptide Fragments",,,,,,,,,,,,,00219525,,JCLBA,3818795,"English","J. CELL BIOL.",Article,Scopus,2-s2.0-0023116945
"Schubert, D., Brass, B., Dumas, J.-P.","Protein complexity of central nervous system cell lines",1986,"Journal of Neuroscience","6","10",,"2829","2836",,10,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0022494740&partnerID=40&md5=d145ec4fae15ef90cbaf0ec8cb635ec6","The Salk Institute for Biological Studies, San Diego, CA 92138-9216, United States","Schubert, D., The Salk Institute for Biological Studies, San Diego, CA 92138-9216, United States; Brass, B., The Salk Institute for Biological Studies, San Diego, CA 92138-9216, United States; Dumas, J.-P., The Salk Institute for Biological Studies, San Diego, CA 92138-9216, United States",[No abstract available],,"animal; cell culture; central nervous system; glia cell; in vitro study; nerve cell; nervous system; nonhuman; priority journal; protein synthesis; Cell Line; Central Nervous System; Extracellular Space; Mesoderm; Nerve Tissue Proteins; Neurons; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.",,"Nerve Tissue Proteins",,,,,,,,,,,,,02706474,,JNRSD,3760937,"English","J. NEUROSCI.",Article,Scopus,2-s2.0-0022494740
"Schubert, D., LaCorbiere, M., Esch, F.","A chick neural retina adhesion and survival molecule is a retinol-binding protein",1986,"Journal of Cell Biology","102","6",,"2295","2301",,31,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0022498720&partnerID=40&md5=1e7fe3f0bdf4124e0fadafebbdf1c15a","The Salk Institute for Biological Studies, San Diego, CA 92138-9216, United States","Schubert, D., The Salk Institute for Biological Studies, San Diego, CA 92138-9216, United States; LaCorbiere, M., The Salk Institute for Biological Studies, San Diego, CA 92138-9216, United States; Esch, F., The Salk Institute for Biological Studies, San Diego, CA 92138-9216, United States","A 20,000-D protein called purpurin has recently been isolated from the growth-conditioned medium of cultured embryonic chick neural retina cells (Schubert, D., and M. La Corbiere, 1985, J. Cell Biol., 101:1071-1077). Purpurin is a constituent of adherons and promotes cell-adheron adhesion by interacting with a cell surface heparan sulfate proteoglycan. It also prolongs the survival of cultured neural retina cells. This paper shows that purpurin is a secretory protein that has sequence homology with a human protein synthesized in the liver that transport retinol in the blood, the serum retinol-binding protein (RBP). Purpurin binds [3H]Retinol, and both purpurin and chick serum RBP stimulate the adhesion of neural retina cells, although the serum protein is less active than purpurin. Purpurin and the serum RBP are, however, different molecules, for the serum protein is ~3,000 D larger than purpurin and has different silver-staining characteristics. Finally, purpurin supports the survival of dissociated ciliary ganglion cells, indicating that RBPs can act as ciliary neurotrophic factors.",,"cell adhesion molecule; purpurin; radioisotope; retinol binding protein; animal cell; chicken; nonhuman; priority journal; retina; visual system; Amino Acid Sequence; Animal; Antigens, Surface; Cell Adhesion; Cell Adhesion Molecules; Cell Survival; Chick Embryo; Ciliary Body; Human; Lectins; Peptide Fragments; Retina; Retinol-Binding Proteins; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.",,"purpurin, 81-54-9; 1,2,4-trihydroxy-9,10-anthracenedione, 81-54-9; Antigens, Surface; Cell Adhesion Molecules; Lectins; Peptide Fragments; Retinol-Binding Proteins",,,,,,,,,,,,,00219525,,JCLBA,3754874,"English","J. CELL BIOL.",Article,Scopus,2-s2.0-0022498720
"Schubert, D., LaCorbiere, M.","Role of purpurin in neural retina histogenesis.",1986,"Progress in clinical and biological research","217 B",,,"3","16",,2,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0022495991&partnerID=40&md5=989f09bd464f78634cd58725c50502da",,"Schubert, D.; LaCorbiere, M.",[No abstract available],,"antiserum; cell adhesion molecule; cell surface receptor; glycoprotein; growth promotor; heparan sulfate; heparin; membrane antigen; proteochondroitin sulfate; proteoheparan sulfate; retinol binding protein; Retinol Binding Proteins; animal; cell adhesion; cell culture; cell differentiation; chick embryo; cytology; drug effect; immunology; metabolism; molecular weight; nerve cell; physiology; retina; review; Animal; Antigens, Surface; Cell Adhesion; Cell Adhesion Molecules; Cell Differentiation; Cells, Cultured; Chick Embryo; Glycoproteins; Growth Substances; Heparan Sulfate Proteoglycan; Heparin; Heparitin Sulfate; Immune Sera; Molecular Weight; Neurons; Proteochondroitin Sulfates; Receptors, Cell Surface; Retina; Retinol-Binding Proteins; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.",,"heparan sulfate, 9050-30-0; heparin, 37187-54-5, 8057-48-5, 8065-01-8, 9005-48-5; Antigens, Surface; Cell Adhesion Molecules; Glycoproteins; Growth Substances; Heparan Sulfate Proteoglycan; Heparin, 9005-49-6; Heparitin Sulfate, 9050-30-0; Immune Sera; Proteochondroitin Sulfates; Receptors, Cell Surface; Retinol-Binding Proteins",,,,,"Schubert, D.",,,,,,,,03617742,,,3018787,"English","Prog Clin Biol Res",Review,Scopus,2-s2.0-0022495991
"Kruijer, W., Schubert, D., Verma, I.M.","Induction of the proto-oncogene fos by nerve growth factor",1985,"Proceedings of the National Academy of Sciences of the United States of America","82","21",,"7330","7334",,123,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0022347794&partnerID=40&md5=8dc6b3f714f898dcbfb5a40d1b5e189b","Salk Institute for Biological Studies, San Diego, CA 92138-9216, United States","Kruijer, W., Salk Institute for Biological Studies, San Diego, CA 92138-9216, United States; Schubert, D., Salk Institute for Biological Studies, San Diego, CA 92138-9216, United States; Verma, I.M., Salk Institute for Biological Studies, San Diego, CA 92138-9216, United States","Nerve growth factor (NGF) causes the differentiation of PC12 cells to sympathetic neuron-like cells and also induces a rapid but transient expression of fos mRNA and protein. fos mRNA transcripts can be detected 5 min after the addition of NGF, are maximally abundant after 30 min, and then their levels decrease. fos protein synthesis parallels the expression of fos mRNA, and the induced fos proteins are located in the nucleus. cAMP, epidermal growth factor, the phorbol ester phorbol 12-myristate 13-acetate, and K+ depolarization also induce the fos gene. Growth of PC12 cells in the presence of dexamethasone, which induces differentiation into chromaffin-like cells, is not accompanied by fos expression. We propose that while fos gene induction is associated with the differentiation of PC12 cells to sympathetic nerve, its enhanced expression is primarily involved in the anabolic responses induced by NGF and many growth factors.",,"cyclic amp; dexamethasone; epidermal growth factor; nerve growth factor; phorbol 13 acetate 12 myristate; radioisotope; animal cell; autonomic nervous system; cell differentiation; cell line; differentiation; endocrine system; gene activation; heredity; in vitro study; nonhuman; pheochromocytoma; priority journal; proto oncogene; rat; Animal; Bucladesine; Cell Differentiation; Cell Line; Comparative Study; Dexamethasone; Epidermal Growth Factor; Gene Expression Regulation; Neoplasm Proteins; Nerve Growth Factors; Pheochromocytoma; Potassium; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fos; Proto-Oncogenes; Rats; RNA, Messenger; RNA, Neoplasm; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Tetradecanoylphorbol Acetate",,"cyclic AMP, 60-92-4; dexamethasone, 50-02-2; epidermal growth factor, 62229-50-9; nerve growth factor, 9061-61-4; phorbol 13 acetate 12 myristate, 16561-29-8; Bucladesine, 362-74-3; Dexamethasone, 50-02-2; Epidermal Growth Factor, 62229-50-9; Neoplasm Proteins; Nerve Growth Factors; Potassium, 7440-09-7; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins; RNA, Messenger; RNA, Neoplasm; Tetradecanoylphorbol Acetate, 16561-29-8",,,,,,,,,,,,,00278424,,PNASA,2997786,"English","PROC. NATL. ACAD. SCI. U. S. A.",Article,Scopus,2-s2.0-0022347794
"Schubert, D., Stallcup, W., LaCorbiere, M., Kidokoro, Y., Orgel, L.","Ontogeny of electrically excitable cells in cultured olfactory epithelium",1985,"Proceedings of the National Academy of Sciences of the United States of America","82","22",,"7782","7786",,15,10.1073/pnas.82.22.7782,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0022401782&partnerID=40&md5=718b94cdba2d30367132a3b945d4f551","The Salk Institute, San Diego, CA 92138, United States","Schubert, D., The Salk Institute, San Diego, CA 92138, United States; Stallcup, W., The Salk Institute, San Diego, CA 92138, United States; LaCorbiere, M., The Salk Institute, San Diego, CA 92138, United States; Kidokoro, Y.; Orgel, L.","A primary system has been developed in which it is possible to study the production of electrically excitable neuron-like cells from a precursor population of olfactory epithelial cells. Rat nasal epithelium was dissociated and placed in culture. The initial surviving cells are flat and ciliated and contain glial fibrillary acidic protein (GFAP). After 3-5 days electrically excitable cells appear that contain neuron-specific enolase but not GFAP. These round cells originate by means of the differentiation of the GFAP-positive flat cell to a round cell, followed by the division of the round cell. Therefore, neuron-like cells can be derived from cells that synthesize GFAP.",,"glial fibrillary acidic protein; radioisotope; animal cell; cell differentiation; cytology; electrophysiology; histology; in vitro study; nervous system; nervous system development; nonhuman; olfactory epithelium; olfactory system; priority journal; rat; tissue culture; Action Potentials; Animals; Cell Differentiation; Cells, Cultured; Epithelial Cells; Glial Fibrillary Acidic Protein; Macrophages; Nasal Cavity; Neuroglia; Neurons; Neurotransmitter Agents; Rabbits; Rats; Rats, Inbred Strains; Receptors, Sensory; Thymidine; Animalia",,"Glial Fibrillary Acidic Protein; Neurotransmitter Agents; Thymidine, 50-89-5",,,,,,,,,,,,,00278424,,PNASA,2866512,"English","PROC. NATL. ACAD. SCI. U. S. A.",Article,Scopus,2-s2.0-0022401782
"Schubert, D., LaCorbiere, M.","Isolation of an adhesion-mediating protein from chick neural retina adherons",1985,"Journal of Cell Biology","101","3",,"1071","1077",,33,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0022215718&partnerID=40&md5=8fc35ea6878b225b07dad8742042c15f","The Salk Institute, San Diego, CA 92138, United States","Schubert, D., The Salk Institute, San Diego, CA 92138, United States; LaCorbiere, M., The Salk Institute, San Diego, CA 92138, United States","Adherons are high molecular weight glycoprotein complexes which are released into the growth medium of cultured cells. They mediate the adhesive interactions of many cell types, including those of embryonic chick neural retina. The cell surface receptor for chick neural retina adherons has been purified, and shown to be a heparan sulfate proteoglycan (Schubert, D., and M. LaCorbiere, 1985, J. Cell. Biol., 100:56-63). This paper describes the isolation and characterization of a protein in neural retina adherons which interacts specifically with the cell surface receptor. The 20,000-mol-wt protein, called retinal purpurin (RP), stimulates neural retina cell-substratum adhesion and prolongs the survival of neural retina cells in culture. The RP protein interacts with heparin and heparan sulfate, but not with other glycosaminoglycans. Monovalent antibodies against RP inhibit RP-cell adhesion as well as adheron-cell interactions. The RP protein is found in neural retina, but not in other tissues such as brain and muscle. These data suggest that RP plays a role in both the survival and adhesive interactions of neural retina cells.",,"membrane receptor; purpurin; cell adhesion; cell culture; chicken; in vitro study; nervous system; nonhuman; priority journal; retina neuroepithelial layer; visual system; Animal; Antigens, Surface; Cell Adhesion; Cell Adhesion Molecules; Cell Survival; Cells, Cultured; Chick Embryo; Eye Proteins; Heparan Sulfate Proteoglycan; Heparitin Sulfate; Molecular Weight; Proteochondroitin Sulfates; Receptors, Cell Surface; Retina; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Tissue Distribution",,"purpurin, 81-54-9; Antigens, Surface; Cell Adhesion Molecules; Eye Proteins; Heparan Sulfate Proteoglycan; Heparitin Sulfate, 9050-30-0; Proteochondroitin Sulfates; Receptors, Cell Surface; retinal purpurin",,,,,,,,,,,,,00219525,,JCLBA,2993313,"English","J. CELL BIOL.",Article,Scopus,2-s2.0-0022215718
"Schubert, D., LaCorbiere, M.","Isolation of a cell-surface receptor for chick neural retina adherons",1985,"Journal of Cell Biology","100","1",,"56","63",,22,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0022000535&partnerID=40&md5=cfb5bb99581f644963b8b8644d56aa04","The Salk Institute, San Diego, CA 92138, United States","Schubert, D., The Salk Institute, San Diego, CA 92138, United States; LaCorbiere, M., The Salk Institute, San Diego, CA 92138, United States","Embryonic chick neural retina cells release glycoprotein complexes, termed adherons, into their culture medium. When adsorbed onto the surface of petri dishes, neural retina adherons increase the initial rate of neural retina cell adhesion. In solution they increase the rate of cell-cell aggregation. Cell-cell and adheron-cell adhesions of cultured retina cells are selectively inhibited by heparan-sulfate glycosaminoglycan, but not by chondroitin sulfate or hyaluronic acid, suggesting that a heparan-sulfate proteoglycan may be involved in the adhesion process. We isolated a heparan-sulfate proteoglycan from the growth-conditioned medium of neural retina cells, and prepared an antiserum against it. Monovalent Fab' fragments of these antibodies completely inhibited cell-adheron adhesion, and partially blocked spontaneous cell-cell aggregation. An antigenically and structurally similar heparan-sulfate proteoglycan was isolated from the cell surface. This proteoglycan bound directly to adherons, and when absorbed to plastic, stimulated cell-substratum adhesion. These data suggest that a heparan-sulfate proteoglycan on the surface of chick neural retina cells acted as a receptor for adhesion-mediating glycoprotein complexes (adherons).",,"cell surface receptor; glycoprotein; radioisotope; animal cell; cell aggregation; cell culture; chicken; embryo; in vitro study; methionine s 35; nonhuman; priority journal; retina neuroepithelial layer; visual system; Animal; Antigens, Surface; Cell Adhesion; Cell Adhesion Molecules; Cell Aggregation; Chick Embryo; Glycosaminoglycans; Heparan Sulfate Proteoglycan; Heparitin Sulfate; Kinetics; Neurons; Proteins; Proteochondroitin Sulfates; Receptors, Antigen; Retina; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.",,"Antigens, Surface; Cell Adhesion Molecules; Glycosaminoglycans; Heparan Sulfate Proteoglycan; Heparitin Sulfate, 9050-30-0; Proteins; Proteochondroitin Sulfates; Receptors, Antigen",,,,,,,,,,,,,00219525,,JCLBA,3965479,"English","J. CELL BIOL.",Article,Scopus,2-s2.0-0022000535
"Cole, G.J., Schubert, D., Glaser, L.","Cell-substratum adhesion in chick neural retina depends upon protein-heparan sulfate interactions",1985,"Journal of Cell Biology","100","4",,"1192","1199",,53,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0021917856&partnerID=40&md5=5eaf583c1fd026d00a27e822af8d7d72","Department of Biological Chemistry, Division of Biology and Biomedical Sciences, Washington University School of Medicine, St. Louis, MO 63110, United States","Cole, G.J., Department of Biological Chemistry, Division of Biology and Biomedical Sciences, Washington University School of Medicine, St. Louis, MO 63110, United States; Schubert, D., Department of Biological Chemistry, Division of Biology and Biomedical Sciences, Washington University School of Medicine, St. Louis, MO 63110, United States; Glaser, L., Department of Biological Chemistry, Division of Biology and Biomedical Sciences, Washington University School of Medicine, St. Louis, MO 63110, United States","Embryonic chick neural retina cells in culture release complexes of proteins and glycosaminogens, termed adherons, which stimulate cell-substratum adhesion when adsorbed to nonadhesive surfaces. Two distinct retinal cell surface macromolecules, a 170,000-mol-wt glycoprotein and a heparin sulfate proteoglycan, are components of adherons that can independently promote adhesion when coated on inert surfaces. The 170,000-mol-wt polypeptide contains a heparin-binding domain, as indicated by its retention on heparin-agarose columns and its ability to bind [3H]heparin in solutions. The attachment of embryonic chick retinal cells to the 170,000-mol-wt protein also depends upon interactions between the protein and the heparin sulfate proteoglycan, since heparin sulfate in solution disrupts adhesion of chick neural retina cells to glass surfaces coated with the 170,000-mol-wt protein. This adhesion is not impaired by chondroitin sulfate or hyaluronic acid, which indicates that inhibition by heparan sulfate is specific. Polyclonal antisera directed against the cell surface heparan sulfate proteoglycan also inhibit attachment of retinal cells to the 170,000-mol-wt protein, which suggests that cell-adheron binding is mediated in parts by interactions between cell surface heparin sulfate proteoglycan and 170,000-mol-wt protein contained in the adheron particles. Previous studies have indicated that this type of cell-substratum adhesion is tissue-specific since retina cells do not attach to muscle adherons (Schubert D., M. LaCorbiere, F.G. Klier, and C. Birdwell, 1983, J. Cell Biol. 96:990-998).",,"glycosaminoglycan; heparan sulfate; animal cell; cell adhesion; cell culture; chicken; cytology; embryo; in vitro study; nonhuman; preliminary communication; priority journal; retina; visual system; Animal; Antigens, Surface; Cell Adhesion; Cell Adhesion Molecules; Cells, Cultured; Chick Embryo; Glycosaminoglycans; Heparin; Heparitin Sulfate; Immunologic Techniques; Molecular Weight; Nerve Tissue Proteins; Retina; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.",,"heparan sulfate, 9050-30-0; Antigens, Surface; Cell Adhesion Molecules; Glycosaminoglycans; Heparin, 9005-49-6; Heparitin Sulfate, 9050-30-0; Nerve Tissue Proteins",,,,,,,,,,,,,00219525,,JCLBA,3156866,"English","J. CELL BIOL.",Article,Scopus,2-s2.0-0021917856
"Traynor, A.E., Schubert, D.","Phospholipases elevate cyclic AMP levels and promote neurite extension in a clonal nerve cell line.",1984,"Brain Research","316","2",,"197","204",,1,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0021445161&partnerID=40&md5=32e31e25156c7575cb3c910ca010f9d4",,"Traynor, A.E.; Schubert, D.","Phospholipases A2 and C increase choline acetyltransferase (CAT) activity and promote neurite extension in PC12 cells. Since these phospholipases also elevate intracellular cyclic AMP, they probably stimulate CAT and neurite outgrowth through their ability to increase cyclic AMP levels. Other possible modes of action of phospholipases such as the release of arachidonic acid or the production of lysolipids are less likely to play a role in this system.",,"arachidonic acid; arachidonic acid derivative; calcium; choline acetyltransferase; cyclic AMP; phospholipase; phospholipase A; phospholipase C; phospholipase D; animal; article; cell clone; cytology; metabolism; mouse; nerve cell; physiology; Animal; Arachidonic Acid; Arachidonic Acids; Calcium; Choline O-Acetyltransferase; Clone Cells; Cyclic AMP; Mice; Neurons; Phospholipase C; Phospholipase D; Phospholipases; Phospholipases A; Support, Non-U.S. Gov't; Support, U.S. Gov't, Non-P.H.S.; Support, U.S. Gov't, P.H.S.",,"arachidonic acid, 506-32-1, 6610-25-9, 7771-44-0; calcium, 7440-70-2; choline acetyltransferase, 9012-78-6; cyclic AMP, 60-92-4; phospholipase C, 9001-86-9; phospholipase D, 9001-87-0; phospholipase, 9013-93-8; Arachidonic Acid, 506-32-1; Arachidonic Acids; Calcium, 7440-70-2; Choline O-Acetyltransferase, EC 2.3.1.6; Cyclic AMP, 60-92-4; Phospholipase C, EC 3.1.4.3; Phospholipase D, EC 3.1.4.4; Phospholipases A, EC 3.1.1.-; Phospholipases, EC 3.1.-",,,,,"Traynor, A.E.",,,,,,,,00068993,,,6087993,"English","Brain Res",Article,Scopus,2-s2.0-0021445161
"Traynor, A.E., Schubert, D.","Phospholipases elevate cyclic AMP levels and promote neurite extension in a clonal nerve cell line",1984,"Developmental Brain Research","14","2",,"197","204",,12,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0021183446&partnerID=40&md5=be6a2eaf3d0c8e167713befd0981373b","The Salk Institute, P.O. Box 85800, San Diego, CA 92138, United States","Traynor, A.E., The Salk Institute, P.O. Box 85800, San Diego, CA 92138, United States; Schubert, D., The Salk Institute, P.O. Box 85800, San Diego, CA 92138, United States","Phospholipases A2 and C increase choline acetyltransferase (CAT) activity and promote neurite extension in PC12 cells. Since these phospholipases also elevate intracellular cyclic AMP, they probably stimulate CAT and neurite outgrowth through their ability to increase cyclic AMP levels. Other possible modes of action of phospholipases such as the release of arachidonic acid or the production of lysolipids are less likely to play a role in this system.",,"choline acetyltransferase; cyclic amp; phospholipase; cloning; in vitro study; nerve cell; nervous system; neurite; nonhuman",,"choline acetyltransferase, 9012-78-6; cyclic AMP, 60-92-4; phospholipase, 9013-93-8",,,,,,,,,,,,,01653806,,DBRRD,,"English","DEV. BRAIN RES.",,Scopus,2-s2.0-0021183446
"Schubert, D., LaCorbiere, M., Klier, F.G., Birdwell, C.","The structure and function of myoblast adherons.",1983,"Cold Spring Harbor Symposia on Quantitative Biology","48 Pt 2",,,"539","549",,11,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0021009837&partnerID=40&md5=89db3eaf3b2d685f15870df6854f684d",,"Schubert, D.; LaCorbiere, M.; Klier, F.G.; Birdwell, C.",[No abstract available],,"glycosaminoglycan; protein; animal; article; cell adhesion; cell culture; cell line; electron microscopy; fluorescent antibody technique; mouse; muscle; physiology; smooth muscle; ultrastructure; Animal; Cell Adhesion; Cell Line; Cells, Cultured; Fluorescent Antibody Technique; Glycosaminoglycans; Mice; Microscopy, Electron; Muscle, Smooth; Muscles; Proteins; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.",,"protein, 67254-75-5; Glycosaminoglycans; Proteins",,,,,"Schubert, D.",,,,,,,,00917451,,,6373108,"English","Cold Spring Harb Symp Quant Biol",Article,Scopus,2-s2.0-0021009837
"Schubert, D., LaCorbiere, M., Klier, F.G., Birdwell, C.","A role for adherons in neural retina cell adhesion",1983,"Journal of Cell Biology","96","4",,"990","998",,22,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0020535665&partnerID=40&md5=4693a044e12b18794f3967c98daaf29c","Salk Inst., San Diego, CA 92138, United States","Schubert, D., Salk Inst., San Diego, CA 92138, United States; LaCorbiere, M., Salk Inst., San Diego, CA 92138, United States; Klier, F.G., Salk Inst., San Diego, CA 92138, United States; Birdwell, C., Salk Inst., San Diego, CA 92138, United States",[No abstract available],,"glycoprotein; adhesion; animal cell; cell adhesion; chicken; electron microscopy; embryo; nonhuman; retina neuroepithelial layer; visual system; Animal; Antigens; Cell Adhesion; Cell Adhesion Molecules; Cell Aggregation; Chick Embryo; Epitopes; Glycosaminoglycans; Immune Sera; Retina; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Time Factors",,"Antigens; Cell Adhesion Molecules; Epitopes; Glycosaminoglycans; Immune Sera",,,,,,,,,,,,,00219525,,JCLBA,6187755,"English","J. CELL BIOL.",Article,Scopus,2-s2.0-0020535665
"Schubert, D., LaCorbiere, M.","Properties of extracellular adhesion-mediating particles in myoblast clone and its adhesion-deficient variant",1982,"Journal of Cell Biology","94","1",,"108","114",,7,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0020324949&partnerID=40&md5=a2af2427f09fe6bf86aa4efe1296b189","Salk Inst., San Diego, CA 92138, United States","Schubert, D., Salk Inst., San Diego, CA 92138, United States; LaCorbiere, M., Salk Inst., San Diego, CA 92138, United States","Both the skeletal muscle myoblast cell line L6 and an adhesion-deficient variant of L6 released glycoprotein complexes, termed adherons, into their culture medium. The adherons from the variant, M3A, differed from those of L6 in a number of properties. M3A adherons were much less effective in promoting the cell-substratum and cell-cell adhesion of myoblasts than L6 particles. The adherons from the two cell lines also differed in their relative sedimentation velocities in sucrose gradients and had different chemical compositions. The M3A particle lacked chondroitin and contained relatively less collagen and fibronectin than the L6 adheron. Both L6 and M3A particles adhered to plastic surfaces and cells equally well in the absence of calcium ions. Neither cell-cell adhesion nor particle aggregation occurred in calcium-free medium. However, in the presence of calcium, the L6 adherons aggregated completely and M3A particles aggregated poorly. These data suggest that at least two sets of interactions are required for adheron-mediated adhesion: a calcium-independent binding of the adheron to the cell, and a calcium-dependent interaction between particles that is directly responsible for adhesion. The M3A variant is blocked at the calcium-dependent step, resulting in an adhesion deficiency.",,"cell adhesion; clone; histology; in vitro study; myoblast; Calcium; Cell Adhesion; Cell Aggregation; Cell Line; Chondroitin; Clone Cells; Collagen; Culture Media; Fibronectins; Glycoproteins; Muscles; Mutation; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.",,"Calcium, 7440-70-2; Chondroitin, 9007-27-6; Collagen, 9007-34-5; Culture Media; Fibronectins; Glycoproteins",,,,,,,,,,,,,00219525,,JCLBA,7119009,"English","J. CELL BIOL.",Article,Scopus,2-s2.0-0020324949
"Traynor, A.E., Schubert, D., Allen, W.R.","Alterations of lipid metabolism in response to nerve growth factor",1982,"Journal of Neurochemistry","39","6",,"1677","1683",,31,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0020352492&partnerID=40&md5=6847203b21ab540ea83aabb2f8be19a4","Salk Inst., San Diego, CA 92138, United States","Traynor, A.E., Salk Inst., San Diego, CA 92138, United States; Schubert, D., Salk Inst., San Diego, CA 92138, United States; Allen, W.R., Salk Inst., San Diego, CA 92138, United States","In response to nerve growth factor (NGF), clonal pheochromocytoma cells flatten and extend neurites capable of making functional synapses. Although no significant changes in overall phospholipid composition occur in the presence of NGF, there is increased incorporation of 32PO4 into phosphatidylinositol and phosphatidic acid within 10 min after the addition of NGF. NGF stimulates the incorporation of 32PO4 into other lipids, such as phosphatidylcholine, to a lesser extent. The kinetics of the NGF-induced phosphatidylinositol responses are different when the cells are in suspension from when they are attached to culture dishes. These changes in phospholipid metabolism are discussed with respect to their role in NGF-induced nerve differentiation.",,"lipid; nerve growth factor; phosphatidylinositol; autonomic nervous system; drug efficacy; endocrine system; in vitro study; nonhuman; pheochromocytoma; phosphate p 32; tissue culture; Adrenal Gland Neoplasms; Animal; Cell Line; Cholesterol; Fatty Acids; Lipids; Nerve Growth Factors; Pheochromocytoma; Phospholipids; Support, U.S. Gov't, Non-P.H.S.; Support, U.S. Gov't, P.H.S.",,"lipid, 66455-18-3; nerve growth factor, 9061-61-4; Cholesterol, 57-88-5; Fatty Acids; Lipids; Nerve Growth Factors; Phospholipids",,,,,,,,,,,,,00223042,,JONRA,7142994,"English","J. NEUROCHEM.",Article,Scopus,2-s2.0-0020352492
"Schubert, D., LaCorbiere, M.","The specificity of extracellular glycoprotein complexes in mediating cellular adhesion",1982,"Journal of Neuroscience","2","1",,"82","89",,17,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0020038616&partnerID=40&md5=35fe151d9000fd856cf8cd587188aace","Salk Inst., San Diego, CA 92138, United States","Schubert, D., Salk Inst., San Diego, CA 92138, United States; LaCorbiere, M., Salk Inst., San Diego, CA 92138, United States",[No abstract available],,"glycoprotein; glycosaminoglycan; in vitro study; muscle; smooth muscle; Animal; Cell Adhesion; Cell Line; Extracellular Space; Glycoproteins; Glycosaminoglycans; Muscle Proteins; Muscle, Smooth; Rats; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.; Sympathetic Nervous System",,"Glycoproteins; Glycosaminoglycans; Muscle Proteins",,,,,,,,,,,,,02706474,,JNRSD,7054398,"English","J. NEUROSCI.",Article,Scopus,2-s2.0-0020038616
"LaCorbiere, M., Schubert, D.","The role of cAMP in the induction of ornithine decarboxylase by nerve and epidermal growth factors",1981,"Journal of Neuroscience Research","6","2",,"211","216",,,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0019473418&partnerID=40&md5=420dcea80c03e34a7f5347fea5449576","Salk Inst., San Diego, Calif., United States","LaCorbiere, M., Salk Inst., San Diego, Calif., United States; Schubert, D., Salk Inst., San Diego, Calif., United States","Nerve growth factor (NGF), epidermal growth factor (EGF), adenosine 3',5'-cyclic monophosphate (cAMP), and cholera toxin all increase the specific activity of ornithine decarboxylase (ODC) in the PC12 nerve-like cell line. A phosphodiesterase inhibitor augments the effect of NGF on the induction of ODC in these cells, while it is only additive with the EGF response. These data suggest that cAMP has an intermediary role in the induction of ODC by NGF and that cAMP is not involved in the EGF response.",,"bucladesine; cholera toxin; cyclic amp; epidermal growth factor; nerve growth factor; ornithine decarboxylase; radioisotope; cell culture; cell line; central nervous system; enzyme induction; human cell; in vitro study; nerve cell; nervous system; ornithine c 14; Carboxy-Lyases; Cell Line; Clone Cells; Cyclic AMP; Enzyme Induction; Epidermal Growth Factor; Kinetics; Nerve Growth Factors; Neurons; Ornithine Decarboxylase; Peptides; Phosphodiesterase Inhibitors; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.",,"bucladesine, 16980-89-5, 362-74-3; cyclic AMP, 60-92-4; epidermal growth factor, 62229-50-9; nerve growth factor, 9061-61-4; ornithine decarboxylase, 9024-60-6; Carboxy-Lyases, EC 4.1.1.; Cyclic AMP, 60-92-4; Epidermal Growth Factor, 62229-50-9; Nerve Growth Factors; Ornithine Decarboxylase, EC 4.1.1.17; Peptides; Phosphodiesterase Inhibitors",,,,,,,,,,,,,03604012,,JNRED,6264091,"English","J. NEUROSCI. RES.",Article,Scopus,2-s2.0-0019473418
"Schubert, D., LaCorbiere, M.","A role of secreted glycosaminoglycans in cell-substratum adhesion",1980,"Journal of Biological Chemistry","255","23",,"11564","11569",,30,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0019175521&partnerID=40&md5=0fbb036fb528a9e0bbd675a8e7ece190","Neurobiol. Lab., Salk Inst., San Diego, Calif. 92138, United States","Schubert, D., Neurobiol. Lab., Salk Inst., San Diego, Calif. 92138, United States; LaCorbiere, M., Neurobiol. Lab., Salk Inst., San Diego, Calif. 92138, United States",[No abstract available],,"glycosaminoglycan; animal experiment; cell adhesion; in vitro study; muscle; myoblast; rat; Animal; Cell Adhesion; Cell Division; Cell Line; Glycosaminoglycans; Kinetics; Muscles; Rats; Structure-Activity Relationship; Support, Non-U.S. Gov't; Support, U.S. Gov't, P.H.S.",,"Glycosaminoglycans",,,,,,,,,,,,,00219258,,JBCHA,7440557,"English","J. BIOL. CHEM.",Article,Scopus,2-s2.0-0019175521
"Schubert, D., LaCorbiere, M.","Altered collagen and glycosaminoglycan secretion by a skeletal muscle myoblast variant",1980,"Journal of Biological Chemistry","255","23",,"11557","11563",,8,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0019217195&partnerID=40&md5=955415a50d65f015efacb69be86d2271","Neurobiol. Lab., Salk Inst., San Diego, Calif. 92138, United States","Schubert, D., Neurobiol. Lab., Salk Inst., San Diego, Calif. 92138, United States; LaCorbiere, M., Neurobiol. Lab., Salk Inst., San Diego, Calif. 92138, United States",[No abstract available],,"collagen; glycosaminoglycan; animal experiment; in vitro study; muscle; myoblast; rat; Amino Acids; Animal; Cell Line; Collagen; Glycosaminoglycans; Macromolecular Systems; Molecular Weight; Muscles; Rats; Variation (Genetics)",,"collagen, 9007-34-5; Amino Acids; Collagen, 9007-34-5; Glycosaminoglycans; Macromolecular Systems",,,,,,,,,,,,,00219258,,JBCHA,7440556,"English","J. BIOL. CHEM.",Article,Scopus,2-s2.0-0019217195
"Napias, C., Olsen, R.W., Schubert, D.","GABA and picrotoxinin receptors in clonal nerve cells [16]",1980,"Nature","283","5744",,"298","299",,9,10.1038/283298a0,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0018865494&partnerID=40&md5=5401436787752a91953710c7f838c4b9","Division of Biomedical Sciences, Department of Biochemistry, University of California, Riverside, CA 92521, United States; Department of Neurobiology, Salk Institute for Biological Studies, PO Box 1809, San Diego, CA 92112, United States","Napias, C., Division of Biomedical Sciences, Department of Biochemistry, University of California, Riverside, CA 92521, United States; Olsen, R.W., Division of Biomedical Sciences, Department of Biochemistry, University of California, Riverside, CA 92521, United States; Schubert, D., Department of Neurobiology, Salk Institute for Biological Studies, PO Box 1809, San Diego, CA 92112, United States","γAminobutyric acid (GABA) is a neurotransmitter which seems to mediate inhibitory synaptic transmission in many regions of the central nervous system (CNS) of vertebrates and invertebrates1. GABA has been shown to act by increasing membrane chloride permeability in invertebrate muscle 2,3, and a similar mechanism has been suggested for the vertebrate CNS4. The response to GABA is inhibited noncompetitively by the convulsant picrotoxinin1-5. Binding sites for radioactive GAB A 6-8 and picrotoxinin9-11 (the active component of picrotoxin) have been described in homogenates of invertebrate muscle and mammalian CNS; these binding sites show many properties expected of postsynaptic membrane macromolecules involved in the receptor-ionophore function of GABA. Nevertheless, unambiguous correlation between biochemical assays and in vivo function is difficult to obtain, especially in heterogeneous tissue such as mammalian CNS. One approach to this problem involves cloned cell lines of neuronal origin which retain in culture the differentiated function to be studied (see, for example, ref. 12). Certain cell lines cloned from rat 13 and mouse14 nervous system possess neuronal properties such as electrical excitability, neurotransmitter synthetic enzymes 12, neurotransmitter uptake15,16, binding of defined ligands to their appropriate neurotransmitter receptors12,17,18, and receptor-coupled responses to neurotransmitters17,19,20. Several cell lines of apparent glial origin have also been described13,21,22. To determine whether binding sites for GABA and picrotoxinin are localised to nerve cells, a variety of clonal cell lines were assayed for their ability to bind those ligands. We report here the presence of GABA and picrotoxinin binding sites with receptor-like properties in several clonal nerve cell lines obtained from the rat CNS, and the absence of such binding sites in many other cell lines of non-neuronal origin. © 1980 Nature Publishing Group.",,"2,4 diaminobutyric acid; 4 aminobutyric acid receptor; drug receptor; homotaurine; methylphenobarbital; muscimol; picrotoxinin; radioisotope; receptor; (1,3 dimethylbutyl)barbituric acid; 4 aminobutyric acid h 3; animal experiment; cell culture; central nervous system; clone; dihydropicrotoxinin h 3; drug absorption; drug administration; drug comparison; drug monitoring; in vitro study; isopropylbicyclophosphoric acid; nerve cell; nervous system; rat; Animal; Brain; Cell Line; Clone Cells; gamma-Aminobutyric Acid; Kinetics; Neuroglia; Picrotoxin; Rats; Receptors, Neurotransmitter; Support, U.S. Gov't, Non-P.H.S.; Support, U.S. Gov't, P.H.S.",,"2,4 diaminobutyric acid, 305-62-4; homotaurine, 3687-18-1; methylphenobarbital, 115-38-8; muscimol, 2763-96-4; picrotoxinin, 17617-45-7; gamma-Aminobutyric Acid, 56-12-2; Picrotoxin, 124-87-8; Receptors, Neurotransmitter",,"amersham",,,"Napias, C.; Division of Biomedical Sciences, Department of Biochemistry, University of California, Riverside, CA 92521, United States",,,,,,,,00280836,,,6243398,"English",,Letter,Scopus,2-s2.0-0018865494
"Schubert, D., LaCorbiere, M., Klier, F.G., Steinbach, J.H.","The modulation of neurotransmitter synthesis by steroid hormones and insulin",1980,"Brain Research","190","1",,"67","79",,64,10.1016/0006-8993(80)91160-9,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0018862436&partnerID=40&md5=04b083c62ab6c3d600bb20ce1fb47a86","Neurobiology Department, The Salk Institute, P.O. Box 1809, San Diego, CA 92112, United States","Schubert, D., Neurobiology Department, The Salk Institute, P.O. Box 1809, San Diego, CA 92112, United States; LaCorbiere, M., Neurobiology Department, The Salk Institute, P.O. Box 1809, San Diego, CA 92112, United States; Klier, F.G., Neurobiology Department, The Salk Institute, P.O. Box 1809, San Diego, CA 92112, United States; Steinbach, J.H., Neurobiology Department, The Salk Institute, P.O. Box 1809, San Diego, CA 92112, United States","Glucocorticoids stimulate tyrosine hydroxylase activity and catecholamine synthesis, while markedly inhibiting acetycholine synthesis and storage in a clone of sympathetic nerve-like cells. Nerve growth factor enhances the effect of glucocorticoids on tyrosine hydroxylase. The steroid effect is specific for glucocorticoids, since 11-desoxycortisol, testosterone, and estradiol-17β do not reproduce the effects of hydrocortisone and dexamethasone. Concomitant with the shift in neurotransmitter synthesis, there is an increase in the mean diameter of intracellular dense core vesicles. In contrast to glucocorticoids, insulin increases the specific activity of choline acetylttransferase through the interaction with typical insulin receptors. Insulin does not, however, alter the morphology of the cells, nor does it block the morphological response of the cells to nerve growth factor. © 1980.","acetylcholine; acetyltransferase; catecholamines; choline; glucocorticoids; nerve growth factor; tyrosine hydroxylase","catecholamine; choline acetyltransferase; cortodoxone; dexamethasone; estradiol; hydrocortisone; insulin; insulin receptor; nerve growth factor; neurotransmitter; testosterone; tyrosine 3 monooxygenase; autonomic nervous system; cell culture; in vitro study; nerve cell; nervous system; sympathetic nerve cell; Acetylcholine; Animal; Cell Line; Choline O-Acetyltransferase; Cortodoxone; Dexamethasone; Dose-Response Relationship, Drug; Estradiol; Glucocorticoids; Hydrocortisone; Insulin; Nerve Growth Factors; Nerve Regeneration; Neurotransmitters; Rats; Support, U.S. Gov't, P.H.S.; Sympathetic Nervous System; Testosterone; Tyrosine 3-Monooxygenase",,"choline acetyltransferase, 9012-78-6; cortodoxone, 152-58-9; dexamethasone, 50-02-2; estradiol, 50-28-2; hydrocortisone, 50-23-7; insulin, 9004-10-8; nerve growth factor, 9061-61-4; testosterone, 58-22-0; tyrosine 3 monooxygenase, 9036-22-0; Acetylcholine, 51-84-3; Choline O-Acetyltransferase, EC 2.3.1.6; Cortodoxone, 152-58-9; Dexamethasone, 50-02-2; Estradiol, 50-28-2; Glucocorticoids; Hydrocortisone, 50-23-7; Insulin, 11061-68-0; Nerve Growth Factors; Neurotransmitters; Testosterone, 57-85-2; Tyrosine 3-Monooxygenase, EC 1.14.16.2",,,,"Aloe, Levi-Montalcini, NGF-induced transformation of immature chromaffin cell in vivo into sympathetic neurons (1979) Proc. nat. Acad. Sci. (Wash.), 76, pp. 1246-1250; Angeletti, Levi-Montalcini, Kettler, Thoenen, Comparative studies on the effect of NGF on sympathetic ganglion and adrenal medulla in newborn rats (1972) Brain Research, 44, pp. 197-206; Argos, Prediction of the secondary structure of mouse NGF and its comparison with insulin (1976) Biochem. biophys. Res. Commun., 70, pp. 805-812; Bunge, Johnson, Ross, Nature and nurture in development of the autonomic ganglion (1978) Science, 199, pp. 1409-1416; Colquhoun, (1971) Lectures on Biostatistics, , Clarendon Press, Oxford; Constantinides, Taylor, Jones, Phenotypic conversion of cultured mouse embryo cells by aza pyrimidine nucleosides (1978) Develop. Biol., 66, pp. 57-71; Coughlin, Boyer, Black, Embryonic development of a mouse sympathetic ganglion in vivo and in vitro (1977) Proc. nat. Acad. Sci. (Wash.), 74, pp. 3438-3442; D'Anzi, Morphological and biochemical observations on catecholamine-storing vesicles of rat adrenomedullary cells during insulin-induced hypoglycemia (1969) Amer. J. Anat., 125, pp. 381-398; Edgar, Thoenen, Selective enzyme induction in a NGF-responsive cell line (1978) Brain Research, 154, pp. 186-190; Frazier, Angeletti, Bradshaw, Nerve growth factor and insulin (1972) Science, 176, pp. 482-488; Gavin, Roth, Jen, Freychet, Insulin receptor in human circulating cells and fibroblasts (1972) Proceedings of the National Academy of Sciences, 69, pp. 747-751; Goodman, Herschman, NGF-mediated induction of tyrosine hydroxylase in a clonal pheochromocytoma cell line (1978) Proc. nat. Acad. Sci. (Wash.), 75, pp. 4587-4590; Greene, Tischler, Establishment of a noradrenergic clonal line of rat adrenal chromaffin cells (1976) Proc. nat. Acad. Sci. (Wash.), 73, pp. 2424-2428; Greene, Rein, Synthesis, storage and release of acetylcholine by a noradrenergic pheochromocytoma cell line (1977) Nature (Lond.), 268, pp. 349-351; Hollenberg, Action of insulin analogues in cultured human fibroblasts reflects biological potency (1976) Life Sci., 18, pp. 521-528; Jones, Hillhouse, Burden, Dynamics and mechanics of corticosteroid feedback at the hypothalamus and anterior pituitary gland (1977) J. Endocr., 73, pp. 405-417; Le Douarin, Renaud, Teillet, Le Douarin, Cholinergic differentiation of presumptive adrenergic neuroblasts in interspecific chimera after heterotopic transplantation (1975) Proc. nat. Acad. Sci. (Wash.), 72, pp. 728-732; Le Douarin, Teillet, Ziller, Smith, Adrenergic differentiation of cells of the cholinergic ciliary and Remak ganglia in avian embryo after in vivo transplantation (1978) Proc. nat. Acad. Sci. (Wash.), 75, pp. 2030-2034; Lipton, Collagen synthesis by normal and bromodeoxyuridine-modulated cells in myogenic culture (1977) Develop. Biol., 61, pp. 153-165; Lucas, Thoenen, Selective induction of glucocorticoids of tyrosine hydroxylase in organ cultures of rat pheochromocytoma (1977) Neuroscience, 2, pp. 1095-1099; Nagaiah, MacDonnell, Guroff, Induction of tyrosine hydroxylase synthesis in rat superior cervical ganglia in vitro by NGF and dexamethasone (1977) Biochem. biophys. Res. Commun., 75, pp. 832-840; Nathanson, Hilfer, Searls, Formation of cartilage by non-chondrogenic cell-types (1978) Develop. Biol., 64, pp. 99-117; Otten, Thoenen, Effect of glucocorticoids on nerve growth factor-mediated enzyme induction in organ cultures of rat sympathetic ganglia: enhanced response and reduced time requirement to inititate enzyme induction (1977) J. Neurochem., 29, pp. 69-75; Partlow, Metabolic Effects of Nerve Growth Factor on Cultured Sympathetic Ganglia (1969) Ph.D. Thesis, pp. 70-315. , Johns Hopkins University; Patrick, Heinemann, Schubert, Biology of cultured nerve and muscle (1978) Ann. Rev. Neurobiol., 1, pp. 417-432; Patterson, Environmental determination of autonomic neurotransmitter functions (1978) Ann. Rev. Neurosci., 1, pp. 1-17; Sato, Yasumura, Retention of differentiated function in dispersed cell culture (1966) Trans. N.Y. Acad. Sci., 28, pp. 1063-1070; Schubert, Heinemann, Kidokoro, Cholinergic metabolism and synapse formation by a rat nerve cell line (1977) Proc. nat. Acad. Sci. (Wash.), 74, pp. 2479-2583; Schubert, Klier, Storage and release of acetylcholine by a clonal cell line (1977) Proc. nat. Acad. Sci. (Wash.), 74, pp. 5184-5188; Schubert, La Corbiere, Cell type transitions involving muscle cells (1977) Pathogenesis of Human Muscular Dystrophies, pp. 812-825. , L.P. Rowland; Schubert, La Corbiere, Whitlock, Stallcup, Alterations in the surface properties of cells responsive to nerve growth factor (1978) Nature (Lond.), 273, pp. 718-719; Unsicker, Krisch, Otten, Thoenen, NGF-induced fiber outgrowth from isolated rat adrenal chromaffin cells. Impairment by glucocorticoids (1978) Proc. nat. Acad. Sci. (Wash.), 75, pp. 3498-3502","Schubert, D.; Neurobiology Department, The Salk Institute, P.O. Box 1809, San Diego, CA 92112, United States",,,,,,,,00068993,,BRREA,6103732,"English","Brain Res.",Article,Scopus,2-s2.0-0018862436
"Schubert, D., LaCorbiere, M.","Role of a 16S glycoprotein complex in cellular adhesion",1980,"Proceedings of the National Academy of Sciences of the United States of America","77","7 II",,"4137","4141",,12,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0018959162&partnerID=40&md5=c8410842422b55152fec6256d4a8fd2e","Neurobiol. Lab., Salk Inst., San Diego, Calif. 92138, United States","Schubert, D., Neurobiol. Lab., Salk Inst., San Diego, Calif. 92138, United States; LaCorbiere, M., Neurobiol. Lab., Salk Inst., San Diego, Calif. 92138, United States",[No abstract available],,"calcium; collagen; fibronectin; glycoprotein; radioisotope; cell adhesion; glucosamine h 3; in vitro study; leucine h 3; muscle; myoblast; sulfuric acid s 35; theoretical study; Animal; Calcium; Cell Adhesion; Cell Aggregation; Cells, Cultured; Extracellular Space; Glycoproteins; Glycosaminoglycans; Hemagglutinins; L Cells (Cell Line); Mice; Molecular Weight; Support, U.S. Gov't, P.H.S.",,"calcium, 7440-70-2; collagen, 9007-34-5; fibronectin, 86088-83-7; Calcium, 7440-70-2; Glycoproteins; Glycosaminoglycans; Hemagglutinins",,,,,,,,,,,,,00278424,,PNASA,6933463,"English","PROC. NATL. ACAD. SCI. U. S. A.",Article,Scopus,2-s2.0-0018959162
"Steinbach, J.H., Schubert, D., Eldridge, L.","Changes in cat muscle contractile proteins after prolonged muscle inactivity",1980,"Experimental Neurology","67","3",,"655","669",,25,10.1016/0014-4886(80)90134-X,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0018891953&partnerID=40&md5=0b51a9a052fc34f468a7a28fe7a36a3d","Neurobiology Department, The Salk Institute, P.O. Box 1809, San Diego, CA 92112, United States; Department of Physiology, School of Medicine, University of California, Los Angeles, CA 90024, United States","Steinbach, J.H., Neurobiology Department, The Salk Institute, P.O. Box 1809, San Diego, CA 92112, United States, Department of Physiology, School of Medicine, University of California, Los Angeles, CA 90024, United States; Schubert, D., Neurobiology Department, The Salk Institute, P.O. Box 1809, San Diego, CA 92112, United States, Department of Physiology, School of Medicine, University of California, Los Angeles, CA 90024, United States; Eldridge, L., Neurobiology Department, The Salk Institute, P.O. Box 1809, San Diego, CA 92112, United States, Department of Physiology, School of Medicine, University of California, Los Angeles, CA 90024, United States","Contractile proteins in cat hind limb muscles were studied to examine the possibility that prolonged inactivity of innervated skeletal muscle results in changes in the complement of contractile proteins synthesized by fast- or slow-twich muscles. Myosin light chains and tropomyosins from cat fast- and slow-twitch skeletal muscles were identified in two-dimensional gel electrophoretic patterns. The protein complement synthesized by initially slow-twitch muscle became more similar to that of fast-twitch after long periods (2 to 3 years) of surgically produced inactivity. In some animals slow-twitch forms of myosin light chains and tropomyosins were not seen in normally slow-twitch muscles. These results are in agreement with data obtained in other studies of contractile and biochemical properties of the inactivated muscles. © 1980.",,"myosin; tropomyosin; animal experiment; cat; fast muscle; muscle; muscle inactivity; protein synthesis; slow muscle; Animal; Cats; Electrophoresis, Polyacrylamide Gel; Female; Hindlimb; Molecular Weight; Muscle Contraction; Muscle Denervation; Myosins; Support, U.S. Gov't, Non-P.H.S.; Support, U.S. Gov't, P.H.S.; Tropomyosin",,"tropomyosin, 72067-79-9; Myosins, EC 3.6.1.4; Tropomyosin",,,,"Al-Amood, Buller, Pope, Long-term stimulation of cat fast twitch skeletal muscle (1973) Nature, 244, pp. 225-227; Barany, Close, The transformation of myosin in cross-reinnervated rat muscles (1971) J. Physiol. (London), 213, pp. 455-474; Booth, Kelso, Effect of hindlimb immobilization on contractile and histochemical properties of skeletal muscle (1973) Pflüger's Arch., 342, pp. 231-238; Brown, Ironton, Motor neurone sprouting induced by prolonged tetrodotoxin block of nerve action potentials (1977) Nature (London), 265, pp. 459-461; Buller, Eccles, Eccles, Interactions between motoneurones and muscles in respect to the characteristic speeds of their responses (1960) J. Physiol. (London), 150, pp. 417-439; Buller, Mommaerts, Serayderian, Enzymic properties of myosin in fast and slow twitch muscles of the cat following cross-innervation (1969) J. Physiol. (London), 205, pp. 581-597; Cangiano, Lutzemberger, Nicotra, Non-equivalence of impulse blockade and denervation in the production of membrane changes in rat skeletal muscle (1977) J. Physiol. (London), 273, pp. 691-706; Cooper, Alterations during immobilization and regeneration of skeletal muscle in cats (1972) J. Bone Joint Surg., 54 A, pp. 919-953; Cummins, Perry, The subunits and biological activity of polymorphic forms of tropomyosin (1974) Biochem. J., 133, pp. 765-777; Czeh, Gallego, Kudo, Kuno, Evidence for the maintenance of motoneurone properties by muscle activity (1978) J. Physiol. (London), 281, pp. 239-252; Davis, Montgomery, The effects of prolonged inactivity upon the contraction characteristics of fast and slow mammalian muscle (1977) J. Physiol. (London), 270, pp. 581-594; Devlin, Emerson, Jr., Coordinate regulation of contractile protein synthesis during myoblast differentiation (1978) Cell, 13, pp. 599-611; Fischbach, Robbins, Changes in contractile properties of disused soleus muscles (1969) J. Physiol. (London), 201, pp. 305-320; Gallego, Huizar, Kudo, Kuno, Disparity of motoneurone and muscle differentiation following spinal transection in the kitten (1978) J. Physiol. (London), 281, pp. 253-265; Garrels, Two-dimensional gel electrophoresis and computer analysis of proteins synthesized by clonal cell lines (1979) J. Biol. Chem., 254, pp. 7961-7977; Garrels, Changes in protein synthesis during myogenesis in a clonal cell line (1979) Dev. Biol., 73, pp. 134-152; Garrels, Gibson, Identification and characterization of multiple forms of actin (1976) Cell, 9, pp. 793-805; Gilliatt, Westgaard, Williams, Extrajunctional acetylcholine sensitivity of inactive muscle fibers in the baboon during prolonged nerve pressure block (1978) J. Physiol. (London), 280, pp. 499-514; Kean, Lewis, McGarrick, Dynamic properties of denervated fast and slow twitch muscle of the cat (1974) J. Physiol. (London), 237, pp. 103-113; Lavoie, Collier, Tenenhouse, Comparison of α-bungarotoxin binding to skeletal muscles after inactivity or denervation (1976) Nature (London), 260, pp. 349-350; Lewis, The effect of denervation on the mechanical and electrical responses of fast and slow mammalian twitch muscle (1972) J. Physiol. (London), 222, pp. 51-75; Lewis, Kean, McGarrick, Dynamic properties of slow and fast muscle and their trophic regulation (1974) Ann. N.Y. Acad. Sci., 228, pp. 105-120; Lømo, Westgaard, Dahl, Contractile properties of muscle control by pattern of muscle activity in the rat (1974) Proceedings of the Royal Society B: Biological Sciences, 187, pp. 99-103; Mills, Bray, Hubbard, Effects of inactivity on membrane potentials in rat muscle (1978) Brain Res., 150, pp. 607-610; O'Farrell, High resolution two-dimensional electrophoresis of proteins (1975) J. Biol. Chem., 250, pp. 4007-4021; Perrie, Smillie, Parry, A phosphorylated light chain component of myosin from skeletal muscle (1973) Cold Spring Harbor Symposia on Quantitative Biology, 37, pp. 17-18; Pestronk, Drachman, Griffin, Effect of muscle disuse on acetylcholine receptors (1976) Nature (London), 260, pp. 352-353; Pette, Muller, Leisner, Vrbova, Time dependent effects on contractile properties, fibre population, myosin light chains and enzymes of energy metabolism in intermittently and continuously stimulated fast twitch muscles of the rabbit (1976) Pflüger's Arch., 364, pp. 103-112; Purves, Sakmann, The effect of contractile activity on fibrillation and extrajunctional acetylcholine sensitivity in rat muscle maintained in organ culture (1974) J. Physiol. (London), 237, pp. 157-182; Rubinstein, Kelly, Myogenic and neurogenic contributions to the development of fast and slow twitch muscles in rat (1978) Dev. Biol., 62, pp. 473-485; Salmons, Gale, Sreter, Ultrastructural aspects of the transformation of muscle fibre type by long term stimulation: changes in Z discs and mitochondria (1978) J. Anat., 237, pp. 27-31; Salmons, Sreter, Significance of impulse activity in the transformation of skeletal muscle type (1976) Nature (London), 263, pp. 30-34; Salmons, Vrbova, The influence of activity on some contractile characteristics of mammalian fast and slow muscles (1969) J. Physiol. (London), 201, pp. 535-549; Sender, Muscle fibrils: solubilization and gel electrophoresis (1971) FEBS Lett., 17, pp. 106-110; Smith, Miniature stimulator for chronic animals (1978) Pflüger's Arch., 376, pp. 93-95; Stromer, Goll, Roth, Morphology of rigor-shortened bovine muscle and the effect of trypsin on pre- and post-rigor myofibrils (1967) J. Cell Biol., 34, pp. 431-445; Tower, Trophic control of non-nervous tissue by the nervous system a study of muscle and bone innervated from an isolated and quiescent region of spinal cord (1937) The Journal of Comparative Neurology, 67, pp. 241-261; Van Winkle, Entman, Barret, Schwartz, Morphological and biochemical correlates skeletal muscle contractility in the cat. II. Physiological and biochemical studies (1978) J. Cell. Physiol., 97, pp. 121-136; Weeds, Light chains from slow twitch muscle myosin (1976) Eur. J. Biochem., 66, pp. 157-173; Weeds, Trentham, Kean, Buller, Myosin from cross-reinnervated cat muscles (1974) Nature (London), 247, pp. 135-139","Steinbach, J.H.; Neurobiology Department, The Salk Institute, P.O. Box 1809, San Diego, CA 92112, United States",,,,,,,,00144886,,EXNEA,7353622,"English","Exp. Neurol.",Article,Scopus,2-s2.0-0018891953
"Schubert, D., Carlisle, W.","[54] Neuronal cells from rodent neoplasma",1979,"Methods in Enzymology","58","C",,"584","590",,1,10.1016/S0076-6879(79)58175-0,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0018296556&partnerID=40&md5=27f48b67fb1b45785903c5928ba30943",,"Schubert, D.; Carlisle, W.",[No abstract available],,,,,,,,,,,,,,,,,00766879,,MENZA,,"English","Methods Enzymol.",Article,Scopus,2-s2.0-0018296556
"Lennon, V.A., Peterson, S., Schubert, D.","Neurectoderm markers retained in phenotypical skeletal muscle cells arising from a glial cell line [23]",1979,"Nature","281","5732",,"586","588",,32,10.1038/281586a0,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0018695039&partnerID=40&md5=6f3b6d8c3e90feb998058efe165a26ed","Neuroimmunology Laboratory, Departments of Neurology and Immunology, Mayo Clinic and Medical School, Rochester, MN 55901, United States; Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92112, United States","Lennon, V.A., Neuroimmunology Laboratory, Departments of Neurology and Immunology, Mayo Clinic and Medical School, Rochester, MN 55901, United States; Peterson, S., Neuroimmunology Laboratory, Departments of Neurology and Immunology, Mayo Clinic and Medical School, Rochester, MN 55901, United States; Schubert, D., Neurobiology Laboratory, Salk Institute for Biological Studies, San Diego, CA 92112, United States","Differentiation in vitro of striated muscle from apparently non-muscle precursor cells has been reported in thymus reticulum1, a fibroblast-like mouse embryo line2 and in a neuronelike cell line derived from a rat brain tumour3. Also Tomozawa and Sueko reported the differentiation of a peripheral neurotumour clonal stem cell line into separate neuronal and glial cell types4. We report here the reproducible and stable phenotypic change of a well characterised rat glial cell line, B9 (refs 5-;7), into multinucleate contractile skeletal muscle. The B9 line was derived from a nitrosoethylurea-induced brain tumour, contains S-100 and 14-3-2 proteins, is electrically non-excitable 5 and has a putative glial-specific surface antigen, G2 (ref. 6). It has been phenotypically stable in its laboratory of origin at Salk Institute since 1973. After being transported to the Mayo Clinic in Minnesota the cells began to change from cuboidal to elongate shape, fuse into contractile multinucleate fibres and express nicotinic acetylcholine receptors (AChR) on their plasma membranes. Striated myofibrils appeared in their cytoplasm. The first sign of mesectodermal differentiation in B9 was the transitory appearance on its surface of Thy-1 which, in the rat, is a marker of thymocytes8, certain brain cell lines7, immature skeletal muscle9,10, mammary myoepithelial lines11 and fibro-blasts12. This antigen was not detected in previous studies at Salk Institute7. The inductive influence is not yet known. We propose that transformation of a neurectodermal line into muscle may be evidence of the capacity of mammalian neurectoderm to give rise to skeletal tissues. The concept that skeletal muscle in different anatomical regions might have different embryonic origins could be relevant to the distribution of muscles affected by certain diseases in man. © 1979 Nature Publishing Group.",,"cell culture; cell differentiation; cytology; glia cell; in vitro study; muscle; muscle cell; nervous system; neurectoderm; Animal; Antigens, Surface; Cell Differentiation; Cell Line; Ectoderm; Human; Muscles; Myasthenia Gravis; Neuroglia; Phenotype; Rats; Receptors, Nicotinic",,"Antigens, Surface; Receptors, Nicotinic",,,,,"Lennon, V.A.; Neuroimmunology Laboratory, Departments of Neurology and Immunology, Mayo Clinic and Medical School, Rochester, MN 55901, United States",,,,,,,,00280836,,,492321,"English",,Letter,Scopus,2-s2.0-0018695039
"Garrels, J.I., Schubert, D.","Modulation of protein synthesis by nerve growth factor",1979,"Journal of Biological Chemistry","254","16",,"7978","7985",,31,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0018695866&partnerID=40&md5=fa609c1ab9b181b146a7cf50a88aa43d","Neurobiol. Lab., Salk Inst., San Diego, Calif. 92112, United States","Garrels, J.I., Neurobiol. Lab., Salk Inst., San Diego, Calif. 92112, United States; Schubert, D., Neurobiol. Lab., Salk Inst., San Diego, Calif. 92112, United States","The effects of nerve growth factor (NGF) and two analogs of cAMP have been studied in the PC12 line of rat pheochromocytoma cells. We have used two-dimensional gel electrophoresis to detect more than 800 proteins from control and NGF-treated cells. Of these proteins, none were qualitatively repressed in response to NGF, and no new proteins appeared after NGF treatment. Visual inspection of the gels showed that approximately 5% of the proteins were detectably increased or decreased in rate of synthesis by NGF, and each of these changes was mimicked by both cAMP analogs. The two-dimensional gel data were further analyzed by a computerized scanning system. This analysis has revealed many significant changes that are smaller than those detected by eye. Approximately 25 to 30% of the proteins analyzed were found to be altered in rate of synthesis by 30% or more. Statistical analysis has shown that the response to NGF and the response to dibutyryl cAMP are highly correlated, even down to changes as small as 30%. No proteins were found to be significantly altered by both dibutyryl cAMP and 8-bromo cAMP, but not by NGF. These results show that NGF causes only quantitative modulations of protein synthesis in PC12 cells, and these dta strongly suggest that the response of PC12 cells to NGF is mediated by cAMP.",,"8 bromo cyclic amp; bucladesine; cyclic amp; nerve growth factor; radioisotope; animal experiment; autonomic nervous system; cell; cell strain; computer analysis; drug analysis; drug comparison; drug metabolism; drug screening; electrophoresis; endocrine system; in vitro study; methionine s 35; pheochromocytoma; protein synthesis; rat; Animal; Bucladesine; Cell Line; Cyclic AMP; Neoplasm Proteins; Nerve Growth Factors; Pheochromocytoma; Rats; Support, U.S. Gov't, P.H.S.; Translation, Genetic",,"8 bromo cyclic AMP, 23583-48-4; bucladesine, 16980-89-5, 362-74-3; cyclic AMP, 60-92-4; nerve growth factor, 9061-61-4; Bucladesine, 362-74-3; Cyclic AMP, 60-92-4; Neoplasm Proteins; Nerve Growth Factors",,,,,,,,,,,,,00219258,,JBCHA,224040,"English","J. BIOL. CHEM.",Article,Scopus,2-s2.0-0018695866
"Schubert, D.","Insulin-induced cell-substratum adhesion",1979,"Experimental Cell Research","124","2",,"446","451",,2,10.1016/0014-4827(79)90222-2,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0018610398&partnerID=40&md5=29487a82396613d35af5fd3ad0ffea45","Neurobiology Laboratory, The Salk Institute, San Diego, CA 92112, United States","Schubert, D., Neurobiology Laboratory, The Salk Institute, San Diego, CA 92112, United States","The effect of insulin on cell-substratum adhesion was examined using clonal cell lines from the nervous system, myoblasts, and lymphoid cells. Insulin increases adhesion in nerve cells, myoblasts, and lymphomas, but not in the glial and myeloma cell lines examined. In a myoblast variant, M3A, the reaction is specific for insulin and its analogues, and is energy and temperature dependent. © 1979.",,"insulin; blood and hemopoietic system; cell adhesion; cell culture; central nervous system; glia; glioma; in vitro study; lymphatic system; lymphocyte; myeloma cell; myoblast; nervous system; Cell Adhesion; Cell Aggregation; Clone Cells; Cyclic AMP; Energy Metabolism; Insulin; Neurons; Proteins; Structure-Activity Relationship; Support, U.S. Gov't, P.H.S.",,"insulin, 9004-10-8; Cyclic AMP, 60-92-4; Insulin, 11061-68-0; Proteins",,,,"Frazier, Angeletti, Bradshaw, (1972) Science, 176, p. 482; Partlow, (1969) Ph.D. thesis, , Johns Hopkins University; Greene, (1977) Dev biol, 58, p. 96; Holley, (1975) Nature, 258, p. 487; Schubert, Whitlock, (1977) Proc natl acad sci US, 74, p. 4055; Schubert, LaCorbière, Whitlock, Stallcup, (1978) Nature, 273, p. 718; Yaffe, (1968) Proc natl acad sci US, 61, p. 477; Tarikas, Schubert, (1974) Proc natl acad sci US, 71, p. 2377; Stallcup, (1977) Brain res, 126, p. 475; Hollenberg, (1976) Life sci, 18, p. 521; Gavin, Roth, Jen, Freychot, (1972) Proceedings of the National Academy of Sciences, 69, p. 747; Heytler, (1963) Biochemistry, 2, p. 357; Evans, Morhen, Jones, Tomkins, (1974) J cell biol, 61, p. 95; Eisen, Nasi, Georgopoulos, Arndt-Jovin, Ostertag, (1977) Cell, 10, p. 689; Bernaert, Wanson, Drochmans, Popowski, (1977) J cell biol, 74, p. 878; Schubert, Humphreys, de Vitry, Jacob, (1971) Dev biol, 25, p. 514; Greene, Tischler, (1976) Proceedings of the National Academy of Sciences, 73, p. 2124; Schubert, Heinemann, Carlisle, Tarikas, Kimes, Patrick, Steinbach, Brandt, (1974) Nature, 249, p. 224; Tashjian, Bancroft, Levine, (1970) J cell biol, 47, p. 61; Margalies, Kuehl, Scharff, (1976) Cell, 8, p. 405; Zwerner, Acton, (1975) J exp med, 142, p. 378; Horibata, Harris, (1970) Exp cell res, 60, p. 61; Hyman, Stallings, (1974) J natl cancer inst, 52, p. 429; Ralph, (1973) J immunol, 110, p. 1470","Schubert, D.; Neurobiology Laboratory, The Salk Institute, San Diego, CA 92112, United States",,,,,,,,00144827,,ECREA,228955,"English","Exp. Cell Res.",Article,Scopus,2-s2.0-0018610398
"Schubert, D.","Early events after the interaction of NGF with sympathetic nerve cells",1979,"Trends in Neurosciences","2","C",,"17","20",,5,10.1016/0166-2236(79)90009-2,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0018608385&partnerID=40&md5=232e00da0c1e78ebd5c7b526f2101c18",,"Schubert, D.","Nerve growth factor (NGF) is a substance which plays an important role in the differentiation, maintenance, and control of direction of growth of sympathetic neurones. In this article, David Schubert describes experiments using a clonal tissue culture line of sympathetic ganglion-like cells and suggests that cAMP, calcium ion fluxes, and increased cell-substratum adhesion are involved in NGF-induced neurite extension. © 1979.",,"calcium; cyclic amp; nerve growth factor; adrenergic system; autonomic nervous system; cell culture; in vitro study; nerve cell; nervous system; protein synthesis; short survey; sympathetic nerve cell",,"calcium, 7440-70-2; cyclic AMP, 60-92-4; nerve growth factor, 9061-61-4",,,,"Bunge, Johnson, Ross, (1978) Science, 199, pp. 1409-1416; Campenot, (1977) Proc. Nat. Acad. Sci. U.S.A., 74, pp. 4516-4519. , 16th Ed; DeLaat, Van Der Saag, Nelemans, Shinitzky, (1978) Biochim. Biophys. Acta, 509, pp. 188-193; Deman, Bruyneel, (1977) J. Cell Sci., 27, pp. 167-191; Devlin, Emerson, (1978) Cell, 13, pp. 599-611; Greene, Tischler, (1976) Proc. Nat. Acad. Sci. U.S.A., 73, pp. 2424-2428. , 16th Ed; Levi-Montalcini, (1976) Prog. Brain Res., 45, pp. 235-258; Luduena, (1973) Dev. Biol., 33, p. 268; Patrick, Heinemann, Schubert, (1978) Annu. Rev. Neurosci., 1, pp. 417-443; Patrick, Stallcup, (1977) Proc. Nat. Acad. Sci. U.S.A., 74, pp. 4689-4693. , 16th Ed; Rasmussen, Goodman, (1977) Physiol. Rev., 57, pp. 421-516; Schubert, LaCorbiere, Whitlock, Stallcup, (1978) Nature (London), 273, pp. 718-722",,,,,,,,,01662236,,TNSCD,,"English","Trends Neurosci.",Article,Scopus,2-s2.0-0018608385
"Schubert, D., LaCorbiere, M., Whitlock, C., Stallcup, W.","Alterations in the surface properties of cells responsive to nerve growth factor",1978,"Nature","273","5665",,"718","723",,108,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0018193884&partnerID=40&md5=73db216d66b224da1179f8f6a3ca36c7","Salk Inst., San Diego, Calif. 92112, United States","Schubert, D., Salk Inst., San Diego, Calif. 92112, United States; LaCorbiere, M., Salk Inst., San Diego, Calif. 92112, United States; Whitlock, C., Salk Inst., San Diego, Calif. 92112, United States; Stallcup, W., Salk Inst., San Diego, Calif. 92112, United States","An initial effect of nerve growth factor on a responsive nerve cell line is to increase intracellular cyclic AMP, which in turn leads to a mobilisation of calcium ions. These events are correlated with structural changes in the plasma membrane, increased cell-substratum adhesion, and neurite outgrowth.",,"alpha methyl mannoside; atropine; calcimycin; calcium; carbachol; cholera toxin; cyclic amp; fucose; galactose; n acetylgalactosamine; n acetylglucosamine; nerve growth factor; ouabain; ricin; scorpion venom; tetrodotoxin; theophylline; tubocurarine chloride; veratridine; vinblastine; wheat germ agglutinin; antigen antibody reaction; autonomic nervous system; cell adhesion; cell culture; cell membrane; drug comparison; in vitro study; nerve cell membrane; nerve growth; neurite; phytohemagglutinin i 125; review; sympathetic nerve cell; Calcium; Cell Adhesion; Cell Aggregation; Cell Differentiation; Cell Line; Cyclic AMP; Dose-Response Relationship, Drug; Lectins; Membrane Potentials; Nerve Growth Factors; Neurons; Potassium; Surface Properties; Vinblastine",,"alpha methyl mannoside, 617-04-9; atropine, 51-55-8, 55-48-1; calcimycin, 52665-69-7; calcium, 7440-70-2; carbachol, 462-58-8, 51-83-2; cyclic AMP, 60-92-4; fucose, 3615-37-0, 3713-31-3; galactose, 26566-61-0, 50855-33-9, 59-23-4; n acetylglucosamine, 7512-17-6; nerve growth factor, 9061-61-4; ouabain, 11018-89-6, 630-60-4; ricin, 9009-86-3; tetrodotoxin, 4368-28-9, 4664-41-9; theophylline, 58-55-9, 5967-84-0, 8055-07-0, 8061-56-1, 99007-19-9; tubocurarine chloride, 57-94-3, 57-95-4, 8006-51-7; veratridine, 71-62-5; vinblastine, 865-21-4; Calcium, 7440-70-2; Cyclic AMP, 60-92-4; Lectins; Nerve Growth Factors; Potassium, 7440-09-7; Vinblastine, 865-21-4",,,,,,,,,,,,,00280836,,NATUA,208002,"English","NATURE",Article,Scopus,2-s2.0-0018193884
"Patrick, J., Heinemann, S., Schubert, D.","Biology of cultured nerve and muscle.",1978,"Annual Review of Neuroscience","1",,,"417","443",,18,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0018228112&partnerID=40&md5=214c56dc6d3674d6d4f9d99ee6f4ee1b",,"Patrick, J.; Heinemann, S.; Schubert, D.","Cells from the nervous system can be grown in culture and exhibit many of the biophysical, biochemical, and morphological properties found in vivo. They can be induced to differentiate in culture and perform some of the interactions that occur in the nervous system, including synaptogenesis. A number of important questions relating to nervous system development and function have been approached in culture in ways that cannot be done in vivo. The use of clonal cell lines should lead to rapid progress in the analysis of the nervous system at the chemical level.",,"acetylcholine; muscarinic receptor; nerve protein; neurotransmitter; nicotinic receptor; animal; biosynthesis; cell clone; cell differentiation; cell line; cell membrane; electrophysiology; glia; metabolism; mouse; muscle; nerve cell; neuroblastoma; physiology; review; Acetylcholine; Animal; Cell Differentiation; Cell Line; Cell Membrane; Clone Cells; Electrophysiology; Mice; Muscles; Nerve Tissue Proteins; Neuroblastoma; Neuroglia; Neurons; Neurotransmitters; Receptors, Muscarinic; Receptors, Nicotinic",,"acetylcholine, 51-84-3, 60-31-1, 66-23-9; Acetylcholine, 51-84-3; Nerve Tissue Proteins; Neurotransmitters; Receptors, Muscarinic; Receptors, Nicotinic",,,,,"Patrick, J.",,,,,,,,0147006X,,,40527,"English","Annu Rev Neurosci",Review,Scopus,2-s2.0-0018228112
"Schubert, D.","NGF-induced alternations in protein secretion and substrate-attached material of a clonal nerve cell line",1978,"Brain Research","155","1",,"196","200",,4,10.1016/0006-8993(78)90325-6,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0017820556&partnerID=40&md5=30060197bfdd481a749fac574732c367","Neurobiology Laboratory, The Salk Institute, P.O. Box 1809, San Diego, CA 92112, United States","Schubert, D., Neurobiology Laboratory, The Salk Institute, P.O. Box 1809, San Diego, CA 92112, United States",[No abstract available],,"bucladesine; collagen; cyclic amp; egtazic acid; glycosaminoglycan; nerve growth factor; protein; radioisotope; action; cell culture; fibroblast; in vitro study; leucine c 14; leucine h 3; nerve cell; peripheral nervous system; protein synthesis; Animal; Bucladesine; Cell Adhesion; Clone Cells; Membrane Proteins; Mitosis; Molecular Weight; Nerve Growth Factors; Nerve Tissue Proteins; Neurons; Support, U.S. Gov't, P.H.S.",,"bucladesine, 16980-89-5, 362-74-3; collagen, 9007-34-5; cyclic AMP, 60-92-4; egtazic acid, 67-42-5; nerve growth factor, 9061-61-4; protein, 67254-75-5; Bucladesine, 362-74-3; Membrane Proteins; Nerve Growth Factors; Nerve Tissue Proteins",,,,"Baum, McDonald, Crystal, Metabolic fate of the major cell surface protein of normal human fibroblasts (1977) Biochem. biophys. Res. Commun., 79, pp. 8-15; Culp, Molecular composition and origin of substrate-attached material from normal and virus transformed cells (1976) J. supermol. Struct., 5, pp. 239-255; Culp, Buniel, Substrate-attached serum and cell proteins in adhesion of mouse fibroblasts (1976) J. Cell Physiol., 88, pp. 89-106; Doljanski, Kapeller, Cell surface shedding — the phenomenon and its possible significance (1976) J. theor. Biol., 62, pp. 253-270; Greene, Tischler, Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to NGF (1976) Proc. nat. Acad. Sci. (Wash.), 73, pp. 2424-2428; Kapeller, Galloz, Grover, Doljanski, Natural shedding of carbohydrate containing macromolecules from cell surfaces (1973) Exp. Cell Res., 79, pp. 152-158; La Mont, Gammon, Isselbacher, Cell-surface glycosyltransferases in cultured fibroblasts increased activity and release during serum stimulated growth (1977) Proceedings of the National Academy of Sciences, 74, pp. 1086-1090; Levi-Montalcini, Angeletti, Angeletti, The nerve growth factor (1972) Struct. Funct. nerv. Tiss., 5, pp. 1-38; Patrick, Heinemann, Schubert, Biology of cultured nerve and muscle (1978) Ann. Rev. Neurobiol., 1, pp. 417-443; Rosen, Culp, Morphology and cellular origins of substrate-attached material from mouse fibroblasts (1977) Exp. Cell Res., 107, pp. 139-149; Schubert, Proteins secreted by clonal cell lines: changes in metabolism with culture growth (1976) Exp. Cell Res., 102, pp. 329-340; Schubert, The substrate-attached material synthesized by clonal cell lines of nerve, glia and muscle (1977) Brain Research, 132, pp. 337-346; Schubert, Whitlock, The alteration of cellular adhesion by nerve growth factor (1977) Proc. nat. Acad. Sci. (Wash.), 74, pp. 4055-4058; Schubert, Kidokoro, Heinemann, Cholinergic metabolism and synapse formation by rat nerve cell line (1977) Proc. nat. Acad. Sci. (Wash.), 74, pp. 2579-2583; Schubert, LaCorbiere, Whitlock, Stallcup, Alterations in the surface properties of cells responsive to nerve growth factor (1978) Nature (Lond.), 273, pp. 718-722; Vogt, Dulbecco, Steps in the neoplastic transformation of hamster embryo cells by polyoma virus (1963) Proc. nat. Acad. Sci. (Wash.), 49, pp. 171-179","Schubert, D.; Neurobiology Laboratory, The Salk Institute, P.O. Box 1809, San Diego, CA 92112, United States",,,,,,,,00068993,,BRREA,210893,"English","Brain Res.",Article,Scopus,2-s2.0-0017820556
"Schubert, D., Whitlock, C.","Alteration of cellular adhesion by nerve growth factor",1977,"Proceedings of the National Academy of Sciences of the United States of America","74","9",,"4055","4058",,71,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0040528925&partnerID=40&md5=0d6cc8c6a5d81e0a960793ce75b0476e","Neurobiol. Lab., Salk Inst., San Diego, Calif. 92112, United States","Schubert, D., Neurobiol. Lab., Salk Inst., San Diego, Calif. 92112, United States; Whitlock, C., Neurobiol. Lab., Salk Inst., San Diego, Calif. 92112, United States","Nerve growth factor increases the initial rates of cell-substratum and cell-cell adhesion of sympathetic nerve cell clone PC12. It also stimulates adenosine 3':5'-cyclic monophosphate accumulation in the cells, and exogenous adenosine 3':5'-cyclic monophosphate increases cell-substratum adhesion. NGF-stimulated adhesion is energy dependent and cold-sensitive and does not require do novo protein synthesis. It is probably mediated by an effect of adenosine 3':5'-cyclic monophosphate on the plasma membrane. Stimulation of cellular adhesion may the first step in NGF-initiated neurite outgrowth by sympathetic nerve cells.",,"alpha bungarotoxin; bucladesine; cyclic amp; cycloheximide; cytochalasin b; nerve growth factor; radioisotope; adhesion; carbonyl cyanide phenylhydrazone; cell adhesion; cell culture; clone; drug comparison; drug interaction; in vitro study; leucine h 3; pheochromocytoma; protein synthesis; rat; sympathetic nerve; sympathetic nerve cell; theoretical study; Bucladesine; Cell Adhesion; Cell Line; Cyclic AMP; Cycloheximide; Kinetics; Nerve Growth Factors; Pheochromocytoma; Support, U.S. Gov't, P.H.S.",,"alpha bungarotoxin, 11032-79-4; bucladesine, 16980-89-5, 362-74-3; cyclic AMP, 60-92-4; cycloheximide, 642-81-9, 66-81-9; cytochalasin B, 14930-96-2; nerve growth factor, 9061-61-4; Bucladesine, 362-74-3; Cyclic AMP, 60-92-4; Cycloheximide, 66-81-9; Nerve Growth Factors",,,,,,,,,,,,,00278424,,PNASA,198815,"English","PROC. NATL. ACAD. SCI. U. S. A.",Article,Scopus,2-s2.0-0040528925
"Schubert, D., Klier, F.G.","Storage and release of acetylcholine by a clonal cell line",1977,"Proceedings of the National Academy of Sciences of the United States of America","74","11",,"5184","5188",,66,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0037934795&partnerID=40&md5=e4ae199ecb64d3b753902d034451d555","Neurobiol. Lab., Salk Inst., San Diego, Calif. 92112, United States","Schubert, D., Neurobiol. Lab., Salk Inst., San Diego, Calif. 92112, United States; Klier, F.G., Neurobiol. Lab., Salk Inst., San Diego, Calif. 92112, United States","The nerve cell line PC12, in its morphologically undifferentiated state, synthesizes, stores, and secretes catecholamines and acetylcholine. At least 60% of the basal level of neurotransmitter release is due to a calcium-dependent mechanism, and the rate of secretion is enhanced by increasing external potassium. A minimum of 80% of the intracellular acetylcholine and catecholamines are stored in particulate structures. The storage site for acetylcholine is dense core vesicles that can be distinguished from those containing catecholamines on the basis of vesicle density on sucrose gradients, vesicle size, and reserpine sensitivity. These results are discussed in relation to what are thought to be the early stages of synapse formation in cell culture.",,"acetylcholine; dopamine; neurotransmitter; noradrenalin; physostigmine; radioisotope; reserpine; cell culture; cell line; choline c 14; choline h 3; clone; in vitro study; leucine c 14; leucine h 3; nerve cell; synaptogenesis; theoretical study; Acetylcholine; Catecholamines; Cell Line; Chromogranins; Clone Cells; Dopamine beta-Hydroxylase",,"acetylcholine, 51-84-3, 60-31-1, 66-23-9; dopamine, 51-61-6, 62-31-7; noradrenalin, 1407-84-7, 51-41-2; physostigmine, 57-47-6, 64-47-1; reserpine, 50-55-5, 8001-95-4; Acetylcholine, 51-84-3; Catecholamines; Chromogranins; Dopamine beta-Hydroxylase, EC 1.14.17.1",,,,,,,,,,,,,00278424,,PNASA,270759,"English","PROC. NATL. ACAD. SCI. U. S. A.",Article,Scopus,2-s2.0-0037934795
"Schubert, D., Heinemann, S., Kidokoro, Y.","Cholinergic metabolism and synapse formation by a rat nerve cell line",1977,"Proceedings of the National Academy of Sciences of the United States of America","74","6",,"2579","2583",,95,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0017656744&partnerID=40&md5=eeadc7e5ebcc8b68d69f551eb94784f5","Neurobiol. Lab., Salk Inst., San Diego, Calif. 92112, United States","Schubert, D., Neurobiol. Lab., Salk Inst., San Diego, Calif. 92112, United States; Heinemann, S., Neurobiol. Lab., Salk Inst., San Diego, Calif. 92112, United States; Kidokoro, Y., Neurobiol. Lab., Salk Inst., San Diego, Calif. 92112, United States","The PC12 clone of a rat pheochromocytoma is able to synthesize acetylcholine. The amount of acetylcholine synthesized, and the specific activity of choline O-acetyltransferase (acetyl-CoA:choline O-acetyltransferase) varies as a function of the culture growth curve and is dependent on cell density. The specific activity of choline acetyltransferase is increased by nerve growth factor, growth-conditioned medium from a variety of cell types, and adenosine 3':5'-monophosphate. Finally, the PC12 cell line is able to form cholinergic synapses with a clonal cell line of skeletal muscle origin.",,"8 bromo cyclic amp; acetylcholine; bucladesine; catecholamine; choline acetyltransferase; cholinergic receptor; cyclic amp; enzyme; nerve growth factor; oxidopamine; radioisotope; theophylline; choline c 14; gas chromatography; histology; in vitro study; inheritance; methodology; microscopy; miniature endplate potential; muscle; pheochromocytoma; rat; synaptogenesis; Acetylcholine; Acetyltransferases; Animal; Cell Line; Choline O-Acetyltransferase; Cyclic AMP; Kinetics; Nerve Growth Factors; Organ Specificity; Pheochromocytoma; Rats; Support, U.S. Gov't, P.H.S.; Synapses; Theophylline",,"8 bromo cyclic AMP, 23583-48-4; acetylcholine, 51-84-3, 60-31-1, 66-23-9; bucladesine, 16980-89-5, 362-74-3; choline acetyltransferase, 9012-78-6; cyclic AMP, 60-92-4; nerve growth factor, 9061-61-4; oxidopamine, 1199-18-4, 28094-15-7, 636-00-0; theophylline, 58-55-9, 5967-84-0, 8055-07-0, 8061-56-1, 99007-19-9; Acetylcholine, 51-84-3; Acetyltransferases, EC 2.3.1.; Choline O-Acetyltransferase, EC 2.3.1.6; Cyclic AMP, 60-92-4; Nerve Growth Factors; Theophylline, 58-55-9",,"burroughs wellcome",,,,,,,,,,,00278424,,PNASA,196294,"English","PROC. NATL. ACAD. SCI. U. S. A.",Article,Scopus,2-s2.0-0017656744
"Schubert, D.","The substrate attached material synthesized by clonal cell lines of nerve, glia, and muscle",1977,"Brain Research","132","2",,"337","346",,10,10.1016/0006-8993(77)90426-7,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0017736051&partnerID=40&md5=26ef92206a56a8534247579e0112b831","Department of Neurobiology, The Salk Institute, San Diego, CA 92112, United States","Schubert, D., Department of Neurobiology, The Salk Institute, San Diego, CA 92112, United States","A large number of clonal cell lines were examined for the deposition of proteins (substrate attached material, SAM) on the substratum of culture dishes. Of the many cell types examined, only nerve, muscle, and glia synthesized SAM containing a predominant species of protein with an apparent molecular weight of 55,000. This 55,000 molecular weight protein is distinguishable from actin, tubulin, and collagen. © 1977.",,"radioisotope; alanine h 3; clone; glia cell; glycine h 3; histidine h 3; in vitro study; leucine c 14; leucine h 3; muscle; nerve cell; proline h 3; protein synthesis; Actins; Clone Cells; Collagen; Leucine; Molecular Weight; Muscles; Nerve Tissue Proteins; Neuroglia; Neurons; Proteins; Support, U.S. Gov't, P.H.S.; Tubulin",,"Actins; Collagen, 9007-34-5; Leucine, 61-90-5; Nerve Tissue Proteins; Proteins; Tubulin",,,,"Boone, Malignant hemangioendotheliomas produced by subcutaneous inoculation of Balb/3T3 cells attached to glass beads (1975) Science, 188, pp. 68-70; Bornstein, Comparative sequence studies of rat skin and tendon collagen. I. Evidence for incomplete hydroxylation of individual prolyl residues in the normal proteins (1967) Biochemistry, 6, pp. 3082-3091; Culp, Substrate-attached glycoproteins mediating adhesion of normal and virus-transformed fibroblasts (1974) J. Cell Biol., 63, pp. 71-83; Culp, Buniel, Substrate-attached serum and cell proteins in adhesion of mouse fibroblasts (1976) J. Cell Physiol., 88, pp. 89-106; Davidson, Winslow, The protein subunit of calf brain neurofilament (1974) J. Neurobiol., 5, pp. 119-133; Eastoe, Composition of collagen and allied proteins (1967) Treatise on Collagen, 1, pp. 1-72. , G.N. Ramachandran, Academic Press, New York; Etlinger, Fischman, M and Z band components and the assembly of myofibrils (1973) Cold Spring Harbor Symposia on Quantitative Biology, 37, pp. 511-522; Feit, Dutton, Barondes, Shelanski, Microtubule protein: identification and transport to nerve endings (1971) J. Cell Biol., 51, pp. 138-147; Gross, Harper, Harris, McCroskery, Highberger, Corbetti, Kang, Animal collagenases: specificity of action and structures of the substance cleavage site (1974) Biochem. biophys. Res. Commun., 61, pp. 605-610; Holley, Kiernan, Control of the initiation of DNA synthesis in 3T3: serum factors (1974) Proc. nat. Acad. Sci. (Wash.), 71, pp. 2908-2911; Kidokoro, Heinemann, Schubert, Brandt, Klier, Synapse formation and neurotrophic effects on muscle cell lines (1976) Cold Spring Harbor Symposia on Quantitative Biology, 39, pp. 373-398; Kimes, Brandt, Characterization of two putative smooth muscle cell lines from rat thoracic aorta (1976) Exp. Cell Res., 98, pp. 349-360; Kimes, Brandt, Properties of a clonal muscle cell line from cat heart (1976) Exp. Cell Res., 98, pp. 367-380; Levitt, Dorfman, Concepts and mechanisms of cartilage differentiation (1974) Current Topics in Developmental Biology, pp. 103-149. , A.A. Moscona, A. Monroy, Academic Press, New York; Nelson, Christian, Nirenberg, Synapse formation between clonal neuroblastomaglioma hybrid cells and striated muscle cells (1976) Proc. nat. Acad. Sci. (Wash.), 73, pp. 123-127; Porter, Todaro, Fonte, A scanning electron microscope study of surface features of viral and spontaneous transformations of mouse Balb/3T3 cells (1973) J. Cell Biol., 59, pp. 633-641; Poste, Greenham, Malucci, Reeven, Alexander, The study of cellular ‘microexudates’ by ellipsometry and their relationship to the cell coat (1973) Exp. Cell Res., 78, pp. 303-313; Rosenberg, Microexudates from cells grown in tissue culture (1960) Biophys. J., 1, pp. 137-159; Schubert, Tarikas, Humphreys, Heinemann, Patrick, Protein synthesis and secretion in a myogenic cell line (1973) Develop. Biol., 33, pp. 18-37; Maurer, (1971) Disc Electrophoresis, , Walter de Gruyther, Berlin; Schubert, Harris, Heinemann, Devine, Characterization of a unique muscle cell line (1974) J. Cell Biol., 61, pp. 398-410; Schubert, Heinemann, Carlisle, Tarikas, Kimes, Patrick, Steinbach, Brandt, Clonal cell lines from the rat central nervous system (1974) Nature (Lond.), 249, pp. 224-226; Schubert, Carlisle, Look, Putative neurotransmitters in clonal cell lines (1975) Nature, 254, pp. 343-344; Schubert, Proteins secreted by clonal cell lines: changes in metabolism with culture growth (1976) Exp. Cell Res., 102, pp. 329-340; Silagi, Control of pigment production in a mouse melanoma cell in vitro (1969) J. Cell Biol., 43, pp. 263-274; Stein, Chang, Bohlen, Imai, Udenfriend, Amino acid analysis with fluorescamine of stained protein bands from polyacrylamide gels (1974) Analyt. Biochem., 60, p. 272; Tarikas, Schubert, Regulation of adenylate kinase and creatine kinase activities in myogenic cells (1974) Proc. nat. Acad. Sci. (Wash.), 71, pp. 2377-2381; Tashjian, Brancroft, Levine, Production of both prolactin and growth hormone by clonal strains of rat pituitary cells (1970) J. Cell Biol., 47, pp. 61-70; Terry, Culp, Substrate-attached glycoproteins from normal and virus-transformed cells (1974) Biochemistry, 13, pp. 414-426; Thompson, Tomkins, Gurran, Induction of tyrosine alpha-ketoglutarate transaminase by steroid hormones in a newly established tissue culture line (1966) Proceedings of the National Academy of Sciences, 51, pp. 296-304; Trowbridge, Ralph, Bevan, Differences in the surface proteins of mouse B and T cells (1975) Proc. nat. Acad. Sci. (Wash.), 72, pp. 157-161; Vogt, Dulbecco, Steps in the neoplastic transformation of hamster embryo cells by polyma virus (1963) Proc. nat. Acad. Sci. (Wash.), 49, pp. 171-179; Weber, Osborne, The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis (1969) J. biol. Chem., 244, pp. 4406-4412; Weiss, Poste, MacKearnin, Willett, Growth of mammalian cells on substrates coated with cellular microexudates (1975) J. Cell Biol., 64, pp. 135-145; Yaffe, Retention of differentiation potentialities during prolonged cultivation of myogenic cells (1968) Proc. nat. Acad. Sci. (Wash.), 61, pp. 477-481; Yaoi, Kanaseki, Role of microexudate carpet in cell division (1972) Nature (Lond.), 237, pp. 283-284","Schubert, D.; Department of Neurobiology, The Salk Institute, San Diego, CA 92112, United States",,,,,,,,00068993,,BRREA,890484,"English","Brain Res.",Article,Scopus,2-s2.0-0017736051
"Klier, F.G., Schubert, D., Heinemann, S.","The ultrastructural differentiation of the clonal myogenic cell line L6 in normal and high K+ medium",1977,"Developmental Biology","57","2",,"440","449",,13,10.1016/0012-1606(77)90228-7,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0017683649&partnerID=40&md5=78b64f916371cdb961659f153086593e","Neurobiology Laboratory, The Salk Institute, P.O. Box 1809, San Diego, CA 92112, United States","Klier, F.G., Neurobiology Laboratory, The Salk Institute, P.O. Box 1809, San Diego, CA 92112, United States; Schubert, D., Neurobiology Laboratory, The Salk Institute, P.O. Box 1809, San Diego, CA 92112, United States; Heinemann, S., Neurobiology Laboratory, The Salk Institute, P.O. Box 1809, San Diego, CA 92112, United States","Cells of the clonal myogenic line L6 were examined electron microscopically at successive stages of growth. L6 cells are developmentally similar to those of chick and rat primary skeletal muscle cultures and skeletal muscle in vivo, with respect to myofibrillogenesis and sarcomere organization. However, the sarcoplasmic reticulum and T systems of L6 myotubes are not as well differentiated as those of primary muscle cultures and adult skeletal muscle. Finally, L6 myotubes show precocious sarcomere differentiation when cultured in medium containing 25 mM potassium. © 1977.",,"potassium; cell culture; electron microscopy; histology; in vitro study; muscle cell; muscle development; rat; sarcomere; theoretical study; Actins; Cell Differentiation; Cell Fusion; Cell Line; Culture Media; Endoplasmic Reticulum; Microscopy, Electron; Muscles; Myosins; Potassium; Sarcolemma; Support, U.S. Gov't, P.H.S.",,"potassium, 7440-09-7; Actins; Culture Media; Myosins, EC 3.6.1.4; Potassium, 7440-09-7",,,,"Yaffe, (1968) Proc. Nat. Acad. Sci. USA, 61, p. 477. , 2nd ed; Richler, Yaffe, (1970) Develop. Biol, 23, p. 1; Shainberg, Yagel, Yaffe, (1971) Develop. Biol, 25, p. 1; Schubert, Tarikas, Humphreys, Heinemann, Patrick, (1973) Develop. Biol, 33, p. 18; Tarikas, Schubert, (1974) Proc. Nat. Acad. Sci. USA, 71, p. 2377. , 2nd ed; Delain, Meienhofer, Proux, Schapira, (1973) Differentiation, 1, p. 349; Patrick, Heinemann, Lindstrom, Schubert, Steinbach, (1972) Proc. Nat. Acad. Sci. USA, 69, p. 2762. , 2nd ed; Steinbach, Patrick, Schubert, Harris, Heinemann, (1973) J. Gen. Physiol, 62, p. 255; Kidokoro, (1973) Nature (London), 241, p. 158; Kidokoro, (1975) J. Physiol, 244, p. 129; Kidokoro, (1975) J. Physiol, 244, p. 145; Harris, Heinemann, Schubert, Tarikas, (1971) Nature (London), 231, p. 296; Kidokoro, Heinemann, Synapse formation between clonal muscle cells and rat spinal cord explants (1975) Nature, 252, p. 593; Kidokoro, Heinemann, Brandt, Schubert, Klier, (1976) Cold Spring Harbor Symp. Quant. Biol, 40, p. 373. , 2nd ed; Vogt, Dulbecco, (1963) Proc. Nat. Acad. Sci. USA, 49, p. 171. , 2nd ed; Reynolds, (1963) J. Cell Biol, 17, p. 208; Przybylski, Blumberg, (1966) Lab. Invest, 15, p. 836; Shimada, Fischman, Moscona, (1967) J. Cell Biol, 35, p. 445; Ishikawa, Bischoff, Holtzer, (1968) J. Cell Biol, 38, p. 538; Ezerman, Ishikawa, DIFFERENTIATION OF THE SARCOPLASMIC RETICULUM AND T SYSTEM IN DEVELOPING CHICK SKELETAL MUSCLE IN VITRO (1967) The Journal of Cell Biology, 35, p. 405; Holtzer, Marshall, Finck, (1957) J. Biophys. Biochem. Cytol, 3, p. 705; Fambrough, Rash, (1971) Develop. Biol, 26, p. 55; Rash, Fambrough, Ultrastructural and electrophysiological correlates of cell coupling and cytoplasmic fusion during myogenesis in vitro (1973) Developmental Biology, 30, p. 166; Fischman, (1972) The Structure and Function of Muscle, p. 75. , G.H. Bourne, 2nd ed., Academic Press, New York; Kimes, Brandt, (1976) Exp. Cell Res, 98, p. 349; Kimes, Brandt, (1976) Exp. Cell Res, 98, p. 367; Rash, Shay, Biesele, (1970) J. Ultrastruct. Res, 33, p. 399; Fischman, (1970) Science, 169, p. 1331; Fischman, (1967) J. Cell Biol, 32, p. 557; Huxley, (1972) The Structure and Function of Muscle, p. 301. , G.H. Bourne, 2nd ed., Academic Press, New York; Etlinger, Fischman, M and Z Band Components and the Assembly of Myofibrils (1972) Cold Spring Harbor Symposia on Quantitative Biology, 37, p. 511; Ishikawa, (1968) J. Cell Biol, 38, p. 51; Huxley, (1957) J. Biophys. Biochem. Cytol, 3, p. 631; Page, Huxley, FILAMENT LENGTHS IN STRIATED MUSCLE (1963) The Journal of Cell Biology, 19, p. 365; Steinbach, (1974) Nature (London), 248, p. 70; Orr, Yoshikawa-Fukada, Ebert, (1972) Proc. Nat. Acad. Sci. USA, 69, p. 243; Lasher, Zagon, (1972) Brain Res, 41, p. 482; Scott, Effect of potassium on neuron survival in cultures of dissociated human nervous tissue (1971) Experimental Neurology, 31, p. 297; Scott, Fischer, (1970) Exp. Neurol, 27, p. 16; Cunningham, Kleutch, Iterbst, (1960) (London) Nature, 186, p. 241; Shimada, (1971) J. Cell Biol, 48, p. 128; Gauthier, Schaeffer, (1974) J. Cell Sci, 14, p. 113; Price, (1973) The Striated Muscle, p. 144. , C. Pearson, F.K. Mostofi, Williams and Wilkins, Baltimore, Md","Klier, F.G.; Neurobiology Laboratory, The Salk Institute, P.O. Box 1809, San Diego, CA 92112, United States",,,,,,,,00121606,,DEBIA,873055,"English","Dev. Biol.",Article,Scopus,2-s2.0-0017683649
"Schubert, D., Lacorbiere, M.","Phenotypic transformation of clonal myogenic cells to cells resembling chondrocytes",1976,"Proceedings of the National Academy of Sciences of the United States of America","73","6",,"1989","1993",,5,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0017116448&partnerID=40&md5=95225d2789bcf1ecf5695cf5ddfc3b2d","Dept. Neurobiol., Salk Inst., San Diego, Calif. 92112, United States","Schubert, D., Dept. Neurobiol., Salk Inst., San Diego, Calif. 92112, United States; Lacorbiere, M., Dept. Neurobiol., Salk Inst., San Diego, Calif. 92112, United States",[No abstract available],,"6 aminonicotinamide; bucladesine; cartilage cell; cell transformation; histology; in vitro study; theoretical study; 6-Aminonicotinamide; Bucladesine; Cartilage; Cell Differentiation; Cell Division; Cell Line; Cells, Cultured; Collagen; Cyclic AMP; Glycosaminoglycans; Muscles; NAD; Phenotype; Procollagen-Proline Dioxygenase",,"6 aminonicotinamide, 329-89-5; bucladesine, 16980-89-5, 362-74-3; 6-Aminonicotinamide, 329-89-5; Bucladesine, 362-74-3; Collagen, 9007-34-5; Cyclic AMP, 60-92-4; Glycosaminoglycans; NAD, 53-84-9; Procollagen-Proline Dioxygenase, EC 1.14.11.2",,,,,,,,,,,,,00278424,,PNASA,180533,"English","PROC. NATL. ACAD. SCI. U. S. A.",Article,Scopus,2-s2.0-0017116448
"Schubert, D., Lacorbiere, M., Watson, J.","Growth regulation of cells grown in suspension culture",1976,"Nature","264","5583",,"266","267",,3,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0017133161&partnerID=40&md5=fa63ec3deb4e1a1eea82f5f863985cb9","Dept. Neurobiol., Salk Inst., San Diego, Calif. 92112, United States","Schubert, D., Dept. Neurobiol., Salk Inst., San Diego, Calif. 92112, United States; Lacorbiere, M., Dept. Neurobiol., Salk Inst., San Diego, Calif. 92112, United States; Watson, J., Dept. Neurobiol., Salk Inst., San Diego, Calif. 92112, United States","Various aspects of a cell's growth cycle can be manipulated in tissue culture. For example, the initiation of DNA synthesis and, in some cases, culture growth, can be enhanced by serum and platelet components, polypeptides purified from growth conditioned medium and urine, insulin, corticosteroids, prostaglandins, cyclic nucleotides and proteolytic enzymes. In addition, at least three purified proteins can initiate DNA synthesis in fibroblast like cells - nerve growth factor, epidermal growth factor and fibroblast growth factor. Disturbance of the culture medium directly over the cultured cells also induces DNA synthesis. Fibroblast like cells have been used in most of these studies, and they grow tightly associated with the culture dish and are strongly anchorage dependent for division. Given the strong anchorage dependence of the test cells, two alternatives could account for the induction of DNA synthesis and growth by the diversity of conditions and 'factors' outlined above. The first would ascribe the effects of these compounds to interactions on the cell surface with a suitable receptor. These are hormone like interactions, thought to be exemplified by compounds such as insulin and purified growth factors. The second alternative represents interactions which function directly through alterations of cell anchorage. For example, the growth stimulating effects of the proteases are presumably affected by modification of the cell substratum (anchorage) interaction. To distinguish between these two alternatives, it should be sufficient to assay the effects of serum and a purified growth factor on the initiation of DNA synthesis in an anchorage dependent cell line, and on a variant which grows in suspension culture. If serum and the growth factor were equally effective in both cell lines, then a disturbance in anchorage could not account for the mitogenic activity, ruling out the second alternative. The first, hormone like, mechanism, however, would be excluded if the growth factor was unable to induce DNA synthesis in the cells grown in suspension. The experiments described support this latter possibility by showing that fibroblast growth factor does not affect the growth of myoblast cells grown in suspension culture.",,"cell culture; cell growth; cell suspension; growth regulation; in vitro study; theoretical study; Animal; Blood; Cell Adhesion; Cell Division; Cell Membrane; Cells, Cultured; Culture Media; DNA; Growth Substances; Muscles; Rats",,"Culture Media; DNA, 9007-49-2; Growth Substances",,,,,,,,,,,,,00280836,,NATUA,1034209,"English","NATURE",Article,Scopus,2-s2.0-0017133161
"Schubert, D., Tarikas, H., LaCorbiere, M.","Neurotransmitter regulation of adenosine 3',5' monophosphate in clonal nerve, glia, and muscle cell lines",1976,"Science","192","4238",,"471","472",,33,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0017231891&partnerID=40&md5=483aaa181f1a87a6c1e0e9befbd5f419","Dept. Neurobiol., Salk Inst., San Diego, Calif. 92112, United States","Schubert, D., Dept. Neurobiol., Salk Inst., San Diego, Calif. 92112, United States; Tarikas, H., Dept. Neurobiol., Salk Inst., San Diego, Calif. 92112, United States; LaCorbiere, M., Dept. Neurobiol., Salk Inst., San Diego, Calif. 92112, United States","Norepinephrine increases the intracellular level of adenosine 3',5' monophosphate (cyclic AMP) in clonal cell lines of nerve, glia, smooth muscle, and skeletal muscle. The largest response is in skeletal muscle, where the cyclic nucleotide concentration is elevated more than 500 fold. Glia and muscle cells, but not nerve cells, respond to dopamine with increased cyclic AMP accumulation. This response appears to be mediated through a beta adrenoreceptor.",,"4 aminobutyric acid; carbachol; cyclic amp; dopa; dopamine; histamine; imipramine; isoprenaline; neurotransmitter; noradrenalin; phentolamine; propranolol; serotonin; theophylline; cell culture; cell line; dose response; drug antagonism; drug comparison; drug response; glia; glia cell; in vitro study; muscle; muscle cell; nerve; smooth muscle; theoretical study; Cell Line; Cyclic AMP; Muscles; Neuroglia; Neurons; Receptors, Adrenergic; Support, U.S. Gov't, P.H.S.",,"4 aminobutyric acid, 28805-76-7, 56-12-2; carbachol, 462-58-8, 51-83-2; cyclic AMP, 60-92-4; DOPA, 587-45-1; dopamine, 51-61-6, 62-31-7; histamine, 51-45-6, 56-92-8, 93443-21-1; imipramine, 113-52-0, 50-49-7; isoprenaline, 299-95-6, 51-30-9, 6700-39-6, 7683-59-2; noradrenalin, 1407-84-7, 51-41-2; phentolamine, 50-60-2, 73-05-2; propranolol, 13013-17-7, 318-98-9, 3506-09-0, 4199-09-1, 525-66-6; serotonin, 50-67-9; theophylline, 58-55-9, 5967-84-0, 8055-07-0, 8061-56-1, 99007-19-9; Cyclic AMP, 60-92-4; Receptors, Adrenergic",,,,,,,,,,,,,00368075,,SCIEA,176728,"English","SCIENCE",Article,Scopus,2-s2.0-0017231891
"Schubert, D.","Proteins secreted by clonal cell lines. Changes in metabolism with culture growth",1976,"Experimental Cell Research","102","2",,"329","340",,9,10.1016/0014-4827(76)90048-3,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0017178686&partnerID=40&md5=a5f8718b6496bac7349e346af147dfab","Department of Neurobiology, The Salk Institute, San Diego, CA 92112, United States","Schubert, D., Department of Neurobiology, The Salk Institute, San Diego, CA 92112, United States","Clonal cell lines release glycoproteins into their culture medium, some of which appear to be derived from the outer cell surface. These proteins do not originate from lysed cells, nor do they comigrate on SDS acrylamide gels with the proteins of substrate attached material. When the proteins released from exponentially dividing cells are compared with those from stationary phase cells, marked differences are found. In addition, the proteins released from normal stationary cells differ from those precociously growth arrested with db-cAMP or by serum deprivation. The spectrum of proteins released by the serum-deprived cells is more like that of normal stationary phase cells than db-cAMP-inhibited cells. © 1976.",,"bucladesine; glycoprotein; protein; cell culture; cell membrane; in vitro study; mouse; theoretical study; Blood; Bucladesine; Cell Division; Cell Membrane; Clone Cells; Culture Media; Cycloheximide; Fucose; Glycoproteins; Lactoperoxidase; Membrane Proteins; Support, U.S. Gov't, P.H.S.",,"bucladesine, 16980-89-5, 362-74-3; protein, 67254-75-5; Bucladesine, 362-74-3; Culture Media; Cycloheximide, 66-81-9; Fucose, 3713-31-3; Glycoproteins; Lactoperoxidase, EC 1.11.1.-; Membrane Proteins",,,,"Atkinson, Summers, (1971) J biol chem, 246, p. 5162; Balsamo, Lilien, (1975) Biochemistry, 14, p. 167; Bekesi, Winzler, (1967) J biol chem, 242, p. 3873; Ben-Or, Doljanski, (1960) Exp cell res, 20, p. 641; Buck, Fuhrer, Soslan, Warren, (1974) J biol chem, 249, p. 1541; Buck, Glick, Warren, (1970) Biochemistry, 8, p. 4567; Buck, Glick, Warren, (1971) Nature, 172, p. 169; Ceccarini, Muramatsu, Tsang, Atkinson, (1975) Proc natl acad sci US, 72, p. 3130; Coffey, Miller, Sellinger, (1964) J biol chem, 239, p. 4011; Cone, Marchalonis, Rolley, (1971) J exp med, 131, p. 1373; Cooper, Codington, Brown, (1974) Proc natl acad sci US, 71, p. 1224; Crane, Miller, (1974) Biochem biophys res commun, 60, p. 1269; Culp, Black, (1972) Biochemistry, 11, p. 2161; Culp, Terry, Buniel, (1975) Biochemistry, 14, p. 406; Furmanski, Silverman, Lubin, (1971) Nature, 233, p. 413; Glick, Buck, (1973) Chem abstr; Glick, Rabinowitz, Sachs, (1973) Biochemistry, 12, p. 4864; Goldberg, Sheer, (1973) Proc natl acad sci US, 70, p. 361; Gottlieb, Merrell, Glaser, (1974) Proc natl acad sci US, 71, p. 1800; Halpern, Rubin, (1970) Exp cell res, 60, p. 86; Halpern, Rubin, (1970) Exp cell res, 60, p. 96; Harris, (1974) Ann rev physiol, 36, p. 251; Hogg, (1974) Proc natl acad sci US, 71, p. 489; Holley, Kiernan, (1971) CIBA foundation symposium on growth control in cell cultures, p. 3. , GEW Wolstenholme, J Knight, Churchill Livingstone, London; Holley, Kiernan, (1974) Proc natl acad sci US, 71, p. 2908; Hsie, Puck, (1971) Proc natl acad sci US, 68, p. 358; Johnson, Friedman, Pastan, (1971) Proc natl acad sci US, 68, p. 425; Kapeller, Galloz, Grover, Doljanski, (1973) Exp cell res, 79, p. 152; Kaufman, Ginsburg, The metabolism of l-fucose by HeLa cells (1968) Experimental Cell Research, 50, p. 127; Kim, Baumler, Carruthers, Bielat, (1975) Proc natl acad sci US, 72, p. 1012; Layman, McGoodwin, Martin, (1971) Proc natl acad sci US, 68, p. 454; McGee, Langness, Udenfriend, (1971) Proc natl acad sci US, 68, p. 1585; Murmatsu, Atkinson, Nathenson, Cell-surface glycopeptides: Growth-dependent changes in the carbohydrate-peptide linkage region (1973) Journal of Molecular Biology, 80, p. 781; Nose, Nitta, Takaoka, Katsuta, (1974) J cell physiol, 84, p. 269; Oppenheimer, (1975) Exp cell res, 92, p. 122; Porter, Puck, Hsie, Kelley, (1974) Cell, 2, p. 145; Poste, Greenham, Mallucci, Reefe, Alexander, (1973) Exp cell res, 78, p. 303; Roberts, Walter, Cetorelli, (1973) Nature, 244, p. 86; Rosenberg, (1960) Biophys j, 1, p. 137; Ruoslahti, Vaheri, Kuusela, Linder, (1973) Biochim biophys acta, 322, p. 352; Schubert, (1970) J mol biol, 51, p. 287; Schubert, Humphreys, DeVitry, Jacob, (1971) Dev biol, 25, p. 514; Schubert, Tarikas, Humphreys, Heinemann, Patrick, (1973) Dev biol, 33, p. 18; Schubert, Harris, Devine, Heinemann, (1974) J cell biol, 61, p. 398; Schubert, (1974) Neurobiology, 4, p. 376; Sheppard, (1971) Proc natl acad sci US, 68, p. 1316; Smets, DeLey, (1974) J cell physiol, 84, p. 343; Stevenson, Stevenson, (1975) Nature, 254, p. 714; Shoham, Sachs, (1974) Exp cell res, 85, p. 8; Sudo, Onodera, (1975) Exp cell res, 91, p. 191; Tanzer, Church, Yaeger, Wampler, Parks, Procollagen: Intermediate Forms Containing Several Types of Peptide Chains and Non-Collagen Peptide Extensions at NH2 and COOH Ends (1971) Proceedings of the National Academy of Sciences, 71, p. 3009; Terry, Culp, (1974) Biochemistry, 13, p. 414; Trowbridge, Ralph, Bevan, (1975) Proc natl acad sci US, 72, p. 157; Vitetta, Uhr, (1972) J exp med, 136, p. 676; Vogt, Dulbecco, (1963) Proc natl acad sci US, 49, p. 171; Warren, Fuhrer, Buck, (1973) Membrane-mediated information, Biochemical functions, 1, p. 142. , PW Kent, Medical and Technical Publisher, London; Weiss, Poste, MacKearnin, Willet, (1975) J cell biol, 64, p. 135; Yaffe, (1968) Proc natl acad sci US, 61, p. 477; Yaoi, Kanaseki, (1972) Nature, 237, p. 283","Schubert, D.; Department of Neurobiology, The Salk Institute, San Diego, CA 92112, United States",,,,,,,,00144827,,ECREA,185076,"English","Exp. Cell Res.",Article,Scopus,2-s2.0-0017178686
"Kidokoro, Y., Heinemann, S., Schubert, D., Brandt, B.L., Klier, F.G.","Synapse formation and neurotrophic effects on muscle cell lines.",1976,"Cold Spring Harbor Symposia on Quantitative Biology","40",,,"373","388",,7,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0016904845&partnerID=40&md5=65f2c1e687656a329f20e323fe5ca142",,"Kidokoro, Y.; Heinemann, S.; Schubert, D.; Brandt, B.L.; Klier, F.G.",[No abstract available],,"acetylcholine; nerve protein; neurotransmitter; tetrodotoxin; animal; article; brain cortex; cell line; central nervous system; dose response; drug effect; electrostimulation; evoked response; growth, development and aging; in vitro study; metabolism; mouse; muscle; nerve ending; neuroblastoma; neuromuscular synapse; physiology; rat; spinal cord; spinal ganglion; synapse; synaptic transmission; ultrastructure; Acetylcholine; Animal; Cell Line; Central Nervous System; Cerebral Cortex; Dose-Response Relationship, Drug; Electric Stimulation; Evoked Potentials; Ganglia, Spinal; In Vitro; Mice; Motor Endplate; Muscles; Nerve Tissue Proteins; Neuroblastoma; Neuromuscular Junction; Neurotransmitters; Rats; Spinal Cord; Support, U.S. Gov't, Non-P.H.S.; Support, U.S. Gov't, P.H.S.; Synapses; Synaptic Transmission; Tetrodotoxin",,"acetylcholine, 51-84-3, 60-31-1, 66-23-9; tetrodotoxin, 4368-28-9, 4664-41-9; Acetylcholine, 51-84-3; Nerve Tissue Proteins; Neurotransmitters; Tetrodotoxin, 4368-28-9",,,,,"Kidokoro, Y.",,,,,,,,00917451,,,7383,"English","Cold Spring Harb Symp Quant Biol",Article,Scopus,2-s2.0-0016904845
"Schubert, D., Carlisle, W., Look, C.","Putative neurotransmitters in clonal cell lines",1975,"Nature","254","5498",,"341","343",,9,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0016665304&partnerID=40&md5=08ad314471bf730bbb3abccee3572628","Dept. Neurobiol., Salk Inst., La Jolla, Calif. 92112, United States","Schubert, D., Dept. Neurobiol., Salk Inst., La Jolla, Calif. 92112, United States; Carlisle, W., Dept. Neurobiol., Salk Inst., La Jolla, Calif. 92112, United States; Look, C., Dept. Neurobiol., Salk Inst., La Jolla, Calif. 92112, United States","The authors used the rat nerve cell lines B35, B50, B65, B103 and B104, and the rat putative glial cell lines B11, B15, B23, B28, B49, B82, B90, B92 and B108, and two other lines of glial origin, C6 and RN2. Additional clonal cell lines examined were: smooth muscles BC3H1 and A10; skeletal muscle L6; plasmacytoma C1 and lymphomas S1A and S49; neuroblastoma clones C1 and N18; melanomas B78 and B559; hepatoma H35; growth hormone and prolactin producing pituitary cells GH3; adrenal cortical line Y1; and the fibroblast cell line 3T3. All cells were grown in modified Eagle's MEM containing 10% fetal calf serum. Early stationary phase cultures, 2 or 3 days after cessation of net cell division, were used exclusively for the determination of free amino acids for cells at this stage of the growth cycle usually express maximum morphological and biochemical differentiation. Cell viability was greater than 95% as measured by the uptake of fluorescein dibutyrate. Cells derived from neuroectoderm contained detectable amounts of GABA and β alanine, although the mesodermally derived muscle and fibroblast cells did not. Thus nerve, glia, melanocytes and neuroblastoma clones had qualitatively similar free amino acid pools distinct from those of muscle and fibroblast cells. It has been shown that nerve and glial cells share a number of additional traits distinct from muscle, such as acetylcholine and catecholamine synthesis, GABA uptake, S100 and 14-3-2 protein synthesis, and a morphological response to cyclic nucleotides. Other cell types, such as those derived from lymphoid tissue, the adrenal cortex and the anterior pituitary, also contained both GABA and β alanine. Thus GABA and β alanine were excluded from most mesodermal tissues as opposed to being uniquely associated with nervous tissue. The apparent exception was the adrenal cortical clone, which is thought to be of mesodermal origin, but contained GABA. The functional similarity between cells of immune and nervous systems has, however, been pointed out repeatedly. In addition, GABA has been found in other tissues in smaller amounts than in the nervous system and may serve a metabolic role. Since no GABA was detected in the culture medium, cells containing GABA probably synthesise it.",,"4 aminobutyric acid; aspartic acid; beta alanine; glutamate decarboxylase; glutamic acid; glycine; neurotransmitter; taurine; adrenal cortex cell; cell culture; cytology; fibroblast; glia cell; hepatoma cell; hypophysis; in vitro study; liver cancer; lymphocyte; lymphoma; melanoma; multiple myeloma; muscle; muscle cell; nerve cell; neuroblastoma; plasma cell; rat; smooth muscle; theoretical study; Alanine; Aminobutyric Acids; Animal; Aspartic Acid; Cell Line; Clone Cells; gamma-Aminobutyric Acid; Glutamates; Glycine; Lymphocytes; Melanocytes; Neuroglia; Neurons; Rats; Synaptic Transmission; Taurine",,"4 aminobutyric acid, 28805-76-7, 56-12-2; aspartic acid, 56-84-8, 6899-03-2; beta alanine, 107-95-9; glutamate decarboxylase, 9024-58-2; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; glycine, 56-40-6, 6000-43-7, 6000-44-8; taurine, 107-35-7; Alanine, 56-41-7; Aminobutyric Acids; Aspartic Acid, 56-84-8; gamma-Aminobutyric Acid, 56-12-2; Glutamates; Glycine, 56-40-6; Taurine, 107-35-7",,,,,,,,,,,,,00280836,,NATUA,235097,"English","NATURE",Article,Scopus,2-s2.0-0016665304
"Klier, G., Schubert, D., Heinemann, S.","Ultrastructural changes accompanying the induced differentiation of clonal rat nerve and glia",1975,"NEUROBIOLOGY","5","1",,"1","7",,3,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0016634807&partnerID=40&md5=18b82aeeec73fbde50ce8ba73743494e","Dept. Neurobiol., Salk Inst., San Diego, Calif. 92112, United States","Klier, G., Dept. Neurobiol., Salk Inst., San Diego, Calif. 92112, United States; Schubert, D., Dept. Neurobiol., Salk Inst., San Diego, Calif. 92112, United States; Heinemann, S., Dept. Neurobiol., Salk Inst., San Diego, Calif. 92112, United States","Dibutyryladenosine 3 5 monophosphate (DBcAMP) induces ultrastructural transformations in clonal rat nerve and glia. Cells cultured in the presence of DBcAMP contain large numbers of aligned microtubules and microfilaments in their elongated processes, while control cultures without DBcAMP are relatively devoid of these structures. In addition, the cells exposed to DBcAMP contain 2000 Å to 6000 Å vesicles which are not observed in control cells.",,"bucladesine; cell culture; cell differentiation; clone; electron microscopy; glia; glia cell; in vitro study; microfilament; microtubule; nerve; nerve cell; nerve cell differentiation; rat; theoretical study; Animal; Bucladesine; Cell Differentiation; Cell Line; Clone Cells; Comparative Study; Cytoplasm; Microtubules; Neuroglia; Neurons; Rats; Stimulation, Chemical; Support, U.S. Gov't, P.H.S.; Time Factors",,"bucladesine, 16980-89-5, 362-74-3; Bucladesine, 362-74-3",,,,,,,,,,,,,12168068,,NBBMA,167317,"English","NEUROBIOLOGY",Article,Scopus,2-s2.0-0016634807
"Kidokoro, Y., Heinemann, S., Schubert, D.","Synapse formation and neurotrophic effects on muscle cell lines",1975,"Symposia on Quantitative Biology","Vol. 40",,,"373","388",,11,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0016583509&partnerID=40&md5=529d83ae24a3d0b0daec05c3608e006d","Dept. Neurobiol., Salk Inst., San Diego, Calif. 92112, United States","Kidokoro, Y., Dept. Neurobiol., Salk Inst., San Diego, Calif. 92112, United States; Heinemann, S., Dept. Neurobiol., Salk Inst., San Diego, Calif. 92112, United States; Schubert, D., Dept. Neurobiol., Salk Inst., San Diego, Calif. 92112, United States","C 1300 neuroblastoma cells were co cultured with myotubes according to methods described by Steinbach and Kidokoro. Phase contrast observations revealed typical contacts which appeared to be structurally different from synapses between spinal cord explants and myotubes. The authors confirmed the findings of Harris that these contacts between neuroblastoma cells and myotubes are functionally inactive. In contrast co cultures of the dorsal part of fetal rat spinal cord and L6 myotubes behaved quite differently. After two weeks of co incubation many myotubes were found to have miniature end plate potentials occurring at rates of 1 to 114 per minute. The cholinergic nature of these potentials was demonstrated by applying d tubocurarine and α neurotoxin. However, KCl failed to enhance the potential frequency. Electron microscopic studies revealed a relatively simple structure. As regards requirements for synapse formation it became evident that α neurotoxin did not prevent synapse formation and that electrical activity in presynaptic nerves is not necessary. Finally the authors tested a great number of cell lines from neurons and muscle systems in vitro. The results of this intensive study concerning biochemical, electrical and ultrastructural aspects should be read in the original article. (Gaillard - Leiden)",,"electron microscopy; histology; in vitro study; muscle fiber culture; myotube; neuroblastoma; neuromuscular synapse; spinal cord; synapse; theoretical study",,,,,,,,,,,,,,,,,SYQBA,,"English","SYMP. QUANT. BIOL.",,Scopus,2-s2.0-0016583509
"Steinbach, J.H., Schubert, D.","Multiple modes of dibutyryl cyclic AMP-induced process formation by clonal nerve and glial cells",1975,"Experimental Cell Research","91","2",,"449","453",,23,10.1016/0014-4827(75)90126-3,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0016691554&partnerID=40&md5=cbd64637da4952dc27d580698affb869","The Neurobiology Department, The Salk Institute, San Diego, CA 92112, United States","Steinbach, J.H., The Neurobiology Department, The Salk Institute, San Diego, CA 92112, United States; Schubert, D., The Neurobiology Department, The Salk Institute, San Diego, CA 92112, United States","Exposure of clonal nerve and glial cells to dibutyryl adenosine-3′,5′-monophosphate (db-cAMP) induced processes. These cellular processes were generated either by the extension of a process (growth) or by retraction of parts of an extended cytoplasm (shrinkage). In all cases, these cells from the central nervous system rounded up in response to db-cAMP, rather than spread on the substratum. © 1975.",,"bucladesine; cell; cell culture; cell metabolism; glia cell; in vitro study; nerve cell; nerve cell culture; theoretical study; Animal; Bucladesine; Cell Line; Cell Movement; Cells, Cultured; Clone Cells; Comparative Study; Cytoplasmic Streaming; Neuroglia; Neurons; Rats; Time Factors",,"bucladesine, 16980-89-5, 362-74-3; Bucladesine, 362-74-3",,,,"Hsie, Puck, (1971) Proc natl acad sci US, 68, p. 358; Hsie, Jones, Puck, (1971) Proc natl acad sci US, 68, p. 1648; Johnson, Friedman, Pastan, (1971) Proc natl acad sci US, 68, p. 425; Johnson, Pastan, (1972) J natl cancer inst, 47, p. 1377; Johnson, Pastan, (1972) Nature new biol, 237, p. 267; Sheppard, (1971) Proc natl acad sci US, 68, p. 1316; Ortiz, Yamada, Hsie, (1973) Proc natl acad sci US, 70, p. 2286; Wahrmann, Winand, Luzzati, (1973) Nature new biol, 245, p. 112; Furmanski, Silverman, Lubin, (1971) Nature, 233, p. 413; Prasad, Hsie, (1971) Nature new biol, 233, p. 141; MacIntyre, Intersgill, Perkins, Vatter, (1972) J cell sci, 11, p. 639; Shapiro, (1973) Nature, 241, p. 203; Schubert, Heinemann, Carlisle, Tarikas, Kimes, Patrick, Steinbach, Brandt, (1974) Nature, 249, p. 224; Schubert, (1974) Neurobiology, , In press; Klier, Schubert, Heinemann, (1974) Neurobiology, , In press; Kimes, Tarikas, Schubert, (1974) Brain res, 79, p. 291; Vogt, Dulbecco, (1963) Proc natl acad sci US, 49, p. 171; Pomerat, Hendelman, Raiborn, Massey, (1967) The neuron, p. 119. , H Hydén, Elsevier, New York; Ginsburg, Solomon, Sreevalson, Freese, (1973) Proceedings of the National Academy of Sciences, 70, p. 2457; Roisen, Murphy, Braden, (1972) J neurobiol, 3, p. 347; Wright, Ceri, Lewis, (1973) Nature new biol, 244, p. 84; Wright, (1973) Exptl cell res, 78, p. 456; Johnson, D'Armiento, Carchman, (1974) Exptl cell res, 85, p. 47","Steinbach, J.H.; The Neurobiology Department, The Salk Institute, San Diego, CA 92112, United States",,,,,,,,00144827,,ECREA,165092,"English","Exp. Cell Res.",Article,Scopus,2-s2.0-0016691554
"Schubert, D.","The uptake of gaba by clonal nerve and glia",1975,"Brain Research","84","1",,"87","98",,18,10.1016/0006-8993(75)90802-1,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0016432174&partnerID=40&md5=f374be45509cedbf46b3b0b9d4e56627","Department of Neurobiology, The Salk Institute, P.O. Box 1809, San Diego, CA 92112, United States","Schubert, D., Department of Neurobiology, The Salk Institute, P.O. Box 1809, San Diego, CA 92112, United States","A number of clonal nerve and glial cell lines are able to accumulate exogenous GABA. The ability of the cells to concentrate GABA is dependent upon external calcium, while the uptake process is sodium dependent and temperature sensitive. GABA uptake by the cell lines is specific with respect to analogue inhibition, but this specificity is different from that observed in brain slices. It is, however, similar to that of glia in the rat sensory ganglia. Although clonal muscle cells can concentrate GABA to a limited extent, a number of other differentiated cells cannot. © 1975.",,"4 aminobutyric acid; amino acid; calcium; sodium; 4 aminobutyric acid h 3; brain; brain slice; cell volume; clone; drug absorption; drug distribution; glia cell; in vitro study; muscle; nerve; nerve cell; rat; sensory ganglion; temperature; theoretical study; Aminobutyric Acids; Animal; Calcium; Cell Line; Clone Cells; gamma-Aminobutyric Acid; Neuroglia; Neurons; Rats; Sodium; Support, U.S. Gov't, P.H.S.; Temperature; Tritium",,"4 aminobutyric acid, 28805-76-7, 56-12-2; amino acid, 65072-01-7; calcium, 7440-70-2; sodium, 7440-23-5; Aminobutyric Acids; Calcium, 7440-70-2; gamma-Aminobutyric Acid, 56-12-2; Sodium, 7440-23-5; Tritium, 10028-17-8",,,,"Amano, Richelson, Nirenberg, Neurotransmitter synthesis by neuroblastoma clones (1972) Proc. nat. Acad. Sci. (Wash.), 69, pp. 258-263. , 4th ed; Anderson, Petersen, Cell growth and division II Experimental studies of cell volume distributions in mammalian suspension cultures (1968) Biophysical Journal, 7, pp. 353-364; Augusti-Tocco, Sato, Establishment of functional clonal lines of neurons from mouse neuroblastoma (1969) Proc. nat. Acad. Sci. (Wash.), 64, pp. 311-316. , 4th ed; Beart, Johnston, Uhr, Competitive inhibition of GABA uptake in rat brain slices by some GABA analogues of restricted conformation (1972) J. Neurochem., 19, pp. 1855-1861; Beart, Johnston, GABA uptake in rat brain slices: inhibition by GABA analogues and by various drugs (1973) J. Neurochem., 20, pp. 319-324; Benda, Lightbody, Sato, Levine, Sweet, Differentiated rat glial cell strain in tissue culture (1968) Science, 161, pp. 370-376; Henn, Hamberger, Glial cell function: uptake of transmitter substances (1971) Proc. nat. Acad. Sci. (Wash.), 68, pp. 2686-2690. , 4th ed; Horibata, Harris, Mouse myelomas and lumphomas in culture (1970) Exp. Cell Res., 60, pp. 61-77; Hutchison, Werrbach, Vance, Haber, Uptake of neurotransmitters by clonal lines of astrocytoma and neuroblastoma in culture. I. Transport of γ-aminobutyric acid (1974) Brain Research, 66, pp. 265-274; Iversen, Neal, The uptake of [3H]GABA by slices of rat cerebral cortex (1968) J. Neurochem., 15, pp. 1141-1149; Iverson, Johnston, GABA uptake in rat central nervous system comparison of uptake in slices and homogenates and the effects of some inhibitors (1971) Journal of Neurochemistry, 18, pp. 1939-1950; Iversen, Schon, The use of autoradiographic techniques for the identification and mapping of transmitter-specific neurons in CNS (1973) New Concepts in Neurotransmitter Regulation, pp. 153-193. , A.J. Mandell, Plenum Press, New York, N.Y; Kuriyama, Weinstein, Roberts, Uptake of γ-aminobutyric acid by mitochondrial and synaptosomal fractions from mouse brain (1969) Brain Research, 16, pp. 479-492; Martin, Smith, Ions and the transport of gamma-aminobutyric acid by synaptosomes (1972) J. Neurochem., 19, pp. 841-855; Martin, Kinetics of the sodium-dependent transport of gamma-aminobutyric acid by synaptosomes (1973) J. Neurochem., 21, pp. 345-356; Orkand, Kravitz, Localization of the sites of γ-aminobutyric acid (GABA) uptake in lobster nerve-muscle preparations (1971) J. Cell Biol., 49, pp. 75-89; Patrick, Heinemann, Lindstrom, Schubert, Steinbach, Appearance of acetylcholine receptors during differentiation of a myogenic cell line (1972) Proc. nat. Acad. Sci. (Wash.), 69, pp. 2762-2766. , 4th ed; Pfeiffer, Wechsler, Biochemically differentiated neoplastic clone of Schwann cells (1972) Proc. nat. Acad. Sci. (Wash.), 69, pp. 2885-2889. , 4th ed; Rotman, Papermaster, Membrane properties of living mammalian cells as studied by enzymatic hydrolysis of fluorogenic esters (1966) Proc. nat. Acad. Sci. (Wash.), 55, pp. 134-141. , 4th ed; Sato, Yasumura, Retention of differentiated function in dispersed cell culture (1966) Trans. N.Y. Acad. Sci., 28, pp. 1063-1072; Schon, Kelly, The characterization of [3H]GABA uptake into the satellite glial cells of rat sensory ganglia (1974) Brain Research, 66, pp. 289-300; Schrier, Thompson, On the role of glial cells in the mammalian nervous system (1974) J. biol. Chem., 249, pp. 1769-1780; In vitro DIFFERENTIATION OF A MOUSE NEUROBLASTOMA (1969) Proceedings of the National Academy of Sciences, 64, pp. 316-323. , 4th ed; Schubert, Heinemann, Carlisle, Tarikas, Kimes, Patrick, Steinbach, Brandt, Clonal cell lines from the rat central nervous system (1974) Nature (Lond.), 249, pp. 224-227; Schubert, Harris, Devine, Heinemann, Characterization of a unique muscle cell line (1974) J. Cell Biol., 61, pp. 398-413; Silagi, Control of pigment production in mouse melanoma cellin vitro (1969) J. Cell Biol., 43, pp. 263-274; Snodgrass, Hedley-Whyte, Lorenoo, GABA transport by nerve ending fractions of cat brain (1973) J. Neurochem., 20, pp. 771-782; Starr, Composition of the incubation medium on the accumulation and metabolism of3H-γ-aminobutyric acid and14C-taurine in isolated rat retina (1973) Biochem. Pharmacol., 22, pp. 1693-1700; Strasberg, Elliott, Further studies on the binding of γ-aminobutyric acid by brain (1967) Canad. J. Biochem., 45, pp. 1795-1807; Tashjian, Bancroft, Levine, Production of both prolactin and growth hormone by clonal strains of rat pituitary tumor cells (1970) J. Cell Biol., 47, pp. 61-70; Thompson, Tomkins, Curran, Induction of tyrosine alpha-ketoglutarate transaminase by steroid hormones in a newly established tissue culture line (1966) Proc. nat. Acad. Sci. (Wash.), 56, pp. 296-303. , 4th ed; Weinstein, Varon, Muhleman, Roberts, A carrier-mediated transfer model for accumulation of14C gamma-aminobutyric acid by subcellular brain particles (1965) Biochem. Pharmacol., 14, pp. 273-288; Yaffe, Retention of differentiation potentialities during prolonged cultivation of myogenic cells (1968) Proc. nat. Acad. Sci. (Wash.), 61, pp. 477-483. , 4th ed","Schubert, D.; Department of Neurobiology, The Salk Institute, P.O. Box 1809, San Diego, CA 92112, United States",,,,,,,,00068993,,BRREA,234772,"English","Brain Res.",Article,Scopus,2-s2.0-0016432174
"Tarikas, H., Schubert, D.","Regulation of adenylate kinase and creatine kinase activities in myogenic cells",1974,"Proceedings of the National Academy of Sciences of the United States of America","71","6",,"2377","2381",,33,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0016184151&partnerID=40&md5=3eb9b08a6c7f09a786255543cb8bdd7b","Neurobiol. Dept., Salk Inst., San Diego, Calif. 92112, United States","Tarikas, H., Neurobiol. Dept., Salk Inst., San Diego, Calif. 92112, United States; Schubert, D., Neurobiol. Dept., Salk Inst., San Diego, Calif. 92112, United States",[No abstract available],,"adenylate kinase; creatine kinase; cell fusion; in vitro study; muscle; rat; theoretical study; Animal; Cell Count; Cell Differentiation; Cell Fusion; Cell Line; Creatine Kinase; Muscles; Phosphotransferases; Rats",,"adenylate kinase, 9013-02-9; creatine kinase, 9001-15-4; Creatine Kinase, EC 2.7.3.2; Phosphotransferases, EC 2.7",,,,,,,,,,,,,00278424,,PNASA,4366764,"English","PROC. NATL. ACAD. SCI. U. S. A.",Article,Scopus,2-s2.0-0016184151
"Schubert, D., Harris, A.J., Devine, C.E., Heinemann, S.","Characterization of a unique muscle cell line",1974,"Journal of Cell Biology","61","2",,"398","413",,122,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0016366972&partnerID=40&md5=f0811b72c3eb40d2a8905eceaae281b4","Dept. Neurobiol., Salk Inst., La Jolla, Calif. 92037, United States","Schubert, D., Dept. Neurobiol., Salk Inst., La Jolla, Calif. 92037, United States; Harris, A.J., Dept. Neurobiol., Salk Inst., La Jolla, Calif. 92037, United States; Devine, C.E., Dept. Neurobiol., Salk Inst., La Jolla, Calif. 92037, United States; Heinemann, S., Dept. Neurobiol., Salk Inst., La Jolla, Calif. 92037, United States","A clonal cell line derived from a mouse neoplasm is described which shares many properties with smooth muscle. The cells have electrically excitable membranes capable of generating overshooting action potentials, and they contract both spontaneously and with electrical stimulation. They respond to the iontophoretic application of acetylcholine with a depolarizing response, and to norepinephrine with a hyperpolarizing response. Electron microscopy reveals that the cells have a morphology similar in many, but not all, respects to that of smooth muscle cells in vivo. The cells secrete soluble collagen like molecules in addition to several proteins of undefined function. Finally, there is an increase in the specific activities of creatine phosphokinase and myokinase associated with increased cell density and the cessation of cell division.",,"acetylcholine; adenylate kinase; creatine kinase; hydroxyproline; noradrenalin; protein; action potential; cancer; cancer cell; cell; cell culture; cell line; cell membrane; clone; collagen protein; electron microscopy; in vitro study; mouse; muscle cell; smooth muscle fiber; theoretical study; Acetylcholine; Action Potentials; Amino Acids; Animal; Cell Line; Clone Cells; Collagen; Creatine Kinase; Electric Stimulation; Electrophoresis, Polyacrylamide Gel; Mice; Mice, Inbred C3H; Microscopy, Electron; Muscle, Smooth; Neoplasm Proteins; Neoplasms, Experimental; Neoplasms, Muscle Tissue; Norepinephrine; Organoids; Phosphotransferases",,"acetylcholine, 51-84-3, 60-31-1, 66-23-9; adenylate kinase, 9013-02-9; creatine kinase, 9001-15-4; hydroxyproline, 51-35-4, 6912-67-0; noradrenalin, 1407-84-7, 51-41-2; protein, 67254-75-5; Acetylcholine, 51-84-3; Amino Acids; Collagen, 9007-34-5; Creatine Kinase, EC 2.7.3.2; Neoplasm Proteins; Norepinephrine, 51-41-2; Phosphotransferases, EC 2.7",,,,,,,,,,,,,00219525,,JCLBA,4363958,"English","J. CELL BIOL.",Article,Scopus,2-s2.0-0016366972
"Schubert, D.","Induced differentiation of clonal rat nerve and glial cells",1974,"NEUROBIOLOGY","4","6",,"376","387",,13,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0016321159&partnerID=40&md5=cdff46c641d2c86c415bc68d3e9c0fb4","Dept. Neurobiol., Salk Inst., San Diego, Calif. 92112, United States","Schubert, D., Dept. Neurobiol., Salk Inst., San Diego, Calif. 92112, United States","The effects of 5 bromodeoxyuridine, serum free medium, and adenosine 3' 5' monophosphate on the morphological differentiation of 5 neuronal and 1 glial cell line are described. 5 bromodeoxyuridine induced cell flattening but not process formation in all 6 cell lines. Serum free medium and dibutyryl adenosine 3' 5' monophosphate reversibly induced neurite formation in the nerve cell lines, but only dibutyryl adenosine 3' 5' monophosphate elicited a comparable response in the glial cell line. Adenosine 3' 5' monophosphate and 8 bromoadenosine 3' 5' monophosphate also induced morphological transformations in these cells. Protein synthesis was not required for the initial morphological changes induced by dibutyryl adenosine 3' 5' monophosphate. Dibutyryl adenosine 3' 5' monophoshate partially protected cells from colchicine induced process retraction, suggesting a functional interaction between these 2 compounds at a site involved in the maintenance of cellular processes.",,"broxuridine; bucladesine; colchicine; cyclic amp; cell differentiation; clone; glia cell; in vitro study; induction; nerve cell; rat; theoretical study; Adenosine Monophosphate; Animal; Bromodeoxyuridine; Cell Differentiation; Cell Division; Cell Line; Cells, Cultured; Colchicine; Neuroblastoma; Neuroglia; Neurons; Rats; Time Factors; Tissue Culture",,"broxuridine, 59-14-3; bucladesine, 16980-89-5, 362-74-3; colchicine, 64-86-8; cyclic AMP, 60-92-4; Adenosine Monophosphate, 61-19-8; Bromodeoxyuridine, 59-14-3; Colchicine, 64-86-8",,,,,,,,,,,,,12168068,,NBBMA,4453351,"English","NEUROBIOLOGY",Article,Scopus,2-s2.0-0016321159
"Steinbach, J.H., Schubert, D., Tarikas, H.","Inhibition of acetylcholine synthesis in neuroblastoma cells by a styrylpyridine analog",1974,"Journal of Neurochemistry","22","4",,"611","613",,7,10.1111/j.1471-4159.1974.tb06905.x,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0016367483&partnerID=40&md5=6c8a2088f4baf3c1e640d54602ba836f","Neurobiol. Dept., Salk Inst., San Diego, Calif. 92112, United States","Steinbach, J.H., Neurobiol. Dept., Salk Inst., San Diego, Calif. 92112, United States; Schubert, D., Neurobiol. Dept., Salk Inst., San Diego, Calif. 92112, United States; Tarikas, H., Neurobiol. Dept., Salk Inst., San Diego, Calif. 92112, United States",[No abstract available],,"acetyl coenzyme a c 14; acetylcholine; choline; choline acetyltransferase; choline c 14; neostigmine; radioisotope; styrylpyridine; styrylpyridine derivative; unclassified drug; article; cancer cell; cell culture; in vitro study; mouse; neuroblastoma; theoretical study; tissue culture; Acetylcholine; Acetyltransferases; Animals; Carbon Radioisotopes; Choline; Clone Cells; Culture Media; Electrophoresis, Paper; Mice; Muscles; Naphthalenes; Neuroblastoma; Pyridinium Compounds; Time Factors; Vinyl Compounds",,"acetylcholine, 51-84-3, 60-31-1, 66-23-9; choline, 123-41-1, 13232-47-8, 1927-06-6, 4858-96-2, 62-49-7, 67-48-1; choline acetyltransferase, 9012-78-6; neostigmine, 114-80-7, 588-17-0, 59-99-4, 8048-84-8; Acetylcholine, 51-84-3; Acetyltransferases, 2.3.1.-; Carbon Radioisotopes; Choline, 62-49-7; Culture Media; Naphthalenes; Pyridinium Compounds; Vinyl Compounds",,,,,,,,,,,,,00223042,,JONRA,4829982,"English","J. NEUROCHEM.",Article,Scopus,2-s2.0-0016367483
"Schubert, D., Heinemann, S., Carlisle, W., Tarikas, H., Kimes, B., Patrick, J., Steinbach, J.H., Culp, W., Brandt, B.L.","Clonal cell lines from the rat central nervous system",1974,"Nature","249","5454",,"224","227",,392,10.1038/249224a0,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0016358141&partnerID=40&md5=1f1a5a01e5ac291b4c213f4a1fcda4a6","Department of Neurobiology, Salk Institute, PO Box 1809, San Diego, CA 92112","Schubert, D., Department of Neurobiology, Salk Institute, PO Box 1809, San Diego, CA 92112; Heinemann, S., Department of Neurobiology, Salk Institute, PO Box 1809, San Diego, CA 92112; Carlisle, W., Department of Neurobiology, Salk Institute, PO Box 1809, San Diego, CA 92112; Tarikas, H., Department of Neurobiology, Salk Institute, PO Box 1809, San Diego, CA 92112; Kimes, B., Department of Neurobiology, Salk Institute, PO Box 1809, San Diego, CA 92112; Patrick, J., Department of Neurobiology, Salk Institute, PO Box 1809, San Diego, CA 92112; Steinbach, J.H., Department of Neurobiology, Salk Institute, PO Box 1809, San Diego, CA 92112; Culp, W., Department of Neurobiology, Salk Institute, PO Box 1809, San Diego, CA 92112; Brandt, B.L., Department of Neurobiology, Salk Institute, PO Box 1809, San Diego, CA 92112","Five neuronal and a large collection of putative glial cell lines from the rat central nervous system have been established in clonal cell culture and partially characterised. These cells shed new light on the distribution of neurotransmitter synthesis and brain-specific antigens among nerve and glia. © 1974 Nature Publishing Group.",,"4 aminobutyric acid; acetylcholinesterase; brain antigen; cholinesterase; cyclic amp; glutamate decarboxylase; neurotransmitter; brain; clone; excitable membrane; glia; glia cell; histology; in vitro study; nerve cell; rat; theoretical study; Aminobutyric Acids; Animals; Bucladesine; Cell Division; Cell Line; Cell Membrane; Clone Cells; Culture Media; Neoplasms, Experimental; Neoplasms, Nerve Tissue; Nerve Tissue Proteins; Neuroblastoma; Neuroglia; Neurons; Neurotransmitter Agents; Nitrosourea Compounds; Rats; Synaptic Transmission",,"4 aminobutyric acid, 28805-76-7, 56-12-2; acetylcholinesterase, 9000-81-1; cholinesterase, 9001-08-5; cyclic AMP, 60-92-4; glutamate decarboxylase, 9024-58-2; Aminobutyric Acids; Bucladesine, 362-74-3; Culture Media; Nerve Tissue Proteins; Neurotransmitter Agents; Nitrosourea Compounds",,,,,"Schubert, D.; Department of Neurobiology, Salk Institute, PO Box 1809, San Diego, CA 92112",,,,,,,,00280836,,,4151463,"English",,Article,Scopus,2-s2.0-0016358141
"Kimes, B., Tarikas, H., Schubert, D.","Neurotransmitter synthesis by two clonal nerve cell lines: with culture growth and morphological differentiation",1974,"Brain Research","79","2",,"291","295",,9,10.1016/0006-8993(74)90419-3,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0016269825&partnerID=40&md5=12c05d5547ea5e02806351b9f0ccbcb9","Neurobiology Department, The Salk Institute, San Diego, CA 92112, United States","Kimes, B., Neurobiology Department, The Salk Institute, San Diego, CA 92112, United States; Tarikas, H., Neurobiology Department, The Salk Institute, San Diego, CA 92112, United States; Schubert, D., Neurobiology Department, The Salk Institute, San Diego, CA 92112, United States",[No abstract available],,"4 aminobutyric acid; acetylcholine; aminooxyacetic acid; choline acetyltransferase; glutamate decarboxylase; neurotransmitter; tyrosine 3 monooxygenase; glutamic acid; tyrosine; 4 aminobutyric acid; acetylcholine; acyltransferase; aminobutyric acid derivative; Carboxy Lyases; carboxylyase; choline; dopamine; glutamic acid derivative; tyrosine 3 monooxygenase; acetic acid derivative; bucladesine; cyclic amp; nerve cell; nerve cell growth; animal; article; biosynthesis; cell clone; cell differentiation; cell division; enzymology; metabolism; nerve cell; rat; synaptic transmission; time; biochemistry; cell culture; cell cycle; cell line; clone; in vitro study; synapse; theoretical study; Acetylcholine; Acetyltransferases; Aminobutyric Acids; Animal; Carboxy-Lyases; Cell Differentiation; Cell Division; Choline; Clone Cells; Dopamine; gamma-Aminobutyric Acid; Glutamates; Neurons; Rats; Synaptic Transmission; Time Factors; Tyrosine 3-Monooxygenase",,"4 aminobutyric acid, 28805-76-7, 56-12-2; acetylcholine, 51-84-3, 60-31-1, 66-23-9; aminooxyacetic acid, 2921-14-4, 645-88-5; choline acetyltransferase, 9012-78-6; glutamate decarboxylase, 9024-58-2; tyrosine 3 monooxygenase, 9036-22-0; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; tyrosine, 16870-43-2, 55520-40-6, 60-18-4; acyltransferase, 9012-30-0, 9054-54-0; carboxylyase, 9027-22-9; choline, 123-41-1, 13232-47-8, 1927-06-6, 4858-96-2, 62-49-7, 67-48-1; dopamine, 51-61-6, 62-31-7; bucladesine, 16980-89-5, 362-74-3; cyclic AMP, 60-92-4; Acetylcholine, 51-84-3; Acetyltransferases, EC 2.3.1.; Aminobutyric Acids; Carboxy-Lyases, EC 4.1.1.; Choline, 62-49-7; Dopamine, 51-61-6; gamma-Aminobutyric Acid, 56-12-2; Glutamates; Tyrosine 3-Monooxygenase, EC 1.14.16.2",,,,"Amano, Richelson, Nirenberg, Neurotransmitter synthesis by neuroblastoma clones (1972) Proc. nat. Acad. Sci. (Wash.), 69, pp. 258-265; Dale, Pharmacology of nerve ending (1935) Proc R Soc Med, 28, pp. 319-332; Haber, Kuriyama, Roberts, An anion stimulated L-glutamic acid decarboxylase in non-neural tissues: occurence and subcellular localization in mouse kidney and developing chick embryo brain (1970) Biochem. Pharmacol., 19, pp. 1119-1136; Mains, Kuriyama, Roberts, L-Glutamic acid decarboxylase: a new type in glial cells and human brain (1976) Science, 168, pp. 598-599; Mains, Patterson, Primary cultures of dissociated sympathetic neurons. I. Establishment of long-term growth in culture and studies of differentiated properties (1973) J. Cell Biol., 59, pp. 329-454; Richelson, Stimulation of tyrosine hydroxylase activity in an adrenergic clone of mouse neuroblastoma by dibutyry (1973) Nature New Biology, 242, pp. 175-177; Schubert, Heinemann, Carlisle, Tarikas, Kimes, Patrick, Steinbatch, Brandt, Clonal cell lines from the rat central nervous system (1974) Nature (Lond.), 249, pp. 224-227; Steinbach, Schubert, Takits, Inhibition of acetylcholine synthesis in neuroblastoma cells by a styrylpyridine analogue (1974) J. Neurochem, 22, pp. 611-613; Waymire, Weiner, Prasad, Regulation of tyrosine hydrolase activity in cultured mouse neuroblastoma cells: elevation induced by analogues of adenosine 3':5' cyclic monophosphate (1972) Proc., 69, pp. 2241-2245","Kimes, B.; Neurobiology Department, The Salk Institute, San Diego, CA 92112, United States",,,,,,,,00068993,,BRREA,4153955,"English","Brain Res.",Article,Scopus,2-s2.0-0016269825
"Steinbach, J.H., Harris, A.J., Patrick, J., Schubert, D., Heinemann, S.","Nerve muscle interaction in vitro: Role of acetylcholine",1973,"Journal of General Physiology","62","3",,"255","270",,22,10.1085/jgp.62.3.255,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0015865286&partnerID=40&md5=c555652ecbb12d39a4c09071293b4005","Neurobiol. Dept., Salk Inst., San Diego, Calif. 92112, United States","Steinbach, J.H., Neurobiol. Dept., Salk Inst., San Diego, Calif. 92112, United States; Harris, A.J., Neurobiol. Dept., Salk Inst., San Diego, Calif. 92112, United States; Patrick, J., Neurobiol. Dept., Salk Inst., San Diego, Calif. 92112, United States; Schubert, D.; Heinemann, S.","Nerve and muscle cells from clonal lines interact in vitro, resulting in the association on the muscle surface of an area of increased acetylcholine sensitivity with a site of nerve muscle contact. This localization of acetylcholine sensitivity on the muscle cell to a site of contact between nerve and muscle was found to occur when acetylcholine receptors on the muscle had been blocked with α neurotoxin. Localization was also found to occur when the nerve cell had been prevented from releasing acetylcholine. It is concluded that neither the presence of active acetylcholine receptors on the muscle, nor the release of acetylcholine from the nerve, was required for the events leading to the localization of acetylcholine sensitivity in vitro.",,"acetylcholine; alpha neurotoxin; cholinergic receptor; cycloheximide; drug receptor; naphthylvinylpyridine derivative; unclassified drug; article; cell culture; in vitro study; mouse; muscle; muscle cell; myoblast; nerve; nerve cell; nerve fiber; neuroblastoma; neuromuscular synapse; neuromuscular transmission; rat; theoretical study; Acetylcholine; Animals; Clone Cells; Iontophoresis; Mice; Muscles; Neurons; Pyridinium Compounds; Rats; Receptors, Cholinergic; Toxins, Biological",,"acetylcholine, 51-84-3, 60-31-1, 66-23-9; cycloheximide, 642-81-9, 66-81-9; Acetylcholine, 51-84-3; Pyridinium Compounds; Receptors, Cholinergic; Toxins, Biological",,"calbiochem",,,,,,,,,,,00221295,,JGPLA,4738329,"English","J. GEN. PHYSIOL.",Article,Scopus,2-s2.0-0015865286
"Schubert, D.","Protein secretion by clonal glial and neuronal cell lines",1973,"Brain Research","56","C",,"387","391",,10,10.1016/0006-8993(73)90358-2,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0015694003&partnerID=40&md5=599061fe3fdbb9da4a680d9d9cd85ee1","Department of Neurobiology, The Salk Institute, San Diego, CA 92112, United States","Schubert, D., Department of Neurobiology, The Salk Institute, San Diego, CA 92112, United States",[No abstract available],,"protein; carbon; leucine; nerve protein; tritium; astrocyte; brain; cell line; clone; glia; glioma; nerve cell; neuroblastoma; rat; theoretical study; animal; article; cell clone; cell culture; cell line; glia; glioma; metabolism; nerve cell; neuroblastoma; polyacrylamide gel electrophoresis; Animal; Carbon Isotopes; Cell Line; Cells, Cultured; Clone Cells; Electrophoresis, Polyacrylamide Gel; Glioma; Leucine; Nerve Tissue Proteins; Neuroblastoma; Neuroglia; Neurons; Rats; Tritium",,"protein, 67254-75-5; carbon, 7440-44-0; leucine, 61-90-5, 7005-03-0; tritium, 10028-17-8; Carbon Isotopes; Leucine, 61-90-5; Nerve Tissue Proteins; Tritium, 10028-17-8",,,,"Augusti-Tocco, Sato, Establishment of functional clonal lines of neurons from mouse neuroblastoma (1969) Proc. nat. Acad. Sci. (Wash.), 64, pp. 311-315; Benda, Lightbody, Sato, Levine, Sweet, Differentiated rat glial cell strain in tissue culture (1968) Science, 161, pp. 370-371; Crick, Diffusion in embryogenesis (1970) Nature (Lond.), 225, pp. 420-422; Furthmayr, Timpl, Characterization of collagen peptides by sodium dodecylsulphate-polyacrylamide electrophoresis (1971) Anal. Biochem., 41, pp. 510-516; Grant, Kefalides, Prockop, The biosynthesis of basement membrane collagen in embryonic chick lens. I (1972) J. biol. Chem., 247, pp. 3539-3544; Guth, Trophic influence of nerve on muscle (1968) Physiol. Rev., 48, pp. 645-687; Herschman, Synthesis and degradation of a brain-specific protein (S100 protein) by clonal cultured human glial cells (1972) J. biol. Chem., 246, pp. 7569-7571; Kefalides, Denduchis, Structural components of epithelial and endothelial basement membranes (1969) Biochemistry, 8, pp. 4613-4621; Layman, McGoodwin, Martin, The nature of collagen synthesized by cultured human fibroblasts (1971) Proc. nat. Acad. Sci. (Wash.), 68, pp. 454-458; Moore, A soluble protein characteristic of the nervous system (1965) Biochem. biophys. Res. Commun., 19, pp. 739-744; Moore, Perez, Specific acidic proteins of the nervous system (1968) Physiological and Biochemical Aspects of Nervous Integration, pp. 343-360. , F.D. Carlson, Prentice-Hall, Englewood Cliffs, N.J; Pfeiffer, Herschman, Lightbody, Sato, Synthesis by a clonal line of rat glial cells of a protein unique to the nervous system (1970) J. cell comp. Physiol., 75, pp. 329-340; Pfeiffer, Wechsler, Chemically differentiated neoplastic clone of Schwann cells (1972) Proc. nat. Acad. Sci. (Wash.), 69, pp. 2885-2889; Schubert, Immunoglobulin biosynthesis, IV. Carbohydrate attachment to immunoglobulin subunits (1970) J. molec. Biol., 51, pp. 287-301; Schubert, Humphreys, Baroni, Cohn, In vitro differentiation of a mouse neuroblastoma (1969) Proc. nat. Acad. Sci. (Wash.), 64, pp. 316-323; Schubert, Humphreys, De Vitry, Jacob, Induced differentiation of a neuroblastoma (1971) Develop. biol., 25, pp. 514-546; Schubert, Tarikas, Humphreys, Heinemann, Patrick, Protein synthesis and secretion in a myogenic cell line (1973) Dev Biol, , in press; Uyeda, Eng, Bignami, Immunological study of the glial fibrillary acidic protein (1972) Brain Research, 37, pp. 81-89; Vogt, Dulbecco, Steps in the neoplastic transformation of hamster embryo cells by polyoma virus (1963) Proceedings of the National Academy of Sciences, 47, pp. 171-179; von Hippel, Structure and stabilization of the collagen molecule in solution (1967) Treatise on Collagen, 1, pp. 253-338. , G.N. Ramachandran, Academic Press, New York; Weber, Osborn, The reliability of molecular weight determinations by dodecylsulfate-polyacrylamide gel electrophoresis (1969) J. biol. Chem., 244, pp. 4406-4412","Schubert, D.; Department of Neurobiology, The Salk Institute, San Diego, CA 92112, United States",,,,,,,,00068993,,BRREA,4715629,"English","Brain Res.",Article,Scopus,2-s2.0-0015694003
"Schubert, D., Tarikas, H., Humphreys, S., Heinemann, S., Patrick, J.","Protein synthesis and secretion in a myogenic cell line",1973,"Developmental Biology","33","1",,"18","37",,33,10.1016/0012-1606(73)90161-9,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0015787919&partnerID=40&md5=4300d624a1fc1a0e81c664622e0a7135","The Salk Institute, Post Office Box 1809, San Diego, CA 92112, United States","Schubert, D., The Salk Institute, Post Office Box 1809, San Diego, CA 92112, United States; Tarikas, H., The Salk Institute, Post Office Box 1809, San Diego, CA 92112, United States; Humphreys, S., The Salk Institute, Post Office Box 1809, San Diego, CA 92112, United States; Heinemann, S., The Salk Institute, Post Office Box 1809, San Diego, CA 92112, United States; Patrick, J., The Salk Institute, Post Office Box 1809, San Diego, CA 92112, United States","Myogenesis in a clonal myoblast cell line is accompanied by an increase in the specific activities of creatine phosphokinase and myokinase and in the rates of synthesis and accumulation of myosin heavy chain. Exponentially dividing myoblasts synthesize myosin heavy chain at a rate of about 1% of their rate of total protein synthesis; this rate increases 7-fold during the differentiation process. Both myoblasts and myotubes secrete a minimum of 12-soluble proteins. Although there is a quantitative change in the rates of appearance of five of these proteins during myogenesis, no qualitative changes in the profile of the secreted proteins are detected. Three of the secreted proteins share several properties of soluble collagen molecules. Basal laminae and polymerized collagen fibrils are associated with myotubes, but not with exponentially dividing myoblasts. © 1973.",,"adenylate kinase; alanine h 3; creatine kinase; fucose h 3; glycine h 3; leucine c 14; leucine h 3; myosin; proline c 14; proline h 3; protein; unclassified drug; article; cell culture; histology; in vitro study; muscle development; myoblast; protein synthesis; rat; theoretical study; Animals; Carbon Radioisotopes; Cell Differentiation; Cell Line; Clone Cells; Collagen; Creatine Kinase; Electrophoresis, Polyacrylamide Gel; Hydroxyproline; Leucine; Muscle Proteins; Muscles; Myofibrils; Myosins; Phosphotransferases; Proline; Rats; Time Factors; Tritium",,"adenylate kinase, 9013-02-9; creatine kinase, 9001-15-4; protein, 67254-75-5; Carbon Radioisotopes; Collagen, 9007-34-5; Creatine Kinase, 2.7.3.2; Hydroxyproline, 51-35-4; Leucine, 61-90-5; Muscle Proteins; Myosins, 3.6.1.4; Phosphotransferases, 2.7.-; Proline, 147-85-3; Tritium, 10028-17-8",,,,"Atkinson, Summers, Purification and properties of HeLa cell plasma membranes (1971) J. Biol. Chem, 246, pp. 5162-5175; Bekesi, Winzler, The metabolism of plasma glycoproteins: Studies on the incorporation of l-fucose-1-14C into tissue and serum in the normal rat (1967) J. Biol. Chem, 242, pp. 3873-3879; Church, Pfeiffer, Tanzer, Collagen biosynthesis: synthesis and secretion of a high molecular weight collagen precursor (procollagen) (1971) Proc. Nat. Acad. Sci. U.S, 68, pp. 2638-2642; Coffey, Miller, Sellinger, The metabolism of l-fucose in the rat (1964) J. Biol. Chem, 239, pp. 4011-4017; Cohen, Hay, Secretion of collagen by embryonic neuroepithelium at the time of spinal cord-somite interaction (1971) Develop. Biol, 26, pp. 578-605; Coleman, Coleman, Muscle differentiation and macromolecular synthesis (1968) Journal of Cellular Physiology, 72, pp. 19-34; Davies, Priest, Collagen synthesis in cu,ltured cells: Regulations between collagen synthesis and cell proliferation (1967) Fed. Proc. Fed. Amer. Soc. Exp. Biol, 26, p. 300. , (Abstract); Dawkins, Lamont, Myogenesis in vitro as demonstrated by immunoflourescent staining with antimuscle serum (1972) Experimental Cell Research, 67, pp. 1-10; Eastoe, Composition of collagen and allied proteins (1967) Treatise on Collagen, 1, pp. 1-72. , G.N. Ramachandran, Academic Press, New York; Ebert, Tolman, Mun, Albright, The molecular basis of the first heart beats (1955) Ann. N.Y. Acad. Sci, 60, pp. 968-985; Furthmayr, Timpl, Characterization of collagen peptides by sodium dodecylsulfate-polyacrylamide electrophoresis (1971) Anal. Biochem, 41, pp. 510-516; Grant, Kefalides, Prockop, The biosynthesis of basement membrane collagen in embryonic chick lens I (1972) J. Biol. Chem, 247, pp. 3539-3544; Gribble, Comstock, Udenfriend, Collagen chain formation and peptidyl proline hydroxylation in monolayer tissue cultures of L-929 fibroblasts (1969) Arch. Biochem. Biophys, 129, pp. 308-316; Harris, Heinemann, Schubert, Tarikas, Trophic interaction between cloned tissue culture lines of nerve and muscle (1971) Nature (London), 231, pp. 296-301; Kaufman, Ginsburg, The metabolism of l-fucose by HeLa cells (1968) Experimental Cell Research, 50, pp. 127-132; Kefalides, Comparative biochemistry of mammalian basement membranes (1970) Chemistry and Molecular Biology of the Intercellular Matrix, pp. 335-573. , E.A. Balazs, Academic Press, New York; Kefalides, Denduchis, Structural components of epithelial and endothelial basement membranes (1969) Biochemistry, 8, pp. 4613-4621; Kidokoro, Development of action potentials in a cloned rat skeletal muscle line (1973) Nature (London), 241, pp. 158-159; Konigsberg, Diffusion-mediated control of myoblast fusion (1971) Develop. Biol, 26, pp. 133-152; Layman, McGoodwin, Martin, The nature of collagen synthesized by cultured human fibroblasts (1971) Proc. Nat. Acad. Sci. U.S, 68, pp. 454-458; Lowry, Rosebrough, Farr, Randall, Protein measurement with the Folin phenol reagent (1951) J. Biol. Chem, 193, pp. 265-275; Mandl, Machennan, Howes, Isolation and characterization of proteinase and collagenase from Cl. histolyticum (1953) J. Clin. Invest, 32, pp. 1323-1330; Medoff, Zwilling, Appearance of myosin in the chick limb bud (1972) Develop. Biol, 28, pp. 138-141; Miller, Isolation and characterization of a collagen from chick cartilage containing three identical α-chains (1971) Biochemistry, 10, pp. 1652-1659; Okazaki, Holtzer, An analysis of myogenesis in vitro using fluorescein-labeled antimyosin (1965) J. Histochem. Cytochem, 13, pp. 726-739; Okazaki, Holtzer, Myogenesis: Fusion, myosin synthesis, and the mitotic cycle (1966) Proc. Nat. Acad. Sci. U.S, 56, pp. 1484-1490; Patrick, Heinemann, Lindstrom, Schubert, Steinbach, Appearance of acetylcholine receptors during differentiation of a myogenic cell line (1972) Proc. Nat. Acad. Sci. U.S, 69, p. 2762; Perry, Myosin adenosinetriphosphatase (1955) Methods Enzymol, 2, p. 582; Peterkofsky, Diegelmann, Use of a mixture of proteinase-free collagenases for the specific assay of collagen in the presence of other proteins (1971) Biochemistry, 10, pp. 988-993; Ramalay, Rosenbloom, Inhibition of proline and lysine hydroxylation prevents normal extrusion of collagen by 3T3 fibroblasts in culture (1971) FEBS Letters, 15, pp. 59-64; Richards, Chung, Menzel, Olcott, Chromatography of myosin on diethylaminoethyl-Sephadex A-50 (1967) Biochemistry, 6, pp. 528-540; Richler, Yaffe, The in vitro cultivation and differentiation capacities of myogenic cell lines (1970) Develop. Biol, 23, pp. 1-22; Rotman, Papermaster, Membrane properties of living mammalian cells as studied by enzymatic hydrolysis of fluorogenic esters (1966) Proc. Nat. Acad. Sci. U.S, 55, pp. 134-141; Schubert, Immunoglobulin biosynthesis. IV. Carbohydrate attachment to immunoglobulin subunits (1970) J. Mol. Biol, 51, pp. 287-301; Schubert, Humphreys, de Vitry, Jacob, Induced differentiation of a neuroblastoma (1971) Develop. Biol, 25, pp. 514-546; Shainberg, Yagil, Yaffe, Alterations of enzymatic activities during muscle differentiation in vitro (1971) Develop. Biol, 25, pp. 1-29; Vogt, Dulbecco, Steps in the neoplastic transformation of hamster embryo cells by polyoma virus (1963) Proc. Nat. Acad. Sci. U.S, 49, pp. 171-179; von Hippel, Structure and stabilization of the collagen molecule in solution (1967) Treatise on Collagen, 1, pp. 253-338. , G.N. Ramachandran, Academic Press, New York; Walter, Roblin, Dulbecco, Protein synthesis in simian virus 40-infected monkey cells (1972) Proc. Nat. Acad. Sci. U.S, 69, pp. 921-924; Weber, Osborn, The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis (1969) J. Biol. Chem, 244, pp. 4406-4412; Yaffe, Retention of differentiation potentialities during prolonged cultivation of myogenic cells (1968) Proc. Nat. Acad. Sci. U.S, 61, pp. 477-483","Schubert, D.; The Salk Institute, Post Office Box 1809, San Diego, CA 92112, United States",,,,,,,,00121606,,DEBIA,4363797,"English","Dev. Biol.",Article,Scopus,2-s2.0-0015787919
"Patrick, J., Heinemann, S.F., Lindstrom, J., Schubert, D., Steinbach, J.H.","Appearance of acetylcholine receptors during differentiation of a myogenic cell line.",1972,"Proceedings of the National Academy of Sciences of the United States of America","69","10",,"2762","2766",,43,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0015410865&partnerID=40&md5=ffc9081565c1662dbe4f9e9c280855b7",,"Patrick, J.; Heinemann, S.F.; Lindstrom, J.; Schubert, D.; Steinbach, J.H.",[No abstract available],,"acetylcholine; carbachol; cholinergic receptor; decamethonium; drug receptor; iodine; toxin; tubocurarine chloride; venom; animal; article; binding site; cell clone; cell differentiation; cell line; drug effect; iontophoresis; metabolism; muscle; osmolarity; physiology; protein binding; snake; time; Acetylcholine; Animal; Binding Sites; Carbachol; Cell Differentiation; Cell Line; Clone Cells; Decamethonium Compounds; Iodine Isotopes; Iontophoresis; Muscles; Osmolar Concentration; Protein Binding; Receptors, Cholinergic; Receptors, Drug; Snakes; Time Factors; Toxins; Tubocurarine; Venoms",,"acetylcholine, 51-84-3, 60-31-1, 66-23-9; carbachol, 462-58-8, 51-83-2; decamethonium, 1420-40-2, 156-74-1, 3198-38-7, 541-22-0; iodine, 7553-56-2; tubocurarine chloride, 57-94-3, 57-95-4, 8006-51-7; Acetylcholine, 51-84-3; Carbachol, 51-83-2; Decamethonium Compounds; Iodine Isotopes; Receptors, Cholinergic; Receptors, Drug; Toxins; Tubocurarine, 57-95-4; Venoms",,,,,"Patrick, J.",,,,,,,,00278424,,,4507600,"English","Proc Natl Acad Sci U S A",Article,Scopus,2-s2.0-0015410865
"Harris, A.J., Heinemann, S., Schubert, D., Tarakis, H.","Trophic interaction between cloned tissue culture lines of nerve and muscle",1971,"Nature","231","5301",,"296","301",,35,10.1038/231296a0,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0015210092&partnerID=40&md5=c8f2b593ddd4d7666c482f42d7a521c9","Salk Institute, PO Box 1809, San Diego, CA 92112; Department of Physiology, University of Otago, Dunedin, New Zealand","Harris, A.J., Salk Institute, PO Box 1809, San Diego, CA 92112, Department of Physiology, University of Otago, Dunedin, New Zealand; Heinemann, S., Salk Institute, PO Box 1809, San Diego, CA 92112; Schubert, D., Salk Institute, PO Box 1809, San Diego, CA 92112; Tarakis, H., Salk Institute, PO Box 1809, San Diego, CA 92112","Tissue culture of neural tumour cells with skeletal muscle provides a model for the early stages of synapse formation. Functional synaptic transmission, however, has not yet been seen. © 1971 Nature Publishing Group.",,,,,,,,,"Harris, A.J.; Department of Physiology, University of Otago, Dunedin, New Zealand",,,,,,,,00280836,,,,"English",,Article,Scopus,2-s2.0-0015210092
"Schubert, D., Tarikas, H., Harris, A.J., Heinemann, S.","Induction of acetylcholine esterase activity in a mouse neuroblastoma.",1971,"Nature: New biology","233","37",,"79","80",,5,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0015226814&partnerID=40&md5=21ed7baa084c43c1263c0a1529ea7573",,"Schubert, D.; Tarikas, H.; Harris, A.J.; Heinemann, S.",[No abstract available],,"acetylcholinesterase; detergent; animal; article; biosynthesis; cell culture; cell differentiation; cell division; cell survival; enzyme induction; enzymology; experimental neoplasm; mouse; neuroblastoma; Acetylcholinesterase; Animal; Cell Differentiation; Cell Division; Cell Survival; Cells, Cultured; Detergents; Enzyme Induction; Mice; Neoplasms, Experimental; Neuroblastoma",,"acetylcholinesterase, 9000-81-1; Acetylcholinesterase, EC 3.1.1.7; Detergents",,,,,"Schubert, D.",,,,,,,,00900028,,,5287000,"English","Nat New Biol",Article,Scopus,2-s2.0-0015226814
"Schubert, D., Humphreys, S., de Vitry, F., Jacob, F.","Induced differentiation of a neuroblastoma",1971,"Developmental Biology","25","4",,"514","546",,93,10.1016/0012-1606(71)90004-2,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0015102269&partnerID=40&md5=8e19c4527912ccd58b729d865cbd5dcf","Service de Génétique Cellulaire, l'Institut Pasteur, du Collège de France, Paris, France; The Salk Institute for Biological Studies, Post Office Box 1809, San Diego, CA 92112, United States","Schubert, D., Service de Génétique Cellulaire, l'Institut Pasteur, du Collège de France, Paris, France, The Salk Institute for Biological Studies, Post Office Box 1809, San Diego, CA 92112, United States; Humphreys, S., Service de Génétique Cellulaire, l'Institut Pasteur, du Collège de France, Paris, France, The Salk Institute for Biological Studies, Post Office Box 1809, San Diego, CA 92112, United States; de Vitry, F., Service de Génétique Cellulaire, l'Institut Pasteur, du Collège de France, Paris, France, The Salk Institute for Biological Studies, Post Office Box 1809, San Diego, CA 92112, United States; Jacob, F., Service de Génétique Cellulaire, l'Institut Pasteur, du Collège de France, Paris, France, The Salk Institute for Biological Studies, Post Office Box 1809, San Diego, CA 92112, United States","Neurite formation in a cloned tissue culture line of mouse neuroblastoma C1300 can be rapidly induced by plating cells in serum-free or conditioned media. This induced differentiation, defined here in terms of neurite formation and a change in macromolecular synthesis, is not initiated by the inhibition of cell division, but requires a strong interaction between the cell and the surface of the culture dish. This interaction is inhibited by several proteins and is enhanced by one or more dialyzable cell metabolites. Neurite formation is reversible, and microtubule formation in neurites is dependent on protein synthesis. © 1971.",,"antimetabolite; DNA; RNA; tumor protein; animal; article; biosynthesis; cell clone; cell differentiation; cell division; drug effect; experimental neoplasm; macromolecule; metabolism; mouse; nerve cell; neuroblastoma; pathophysiology; tissue culture; Animal; Antimetabolites; Cell Differentiation; Cell Division; Clone Cells; DNA, Neoplasm; Macromolecular Systems; Mice; Neoplasm Proteins; Neoplasms, Experimental; Neuroblastoma; Neurons; RNA, Neoplasm; Tissue Culture",,"DNA, 9007-49-2; RNA, 63231-63-0; Antimetabolites; DNA, Neoplasm; Macromolecular Systems; Neoplasm Proteins; RNA, Neoplasm",,,,"Augusti-Tocco, Sato, Establishment of functional clonal lines of neurons from mouse neuroblastoma (1969) Proc. Nat. Acad. Sci. U. S, 64, pp. 311-315; Bacchetti, Whitmore, Actinomycin D: Effects on mouse L-cells (1969) Biophys. J, 9, pp. 1427-1444; Blume, Gilbert, Wilson, Farber, Rosenberg, Nirenberg, Regulation of actylcholinesterase in neuroblastoma cells (1970) Proc. Nat. Acad. Sci. U. S, 67, pp. 786-792; Grobstein, Differentiation of vertebrate Cells (1959) The Cell, 1, pp. 437-496. , J. Brachet, A. Mirsky, Academic Press, New York; Harris, Dennis, Acetylcholine sensitivity and distribution on mouse neuroblastoma cells (1970) Science, 167, pp. 1253-1255; Holley, Kiernan, “Contact inhibition” of cell division in 3T3 cells (1968) Proc. Nat. Acad. Sci. U. S, 60, pp. 300-304; Marantz, Ventilla, Shelanski, Vinblastin-induced precipitation of microtubule protein (1969) Science, 165, pp. 498-499; Olmsted, Carlson, Klebe, Ruddle, Rosenbaum, Isolation of microtubule protein from cultured mouse neuroblastoma cells (1970) Proc. Nat. Acad. Sci. U. S, 65, pp. 129-136; Rotman, Papermaster, Membrane properties of living mammalian cells as studied by enzymatic hydrolysis of fluorogenic esters (1966) Proc. Nat. Acad. Sci. U. S, 55, pp. 134-141; Schubert, Immunoglobulin biosynthesis. IV. Carbohydrate attachment to immunoglobulin subunits (1970) J. Mol. Biol, 51, pp. 287-301; Schubert, Jacob, 5-Bromodeoxyuridine induced differentiation of a mouse neuroblastoma (1970) Proc. Nat. Acad. Sci. U. S, 67, pp. 247-254; Schubert, Humphreys, Baroni, Cohn, In vitro differentiation of a mouse neuroblastoma (1969) Proc. Nat. Acad. Sci. U. S, 64, pp. 316-323; Seeds, Gilman, Amano, Nirenberg, Regulation of axon formation by clonal lines of a neural tumor (1970) Proc. Nat. Acad. Sci. U. S, 66, pp. 160-167; Vogt, Dulbecco, Steps in the neoplastic transformation of hamster embryo cells by polyoma virus (1963) Proc. Nat. Acad. Sci. U. S, 49, pp. 171-179; Weisenberg, Vorisy, Taylor, The colchicine-binding protein of mammalian brain and its relation to microtubules (1968) Biochemistry, 7, pp. 4466-4478","Schubert, D.; Service de Génétique Cellulaire, l'Institut Pasteur, du Collège de France, Paris, France",,,,,,,,00121606,,DEBIA,5166556,"English","Dev. Biol.",Article,Scopus,2-s2.0-0015102269
"Schubert, D., Roman, A., Cohn, M.","Anti-Nucleic acid specificities of mouse myeloma immunoglobulins",1970,"Nature","225","5228",,"154","158",,15,10.1038/225154a0,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0014938767&partnerID=40&md5=13f3a73b3005de9b8714eb6584be274f","Salk Institute for Biological Studies, San Diego, CA","Schubert, D., Salk Institute for Biological Studies, San Diego, CA; Roman, A., Salk Institute for Biological Studies, San Diego, CA; Cohn, M., Salk Institute for Biological Studies, San Diego, CA","Three mouse myeloma immunoglobulins were shown to have antibody specificities for DNA. Two of these proteins bound denatured DNA and RNA in preference to double stranded DNA; the third was unable to distinguish them. © 1970 Nature Publishing Group.",,"hapten; immunoglobulin; nucleic acid; tumor protein; antibody production; article; binding site; chemical model; DNA denaturation; immunology; multiple myeloma; pH; Antibody Formation; Binding Sites; Gamma-Globulins; Haptens; Hydrogen-Ion Concentration; Models, Chemical; Multiple Myeloma; Neoplasm Proteins; Nucleic Acid Denaturation; Nucleic Acids",,"immunoglobulin, 9007-83-4; Gamma-Globulins; Haptens; Neoplasm Proteins; Nucleic Acids",,,,,"Schubert, D.; Salk Institute for Biological Studies, San Diego, CA",,,,,,,,00280836,,,,"English",,Article,Scopus,2-s2.0-0014938767
"Schubert, D., Cohn, M.","Immunoglobulin biosynthesis. V. Light chain assembly",1970,"Journal of Molecular Biology","53","3",,"305","320",,8,10.1016/0022-2836(70)90067-7,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0014945486&partnerID=40&md5=b3e8e52d0ba1a22d9fe2c72b0620992d","The Salk Institute for Biological Studies San Diego, CA, United States","Schubert, D., The Salk Institute for Biological Studies San Diego, CA, United States; Cohn, M., The Salk Institute for Biological Studies San Diego, CA, United States","A protein one-half the size of and antigenically related to light chain was found in immunoglobulin and light chain producing myelomas. The kinetics of its turnover are not consistent with its being a degradation product of light chain. The possibility that this immunoglobulin fragment is a synthetic intermediate in light chain biosynthesis is analyzed and discussed in the context of other data on light chain biosynthesis. © 1969.",,"antiserum; carbon; cycloheximide; immunoglobulin; immunoglobulin G; leucine; tritium; animal; article; biosynthesis; cell line; gel; gel electrophoresis; kinetics; metabolism; molecular weight; mouse; multiple myeloma; rabbit; ribosome; tissue culture; Animal; Carbon Isotopes; Cell Line; Cycloheximide; Electrophoresis, Disc; Gels; Immune Sera; Immunoglobulin G; Immunoglobulins; Kinetics; Leucine; Mice; Molecular Weight; Multiple Myeloma; Rabbits; Ribosomes; Tissue Culture; Tritium",,"carbon, 7440-44-0; cycloheximide, 642-81-9, 66-81-9; immunoglobulin G, 97794-27-9; immunoglobulin, 9007-83-4; leucine, 61-90-5, 7005-03-0; tritium, 10028-17-8; Carbon Isotopes; Cycloheximide, 66-81-9; Gels; Immune Sera; Immunoglobulin G; Immunoglobulins; Leucine, 61-90-5; Tritium, 10028-17-8",,,,"Becker, Rich, (1966) Nature, 212, p. 142; Cioli, Baglioni, (1967) γ-Globulins, Nobel Symposium no. 3, p. 401. , J. Killander; Cohn, (1968) Rutgers Symposium on Nucleic Acids in Immunology, p. 671. , O.J. Plescia, W. Braun, Springer-Verlag, New York, N.Y; Cohn, Notani, Rice, (1969) Immunochemistry, 6, p. 111; Feldman, Yagil, (1969) Biochem. Biophys. Res. Comm, 37, p. 198; Fleischman, Synthesis of the Rabbit  G Heavy Chain (1967) Cold Spring Harbor Symposia on Quantitative Biology, 32, p. 233; Frangione, Milstein, (1969) Nature, 224, p. 597; Kimmel, (1969) Biochim. biophys. Acta, 182, p. 361; Kleinkauf, Gevers, Lipmann, (1969) Proc. Nat. Acad. Sci., Wash, 62, p. 226; Koshland, Davis, Fujita, (1969) Proc. Nat. Acad. Sci., Wash, 63, p. 1274; Kuff, Roberts, (1967) J. Mol. Biol, 26, p. 211; La Via, Vatter, Hammond, Northup, (1967) Proc. Nat. Acad. Sci., Wash, 57, p. 79; Lennox, Knopf, Munro, Parkhouse, A Search for Biosynthetic Subunits of Light and Heavy Chains of Immunoglobulins (1967) Cold Spring Harbor Symposia on Quantitative Biology, 32, p. 249; Matsuoka, Yagi, Moore, Pressman, (1969) J. Immunol, 103, p. 962; Schubert, (1968) Proc. Nat. Acad. Sci., Wash, 60, p. 683; Schubert, (1970) J. Mol. Biol, 51, p. 287; Schubert, Cohn, (1968) J. Mol. Biol, 38, p. 273; Schubert, Horibata, (1968) J. Mol. Biol, 38, p. 263; Schubert, Jobe, Cohn, (1968) Nature, 220, p. 882; Schubert, Munro, Ohno, (1968) J. Mol. Biol, 38, p. 253; Shapiro, Scharff, Maizel, Uhr, (1966) Proc. Nat. Acad. Sci., Wash, 56, p. 216; Shapiro, Vinuela, Maizel, (1967) Biochem. Biophys. Res. Comm, 28, p. 815; Solomon, McLaughlin, (1969) J. Biol. Chem, 244, p. 3393; Terry, Ohms, (1970) Proc. Nat. Acad. Sci., Wash, 66, p. 558; Warner, Knopf, Rich, (1963) Proc. Nat. Acad. Sci., Wash, 49, p. 122; Williamson, Askonas, (1967) J. Mol. Biol, 23, p. 201","Schubert, D.; The Salk Institute for Biological Studies San Diego, CA, United States",,,,,,,,00222836,,JMOBA,5531212,"English","J. Mol. Biol.",Article,Scopus,2-s2.0-0014945486
"Schubert, D., Jacob, F.","5-bromodeoxyuridine-induced differentiation of a neuroblastoma.",1970,"Proceedings of the National Academy of Sciences of the United States of America","67","1",,"247","254",,100,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0014854271&partnerID=40&md5=a977e1db00acf052e1d6dd719ebea8c3",,"Schubert, D.; Jacob, F.",[No abstract available],,"broxuridine; carbon; colchicine; cycloheximide; cytarabine; dactinomycin; DNA; leucine; mitomycin; puromycin; thymidine; tritium; animal; article; biosynthesis; cell differentiation; cell division; cell line; drug effect; metabolism; mouse; nerve cell; neuroblastoma; phenotype; tissue culture; Animal; Bromodeoxyuridine; Carbon Isotopes; Cell Differentiation; Cell Division; Cell Line; Colchicine; Cycloheximide; Cytarabine; Dactinomycin; DNA; Leucine; Mice; Mitomycins; Neuroblastoma; Neurons; Phenotype; Puromycin; Thymidine; Tissue Culture; Tritium",,"broxuridine, 59-14-3; carbon, 7440-44-0; colchicine, 64-86-8; cycloheximide, 642-81-9, 66-81-9; cytarabine, 147-94-4, 69-74-9; dactinomycin, 1402-38-6, 1402-58-0, 50-76-0; DNA, 9007-49-2; leucine, 61-90-5, 7005-03-0; mitomycin, 1404-00-8; puromycin, 53-79-2, 58-58-2; thymidine, 50-89-5; tritium, 10028-17-8; Bromodeoxyuridine, 59-14-3; Carbon Isotopes; Colchicine, 64-86-8; Cycloheximide, 66-81-9; Cytarabine, 147-94-4; Dactinomycin, 50-76-0; DNA, 9007-49-2; Leucine, 61-90-5; Mitomycins; Puromycin, 53-79-2; Thymidine, 50-89-5; Tritium, 10028-17-8",,,,,"Schubert, D.",,,,,,,,00278424,,,5272316,"English","Proc Natl Acad Sci U S A",Article,Scopus,2-s2.0-0014854271
"Schubert, D.","Immunoglobulin biosynthesis. IV. Carbohydrate attachment to immunoglobulin subunits",1970,"Journal of Molecular Biology","51","2",,"287","301",,32,10.1016/0022-2836(70)90143-9,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0014966122&partnerID=40&md5=553f252115324ebd770ec7170246db43","The Salk Institute for Biological Studies San Diego, CA, United States","Schubert, D., The Salk Institute for Biological Studies San Diego, CA, United States","There are two forms of heavy chain in IgA and IgM immunoglobulin producing mouse myelomas. One form, which contains carbohydrate, was found both intra-cellularly and in secreted immunoglobulin, while the other, devoid of carbohydrate, was found exclusively inside the cell. Detectable carbohydrate was attached to heavy chains at least two minutes after their release from ribosomes; no carbohydrate was found on light chains. Similarly, no carbohydrate was detected on nascent ribosome-bound heavy chains. The role of carbohydrate is discussed with respect to the mechanism of immunoglobulin secretion. © 1970.",,"carbon; glucosamine; glucose; immunoglobulin; immunoglobulin G; immunoglobulin M; leucine; tritium; animal; article; biosynthesis; cell line; experimental neoplasm; gel chromatography; gel electrophoresis; metabolism; molecular weight; mouse; multiple myeloma; protein binding; protein electrophoresis; rabbit; Animal; Blood Protein Electrophoresis; Carbon Isotopes; Cell Line; Chromatography, Gel; Electrophoresis, Disc; Glucosamine; Glucose; Immunoglobulin G; Immunoglobulin M; Immunoglobulins; Leucine; Mice; Molecular Weight; Multiple Myeloma; Neoplasms, Experimental; Protein Binding; Rabbits; Tritium",,"carbon, 7440-44-0; glucosamine, 3416-24-8, 4607-22-1; glucose, 50-99-7, 84778-64-3; immunoglobulin G, 97794-27-9; immunoglobulin M, 9007-85-6; immunoglobulin, 9007-83-4; leucine, 61-90-5, 7005-03-0; tritium, 10028-17-8; Carbon Isotopes; Glucosamine, 3416-24-8; Glucose, 50-99-7; Immunoglobulin G; Immunoglobulin M; Immunoglobulins; Leucine, 61-90-5; Tritium, 10028-17-8",,,,"Abel, Grey, (1968) Biochemistry, 7, p. 2682; Abel, Spiegelberg, Grey, (1968) Biochemistry, 7, p. 1271; Andrews, (1965) Biochem. J, 96, p. 595; Becker, Rich, (1966) Nature, 212, p. 142; Cohn, Natural History of the Myeloma (1967) Cold Spring Harbor Symposia on Quantitative Biology, 32, p. 211; Davie, Osterland, CHEMICAL CHARACTERIZATION OF GLYCOPEPTIDES FROM HUMAN gammaM-GLOBULINS (1968) Journal of Experimental Medicine, 128, p. 699; Dawson, Clamp, Investigations on the oligosaccharide units of an A myeloma globulin. (1968) Biochem J, 107, p. 341; Deutsch, (1967) Nobel Symposium III, p. 153. , J. Killander, Almqvist & Wiksell, Stockholm; Ein, Buell, Fahey, (1969) J. Clin. Invest, 48, p. 785; Eisen, Simms, Potter, (1968) Biochemistry, 7, p. 4126; Fleischman, Pain, Porter, Reduction of gamma-globulins. (1962) Arch Biochem Biophys, p. 174; Franklin, (1964) J. Exptl Med, 120, p. 691; Franklin, Lowenstein, Bigelow, Meltzer, Heavy chain disease—A new disorder of serum γ-globulins (1964) The American Journal of Medicine, 37, p. 332; Horibata, Harris, Mouse myelomas and lymphomas in culture. (1970) Exp Cell Res, , in the press; Leduc, Avrameas, Bouteille, ULTRASTRUCTURAL LOCALIZATION OF ANTIBODY IN DIFFERENTIATING PLASMA CELLS (1967) Journal of Experimental Medicine, 127, p. 109; Neher, Siegel, Ultrastructure of Antibody Release from Plaque Forming Cells (1968) Vox Sanguinis, 14, p. 63; Palade, Siekevitz, (1956) J. Biophys. Biochem. Cytol, 2, p. 671; dePetris, Karlsbad, Pernis, LOCALIZATION OF ANTIBODIES IN PLASMA CELLS BY ELECTRON MICROSCOPY (1963) Journal of Experimental Medicine, 117, p. 849; Potter, (1967) Methods in Cancer Research II, p. 105. , H. Busch, Academic Press, New York; Redman, Sabatini, (1966) Proc. Nat. Acad. Sci., Wash, 56, p. 608; Redman, Siekevitz, Palade, (1966) J. Biol. Chem, 241, p. 1150; Rifkind, Osserman, Hsu, Morgan, THE INTRACELLULAR DISTRIBUTION OF GAMMA GLOBULIN IN A MOUSE PLASMA CELL TUMOR (X5563) AS REVEALED BY FLUORESCENCE AND ELECTRON MICROSCOPY (1962) Journal of Experimental Medicine, 116, p. 423; Rotman, Papermaster, (1966) Proc. Nat. Acad. Sci., Wash, 55, p. 134; Schubert, Cohn, (1968) J. Mol. Biol, 38, p. 273; Schubert, D. & Cohn, M. (1970). In preparationSchubert, Horibata, (1968) J. Mol. Biol, 38, p. 263; Schubert, Jobe, Cohn, (1968) Nature, 220, p. 882; Schubert, Munro, Ohno, (1968) J. Mol. Biol, 38, p. 253; Seki, Appella, Itano, Chain models of 6.6S and 3.9S mouse myeloma gamma A immunoglobulin molecules. (1968) Proceedings of the National Academy of Sciences, 61, p. 1072; Seligmann, Danon, Hurez, Mihaesco, Preud'homme, (1968) Science, 162, p. 1396; Shapiro, Vinuela, Maizel, (1967) Biochem. Biophys. Res. Comm, 28, p. 815; Small, Kehn, Lamm, (1963) Science, 142, p. 393; Swensen, Kern, THE SYNTHESIS AND SECRETION OF  -GLOBULINS BY LYMPH NODE CELLS, I. THE MICROSOMAL COMPARTMENTALIZATION OF  -GLOBULINS (1967) Proceedings of the National Academy of Sciences, 57, p. 417; Vogt, Dulbecco, (1963) Proc. Nat. Acad. Sci., Wash, 49, p. 171","Schubert, D.; The Salk Institute for Biological Studies San Diego, CA, United States",,,,,,,,00222836,,JMOBA,5530394,"English","J. Mol. Biol.",Article,Scopus,2-s2.0-0014966122
"Schubert, D., Humphreys, S., Baroni, C., Cohn, M.","In vitro differentiation of a mouse neuroblastoma.",1969,"Proceedings of the National Academy of Sciences of the United States of America","64","1",,"316","323",,123,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0014565011&partnerID=40&md5=ee5a6780c2881289affa4841aec47dd9",,"Schubert, D.; Humphreys, S.; Baroni, C.; Cohn, M.",[No abstract available],,"mixed function oxidase; tyrosine; animal; article; cell differentiation; cell line; cytology; electron microscopy; enzymology; experimental neoplasm; mouse; nerve cell; neuroblastoma; pathology; phase contrast microscopy; staining; tissue culture; Animal; Cell Differentiation; Cell Line; Mice; Microscopy, Electron; Microscopy, Phase-Contrast; Mixed Function Oxygenases; Neoplasms, Experimental; Neuroblastoma; Neurons; Staining and Labeling; Tissue Culture; Tyrosine",,"mixed function oxidase, 9040-60-2; tyrosine, 16870-43-2, 55520-40-6, 60-18-4; Mixed Function Oxygenases, EC 1.-; Tyrosine, 55520-40-6",,,,,"Schubert, D.",,,,,,,,00278424,,,4189500,"English","Proc Natl Acad Sci U S A",Article,Scopus,2-s2.0-0014565011
"Schubert, D., Cohn, M.","Immunoglobulin biosynthesis. III. Blocks in defective synthesis",1968,"Journal of Molecular Biology","38","3",,"273","288",,17,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0014370636&partnerID=40&md5=e40762c4bc4ac923c6ea1521b5756083","The Salk Institute for Biological Studies San Diego, CA, United States","Schubert, D., The Salk Institute for Biological Studies San Diego, CA, United States; Cohn, M., The Salk Institute for Biological Studies San Diego, CA, United States","Mouse myeloma mutants derived from ADJPC5, MOPC104 and X5563 were compared with their wild types with respect to heavy and light chain synthesis and immunoglobulin assembly. It was shown that two mutants which secrete only light chain synthesize a heavy chain. There was a block in the dimerization of heavy and light chain which produces the LH intermediate in IgG and IgM immunoglobulin-producing plasma cell tumors. Neither heavy nor light chain synthesis was detected in the third mutant, which secreted no unique protein. Immunoglobulin biosynthesis, control, and secretion are discussed in relation to these mutants. © 1968.",,"immunoglobulin; leucine; protein; ribonuclease; tritium; animal; article; biosynthesis; density gradient centrifugation; experimental neoplasm; gel electrophoresis; metabolism; mouse; multiple myeloma; mutation; precipitation; ribosome; spectrophotometry; Animal; Centrifugation, Density Gradient; Electrophoresis, Disc; Gamma-Globulins; Leucine; Mice; Multiple Myeloma; Mutation; Neoplasms, Experimental; Precipitation; Proteins; Ribonucleases; Ribosomes; Spectrophotometry; Tritium",,"immunoglobulin, 9007-83-4; leucine, 61-90-5, 7005-03-0; protein, 67254-75-5; ribonuclease, 59794-03-5, 9001-99-4; tritium, 10028-17-8; Gamma-Globulins; Leucine, 61-90-5; Proteins; Ribonucleases, EC 3.1.-; Tritium, 10028-17-8",,,,,"Schubert, D.; The Salk Institute for Biological Studies San Diego, CA, United States",,,,,,,,00222836,,JMOBA,,"English","J. Mol. Biol.",Article,Scopus,2-s2.0-0014370636
"Schubert, D., Munro, A., Ohno, S.","Immunoglobulin biosynthesis. I. A myeloma variant secreting light chain only",1968,"Journal of Molecular Biology","38","3",,"253","262",,9,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0014368252&partnerID=40&md5=e6695b9a583bf24d793860c21c98f5b6","The Salk Institute for Biological Studies San Diego, CA, United States; City of Hope Duarte, CA, United States","Schubert, D., The Salk Institute for Biological Studies San Diego, CA, United States, City of Hope Duarte, CA, United States; Munro, A., The Salk Institute for Biological Studies San Diego, CA, United States, City of Hope Duarte, CA, United States; Ohno, S., The Salk Institute for Biological Studies San Diego, CA, United States, City of Hope Duarte, CA, United States","A mutant mouse myeloma cell line was derived from ADJPC5, which secretes an IgG2a immunoglobulin. The variant had lost the ability to synthesize immunoglobulin, but continued to secrete light chain. This light chain, and the light chain from ADJPC5 immunoglobulin, were indistinguishable as defined by peptide mapping of the secreted serum, and urinary proteins. Karyotype analysis showed that the mutant was derived from one of the 14 stem-lines observed in the wildtype myeloma. There was no detectable internal immunoglobulin in the variant, ruling out a block in secretion. It was also shown that the differential rate of light chain secretion was identical in ADJPC5 and its derivative. © 1968.",,"antiserum; carbon; immunoglobulin; leucine; peptide; tritium; trypsin; animal; article; biosynthesis; electrophoresis; experimental neoplasm; gel chromatography; ion exchange chromatography; karyotyping; kinetics; metabolism; mouse; multiple myeloma; proteinuria; time; Animal; Carbon Isotopes; Chromatography, Gel; Chromatography, Ion Exchange; Electrophoresis; Gamma-Globulins; Immune Sera; Karyotyping; Kinetics; Leucine; Mice; Multiple Myeloma; Neoplasms, Experimental; Peptides; Proteinuria; Time Factors; Tritium; Trypsin",,"carbon, 7440-44-0; immunoglobulin, 9007-83-4; leucine, 61-90-5, 7005-03-0; tritium, 10028-17-8; trypsin, 9002-07-7; Carbon Isotopes; Gamma-Globulins; Immune Sera; Leucine, 61-90-5; Peptides; Tritium, 10028-17-8; Trypsin, EC 3.4.21.4",,,,,"Schubert, D.; The Salk Institute for Biological Studies San Diego, CA, United States",,,,,,,,00222836,,JMOBA,4180611,"English","J. Mol. Biol.",Article,Scopus,2-s2.0-0014368252
"Schubert, D., Horibata, K.","Immunoglobulin biosynthesis. II. Four independently isolated myeloma variants",1968,"Journal of Molecular Biology","38","3",,"263","271",,8,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0014370815&partnerID=40&md5=68b2f2ffec07378cec5ce2013828d9b0","The Salk Institute for Biological Studies San Diego, CA, United States","Schubert, D., The Salk Institute for Biological Studies San Diego, CA, United States; Horibata, K., The Salk Institute for Biological Studies San Diego, CA, United States","Four variant mouse myelomas are described which have lost the ability to produce immunoglobulin. These cell lines were compared with the original immunoglobulin-producing lines with respect to their secreted proteins, karyotype, transplantation characteristics, and intracellular immunoglobulin. Karyotype and transplantation data argue in favor of the derivation of the variants from their respective immunoglobulin-producing lines. One variant, that of MOPC104, secreted a light chain which was indistinguishable from the light chain of the wildtype immunoglobulin; the other three variant lines secreted no unique protein. None of the derivatives has demonstrable intracellular immunoglobulin, indicating that they are not blocked at the secretory step. © 1968.",,"antiserum; carbon; immunoglobulin; leucine; peptide; protein; tritium; allotransplantation; animal; article; biosynthesis; cancer transplantation; experimental neoplasm; gel chromatography; ion exchange chromatography; karyotyping; metabolism; mouse; multiple myeloma; mutation; paper chromatography; species difference; Animal; Carbon Isotopes; Chromatography, Gel; Chromatography, Ion Exchange; Chromatography, Paper; Gamma-Globulins; Immune Sera; Karyotyping; Leucine; Mice; Multiple Myeloma; Mutation; Neoplasm Transplantation; Neoplasms, Experimental; Peptides; Proteins; Species Specificity; Transplantation, Homologous; Tritium",,"carbon, 7440-44-0; immunoglobulin, 9007-83-4; leucine, 61-90-5, 7005-03-0; protein, 67254-75-5; tritium, 10028-17-8; Carbon Isotopes; Gamma-Globulins; Immune Sera; Leucine, 61-90-5; Peptides; Proteins; Tritium, 10028-17-8",,,,,"Schubert, D.; The Salk Institute for Biological Studies San Diego, CA, United States",,,,,,,,00222836,,JMOBA,4180612,"English","J. Mol. Biol.",Article,Scopus,2-s2.0-0014370815
"Schubert, D., Jobe, A., Cohn, M.","Mouse myelomas producing precipitating antibody to nucleic acid bases and/or nitrophenyl derivatives",1968,"Nature","220","5170",,"882","885",,33,10.1038/220882a0,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0014435525&partnerID=40&md5=143ae549dd30aa13f8baa68e6269ff26","Salk Institute for Biological Studies, San Diego, CA, United States","Schubert, D., Salk Institute for Biological Studies, San Diego, CA, United States; Jobe, A., Salk Institute for Biological Studies, San Diego, CA, United States; Cohn, M., Salk Institute for Biological Studies, San Diego, CA, United States","About 10 per cent of mouse myeloma proteins have antibody activity directed against various combinations of purine, 5-acetyl uracil, dinitrophenyl and trinitrophenyl groups. © 1968 Nature Publishing Group.",,"2,4 dinitrophenol; aminocaproic acid derivative; antibody; autoantibody; bovine serum albumin; hapten; immunoglobulin; purine derivative; pyrimidine derivative; tumor protein; uracil; animal; antigen antibody reaction; article; immunology; mouse; multiple myeloma; precipitation; Aminocaproic Acids; Animal; Antibodies; Antigen-Antibody Reactions; Autoantibodies; Dinitrophenols; Gamma-Globulins; Haptens; Mice; Multiple Myeloma; Neoplasm Proteins; Precipitation; Purines; Pyrimidines; Serum Albumin, Bovine; Uracil",,"2,4 dinitrophenol, 25550-58-7, 51-28-5; immunoglobulin, 9007-83-4; uracil, 66-22-8; Aminocaproic Acids; Antibodies; Autoantibodies; Dinitrophenols; Gamma-Globulins; Haptens; Neoplasm Proteins; Purines; Pyrimidines; Serum Albumin, Bovine; Uracil, 66-22-8",,,,,"Schubert, D.; Salk Institute for Biological Studies, San Diego, CA, United States",,,,,,,,00280836,,,,"English",,Article,Scopus,2-s2.0-0014435525
"Schubert, D.","Immunoglobulin assembly in a mouse myeloma.",1968,"Proceedings of the National Academy of Sciences of the United States of America","60","2",,"683","690",,22,,"http://www.scopus.com/inward/record.url?eid=2-s2.0-0014291946&partnerID=40&md5=9152eb15294e072f66c4b40091cb45d0",,"Schubert, D.",[No abstract available],,"immunoglobulin; leucine; tritium; animal; antigen antibody reaction; article; biosynthesis; cell clone; density gradient centrifugation; electrophoresis; in vitro study; metabolism; mouse; multiple myeloma; precipitation; rabbit; ribosome; Animal; Antigen-Antibody Reactions; Centrifugation, Density Gradient; Clone Cells; Electrophoresis; Gamma-Globulins; In Vitro; Leucine; Mice; Multiple Myeloma; Precipitation; Rabbits; Ribosomes; Tritium",,"immunoglobulin, 9007-83-4; leucine, 61-90-5, 7005-03-0; tritium, 10028-17-8; Gamma-Globulins; Leucine, 61-90-5; Tritium, 10028-17-8",,,,,"Schubert, D.",,,,,,,,00278424,,,4178281,"English","Proc Natl Acad Sci U S A",Article,Scopus,2-s2.0-0014291946
